<SEC-DOCUMENT>0001872789-23-000031.txt : 20231129
<SEC-HEADER>0001872789-23-000031.hdr.sgml : 20231129
<ACCEPTANCE-DATETIME>20231129163146
ACCESSION NUMBER:		0001872789-23-000031
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		111
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231129
DATE AS OF CHANGE:		20231129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Embecta Corp.
		CENTRAL INDEX KEY:			0001872789
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				871583942
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41186
		FILM NUMBER:		231452693

	BUSINESS ADDRESS:	
		STREET 1:		1209 ORANGE STREET
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801
		BUSINESS PHONE:		8624010000

	MAIL ADDRESS:	
		STREET 1:		1209 ORANGE STREET
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Berra Newco, Inc.
		DATE OF NAME CHANGE:	20210714
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>embc-20230930.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:4102c7ef-a746-4e09-abe6-45c91f406b23,g:4bb25894-924e-4e32-9a1d-8a6b6ed5cbfa,d:209d71ebb5944f1aadd70761506c49b3--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:embc="http://www.embecta.com/20230930" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>embc-20230930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-32">0001872789</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-33">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-34">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-35">false</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="f-38">http://fasb.org/us-gaap/2023#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="f-39">http://fasb.org/us-gaap/2023#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="f-40">http://fasb.org/us-gaap/2023#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="f-44">http://fasb.org/us-gaap/2023#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="f-45">http://fasb.org/us-gaap/2023#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="f-46">http://fasb.org/us-gaap/2023#ProductMember</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-36" decimals="INF" name="embc:CommonStockShareIssuanceRatio" scale="0" id="f-342">0.2</ix:nonFraction><ix:nonNumeric contextRef="c-37" name="embc:HostingArrangementServiceContractAssetsInServiceUsefulLife" id="f-353">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-86" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-502">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-92" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-510">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-86" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-583">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-119" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-620">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="c-90" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-621">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-91" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-622">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-929">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-930">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-945">http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="f-946">http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-951">http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-952">http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-955">http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-956">http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="embc-20230930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">embc:PropertyPlantAndEquipmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">embc:PropertyPlantAndEquipmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">embc:DeferredIncomeTaxesAndOtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>embc:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>embc:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:NonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:NonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A675SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:ShareBasedPaymentArrangementLiabilityAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:ShareBasedPaymentArrangementLiabilityAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:ShareBasedPaymentArrangementLiabilityAwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceStockUnitsPSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">embc:CustomerRelationshipAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">embc:CustomerRelationshipAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">embc:CustomerRelationshipAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A500SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A675SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A675SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredTermLoanBMaturingMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredTermLoanBMaturingMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredTermLoanBMaturingMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredRevolvingCreditFacilityMaturing2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredRevolvingCreditFacilityMaturing2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-31</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredRevolvingCreditFacilityMaturing2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredTermLoanBMaturingMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A500SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A675SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">embc:CustomerOneCustomerTwoAndCustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">embc:CustomerOneCustomerTwoAndCustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">embc:CustomerOneAndCustomerTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">embc:BuildingLeaseSixYearExtensionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">embc:BuildingLeaseFourYearExtensionOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:NonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:NonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">embc:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">embc:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001872789</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-28</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-49 f-48 f-47" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i209d71ebb5944f1aadd70761506c49b3_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">September&#160;30</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="padding-left:27pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _&#160;to _</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-41186</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="embc-20230930_g1.jpg" alt="embecta_rgb_sm.jpg" style="height:67px;margin-bottom:5pt;vertical-align:text-bottom;width:164px"/></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">EMBECTA CORP.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="padding-left:0.72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">87-1583942</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(I.R.S. employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">identification no.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">300 Kimball Drive, Suite 300</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Parsippany</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">07054</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Zip code)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">862</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">401-0000</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.295%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Trading</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Name of each exchange</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">EMBC</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">The Nasdaq Stock Market LLC</ix:nonNumeric> (Nasdaq Global Select Market)</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(g) of the Act: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">None</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">Yes</ix:nonNumeric> &#9746; No &#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Yes &#9744; <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric> &#9746;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;No&#160;&#160;&#9744;&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accelerated filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-accelerated filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Smaller reporting company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.                        Yes <ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-26">&#9746;</ix:nonNumeric>    No  &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-27">&#9744;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). &#160;&#160;&#160;&#160;Yes&#160;&#9744;&#160;&#160;&#160;No&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-28">&#9746;</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The aggregate market value of the voting common equity held by non-affiliates of the registrant, computed by reference to the closing price at which the common stock was sold as of the end of the second fiscal quarter ended March 31, 2023, was approximately $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="f-29">1.6</ix:nonFraction>&#160;billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The registrant had outstanding <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-30">57,334,621</ix:nonFraction> shares of common stock as of November&#160;20, 2023.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-31" escape="true">The information required by Items 10, 11, 12, 13 and 14 of  Part III of this Annual Report on Form 10-K is incorporated by reference to the Registrant&#8217;s definitive proxy statement for its 2024 Annual Meeting of Stockholders (the &#8220;2024 Proxy Statement&#8221;), which will be filed pursuant to Regulation 14A with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) within 120 days after the end of the fiscal year to which this report relates.</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Embecta Corp. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Form 10-K Annual Report</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Page</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_13">Part I.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 1.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_16">Business.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 1A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_25">Risk Factors.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 1B.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_28">Unresolved Staff Comments.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_28">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 2.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_31">Properties.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_31">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 3.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_34">Legal Proceedings. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_34">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 4.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_37">Mine Safety Disclosures. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_37">29</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_40">Part II.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 5.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_43">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_43">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 6.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_49">[ Reserved ].</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_49">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 7.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_52">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_52">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 7A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_103">Quantitative and Qualitative Disclosures About Market Risk.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_103">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 8.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_106">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_106">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 9.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_229">Changes in and Disagreements With Accountants on Accounting and Financial Disclosures.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_229">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 9A.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_232">Controls and Procedures.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_232">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 9B.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_235">Other Information. </a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 9C.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_238">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_241">Part III.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_241">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 10.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_244">Directors, Executive Officers and Corporate Governance.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_244">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 11.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_247">Executive Compensation.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_247">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 12.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_250">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_250">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 13.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_253">Certain Relationships and Related Transactions, and Director Independence.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_253">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 14.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_256">Principal Accountant Fees and Services.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_256">78</a></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_259">Part IV.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_259">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 15.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_262">Exhibits and Financial Statement Schedules.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_262">79</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Item 16.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_265">Form 10-K Summary.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_265">81</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i209d71ebb5944f1aadd70761506c49b3_268">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i209d71ebb5944f1aadd70761506c49b3_268">82</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_16"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 1. Business.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_859"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">General</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta Corp. (also referred to herein as "Embecta") was formed through a spin-off of the diabetes care business (the "Separation") from Becton, Dickinson and Company ("BD"). All references in this Form 10-K to "Embecta", "the Company", "we", "our" or "us" refer to Embecta Corp., a Delaware corporation, and its subsidiaries, unless otherwise indicated by the context. </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022 (the "Separation Date"), Embecta and BD entered into a Separation and Distribution Agreement (the "Separation and Distribution Agreement"). Pursuant to the Separation and Distribution Agreement, BD agreed to spin off its diabetes care business ("Diabetes Care Business") into Embecta, a new, publicly traded company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are a leading global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. As we approach our 100-year centennial, we believe that our products have become one of the most widely recognized and respected brands in diabetes management throughout the world. We estimate that our products are used by more than 30 million people in over 100 countries for insulin administration and to aid with the daily management of diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have a broad portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices, which are complemented by our proprietary digital application designed to assist people with managing their diabetes. Our conventional pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. We also sell safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Our conventional and safety pen needles are compatible and frequently used with widely available pen injectors in the market today. In addition to pen needles, we sell sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. We also sell safety insulin syringes, which have a sliding safety arm that can be activated with one-hand after the injection to help prevent needlestick exposure and injury during injection and disposal.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to selling pen needles, syringes and safety devices, we seek to promote advances in diabetes care through thought leadership, and engagement with the diabetes community, healthcare providers and other stakeholders. To foster connection with and offer support to people with diabetes, we launched our diabetes care app in 2018, which has been downloaded more than 600,000 times. The diabetes care app serves as a channel for our support, education of and engagement with the diabetes community. In addition, we intend to continue to explore strategic collaborative partnerships and acquisition opportunities that enable us to accelerate our growth. We intend to selectively pursue strategic collaborative opportunities that give us access to innovative technologies, complementary product lines, and new markets.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_786"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Global Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our global manufacturing and distribution network, together with our commercial team, enable us to produce and distribute our products to end users and healthcare providers in over 100 countries. We have three manufacturing sites located in Ireland, the United States and China. We believe that these manufacturing sites enable us to efficiently and consistently produce high-quality, safe and reliable products. We distribute our products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels. Our commercial team and distribution networks enable us to reach a broad base of customers across the globe.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_795"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Raw Materials and Components</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We use a broad range of raw materials in the manufacture of our products. We purchase all our raw materials and certain components from third-party suppliers. The primary materials that make up our pen needles and insulin syringes are cannula, plastic resin, adhesive, needle lubricants, rubber stoppers and packaging material. We purchase most of these and other materials from a single or limited number of sources for various reasons, including quality assurance, cost-effectiveness, and continuity of supply, among others.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, we entered into a cannula supply agreement with BD, whereby BD sells to us cannulas for incorporation into our pen needles and syringes. Subsequent to the Separation, BD retained ownership of all cannula production activities and the associated intellectual property rights of BD and its subsidiaries relating to cannula, the manufacture thereof and other critical cannula-related technology.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The design and formulation of certain materials and components is proprietary and the intellectual property rights may be owned exclusively by one party. In the case of sole sourced parts, we manage risk through holding inventory ourselves and at our suppliers' facilities to ensure continuity of supply and lower the risk of disruption.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_803"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Research and Development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our strategy seeks to update and develop enhanced technology for our portfolio of current and future products by focusing on patient unmet needs and market expansion. As we develop these products we intend to apply for clearance from the United States Food and Drug Administration (the &#8220;FDA&#8221;) and similar regulatory authorities in jurisdictions outside of the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For example, we are currently working on developing an insulin patch pump focused on serving the needs of people living with Type 2 diabetes. We anticipate this insulin patch pump will have an increased reservoir size to hold more insulin and a simplified user interface compared to existing insulin patch pumps, and overall provide for an improved user experience. </span></div><div id="i209d71ebb5944f1aadd70761506c49b3_811"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Intellectual Property and Licenses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intellectual property is a strategic priority for our business. We use a combination of patents, copyrights, trademarks, trade secrets, nondisclosure agreements and other measures to establish and protect our proprietary rights. In many cases, we own this intellectual property directly, but in other cases, we access technologies through a combination of license and supply arrangements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While no single patent or patent family is material to our business, our pen needle and syringe products contain features that are protected by a portfolio of utility and design patents, including features related to safety, comfort and ease of use. In addition, potential features of our insulin patch pump technology currently under development and software we market to end users for managing diabetes are covered by a variety of patents and patent applications. Generally, patent protection for these products and technologies is sought in the United States, Canada, Europe, China and Japan. We are not aware of any pending third-party claims or challenges that would be expected to materially affect the patent protection of these products or technologies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2023, we held about 750 patents in the United States and in various foreign countries in which we conduct business, as well as about 130 patents pending. The majority of our United States and foreign patents for individual products are in force for twenty years from the initial filing date. The actual protection afforded by a patent, which can vary from country to country, depends upon the type of patent, the scope of its coverage and the availability of legal remedies in the country.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our products and services are sold around the world under various trade names, trademarks and brand names, which we consider to be valuable in the marketing of our products in each segment. As of September 30, 2023, we had about 250 trademark registrations in the United States and in various foreign countries in which we conduct business, as well as about 200 trademark applications pending worldwide.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta owns, and BD provides Embecta a license to use, intellectual property rights necessary to operate our business. BD grants Embecta a license to use such intellectual property rights on the terms and conditions set forth in an intellectual property matters agreement, which are described under &#8220;Agreements Related to the Separation.&#8221;</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_819"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Competition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The diabetes care industry is highly competitive, subject to rapid change and significantly affected by new product introductions and innovation. Our products compete across a continuum of therapies and administration modalities designed to manage diabetes. We face competition and innovation from both new and existing companies pursuing new delivery devices, injection technologies, drugs, and therapeutics for the treatment of diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Companies with whom we currently compete in the diabetes drug injection business include Novo Nordisk, HTL-Strefa, Terumo Medical Corporation, and Ypsomed. We also compete with providers of insulin pumps and other insulin administration devices. We compete in the marketplace based on a number of factors, including product quality, clinical innovation, price, service, reputation and commercial excellence.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_827"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Regulation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Changes in legislation or government policies, including with respect to licensing, health information privacy and data privacy and healthcare costs, reimbursement, coverage and access, can have a material impact on our worldwide operations. Our operations are subject to, and affected by, regulations of medical devices promulgated by federal, state and local authorities in the United States, including the FDA, and other regulatory authorities with jurisdiction over our foreign operations. FDA regulations govern, among other things, product design and development, preclinical and clinical testing, pre-market clearance and approval, manufacturing, labeling, product storage, advertising and promotion, sales and distribution, post-market adverse event reporting, postmarket surveillance, complaint handling, repair or recall of products and record keeping. These regulations not only affect products in our existing markets, but also our ability to market new products under development. For existing and potential new products, failure to comply with ongoing regulatory requirements can result in enforcement actions by the FDA and other regulatory agencies, which may include warning letters that require corrective action, fines, injunctions, rescissions of previously granted clearances and/or approvals and other penalties.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We maintain robust FDA Quality System Regulation and ISO Quality Systems that establish standards for our product design, manufacturing, and distribution processes, inclusive of Current Good Manufacturing Practices. The FDA and other regulatory agencies engage in periodic reviews and inspections of our quality systems, as well as product performance and advertising and promotional materials. As a medical device manufacturer and distributor, our manufacturing facilities and the facilities of our suppliers are subject to periodic inspection by the FDA, certain corresponding state agencies, and other regulatory bodies. Prior to marketing or selling most of our products, we must secure clearance or approval from the FDA and counterpart non-United States regulatory agencies. These regulatory controls, as well as any changes in agency policies, can affect the time and cost associated with the development, introduction and continued availability of new and existing products. Where possible, we anticipate these factors in product development and planning processes. These agencies possess the authority to take various administrative and legal actions against us, such as product recalls, product seizures and other civil and criminal sanctions. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">International sales of our products are subject to foreign government regulations, which may vary substantially from country to country. The time required to obtain clearance or approval by a foreign regulatory authority may be longer or shorter than that required for FDA clearance or approval, and the requirements may differ significantly, particularly outside of the European Union, Canada and other industrialized countries. In addition, other jurisdictions continue to update requirements for marketing and sale of products in their geography, often becoming more stringent. As we operate in other regions and continue to expand into emerging markets, new requirements may require updates to our quality management system. These global changes are monitored and reviewed as part of the overall quality lifecycle. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For further discussion of risks related to government regulations, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8220;Risk Factors&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in Item 1A. </span></div><div id="i209d71ebb5944f1aadd70761506c49b3_835"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Agreements Related to the Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, the Company entered into the Separation and Distribution Agreement, which contains provisions that, among other things, relate to (i) assets, liabilities and contracts to be transferred, assumed and assigned to each of Embecta and BD (including certain deferred assets and liabilities) as part of the Separation, (ii) cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of Embecta's business with Embecta and financial responsibility for the obligations and liabilities of BD&#8217;s remaining businesses with BD, (iii) procedures with respect to claims subject to indemnification and related matters, (iv) the allocation among Embecta and BD of rights and obligations under existing insurance policies with respect to occurrences prior to completion of the Separation, as well as the right to proceeds and the obligation to incur certain deductibles under certain insurance policies, and (v) procedures governing Embecta&#8217;s and BD&#8217;s obligations and allocations of liabilities with respect to ongoing litigation matters that may implicate each of BD&#8217;s business and Embecta&#8217;s business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Agreements that Embecta entered into with BD that govern aspects of Embecta's relationship with BD following the Separation include, but are not limited to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Transition Services Agreements ("TSA") - Pursuant to the TSA, and the related Logistics Services Agreement (&#8220;LSA&#8221;), Embecta and BD and their respective affiliates provide each other, on an interim, transitional basis, various services, including, but not limited to, information technology, procurement, quality and regulatory affairs, medical affairs, tax and treasury services, distribution logistics, and shared services infrastructure support for order-to-cash, source-to-pay, and record-to-report (collectively, the &#8220;Interim Business Continuity Processes&#8221;). The agreed-upon charges for such services are generally intended to allow the servicing party to charge a price comprised of out-of-pocket costs and expenses and a predetermined profit in the form of a mark-up of such out-of-pocket costs and expenses. The service recipient may terminate any services by giving prior written notice to the provider of such services and paying any applicable wind-down charges. Such services provided pursuant to the TSA were to terminate no later than April 1, 2024, 24 months following the Separation, and such services provided pursuant to the LSA were to terminate no later than January 1, 2024, which BD has agreed to extend through March 31, 2024. However, BD has granted a limited extension until November 1, 2024 of certain services under the TSA, LSA and other transaction documents in a limited set of markets (the "Extension") to support the Interim Business Continuity Processes, subject to the condition in the next sentence. The Extension is conditioned upon BD obtaining a supplemental private letter ruling to the private letter ruling that it received in connection with the Separation and the distribution, in form and substance reasonably satisfactory to BD (the "Supplemental PLR").  </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Distribution Agreements - Embecta and BD entered into distribution agreements for certain territories, principally in the Asia Pacific Region and Latin America, whereby a subsidiary of BD has been appointed as a distributor of Embecta or its relevant subsidiaries to support certain commercial operations of the diabetes care business on a transitional basis in these regions for a maximum of two years. The distribution agreements will each continue until either (1) certain governmental approvals needed to distribute products in the defined territory are obtained and order-to-cash processes and other services of the Company for such territory are migrated to an alternative commercial arrangement between the parties or (2) the applicable services are transitioned to a third-party distributor or independently performed by Embecta, but in any event no longer than the maximum term of two </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">years, except certain such agreements may be extended in connection with the Extension. Embecta shall pay BD a return of 1.5% to 2.0% of net revenue for each territory. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Cannula Supply Agreement - Embecta and BD entered into a cannula supply agreement whereby BD sells to Embecta cannulas for incorporation into Embecta's existing syringes and pen needles, safety syringes and safety pen needles, and products currently under development. BD retains ownership of all cannula technology, cannula production activities and the intellectual property rights therein. Embecta is limited to a maximum number of cannulas that it can purchase under the cannula supply agreement, which will be an absolute upper limit of cannulas per year and yearly limits that vary with annual demand. The cannula supply agreement is terminable by Embecta without cause by providing at least 36 months&#8217; written notice; however, such termination can be effective no earlier than five years from the Separation. The cannula supply agreement will be terminable by BD without cause by providing at least 36 months&#8217; written notice; however, such termination can be effective no earlier than ten years from the Separation. However, in the event of a change of control of Embecta, BD has the right to terminate the cannula supply agreement in its sole discretion. The cannula supply agreement will also terminate automatically, subject to a 36-month wind-down period, if Embecta&#8217;s yearly forecast is below the required minimum purchase amount, and the parties have other customary termination rights for material breach or bankruptcy of the other party.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Tax Matters Agreement - Pursuant to the tax matters agreement, Embecta agreed to certain covenants that contain restrictions intended to preserve the tax-free status of the distribution and certain related transactions. Embecta may take certain actions prohibited by these covenants only if Embecta obtains and provides to BD an opinion from a United States tax counsel or accountant of recognized national standing, in either case satisfactory to BD, to the effect that such action would not jeopardize the tax-free status of the distribution and certain related transactions, or if Embecta obtains prior written consent of BD. Embecta is barred from taking any action, or failing to take any action, where such action or failure to act adversely affects or could reasonably be expected to adversely affect the tax-free status of the distribution and certain related transactions or result in certain other taxes to BD, for all relevant time periods. In addition, during the period ending two years after the Separation, these covenants include specific restrictions on Embecta&#8217;s (i) discontinuing the active conduct of Embecta&#8217;s trade or business; (ii) issuance or sale of stock or other securities (including securities convertible into Embecta stock, but excluding certain compensatory arrangements); (iii) liquidating, merging, or consolidating with any other person; (iv) amending Embecta&#8217;s certificate of incorporation (or other organizational documents) or taking any other action, whether through a stockholder vote or otherwise, affecting the voting rights of Embecta common stock; (v) sales of assets outside the ordinary course of business; and (vi) entering into any other corporate transaction which would cause Embecta to undergo a 50% or greater change in its stock ownership.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Logistics Services Agreement - Embecta and BD entered into a logistics services agreement whereby BD provides Embecta with certain order-to-cash and logistics services to support certain commercial operations for a maximum term of two years, which BD has agreed to extend through March 31, 2024. Embecta will pay BD (i) reimbursable costs, including all shipping costs, selling costs, general administration costs, costs of goods, research and development services costs, and other income and expenses related solely to the diabetes care business, that are incurred by BD directly, as allocated costs or as costs payable to a third party and (ii) a monthly administrative fee of 1.0% of net revenue (which will increase to 1.25% of net revenue after January 1, 2024).</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Other agreements that Embecta entered into with BD include, but are not limited to, an employee matters agreement, an intellectual property matters agreement, local support services agreements, certain other manufacturing arrangements and a process services agreement and lease agreement for a manufacturing facility location in Holdrege, Nebraska.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_843"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Human Resources ("HR")</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2023, we had approximately 2,200 regular employees globally (which includes deferred closing countries), with approximately 925 employees in the United States. Our talented employees are an integral reason for our standing as one of the world's leading diabetes care companies. Our success is dependent on our ability to attract, engage and retain the best talent that reflects our diverse communities. To do so, we focus on the most critical areas that help create a great workplace and enable our business priorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At Embecta our mission, vision and values inspire passion and purpose in the day-to-day work of our employees. Our mission of developing and providing solutions to make life better for people living with diabetes helps us attract potential employees interested in making a difference to the world. As a new company, we have the unique opportunity to integrate Environment, Social, Governance ("ESG") as well as Diversity, Equity &amp; Inclusion ("DE&amp;I") principles into the foundation of our HR practices.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We focus on providing a personalized experience from the moment an employee considers joining the Embecta team. In addition to helping make life better for people living with diabetes, our employee value proposition includes a strong rewards package, a focus on development, and engaging with our employees as we shape our new company together.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At Embecta, our Total Rewards programs enable behaviors that drive performance, reward results and create long-term value for our stockholders and employees. We continually monitor our programs and policies to ensure they are competitive and have a clear link to our business and talent strategy. We pay for performance and are committed to compensating employees fairly and equitably. Our employee benefit programs provide flexibility and choice, and enrich the health, well-being and security of our employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are building a learning culture where employees at all levels of the organization are encouraged to grow and improve, including company-wide training on compliance, job related technical training, leadership development, and easy access to virtual on demand learning. At Embecta, long term succession planning and capability building are integral to our talent practices that are aimed at helping our employees be the best versions of themselves while simultaneously building our future talent pipeline. All employees are encouraged to establish individual, team and development goals in partnership with their manager to ensure clarity and alignment to our business goals while retaining focus on growth and development.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In alignment with our continuous improvement culture, we seek feedback through surveys and other means so that employees can share their perspectives on ways to continuously improve our workplace climate. As a newly independent company with agility at its core, employee feedback helps us make adjustments in our ways of working and embedding our values. What we do at Embecta is personal to Embecta employees, and our HR practices are designed to enable our employees in fulfilling our mission of helping people with diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Diversity, Equity &amp; Inclusion</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta engages a workforce that reflects the communities where we operate. Our workforce, including our leadership team, and our board of directors, includes diverse members and teams. Our commitment to DE&amp;I is embedded in our values. We believe that employee diversity makes us better at identifying opportunities and solving problems. We are committed to creating and sustaining an environment where everyone brings their authentic selves to work, to help us fulfill our mission of helping people with diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate Responsibility ("CR") and Environmental, Social and Governance ("ESG")</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta is in the process of developing a standalone multi-year strategy to advance its ESG initiatives. The focus in fiscal year 2023 was to evaluate Embecta&#8217;s global ESG risks and impacts. This evaluation phase commenced with a Sustainability Materiality Assessment and an internal review of the United Nations Sustainable Development Goals. Separately, the governance structures for managing ESG topics and updates were documented via the Company's Enterprise Risk Committee charter. Embecta plans to provide an updated Sustainability Report during its 2024 fiscal year.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_851"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Available Information</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta maintains a website at www.embecta.com. The Company makes available its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K (and amendments to those reports) as soon as reasonably practicable after those reports are electronically filed with, or furnished to, the Securities and Exchange Commission (&#8220;SEC&#8221;). These filings may be obtained and printed free of charge at investors.embecta.com.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the written charters of the Audit Committee; the Compensation and Management Development Committee; the Corporate Governance and Nominating Committee; and the Technology, Quality and Regulatory Committee of the Board of Directors, Embecta&#8217;s Corporate Governance Principles and its Code of Conduct, are available and may be printed free of charge at Embecta&#8217;s website at https://investors.embecta.com/corporate-governance/documents-charters. Printed copies of these materials, this Annual Report on Form 10-K, and Embecta&#8217;s reports and statements filed with, or furnished to, the SEC, may also be obtained, without charge, by contacting the Corporate Secretary, Embecta, 300 Kimball Dr., Suite 300, Parsippany, New Jersey 07054, telephone 862-401-0000. In addition, the SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta also routinely posts important information for investors on its website at investors.embecta.com. Embecta may use this website as a means of disclosing material, non-public information and for complying with its disclosure obligations under Regulation FD adopted by the SEC. Our website and the information contained therein or connected thereto shall not be deemed to be incorporated into this Annual Report.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_25"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 1A. Risk Factors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">You should carefully consider the following risks and other information in this Annual Report on Form 10-K in evaluating Embecta and Embecta common stock. The summary below provides an overview of many of the risks and uncertainties we encounter that are described in this Annual Report on Form 10-K that could materially and adversely affect Embecta&#8217;s business, financial condition or results of operations. An investment in our common stock involves a variety of risks and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">uncertainties. Additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business, financial condition, operating results, liquidity, and future prospects. The risks we face include, but are not limited to, the following:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Embecta&#8217;s Business </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The medical technology industry is very competitive. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta generates a significant amount of its profits and cash flows from a few key products, and any events that adversely affect the sale or profitability of these products could have an adverse impact on Embecta&#8217;s sales, results of operations and cash flows. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Technological breakthroughs in diabetes treatment or prevention may reduce demand for Embecta&#8217;s products. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta obtains components and raw materials for its products from third parties, including BD. These third parties may fail to perform under their agreements with Embecta, or there may be a reduction or interruption in the manufacturing and supply of these components and raw materials. Any such failure to perform or a reduction or interruption in supply could have a material adverse effect on Embecta&#8217;s business and operations. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may experience difficulties and delays in the manufacturing of its products or sterilization operations, and any such difficulties and delays could adversely affect Embecta&#8217;s business. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">A substantial portion of Embecta&#8217;s revenue is derived from sales to a few customers. If these customers reduce the amount of product that they purchase from Embecta, reduce the amount that they are willing to pay for such products or increase charges to distribute such products, Embecta&#8217;s business, financial condition and results of operations could be adversely affected. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta&#8217;s products are subject to continuous reimbursement, coverage and access scrutiny by both private and government payers, including the scope of products covered, access and coverage among product brands and manufacturers, reimbursement limitations and price adjustment restrictions. A change in any of these factors could have an adverse impact on Embecta&#8217;s financial condition and results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may enter into strategic collaborations, in-licensing arrangements or alliances with third parties that may not result in the development of commercially viable products or the generation of revenue. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta&#8217;s sales and marketing efforts rely upon independent distributors that are free to market products that compete with Embecta&#8217;s products, and if Embecta is unable to maintain or expand its network of independent distributors, its business could be materially adversely affected. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta&#8217;s future growth is dependent in part upon the development of new products, and there can be no assurance that such products will be developed or be successful. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">If the third parties on which Embecta relies to conduct its clinical trials and to assist it with pre-clinical development do not perform as contractually required or expected, or if market or clinical studies are unfavorable to its products in development, Embecta may not be able to obtain regulatory clearance or approval or commercialize its products. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may be unable to maintain strong relationships with physicians and other healthcare professionals which could adversely affect its business. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may not be able to successfully execute its acquisition strategy, which could adversely affect its financial condition and results of operations. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta&#8217;s international operations subject it to certain business risks. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta&#8217;s business and operations are subject to risks related to climate change. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta's may be exposed to environmental, social and governance risks.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta's intellectual property and proprietary technology are material to its business operations and are subject to infringement and other risks.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Breaches of Embecta&#8217;s information systems or cyberattacks could adversely affect our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">A disruption at one of our facilities could adversely affect our business and operating results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Insurance coverage may be inadequate or unavailable to cover any product liability losses we incur.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta is subject to a number of restrictive covenants under its indebtedness, including customary operating restrictions and financial covenants, which could restrict Embecta&#8217;s ability to pay dividends or adversely affect its financing options and liquidity position. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta is subject to risks associated with public health threats, such as the COVID-19 pandemic, which could have a material adverse effect on Embecta's financial condition and results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to the Separation and Distribution from BD </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta has a limited history of operating as an independent company, and its historical financial information may not be a reliable indicator of its future results. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Since the Separation, Embecta&#8217;s financial profile has changed, and it is a smaller, less diversified company than BD prior to the Separation.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may not achieve some or all of the expected benefits of the Separation. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">In order to conduct its operations and meet its financial reporting and other obligations, Embecta relies on certain services provided by BD pursuant to the transaction documents entered into with BD in connection with the Separation, including the TSA and the LSA. If Embecta is unable to extend the services on the terms contemplated by the Extension or replace the services that BD currently provides to it on terms that are at least as favorable to Embecta as the terms on which BD is providing these services, or if BD otherwise terminates any of the services, Embecta&#8217;s business, financial condition and results of operations may be materially adversely affected. Following the end of the transition period, Embecta will be required to rebrand its products to remove the BD name, transfer or obtain new manufacturing, supply chain, regulatory and product licenses and registrations in the name of Embecta, which could adversely affect its ability to attract and maintain end users or which could result in delays or interruptions of Embecta's commercialization and distribution operations or the loss of customers or revenue, all of which could adversely affect its financial condition and results of operations. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Following the end of the transition period, Embecta will be required to rebrand its products to remove the BD name, transfer or obtain new manufacturing, supply chain, regulatory and product licenses and registrations in the name of Embecta, which could adversely affect its ability to attract and maintain end users or which could result in delays or interruptions of Embecta's commercialization and distribution operations or the loss of customers or revenue, all of which could adversely affect its financial condition and results of operations. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta has incurred debt obligations that could adversely affect its business and profitability and its ability to meet other obligations. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may be affected by significant restrictions under the tax matters agreement, including on its ability to engage in certain corporate transactions for a two-year period after the Separation Date, in order to avoid triggering significant tax-related liabilities. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may be held liable to BD if it fails to perform under its agreements with BD. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">There could be significant income tax liability if the Separation or certain related transactions are determined to be taxable for United States federal income tax purposes. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The transfer to Embecta of certain contracts, permits and other assets and rights may require the consents, approvals of, or provide other rights to, third parties and governmental authorities. If such consents or approvals are not obtained, Embecta may not be entitled to the full benefit of such contracts, permits and other assets and rights, which could increase its expenses or otherwise harm its business and financial performance. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The closing of the Separation was deferred in certain jurisdictions, and may not occur at all in such jurisdictions, due to local regulatory requirements, which may adversely affect Embecta&#8217;s manufacturing, business, financial condition and results of operations. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Satisfaction of indemnification obligations following the distribution could have a material adverse effect on Embecta&#8217;s financial condition, results of operations and cash flows. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Embecta&#8217;s Common Stock </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The price and trading volume of Embecta&#8217;s common stock may be volatile, and stockholders could lose all or part of their investment in Embecta. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta cannot guarantee the timing, amount or payment of any dividends on its common stock. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Anti-takeover provisions could enable Embecta&#8217;s Board of Directors to resist a takeover attempt by a third-party and limit the power of its stockholders. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta&#8217;s amended and restated certificate of incorporation designates the state courts within the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by Embecta stockholders, which could discourage lawsuits against Embecta and its directors and officers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The risks described below may not be the only risks we face but are risks we believe may be material at this time. Other risks of which we are not yet aware, or that we currently believe are not material, may also materially adversely impact our business, financial condition or results of operations.  If any of the events or circumstances described below occurs, our business, financial condition or results of operations could be adversely impacted and the value of an investment in our securities could decline. Investors and prospective investors should consider the risks described below and the information </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">contained under the caption &#8220;Cautionary Statements Regarding Forward-Looking Statements&#8221; and elsewhere in this Annual Report on Form 10-K before deciding whether to invest in our securities. We may update these risk factors in our future periodic reports.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Embecta&#8217;s Business </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The medical technology industry is very competitive. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta faces significant competition from a wide range of companies in each market in which its products are sold. These include large companies with multiple product lines and non-traditional entrants such as technology companies, some of which may have greater financial and marketing resources than Embecta in the United States or other markets, as well as smaller, more specialized companies. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s ability to compete will also be affected by changing preferences and requirements of people with diabetes, as well as changes in the ways healthcare services are delivered. Efforts to contain healthcare costs by governments and the private sector are also resulting in increased emphasis on products that reduce costs, improve clinical results and expand access. Embecta&#8217;s ability to remain competitive will depend on how well it will meet these changing market demands in terms of its product offerings and marketing approaches. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The medical technology industry is subject to rapid technological change and frequent introduction of new products. The development of new or improved products, processes or technologies by other companies (such as new technologies to administer insulin) that provide better features, pricing, clinical outcomes or economic value may make Embecta&#8217;s existing or new products less competitive. In some instances, competitors, including pharmaceutical companies, also offer, or are attempting to develop, alternative therapies, including oral anti-diabetic drugs, GLP-1s and GLP-1 combination products, for disease states (including diabetes) that may be delivered without a medical device, such as pen needles. Lower cost producers have also created pricing pressure, particularly in emerging markets. There can be no assurance that Embecta&#8217;s products will be commercially successful, and it is possible that its business will be adversely affected from time to time as a result of products developed by its competitors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consolidation among payers, retailers, wholesalers, healthcare systems, and other providers is resulting in greater purchasing power for these companies. Group purchasing organizations and integrated health delivery networks have also served to concentrate purchasing decisions for some customers, which has led to downward pricing pressure for medical device suppliers. Further consolidation in the industry could intensify competition among medical device suppliers and exert additional pressure on the demand for, and prices of, Embecta&#8217;s products. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta generates a significant amount of its profits and cash flows from a few key products, and any events that adversely affect the sale or profitability of these products could have an adverse impact on Embecta&#8217;s sales, results of operations and cash flows. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s ability to generate profits and operating cash flow depends largely upon the continued profitability of its key products, such as its pen needles and syringes. For example, for the fiscal year ended September 30, 2023, sales of pen needles (including both conventional and safety pen needles) accounted for $912 million, or 81%, of total net revenues. Any event that adversely affects the sale or profitability of this product could adversely affect Embecta&#8217;s sales, results of operations and cash flows. These adverse events could include a decrease in the demand for such products, the pressure to decrease the price of such products, any increase in costs of manufacturing such products or other supply chain disruptions, increased availability of competitive products, increased competition from the introduction of new products related to the treatment of diabetes or removal from the market of these products for any reason. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Technological breakthroughs in diabetes treatment or prevention may reduce demand for Embecta&#8217;s products. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The diabetes treatment industry is subject to technological change and product innovation. A number of companies and medical researchers are pursuing new ways to deliver insulin to patients, including insulin administration technologies that do not require the use of a needle, or to treat diabetes without the use of insulin or by delaying the use of insulin, such as oral anti-diabetic drugs, GLP-1s and GLP-1 combination products. If they are successful in developing and commercializing these technologies or treatment therapies, the demand for Embecta&#8217;s products could decline. Furthermore, the National Institutes of Health and other supporters of diabetes research are continually seeking ways to prevent diabetes. Any technological breakthroughs in diabetes prevention or treatment could decrease demand for Embecta&#8217;s products and have a material adverse effect on its business or results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta obtains components, services and raw materials for its products from third parties, including BD. These third parties may fail to perform under their agreements with Embecta, or there may be a reduction or interruption in the manufacturing and supply of these components and raw materials. Any such failure to perform or a reduction or interruption in supply could have a material adverse effect on Embecta&#8217;s business and operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta relies on a number of third parties to supply and manufacture the components, services and raw materials for its products. For example, in connection with the Separation and prior to the distribution, Embecta and BD entered into a cannula supply agreement, whereby BD sells to Embecta cannulas for incorporation into Embecta&#8217;s products for sale within the diabetes care sector. Cannulas are a component part of a wide variety of medical devices that use needles to deliver fluid into, or through which blood is drawn from, the body. BD retains ownership of all cannula production activities and all intellectual property rights of BD and its subsidiaries relating to cannula, the manufacture thereof and other critical cannula-related technology. Pricing under the cannula supply agreement is determined by BD based on several factors, including Embecta's yearly forecast, the cost of raw materials and other cost methodologies. The cannula supply agreement is terminable by BD without cause by providing at least 36 months&#8217; written notice; however, such termination can be effective no earlier than ten years from the Separation. In the event of a change of control of Embecta, BD also has the right to terminate the cannula supply agreement. The cannula supply agreement will also terminate automatically, subject to a 36-month wind-down period, if Embecta&#8217;s yearly forecast is below the required minimum purchase amount, and the parties will have other customary termination rights for material breach or bankruptcy of the other party. Embecta is also limited to a maximum number of cannulas that it can purchase under the cannula supply agreement. If BD fails to perform under this agreement or BD terminates this agreement in accordance with its terms and, in either case, Embecta cannot find a way to purchase cannula from another party or manufacture cannula, or if Embecta needs to purchase more cannula than it is permitted under cannula supply agreement, Embecta may have insufficient cannulas for its products, which could materially adversely affect Embecta&#8217;s business, financial condition or results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, in connection with the Separation, Embecta and BD entered into a lease agreement for a manufacturing facility location in Holdrege, Nebraska that Embecta leases from BD and several contract manufacturing agreements where BD provides certain manufacturing services to Embecta. If BD is unable to perform under these arrangements, terminates certain services or modifies its operations and Embecta cannot find substantially similar alternatives to perform these services or is forced to change its operations as a result, Embecta may incur additional costs, delays or other deficiencies in its operations, which could materially adversely affect Embecta&#8217;s business, financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta also obtains other component parts and raw materials from other third parties. In many cases, Embecta does not have long-term supply agreements with suppliers of these component parts and raw materials, and its arrangements with these suppliers are on a purchase-order basis. Certain raw materials that we obtain from suppliers are subject to fluctuations in price and availability attributable to a number of factors, including general economic conditions, commodity price fluctuations, the demand by other companies for the same raw materials and the availability of complementary and substitute materials. In some cases, Embecta&#8217;s agreements with suppliers can be terminated by either party by convenience upon short notice. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain raw materials and components used in the manufacture of pen needles and syringes, including cannulas, certain oil-based resins and rubber stoppers, are not always available from multiple sources. New laws or regulations adopted in response to climate change could also increase energy and transportation costs, as well as the costs of certain raw materials and components. In addition, for quality assurance, cost-effectiveness and other reasons, Embecta purchases certain raw materials and components from a single supplier. The price and supply of these materials and components may be affected or disrupted for reasons beyond Embecta&#8217;s control. While Embecta works with suppliers to ensure continuity of supply, no assurance can be given that these efforts will be successful. In the event that any of its existing supply arrangements are terminated or there is a reduction or interruption of supply under these existing arrangements, Embecta expects that it will be able to enter into new arrangements with alternative suppliers, but these new arrangements may be on terms that are less favorable, including with respect to price and volume, and it may be costly or cause delays in Embecta&#8217;s manufacturing process to transition to a new supplier, particularly in cases in which Embecta must comply with regulatory requirements relating to qualification of new suppliers. The termination, reduction or interruption in supply of these raw materials and components could adversely impact Embecta&#8217;s ability to manufacture and sell certain of its products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-party suppliers may encounter problems during manufacturing for a variety of reasons, including failure to follow specific protocols and procedures, failure to comply with applicable regulations, equipment malfunction, component part supply constraints, and environmental factors, any of which could delay or impede their ability to supply the components and raw materials for Embecta&#8217;s products. Any such failure to perform or a reduction or interruption in supply could have a material adverse effect on Embecta&#8217;s business and operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta may experience difficulties and delays in the manufacturing of its products or sterilization operations, and any such difficulties and delays could adversely affect Embecta&#8217;s business. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta may experience difficulties and delays inherent in manufacturing its products, such as failure of Embecta or its suppliers to comply with applicable regulations and quality assurance guidelines, which failures may lead to: manufacturing shutdowns or manufacturing delays; delays related to the construction of new facilities or the expansion of existing facilities; and other manufacturing or distribution problems, including changes in manufacturing production sites and limits to manufacturing capacity resulting from regulatory requirements, changes in types of products produced and physical limitations that could affect supply. In addition, Embecta could experience difficulties or delays in manufacturing its products caused by natural disasters. Manufacturing difficulties can also result in product shortages, leading to lost sales and reputational harm. In addition, many of Embecta&#8217;s products require sterilization prior to sale. In some instances, only a few facilities are qualified under applicable regulations to conduct this sterilization. To the extent Embecta or third parties (including BD) are unable to sterilize Embecta&#8217;s products, whether due to lack of capacity, increased demand, regulatory requirements or changes or otherwise, Embecta may be unable to transition sterilization to other sites or modalities in a timely or cost effective manner, or at all, which could have an adverse impact on Embecta&#8217;s business. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">A substantial portion of Embecta&#8217;s revenue is derived from sales to a few customers. If these customers reduce the amount of product that they purchase from Embecta, reduce the amount that they are willing to pay for such products or increase charges to distribute such products, Embecta&#8217;s business, financial condition and results of operations could be adversely affected. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A substantial portion of Embecta&#8217;s revenue is derived from sales to a few customers. For example, for the fiscal year ended September 30, 2023, gross sales to McKesson Corporation, Cardinal Health and Cencora, Embecta&#8217;s three largest distributors, together represented approximately 40% of Embecta&#8217;s worldwide gross sales. The costs charged by these and other distributors to distribute Embecta&#8217;s products is also subject to negotiation, and such distributors may propose increases in such charges from time to time. In addition, for the fiscal year ended September 30, 2023, direct gross sales to the five largest retail pharmacies for Embecta&#8217;s products together represented approximately 14% of Embecta&#8217;s worldwide gross sales. If any of Embecta&#8217;s largest customers reduce the amount of product that they purchase from Embecta, negotiate a reduced price for such products or increase the charges to distribute such products, each could have a material adverse effect on Embecta&#8217;s business, financial condition and results of operations. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s products are subject to continuous reimbursement, coverage and access scrutiny by both private and government payers, including the scope of products covered, access and coverage among product brands and manufacturers, reimbursement limitations and price adjustment restrictions. A change in any of these factors could have an adverse impact on Embecta&#8217;s financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the United States, both public and private payers continue to take aggressive steps to control their expenditures for medical devices by placing restrictions on how many and which brands of devices they will provide coverage for across the spectrum of available products. Important competitive factors include quality, price, price guarantees and demonstrated ability to supply markets. Any failure by Embecta to differentiate its products with existing payers based on these and other factors or establish new payer relationships may adversely affect its financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, consolidation and integration among healthcare institutions and providers significantly affects the competitive landscape for medical devices. Health plans, pharmacy benefit managers, wholesalers, and other supply chain stakeholders have been consolidating into fewer, larger entities, thus enhancing their purchasing strength and importance. Specifically, private third-party insurers and governments typically maintain formularies that specify coverage (the conditions under which drugs and medical devices are included on a plan&#8217;s formulary) and reimbursement (including both the associated out-of-pocket cost to the consumer and payment to the distributor) to control costs by negotiating discounted prices, inflation guarantees and other terms in exchange for formulary inclusion. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Adverse formulary placement can lead to reduced usage of a medical device for the relevant patient population due to coverage restrictions, such as prior authorizations and formulary exclusions, or due to reimbursement limitations that result in higher consumer out-of-pocket cost, such as nonpreferred co-pay tiers, increased co-insurance levels, and higher deductibles. Consequently, medical device companies compete for formulary placement not only on the basis of product attributes but also by providing rebates. Price to the end customer is an increasingly important factor in formulary decisions, particularly in treatment areas in which the payer has taken the position that multiple branded products are therapeutically comparable (like that of diabetes). These downward pricing pressures could continue to negatively affect Embecta&#8217;s business. In addition to formulary placement, changes in insurance designs continue to drive greater consumer cost-sharing through high deductible plans and higher co-insurance or co-pays, increasing consumer sensitivity to product choice. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta is consistently managing the burden of continued pressures associated with payers&#8217; discount requirements to maintain positive formulary positions. If Embecta fails to maintain these formulary positions or reduces prices on its </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">products to maintain these formulary positions, it could adversely affect Embecta&#8217;s results of operations. In addition to the evolving payer market that continues to put price pressure on Embecta&#8217;s products, new competitors have emerged. Competitors that are new to the pen needle and insulin syringe categories, along with some that have emerged to begin engaging with payers, have accelerated the focus on these product categories, providing payers more choices for formulary partners within these medical device categories.     </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the ongoing challenges faced across the United States, Embecta faces similar access, pricing and reimbursement trends outside of the United States. Although payers&#8217; preferences for particular devices varies regionally, key foundational considerations for choice include: product specifications, clinical evidence demonstrating efficacy, positive clinical outcomes, investment in proper injection technique training for customers and patients, and pricing. Embecta is challenged to deliver new, innovative and differentiated products, along with price concessions, in markets outside of the United States, and price guarantees in these regions are critical to maintain access to key distributors and end users. For example, in EMEA (which includes Europe, the Middle East and Africa), the demand for medical devices that are paid out of pocket by the end user is limited. Access to these products is largely defined by the availability and size of government reimbursement, or, in a limited number of countries, the ability of manufacturers to negotiate reimbursement directly with insurance companies. In China, the most notable threat continues to be access through volume-based procurement and Group Purchasing Organizations ("GPOs"), with potential significant price erosion and cost containment within the healthcare landscape. These continued pricing pressures could adversely affect Embecta&#8217;s financial condition and results of operations. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta may enter into strategic collaborations, in-licensing arrangements or alliances with third parties that may not result in the development of commercially viable products or the generation of revenue. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the ordinary course of its business, Embecta may enter into strategic collaborations, in-licensing arrangements or alliances to develop product candidates. Other companies, including those with substantially greater financial, marketing, sales, technology or other resources, may compete with us for these arrangements. These arrangements are subject to a variety of risks, including: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may not identify or secure these collaborations in a timely manner, on a cost-effective basis, on acceptable terms or at all;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">these collaborations may not result in the development of products that achieve commercial success or result in any revenue to Embecta; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may not exercise sole decision making authority with respect to material development, regulatory submission, or commercial decisions under these collaborations, resulting in gridlock with its partners, and its collaborators may have economic or business interests or goals that are, or that may become, inconsistent with its business interests or goals; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta may have limited control over the amount and timing of resources that its current collaborators or any future collaborators devote to its collaborators&#8217; or its future products; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">disputes between Embecta and its collaborators may result in litigation or arbitration that would increase Embecta&#8217;s expenses and divert the attention of its management; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">these collaborations may be terminated or dissolved in accordance with their terms prior to the development of any Embecta products or any realization by Embecta of any other benefits. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s sales and marketing efforts rely upon independent distributors that are free to market products that compete with Embecta&#8217;s products, and if Embecta is unable to maintain or expand its network of independent distributors, its business could be materially adversely affected. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta believes that a significant portion of its sales will continue to be from independent distributors for the foreseeable future, and it is possible that the percentage of its sales from independent distributors could increase. None of Embecta&#8217;s independent distributors in the United States has been required to sell Embecta&#8217;s products exclusively, and each of them may freely sell the products of Embecta&#8217;s competitors. If Embecta is unable to maintain or expand its network of independent distributors, its sales may be negatively affected. For the fiscal year ended September 30, 2023, McKesson Corporation, Cardinal Health and Cencora, Embecta&#8217;s three largest distributors, together represented approximately 40% of Embecta&#8217;s worldwide gross sales. If any of Embecta's key independent distributors were to cease to distribute Embecta&#8217;s products or reduce their promotion of such products as compared to the products of Embecta&#8217;s competitors, Embecta may need to seek alternative independent distributors or increase its reliance on other independent distributors or its direct sales representatives, which alternative arrangements may not be sufficient to prevent a material reduction in sales of its products. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s future growth is dependent in part upon the development of new products, and there can be no assurance that such products will be developed or be successful. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant element of Embecta&#8217;s strategy is to increase revenue growth by focusing on innovation and new product development. For example, Embecta is currently working on developing an insulin patch pump focused on serving the needs of people with Type 2 diabetes. However, potential products are still in the product development phase, and Embecta has not yet submitted an application to the FDA seeking clearance for these products. In addition, even if Embecta submits an application to the FDA for clearance, there is no assurance that such clearance will be obtained or that Embecta will be able to market and sell such products successfully. New product development requires significant investment in research and development. The results of Embecta&#8217;s product development efforts may be affected by a number of factors, including Embecta&#8217;s ability to anticipate the needs of people with diabetes, successfully complete clinical trials, obtain regulatory clearance and approvals for its products, manufacture such products in a cost-effective manner, obtain appropriate intellectual property protection for such products, gain and maintain market acceptance of such products, secure distribution channels, and obtain access, coverage and reimbursement for such products. There can be no assurance that Embecta will be able to successfully develop or commercialize any products now in development or that Embecta may seek to develop or commercialize in the future. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If the third parties on which Embecta relies to conduct its clinical trials and to assist it with pre-clinical development do not perform as contractually required or expected, or if market or clinical studies are unfavorable to its products in development, Embecta may not be able to obtain regulatory clearance or approval or commercialize its products. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta relies on third parties, such as contract research organizations, medical institutions, clinical investigators, contract laboratories and other third parties, to conduct some of its clinical trials, human factors studies and pre-clinical investigations. If these third parties do not successfully carry out their contractual duties or regulatory obligations or meet expected deadlines, or if the quality or accuracy of the data they obtain is compromised due to failure to adhere to the clinical protocols or regulatory requirements or for other reasons, Embecta&#8217;s pre-clinical development activities or clinical trials may be extended, delayed, suspended or terminated, and Embecta may not be able to obtain regulatory clearance or approval for, or successfully commercialize, its products on a timely basis, or at all, and Embecta&#8217;s business and operating results may be adversely affected. Furthermore, such third parties may experience delays in conducting such studies and trials for reasons outside of their control. In addition, Embecta faces the risk of potential unauthorized disclosure or misappropriation of its intellectual property by contract research organizations, which may reduce Embecta&#8217;s trade secret protection and allow its potential competitors to access and exploit its proprietary technology.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, if future clinical trials fail to support the efficacy or safety of Embecta&#8217;s current or future products or if the data obtained from such studies are unfavorable or inadequate to support satisfactory conclusions about Embecta&#8217;s current or future products, Embecta&#8217;s sales may be adversely affected and may have a material adverse effect on its business, financial condition and results of operations. In addition, future clinical studies or other articles regarding Embecta&#8217;s existing products or any competing products may be published that either support a claim, or are perceived to support a claim, that a competitor&#8217;s product is clinically more effective or easier to use than Embecta&#8217;s existing products or products in development or that any such product is not as effective as Embecta claims. Any of these events may negatively affect Embecta&#8217;s sales efforts and result in decreased revenue.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s failure to maintain strong relationships with physicians and other healthcare professionals could adversely affect its business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta depends on its ability to maintain strong working relationships with physicians and other healthcare professionals in connection with research and development for some of its products. Embecta relies on these professionals to provide it with considerable knowledge and advice regarding the development and use of these products. If Embecta fails to maintain its working relationships with physicians and, as a result, no longer has the benefit of their knowledge and advice, Embecta&#8217;s products may not be developed in a manner that is responsive to the needs and expectations of the professionals who use and support such products, which could have a material adverse effect on Embecta&#8217;s business. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta may not be able to successfully execute its acquisition strategy, which could adversely affect its financial condition and results of operations. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta intends to explore strategic partnerships and acquisition opportunities that enable it to accelerate its growth. There is no assurance that future acquisitions will be available on attractive terms and Embecta&#8217;s ability to consummate any acquisition will be subject to various risks and uncertainties, including the negotiation of agreements on satisfactory terms, obtaining applicable regulatory clearances and approvals and, after consummation, achieving anticipated synergies and other benefits. If Embecta does not successfully execute on its acquisition strategy, it could adversely affect its financial condition and results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s international operations subject it to certain business risks. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A substantial amount of Embecta&#8217;s sales come from its operations outside the United States, and Embecta intends to continue to pursue growth opportunities outside of the United States, especially in emerging markets. Embecta&#8217;s international operations subject it to certain risks relating to, among other things, fluctuations in foreign currency exchange, local economic and political conditions, competition from local companies, increases in trade protectionism, United States relations with the governments of the foreign countries in which Embecta operates, foreign regulatory requirements or changes in such requirements, changes in local healthcare payment systems and healthcare delivery systems, local product preferences and requirements, longer payment terms for account receivables than we experience in the United States, difficulty in establishing, staffing and managing foreign operations, changes to international trade agreements and treaties, changes in tax laws, weakening or loss of the protection of intellectual property rights in some countries and import or export licensing requirements. The success of Embecta&#8217;s international operations also depends, in part, on its ability to make necessary infrastructure enhancements to, among other things, its production facilities and sales and distribution networks. These and other factors may adversely impact its ability to pursue its growth strategy in these regions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the risks discussed elsewhere, other risks associated with doing business internationally, include, but are not limited to: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">political instability and actual or anticipated military or political conflicts; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">trade protection measures and barriers, such as tariffs, and import and export licensing and control requirements; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">negative consequences from changes in or interpretations of tax laws; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">difficulty in establishing, staffing and managing international operations; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">difficulties associated with foreign legal systems, including increased costs associated with enforcing contractual obligations in foreign jurisdictions; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">changes in regulatory requirements; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">adapting to the differing laws and regulations, business and clinical practices, and consumer preferences in foreign markets; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">difficulties in managing foreign relationships and operations, including any relationships that we establish with foreign partners, distributors or sales or marketing agents; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">difficulty in collecting accounts receivable and longer collection periods. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the U.S. Foreign Corrupt Practices Acts (FCPA), the U.K. Bribery Act, and similar anti-corruption and anti-bribery laws enacted outside the United States generally prohibit companies and their intermediaries from making improper payments to foreign officials for the purpose of obtaining or retaining business. Global enforcement of anti-corruption laws has increased substantially in recent years, with more enforcement proceedings by United States and foreign governmental agencies and the imposition of significant fines and penalties. Embecta&#8217;s international operations, which often involve customer relationships with foreign governments or government-sponsored healthcare systems, create the risk that there may be unauthorized payments or offers of payments made by employees, consultants, sales agents or distributors. Because Embecta does business in the U.K., the U.K. Bribery Act also extends to its interaction with public and private sector entities and persons outside the U.K., including in the United States. Embecta&#8217;s policies mandate compliance with these laws. Embecta operates in parts of the world that have experienced governmental corruption to some degree, and in certain circumstances strict compliance with anti-bribery laws may conflict with local customs and practices. Despite Embecta&#8217;s training and compliance programs, its internal control policies and procedures may not always protect Embecta from reckless or criminal acts committed by its employees or agents. Any alleged or actual violations of these laws may subject Embecta to government investigations and significant criminal or civil sanctions and other liabilities, including exclusion from government contracting, which could negatively affect our reputation, could disrupt Embecta&#8217;s business and have a material adverse effect on its results of operations, financial condition, and cash flow. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Changes in United States policy regarding international trade, including import and export regulation and international trade agreements, could also negatively impact Embecta&#8217;s business. The United States has imposed tariffs and export controls on certain goods and products imported from China and certain other countries, which has resulted in retaliatory tariffs by China and other countries. Additional tariffs imposed by the United States on a broader range of imports, or further retaliatory trade measures taken by China or other countries in response, could result in an increase in supply chain costs that Embecta may not be able to offset or that otherwise adversely impact its results of operations. In addition, political tensions between the United States and China have escalated in recent years. Rising political tensions could reduce trade, investment and other economic activities between the two major economies. Any of these factors could have a material adverse effect on Embecta&#8217;s business, prospects, financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The departure of the United Kingdom from the European Union (&#8220;EU&#8221;) (commonly known as &#8220;Brexit&#8221;) on January 31, 2020 created uncertainties affecting business operations in the United Kingdom, the EU and a number of other countries, including with respect to compliance with the regulatory regimes regarding the labeling and registration of the products </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta sells in these markets. Embecta could face increased costs, volatility in exchange rates, market instability and other risks as a result of Brexit. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The military conflict between Russia and Ukraine has resulted in the implementation of sanctions by the United States and other governments against Russia and has caused significant volatility and disruptions to the global markets. It is not possible to predict the short- and long-term implications of this conflict, which could include but are not limited to further sanctions, uncertainty about economic and political stability, increases in inflation rate and energy prices, supply chain challenges and adverse effects on currency exchange rates and financial markets. In addition, the United States government reported that United States sanctions against Russia in response to the conflict could lead to an increased threat of cyberattacks against United States companies. These increased threats could pose risks to the security of Embecta&#8217;s Information Technology systems, networks and product offerings, as well as the confidentiality, availability and integrity of Embecta&#8217;s data. In addition, the recent hostilities in Israel could develop to have a more widespread economic and geopolitical affect in the Middle East and Europe, and/or economic sanctions between or among countries, as well as general geopolitical issues in the Middle East. This may impact oil production capacity, oil prices, and disruptions in supply chain and shipping routes in the Middle East. These impacts may further cause increases in resin costs, as well as energy costs. If these conflicts develop beyond these areas or further intensify, they could have an adverse impact on Embecta&#8217;s business operations in the EU, the Middle East or other affected areas. Embecta is continuing to monitor the situations in Ukraine, Israel and globally as well as assess their potential impact on Embecta&#8217;s business, including impacts to suppliers and customers. Although operations in Russia, Ukraine and Israel do not currently constitute a material portion of Embecta&#8217;s business, a significant escalation or further expansion of the conflicts&#8217; current scope or related disruptions to the global markets could have a material adverse effect on Embecta&#8217;s results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, and the Bureau of Industry and Security at the U.S. Department of Commerce, administer certain laws and regulations that restrict U.S. persons and, in some instances, non-U.S. persons, in conducting activities, and transacting business with or making investments in certain countries, governments, entities and individuals subject to U.S. economic sanctions. Due to Embecta&#8217;s international operations, it is subject to such laws and regulations, which are complex, restrict its business dealings with certain countries and individuals, and are constantly changing. Further restrictions may be enacted, amended, enforced or interpreted in a manner that materially impacts Embecta&#8217;s operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Violations of these regulations are punishable by civil penalties, including fines, denial of export privileges, injunctions, asset seizures, debarment from government contracts and revocations or restrictions of licenses, as well as criminal fines and imprisonment. Embecta has established procedures designed to assist with its compliance with such laws and regulations. However, Embecta has only limited experience dealing with these laws and regulations and it cannot guarantee that its procedures will effectively prevent it from violating these regulations in every transaction in which Embecta may engage. Any such violation could adversely affect Embecta&#8217;s reputation, business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s business and operations are subject to risks related to climate change.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The long-term effects of global climate change present risks to Embecta&#8217;s business and operations. Extreme weather, natural disasters or other conditions caused by climate change could adversely impact its supply chain and the availability and cost of raw materials and components, energy supply, transportation or other inputs required for the operation of its business. Such conditions could also result in physical damage to products, plants and distribution centers, or our suppliers' facilities, as well as the infrastructure and facilities of hospitals, medical care facilities and other customers. Additionally, increased environmental regulation, including to address climate change, may result in increases in the costs to operate its business or restrict certain aspects of its activities. These events could adversely affect Embecta&#8217;s operations and our financial performance.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta's business could be negatively impacted by evolving regulations, policies and expectations relating to environmental, social and governance (ESG) initiatives, setting related goals, collecting data and disclosing related information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There is an increasing focus from certain investors, customers, consumers, employees and other stakeholders concerning ESG matters. Additionally, public interest and legislative pressure related to public companies&#8217; ESG practices continue to grow. These changing rules, regulations and stakeholder expectations have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. A number of participants in the medical device industry are also joining voluntary ESG groups or organizations, such as the Responsible Business Alliance. These ESG provisions and initiatives are subject to change, can be unpredictable, and may be difficult and expensive for us to comply with, given the complexity of our supply chain and operations.  If our ESG practices fail to meet regulatory requirements or investor, customer, consumer, employee or other stakeholders' evolving expectations and standards in areas including environmental stewardship, support for local communities, Board of Directors and employee diversity, human capital management, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">employee health and safety practices, product quality, supply chain management, corporate governance and transparency, our reputation, brand and employee retention may be negatively impacted, and our customers and suppliers may be unwilling to continue to do business with us. Further, statements about our ESG-related initiatives and goals, and progress against those goals, may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. In addition, we could be criticized for the scope or nature of such initiatives or goals, or for any revisions to these goals. If we do not adapt to or comply with new regulations, or fail to meet evolving investor, industry or stakeholder expectations and concerns regarding ESG issues, investors may reconsider their capital investment in our Company, and customers may choose to stop purchasing our products, which could have a material adverse effect on our reputation, business or financial condition.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Foreign currency exchange rate, inflation, commodity price, energy and oil prices and supply, and interest rate fluctuations may adversely affect Embecta&#8217;s financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta is exposed to a variety of market risks, including the effects of changes in foreign currency exchange rates, commodity prices, energy resource prices and uninterrupted energy supply, and interest rates. Products manufactured in, and sold into, regions outside of the United States represent a significant portion of Embecta&#8217;s operations. The Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K reflect translation of financial statements denominated in non-United States currencies to United States dollars as well as the foreign currency exchange gains and losses resulting from the re-measurement of assets and liabilities. A strengthening or weakening of the United States dollar in relation to the foreign currencies of the countries in which Embecta sells or manufacture its products, such as the euro, will affect its United States dollar-reported revenue and income. Changes in the relative values of currencies may, in some instances, have a significant effect on its results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Many of Embecta&#8217;s products have significant resin content. Embecta also uses quantities of other commodities, such as rubber, corrugate and steel. Increases in the prices of these commodities, including due to inflation in the United States or in other markets, could increase the production and other input costs of Embecta&#8217;s products. Embecta may not be able to pass on these costs to its customers, which could have a material adverse effect on its results of operations and cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Russia and Ukraine conflict, the Israel-Hamas war and the growing geopolitical tensions between China and Taiwan, coupled with possible related supply chain shortages may affect the energy power and oil sector&#8217;s networks and ability to supply their customers, including Embecta. These disruptions may lead to manufacturing shutdowns, raw material and component shortages, supply chain and logistics constraints, project delays, loss of productivity, divergent product standards and regulations, trade policies, labor shortages, commodity shortages, and price increases, among others. Embecta relies on uninterrupted energy to power its manufacturing facilities and any disruption could adversely affect its operations. In addition, increases in energy and oil prices could increase the production, raw materials and other costs of Embecta&#8217;s operations and products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Increases in interest rates may adversely affect the financial condition of Embecta&#8217;s distributors and suppliers, thereby adversely affecting their ability to buy Embecta&#8217;s products and supply the components or raw materials needed by Embecta, in each case adversely affecting Embecta&#8217;s financial condition or results of operations. If the United States Federal Reserve continues to raise the benchmark interest rate, then Embecta would expect the interest expense on its variable rate debt to increase in fiscal 2024. To the extent Embecta borrows under its revolving credit facility, it will also be subject to risks related to changes in interest rates.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Fluctuations in Embecta&#8217;s effective tax rate and changes to tax laws may adversely affect it. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a global company, Embecta is subject to taxation in numerous countries, states and other jurisdictions. Embecta&#8217;s effective tax rate is derived from a combination of applicable tax rates in the various countries, states and other jurisdictions in which it operates. In preparing its financial statements, Embecta estimates the amount of tax that will become payable in each of these jurisdictions and significant judgement is required in determining our worldwide provision for income taxes. Embecta&#8217;s effective tax rate may, however, differ from the estimated amount due to numerous factors, including a change in overall profitability, geographical mix of earnings before income taxes, tax discrete items that are not recurring in nature, and changes in tax laws, including potential proposed tax legislation. The Organization for Economic Cooperation and Development ("OECD") has developed major reform of the international tax system with respect to a global minimum 15% tax rate. In December 2022, European Union member states agreed to adopt the OECD&#8217;s minimum tax rules, which are expected to begin going into effect in tax years beginning on January 1, 2024 or later. Certain other countries have enacted the law changes and other countries are considering changes to their tax laws; the impact of the changes will go into effect for the Company beginning in fiscal year 2025. The Company is evaluating the impact of these proposed and enacted changes.  If any potential legislative proposals are ultimately enacted, they could materially impact Embecta&#8217;s tax provision, cash tax liability and effective tax rate. Any of these factors could cause Embecta to experience an effective tax rate significantly different from previous periods or its current expectations, which could have an adverse effect on its business, financial condition, results of operations and cash flows. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If Embecta fails to protect its intellectual property or proprietary technology, such failure could adversely affect its business and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta relies primarily on patent, trademark and trade secret laws, as well as confidentiality and non-disclosure agreements covering its know-how and confidential information, to protect its proprietary technologies. Third parties, including its competitors, may contest or oppose its patents and trademarks and future patent and trademark applications, and if such patents or trademarks are successfully challenged, it may be easier for its competitors to offer the same or similar products or technologies or require Embecta to rebrand its products. Embecta can also lose the protection afforded by these intellectual property assets through patent expirations, legal challenges or governmental action. Patents attained by competitors may also adversely affect Embecta&#8217;s competitive position. In addition, competitors may seek to invalidate patents on its products or claim that its products infringe upon their intellectual property, which could result in a loss of competitive advantage or the payment of significant legal fees, damage awards and past or future royalties, as well as injunctions against future sales of its products. Embecta has entered into confidentiality agreements and intellectual property assignment agreements with its officers, certain employees, consultants and potential collaborators regarding its intellectual property and proprietary technology. In the event of unauthorized use or disclosure or other breaches of those agreements, Embecta may not be provided with meaningful protection for its trade secrets, know-how or other proprietary information. Embecta also operates in countries that do not protect intellectual property rights to the same extent as in the United States, which could make it easier for competitors to compete with Embecta in those countries. The loss of a significant portion of its portfolio of intellectual property assets may have an adverse effect on its business and results of operations. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s products or processes may infringe the intellectual property rights of others, which may cause Embecta to pay unexpected litigation costs, damages, or settlement fees (including royalties) or prevent Embecta from selling its products.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta cannot be certain that its products, both existing and in development, do not and will not infringe issued patents or other intellectual property rights of third parties. Embecta may be subject to legal proceedings and claims in the ordinary course of its business, including claims of alleged infringement of the intellectual property rights of third parties. Patentability, invalidity, freedom-to-operate or other opinions may be required to determine the scope and validity of third-party proprietary rights. The nature of claims contained in unpublished patent filings around the world is unknown to Embecta and it is not possible to know which countries patent holders may choose for an extension of their filings under the Patent Cooperation Treaty or other mechanisms. Embecta may also be subject to claims based on the actions of employees and consultants with respect to the usage or disclosure of intellectual property learned at other employers. Any such claims, whether or not meritorious, could result in litigation and divert the time and attention of its management team. Consequently, Embecta is unable to guarantee that it will be able to manufacture, use, offer for sale, sell or import any of its commercial products or products in development in the event of an infringement action. If Embecta is found liable for infringement, it may be required to enter into licensing agreements (which may not be available on acceptable terms or at all) or to pay damages or cease developing, making or selling certain products. Even if Embecta were able to obtain a license, the rights may be non-exclusive, which could potentially limit its competitive advantage. Ultimately, Embecta could be prevented from commercializing any products that it may commercialize or promote or be forced to cease some aspects of its business operations, if, as a result of actual or threatened patent infringement or other claims, it is unable to enter into licenses on acceptable terms. This inability to enter into licenses or the ability to exclude others from using proprietary rights could have a material adverse effect on Embecta&#8217;s reputation, business, financial condition or results of operations. Embecta may also need to redesign some of Embecta&#8217;s products or processes to avoid future infringement liability. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Breaches of Embecta&#8217;s information systems and cyberattacks aimed at accessing Embecta&#8217;s devices, products and services or related devices, products and services could have a material adverse effect on its operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta faces various security threats on a regular basis, including ongoing cyber security threats to and attacks on our information technology infrastructure. &#8239;Some of Embecta&#8217;s products, and products in development may, include information systems that collect data, including sensitive medical information, regarding patients and patient therapy on behalf of Embecta&#8217;s customers and some connect to Embecta&#8217;s systems for maintenance and management purposes. Embecta uses its and certain third party, including BD's, information technology systems to manage or support a variety of business processes and activities, including sales, shipping, billing, customer service, procurement, supply chain, manufacturing, and accounts payable. In addition, Embecta uses enterprise information technology systems to record, process, and summarize transactions and other financial information and results of operations for internal reporting purposes and to comply with financial reporting, legal, and tax regulatory requirements. Embecta deploys defenses against such threats and attacks and works to secure the integrity of its data systems using techniques, hardware, and software typical of companies of its size and scope. Despite Embecta&#8217;s security measures, however, its information technology and infrastructure may be vulnerable to attacks by increasingly sophisticated intruders or others who try to cause harm to or interfere with its normal use of its systems. They are also susceptible to breach due to employee error, malfeasance, or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">other disruptions. Embecta&#8217;s suppliers, distributors, contractors, service providers, and other third parties with whom it does business also could be subject to cyber threats and attacks that are similar in frequency and sophistication. In many cases, Embecta has to rely on the controls and safeguards put in place by these suppliers, distributors, contractors, service providers, including BD, and other third parties to defend against, respond to, and report these attacks. Many of Embecta&#8217;s information systems are cloud-hosted and managed by these third-party vendors, some of which may have access to confidential business, employee, healthcare professional, and/or customer information. Embecta&#8217;s information technology systems may also be susceptible to damage, disruptions, or shutdowns due to computer viruses, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors, or catastrophic events. Any failure by Embecta to maintain or protect its information technology systems and data integrity, including from cyberattacks, intrusions, disruptions, or shutdowns, could result in the unauthorized access to customer data and personally identifiable information, theft of intellectual property or other misappropriation of assets or the loss of key data and information, or otherwise compromise Embecta&#8217;s confidential or proprietary information and disrupt its operations. The potential impact of future cyber incidents can vary widely in severity and scale. This could also impact Embecta&#8217;s compliance with privacy and other laws and regulations and could result in actions by regulatory bodies or civil litigation. There can be no assurance that the various procedures and controls Embecta utilizes to mitigate these threats will be sufficient to prevent disruptions to its systems, in part because (i) cyberattack techniques change frequently and, at times, new techniques are not recognized until launched, and (ii) cyberattacks can originate from a wide variety of sources. Embecta will continue to evaluate organization risk priorities and dedicate resources to protect against unauthorized access, and work to align to industry-leading cybersecurity frameworks to incorporate cybersecurity into its enterprise systems, manufacturing processes and products. Embecta&#8217;s results of operations could be adversely affected if these systems are interrupted or damaged or fail for any extended period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, medical devices are increasingly connected to the internet, healthcare networks, and other medical devices to provide features that improve healthcare and increase the ability of healthcare providers to treat patients and patients to manage their conditions. For example, Embecta is pursuing collaborations to enable the connectivity and interoperability of its insulin patch pump in development with third-party patient monitoring products, which may in turn be connected with the internet, healthcare networks and other medical devices. These same features may also increase cybersecurity risks and the risks of unauthorized access and use by third parties, as noted by the FDA&#8217;s warning that insulin pumps may have cybersecurity vulnerabilities and could be manipulated by hackers, causing danger to people with diabetes. As such, a cyberattack which intrudes, disrupts, or corrupts Embecta&#8217;s devices, products, and services, or related devices, products, and services could impact the quality-of-care patients receive or the confidentiality of patient information. Additionally, modifying or using any such devices, products, or services in a way inconsistent with Embecta&#8217;s FDA clearances and approvals may create risks to users and potential exposure to the company.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta needs to attract and retain key employees to be competitive. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s ability to compete effectively depends upon its ability to attract and retain executives and other key employees. Competition for experienced employees, particularly for persons with specialized skills, can be intense. Embecta&#8217;s ability to recruit such talent will depend on a number of factors, including compensation and benefits, work location and work environment. If Embecta cannot effectively recruit and retain qualified executives and employees, its business could be adversely affected. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s business may be adversely affected by work stoppages, union negotiations and labor disputes. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2023, only certain employees, all outside of the United States and representing approximately 35% of our headcount (approximately 17% of those employees are in deferred closing countries), are represented by various unions, works council and other collective bargaining groups. As of September 30, 2023, approximately 48% of those employees within these groups have collective bargaining power. In addition, on January 1, 2023, the BD Shanghai, China employees transferred from the BD local legal entity to the Embecta local legal entity. Embecta Shanghai, China employees participate in unions, as required by China regulations, and as was established by BD prior to the transfer. As of September 30, 2023, these unions do not have collective bargaining agreements. Historically, the effects of collective bargaining and other similar labor agreements have not been significant. However, if a larger number of Embecta&#8217;s employees were to unionize, including in the wake of any future legislation or administrative regulation that makes it easier for employees to unionize, the effect could be significant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant portion of Embecta&#8217;s unionized employees have collective bargaining agreements. Any inability to negotiate acceptable new contracts and new terms and conditions under these collective bargaining arrangements could cause strikes or other work stoppages, including at our Ireland manufacturing facility, and new contracts could result in increased operating costs for Embecta. If any strikes or other work stoppages occur, or if additional employees become represented by a union, a disruption of Embecta&#8217;s operations and higher labor costs could result. Labor relations matters affecting Embecta&#8217;s suppliers of products and services could also adversely affect Embecta&#8217;s business from time to time. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta is subject to extensive regulation. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s operations are global and are affected by complex state, federal and international laws relating to healthcare, environmental protection, antitrust, anti-corruption, marketing, fraud and abuse (including anti-kickback and false claims laws), import and export control, product safety and efficacy, employment, privacy, financial transparency, conflict minerals and other areas. Violations of these laws can result in criminal or civil sanctions, including substantial fines and, in some cases, exclusion from participation in healthcare programs such as Medicare and Medicaid. Environmental laws, particularly with respect to the emission of greenhouse gases, such as taxes on fuel and energy, to mitigate the impacts of climate change, are becoming more stringent throughout the world, which may increase Embecta&#8217;s costs of operations or necessitate closures of or changes to its manufacturing plants or processes or those of its suppliers, or result in liability to Embecta. Embecta is also subject to various laws and regulations relating to the safety and effectiveness of medical devices, including relating to design, development and manufacturing, product traceability and record keeping procedures, product complaints, complaint reporting, recalls and field safety corrective actions, advertising and promotion and clinical trials and post-market studies with respect to its products. Failure to comply with these laws may result in enforcement actions by the FDA or other similar regulatory agencies and other liability to Embecta. The enactment of additional laws or changes in existing laws may increase compliance costs or otherwise adversely impact Embecta&#8217;s operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta is also subject to numerous post-marketing regulatory requirements, which include quality system regulations related to the manufacture of its devices, labeling regulations, and medical device reporting regulations. The last of these regulations requires Embecta to report to the FDA if its devices cause or contribute to a death or serious injury, or malfunction in a way that would likely cause or contribute to a death or serious injury if the malfunction recurred. If Embecta fails to comply with present or future regulatory requirements that are applicable to it, it may be subject to enforcement action by the FDA, which may include any of the following sanctions:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">untitled letters, warning letters, fines, injunctions, consent decrees, and civil penalties;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">customer notification, or orders for repair, replacement, or refunds;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">voluntary or mandatory recall or seizure of our current or future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">administrative detention by the FDA of medical devices believed to be adulterated or misbranded;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">operating restrictions, suspension or shutdown of production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">refusing our requests for 510(k) clearance of new products, new intended uses or modifications to Embecta&#8217;s current products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">rescinding 510(k) clearance or suspending that have already been granted; or</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">criminal prosecution.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the EU has adopted the EU Medical Device Regulation (the &#8220;EU MDR&#8221;), which imposes stricter requirements for the marketing and sale of medical devices, including in the area of labeling requirements, clinical evidence requirements, quality systems and post-market surveillance. The EU MDR has been fully operational for previously approved self-certified medical devices (class I) since May 2021, and companies have until May 2024 to meet the requirements for medical devices with a valid conformity assessment certificate (class II and III). Complying with and maintaining devices under these regulations requires Embecta to incur significant expenditures. Additionally, the availability of EU notified body services certified to assist Embecta with validation of, and compliance with, the new requirements is limited, which may delay the marketing approval for some of Embecta's products under the EU MDR. Any such delays, or any failure to meet these requirements could adversely impact our business in the EU and other non-EU regions that tie their product registrations to EU conformity requirements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Healthcare reform may have a material adverse effect on Embecta&#8217;s financial condition and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Political, economic and regulatory developments have effected fundamental changes in the healthcare industry. In response to perceived increases in health care costs in recent years, there have been, and continue to be, proposals by the federal government, state governments, regulators, and third-party payors to control these costs and, more generally, to reform the U.S. health care system. Certain of these proposals could limit the prices Embecta is able to charge for its products or the amounts of reimbursement available for its products and could limit the acceptance and availability of its products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Patient Protection and Affordable Care Act (the &#8220;Affordable Care Act&#8221;) substantially changed the way healthcare is financed by both government and private insurers. It also encourages improvements in the quality of healthcare products and services and significantly impacts the United States pharmaceutical and medical device industries by, among other things, imposing certain stringent compliance, recordkeeping, and reporting requirements on companies in various sectors of the life sciences industry, and enhanced penalties for non-compliance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta cannot predict at this time the full impact of the Affordable Care Act or other new legislation, agency priorities, rulemaking and healthcare reform measures from U.S. federal or state governments, foreign governments, or third-party payors that may be adopted or implemented in the future on Embecta&#8217;s financial condition, results of operations and cash </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">flows. Although several legislative initiatives to repeal and replace the Affordable Care Act have been proposed, and legal challenges to the constitutionality of the Affordable Care Act or its component parts have been made, the nature and effect of any modification or repeal of, or legislative substitution for, the Affordable Care Act, or any court decision regarding the Affordable Care Act&#8217;s validity, is uncertain, and Embecta cannot predict the effect that any of these events would have on the longer-term viability of the act, or on Embecta&#8217;s financial condition, results of operations or cash flows. However, any changes that create stricter and more costly compliance obligations or lower reimbursement for Embecta&#8217;s products could materially and adversely affect its business, financial condition and results of operations. Future significant changes in the healthcare systems in the United States or elsewhere could also have a negative impact on the demand for Embecta&#8217;s current and future products. These include changes that may reduce reimbursement rates for its products and changes that may be proposed or implemented by the current or future laws or regulations.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Certain modifications to Embecta&#8217;s products may require new 510(k) clearances or other marketing authorizations and may require Embecta to recall or cease marketing its products. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Once a medical device is permitted to be legally marketed in the United States pursuant to a 510(k) clearance, a manufacturer may be required to notify the FDA of certain modifications to the device. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Manufacturers determine in the first instance whether a change to a product requires a new 510(k) clearance or premarket submission, but the FDA may review any manufacturer&#8217;s decision. The FDA may not agree with Embecta&#8217;s decisions regarding whether new clearances are necessary. Embecta has made modifications to its products in the past and has determined based on its review of the applicable FDA regulations and guidance that in certain instances new 510(k) clearances or other premarket submissions were not required. Embecta may make similar modifications or add additional features in the future that it believes does not require a new 510(k) clearance. If the FDA disagrees with Embecta&#8217;s determinations and requires it to submit new 510(k) notifications, Embecta may be required to cease marketing or to recall the modified product until it obtains clearance, and it may be subject to significant regulatory fines or penalties. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta may be subject to enforcement actions if it engages in improper marketing or promotion of its products. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s promotional materials and training methods must comply with applicable laws, regulations and regulatory authority&#8217;s rules and guidelines, including the FDA and the Federal Trade Commission (the &#8220;FTC&#8221;). If the FDA, the FTC or another regulatory agency determines that Embecta&#8217;s promotional or training material constitutes off-label, false or misleading, unfair or deceptive promotion of its products, it could request that Embecta modify its training or promotional materials or subject Embecta to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider Embecta&#8217;s promotional, educational or training materials to constitute off-label, false or misleading, unfair or deceptive promotion of its products, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement, and reputational harm. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta is subject to complex and evolving laws and regulations regarding privacy and data protection, many of which are subject to change and uncertain interpretation, which could result in claims, changes to its business practices, penalties, increased cost of operations or declines in user growth or engagement, or otherwise adversely affect its business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta is subject to complex and frequently changing laws in the United States and elsewhere regarding privacy and the processing, collection, use, storage and protection of personal information, and noncompliance with these laws could result in substantial fines or litigation. For instance, the EU has also adopted the General Data Protection Regulation (&#8220;GDPR&#8221;), which applies to personal data involved in Embecta&#8217;s operations in the EU or products and services that Embecta offers to EU users involving personal data. The GDPR contains a range of compliance obligations that could require Embecta to change its existing business practices policies, and significantly increases financial penalties for noncompliance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the state of California, the California Consumer Privacy Act (&#8220;CCPA&#8221;), which provides certain privacy rights and consumer protection for residents of the state became effective in 2020, and the California Privacy Rights Act, which amends and expands the CCPA, went into effect on January 1, 2023. These consumer rights include the right to know what personal information is collected, the right to know whether the data is sold or disclosed and to whom, the right to request a company to delete the personal information it has collected, the right to opt-out of the sale of personal information and the right to non-discrimination in terms of price or service when a consumer exercises a privacy right. California&#8217;s and other states&#8217; laws apply more broadly and now or in the future may reach data we hold that relates to employees and healthcare providers, not just customers. In addition, data security protection laws passed by the federal government and many states require notification to data subjects, including customers and others, when there is a security breach of personal data. The CCPA also created a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. The effects of state data protection laws are significant and may cause Embecta to incur substantial costs and expenses to ensure ongoing compliance. If Embecta fails to comply with these regulations, it could be subject to civil sanctions, including fines and penalties for noncompliance. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, foreign data protection, privacy, and other laws and regulations can be more restrictive than those in the United States. Data localization laws in some countries generally mandate that certain types of data collected in a particular country be stored and/or processed within that country. Embecta could be subject to audits in Europe and around the world, particularly in the areas of consumer and data protection, as Embecta continues to grow and expand its operations. Legislators and regulators may make legal and regulatory changes, or interpret and apply existing laws, in ways that make Embecta&#8217;s products less useful to users, require us to incur substantial costs, expose us to unanticipated civil or criminal liability, or cause us to change Embecta&#8217;s business practices. These changes or increased costs could affect Embecta&#8217;s business and results of operations. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">A disruption at one of Embecta's facilities could adversely affect our business and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although Embecta operates in multiple locations, manufacturing of its pen needles and syringes is conducted, and its components for such products are primarily stored, at its facilities in the United States, Ireland and China. Political or financial instability, currency fluctuations, the outbreak of pandemics such as COVID-19, labor unrest, transport capacity and costs, port security, supply chain disruptions, wars, weather conditions, natural disasters, or other events that could slow or disrupt port activities and affect foreign trade are beyond Embecta&#8217;s control and could materially disrupt its supply of product from any of these locations, increase its costs, and/or adversely affect its results of operations. Further, following the COVID-19 pandemic there may be increased pressure for United States medical device companies to reduce dependency on China for their supply chain and reevaluating nearshoring strategies. Embecta takes precautions to ensure that its third-party contractors and logistics entities safeguard Embecta&#8217;s assets, including insurance, health and safety protocols, and off-site storage of computer data. However, a natural or other disaster, such as a fire or flood, could cause substantial delays in Embecta&#8217;s operations, damage or destroy its manufacturing equipment and/or inventory and cause it to incur additional expenses. The insurance Embecta maintains may not be adequate to cover its losses in any particular case. With or without insurance, damage to Embecta&#8217;s facility, manufacturing equipment, inventory or other property or to any of its suppliers, may have a material adverse effect on Embecta&#8217;s business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A significant amount of Embecta&#8217;s inventories of finished goods is stored in distribution centers around the world, but primarily in various distribution centers in the United States and Europe. Embecta takes precautions to safeguard its facilities and data infrastructure. However, vandalism, terrorism, unplanned power outages, cyberattacks or a natural disaster, such as an earthquake, fire or flood, or other catastrophic event, could damage or destroy Embecta&#8217;s inventories of component supplies and finished goods, cause substantial delays in its operations, result in the loss of key information, result in reduced sales, and cause Embecta to incur additional expenses. Embecta&#8217;s insurance coverage may not be sufficient to provide coverage with respect to the damages incurred in any particular case, and its insurance carrier may deny coverage with respect to all or a portion of its claims. Regardless of the level of insurance coverage or other precautions taken, damage to Embecta&#8217;s facilities may have a material adverse effect on is business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Insurance coverage may be inadequate or unavailable to cover any product liability losses Embecta incurs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s business exposes it to potential product liability claims that are inherent in the design, manufacture, testing, inspection, and sale of medical devices. Embecta is subject to product liability lawsuits alleging that component failures, manufacturing flaws, manufacturing defects, negligence in manufacturing, design defects, negligence in design, or inadequate disclosure of product-related risks, warnings, or product-related information resulted in an unsafe condition, injury or death to customers. The risk of one or more product liability claims or lawsuits may be even greater after Embecta launches new products with new features or enters new markets where it has no prior experience selling its products and relies on newly-hired staff or new independent distributors or contractors to provide new customer training and customer support. In addition, the misuse of Embecta&#8217;s products or the failure of customers to adhere to operating guidelines could cause significant harm to customers, including death, which could result in product liability claims. Product liability lawsuits and claims, safety alerts or product recalls, with or without merit, regardless of any available insurance coverage, could cause Embecta to incur substantial costs, and could place a significant strain on its financial resources, divert the attention of management from Embecta&#8217;s core business, harm Embecta&#8217;s reputation and adversely affect its ability to attract and retain customers, any of which could have a material adverse effect on Embecta&#8217;s business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta is subject to a number of restrictive covenants under its indebtedness, including customary operating restrictions and financial covenants, which could restrict Embecta's ability to pay dividends or adversely affect its financing options and liquidity position.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta's current indebtedness contains, and any future indebtedness may contain, customary operating restrictions and financial covenants. This indebtedness may adversely affect Embecta's ability to operate or grow its business or could have other material adverse consequences, including by:</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">limiting Embecta's ability to obtain additional financing in the future for working capital, capital expenditures and acquisitions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">limiting Embecta's ability to refinance its indebtedness on terms acceptable to Embecta or at all;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">restricting Embecta's operations or development plans;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">requiring Embecta to dedicate a significant portion of its cash flows from operations to paying amounts due under its indebtedness, thereby reducing funds available for other corporate purposes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">impeding Embecta's ability to pay dividends;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">making Embecta more vulnerable to economic downturns; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">limiting Embecta's ability to withstand competitive pressures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any of these restrictions on Embecta's ability to operate its business in its discretion could adversely affect its business by, among other things, limiting Embecta's ability to adapt to changing economic, financial or industry conditions and to take advantage of corporate opportunities, including opportunities to obtain debt financing, repurchase stock, refinance or pay principal on Embecta's outstanding debt, dispose of property, complete acquisitions for cash or debt, or make other investments. In addition, events beyond Embecta's control, including prevailing economic, financial, and industry conditions, could affect Embecta's ability to satisfy applicable financial covenants, and Embecta cannot assure you that it will satisfy them.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any failure to comply with the restrictions of Embecta's current indebtedness, or any future financing agreements, including as a result of events beyond Embecta's control, may result in an event of default under these agreements, which in turn may result in defaults or acceleration of obligations under these agreements and other agreements, giving Embecta's lenders and other debt holders the right to terminate any commitments they may have made to provide Embecta with further funds and to require Embecta to repay all amounts then outstanding.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta is subject to risks associated with public health threats, such as the COVID-19 pandemic, which could have a material adverse effect on Embecta's financial condition and results of operation. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta is subject to risks associated with public health threats, such as the COVID-19 pandemic. Public health threats have the potential to significantly impact Embecta&#8217;s supply chain if the manufacturing plants that produce its products, raw materials or product components, the distribution centers where Embecta manages its inventory or the operations of its logistics and other service providers, including third parties that sterilize its products, are disrupted, temporarily closed or experience worker shortages for a sustained period of time. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s manufacturing sites in China, Ireland and the United States, where Embecta manufactures a significant amount of products, largely avoided any significant disruption due to the COVID-19 pandemic. However, notwithstanding that each of these communities has experienced a relative recovery in COVID-19 transmission and a lessening of restrictions related to COVID-19, a future outbreak of a public health threat, including COVID-19, at any of Embecta&#8217;s manufacturing sites in China, Ireland and/or the United States or in the surrounding communities, could lead to delays in the manufacturing of Embecta&#8217;s products, which could have a material adverse effect on Embecta&#8217;s business and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Moreover, any resurgence in COVID-19 infections, including due to new variants of the virus for which current vaccines may not be effective, and public health measures could result in the imposition of new governmental lockdowns, quarantine requirements or other restrictions to slow the spread of the virus. The extent to which fear of exposure to or actual effects of COVID-19, new variants, disease outbreak, epidemic or a similar widespread health concern impacts our business will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the speed and extent of geographic spread of the disease, the duration of the outbreak, travel restrictions, the efficacy of vaccination and treatment; impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy, the timing, scope and effectiveness of U.S. and international governmental response, and the impact on the health, well-being and productivity of our employee. These could result in closures or other restrictions that significantly disrupt Embecta&#8217;s operations or those of distributors or suppliers in Embecta&#8217;s supply chain, which could adversely affect Embecta's financial condition. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to the Separation from BD</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta has a limited history of operating as an independent company, and its historical financial information may not be a reliable indicator of its future results. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain historical information about Embecta in this Annual Report on Form 10-K refers to the diabetes care business as operated by and integrated with BD. Certain historical financial information of Embecta&#8217;s fiscal year 2022 included in this Annual Report on Form 10-K is derived from the accounting records of BD. Accordingly, certain historical financial information included in this Annual Report on Form 10-K does not necessarily reflect the financial condition, results of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">operations or cash flows that we would have achieved in previous fiscal years as a separate, publicly traded company during such periods or those that Embecta will achieve in the future primarily as a result of the factors described below: </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Generally, prior to the Separation, Embecta&#8217;s working capital requirements and capital for its general corporate purposes, including capital expenditures and acquisitions, were historically satisfied as part of the corporate-wide cash management policies of BD. On a going forward basis, Embecta&#8217;s results of operations and cash flows may be more volatile, and it may need to obtain additional financing from banks, through public offerings or private placements of debt or equity securities, strategic relationships or other arrangements, which may or may not be available and may be more costly. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Prior to the Separation, Embecta&#8217;s business was operated by BD as part of its broader corporate organization, rather than as an independent company. BD or one of its affiliates performed various corporate functions for us, such as legal, treasury, accounting, auditing, human resources, investor relations, and finance. The historical financial results for the periods prior to the Separation reflect allocations of corporate expenses from BD for such functions, which are likely to be less than the expenses we would have incurred had we operated as a separate publicly traded company. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta&#8217;s business shared economies of scope and scale in costs, employees, vendor relationships and customer relationships with BD. While we have sought to minimize the impact on Embecta when separating these arrangements, there is no guarantee these arrangements will continue to capture these benefits in the future. While Embecta has entered into transition agreements that govern certain commercial and other relationships between it and BD, those arrangements may not capture the benefits to Embecta's business that resulted from being integrated with the other affiliates of BD.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Prior to the Separation, Embecta&#8217;s business utilized the advantage of BD&#8217;s overall size and scope to procure more advantageous arrangements. As a standalone company, Embecta may be unable to obtain similar arrangements to the same extent as BD did, or on terms as favorable as those BD obtained, prior to completion of the Separation. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The cost of capital for Embecta&#8217;s business may be higher than when Embecta was integrated with BD and leveraged BD&#8217;s cost of capital. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Other significant changes may occur in Embecta&#8217;s cost structure, management, effective tax rate, financing and business operations as a result of operating as a company separate from BD. For additional information about the past financial performance of its business and the basis of presentation of the historical combined financial statements, see Item 7 and Item 8 of this Annual Report on Form 10-K. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Since the Separation, Embecta&#8217;s financial profile has changed, and it is a smaller, less diversified company than BD prior to the Separation. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Separation has resulted in Embecta being a smaller, less diversified company than BD. As a result, Embecta may be more vulnerable to changing market conditions, which could have a material adverse effect on its business, financial condition and results of operations. In addition, the diversification of Embecta&#8217;s revenues, costs, and cash flows has diminished as a standalone company, such that its results of operations, cash flows, working capital and financing requirements may be subject to increased volatility and its ability to fund capital expenditures and investments, pay dividends and service debt may be diminished. We also have less capital allocation efficiency and flexibility, as Embecta no longer has access to cash flows from BD to fund Embecta&#8217;s business.  </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta may not achieve some or all of the expected benefits of the Separation. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta may not be able to achieve the full strategic and financial benefits expected to result from the Separation, or such benefits may be delayed or not occur at all. The Separation is expected to provide the following benefits, among others: (1) enabling management of Embecta to more effectively pursue the distinct operating priorities and strategies of its business; (2) permitting Embecta to allocate financial resources to meet the unique needs of its business, which will allow us to intensify our focus on distinct strategic priorities and to more effectively pursue our own distinct capital structures and capital allocation strategies; (3) allowing Embecta to more effectively articulate a clear investment thesis to attract a long-term investor base suited to our business and providing investors with a distinct and targeted investment opportunity; (4) creating an independent equity security tracking Embecta&#8217;s underlying business, affording Embecta with direct access to the capital markets and facilitating its ability to consummate future acquisitions or other transactions using its common stock; and (5) permitting Embecta to more effectively recruit, retain and motivate employees through the use of stock-based compensation that more closely aligns management and employee incentives with specific business goals and objectives related to Embecta&#8217;s business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta may not achieve these and other anticipated benefits for a variety of reasons, including, among others: (1) the ongoing transition and separation activities may demand significant management resources and require significant amounts of management&#8217;s time and effort, which may divert management&#8217;s attention from operating and growing Embecta&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">business; (2) Embecta may be more susceptible to market fluctuations, and other adverse events than if it were still a part of BD because Embecta&#8217;s business is less diversified than BD&#8217;s businesses prior to the completion of the Separation; (3) as a standalone company, Embecta may be unable to obtain certain goods, services and technologies at prices or on terms as favorable as those BD obtained prior to completion of the Separation; (4) the Separation may require Embecta to pay costs that could be substantial and material to its financial resources, including accounting, tax, legal and other professional services costs, recruiting and relocation costs associated with hiring key senior management and personnel new to Embecta, tax costs and costs to separate information systems, including its enterprise resource planning systems; (5) under the terms of the tax matters agreement that Embecta entered into with BD, it is restricted from taking certain actions that could cause the distribution or certain related transactions to fail to qualify as tax-free to BD and BD shareholders, or could result in certain other taxes to BD, and these restrictions may limit us for a period of time from pursuing certain strategic transactions and equity issuances or engaging in other transactions that might increase the value of its business; and (6) the contractual arrangements between Embecta and BD are on less favorable terms than the prior existing intercompany arrangements from which Embecta benefited, and such arrangements may be inadequate to provide for the ongoing operation and growth of Embecta&#8217;s business. If Embecta fails to achieve some or all of the benefits expected to result from the Separation, or if such benefits are delayed, it could have a material adverse effect on its competitive position, business, financial condition, results of operations and cash flows. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">In order to conduct its operations and meet its financial reporting and other obligations, Embecta relies on certain services provided by BD pursuant to the transaction documents entered into with BD in connection with the Separation, including the TSA and the LSA.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If Embecta is unable to extend the services on the terms contemplated by the Extension or replace the services that BD currently provides to it on terms that are at least as favorable to Embecta as the terms on which BD is providing these services, or if BD otherwise terminates any of the services, Embecta&#8217;s business, financial condition and results of operations may be materially adversely affected. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, Embecta and BD entered into various agreements, including a Separation and Distribution Agreement, a TSA, an LSA, a tax matters agreement, an employee matters agreement, a cannula supply agreement, contract manufacturing agreements, an intellectual property matters agreement, distribution agreements and other transaction agreements.  See &#8220;Agreements Related to the Separation&#8221; in Item 1. Certain of these agreements provide for the performance of services by each company for the benefit of the other for a period of time after the Separation.  Embecta relies on certain services provided by BD pursuant to the TSA, the LSA, and other transaction agreements entered into with BD in connection with the Separation, including with respect to information technology, procurement, quality and regulatory affairs, medical affairs, tax and treasury services, distribution logistics, shared services infrastructure support and enterprise resource planning, accounting and reporting and other systems, in order to conduct its operations and meet its financial reporting and other obligations.  Embecta and BD have agreed to extend certain services under the TSA, the LSA and other transaction agreements in a limited set of markets, subject to the condition described below, to support the Interim Business Continuity Processes. The Extension is being entered into to reduce potential operational disruptions related to certain services that BD currently provides to Embecta pursuant to the TSA, the LSA, and other transaction agreements, which Embecta has determined will likely not be fully replaced prior to April 1, 2024, the date by which several such services were to terminate prior to the Extension. The Extension is conditioned upon BD obtaining the Supplemental PLR.  Although Embecta believes that BD will be able to obtain the Supplemental PLR, such process may be delayed, the Supplemental PLR may not be obtained, and there can be no assurance that the Supplemental PLR will be obtained by March 31, 2024, or at all. If the Extension does not occur, Embecta&#8217;s business, financial condition and results of operations would be adversely affected. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s ability to effectively manage and operate its business depends significantly on the systems provided by BD.  For example, Embecta currently relies upon BD to perform certain activities in markets in which it is unable to independently import, distribute, buy or sell certain products pending its receipt of required licenses, permits, and regulatory registrations. Embecta also relies on the services provided by BD to meet its financial reporting and other obligations.  This includes relying on certain services from BD for material financial consolidation and reporting design and operation disclosure controls and procedures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Once the TSA, the LSA, and other transaction agreements, or any extension thereto, expire or terminate, if Embecta is unable to extend or replace the services that BD currently provides to it under the TSA, the LSA and other transaction agreements, until it is able to extend such services, complete the steps necessary to perform these services itself or otherwise materially replace these services on substantially similar terms and conditions, Embecta may not be able to effectively operate its business or maintain effective financial and management controls and reporting systems. This could impair Embecta&#8217;s ability to effectively sell, distribute and commercialize its products, generate revenue, comply with local regulatory regulations, meet SEC reporting obligations and internal control over financial reporting, maintain its stock exchange listing, service its existing indebtedness and comply with the debt covenants under its existing indebtedness. Any such occurrence may have a material adverse effect on Embecta&#8217;s business, financial condition and results of operations.   </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, Embecta may not be successful in timely, effectively or efficiently implementing these systems and services or in transitioning from BD&#8217;s systems to Embecta&#8217;s systems.  Embecta will continue to engage in the process of creating its </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">own, or engaging third parties separate from BD to provide, systems and services to replace many of the systems and services that BD currently provides to Embecta once the TSA, the LSA and other transaction agreements, or any extension thereto, expires or is terminated including, for example, information technology infrastructure, enterprise resource planning and other systems, logistics, employee, customer, vendor and accounting support services, distribution and regulatory support and services and accounting and reporting systems. Embecta expects this process to be complex, time-consuming and costly. Embecta may incur temporary interruptions in business operations if it cannot transition effectively from BD&#8217;s existing operating systems, logistics, distribution and regulatory support, databases and programming languages that support these functions to its own systems. The failure to implement the new systems and transition data successfully and cost-effectively could disrupt Embecta&#8217;s business operations, including preventing Embecta from paying suppliers and employees, receiving revenue from its customers, entering into new agreements, selling or delivering products in certain jurisdictions, complying with financial reporting and other obligations and performing administrative or other services on a timely basis, which could adversely affect Embecta&#8217;s financial condition and results of operations.  In addition, Embecta&#8217;s costs for the operation of these systems may be higher than the amounts reflected in its historical combined financial statements.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Following the end of the transition period, Embecta will be required to rebrand its products to remove the BD name, transfer or obtain new manufacturing, supply chain, regulatory and product licenses and registrations in the name of Embecta, which could adversely affect its ability to attract and maintain customers and end users or which could result in delays or interruptions of Embecta's commercialization and distribution operations or the loss of customers and revenue, all of which could adversely affect its financial conditions and results of operations. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta has historically marketed its products using the &#8220;BD&#8221; name and logo, which is a globally recognized brand with a strong reputation for high-quality products among people with diabetes and Embecta&#8217;s distributors. Under the terms of the agreements entered into with BD in connection with the Separation and Distribution, Embecta received a temporary license to use the &#8220;BD&#8221; and &#8220;Becton Dickinson&#8221; name and logo on its products and marketing, certain legal entities and relevant regulatory registrations. Following the expiration of this license, Embecta will be required to rebrand and update, as applicable, its products and marketing, manufacturing, supply chain, and regulatory registrations and licenses using the &#8220;Embecta&#8221; name or other names and marks and remove the &#8220;BD&#8221; name and logo on its products and marketing, registrations and licenses. These new names and brands may not benefit from the same recognition and association with product quality as the BD name, which could adversely affect Embecta&#8217;s ability to attract and maintain its customers and end users, who may prefer to use products with a stronger brand identity. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The failure to timely transfer, or in certain instances obtain new, registrations and licenses in the &#8220;Embecta&#8221; name could result in delays or interruptions in Embecta&#8217;s ability to continuously commercialize, import, export, market, promote, sell and otherwise distribute its products to its customers. This could result in customer dissatisfaction and turnover to our competitors, which could further result in loss of revenue for Embecta. In addition, Embecta will be required to closely collaborate with its customers, and ensure the proper changes, modifications, system inputs, supply chain logistics, administration, and adjudication operations are properly transitioned within the customer&#8217;s internal infrastructure, processes and systems, in order to successfully achieve the transition. Embecta&#8217;s or its customer&#8217;s inability to properly achieve these transitions could result in disruptions to Embecta&#8217;s product end-to-end product flow management and end-user access to products, which could adversely affect Embecta&#8217;s financial condition and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta has incurred debt obligations that could adversely affect its business and profitability and its ability to meet other obligations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta currently has approximately $1,636 million in aggregate principal amount of indebtedness outstanding as of September&#160;30, 2023 (not including undrawn commitments of $500 million under its revolving credit facility). Embecta may also incur additional indebtedness in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This significant amount of debt could potentially have important consequences to Embecta and its debt and equity investors, including: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">requiring a substantial portion of its cash flow from operations to make interest payments; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">making it more difficult to satisfy debt service and other obligations; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">increasing the risk of a future credit ratings downgrade of its debt, which could increase future debt costs and limit the future availability of debt financing; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">increasing its vulnerability to general adverse economic and industry conditions; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow its business; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">limiting Embecta&#8217;s flexibility in planning for, or reacting to, changes in its business and the industry; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">placing Embecta at a competitive disadvantage relative to its competitors that may not be as highly leveraged with debt; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">limiting Embecta&#8217;s ability to borrow additional funds as needed or take advantage of business opportunities as they arise, pay cash dividends or repurchase ordinary shares. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the extent that Embecta incurs additional indebtedness, the foregoing risks could increase. In addition, Embecta&#8217;s actual cash requirements in the future may be greater than expected. Its cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and Embecta may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to refinance its debt. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta may be affected by significant restrictions under the tax matters agreement, including on its ability to engage in certain corporate transactions for a two-year period after the distribution, in order to avoid triggering significant tax-related liabilities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under current United States federal income tax law, a spin-off that otherwise qualifies for tax-free treatment can be rendered taxable to the parent corporation and its stockholders as a result of certain post-spin-off transactions, including certain acquisitions of shares or assets of the spun-off corporation. Under the tax matters agreement that Embecta entered into with BD, Embecta is restricted from taking certain actions that could prevent the distribution and certain related transactions from being tax-free for United States federal income tax purposes, or could result in certain other taxes to BD. In particular, under the tax matters agreement, for the two-year period following the Separation Date, as described in the section entitled &#8220;Agreements Related to the Separation,&#8221; in Item 1 of this Annual Report on Form 10-K, Embecta is subject to specific restrictions on its ability to pursue or enter into acquisition, merger, sale and redemption transactions with respect to Embecta stock. These restrictions may limit Embecta&#8217;s ability to pursue certain strategic transactions or other transactions that it may believe to be in the best interests of its stockholders or that might increase the value of its business. In addition, under the tax matters agreement, Embecta may be required to indemnify BD and its affiliates against any tax-related liabilities incurred by them as a result of the acquisition of Embecta&#8217;s stock or assets, even if Embecta does not participate in or otherwise facilitate the acquisition, or as a result of certain other actions taken by Embecta. Furthermore, Embecta will be subject to specific restrictions on discontinuing the active conduct of its trade or business, the issuance or sale of stock or other securities (including securities convertible into Embecta stock but excluding certain compensatory arrangements), and sales of assets outside the ordinary course of business. Such restrictions may reduce Embecta&#8217;s strategic and operating flexibility. For more information, see the section entitled &#8220;Agreements Related to the Separation&#8221; in Item 1 of this Annual Report on Form 10-K. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta may be held liable to BD if it fails to perform under its agreements with BD, and the performance of such services may negatively affect Embecta&#8217;s business and operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, Embecta and BD entered into various Separation Agreements that provide for the performance of certain services by each company for the benefit of the other for a period of time after the Separation. If Embecta does not satisfactorily perform its obligations under these agreements, it may be held liable for any resulting losses suffered by BD, subject to certain limits. In addition, during the transition services periods under the transition services agreement, Embecta&#8217;s management and employees may be required to divert their attention away from its business in order to provide services to BD, which could adversely affect Embecta&#8217;s business. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s agreements with BD may be on terms that are less beneficial to Embecta than the terms may have otherwise been from unaffiliated third parties. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Separation Agreements were prepared in the context of the Separation while Embecta was still a wholly owned subsidiary of BD. Accordingly, during the period in which the terms of those agreements were prepared, Embecta did not have an independent Board of Directors or a management team that was independent of BD. As a result, the terms of those agreements may not reflect terms that would have resulted from arm&#8217;s-length negotiations between unaffiliated third parties. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If there is a determination that the distribution or certain related transactions are taxable for United States federal income tax purposes, BD and its stockholders could incur significant tax liabilities, and Embecta could incur significant liabilities pursuant to its indemnification obligations under the tax matters agreement. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BD received a private letter ruling from the Internal Revenue Service (&#8220;IRS&#8221;) to the effect that, among other things, the Separation and the Distribution will qualify as a transaction that is tax-free for United States federal income tax purposes under Sections 368(a)(1)(D), 355, and 361 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). It was a condition to the distribution that BD receive (i) a private letter ruling from the IRS, satisfactory to the BD Board of Directors, regarding certain United States federal income tax matters relating to the Separation and Distribution and (ii) an opinion of its outside tax counsel, satisfactory to the BD Board of Directors, regarding the qualification of the contribution of assets from BD to Embecta and the distribution, taken together, as a &#8220;reorganization&#8221; within the meaning of Sections </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">368(a)(1)(D) and 355 of the Code and such opinion has not been withdrawn or rescinded. The opinion of its outside tax counsel and the private letter ruling are based upon and rely on, among other things, various facts and assumptions, as well as certain representations, statements and undertakings of BD and Embecta, including facts, assumptions, representations, statements and undertakings relating to the past and future conduct of the companies&#8217; respective businesses and other matters. If any of these facts, assumptions, representations and statements are or become inaccurate or incomplete, or if any such undertaking is not complied with, BD may not be able to rely on the opinion of its outside tax counsel or the private letter ruling, and the conclusions reached therein could be jeopardized. Further, the Extension is conditioned upon BD obtaining the Supplemental PLR. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Notwithstanding BD&#8217;s receipt of a private letter ruling from the IRS and the opinion of its outside tax counsel, the IRS could determine on audit that the distribution or certain related transactions are taxable for United States federal income tax purposes if it determines that any of the facts, assumptions, representations, statements and undertakings upon which the private letter ruling or the opinion was based are incorrect or have been violated, or if it disagrees with any of the conclusions in the opinion. Additionally, although Embecta believes that BD will be able to obtain the Supplemental PLR, such process may be delayed, the Supplemental PLR may not be obtained, and there can be no assurance that the Supplemental PLR will be obtained by March 31, 2024, or at all. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accordingly, notwithstanding BD&#8217;s receipt of a private letter ruling from the IRS and the opinion of its outside tax counsel, there can be no assurance that the IRS will not assert that the distribution or certain related transactions do not qualify for tax-free treatment for United States federal income tax purposes, or that a court would not sustain such a challenge. In the event the IRS were to prevail in such a challenge, BD and BD&#8217;s shareholders could incur significant tax liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under the tax matters agreement that Embecta entered into with BD, Embecta generally is required to indemnify BD for any taxes incurred by BD that arise as a result of any representations made by Embecta being inaccurate or Embecta taking or failing to take, as the case may be, certain actions, including in each case those provided in connection with the private letter ruling from the IRS or the opinion of its outside tax counsel that result in the distribution and certain related transactions failing to qualify as tax-free for United States federal income tax purposes or result in certain other taxes to BD, which indemnity is also applicable in connection with the Extension.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any such indemnification could materially adversely affect Embecta&#8217;s financial condition, results of operations and cash flows. For a more detailed discussion, see &#8220;Agreements Related to the Separation&#8221; in Item 1 of this Annual Report on Form 10-K. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The transfer to Embecta of certain contracts, permits and other assets and rights may require the consents, approvals of, or provide other rights to, third parties and governmental authorities. If such consents or approvals are not obtained, Embecta may not be entitled to the full benefit of such contracts, permits and other assets and rights, which could increase its expenses or otherwise harm its business and financial performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The separation and distribution agreement provides that certain contracts, permits and other assets and rights are to be transferred from BD or its subsidiaries to Embecta or its subsidiaries in connection with the Separation. The transfer of certain of these contracts, permits and other assets and rights may require consents or approvals of third parties or governmental authorities or provide other rights to third parties. In addition, in some circumstances, Embecta and BD are joint beneficiaries of contracts, and Embecta and BD may need the consents of third parties in order to split or separate the existing contracts or the relevant portion of the existing contracts to Embecta or BD. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Some parties may use consent requirements or other rights to seek to terminate contracts or obtain more favorable contractual terms from us, which, for example, could take the form of unfavorable price increases. This could require us to expend additional resources in order to obtain the services or assets previously provided under the contract, or require us to seek arrangements with new third parties or obtain letters of credit or other forms of credit support. If Embecta is unable to obtain required consents or approvals, it may be unable to obtain the benefits, permits, assets and contractual commitments that are intended to be allocated to Embecta as part of its Separation from BD, and Embecta may be required to seek alternative arrangements to obtain services and assets that may be more costly and/or of lower quality. The termination or modification of these contracts or permits or the failure to timely complete the transfer or separation of these contracts or permits could negatively affect Embecta&#8217;s business, financial condition, results of operations and cash flows. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The closing of the Separation was deferred in certain jurisdictions, and may not occur at all in such jurisdictions, due to local regulatory requirements, which may adversely affect Embecta&#8217;s manufacturing, business, financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The closing of the transfer of certain assets related to the Diabetes Care Business in certain jurisdictions, including China, Mexico, and Italy, as contemplated by the Separation and Distribution Agreement did not occur at the Separation and may not occur due to local regulatory requirements. If Embecta is unable to obtain required approval of local regulators or otherwise comply with such local regulatory requirements to effect the Separation in these jurisdictions, it may be unable to obtain the assets that are intended to be allocated to Embecta as part of its separation from BD. A temporary suspension of manufacturing operations associated with the regulatory approvals and transitions, including for inspections, may be required. A temporary suspension of manufacturing operations has already been initiated in China. These temporary </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">suspensions, and any unforeseen delays in the termination of any suspension, may ultimately impact Embecta&#8217;s ability to continuously supply its products to such jurisdictions and any other markets that receive such products. The failure to timely complete the transfer of these local assets or interruptions resulting from these foreign transfers could negatively affect Embecta&#8217;s business, financial condition, results of operations and cash flows.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Satisfaction of indemnification obligations could have a material adverse effect on Embecta&#8217;s financial condition, results of operations and cash flows. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Separation and Distribution Agreement and certain other agreements Embecta entered into with BD in connection with the separation and distribution, BD agreed to indemnify Embecta for certain liabilities, and Embecta will agree to indemnify BD for certain liabilities as discussed further in &#8220;Agreements Related to the Separation&#8221; in Item 1 of this Annual Report on Form 10-K. Indemnities that Embecta will be required to provide BD could negatively affect Embecta&#8217;s business, particularly with respect to indemnities provided in the tax matters agreement. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The indemnity from BD may not be sufficient to protect Embecta against the full amount of such liabilities if, for example, BD is not able to fully satisfy its indemnification obligations. Moreover, even if Embecta ultimately succeeds in recovering from BD any amounts for which it is held liable, Embecta may be temporarily required to bear these losses itself, requiring Embecta to divert cash that would otherwise have been used in furtherance of its operating business. In addition, third parties could also seek to hold Embecta responsible for any of the liabilities that BD has agreed to retain. Each of these risks could have a material adverse effect on Embecta&#8217;s financial condition, results of operations and cash flows. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Embecta Common Stock </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The price of Embecta common stock may fluctuate significantly, and stockholders could lose all or part of their investment in Embecta. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We cannot predict the prices at which shares of Embecta common stock may trade. Given the competitiveness of the life sciences and medical device industry, the prices at which shares of Embecta common stock trade may fluctuate more significantly than might otherwise be typical, even with other market conditions, including general volatility, held constant. This volatility could negatively impact Embecta&#8217;s ability to raise additional capital or utilize equity as consideration in any acquisition transactions Embecta may pursue, and could make it more difficult for existing stockholders to sell their shares of the common stock at a price they consider acceptable or at all. The market price of Embecta common stock may fluctuate significantly due to a number of factors, some of which may be beyond our control, including: </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">actual or anticipated fluctuations in Embecta&#8217;s operating results, including those associated with the Interim Business Continuity Processes; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta&#8217;s liquidity and ability to obtain additional capital, including the market&#8217;s reaction to any capital-raising transaction Embecta may pursue; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">changes in earnings estimated by securities analysts or Embecta&#8217;s ability to meet those estimates; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the operating and stock price performance of comparable companies; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">sales of substantial amounts of Embecta&#8217;s common stock, or the perception that substantial amounts of Embecta&#8217;s common stock may be sold, by stockholders in the public market; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">changes to the regulatory and legal environment under which Embecta operates; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">any negative decisions by the FDA or similar regulatory bodies inside and outside of the United States regarding Embecta&#8217;s products and product candidates; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">actual or anticipated fluctuations in commodities prices; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">analyst research reports, recommendation and changes in recommendations, price targets, and withdrawals of coverage;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">changes in the diabetes care landscape, including changes to consumer habits and market dynamics for means and methods of insulin delivery or alternative means of diabetes management without the use of insulin or by delaying the use of insulin; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">domestic and worldwide economic conditions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the stock market in general, and the market for stock of companies in the life sciences and medical device industries in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of comparable companies. In the past, following periods of volatility in the overall market and the market price of a particular company&#8217;s securities, securities class action litigation has often been instituted against a company. This type of litigation, if instituted against Embecta, could result in substantial costs and a diversion of its management&#8217;s attention and resources. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Your percentage of ownership in Embecta may be diluted in the future. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the future, your percentage ownership in Embecta may be diluted because of equity issuances for acquisitions, capital market transactions or otherwise, including any equity awards that Embecta will grant to its directors, officers and employees. Embecta employees will have stock-based awards granted from time to time based on various employee benefit plans. Such awards will have a dilutive effect on Embecta&#8217;s earnings per share, which could adversely affect the market price of Embecta common stock.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta cannot guarantee the timing, amount or payment of dividends on its common stock. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta currently expects that it will pay a regular cash dividend. However, the timing, declaration, amount and payment of any dividends will be within the discretion of Embecta&#8217;s Board of Directors, and will depend upon many factors, including Embecta&#8217;s financial condition, earnings, capital requirements of its operating subsidiaries, covenants associated with certain of Embecta&#8217;s debt service obligations, legal requirements, regulatory constraints, industry practice, ability to access capital markets, and other factors deemed relevant by Embecta&#8217;s Board of Directors. Moreover, Embecta cannot guarantee that it will continue to pay any dividends in the future and cannot guarantee the amount of any such dividends. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Anti-takeover provisions could enable Embecta&#8217;s Board of Directors to resist a takeover attempt by a third-party and limit the power of its stockholders. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s amended and restated certificate of incorporation and amended and restated bylaws contain, and Delaware law contains, provisions that are intended to deter coercive takeover practices and inadequate takeover bids by making such practices or bids unacceptably expensive to the bidder and to encourage prospective acquirers to negotiate with Embecta&#8217;s Board of Directors rather than to attempt a hostile takeover. These provisions include, among others: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">until the annual stockholder meeting in 2026, Embecta&#8217;s Board of Directors will be divided into three classes, with each class consisting, as nearly as may be possible, of one-third of the total number of directors, which could have the effect of making the replacement of incumbent directors more time consuming and difficult; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">as long as the Board of Directors is classified, Embecta directors can be removed by stockholders only for cause; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">vacancies occurring on the Board of Directors can only be filled by a majority of the remaining members of Embecta&#8217;s Board of Directors or by a sole remaining director; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">stockholders do not have the right to call a special meeting or act by written consent; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Embecta&#8217;s Board of Directors has the power to designate and issue, without any further vote or action by the Embecta stockholders, shares of preferred stock from time to time in one or more series; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">stockholders have to follow certain procedures and notice requirements in order to present certain proposals or nominate directors for election at stockholder meetings. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, Embecta will be subject to Section 203 of the Delaware General Corporate Law, which could have the effect of delaying or preventing a change of control that you may favor. Section 203 provides that, subject to limited exceptions, persons that acquire, or are affiliated with persons that acquire, more than 15% of the outstanding voting stock of a Delaware corporation may not engage in a business combination with that corporation, including by merger, consolidation or acquisitions of additional shares, for a three-year period following the date on which that person or any of its affiliates becomes the holder of more than 15% of the corporation&#8217;s outstanding voting stock. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe these provisions will protect Embecta stockholders from coercive or otherwise unfair takeover tactics by requiring potential acquirers to negotiate with Embecta&#8217;s Board of Directors and by providing the Board with more time to assess any acquisition proposal. These provisions are not intended to make Embecta immune from takeovers; however, these provisions will apply even if the offer may be considered beneficial by some stockholders and could delay or prevent an acquisition that Embecta&#8217;s Board of Directors determines is not in the best interests of Embecta and its stockholders. These provisions may also prevent or discourage attempts to remove and replace incumbent directors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, an acquisition or further issuance of Embecta common stock could trigger the application of Section 355(e) of the Code, causing the distribution to be taxable to BD. Under the tax matters agreement, Embecta would be required to indemnify BD for the resulting tax, and this indemnity obligation might discourage, delay or prevent a change of control that Embecta stockholders may consider favorable. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Embecta&#8217;s amended and restated certificate of incorporation designates the state courts within the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by Embecta stockholders, which could discourage lawsuits against Embecta and its directors and officers. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s amended and restated certificate of incorporation provides that, unless Embecta (through approval of the Board of Directors) consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (1) any derivative action brought on behalf of Embecta, (2) any action asserting a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">claim of breach of a fiduciary duty owed by any director or officer or other employee of Embecta to Embecta or Embecta&#8217;s stockholders, (3) any action asserting a claim against Embecta or any director or officer or other employee of Embecta arising pursuant to, or seeking to enforce any right, obligation or remedy under, any provision of the Delaware General Corporation Law (&#8220;DGCL&#8221;) or Embecta&#8217;s amended and restated certificate of incorporation or amended and restated bylaws (as either may be amended from time to time), (4) any action asserting a claim against Embecta or any director or officer or other employee of Embecta governed by the internal affairs doctrine, which is a conflict of laws principle which recognizes that only one state should have the authority to regulate a corporation&#8217;s internal affairs or (5) any action as to which the DGCL (as it may be amended from time to time) confers jurisdiction on the Court of Chancery of the State of Delaware. If and only if the Court of Chancery of the State of Delaware dismisses any such action for lack of subject matter jurisdiction, such action may be brought in another state court sitting in the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware). These exclusive forum provisions will apply to all covered actions, including any covered action in which the plaintiff chooses to assert a claim or claims under federal law in addition to a claim or claims under Delaware law. These exclusive forum provisions will not apply to actions asserting only federal law claims under the Securities Act of 1933, as amended, (the "Securities Act") or the Securities Exchange Act of 1934, as amended (the "Exchange Act") regardless of whether the state courts in the State of Delaware have jurisdiction over those claims. Although Embecta believes the exclusive forum provision benefits it by providing increased consistency in the application of law in the types of lawsuits to which it applies, the provision may limit the ability of Embecta stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with Embecta or its directors or officers, and it may be costlier for Embecta stockholders to bring a claim in the Court of Chancery of the State of Delaware than other judicial forums, each of which may discourage such lawsuits against Embecta and its directors and officers. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although Embecta&#8217;s amended and restated certificate of incorporation includes this exclusive forum provision, it is possible that a court could rule that this provision is inapplicable or unenforceable. Alternatively, if a court were to find this exclusive forum provision inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings described above, Embecta may incur additional costs associated with resolving such matters in other jurisdictions, which could negatively affect its business, results of operations and financial condition. </span></div><div id="i209d71ebb5944f1aadd70761506c49b3_28"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 1B. Unresolved Staff Comments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_31"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 2. Properties.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta's corporate headquarters is located in Parsippany, New Jersey, USA. The Company also maintains secondary regional headquarters at leased office facilities in Eysins, Switzerland and Shanghai, China. The Company has a global research and development center in a leased office/lab facility located in Andover, Massachusetts, USA. Embecta has three manufacturing facilities located in Ireland, the United States, and China which occupy an aggregate of approximately 800,000 square feet of floor space. Due to certain regulatory requirements resulting in the delay of the local closing of the Separation in China, BD and its respective subsidiaries have agreed to hold the relevant Embecta assets in China for the use and benefit of Embecta and its respective subsidiaries entitled to such assets in this location and to manage and operate this business on behalf of Embecta in the ordinary course of business in accordance with the past practice of the Diabetes Care Business. Embecta and BD have agreed to defer this local affiliate closing at this location to the time when such regulatory approvals are received.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 3. Legal Proceedings. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are from time to time subject to claims and litigation arising in the ordinary course of business. These claims and litigation may include, among other things, allegations of violations of United States and foreign health regulation and privacy laws and related regulations, as well as claims or litigation relating to product liability, intellectual property, breach of contract and tort, environmental, securities and employment matters. We operate in multiple jurisdictions and, as a result, claims in one jurisdiction may lead to claims or regulatory penalties in other jurisdictions. There can be no assurance as to the ultimate outcome of a legal proceeding; however, we intend to defend vigorously against any pending or future claims and litigation, other than matters deemed appropriate for settlement. We accrue a liability for legal claims when payments associated with the claims become probable and the costs can be reasonably estimated. The actual costs of resolving legal claims may be substantially higher or lower than the amounts accrued for those claims. As of September 30, 2023, we were not a party to or subject to any material proceedings.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_37"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 4. Mine Safety Disclosures. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Not applicable. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_43"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Market Information</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta&#8217;s common stock is listed on the Nasdaq Global Select Market ("Nasdaq") under the symbol "EMBC". As of October 31, 2023, there were approximately 6,900 stockholders of record. This number does not include beneficial owners who hold Embecta's common stock in nominee or "street name" accounts through brokers or banks.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fiscal year ended September 30, 2023, Embecta did not repurchase any of its outstanding common stock.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Dividends</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">On December 20, 2022, Embecta's Board of Directors declared a quarterly dividend of $0.15 for each issued and outstanding share of Embecta's common stock. The dividend was paid on January 11, 2023 to stockholders of record at the close of business on December 30, 2022.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">On February 14, 2023, Embecta's Board of Directors declared a quarterly dividend of $0.15 for each issued and outstanding share of Embecta's common stock. The dividend was paid on March 13, 2023 to stockholders of record at the close of business on February 27, 2023.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">On May 12, 2023, Embecta's Board of Directors declared a quarterly dividend of $0.15 for each issued and outstanding share of Embecta's common stock. The dividend was paid on June 13, 2023 to stockholders of record at the close of business on May 29, 2023.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">On August 8, 2023, Embecta's Board of Directors declared a quarterly dividend of $0.15 for each issued and outstanding share of Embecta's common stock. The dividend was paid on September 13, 2023 to stockholders of record at the close of business on August 25, 2023.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">On November 21, 2023, Embecta's Board of Directors declared a quarterly dividend of $0.15 for each issued and outstanding share of Embecta's common stock. The dividend is payable on December 15, 2023 to stockholders of record at the close of business on December 4, 2023.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Performance Graph</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following graph compares the cumulative total stockholder returns for the period from the Separation Date of April 1, 2022 to September 30, 2023 for (i) Embecta's common stock; (ii) the Nasdaq Composite Index; (iii) the Dow Jones U.S. Select Medical Equipment Index which is comprised of medical equipment companies; and (iv) the S&amp;P Smallcap 600 Health Care Index. For the year ended September 30, 2023, the Company has elected to present the S&amp;P Smallcap 600 Healthcare index for its peer group comparison. The Company believes that the holdings of this index more accurately reflect its peer companies. Since the Dow Jones U.S. Select Medical Equipment Index was presented in the prior year, it has also been presented in the current year for comparison purposes. The graph assumes an investment of $100 on April 1, 2022 through the last trading day of the year ended September 30, 2023. The calculation of cumulative stockholder return includes reinvestment of dividends in the common stock and in each index. The performance shown is not necessarily indicative of future performance.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><img src="embc-20230930_g2.jpg" alt="Picture1.jpg" style="height:430px;margin-bottom:5pt;vertical-align:text-bottom;width:518px"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Unregistered Sales Of Equity Securities And Use Of Proceeds</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We did not sell any unregistered equity securities during the three months ended September 30, 2023.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_49"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 6. [ Reserved ]</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_52"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The following discussion and analysis should be read in conjunction with the Consolidated Financial Statements and accompanying notes presented in Item 8 of this Annual Report on Form 10-K. Within the tables presented throughout this discussion, certain columns may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Dollar amounts are in millions except per share amounts or as otherwise specified. References to years throughout this discussion relate to our fiscal years, which end on September 30.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_55"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Company Overview </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are a leading global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. As we approach our 100-year centennial, we believe that our products have become one of the most widely recognized and respected brands in diabetes management throughout the world. We estimate that our products are used by more than 30 million people in over 100 countries for insulin administration and to aid with the daily management of diabetes. Our business traces its origins to 1924, when BD developed the first dedicated insulin syringe. Since then, we have built a world-class organization with a unique manufacturing supply chain and commercial footprint.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have a broad portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices, which are complemented by our proprietary digital application designed to assist people with managing their diabetes. Our conventional pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. We also sell safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Our conventional and safety pen needles are compatible and frequently used with widely available pen injectors in the market today. In addition to pen needles, we sell sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. We also sell safety insulin syringes, which have a sliding safety shield that can be activated with one-hand after the injection to help prevent needlestick exposure and injury during injection and disposal.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We primarily sell our products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_58"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Separation from BD </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Separation and Distribution Agreement, the Separation from BD was completed on April 1, 2022. On March 22, 2022, the record date for the distribution, 57,012,925 issued and outstanding shares of Embecta common stock were distributed pro-rata to BD stockholders as of the close of business, determined by applying a ratio of one share of Embecta common stock for every five shares of BD common stock. "Regular-way" trading of Embecta common stock began on April 1, 2022, under the ticker symbol "EMBC".</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Prior to Separation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the Company was referred to as the Diabetes Care Business. For periods prior to April 1, 2022, the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K included certain assets and liabilities that were historically held at the BD corporate level, but are specifically identifiable or otherwise allocable to the Diabetes Care Business. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Post Separation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the periods subsequent to April 1, 2022, as a standalone publicly traded company, Embecta presents its financial statements on a consolidated basis. The Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K have been prepared in accordance with accounting principles generally accepted in the United States of America.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_61"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Key Trends Affecting Our Results of Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Competition. The regions in which we conduct our business and the medical devices industry in general are highly competitive. We face significant competition from a wide range of companies in a highly regulated industry. These include large companies with multiple product lines, some of which may have greater financial and marketing resources than us, as well as smaller more specialized companies. Non-traditional entrants, such as technology companies, are also entering into the diabetes care industry and its adjacent markets, some of which may have greater financial and marketing resources than us.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pricing Pressures. The increased scrutiny by regulators on healthcare spending, which accelerated in light of the COVID-19 pandemic, along with a shift towards volume-based procurement and group purchasing organizations, which generally values lower cost over product features, benefits and quality, have placed significant pressure on Embecta to lower price in both developed and emerging markets. These trends may reduce our operating margins, which are only partially offset by our ability to differentiate our products and sell at higher prices</span><span style="background-color:#ffffff;color:#70ad47;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commoditization of Injection Devices. Given the growing demand for medical devices to assist in the treatment of diabetes and difficulties around access to diabetes care due to complex and costly insurance plans, patient care is increasingly focused on providing more affordable products, which has led to the commoditization of more traditional injection delivery devices, such as insulin syringes and pen needles. Existing and new local and regional low-cost providers, in combination with a shift from insulin vials to insulin pens, have made the pen needle category highly competitive. This has forced providers to provide clinical evidence to differentiate their products.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Changes in Clinical Practice. Introduction of new drugs and increased penetration of oral anti-diabetic drugs (e.g., SGLT-2s), GLP-1s and GLP-1 combination products have delayed initiation of insulin therapy and contributed to less demand for our products. New drug therapies in development are targeted to challenge the current diabetes treatment paradigm, including insulin use. Insulin therapy in developed markets continues to transition to infusion pumps.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Decentralization of Chronic Care. Many countries are facing an aging population and a rapidly growing number of people living with diabetes. While healthcare investments in certain regions continue to grow, there is an increased burden on physicians and longer wait times for patients. Healthcare delivery for non-emergency diabetes care is expected to continue shifting outside of hospitals to primary care providers, which could have a material impact on our results of operations.</span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Political and Economic Instability in Emerging Markets. We operate in a number of emerging markets, many of which are subject from time to time to significant political and economic disruptions. However, the number of countries we provide products to and our proactive channel management strategies help us manage this variability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Recent Developments</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continue to face increases in the cost and disrupted availability of raw materials, components, and other inputs necessary to manufacture and distribute our products due to constraints and inflation within the global supply chain, as well as increases in the cost and time to distribute our products. To date we have been able to successfully mitigate this disruption and provide uninterrupted supply to our customers by increasing our inventory levels and taking other measures.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continue to monitor and respond to the escalating conflict in Ukraine and the associated sanctions and other restrictions. We also are monitoring and responding to the Israel-Hamas war. As of November&#160;29, 2023, there is no material impact to our business operations and financial performance in Ukraine and Israel. The full impact of the conflicts on our business operations and financial performance remains uncertain and will depend on future developments, including the severity and duration of the conflicts and their impact on regional and global economic conditions. We will continue to monitor and respond to the conflicts and assess the related restrictions and other effects on our business. See Item 1A of this Annual Report on Form 10-K for further details.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, our revenues and results of operations have been affected by various fluctuations in macroeconomic conditions and regulatory and policy changes, both on a global level and in particular markets, which include inflation and slowing economic growth and contractions, a rising interest rate environment, supply chain interruptions, tariff policy changes, volatility in capital markets and the availability of credit, tax rates and the rate of exchange between the United States dollar and foreign currencies. The nature and extent of the impact of these factors among others varies by region and remains uncertain and unpredictable and may affect our business.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_70"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Results of Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For a discussion of Results of Operations of fiscal year 2022 compared to fiscal year 2021 see our Annual Report on Form 10-K for the year ended September 30, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the years ended September&#160;30, 2023 and 2022, our Consolidated Statements of Income are as follows: </span></div><div style="margin-bottom:6pt;margin-top:15pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.175%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,120.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,129.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of products sold</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">370.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">354.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Gross Profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">749.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">774.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling and administrative expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">341.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">294.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">85.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">66.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Impairment expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">58.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">99.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">528.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">465.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">221.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">309.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(107.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(46.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income Before Income Taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">105.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">256.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income tax provision</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">33.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">70.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">223.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net Income per common share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Year Ended September&#160;30, 2023 Summary (on a comparative basis)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Key financial results for the year ended September 30, 2023 were as follows: </span></div><div style="margin-top:8pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Revenue decreased by $8.7 million to $1,120.8 million from $1,129.5 million; </span></div><div style="margin-top:8pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Gross profit decreased by $25.0 million to $749.9 million, compared to $774.9 million. Gross profit as a percent of revenue was 66.9%, as compared to 68.6% in the prior year comparative period;</span></div><div style="margin-top:8pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Operating income decreased by $88.1&#160;million to $221.5&#160;million from $309.6&#160;million; and </span></div><div style="margin-top:8pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Net income decreased by $153.2&#160;million to $70.4 million from $223.6 million. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_769"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenues</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:115%">Our revenues decreased by $8.7&#160;million, or 0.8%, to $1,120.8 million for the twelve months ended September 30, 2023 as compared to revenues of $1,129.5 million for the twelve months ended September 30, 2022. The decrease in revenues was primarily driven by $26.5 million associated with the negative impact of foreign currency translation primarily due to the strengthening of the U.S. dollar and a $1.9 million decrease in contract manufacturing related to sales of non-diabetes products to BD. This was partially offset by $19.7 million of favorable changes in price and volume.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues by geographic region are as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.627%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.659%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">601.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">600.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">519.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">529.2</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,120.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,129.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cost of products sold</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cost of products sold increased by $16.3 million, or 4.6%, to $370.9&#160;million for the year ended September 30, 2023 as compared to $354.6&#160;million for the year ended September 30, 2022. Cost of products sold as a percentage of revenues were 33.1% for the year ended September 30, 2023 as compared to 31.4% for the year ended September 30, 2022. The increase in cost of products sold between periods was primarily driven by the impact of inflation on the costs of certain raw materials (including freight), direct labor, and overhead. The increase was also driven by higher costs associated with the Cannula Supply Agreement with BD post Separation. We intend to continue to work to improve productivity to help partially offset these increased costs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating expenses in 2023 and 2022 were as follows:</span></div><div style="margin-top:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.769%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.267%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Increase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Millions of dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and administrative expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">% of revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">nm = not meaningful</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Selling and administrative expenses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our selling and administrative expenses increased by $46.5 million, or 15.8%, to $341.3&#160;million for the year ended September 30, 2023 as compared to $294.8&#160;million for the year ended September 30, 2022. The increase year over year was primarily driven by an increase in compensation and benefit costs due to increased headcount attributed to the Separation and Embecta becoming a stand-alone publicly-traded company. Also contributing to the increase period over period were costs incurred attributed to the LSA with BD whereby BD provides Embecta with certain order-to-cash and logistics services to support certain commercial operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Research and development expenses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our research and development expenses increased by $18.3 million, or 27.4%, to $85.2&#160;million for the year ended September 30, 2023 as compared to $66.9&#160;million for the year ended September 30, 2022. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase was primarily attributed to increased investment in new products which includes our insulin patch pump as well as amounts paid in connection with a collaboration arrangement. For details on the collaboration arrangement refer to Note 5 to the Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Impairment expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2023, the Company recorded impairment charges of $2.5&#160;million related to the abandonment of certain manufacturing equipment in China that is no longer in use that were inherited as part of the spin from BD. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Machinery, equipment and fixtures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in our Consolidated Balance Sheets in Item 8 of this Annual Report on Form 10-K. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Impairment expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2022, the Company recorded impairment charges of $58.9&#160;million related to the abandonment of certain manufacturing production lines in the United States that are no longer expected to be completed. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Construction in progress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in our Consolidated Balance Sheets in Item 8 of this Annual Report on Form 10-K. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Impairment expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other operating expenses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We incurred other operating expenses of $99.4&#160;million and $44.7 million for the years ended September&#160;30, 2023 and 2022, respectively. The costs incurred primarily relate to accounting, auditing, and legal services, including costs to establish certain stand-alone corporate functions and other costs associated with the abandonment of certain manufacturing production lines discussed above. As we continue to stand-up various corporate functions as a stand-alone publicly-traded company, we expect to incur costs associated with the same type of activities in fiscal year 2024, however, we currently expect the amount of those costs to be less in fiscal year 2024 as compared to fiscal year 2023. During the year ended September 30, 2023, the Company recorded approximately $5.6 million of severance costs related to the optimization of certain business functions. These costs were primarily recorded in the U.S. and severance costs were not material to any comparable prior year periods presented.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Interest expense, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest expense, net increased to $107.0 million for the year ended September 30, 2023, from $46.2 million for the year ended September 30, 2022 primarily as a result of debt having been outstanding for a longer period of time for fiscal year 2023 as compared to fiscal year 2022 and higher interest rates on our variable rate debt. This was offset by an increase in interest income of $8.8 million as a result of amounts held in interest bearing accounts and money market funds. If the United States Federal Reserve maintains interest rates at these levels, or continues to raise the benchmark interest rate, then we would expect the interest expense on our variable rate debt to increase in fiscal year 2024 as compared to fiscal year 2023. See "Liquidity and Capital Resources" below and Note 12 to the Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K for a further description of our long-term debt.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other income (expense), net</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other income (expense), net decreased by $2.0 million to $(8.8) million for the year ended September&#160;30, 2023 as compared to $(6.8) million for the year ended September 30, 2022. The costs incurred primarily relate to amounts due to BD for income taxes payable incurred in deferred jurisdictions where BD is considered the primary obligor.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Income tax provision</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase in the Company's effective income tax rate for fiscal year 2023 as compared to fiscal year 2022 was primarily due to the establishment of a valuation allowance against interest expense carryforwards in the U.S., an increase in U.S. tax on foreign earnings primarily because of limitations on the utilization of foreign tax credits and higher withholding taxes on unremitted foreign earnings; partially offset by increased tax benefits from non-taxable items and change in geographical mix of earnings.  In addition, for fiscal year 2023 the Company recorded a tax benefit for the establishment of net deferred tax assets incurred in connection with the ongoing separation of the Diabetes Care Business from BD partially offset by a return to provision adjustment from the prior year.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2023, the Company has recorded deferred taxes on the undistributed earnings of foreign subsidiaries.  The vast majority of these taxes were accrued, in part, because the Company does not meet certain holding period requirements for stock ownership.  During fiscal year 2024, the Company anticipates that it will meet these requirements at </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">which time approximately $18.0 million of the accrued balance as of September 30, 2023 will be recorded as a reduction to income tax expense.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_85"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For discussion on Liquidity and Capital Resources pertaining to the fiscal years 2022 and 2021 see our Annual Report on Form 10-K for the year ended September 30, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe that our cash and our cash equivalents and cash from operations, together with our borrowing capacity under our revolving credit facility, will provide sufficient financial flexibility to fund seasonal and other working capital requirements, capital expenditures, debt service requirements and other obligations, cash dividends on common shares and additional growth opportunities for the foreseeable future. However, should it become necessary, we believe that our credit profile should provide us with access to additional financing in order to fund normal business operations, make interest payments, fund growth opportunities and satisfy upcoming debt maturities.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Debt-Related Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2022, and in connection with the Separation, Embecta issued $500.0 million aggregate principal amount of 5.00% senior secured notes due February 15, 2030 (the "5.00% Notes"). </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest payments on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.00%</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes are due semi-annually in February and August until maturity. Interest payments began in August 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2022, Embecta entered into a credit agreement, providing for a Term Loan B Facility (the "Term Loan") in the amount of $950.0 million, with a </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">seven</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-year </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">term that matures in March 2029 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a Revolving Credit Facility in an aggregate principal amount of up to $500.0&#160;million, with a </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">five</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-year term that matures in 2027. </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The interest rate on the Term Loan is 300 basis points over the secured overnight financing rate (&#8220;SOFR&#8221;), with a 0.50% SOFR floor. Principal and interest payments on the Term Loan began on June 30, 2022. Such quarterly principal payments are calculated as 0.25% of the initial principal amount, with the remaining balance payable upon maturity. Principal amounts repaid under the Term Loan may not be reborrowed by us. Borrowings under the Revolving Credit Facility bear interest, at Embecta&#8217;s option, initially at an annual rate equal to (a) in the case of loans denominated in United States dollars (i) the SOFR or (ii) the alternate base rate or (b) in the case of loans denominated in Euros, the EURIBOR rate, in each case plus an applicable margin specified in the credit agreement. A commitment fee applies to the unused portion of the Revolving Credit Facility, equal to 0.25% per annum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. As of September&#160;30, 2023, no amount has been drawn on the Revolving Credit Facility. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, Embecta has outstanding $200.0 million of senior secured notes (the "6.75% Notes"), which </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">carry an interest rate of 6.75% and are due February 2030. </span><span style="background-color:#ffffff;color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest payments on the 6.75% Notes are due semi-annually in February and August until maturity. Interest payments began in August 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The credit agreement and the indentures for the 5.00% Notes and the 6.75% Notes contain customary financial covenants, including a total net leverage ratio covenant, which measures the ratio of (i) consolidated total net debt to (ii) consolidated earnings before interest, taxes, depreciation and amortization, and subject to other adjustments, must meet certain defined limits which are tested on a quarterly basis in accordance with the terms of the credit agreement and indentures governing the 5.00% Notes and the 6.75% Notes. In addition, the credit agreement contains covenants that limit, among other things, our ability to prepay, redeem or repurchase our subordinated and junior lien debt, incur additional debt, make acquisitions, merge with other entities, pay dividends or distributions, redeem or repurchase equity interests, and create or become subject to liens. As of September&#160;30, 2023, we were in compliance with all of such covenants. The credit agreement and the senior secured are secured by substantially all assets of Embecta and each subsidiary guarantor, subject to certain exceptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a summary of Embecta's total debt outstanding as of September&#160;30, 2023:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">935.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-align:justify;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.00% Notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">500.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:10pt;text-align:justify;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.75% Notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">200.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total principal debt issued</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,635.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(9.5)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(32.4)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,593.9</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The schedule of principal payments required on long-term debt for the next five years and thereafter is as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain measures relating to our total debt outstanding as of September&#160;30, 2023 were as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,603.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Short-term debt as a percentage of total debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average cost of total debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Leases</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In conjunction with the Separation, we entered into a lease agreement with BD pursuant to which the Company would lease approximately 278,000 square feet of manufacturing space and equipment at BD's manufacturing facility in Holdrege, Nebraska for an initial term of ten years. The lease is classified as a finance lease. The Company has an option to extend the lease term for an additional period of up to five years.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, we entered into a real estate lease for a new Corporate Headquarters located in Parsippany, New Jersey, United States. The lease commenced during the second quarter of fiscal year 2023 and has an initial term of ten years. The lease is classified as an operating lease. The Company has options to extend the lease for an additional period of six years and to extend for a subsequent additional period of four years after the expiration of the first extension period.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Maturities of our finance lease and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">54.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">27.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">82.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Factoring Agreements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In conjunction with the Separation, we entered into Trade Receivable Factoring Agreements (the "Factoring Agreements") with BD. Embecta owes BD a service fee calculated as 0.1% of annual revenues related to countries subject to the agreement, in exchange for the services provided by BD pursuant to the Factoring Agreements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Access to Capital and Credit Ratings </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2023 and June 2023, Moody&#8217;s Investor Services and Standard &amp; Poor&#8217;s Ratings Services published updates to our credit ratings of Ba3 and B+, respectively. These ratings remain unchanged from the initial published ratings from January 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash and cash equivalents were $326.5 million as of September 30, 2023 as compared to $330.9 million as of September 30, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The primary sources and uses of cash that contributed to the $4.4 million decrease were:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2022 Cash and cash equivalents balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used for investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used for financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2023 Cash and cash equivalents balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net cash provided by operating activities was primarily attributable to:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash adjustments related to depreciation and amortization, impairment of property, plant and equipment, stock-based compensation, and deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in trade receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in amounts due from/due to Becton, Dickinson and Company</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in income and other net taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in other assets and liabilities, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase in accounts payable and accrued expenses is primarily due to increases in net liabilities for deferred closing entities, which was offset by our annual incentive bonus payment in January 2023. The decrease in trade receivables primarily relates to the timing of payments received from customers. The increase in inventories is primarily driven by a concerted effort to build inventory to meet expected demand in anticipation of our enterprise resource planning ("ERP") system platform go-live dates and process to comply with European Union Regulation MDR. The increase in amounts due from/due to Becton, Dickinson and Company primarily relates to factored receivables and inventory purchases for which payment has not yet been collected from BD as of September 30, 2023. Increases in prepaid expenses and other are primarily driven by increased subscription contracts primarily associated with our new ERP platform and increases in net assets for deferred closing entities. The decrease in income and other net taxes payable was primarily due to the timing of required tax payments. The increase in other assets and liabilities, net is primarily due to costs capitalized associated with the implementation of our new ERP system. All other movements related to working capital were due to timing of payments and receipts of cash in the ordinary course of business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net cash used for investing activities was primarily attributable to $26.5&#160;million of capital expenditures during the year to support further expansion of our business and operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net cash used for financing activities was primarily attributable to:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments related to tax withholding for stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on finance lease</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_665"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contractual Obligations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contractual obligations as of September 30, 2023, which require material cash requirements in the future, consist of purchase obligations and lease obligations. Purchase obligations are enforceable and legally binding obligations for purchases of goods and services which include inventory purchase commitments. Over the next several years, we expect to incur significant costs associated with information technology infrastructure as we continue to transition to our own systems. Lease obligations include lease agreements for which a contract has been signed even if the lease has not yet commenced. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2023, total payments due for purchase obligations and lease obligations aggregate to approximately $227 million and $82 million, respectively, and will be expended over the next several years. Contractual obligations due within the next twelve months approximate $141 million related to purchase commitments and $9 million related to lease obligations.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_97"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Critical Accounting Policies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following discussion supplements the descriptions of our accounting policies contained in Note 3 to the Consolidated Financial Statements contained in Item 8 of this Annual Report on Form 10-K. Financial Statements and Supplementary Data. The preparation of the Consolidated Financial Statements requires management to use estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements. Some of those judgments can be subjective and complex and, consequently, actual results could differ from those estimates. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. For any given estimate or assumption made by management, it is possible that other people applying reasonable judgment to the same facts and circumstances could develop different estimates. Actual results that differ from management&#8217;s estimates could have an unfavorable effect in our Consolidated Financial Statements. Management believes the following critical accounting policies reflect the more significant judgments and estimates used in the preparation of the Consolidated Financial Statements:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our revenues are primarily recognized when the customer obtains control of the product sold, which is generally upon shipment or delivery, depending on the delivery terms specified in the distribution or sales agreement.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our gross revenues are subject to a variety of deductions, which include rebates, chargebacks, sales discounts and sales returns. These deductions represent estimates of the related obligations, and judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates are based upon prices determined under our agreements with the end-user customers. Additional factors considered in the estimate of our rebate liability include the quantification of inventory that is either in stock at or in transit to our distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Stock-Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We expense all stock-based payment awards to employees over the requisite service period based on the grant date fair value of the awards. The fair value of certain stock-based awards that have been granted in the past are determined using the Black-Scholes-Merton ("BSM") option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the awards.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax basis of assets and liabilities at the applicable tax rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We maintain valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, we evaluate factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, the Company engages in transactions in which tax consequences may be subject to uncertainty. The Company conducts business and files tax returns in numerous jurisdictions based on its interpretation of tax laws and regulations. In evaluating the Company&#8217;s tax provision, the Company establishes a reserve for uncertain tax positions </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">unless such positions are determined to be more likely than not of being sustained upon examination based on the technical merits. The Company&#8217;s policy is to recognize, when applicable, interest and penalties on uncertain tax positions as part of income tax expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, our operations were included in the tax returns of BD. Income taxes as presented in the Consolidated Financial Statements attribute current and deferred income tax assets and liabilities of BD to us in a manner that is systematic, rational, and consistent with the asset and liability method prescribed by the accounting guidance for income taxes. Our income tax provision prior to the Separation was prepared using the separate return method. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if we were a separate taxpayer and a standalone enterprise. We believe the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additional disclosures regarding our accounting for income taxes are provided in Note 14 to the Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_100"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cautionary Statements Regarding Forward-Looking Statements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Annual Report on Form 10-K contains statements that constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995 and other securities laws. Forward-looking statements include those containing such words as &#8220;anticipates,&#8221; &#8220;believes,&#8221; "can," &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;forecasts,&#8221; &#8220;goal,&#8221; &#8220;guidance,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;outlook,&#8221; &#8220;plans,&#8221; "possible," &#8220;projects,&#8221; &#8220;seeks,&#8221; &#8220;sees,&#8221; &#8220;should,&#8221; &#8220;targets,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or other words of similar meaning. All statements that reflect Embecta&#8217;s expectations, assumptions or projections about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, forecasts relating to discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth and cash flows) and statements regarding Embecta&#8217;s strategy for growth, future product development, regulatory clearances and approvals, competitive position and expenditures. Forward-looking statements are based upon our present intent, beliefs or expectations, are not guarantees of future performance and are subject to numerous risks, uncertainties, and changes in circumstances that are difficult to predict. Although Embecta believes that the expectations reflected in any forward-looking statements it makes are based on reasonable assumptions, it can give no assurance that these expectations will be attained and it is possible that actual results may differ materially from those indicated by these forward-looking statements due to a variety of risks and uncertainties. Such risks and uncertainties include, but are not limited to: </span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Competitive factors that could adversely affect Embecta&#8217;s operations, including adoption of new drug therapies for treatment of diabetes, new product introductions by Embecta&#8217;s competitors, the development of new technologies, lower cost producers that create pricing pressure and consolidation resulting in companies with greater scale and market presence than Embecta. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The risk that Embecta is unable to extend the TSA, the LSA, and other transaction agreements or replace the services, including the Interim Business Continuity Processes, that BD currently provides to it on substantially similar terms as the terms on which BD is providing these services or that BD terminates such services.</span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Any failure by BD to perform its obligations under the various separation agreements entered into in connection with the Separation and distribution, including the cannula supply agreement. </span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Any events that adversely affect the sale or profitability of one of Embecta&#8217;s key products or the revenue delivered from sales to its key customers. </span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Increases in operating costs, including fluctuations in the cost and availability of oil-based resins, other raw materials, and energy as well as certain components, used in its products, the ability to maintain favorable supplier arrangements and relationships, and the potential adverse effects of any disruption in the availability of such items. </span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Changes in reimbursement practices of governments or private payers or other cost containment measures. </span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The adverse financial impact resulting from unfavorable changes in foreign currency exchange rates, as well as regional, national and foreign economic factors, including inflation, deflation, and fluctuations in interest rates, and their potential effect on its operating performance. </span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of changes in United States, federal laws, and policy that could affect fiscal and tax policies, healthcare and international trade, including import and export regulation and international trade agreements. In particular, tariffs or other trade barriers imposed by the United States or other countries could adversely impact its supply chain costs or otherwise adversely impact its results of operations.</span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Any new pandemic, such as COVID-19, or any geopolitical instability on Embecta&#8217;s business, including disruptions in its operations and supply chains. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">New or changing laws and regulations affecting Embecta&#8217;s domestic and foreign operations, or changes in enforcement practices, including laws relating to healthcare, environmental protection, trade, monetary and fiscal policies, taxation (including tax reforms that could adversely impact multinational corporations) and licensing and regulatory requirements for products. </span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The expected benefits of the Separation from BD. </span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Risks associated with indebtedness and our use of indebtedness available to us.</span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The risk that ongoing dis-synergy costs, costs of restructuring transactions and other costs incurred in connection with the Separation will exceed Embecta's estimates of these costs. </span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The impact of the Separation on Embecta's businesses and the risk that the full Separation may be more difficult, time-consuming or costly than expected, including the impact on its resources, systems, including enterprise resource planning, procedures and controls, diversion of management&#8217;s attention and the impact on relationships with customers, suppliers, employees and other business counterparties.</span></div><div style="margin-top:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The risk that we may not complete strategic collaborative partnerships and acquisition opportunities that enable us to accelerate our growth or strategic collaborative opportunities that give us access to innovative technologies, complementary product lines, and new markets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There can be no assurance that the transactions or uncertainties described above will in fact be consummated or occur in the manner described or at all. As a result, you should not place undue reliance upon our forward-looking statements. The above list of factors is not exhaustive or necessarily in order of importance. For additional information on identifying factors that may cause actual results to vary materially from those stated in forward-looking statements, see the discussions under Item 1A, &#8220;Risk Factors,&#8221; or in our other filings with the SEC. Any forward-looking statement speaks only as of the date on which it is made, and Embecta expressly disclaims and assumes no obligation to update or revise such statement, whether as a result of new information, future events or otherwise, except as required by applicable law. </span></div><div id="i209d71ebb5944f1aadd70761506c49b3_103"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 7A. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to the items noted below, the information required by this item is included in Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, and in Notes 3, 12 and 15 to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K, and is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Foreign Currency Exchange and Other Rate Risks</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We operate on a global basis and are exposed to the risk that changes in foreign currency exchange rates could adversely affect our financial condition, results of operations and cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, we enter into foreign currency forward exchange contracts with major financial institutions to manage currency exposures for transactions denominated in a currency other than an entity&#8217;s functional currency. As a result, the impact of foreign currency gains/losses recognized in earnings are partially offset by gains/losses on the related foreign currency forward exchange contracts in the same reporting period. Refer to Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments and Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K for further information.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consequently, foreign currency exchange contracts would not subject us to material risk due to exchange rate movements, because gains and losses on these contracts offset gains and losses on the assets, liabilities or transactions being hedged. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> - Our interest rate risk as of September 30, 2023 relates primarily to our Term Loan. The interest rate is set at 300 basis points over the SOFR, with a 0.50% SOFR floor. Based on our outstanding borrowings at September&#160;30, 2023, a 100 basis points change in interest rates would have impacted interest expense on the Term Loan by $9.4 million on an annualized basis. To the extent we borrow on our revolving credit facility, we will also be subject to risks related to changes in SOFR. Refer to Note 12 to the Consolidated Financial Statements in Item 8 of this Annual Report on Form 10-K for further information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 8. Financial Statements and Supplementary Data.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_898"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the Shareholders and the Board of Directors of Embecta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Corp.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Opinion on the Financial Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have audited the accompanying consolidated balance sheets of Embecta Corp (the Company) as of September 30, 2023 and 2022, the related consolidated statements of income, comprehensive income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> equity, and cash flows for each of the three years in the period ended September 30, 2023, and the related notes</span><span style="background-color:#f4f4f4;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at September 30, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended September 30, 2023, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of September 30, 2023, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework)&#160;and our report dated November&#160;29, 2023 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Critical Audit Matter</span><span style="background-color:#f4f4f4;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures</span><span style="background-color:#f4f4f4;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to which it relates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income Taxes</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt;margin-top:3.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Notes 3 and 14 to the consolidated financial statements, the Company&#8217;s provision for income taxes post-Separation contemplates its stand-alone legal entity structure. The Company&#8217;s income tax provision for 2023 was $35.3 million. In addition, as of September 30, 2023, the Company recorded a liability for unrecognized tax benefits of $7.2 million, and total deferred tax assets and liabilities of $78.1 million and $33.3 million, respectively.  </span></div><div style="margin-bottom:8pt;margin-top:3.75pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Given the multi-jurisdictional nature of the business, the complexity of the tax rules across the various countries the Company operates in, and the stand-alone legal entity structure, auditing management&#8217;s accounting for uncertain tax positions required a high degree of auditor judgment and increased extent of effort, including the need to involve our tax subject matter professionals.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s evaluation of uncertain tax positions, including assessment of technical merits of positions.  With the support of our tax subject matter professionals, our audit procedures included evaluating the appropriateness of transfer pricing assumptions underlying the income tax provision. For example, we developed an expectation of the foreign income tax expense by jurisdiction and compared it to the recorded balances.  We involved our tax subject matter professionals to evaluate the technical merits of the Company&#8217;s accounting for its tax positions, including assessing correspondence with the relevant tax authorities and evaluating third-party advice obtained.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-36">ERNST &amp; YOUNG LLP</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-37">New York, New York</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">November&#160;29, 2023</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_938"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%;text-decoration:underline">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the Shareholders and the Board of Directors of Embecta Corp. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Opinion on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have audited Embecta Corp&#8217;s internal control over financial reporting as of September 30, 2023, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), (the COSO criteria). In our opinion, Embecta Corp. (the Company) maintained, in all material respects, effective internal control over financial reporting as of September 30, 2023, based on the COSO criteria.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements of the Company as of September 30, 2023 and 2022, the related consolidated statements of income, comprehensive income and cash flows for each of the three years in the period ended September 30, 2023, and the related notes and our report dated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">November&#160;29, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:6pt;margin-top:24pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ ERNST &amp; YOUNG LLP</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">New York, New York </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">November&#160;29, 2023</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Embecta Corp. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended September 30</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">R<span style="-sec-ix-hidden:f-38"><span style="-sec-ix-hidden:f-39"><span style="-sec-ix-hidden:f-40">evenues</span></span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-41">1,120.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-42">1,129.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-43">1,165.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="-sec-ix-hidden:f-44"><span style="-sec-ix-hidden:f-45"><span style="-sec-ix-hidden:f-46"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-47">370.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-48">354.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="f-49">364.9</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Gross Profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-50">749.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-51">774.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="f-52">800.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-53">341.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-54">294.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="f-55">240.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-56">85.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-57">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-58">63.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Impairment expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-59">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="f-60">58.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="f-61">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherGeneralExpense" scale="6" id="f-62">99.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherGeneralExpense" scale="6" id="f-63">44.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherGeneralExpense" scale="6" id="f-64">4.8</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-65">528.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-66">465.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="f-67">308.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating Income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-68">221.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-69">309.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-70">492.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="f-71">107.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="f-72">46.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:fixed-zero" scale="6" id="f-73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-74">8.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-75">6.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="f-76">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-77">105.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-78">256.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-79">494.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-80">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-81">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-82">80.1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 68.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-83">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-84">223.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-85">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net Income per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-86">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-87">3.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-88">7.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-89">1.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-90">3.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-91">7.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:10.909%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">For periods prior to the Separation, this income statement line includes cost of products sold from related party inventory purchases. Refer to Note 4 for further detail.</span></ix:footnote></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See notes to the Consolidated Financial Statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Embecta Corp.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended September 30</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net Income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-92">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-93">223.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-94">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other Comprehensive Income (Loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Benefit plan net loss and prior service credit, net of amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-95">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="6" id="f-97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-98">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-99">64.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-100">8.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 11pt;text-indent:-10pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-101">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-102">64.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-103">8.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-104">86.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-105">159.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-106">405.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See notes to the Consolidated Financial Statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Embecta Corp.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">September 30</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-107">326.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-108">330.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:47.37pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Trade receivables, net (net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-109">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-110">1.3</ix:nonFraction> million as of September&#160;30, 2023 and September&#160;30, 2022, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-111">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-112">22.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Inventories:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 68.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="6" id="f-113">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="6" id="f-114">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 68.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="f-115">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="f-116">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 68.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="f-117">111.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="f-118">93.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 68.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-119">152.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-120">122.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Amounts due from Becton, Dickinson and Company</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="f-121">142.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="f-122">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-123">111.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-124">77.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 68.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Current Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="f-125">749.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="f-126">664.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Property, Plant and Equipment, Net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-127">300.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-128">301.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Goodwill and Other Intangible Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-129">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-130">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred Income Taxes and Other Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="f-131">140.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" scale="6" id="f-132">95.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-133">1,214.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-134">1,086.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Liabilities and Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 42.37pt;text-align:left;text-indent:-22.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="f-135">53.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="f-136">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="f-137">118.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="f-138">104.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Amounts due to Becton, Dickinson and Company</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsPayableOtherCurrent" scale="6" id="f-139">73.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccountsPayableOtherCurrent" scale="6" id="f-140">66.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Salaries, wages and related items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-141">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-142">48.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current debt obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-143">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-144">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-145">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-146">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-147">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-148">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 68.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Current Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-149">353.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-150">301.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred Income Taxes and Other Liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" scale="6" id="f-151">57.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" scale="6" id="f-152">46.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Long-Term Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-153">1,593.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-154">1,598.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non Current Finance Lease Liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-155">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-156">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Commitments and Contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-6" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-157"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-7" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-158"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Embecta Corp. Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:47.37pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-159"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-160">0.01</ix:nonFraction></ix:nonFraction> par value</span></div><div style="padding-left:47.37pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Authorized - <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-161"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-162">250,000,000</ix:nonFraction></ix:nonFraction></span></div><div style="padding-left:47.37pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Issued and outstanding - <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-163"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-164">57,333,353</ix:nonFraction></ix:nonFraction> as of September&#160;30, 2023 and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-165"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-166">57,055,327</ix:nonFraction></ix:nonFraction> as of September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-167">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="f-168">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="f-169">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AdditionalPaidInCapital" scale="6" id="f-170">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-171">541.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-172">577.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-173">309.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-174">324.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 68.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-175">821.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-176">891.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Liabilities and Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-177">1,214.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-178">1,086.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See notes to the Consolidated Financial Statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Equity </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Embecta Corp.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net Investment from Becton, Dickinson and Company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance at October 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-179">833.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-180">261.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-181">572.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income attributable to Diabetes Care Business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-182">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-183">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive loss, net of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-184">8.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-185">8.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net transfers to Becton, Dickinson and Company</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="embc:NetParentInvestmentNetTransfersToParent" scale="6" id="f-186">383.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentNetTransfersToParent" scale="6" id="f-187">383.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-188">864.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-189">270.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-190">594.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance at October 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-191">864.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-192">270.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-193">594.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net transfers to Becton, Dickinson and Company including Separation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="embc:NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" scale="6" id="f-194">390.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" sign="-" name="embc:NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" scale="6" id="f-195">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" scale="6" id="f-196">380.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Issuance of common stock in connection with the Separation and reclassification of Net Investment from Becton, Dickinson and Company</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-197">57,012,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" scale="6" id="f-198">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" scale="6" id="f-199">613.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" scale="6" id="f-200">613.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" format="ixt:fixed-zero" scale="6" id="f-201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net consideration paid to Becton, Dickinson, and Company in connection with Separation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="embc:NetParentInvestmentConsiderationPaidForSeparation" format="ixt:num-dot-decimal" scale="6" id="f-202">1,266.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentConsiderationPaidForSeparation" format="ixt:num-dot-decimal" scale="6" id="f-203">1,266.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income attributable to Embecta Corp.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-204">45.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-205">178.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-206">223.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive loss, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-207">64.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-208">64.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-209">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-210">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-211">0.15</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="f-212">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="f-213">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Issuance of shares related to stock-based compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-214">42,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance at September 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-215">57,055,327</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-216">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-217">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-218">577.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="6" id="f-219">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-220">324.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-221">891.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance at October 1, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-222">57,055,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-223">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-224">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-225">577.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-226">324.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-227">891.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income attributable to Embecta Corp.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-228">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-229">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive loss, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-230">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-231">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stock-based compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-232">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-233">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Common dividends ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-234">0.15</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="f-235">34.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DividendsCommonStock" scale="6" id="f-236">34.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Issuance of shares related to stock-based compensation plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-237">278,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-238">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="f-239">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-240">57,333,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-241">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-242">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-243">541.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-244">309.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-245">821.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See notes to the Consolidated Financial Statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.333%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_124"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Embecta Corp.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years Ended September 30</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.782%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating Activities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-246">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-247">223.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-248">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to net income to derive net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-249">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-250">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-251">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-252">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-253">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:fixed-zero" scale="6" id="f-254">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Impairment of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="f-255">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="f-256">58.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="f-257">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-258">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-259">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-260">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-261">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-262">26.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-263">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 56.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Trade receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-264">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-265">122.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-266">31.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 56.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-267">28.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-268">23.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-269">18.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 56.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Due from/due to Becton, Dickinson and Company</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="embc:IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" scale="6" id="f-270">23.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" scale="6" id="f-271">47.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" format="ixt:fixed-zero" scale="6" id="f-272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 56.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-273">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-274">44.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-275">11.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 56.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable, accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-276">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-277">76.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-278">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 56.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income and other net taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="f-279">12.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="f-280">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" format="ixt:fixed-zero" scale="6" id="f-281">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 68.37pt;text-align:left;text-indent:-31.5pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets and liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="6" id="f-282">16.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="6" id="f-283">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="6" id="f-284">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net Cash Provided by Operating Activities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-285">67.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-286">412.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-287">456.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-288">26.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-289">23.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-290">36.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Acquisition of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="6" id="f-291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="f-292">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="f-293">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net Cash Used for Investing Activities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-294">26.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-295">24.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-296">39.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from the issuance of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="f-297">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-298">1,450.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="f-299">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Payments on long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="f-300">9.5</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="f-301">4.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="f-302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Payment of long-term debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="6" id="f-303">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="f-304">33.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="6" id="f-305">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Payment of revolving credit facility fees</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="embc:PaymentOfRevolvingCreditFacilityFees" format="ixt:fixed-zero" scale="6" id="f-306">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:PaymentOfRevolvingCreditFacilityFees" scale="6" id="f-307">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:PaymentOfRevolvingCreditFacilityFees" format="ixt:fixed-zero" scale="6" id="f-308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Payments related to tax withholding for stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-309">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="f-310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="f-311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Payments on finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-312">1.2</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-313">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:fixed-zero" scale="6" id="f-314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Dividend payments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-315">34.4</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="f-316">8.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:fixed-zero" scale="6" id="f-317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net consideration paid to Becton, Dickinson and Company in connection with the Separation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="embc:PaymentForSpinoffTransactionFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-318">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:PaymentForSpinoffTransactionFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="f-319">1,266.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:PaymentForSpinoffTransactionFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-320">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net transfers to Becton, Dickinson and Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="embc:NetTransfersToParentFinancingActivities" format="ixt:fixed-zero" scale="6" id="f-321">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetTransfersToParentFinancingActivities" scale="6" id="f-322">177.9</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetTransfersToParentFinancingActivities" scale="6" id="f-323">417.1</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net Cash Used for Financing Activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-324">48.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-325">48.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-326">417.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="f-327">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="f-328">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:fixed-zero" scale="6" id="f-329">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net Change in Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-330">4.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-331">330.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:fixed-zero" scale="6" id="f-332">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Opening Cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-333">330.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Closing Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-336">326.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-337">330.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="6" id="f-338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">See notes to the Consolidated Financial Statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Embecta Corp.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_130"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-339" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 1 &#8212; Background</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta Corp. ("Embecta" or the "Company") is a leading global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a broad portfolio of marketed products, including a variety of pen needles, syringes and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The Company primarily sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022 (the "Separation Date"), Embecta and Becton, Dickinson and Company ("BD") entered into a Separation and Distribution Agreement (the "Separation and Distribution Agreement"). Pursuant to the Separation and Distribution Agreement, BD agreed to spin off its diabetes care business (the "Diabetes Care Business") into Embecta, a new, publicly traded company (the "Separation"). </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Separation occurred by means of a pro-rata distribution (the "Distribution") of all of Embecta&#8217;s issued and outstanding shares of common stock on the basis of one share of Embecta common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-34" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-340">0.01</ix:nonFraction> per share, for every five shares of BD common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-35" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-341">1.00</ix:nonFraction> per share, held as of the close of business on March 22, 2023, the record date for the distribution. Embecta is now a standalone publicly traded company and, on April 1, 2022, regular-way trading of Embecta common stock commenced on the Nasdaq Global Select Market under the ticker symbol "EMBC".</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, BD and Embecta entered into various agreements to provide a framework for the relationship between BD and Embecta after the Separation, including, but not limited to, a separation and distribution agreement, a transition services agreement, a tax matters agreement, an employee matters agreement, a cannula supply agreement, contract manufacturing agreements, an intellectual property matters agreement, a logistics services agreement, distribution agreements, factoring and receivables agreements, local support and service agreements and other transaction documents.</span></div></ix:nonNumeric><div id="i209d71ebb5944f1aadd70761506c49b3_139"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="f-343" continuedAt="f-343-1" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 2 &#8212; Basis of Presentation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="f-344" continuedAt="f-344-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, the Company became a standalone publicly traded company, and its financial statements are now presented on a consolidated basis. Prior to the Separation on April 1, 2022, the Company&#8217;s historical combined financial statements were prepared on a standalone basis and were derived from BD's consolidated financial statements and accounting records. The financial statements for all periods presented, including the historical results of the Company prior to April 1, 2022, are now referred to as "Consolidated Financial Statements", and have been prepared pursuant to the rules and regulations for reporting on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Prior to Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the Company was referred to as the Diabetes Care Business. The assets, liabilities, revenue and expenses of the Diabetes Care Business were reflected in the combined financial statements on a historical cost basis, as included in the consolidated financial statements of BD, using the historical accounting policies applied by BD. The Consolidated Financial Statements did not purport to reflect what the Company&#8217;s results of operations, comprehensive income, financial position, equity or cash flows would have been had the Company operated as a standalone public company during the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Diabetes Care Business had historically functioned together with the other businesses controlled by BD. Accordingly, the Diabetes Care Business relied on BD&#8217;s corporate and other support functions for its business. Therefore, for the period prior to the Separation, certain corporate and shared costs were allocated to the Diabetes Care Business based on a specific identification basis or, when specific identification was not practicable, a proportional cost allocation method, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt">expenses related to BD support functions, including expenses for facilities, executive oversight, treasury, finance, legal, human resources, shared services, compliance, procurement, information technology and other corporate functions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:9.96pt">certain manufacturing and supply costs incurred by BD, including facility management, distribution, logistics, planning and global quality.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.19pt">certain costs incurred by BD&#8217;s Medication Delivery Solutions organizational unit in relation to selling and marketing activities, and related administrative support functions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">iv.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt">certain costs incurred by BD for activities related to device research and development, as well as medical and regulatory affairs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">stock-based compensation expenses (see Note 10).</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">vi.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt">certain compensation expenses maintained on a centralized basis such as certain employee benefit expenses.</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-343-1"><ix:continuation id="f-344-1" continuedAt="f-344-2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management believes these cost allocations were a reasonable reflection of the utilization of services provided to, or the benefit derived by, the Diabetes Care Business during the period prior to the Separation, though the allocations may not be indicative of the actual costs that would have been incurred had the Diabetes Care Business operated as a standalone public company. Actual costs that may have been incurred if the Diabetes Care Business had been a standalone company would depend on a number of factors, including the chosen organizational structure, whether functions were outsourced or performed by Diabetes Care Business employees, and strategic decisions made in areas such as manufacturing, selling and marketing, research and development, information technology and infrastructure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BD utilized a centralized approach to cash management and the financing of its operations. Cash generated by the Diabetes Care Business was routinely transferred into accounts managed by BD&#8217;s centralized treasury function and cash disbursements related to operations prior to the Separation were funded as needed by BD. Balances held by the Diabetes Care Business with BD for cash transfers and loans were reflected as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due to Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> prior to the Separation. All other cash and cash equivalents and related transfers between BD and the Diabetes Care Business were generally held centrally through accounts controlled and maintained by BD and were not specifically identifiable to the Diabetes Care Business. Accordingly, such balances were accounted for through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. BD&#8217;s third-party debt and related interest expense were not attributed to the Diabetes Care Business because the business was not the legal obligor of the debt and the borrowings were not specifically identifiable to the business.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-345" continuedAt="f-345-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the Diabetes Care Business, transactions with BD affiliates were included in the Consolidated Statements of Income and related balances were reflected as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due to Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Related Party Loans Payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Other balances between the Diabetes Care Business and BD were considered to be effectively settled in the Consolidated Financial Statements at the time the transactions were recorded.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As the separate legal entities that made up the Diabetes Care Business were not historically held by a single legal entity, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was shown in lieu of stockholders&#8217; equity in these Consolidated Financial Statements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> represented BD&#8217;s interest in the recorded assets of the Diabetes Care Business and the cumulative investment by BD through the date of the Separation, inclusive of operating results.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For periods prior to the Separation, income tax expense and tax balances in the Consolidated Financial Statements were calculated on a separate tax return basis. The separate tax return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company was a separate taxpayer and a standalone enterprise. Management believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provision for income taxes for the period prior to the Separation was calculated by applying an estimated effective income tax rate for the full year to ordinary income adjusted by the tax impact of discrete items.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">As of the Separation Date</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain assets and liabilities, including patents and unrecognized tax benefits that were included in the Consolidated Balance Sheet prior to the Separation, have been retained by BD post-Separation and therefore were transferred to BD through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Company's Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, additional pension assets, deferred tax assets, other compensation obligations, and certain other assets and liabilities were transferred to the Company through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and the Company recorded these in the Consolidated Balance Sheet. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As part of the Separation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">was reclassified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Common Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accumulated Deficit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Post Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following the Separation, certain functions continue to be provided by BD under the Transition Services Agreements or are being performed using Embecta&#8217;s own resources or third-party service providers. Additionally, under manufacturing and supply agreements, the Company manufactures certain products for BD, or its applicable affiliate and BD manufactures certain products for the Company. The Company incurred certain costs in its establishment as a standalone public company and expects to incur ongoing additional costs associated with operating as an independent, publicly traded company.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-345-1">All intercompany transactions and accounts within Embecta have been eliminated.</ix:continuation> </span></div><ix:continuation id="f-344-2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain reclassifications were made to conform the prior period Consolidated Financial Statements to the current period presentation.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_142"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-346" continuedAt="f-346-1" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 3 &#8212; Summary of Accounting Policies</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-347" continuedAt="f-347-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recognizes revenue from product sales and considers performance obligations satisfied when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement. The Company acts as the principal in its customer arrangements and therefore records revenue on a gross basis. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. The point in time upon which shipment or delivery occurs is the most faithful depiction of when control of the goods transfers to the customer. Variable consideration such as rebates, chargebacks, sales discounts, and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additional disclosures regarding the Company&#8217;s accounting for revenue recognition are provided in Note 8.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-348" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cash and Cash Equivalents</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash and cash equivalents include all highly liquid investments with a maturity of three months or less at the date of acquisition. Interest income on Cash and cash equivalents is recorded as earned.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="f-349" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Trade Receivables</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#8217;s estimate of probable credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-350" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Inventories</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="embc:HostingArrangementServiceContractPolicyTextBlock" id="f-351" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cloud Computing Arrangements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company capitalizes costs incurred to implement cloud computing arrangements that are service contracts within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Prepaid expenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Company's Condensed Consolidated Balance Sheets. Implementation costs associated with cloud computing arrangements are capitalized when incurred during the application development phase. Once the implementation of a cloud computing arrangement is complete and ready for its intended use, the Company amortizes the costs over the expected term of the hosting arrangement using the straight-line method to the same income statement line as the associated cloud operating expenses. The total balance of capitalized costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">associated with these arrangements as of September&#160;30, 2023 is $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-352">38.0</ix:nonFraction>&#160;million which primarily relates to the implementation of the Company's new enterprise resource planning ("ERP") system. These capitalized costs are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Costs amortized during fiscal year ended September 30, 2023 were not material to the Company's consolidated financial results. As of September&#160;30, 2023, cloud computing arrangement assets in-service have useful lives which range from approximately <span style="-sec-ix-hidden:f-353">three</span> to <ix:nonNumeric contextRef="c-38" name="embc:HostingArrangementServiceContractAssetsInServiceUsefulLife" format="ixt-sec:durwordsen" id="f-354">nine years</ix:nonNumeric>.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2022, the Company commenced on the process of building a new ERP system to replace the existing systems provided by BD. The ERP system is designed to accurately maintain the Company's financial records used to report operating results. The implementation of the ERP will occur in phases. The first phase of the ERP system implementation began in the fourth quarter of 2023.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-355" continuedAt="f-355-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is principally provided on the straight-line basis over estimated useful lives, which range from <ix:nonNumeric contextRef="c-39" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-356">20</ix:nonNumeric> to <ix:nonNumeric contextRef="c-40" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-357">45</ix:nonNumeric> years for buildings, <ix:nonNumeric contextRef="c-41" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-358">4</ix:nonNumeric> to <ix:nonNumeric contextRef="c-42" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-359">13</ix:nonNumeric> years for machinery and equipment and <ix:nonNumeric contextRef="c-43" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-360">1</ix:nonNumeric> to <ix:nonNumeric contextRef="c-44" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-361">20</ix:nonNumeric> years for leasehold improvements. Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-362">31.5</ix:nonFraction>&#160;million in 2023, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-363">31.0</ix:nonFraction>&#160;million in 2022, and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-364">37.2</ix:nonFraction>&#160;million in 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant and equipment are periodically reviewed when impairment indicators are present to assess recoverability or a decision has been made to abandon efforts associated with construction in progress assets. Recoverability is determined by comparing the carrying values of the assets or asset groups to the undiscounted cash flows to be generated from the use and eventual disposition of such assets or asset groups. If the asset&#8217;s or asset group&#8217;s carrying value exceeds such </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-346-1" continuedAt="f-346-2"><ix:continuation id="f-355-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">undiscounted cash flows, the assets or asset groups are not recoverable and an impairment loss is recognized based on the amount by which the carrying value of the asset or asset group exceeds its calculated fair value.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:InterestCapitalizationPolicyPolicyTextBlock" id="f-365" continuedAt="f-365-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Capitalized Interest</span></div></ix:nonNumeric><div style="text-align:justify"><ix:continuation id="f-365-1" continuedAt="f-365-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The interest cost on capital projects is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended September 30, 2023 and 2022, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="6" id="f-366">4.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-5" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="6" id="f-367">5.2</ix:nonFraction> million of interest expense, respectively, into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and capitalized $<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-5" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="6" id="f-368">0.9</ix:nonFraction> million of interest expense into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-365-2"> during the year ended September 30, 2023.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="f-369" continuedAt="f-369-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Advertising Costs </span></div></ix:nonNumeric><div style="text-align:justify"><ix:continuation id="f-369-1" continuedAt="f-369-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advertising costs are expensed as incurred and included in S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">elling and administrative expense</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-369-2">.</ix:continuation> The Company recorded advertising costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-370">15.5</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-371">11.6</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-372">9.3</ix:nonFraction>&#160;million in 2023, 2022 and 2021, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="f-373" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill represents the excess of the consideration transferred over the fair value of net assets of businesses acquired. The Company has <ix:nonFraction unitRef="reporting_unit" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="f-374">one</ix:nonFraction> reporting unit. Goodwill is evaluated for impairment as of July 1 each year, or more frequently if impairment indicators exist, by first assessing qualitative factors to determine whether it is more likely than not that fair value is less than carrying value. If the Company concludes it is more likely than not that fair value is less than carrying value, a quantitative fair value test is performed. If carrying value is greater than fair value, a goodwill impairment charge will be recorded for the difference (up to the carrying value of goodwill). The Company completed the annual goodwill impairment test as of July 1, 2023 and concluded that no impairment to goodwill was necessary as the fair value of the Company's <ix:nonFraction unitRef="reporting_unit" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="f-375">one</ix:nonFraction> reporting unit was significantly in excess of the carrying value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No goodwill impairments were identified during the years ended September 30, 2022, or 2021, and no accumulated impairment losses are recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortized intangible assets primarily consist of patents and customer relationships. Patents are generally amortized over <ix:nonNumeric contextRef="c-48" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-376">20</ix:nonNumeric> years using the straight-line method. Customer relationship assets are generally amortized over periods ranging from <ix:nonNumeric contextRef="c-49" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-377">10</ix:nonNumeric> to <ix:nonNumeric contextRef="c-50" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-378">15</ix:nonNumeric> years, using the straight-line method. Other intangibles with finite useful lives are amortized over periods principally ranging from <ix:nonNumeric contextRef="c-51" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-379">1</ix:nonNumeric> to <ix:nonNumeric contextRef="c-52" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-380">40</ix:nonNumeric> years, using the straight-line method. Finite-lived intangible assets are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#8217;s carrying value exceeds its calculated fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-381" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Foreign Currency Translation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Generally, foreign subsidiaries&#8217; functional currency is the local currency of operations and the net assets of foreign operations are translated into United States dollars using current exchange rates. The United States dollar results that arise from such translation are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="embc:ShippingAndHandlingPolicyPolicyTextBlock" id="f-382" continuedAt="f-382-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Shipping and Handling Costs</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-382-1">The Company considers its shipping and handling costs to be contract fulfillment costs and records them within selling and administrative expense.</ix:continuation> Shipping and handling costs were $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-383">36.9</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-384">27.4</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-385">13.6</ix:nonFraction>&#160;million in 2023, 2022, and 2021, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="f-386" continuedAt="f-386-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contingencies</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-386-1">The Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries).</ix:continuation> Additional disclosures regarding the Company&#8217;s accounting for contingencies are provided in Note 7.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-387" continuedAt="f-387-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Stock-Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, certain of the Company&#8217;s employees historically participated in BD&#8217;s stock-based compensation plans. Stock-based compensation expense was either allocated to the Company based on a proportionate cost allocation method or recorded based on specific identification. Effective April 1, 2022, the Company established the 2022 Employee and Director Equity Based Compensation Plan (the "Plan"). The Plan provides for the grant of various types of awards, including restricted stock unit ("RSU") awards, stock appreciation rights, stock options, performance-based awards and cash awards. Under the Plan, the exercise price of awards, if any, is set on the grant date and generally may not be less than </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-346-2" continuedAt="f-346-3"><ix:continuation id="f-387-1"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the fair market value per share on that date. The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards. For awards that ultimately settle in cash, we treat them as liability awards and mark the award to market each reporting period and recognize any adjustment in our Consolidated Statements of Income. The Company recognizes stock-based compensation cost only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants. The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change (see Note 10).</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="f-388" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Benefit Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the defined benefit plans in which the Company participated related primarily to plans sponsored by BD and for which other businesses of BD also participate (the "Shared Plans"). The Company accounted for the Shared Plans as multiemployer plans and therefore the related assets and liabilities were not reflected in the Consolidated Balance Sheets. For such periods prior to the Separation, the Consolidated Statements of Income reflect a proportional allocation of net periodic benefit cost for the Shared Plans associated with the Company. The Company's participation in the defined pension and postretirement benefit plans sponsored by BD concluded upon the completion of the Separation on April 1, 2022. At and after Separation, Embecta became the plan sponsor for certain non-United States defined benefit pension plans (see Note 18).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-389" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Research and Development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development costs are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-390" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax basis of assets and liabilities at the applicable tax rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, the Company engages in transactions in which tax consequences may be subject to uncertainty. The Company conducts business and files tax returns in numerous jurisdictions based on its interpretation of tax laws and regulations. In evaluating the Company&#8217;s tax provision, the Company establishes a reserve for uncertain tax positions unless such positions are determined to be more likely than not of being sustained upon examination based on the technical merits.  The Company&#8217;s policy is to recognize, when applicable, interest and penalties on uncertain tax positions as part of income tax expense.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Tax Cuts and Jobs Act was enacted on December 22, 2017 and introduced an additional United States tax on the earnings of non-United States subsidiaries which are referred to as Global Intangible Low Taxed Income (&#8220;GILTI&#8221;). The Company has elected to treat GILTI as a period cost. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the Company's operations were included in the tax returns of BD. Income taxes as presented in the Consolidated Financial Statements attribute current and deferred income tax assets and liabilities of BD to the Company in a manner that is systematic, rational, and consistent with the asset and liability method prescribed by the accounting guidance for income taxes. The Company's income tax provision prior to the Separation was prepared using the separate return method. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company were a separate taxpayer and a standalone enterprise. The Company believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.</span></div></ix:nonNumeric><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additional disclosures regarding the Company's accounting for income taxes are provided in Note 14.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-391" continuedAt="f-391-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Segment Data</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company operates and reports its financial information as <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-392"><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-393">one</ix:nonFraction></ix:nonFraction> segment. In making this determination, the Company (i) determines its Chief Operating Decision Maker (&#8220;CODM&#8221;), (ii) identifies and analyzes potential business components, (iii) </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-346-3" continuedAt="f-346-4"><ix:continuation id="f-391-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">identifies its operating segments and (iv) determines whether there are multiple operating segments requiring presentation as reportable segments. The Company&#8217;s decision to report as <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-394">one</ix:nonFraction> segment is based upon the following: (1) its internal organizational structure; (2) the manner in which its operations are managed; and (3) the criteria used by the Company&#8217;s President, its CODM, to evaluate performance of the Company&#8217;s business and allocate resources and capital.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-395" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Fair Value Measurements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#8217;s fair value measurements are provided in Note 15.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Level 1&#8212;Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Level 2&#8212;Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Level 3&#8212;Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-396" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Leases</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company determines whether an arrangement contains a lease at inception. If a lease is identified in an arrangement, the Company recognizes a right-of-use asset and liability in the Company's Consolidated Balance Sheets and determine whether the lease should be classified as a finance or operating lease. The Company does not recognize assets or liabilities for leases with lease terms of less than 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i) there is a transfer of ownership of the leased asset to Embecta by the end of the lease term, (ii) the Company holds an option to purchase the leased asset that the Company is reasonably certain to exercise, (iii) the lease term is for a major part of the remaining economic life of the leased asset, (iv) the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v) the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the implicit rate is not readily determinable, the Company utilizes its incremental borrowing rate at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease payments are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method over the shorter of the useful life of the related asset or the lease term. Finance lease payments are bifurcated into (i) a portion that is recorded as imputed interest expense and (ii) a portion that reduces the finance liability associated with the lease.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For lease arrangements that are recognized on the Company&#8217;s Consolidated Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. Variable lease payments are expensed as incurred. If a lease includes an option to extend or terminate the lease, the Company reflects the option in the lease term if it is reasonably certain the Company will exercise the option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Finance leases are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Current finance lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Non Current Finance Lease Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and operating leases are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Company's Consolidated Balance Sheets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-397" continuedAt="f-397-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses, including determining the allocation of shared costs and expenses from BD, depreciable and amortizable lives, sales returns and allowances, rebate accruals, restructuring costs, inventory reserves and taxes on income as reflected in the Consolidated Financial Statements. Actual results could differ from these estimates. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:continuation id="f-397-1" continuedAt="f-397-2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net investment from Becton, Dickinson and Company</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-397-2"> represented BD&#8217;s interest in the recorded assets of the Company and the cumulative investment by BD in the Company through the date of the Separation, inclusive of operating results and the net effect of the transactions with and allocations from BD.</ix:continuation> See Notes 2 and 4 for additional information.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-346-4"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Supplemental Disclosures Of Cash Flow Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash paid for interest related to debt during the year ended September 30, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="f-398">111.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="f-399">38.9</ix:nonFraction> million, respectively. The Company did <ix:nonFraction unitRef="usd" contextRef="c-15" decimals="INF" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:fixed-zero" scale="0" id="f-400">not</ix:nonFraction> have any debt outstanding during the year ended September 30, 2021. Cash paid for income taxes, net of refunds, for the years ended September 30, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="f-401">30.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="f-402">15.6</ix:nonFraction> million, respectively. For the year ended September 30, 2021, the Company's current tax liabilities computed under the separate return method are considered to be effectively settled at the time the transaction is recorded, with the offset recorded against </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-403" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers, as if it had originated the contracts. The Company adopted this guidance at the beginning of fiscal year 2023 and it did not materially impact the Company's Condensed Consolidated Financial Statements.</span></div></ix:nonNumeric></ix:continuation><div id="i209d71ebb5944f1aadd70761506c49b3_151"></div><ix:nonNumeric contextRef="c-1" name="embc:ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock" id="f-404" continuedAt="f-404-1" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 4 &#8212; Third Party Arrangements and Related Party Disclosures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Separation, BD ceased to be a related party to Embecta and accordingly, no related party transactions or balances are reported subsequent to April 1, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, the Company entered into the Separation and Distribution Agreement, which contains provisions that, among other things, relate to (i) assets, liabilities and contracts to be transferred, assumed and assigned to each of Embecta and BD (including certain deferred assets and liabilities) as part of the Separation, (ii) cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of Embecta's business with Embecta and financial responsibility for the obligations and liabilities of BD&#8217;s remaining businesses with BD, (iii) procedures with respect to claims subject to indemnification and related matters, (iv) the allocation among Embecta and BD of rights and obligations under existing insurance policies with respect to occurrences prior to completion of the Separation, as well as the right to proceeds and the obligation to incur certain deductibles under certain insurance policies, and (v) procedures governing Embecta&#8217;s and BD&#8217;s obligations and allocations of liabilities with respect to ongoing litigation matters that may implicate each of BD&#8217;s business and Embecta&#8217;s business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Agreements that Embecta entered into with BD that govern aspects of Embecta's relationship with BD following the Separation include, but are not limited to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Transition Services Agreements ("TSA") - Pursuant to the TSA, Embecta and BD and their respective affiliates provide each other, on an interim, transitional basis, various services, including, but not limited to, information technology, human resources, procurement, quality and regulatory affairs, medical affairs, tax and treasury services. The agreed-upon charges for such services are generally intended to allow the servicing party to charge a price comprised of out-of-pocket costs and expenses and a predetermined profit in the form of a mark-up of such out-of-pocket costs and expenses. The services will terminate no later than <ix:nonNumeric contextRef="c-36" name="embc:TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum" format="ixt-sec:durmonth" id="f-405">24</ix:nonNumeric> months following the Separation, subject to the Extension. The Extension is conditioned upon BD obtaining a supplemental private letter ruling. The service recipient may terminate any services by giving prior written notice to the provider of such services and paying any applicable wind-down charges.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Trade Receivables Factoring Agreements - Embecta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and BD entered into trade receivables factoring agreements (the "Factoring Agreements"), under which Embecta transfers certain net trade receivable assets to BD, and pays a service fee calculated as <ix:nonFraction unitRef="number" contextRef="c-56" decimals="INF" name="embc:ContractuallySpecifiedServicingFeesPercentage" scale="-2" id="f-406">0.1</ix:nonFraction>% of annual revenues related to countries subject to the Factoring Agreements in exchange for the services provided by BD. Per the terms of the Factoring Agreements, the Company and its relevant subsidiaries sell receivables to the corresponding BD subsidiary in the same jurisdiction and such BD subsidiary collects the receivables from Company's customers. The BD subsidiary assumes the credit risk in respect of the receivables, and accordingly deducts a factoring fee from the purchase price of such receivables. Accordingly, Embecta accounts for the transfer as sales of trade receivables by recognizing an increase to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Trade Receivables, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Balance Sheets when proceeds from the transactions are received. The transfers are presented in the Consolidated Statements of Cash Flows as operating activities and the related service fee is presented as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other income (expense), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Statements of Income. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Distribution Agreements - Embecta and BD entered into distribution agreements for certain territories, principally in the Asia Pacific Region and Latin America, whereby a subsidiary of BD is appointed as a distributor of Embecta or its relevant subsidiaries to support certain commercial operations of the diabetes care business on a transitional basis in these regions for a maximum of <ix:nonNumeric contextRef="c-56" name="embc:DistributionAgreementDistributorAppointmentMaximumTerm" format="ixt-sec:durwordsen" id="f-407">two years</ix:nonNumeric>. The distribution agreements will each continue </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-404-1" continuedAt="f-404-2"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">until either (1) certain governmental approvals needed to distribute products in the defined territory are obtained and order-to-cash processes and other services of the Company for such territory are migrated to an alternative commercial arrangement between the parties or (2) the applicable services are transitioned to a third-party distributor or independently performed by Embecta, but in any event no longer than the maximum term of <ix:nonNumeric contextRef="c-56" name="embc:DistributionAgreementDistributorAppointmentMaximumTerm" format="ixt-sec:durwordsen" id="f-408">two years</ix:nonNumeric>, except certain such agreements may be extended in connection with the Extension. Embecta shall pay BD a return of <ix:nonFraction unitRef="number" contextRef="c-57" decimals="INF" name="embc:DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" scale="-2" id="f-409">1.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-58" decimals="INF" name="embc:DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" scale="-2" id="f-410">2.0</ix:nonFraction>% of net revenue for each territory.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Cannula Supply Agreement - Embecta and BD entered into a cannula supply agreement whereby BD sells to Embecta cannulas for incorporation into Embecta's existing syringes and pen needles, safety syringes and safety pen needles, and products currently under development. BD retains ownership of all cannula technology, cannula production activities and the intellectual property rights therein. Embecta is limited to a maximum number of cannulas that it can purchase under the cannula supply agreement, which will be an absolute upper limit of cannulas per year and yearly limits that vary with annual demand. The cannula supply agreement is terminable by Embecta without cause by providing at least <ix:nonNumeric contextRef="c-56" name="embc:CannulaSupplyAgreementTerminationNoticePeriodMinimum" format="ixt-sec:durmonth" id="f-411">36</ix:nonNumeric> months&#8217; written notice; however, such termination can be effective no earlier than <ix:nonNumeric contextRef="c-56" name="embc:CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" format="ixt-sec:durwordsen" id="f-412">five years</ix:nonNumeric> from the Separation. The cannula supply agreement will be terminable by BD without cause by providing at least <ix:nonNumeric contextRef="c-59" name="embc:CannulaSupplyAgreementTerminationNoticePeriodMinimum" format="ixt-sec:durmonth" id="f-413">36</ix:nonNumeric> months&#8217; written notice; however, such termination can be effective no earlier than <ix:nonNumeric contextRef="c-59" name="embc:CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" format="ixt-sec:durwordsen" id="f-414">ten years</ix:nonNumeric> from the Separation. However, in the event of a change of control of Embecta, BD has the right to terminate the cannula supply agreement in its sole discretion. The cannula supply agreement will also terminate automatically, subject to a <ix:nonNumeric contextRef="c-56" name="embc:CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod" format="ixt-sec:durmonth" id="f-415">36</ix:nonNumeric>-month wind-down period, if Embecta&#8217;s yearly forecast is below the required minimum purchase amount, and the parties have other customary termination rights for material breach or bankruptcy of the other party.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Tax Matters Agreement - Pursuant to the tax matters agreement, Embecta agreed to certain covenants that contain restrictions intended to preserve the tax-free status of the distribution and certain related transactions. Embecta may take certain actions prohibited by these covenants only if Embecta obtains and provides to BD an opinion from a United States tax counsel or accountant of recognized national standing, in either case satisfactory to BD, to the effect that such action would not jeopardize the tax-free status of the distribution and certain related transactions, or if Embecta obtains prior written consent of BD. Embecta is barred from taking any action, or failing to take any action, where such action or failure to act adversely affects or could reasonably be expected to adversely affect the tax-free status of the distribution and certain related transactions or result in certain other taxes to BD, for all relevant time periods. In addition, during the period ending <ix:nonNumeric contextRef="c-56" name="embc:TaxMattersAgreementCovenantRestrictionsPeriod" format="ixt-sec:durwordsen" id="f-416">two years</ix:nonNumeric> after the Separation, these covenants include specific restrictions on Embecta&#8217;s (i) discontinuing the active conduct of Embecta&#8217;s trade or business; (ii) issuance or sale of stock or other securities (including securities convertible into Embecta stock, but excluding certain compensatory arrangements); (iii) liquidating, merging, or consolidating with any other person; (iv) amending Embecta&#8217;s certificate of incorporation (or other organizational documents) or taking any other action, whether through a stockholder vote or otherwise, affecting the voting rights of Embecta common stock; (v) sales of assets outside the ordinary course of business; and (vi) entering into any other corporate transaction which would cause Embecta to undergo a <ix:nonFraction unitRef="number" contextRef="c-56" decimals="INF" name="embc:TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold" scale="-2" id="f-417">50</ix:nonFraction>% or greater change in its stock ownership.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Logistics Services Agreement - Embecta and BD entered into a logistics services agreement whereby BD provides Embecta with certain order-to-cash and logistics services to support certain commercial operations for a maximum term of <ix:nonNumeric contextRef="c-56" name="embc:LogisticsServicesAgreementMaximumTerm" format="ixt-sec:durwordsen" id="f-418">two years</ix:nonNumeric>, which BD has agreed to extend through March 31, 2024. Embecta will pay BD</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (i) reimbursable costs, including all shipping costs, selling costs, general administration costs, costs of goods, research and development services costs, and other income and expenses related solely to the diabetes care business, that are incurred by BD directly, as allocated costs or as costs payable to a third party and (ii) a monthly administrative fee of <ix:nonFraction unitRef="number" contextRef="c-56" decimals="INF" name="embc:LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" scale="-2" id="f-419">1.0</ix:nonFraction>% of net revenue (which will increase to <ix:nonFraction unitRef="number" contextRef="c-60" decimals="INF" name="embc:LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" scale="-2" id="f-420">1.25</ix:nonFraction>% of net revenue after January 1, 2024).</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Other agreements that Embecta entered into with BD include, but are not limited to, the employee matters agreement ("EMA"), an intellectual property matters agreement, local support services agreements, certain other manufacturing arrangements and a process services agreement and lease agreement for a manufacturing facility located in Holdrege, Nebraska. See Note 17 for more information on the lease agreement for Holdrege. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As it pertains to the Distribution Agreements noted above, Embecta has determined it is the principal under these arrangements and is entitled to all the benefits, and is liable for all the risks, related to the inventory and receivables. Additionally, Embecta has latitude in pricing, has the ability to direct BD regarding decisions over inventory, and is responsible for all credit and collections risks and losses associated with the related receivables when there is no factoring agreement in place. As such, Embecta recognizes these sales on a gross basis.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount due from BD under the above agreements was $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-421">142.4</ix:nonFraction>&#160;million at September&#160;30, 2023 and is reflected in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The amount due to BD under these agreements was $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:AccountsPayableOtherCurrent" format="ixt:num-dot-decimal" scale="6" id="f-422">73.1</ix:nonFraction> million at September&#160;30, 2023 and is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due to Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The closing of the transfers of certain assets and liabilities related to the Diabetes Care Business in certain jurisdictions, including China, Mexico, and Italy, as contemplated by the Separation and Distribution Agreement did not occur at </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-404-2" continuedAt="f-404-3"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Separation. The transfers of the remaining relevant local assets and liabilities for these deferred countries are expected to close at a future date. As of September&#160;30, 2023, the Company estimates that amounts due to BD related to certain assets and liabilities in deferred close jurisdictions is $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-423">29.7</ix:nonFraction>&#160;million and are reflected in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. As of September&#160;30, 2023, the Company estimates that amounts due from BD related to certain assets and liabilities in deferred close jurisdictions are $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-424">8.4</ix:nonFraction>&#160;million and is reflected in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Prepaid expenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the Company did not operate as a standalone business and the Consolidated Financial Statements were derived from the consolidated financial statements and accounting records of BD. The following disclosure summarizes activity between the Company and BD up to the Separation, including the affiliates of BD that were not part of the Separation.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the years ended September 30, 2022 and 2021, cost of products sold from related party inventory purchases were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RelatedPartiesAmountInCostOfSales" format="ixt:num-dot-decimal" scale="6" id="f-425">28.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RelatedPartiesAmountInCostOfSales" format="ixt:num-dot-decimal" scale="6" id="f-426">40.6</ix:nonFraction> million, respectively. For the year ended September 30, 2023 there were <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:RelatedPartiesAmountInCostOfSales" format="ixt:fixed-zero" scale="6" id="f-427">no</ix:nonFraction> cost of products sold from related party inventory purchases.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Corporate and Medical Segment Allocations from BD</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, BD provided significant corporate, finance, human resources, information technology, facilities, and legal services, among others (collectively, &#8220;General Corporate Expenses&#8221;) to the Company. Some of these services continue to be provided by BD to the Company on a temporary basis under the TSA. For purposes of these Consolidated Financial Statements for the periods prior to the Separation, the General Corporate Expenses have been allocated to the Company. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="f-428" continuedAt="f-428-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocations of General Corporate Expenses are reflected in the Consolidated Statements of Income as follows: </span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><ix:continuation id="f-428-1" continuedAt="f-428-2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.448%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="embc:GeneralCorporateExpenses" scale="6" id="f-429">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="embc:GeneralCorporateExpenses" scale="6" id="f-430">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling and administrative expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="embc:GeneralCorporateExpenses" scale="6" id="f-431">47.9</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="embc:GeneralCorporateExpenses" scale="6" id="f-432">98.3</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="embc:GeneralCorporateExpenses" scale="6" id="f-433">3.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="embc:GeneralCorporateExpenses" scale="6" id="f-434">5.2</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" sign="-" name="embc:GeneralCorporateExpenses" scale="6" id="f-435">0.6</ix:nonFraction>)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-5" sign="-" name="embc:GeneralCorporateExpenses" scale="6" id="f-436">1.3</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total General Corporate Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:GeneralCorporateExpenses" scale="6" id="f-437">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:GeneralCorporateExpenses" scale="6" id="f-438">115.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These expenses were allocated to the Company on a pro rata basis of global and regional revenues, headcount, research and development spend and other drivers. Management believes the assumptions underlying the Consolidated Financial Statements, including the assumptions regarding allocating General Corporate Expenses from BD, are reasonable. Nevertheless, the Consolidated Financial Statements for periods prior to the Separation may not include all of the actual expenses that would have been incurred and may not reflect the Company&#8217;s Consolidated results of operations, financial position and cash flows had it been a standalone public company during the periods presented. Actual costs that would have been incurred if the Company had been a standalone public company would depend on multiple factors, including organizational structure and strategic decisions made in various areas, including information technology and infrastructure. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Related party transactions  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following transactions represent activity in the ordinary course of business between the Company and BD prior to the Separation for certain materials for use in production of certain medical products that were not at arm&#8217;s length. <ix:continuation id="f-428-2" continuedAt="f-428-3">The following table summarizes such former related party purchases as follows: </ix:continuation></span></div><ix:continuation id="f-428-3" continuedAt="f-428-4"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.447%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases from BD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-5" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="6" id="f-439">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="6" id="f-440">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All significant intercompany transactions between the Company and BD prior to the Separation have been included in the Consolidated Financial Statements and are considered to be effectively settled for cash at the time the transaction is recorded. For the period prior to the Separation, the total net effect of the settlement of these intercompany transactions is reflected in the Consolidated Statements of Cash Flows as a financing activity and in the Consolidated Balance Sheets as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, net transfers to BD were included within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#160;in the Consolidated Statements of Equity and represent the net effect of transactions between the Company and BD. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-404-3"><ix:continuation id="f-428-4" continuedAt="f-428-5"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the components of the net transfers to BD as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.447%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cash pooling and general financing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentCashPoolingAndGeneralFinancingActivities" scale="6" id="f-441">255.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentCashPoolingAndGeneralFinancingActivities" scale="6" id="f-442">599.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Corporate and segment allocations, excluding non-cash stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" scale="6" id="f-443">50.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" scale="6" id="f-444">109.9</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Taxes deemed settled with BD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentTaxesDeemedSettledWithParent" scale="6" id="f-445">16.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentTaxesDeemedSettledWithParent" scale="6" id="f-446">72.5</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other Separation related adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="embc:NetParentInvestmentSeparationRelatedAdjustments" scale="6" id="f-447">11.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentSeparationRelatedAdjustments" format="ixt:fixed-zero" scale="6" id="f-448">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net transfers to BD as reflected in the Consolidated Statements of Cash Flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" scale="6" id="f-449">177.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" scale="6" id="f-450">417.1</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentShareBasedCompensationExpense" scale="6" id="f-451">8.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentShareBasedCompensationExpense" scale="6" id="f-452">12.5</ix:nonFraction>)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Pension expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentPensionExpense" scale="6" id="f-453">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentPensionExpense" scale="6" id="f-454">9.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net consideration paid to BD in connection with the Separation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentConsiderationPaidForSeparation" format="ixt:num-dot-decimal" scale="6" id="f-455">1,266.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentConsiderationPaidForSeparation" format="ixt:fixed-zero" scale="6" id="f-456">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Related party senior secured notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentRelatedPartyDebtIssued" scale="6" id="f-457">197.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentRelatedPartyDebtIssued" format="ixt:fixed-zero" scale="6" id="f-458">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other transfers to (from) BD, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentOtherTransfersToFromParentNet" scale="6" id="f-459">84.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="embc:NetParentInvestmentOtherTransfersToFromParentNet" scale="6" id="f-460">11.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net transfers to BD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:NetParentInvestmentNetTransfersToParent" format="ixt:num-dot-decimal" scale="6" id="f-461">1,712.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:NetParentInvestmentNetTransfersToParent" scale="6" id="f-462">383.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:2pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-428-5" continuedAt="f-428-6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt"><ix:continuation id="f-428-6">The nature of activities includes financing activities for capital transfers, cash sweeps and other treasury services. As part of this activity, cash balances were swept to BD on a daily basis under the BD Treasury function and the Company receives capital from BD for its cash needs.</ix:continuation> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Related Party Senior Secured Notes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 31, 2022, Embecta issued $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-463">200.0</ix:nonFraction> million of senior secured notes to BD</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (the "Related Party Notes"). </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Related Party Notes issued to BD were not issued for cash and instead were subject to a debt-for-debt exchange which occurred on April 1, 2022. As of April 1, 2022 t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">he Related Party Notes were reclassified to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Balance Sheets as the Related Party Notes are third party debt for periods post Separation.</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Refer to Note 12 for further information.</span></div></ix:continuation><div id="i209d71ebb5944f1aadd70761506c49b3_702"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-464" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 5 &#8212; Collaboration Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2023, the Company entered into a collaboration agreement with a third-party to develop and commercialize an interoperable automated glycemic controller ("iAGC") to complement the Company's insulin patch pump currently in development. The Company believes that both parties are active participants in the operating activities of the collaboration and exposed to certain risks and rewards depending on commercial success. The transaction included an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-465">2.5</ix:nonFraction>&#160;million for project costs, which was expensed to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Research and development expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> during the year ended September&#160;30, 2023. Upon successful commercialization of the iAGC, the Company will be responsible for the sales and marketing effort and would pay a royalty to the third-party based on future product sales to customers. The Company expects that it will be the principal in the end customer sale and <ix:nonFraction unitRef="number" contextRef="c-73" decimals="INF" name="embc:CollaborativeArrangementPrincipalRightsPercentage" scale="-2" id="f-466">100</ix:nonFraction>% of product sales will be included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and any royalty payments and continued project costs after commercialization will be included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> as they are incurred.</span></div></ix:nonNumeric><div id="i209d71ebb5944f1aadd70761506c49b3_157"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherOperatingIncomeAndExpenseTextBlock" id="f-467" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 6 &#8212; Other Operating Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, the Company incurred separation and stand-up costs of approximately </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="embc:SeparationAndStandupCosts" format="ixt:num-dot-decimal" scale="6" id="f-468">92.7</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:SeparationAndStandupCosts" format="ixt:num-dot-decimal" scale="6" id="f-469">44.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:SeparationAndStandupCosts" format="ixt:num-dot-decimal" scale="6" id="f-470">4.8</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> during the years ended September&#160;30, 2023, 2022, and 2021, respectively. The costs incurred primarily consist of costs associated with accounting, auditing, legal services, supply chain, employee retention, the implementation of the Company's new ERP system, and certain other costs to establish certain stand-alone functions to assist with the transition to being a stand-alone entity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2023, the Company recorded approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-471">5.6</ix:nonFraction>&#160;million of severance costs related to the optimization of certain business functions. These costs were primarily recorded in the U.S. and severance costs were not material to any comparable prior year periods presented. Liabilities for costs associated with these activities were not material to any period presented. For the years ended September 30, 2022, and 2021 severance costs were <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="0" id="f-472"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="0" id="f-473">not</ix:nonFraction></ix:nonFraction> material to the Company's Consolidated Statements of Income.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_160"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LossContingencyDisclosures" id="f-474" continuedAt="f-474-1" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 7 &#8212; Contingencies </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is subject to potential liabilities under government regulations and various claims and legal actions that are pending or may be asserted from time-to-time. These matters arise in the ordinary course and conduct of the Company&#8217;s business and include, for example, commercial, product liability, breach of contract and tort, intellectual property, product liability, environmental, securities and employment matters. The Company intends to continue to defend itself vigorously in such matters and when warranted, take legal action against others. Furthermore, the Company regularly assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in its financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">An estimated loss contingency is accrued in the Company&#8217;s Financial Statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company&#8217;s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company&#8217;s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-474-1">The Company was not a party to any material legal proceedings at September&#160;30, 2023 or September&#160;30, 2022, nor is it a party to any material legal proceedings as of the date of issuance of these Consolidated Financial Statements.</ix:continuation> </span></div><div id="i209d71ebb5944f1aadd70761506c49b3_166"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-475" continuedAt="f-475-1" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 8 &#8212; Revenues </span></div><ix:continuation id="f-347-1" continuedAt="f-347-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Measurement of Revenues </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Payment terms extended to the Company&#8217;s customers are based upon commercially reasonable terms for the markets in which the Company&#8217;s products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible. The allowance for doubtful accounts for trade receivables is not material to the Company&#8217;s consolidated financial results. </span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-347-2">The Company&#8217;s gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts, and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company&#8217;s agreements primarily with its end-user customers. Additional factors considered in the estimate of the Company&#8217;s rebate liability include the quantification of inventory that is either in stock at or in transit to the Company&#8217;s distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates.</ix:continuation> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s liability attributed to variable consideration at September&#160;30, 2023 and September&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ContractWithCustomerRefundLiability" format="ixt:num-dot-decimal" scale="6" id="f-476">36.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ContractWithCustomerRefundLiability" format="ixt:num-dot-decimal" scale="6" id="f-477">43.8</ix:nonFraction> million, respectively. Sales deductions recorded as a reduction of gross revenues for the years ended September&#160;30, 2023, 2022 and 2021 were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="embc:RevenueFromContractWithCustomerSalesDeductionsRecognized" format="ixt:num-dot-decimal" scale="6" id="f-478">411.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="embc:RevenueFromContractWithCustomerSalesDeductionsRecognized" format="ixt:num-dot-decimal" scale="6" id="f-479">336.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="embc:RevenueFromContractWithCustomerSalesDeductionsRecognized" format="ixt:num-dot-decimal" scale="6" id="f-480">298.7</ix:nonFraction>&#160;million respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Disaggregation of Revenues </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Disaggregation of revenue by geographic region is provided within Note 9. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Assets and Liabilities </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company does not have contract liabilities. Contract assets consist of the Company&#8217;s right to consideration that is conditional upon its future performance pursuant to private label agreements and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Prepaid expenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Balance Sheets. </span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-475-1">The Company&#8217;s contract asset balance was $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-481"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="f-482">1.2</ix:nonFraction></ix:nonFraction> million as of each of September&#160;30, 2023 and 2022.</ix:continuation> </span></div><div id="i209d71ebb5944f1aadd70761506c49b3_169"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-483" continuedAt="f-483-1" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 9 &#8212; Segment and Geographical Data </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating segments are identified as components of an enterprise in which discrete financial information is available for evaluation by the CODM in making decisions regarding assessing business performance and allocating resources and capital. Management has concluded that the Company operates in <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-484">one</ix:nonFraction> segment based upon the information used by the CODM in evaluating the performance of the Company&#8217;s business and allocating resources and capital. </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-483-1" continuedAt="f-483-2"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Disaggregation of Revenues </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has distribution agreements with regional or national distributors (including wholesalers and medical suppliers) to ensure broad availability of its products as well as a direct sales force in certain countries and regions around the world. In the United States and Canada, the Company utilizes its large and small key account managers that call on payers, retailers, wholesalers and institutional customers, and field-based territory managers that call on health care providers and pharmacies. In certain markets within Europe, the Company has dedicated sales representatives and in certain regions of the Middle East and Africa, the Company has distribution agreements. In Asia, the Company has distribution agreements and in China, the Company relies on its own commercial team to support sales execution. In Latin America, the Company maintains distribution agreements and direct sales representatives. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company disaggregates its revenue by geography as management believes this category best depicts how the nature, amount, and timing of revenues and cash flows are affected by economic factors. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="f-485" continuedAt="f-485-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues by geographic region are as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-486">601.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-487">600.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-488">609.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-489">519.4</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-490">529.2</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-491">555.9</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-492">1,120.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-493">1,129.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-494">1,165.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:10.909%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="f-485-1" continuedAt="f-485-2"><ix:continuation id="f-483-2" continuedAt="f-483-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt"><ix:continuation id="f-485-2"><ix:continuation id="f-483-3">For the years ended September&#160;30, 2023, 2022, and 2021 no individual country outside of the United States generated net revenues that represented more than 10.0% of total revenues.</ix:continuation></ix:continuation> </span></div><div id="i209d71ebb5944f1aadd70761506c49b3_172"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-495" continuedAt="f-495-1" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 10 &#8212; Stock-Based Compensation</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Prior to Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, certain of the Company's employees participated in stock-based compensation plans sponsored by BD. Under these plans BD granted time-vested restricted stock units ("TVUs"), stock appreciation rights ("SARs"), and performance share units ("PSUs") to certain management level employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation on April 1, 2022, share-based compensation expense in the Consolidated Statements of Income is representative of those employees who were dedicated to the Diabetes Care Business. Additionally, share-based compensation expense was allocated to the Diabetes Care Business for BD Corporate and Medical Segment employees who were not dedicated solely to the Diabetes Care Business. This stock-based compensation expense was allocated using a proportional cost allocation method and is included as a component of corporate allocations for periods prior to the Separation. The amounts presented for the periods prior to the Separation are not necessarily indicative of future awards and do not necessarily reflect the costs that the Company would have incurred as an independent company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">As of Separation Date and Periods Post Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, and in accordance with the EMA, Embecta's employees with outstanding former BD share-based awards received replacement share-based awards under the Plan. The ratio used to convert the BD share-based awards was designed to preserve the aggregate intrinsic value of the award immediately after the Separation when compared to the aggregate intrinsic value of the award immediately prior to Separation. As a result of the award modification, Embecta will incur $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" format="ixt:num-dot-decimal" scale="6" id="f-496">6.1</ix:nonFraction>&#160;million of incremental stock-based compensation expense. Of this amount, $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="embc:ShareBasedPaymentArrangementPlanModificationExpenseRecognized" format="ixt:num-dot-decimal" scale="6" id="f-497">1.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="embc:ShareBasedPaymentArrangementPlanModificationExpenseRecognized" format="ixt:num-dot-decimal" scale="6" id="f-498">2.3</ix:nonFraction>&#160;million was recognized during the year ended September 30, 2023 and 2022, respectively. $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-499">2.0</ix:nonFraction>&#160;million will be recognized at a future date over the awards' remaining vesting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective April 1, 2022, Embecta established the Plan. A total of <ix:nonFraction unitRef="shares" contextRef="c-84" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-500">7,000,000</ix:nonFraction> shares of common stock are authorized under the Plan. The Plan provides for the grant of various types of awards including RSU awards, SARs, stock options, performance-based awards and other stock-based awards. Under the Plan, the exercise price of awards, if any, is set on the grant date and may not be less than the fair market value per share on that date. Generally SARs have a term of <ix:nonNumeric contextRef="c-85" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-501">ten years</ix:nonNumeric> and a <span style="-sec-ix-hidden:f-502">three</span> or <ix:nonNumeric contextRef="c-87" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-503">four year</ix:nonNumeric> vesting period, subject to limited exceptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recognizes stock-based compensation cost only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants. The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-495-1" continuedAt="f-495-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, Embecta granted <ix:nonFraction unitRef="shares" contextRef="c-88" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-504">48,192</ix:nonFraction> potential shares to non-employee directors in the form of RSUs, which vest at the earlier of (i) the first anniversary of the grant date or (ii) the date of the first annual meeting of stockholders, subject to continued service of the recipients.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 4, 2022 and in connection with the Separation, Embecta granted <ix:nonFraction unitRef="shares" contextRef="c-89" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-505">860,611</ix:nonFraction> of potential shares to members of the Embecta leadership team as a one-time sign-on equity grant, subject to continued employment, comprised of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"><ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-506">172,787</ix:nonFraction> grants of time-vested RSUs which cliff vest on the third anniversary after grant date;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"><ix:nonFraction unitRef="shares" contextRef="c-91" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-507">528,167</ix:nonFraction> grants of SARs which cliff vest on the third anniversary after grant date and;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"><ix:nonFraction unitRef="shares" contextRef="c-92" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-508">27,653</ix:nonFraction> of TVUs and <ix:nonFraction unitRef="shares" contextRef="c-93" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-509">132,004</ix:nonFraction> of SARs granted to the Embecta's chief executive officer which vest evenly over <span style="-sec-ix-hidden:f-510">three</span> and <ix:nonNumeric contextRef="c-93" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-511">four years</ix:nonNumeric>, respectively.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Stock-Based Compensation Expense </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-512" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total direct and allocated stock-based compensation expense for the years ended September&#160;30, 2023, 2022, and 2021 and the respective income tax benefits recognized by the Company in the Consolidated Statements of Income are as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.388%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-513">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-514">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-515">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-516">18.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-517">14.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-518">7.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-519">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-520">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-521">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Stock-Based Compensation Expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-522">21.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-523">18.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-524">12.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Tax benefit associated with stock-based compensation costs recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-525">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-526">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-527">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company's total stock-based compensation expense by classification of award:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:55.131%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Equity Awards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-528">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-529">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-530">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Liability Awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-531">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="f-532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="f-533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-534">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-535">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-536">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company's total stock-based compensation expense by award type for the years ended September&#160;30, 2023 and 2022, subsequent to the Separation:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:70.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Time-Vested Restricted Stock Units (TVUs)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-537">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-538">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Performance-Based Restricted Stock Units (PSUs)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-539">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="f-540">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock Appreciation Rights (SARs)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-541">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-542">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-543">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-544">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Time Vested Restricted Stock Units</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> ended September 30, 2023</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Embecta granted <ix:nonFraction unitRef="shares" contextRef="c-103" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-545">680,281</ix:nonFraction> RSUs in the form of TVUs to employees which vest ratably over <ix:nonNumeric contextRef="c-103" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-546">three years</ix:nonNumeric>, subject to continued employment of the recipients. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TVUs vest on a graded basis over a period of <ix:nonNumeric contextRef="c-103" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-547">three years</ix:nonNumeric>. The related stock-based compensation expense is recorded over the requisite service period, which is the vesting period or is based on retirement eligibility. The fair value of all TVUs is based on the market value of the Company&#8217;s stock on the date of grant.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-495-2" continuedAt="f-495-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" id="f-548" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of TVUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stock Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at October 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-110" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-549">977.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-110" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-550">28.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-103" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-551">680.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-103" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-552">31.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Distributed*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-103" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-553">386.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-103" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-554">28.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-103" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-555">82.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-103" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-556">29.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-111" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-557">1,188.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-111" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-558">29.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected to vest at September 30</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-111" decimals="-2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-559">1,134.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-111" decimals="2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" scale="0" id="f-560">29.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">*The amounts distributed include shares withheld for taxes that are not formally issued to the market.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average grant date fair value of TVUs granted during the years 2023 and 2022 are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average grant date fair value of units granted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-103" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-561">31.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-112" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-562">31.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The total fair value of TVUs vested during the years 2023 and 2022 was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total fair value of units vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-563">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-564">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2023, the weighted average remaining vesting term of TVUs is <ix:nonNumeric contextRef="c-103" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-565">1.5</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Performance Based Restricted Stock Units</span></div><div style="text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> ended September 30, 2023</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Embecta awarded <ix:nonFraction unitRef="shares" contextRef="c-113" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-566">244,192</ix:nonFraction> RSUs in the form of PSUs to certain executive officers and employees which vest after <ix:nonNumeric contextRef="c-113" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-567">three years</ix:nonNumeric>, subject to continued employment of the recipients and the achievement of certain performance metric targets. For a portion of these awards, the Company has identified certain performance metrics and targets that will be fully established at a future date. The Company has determined that the service inception date precedes the grant date for these awards as (a) the awards were authorized prior to establishing an accounting grant date, (b) the recipients began providing services prior to the grant date, and (c) there are performance conditions that, if not met by the accounting grant date, will result in the forfeiture of the awards. As the service inception date precedes the accounting grant date, the Company recognizes stock-based compensation expense for each separately-vesting tranche over the requisite service period based on the fair value at each reporting date. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PSUs cliff vest on the third anniversary after grant date. The related stock-based compensation expense is recorded over the requisite service period, which is the vesting period or is based on retirement eligibility. The fair value of all PSUs is based on the market value of the Company&#8217;s stock on the date of grant.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" id="f-568" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of PSUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stock Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at October 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-114" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="3" id="f-569">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-114" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-570">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-105" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-571">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-105" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-572">30.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Distributed</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-105" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="3" id="f-573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-105" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-105" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-575">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-105" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-576">30.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-115" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-577">57.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-115" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-578">30.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected to vest at September 30</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-115" decimals="-2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" scale="3" id="f-579">54.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-115" decimals="2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" scale="0" id="f-580">30.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average grant date fair value of PSUs granted during 2023 is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average grant date fair value of units granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-105" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-581">30.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2023, the weighted average remaining vesting term of PSUs is <ix:nonNumeric contextRef="c-105" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-582">2.2</ix:nonNumeric> years.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-495-3"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Stock Appreciation Rights</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">SARs represent the right to receive, upon exercise, shares of common stock having a value equal to the difference between the market price of common stock on the date of exercise and the exercise price on the date of grant. SARs generally vest over a period of <span style="-sec-ix-hidden:f-583">three</span> to <ix:nonNumeric contextRef="c-87" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-584">four years</ix:nonNumeric> and have a term of <ix:nonNumeric contextRef="c-85" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-585">ten years</ix:nonNumeric>. The fair value of awards are estimated on the date of grant using a Black-Scholes-Merton (&#8220;BSM&#8221;) model. The BSM assumptions include expected dividend yield, risk-free interest rate, volatility, and term of the SARs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the SARs granted during 2022, the Company used the BSM to determine the fair value of the SARs as of the grant date. In applying this model, the Company uses both historical data and current market data to estimate the fair value of its SARs. The expected dividend yield is based on forecasted patterns of dividend payments. The risk-free interest rate is based on the rate at grant date of zero-coupon United States Treasury Notes with a term equal to the expected term of the SAR. Expected volatility is estimated using historical volatility. Due to the lack of trading history of Embecta's stock at the time of valuation efforts, the historical component of expected volatility is based on historical monthly price changes of the peer group within the industry. BD's historical data for Embecta employees was used to estimate equity award exercise and employee termination behavior within the valuation model. The expected term represents the amount of time that SARs granted are expected to be outstanding based on historical and forecasted exercise behavior. <ix:nonNumeric contextRef="c-1" name="embc:ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock" id="f-586" continuedAt="f-586-1" escape="true">The weighted average fair value of SARs was determined using the following assumptions:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-586-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:89.809%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-116" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-587">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-116" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-588">37.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-116" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-589">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected life</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-116" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-590">6.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Fair value per SAR</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-117" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-591">9.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" id="f-592" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of SARs outstanding as of September 30, 2023 and changes and changes during the year then ended is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">SARs (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Aggregate Intrinsic Value </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at October 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-117" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-593">1,916.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-117" decimals="2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="f-594">28.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-107" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:fixed-zero" scale="3" id="f-595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-107" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="3" id="f-597">25.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-598">21.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="c-107" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" scale="3" id="f-599">59.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-600">29.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-118" decimals="-2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-601">1,831.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-118" decimals="2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="f-602">29.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-107" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-603">7.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:fixed-zero" scale="6" id="f-604">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested and expected to vest at September 30</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-118" decimals="-2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-605">1,740.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-118" decimals="2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-606">29.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-107" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-607">7.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:fixed-zero" scale="6" id="f-608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-118" decimals="-2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" scale="3" id="f-609">179.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-118" decimals="2" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" scale="0" id="f-610">26.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-107" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-611">6.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" format="ixt:fixed-zero" scale="6" id="f-612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">*The amounts exercised include shares withheld for taxes that are not formally issued to the market.</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of SARs exercised during the years 2023 and 2022 is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total intrinsic value of SARs exercised</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" scale="6" id="f-613">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" scale="6" id="f-614">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total fair value of SARs exercised</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" scale="6" id="f-615">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" scale="6" id="f-616">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Unrecognized Compensation Expense and Other Stock Plans</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount of unrecognized compensation expense for all non-vested stock-based awards as of September 30, 2023, is approximately $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-617">28.2</ix:nonFraction>&#160;million, which is expected to be recognized over a weighted-average remaining life of approximately <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-618">1.8</ix:nonNumeric> years. At September 30, 2023, <ix:nonFraction unitRef="shares" contextRef="c-83" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="f-619">3.4</ix:nonFraction>&#160;million shares were authorized for future grants under the Plan.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_184"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-623" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 11 &#8212; Goodwill and Other Intangible Assets </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="f-624" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill and Other Intangible Assets consisted of: </span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Amortized intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Patents &#8211; gross</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-120" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-625">12.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-626">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-627">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-628">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-629">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Patents &#8211; net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-630">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-631">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Customer Relationships and Other &#8211; gross</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-122" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-632">5.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-633">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-634">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-635">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-636">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Customer Relationships and Other &#8211; net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-637">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-638">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-639">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-640">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-641">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-642">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Goodwill and Other Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-643">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="6" id="f-644">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-645">1.2</ix:nonFraction>&#160;million for the year ended September 30, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-646">0.7</ix:nonFraction>&#160;million for the year ended September 30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-647">0.3</ix:nonFraction>&#160;million for the year ended September 30, 2021, respectively. The estimated intangible asset amortization expense for each of the fiscal years ended September 30, 2024 through 2028 is expected to approximate $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="f-648"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="f-649"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="6" id="f-650"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="f-651"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="f-652">1.1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;million per year and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="f-653">3.6</ix:nonFraction>&#160;million for years subsequent thereafter.</span></div></ix:nonNumeric><div id="i209d71ebb5944f1aadd70761506c49b3_190"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LongTermDebtTextBlock" id="f-654" continuedAt="f-654-1" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 12 &#8212; Long-Term Debt</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-125" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-655">5.00</ix:nonFraction>% Senior Secured Notes due 2030</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 10, 2022 Embecta issued $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-656">500.0</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="c-125" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-657">5.00</ix:nonFraction>% senior secured notes due February 15, 2030 (the &#8220;<ix:nonFraction unitRef="number" contextRef="c-125" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-658">5.00</ix:nonFraction>% Notes&#8221;). </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest payments on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-125" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-659">5.00</ix:nonFraction>%</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes are due semi-annually in February and August until maturity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-126" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-660">6.75</ix:nonFraction>% Senior Secured Notes due 2030</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 31, 2022, Embecta issued $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-661">200.0</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="c-72" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-662">6.75</ix:nonFraction>% Related Party Notes at a discount of $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-5" name="embc:DebtInstrumentDiscountGross" format="ixt:num-dot-decimal" scale="6" id="f-663">3.0</ix:nonFraction>&#160;million. </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Related Party Notes issued to BD were not issued for cash and instead were subject to a debt-for-debt exchange which occurred on April 1, 2022. As such, the issuance of the Related Party Notes is a non-cash financing activity and is not presented in the Consolidated Statements of Cash Flows for the year ended September 30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, BD transferred the Related Party Notes with a notional value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-664">200.0</ix:nonFraction>&#160;million</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> issued by Embecta to Morgan Stanley in exchange for certain notes of BD that were purchased by Morgan Stanley pursuant to a tender offer. Morgan Stanley then sold the senior secured notes to qualified institutional buyers in the United States pursuant to Rule 144A under the Securities Act of 1933, as amended. As of April 1, 2022, the <ix:nonFraction unitRef="number" contextRef="c-126" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-665">6.75</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">senior secured notes (the "<ix:nonFraction unitRef="number" contextRef="c-126" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-666">6.75</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes")</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> became third party debt of Embecta. Interest payments on the <ix:nonFraction unitRef="number" contextRef="c-126" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-667">6.75</ix:nonFraction>% Notes are due semi-annually in February and August until maturity. The <ix:nonFraction unitRef="number" contextRef="c-126" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-668">6.75</ix:nonFraction>% Notes will mature on February 15, 2030.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 31, 2022, Embecta entered into a credit agreement (the &#8220;Credit Agreement&#8221;), providing for: </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:28pt">a Term Loan B Facility (the "Term Loan") in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-669">950.0</ix:nonFraction>&#160;million, with a </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-129" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-670" continuedAt="f-670-1">seven</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-670-1">-year</ix:continuation> </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">term that matures in March 2029. The interest rate is <ix:nonFraction unitRef="number" contextRef="c-130" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="f-671">300</ix:nonFraction> basis points over the secured overnight financing rate (&#8220;SOFR&#8221;), with a <ix:nonFraction unitRef="number" contextRef="c-130" decimals="INF" name="embc:DebtInstrumentVariableRateFloor" scale="-2" id="f-672">0.50</ix:nonFraction>% SOFR floor. The Term Loan was issued at a discount of <ix:nonFraction unitRef="number" contextRef="c-128" decimals="4" name="embc:DebtInstrumentDiscountPercentage" scale="-2" id="f-673">0.50</ix:nonFraction>%. Principal and interest payments on the Term Loan commenced on June 30, 2022. Such quarterly principal payments are calculated as <ix:nonFraction unitRef="number" contextRef="c-129" decimals="INF" name="embc:DebtInstrumentPeriodicPaymentPrincipalPercentage" scale="-2" id="f-674">0.25</ix:nonFraction>% of the initial principal amount, with the remaining balance payable upon maturity;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:28pt">a Revolving Credit Facility (the "Revolving Credit Facility") in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-675">500.0</ix:nonFraction>&#160;million, with a </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-132" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-676" continuedAt="f-676-1">five</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-676-1">-year</ix:continuation> term that matures in 2027. </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Borrowings under the Revolving Credit Facility bear interest, at Embecta&#8217;s option, at an annual rate equal to (a) in the case of loans denominated in United States dollars (i) the SOFR or (ii) the alternate base rate or (b) in the case of loans denominated in Euros, the EURIBOR rate, in each case plus an applicable margin specified in the credit agreement. A commitment fee applies to the unused portion of the Revolving Credit Facility, equal to <ix:nonFraction unitRef="number" contextRef="c-132" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-677">0.25</ix:nonFraction>% per annum. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September&#160;30, 2023, <ix:nonFraction unitRef="usd" contextRef="c-133" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="f-678">no</ix:nonFraction> amount has been drawn on the Revolving Credit Facility. </span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-654-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The credit agreement and the senior secured notes are secured by substantially all assets of Embecta and each subsidiary guarantor, subject to certain exceptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Credit Agreement and the indentures for Embecta's outstanding <ix:nonFraction unitRef="number" contextRef="c-125" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-679">5.00</ix:nonFraction>% Notes and <ix:nonFraction unitRef="number" contextRef="c-126" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-680">6.75</ix:nonFraction>% Notes contain customary financial covenants, including a total net leverage ratio covenant, which measures the ratio of (i) consolidated total net debt to (ii) consolidated earnings before interest, taxes, depreciation and amortization, and subject to other adjustments, must meet certain defined limits which are tested on a quarterly basis in accordance with the terms of the Credit Agreement and the <ix:nonFraction unitRef="number" contextRef="c-125" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-681">5.00</ix:nonFraction>% Notes and </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-126" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-682">6.75</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes. In addition, the Credit Agreement contains covenants that will limit, among other things, Embecta&#8217;s ability to prepay, redeem or repurchase its subordinated and junior lien debt, incur additional debt, make acquisitions, merge with other entities, pay dividends or distributions, redeem or repurchase equity interests, and create or become subject to liens. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-683" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a summary of Embecta's total debt outstanding as of September&#160;30, 2023:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Term Loan due March 2029</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-684">935.8</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-align:justify;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-135" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-685">5.00</ix:nonFraction>% Notes due February 2030</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-686">500.0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:10pt;text-align:justify;text-indent:-10pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-136" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-687">6.75</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"> Notes due February 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="f-688">200.0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total principal debt issued</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="f-689">1,635.8</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="f-690">9.5</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="f-691">32.4</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-692">1,593.9</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The debt issuance costs on the Term Loan, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-125" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-693">5.00</ix:nonFraction>%</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes, <ix:nonFraction unitRef="number" contextRef="c-126" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-694">6.75</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and the discount on the Term Loan are reported in the Consolidated Balance Sheets as a reduction of debt and are amortized as a component of </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Interest expense, net</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> over the term of the related debt using the effective interest method.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-695" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The schedule of principal payments required on long-term debt for the next five fiscal years and thereafter is as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:88.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="f-696">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="f-697">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="f-698">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="f-699">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="f-700">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="f-701">1,588.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair value of long-term debt (including current portion) at September&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-702">1,474.2</ix:nonFraction>&#160;million compared with a carrying value (which includes a reduction for unamortized debt issuance costs and discounts) of $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-703">1,603.4</ix:nonFraction>&#160;million. Fair value was estimated using inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability and would be considered Level 2 in the fair value hierarchy.</span></div></ix:continuation><div id="i209d71ebb5944f1aadd70761506c49b3_196"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-704" continuedAt="f-704-1" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 13 &#8212; Earnings per Share</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, the date of the Separation, <ix:nonFraction unitRef="shares" contextRef="c-36" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-705">57,012,925</ix:nonFraction> shares of Embecta's common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-34" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-706">0.01</ix:nonFraction> per share, were distributed to BD shareholders of record as of March 22, 2022, the record date of the distribution. This share amount is utilized for the calculation of earnings per basic and diluted common share for all periods presented prior to the Separation.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, and in accordance with the EMA, Embecta's employees with outstanding former BD share-based awards received replacement share-based awards under the Plan. The ratio used to convert the BD share-based awards was designed to preserve the aggregate intrinsic value of the award immediately after the Separation when compared to the aggregate intrinsic value of the award immediately prior to the Separation (see Note 10 for additional details).</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-707" continuedAt="f-707-1" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The calculation of earnings per basic and diluted common share for the </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">years ended September 30, 2023, 2022 and 2021 were as follows:</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-704-1"><ix:continuation id="f-707-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:68.399%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.459%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.459%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">($ in millions and shares in thousands, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income attributable to Embecta</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-708">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-709">223.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-710">414.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average number of shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-711">57,248</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-712">57,024</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-713">57,013</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock awards and equity units (share equivalent)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-714">510</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-715">437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="f-716">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-717">57,758</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-718">57,461</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-719">57,013</ix:nonFraction></span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per common share - Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-720">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-721">3.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-722">7.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per common share - Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-723">1.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-724">3.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-725">7.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For periods prior to the Separation, it is assumed that there were no dilutive equity instruments as there were no equity awards of Embecta outstanding prior to the Separation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For periods subsequent to the Separation, diluted earnings per share is computed by giving effect to all potentially dilutive stock awards that are outstanding. The computation of earnings per diluted share excludes the effect of the potential exercise of stock-based awards, when the effect of the potential exercise would be anti-dilutive. For both 2023 and 2022, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-726"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="f-727">1.8</ix:nonFraction></ix:nonFraction>&#160;million of dilutive share equivalents issuable under stock-based compensation plans were excluded from the diluted shares outstanding calculation because the result would have been antidilutive.</span></div></ix:continuation><div id="i209d71ebb5944f1aadd70761506c49b3_199"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-728" continuedAt="f-728-1" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 14 &#8212; Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Income (Loss) Before Income Taxe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">s</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-729" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Before Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for the years ended September 30 consisted of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-730">100.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-731">29.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-732">87.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-733">206.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-734">285.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-735">407.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-736">105.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-737">256.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-738">494.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Provision (benefit) for Income Taxes</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-739" continuedAt="f-739-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provision (benefit) for income taxes for the years ended September 30 consisted of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-740">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-741">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-742">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-743">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-744">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-745">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-746">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-747">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-748">59.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-749">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-750">59.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-751">82.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-752">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-753">31.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-754">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-755">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-756">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-757">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-758">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-759">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-760">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-761">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-762">26.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-763">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-764">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-765">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-766">80.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's income tax provision for the first half of 2022 and the year ended September 30, 2021 were prepared using a separate return method. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company was a separate taxpayer and a standalone enterprise. The Company believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For a portion of fiscal year 2022 and all periods prior to the Separation, the Company&#8217;s domestic and foreign operations were included in BD&#8217;s domestic consolidated and foreign tax returns, and payments to all tax authorities were made by BD on the Company&#8217;s behalf. The Company filed its own foreign tax return and made its own foreign tax payments in Ireland. The Company&#8217;s current tax liabilities computed under the separate return method were considered to be effectively settled in the consolidated financial statements at the time the transaction was recorded, with the offset recorded against Net parent investment.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-728-1" continuedAt="f-728-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Tax Rate Reconciliation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-767" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A reconciliation of federal statutory tax rate to the Company's effective income tax rate was as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-768">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-769">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-770">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" format="ixt:fixed-zero" scale="-2" id="f-771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-772">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-773">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-774">17.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-775">7.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="f-776">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US tax on foreign earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="f-777">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="f-778">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="f-779">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes on unremitted foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="embc:EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" scale="-2" id="f-780">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="embc:EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" scale="-2" id="f-781">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="embc:EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" format="ixt:fixed-zero" scale="-2" id="f-782">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="f-783">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="f-784">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="f-785">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-786">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="-2" id="f-787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="-2" id="f-788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="f-789">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="f-790">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="f-791">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nontaxable items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome" scale="-2" id="f-792">8.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome" scale="-2" id="f-793">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome" format="ixt:fixed-zero" scale="-2" id="f-794">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-795">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:fixed-zero" scale="-2" id="f-796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:fixed-zero" scale="-2" id="f-797">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-798">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-799">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" format="ixt:fixed-zero" scale="-2" id="f-800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-801">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-802">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-803">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase in the Company's effective income tax rate for fiscal year 2023 as compared to fiscal year 2022 was primarily due to the establishment of a valuation allowance against interest expense carryforwards in the U.S., an increase in U.S. tax on foreign earnings primarily because of limitations on the utilization of foreign tax credits and higher withholding taxes on unremitted foreign earnings; partially offset by increased tax benefits from non-taxable items and change in geographical mix of earnings.  For fiscal year 2023, the Other, net included a tax benefit for the establishment of net deferred tax assets incurred in connection with the ongoing separation of the Diabetes Care Business from BD, partially offset by a return to provision adjustment from the prior year.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The decrease in the Company's effective income tax rate for fiscal year 2022 as compared to fiscal year 2021 was primarily due to the change in geographical mix of earnings and favorable unrecognized tax benefits recorded in fiscal year 2022; partially offset by tax expense that have been provided on undistributed earnings of foreign subsidiaries.    </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-728-2" continuedAt="f-728-3"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Deferred Income Taxes</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-804" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred income taxes at September 30 consisted of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="f-805">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="f-806">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="f-807">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="6" id="f-808">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="f-809">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="f-810">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="f-811">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="6" id="f-812">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" scale="6" id="f-813">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="embc:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" scale="6" id="f-814">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:DeferredTaxAssetsLeasingArrangements" scale="6" id="f-815">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="embc:DeferredTaxAssetsLeasingArrangements" scale="6" id="f-816">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetInterestCarryforward" scale="6" id="f-817">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetInterestCarryforward" format="ixt:fixed-zero" scale="6" id="f-818">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" scale="6" id="f-819">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="embc:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" scale="6" id="f-820">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-821">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="f-822">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross deferred tax assets before valuation allowance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="f-823">109.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="f-824">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-825">31.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-826">10.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="f-827">78.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="f-828">76.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes on unremitted foreign earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="f-829">20.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="f-830">8.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="f-831">12.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="f-832">9.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-833">33.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-834">17.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities) (i)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="f-835">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="f-836">58.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt">Net deferred tax assets are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and net deferred tax liabilities are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Balance Sheets.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred tax assets and liabilities are netted in the Consolidated Balance Sheets by separate tax jurisdictions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2023 and September 30, 2022, the Company has recorded deferred taxes on undistributed earnings of foreign subsidiaries.  The vast majority of these taxes were accrued, in part, because the Company does not meet certain holding period requirements for stock ownership.  During fiscal year 2024, the Company anticipates that it will meet these requirements at which time approximately $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-837">18.0</ix:nonFraction>&#160;million of the accrued balance as of September 30, 2023 will be recorded as a reduction to income tax expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2023 the Company has recorded valuation allowances of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-838">31.6</ix:nonFraction>&#160;million due to the uncertainty that exists regarding future realizability of certain deferred tax assets primarily for interest expense carryforwards in the U.S. related to limitations on the annual deductibility of such interest, state net operating losses, state tax credits and deferred tax assets related to certain foreign manufacturing operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2022, the Company has recorded valuation allowances of $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-839">10.4</ix:nonFraction>&#160;million for deferred tax assets related to certain foreign manufacturing operations.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The approximate tax reduction related to a tax holiday in Switzerland in which the Company does business is $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxHolidayAggregateDollarAmount" format="ixt:num-dot-decimal" scale="6" id="f-840">2.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare" scale="0" id="f-841">0.04</ix:nonFraction> impact on diluted earnings per share in fiscal year 2023. The tax holiday will expire in 2026.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tax loss and credit carryforwards consist of approximately $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-842">1.0</ix:nonFraction>&#160;million of state income tax credit carryforwards and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-843">5.6</ix:nonFraction>&#160;million net operating loss carryforwards in various jurisdictions.  Approximately $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:OperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-844">1.0</ix:nonFraction>&#160;million of net operating loss carryforwards will not expire and the remaining carryforwards expire in varying amounts from 2028 through 2042.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-728-3"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Unrecognized Tax Benefits</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-845" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at October 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-846">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-847">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-848">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase due to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-849">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-850">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-851">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase due to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-852">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="f-853">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-854">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease due to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-855">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-856">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="f-857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease due to settlements with tax authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="6" id="f-858">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="6" id="f-859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="f-860">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease due to lapse of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-861">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="f-862">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="f-863">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-864">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-865">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-866">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits including interest and penalties that would affect the effective tax rate if recognized</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="f-867">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="f-868">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="f-869">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For a portion of fiscal year 2022 and all periods prior to the Separation, the Company&#8217;s domestic and foreign operations were included in BD&#8217;s domestic consolidated and foreign tax returns, with the exception of Ireland.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company conducts business and files tax returns in numerous countries and currently has no tax audits in progress for the period after the Separation. </span></div><ix:continuation id="f-739-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following were included for the years ended September 30 as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Statements of Income and the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and penalties expense (benefit) associated with unrecognized tax benefits on the Consolidated Statements of Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="f-870">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" sign="-" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="f-871">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="f-872">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and penalties associated with unrecognized tax benefits on the Consolidated Balance Sheets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="f-873">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="f-874">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="f-875">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i209d71ebb5944f1aadd70761506c49b3_205"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-876" continuedAt="f-876-1" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 15 &#8212; Financial Instruments and Fair Value Measurements </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-877" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following reconciles </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> reported within the Consolidated Balance Sheets as of September&#160;30, 2023 and September&#160;30, 2022, to the total amounts shown in the Consolidated Statements of Cash Flows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-878">326.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-879">330.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> includes cash held in money market funds and other cash equivalents. All cash and cash equivalents are Level 1 in the fair value hierarchy. Interest income on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestIncomeOther" format="ixt:num-dot-decimal" scale="6" id="f-880">9.4</ix:nonFraction>&#160;million for the year ended September&#160;30, 2023 and is included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Interest expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. For the years ended September 30, 2022 and 2021, interest income was <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:InterestIncomeOther" format="ixt:fixed-zero" scale="0" id="f-881"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:InterestIncomeOther" format="ixt:fixed-zero" scale="0" id="f-882">not</ix:nonFraction></ix:nonFraction> material to the Company's Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Foreign Currency Risks and Related Strategies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has foreign currency exposures throughout Europe, Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="f-883" continuedAt="f-883-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-884">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-885">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other income (expense), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-876-1" continuedAt="f-876-2"><ix:continuation id="f-883-1"><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">hedging costs associated with the derivative instruments. Gains and losses recognized to date on these instruments were not material to the Company's Consolidated Financial Statements.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Nonrecurring Fair Value Measurements </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Non-financial assets, including property, plant and equipment as well as intangible assets, are measured at fair value when there are indicators of impairment and these assets are recorded at fair value only when an impairment is recognized. These measurements of fair value are generally based upon Level 3 inputs, including values estimated using the income approach. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2023, the Company recorded impairment charges of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-886">2.5</ix:nonFraction>&#160;million related to the abandonment of certain manufacturing equipment in China that is no longer in use that were inherited as part of the spin from BD. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Machinery, equipment and fixtures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Impairment expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2022, the Company recorded impairment charges of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-887">58.9</ix:nonFraction>&#160;million related to the abandonment of certain manufacturing production lines in the United States that are no longer expected to be completed. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Construction in progress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Impairment expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2021, the Company recorded impairment charges related to certain construction in progress assets related to discontinued projects totaling $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-888">13.8</ix:nonFraction>&#160;million. The impairment charges were recorded to adjust the carrying amount of the assets to the assets&#8217; fair values, which were estimated through a discounted cash flow model that utilized Level 3 inputs. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Historically and prior to the Separation, the Company&#8217;s operations formed part of BD&#8217;s monitoring of concentrations of credit risk associated with financial institutions for which BD conducted business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September&#160;30, 2023, the Company had transferred the majority of its trade receivables to BD under the Factoring Agreements (see Note 4). As a result, the Company is no longer exposed to credit risk associated with those transferred receivables and does not have material credit risk exposure associated with the remaining $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-889">16.7</ix:nonFraction> million of trade receivables. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Three of the Company&#8217;s customers represented at least 10.0% of total gross revenues individually and, in the aggregate, represented approximately <ix:nonFraction unitRef="number" contextRef="c-141" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-890">40.2</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-142" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-891">40.1</ix:nonFraction>% for the years ended September&#160;30, 2023 and 2022, respectively. Two customers represented at least 10.0% of total revenues individually and, in the aggregate, represented approximately <ix:nonFraction unitRef="number" contextRef="c-143" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-892">30.7</ix:nonFraction>% of total revenues for the year ended September 30, 2021. </span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="f-876-2">Substantially all of the Company&#8217;s trade receivables are due from public and private entities involved in the healthcare industry. The Company does not normally require collateral from its customers.</ix:continuation> </span></div><div id="i209d71ebb5944f1aadd70761506c49b3_208"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-893" continuedAt="f-893-1" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 16 &#8212; Property, Plant and Equipment</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-894" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, Plant and Equipment, Net consisted of: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-895">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-896">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-897">124.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-898">123.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-899">567.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-900">505.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-901">9.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-902">6.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-903">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-904">64.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-905">747.9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="6" id="f-906">701.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="f-907">447.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="f-908">400.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Property, Plant and Equipment, Net</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-909">300.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="f-910">301.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2023, the Company recorded impairment charges of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-911">2.5</ix:nonFraction>&#160;million related to the abandonment of certain manufacturing equipment in China that is no longer in use that were inherited as part of the spin from BD. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Machinery, equipment and fixtures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-893-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2022, the Company recorded impairment charges of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="f-912">58.9</ix:nonFraction>&#160;million related to the abandonment of certain manufacturing production lines in the United States that are no longer expected to be completed. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Construction in progress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Impairment expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income.</span></div></ix:continuation><div id="i209d71ebb5944f1aadd70761506c49b3_211"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-914" continuedAt="f-914-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-913" continuedAt="f-913-1" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 17 &#8212; Leases</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Finance Lease</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In conjunction with the Separation, we entered into a lease agreement with BD pursuant to which the Company would lease approximately <ix:nonFraction unitRef="sqft" contextRef="c-6" decimals="-3" name="embc:LesseeFinanceLeaseAreaOfPremisesLeased" format="ixt:num-dot-decimal" scale="0" id="f-915">278,000</ix:nonFraction> square feet of manufacturing space and equipment at BD's manufacturing facility in Holdrege, Nebraska for an initial term of <ix:nonNumeric contextRef="c-6" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:durwordsen" id="f-916">ten years</ix:nonNumeric> and an option for the Company to extend the lease term for an additional period of up to <ix:nonNumeric contextRef="c-6" name="us-gaap:LesseeFinanceLeaseRenewalTerm1" format="ixt-sec:durwordsen" id="f-917">five years</ix:nonNumeric>. This lease is classified as a finance lease.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2023, the Company recorded total finance lease costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="embc:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-918">4.8</ix:nonFraction> million which is comprised of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="6" id="f-919">2.4</ix:nonFraction> million attributable to depreciation of assets and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-920">2.4</ix:nonFraction> million attributable to interest expense associated with the lease liability. The amounts are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Interest expense, net,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> respectively. For the year ended September 30, 2022, total finance lease costs were <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="embc:FinanceLeaseCost" format="ixt:fixed-zero" scale="0" id="f-921">not</ix:nonFraction> material to the Company's Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Operating Leases</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's operating leases primarily relate to its real estate leases that are not classified as finance leases. The Company entered into a real estate lease for a new Corporate Headquarters located in Parsippany, NJ which commenced during the second quarter of fiscal year 2023 for an initial term of <ix:nonNumeric contextRef="c-2" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-922">ten years</ix:nonNumeric>. The Company has options to extend the lease for additional period of <ix:nonNumeric contextRef="c-154" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-923">six years</ix:nonNumeric> and to extend for a subsequent additional period of <ix:nonNumeric contextRef="c-155" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-924">four years</ix:nonNumeric>, after the expiration of the first extension period.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2023 operating lease costs were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-925">4.5</ix:nonFraction> million. For the years ended September 30, 2022, and 2021 total operating lease costs were <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:OperatingLeaseCost" format="ixt:fixed-zero" scale="0" id="f-926"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:OperatingLeaseCost" format="ixt:fixed-zero" scale="0" id="f-927">not</ix:nonFraction></ix:nonFraction> material to the Company's Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Aggregate Lease Information</span></div><ix:nonNumeric contextRef="c-1" name="embc:AssetsAndLiabilitiesLesseeTableTextBlock" id="f-928" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's leases are included in its Consolidated Balance Sheets as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:55.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.992%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Finance Lease</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-929"><span style="-sec-ix-hidden:f-930">Property, Plant, and Equipment, Net</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-931">33.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-932">35.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Finance Lease Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-933">33.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="f-934">35.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current finance lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-935">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-936">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non Current Finance Lease Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-937">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-938">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Finance Lease Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-939">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-940">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-6" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-941">13.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-7" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-942">14.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-943">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-944">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-945"><span style="-sec-ix-hidden:f-946">Deferred Income Taxes and Other Assets</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-947">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-948">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Lease Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-949">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-950">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-951"><span style="-sec-ix-hidden:f-952">Accrued expenses</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-953">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-954">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-955"><span style="-sec-ix-hidden:f-956">Deferred Income Taxes and Other Liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-957">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-958">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Lease Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-959">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-960">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-6" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-961">7.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-962">3.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-963">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-964">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-914-1"><ix:continuation id="f-913-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-965" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Supplemental cash flow information related to leases was as follows as of September 30, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Right of use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finance Lease</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="6" id="f-966">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-967">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating Leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-968">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-969">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2021 right of use assets obtained in exchange for lease liabilities was not material.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.719%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash paid for amounts included in the measurement of lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flows from Operating Leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-970">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Financing cash flows from Finance Lease</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-971">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flows from Finance Lease</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-972">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the years ended September 30, 2022, and 2021 cash paid for amounts included in the measurement of lease liabilities were not material.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-974" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-973" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Maturities of the Company's finance and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:36.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-975">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-976">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:LesseeLeaseLiabilityToBePaidYearOne" scale="6" id="f-977">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-978">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-979">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:LesseeLeaseLiabilityToBePaidYearTwo" scale="6" id="f-980">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-981">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-982">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:LesseeLeaseLiabilityToBePaidYearThree" scale="6" id="f-983">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-984">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-985">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:LesseeLeaseLiabilityToBePaidYearFour" scale="6" id="f-986">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-987">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-988">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:LesseeLeaseLiabilityToBePaidYearFive" scale="6" id="f-989">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-990">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-991">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:LesseeLeaseLiabilityToBePaidDueAfterYearFive" scale="6" id="f-992">47.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="f-993">54.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-994">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:LesseeLeaseLiabilityToBePaid" scale="6" id="f-995">82.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-996">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-997">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:LesseeLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-998">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-999">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-1000">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="embc:LesseeLeaseLiability" scale="6" id="f-1001">56.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_214"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-1002" escape="true"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 18 &#8212; Benefit Plans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Defined Benefit Plans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation on April 1, 2022, Embecta participated in BD's non-United States plans. BD has defined benefit pension plans covering eligible employees in certain of its international subsidiaries. The Company participated in BD's benefit plans as though it was a participant in a multi-employer plan with the other businesses of BD. The retirement benefits accounting guidance provides that liabilities beyond any contributions currently due and unpaid are not required to be reported. Accordingly, no assets or liabilities associated with plans where the Company was a participant in a multi-employer plan with the other businesses of BD have been reflected in the Company&#8217;s Consolidated Balance Sheets. The Consolidated Statements of Income include expense allocations for these benefits, which were determined using a proportional allocation method. Total benefit plan expense allocated to the Company for the years ended September 30, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="f-1003">3.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="f-1004">9.0</ix:nonFraction>&#160;million, respectively. Except for deferred closing countries, the Company's participation in the defined pension and postretirement benefit plans sponsored by BD concluded upon the completion of the Separation on April 1, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of April 1, 2022, Embecta became the plan sponsor for certain global defined benefit pension plans. These Consolidated Financial Statements reflect the periodic benefit costs and funded status of such plans. The Company uses September 30 as the year-end measurement date for these plans. Net periodic benefit cost for the Company&#8217;s global defined benefit pension plans for the years ended September 30, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="f-1005">1.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="f-1006">0.7</ix:nonFraction>&#160;million, respectively. Of the plans, the defined benefit pension plan covering employees in Switzerland (the "Swiss Plan") is the only defined benefit pension plan material to the Company's Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's Swiss Plan is a government-mandated retirement account balance plan. Companies within the Swiss regulatory environment have substantial freedom in setting their pension plan design (e.g. with regards to the salary covered, level of retirement benefits, or overall benefit design) provided the benefits are always at least equal to the minimum requirements as defined by law. Most employers provide higher benefits than those required by law, which is the case for Embecta. The minimum level of retirement benefit is expressed by a cash balance formula with age-related contribution rates (or "retirement credits") based on an insured salary defined by law, and a minimum required interest crediting rate which is set by the government (1.00% in 2023 and 2022). The sum of the Company's contributions should be at least equal to the sum of employee contributions. Contributions to the Swiss Plan are invested into a diversified fund managed by an investment fiduciary. As of September&#160;30, 2023 and 2022, the Swiss plan had an unfunded net pension obligation of $<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="6" id="f-1007">1.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="6" id="f-1008">0.6</ix:nonFraction>&#160;million, respectively, and plan assets that totaled $<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-1009">14.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="f-1010">8.0</ix:nonFraction>&#160;million, respectively. Since the Separation, the Company recognized net periodic benefit cost totaling $<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="f-1011">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="f-1012">0.2</ix:nonFraction> million during the fiscal years ended September 30, 2023 and 2022, respectively, related to the Company's Swiss plan, of which $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="f-1013">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="f-1014">0.1</ix:nonFraction> million was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other income (expense), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">during the fiscal years ended September 30, 2023 and 2022, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Defined Contribution Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has various defined contribution savings plans that cover substantially all employees in the United States, Ireland, and Japan. The Company matches a certain percentage of each employee&#8217;s contributions as per the provisions of the plans. Total employer contributions by the Company to the plans were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="f-1015">14.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="f-1016">8.9</ix:nonFraction> million for the fiscal years ended September 30, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Between April 1, 2022 and September 30, 2022, BD remained the defined benefit pension plan sponsor for certain Embecta employees in Ireland. The Company accounts for this plan as though it was a participant in a multi-employer plan with other businesses of BD.  The amount of contributions to BD for this plan are included in the amounts noted above. At the Separation Date, Embecta effectuated an Embecta sponsored defined contribution pension plan for certain other employees in Ireland. On October 1, 2022, any Embecta employees who remained participating in the BD defined benefit pension plan ceased participating and these employees began participating in an Embecta sponsored defined contribution pension plan that was effectuated at the Separation Date. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On the date of the Separation, the Company established a Deferred Compensation Plan in which certain directors and employees of the Company may defer the payment and taxation of up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="embc:DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage" scale="-2" id="f-1017">75</ix:nonFraction>% of their base salary and up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="embc:DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage" scale="-2" id="f-1018">100</ix:nonFraction>% of bonus amounts and other eligible cash compensation. A participant's deferrals are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator. The amounts accrued under this plan were $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1019">6.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1020">3.7</ix:nonFraction> million as of September&#160;30, 2023, and 2022, respectively.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_220"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="f-1021" escape="true"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 19 &#8212; Supplemental Financial Information</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Trade Receivables, Net</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="f-1022" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amounts recognized in fiscal years 2023, 2022 and 2021 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:43.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance for Doubtful Accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance for Cash Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1023">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1024">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1025">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1026">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1027">16.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1028">16.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1029">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1030">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1031">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1032">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1033">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1034">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1035">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1036">18.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1037">18.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deductions and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1038">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1039">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1040">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1041">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1042">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1043">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1044">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1045">18.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1046">18.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1047">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1048">18.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="f-1049">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1050">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="f-1051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1052">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(a) Accounts written off</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(b) Amounts factored to BD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Long-Lived Assets</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="f-1053" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Long-lived assets, which include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Goodwill and Other Intangibles, net,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> by geographic area where located at September 30, 2023 and 2022 is as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1054">109.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1055">109.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Europe, Middle East, and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1056">176.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1057">174.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1058">38.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1059">42.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1060">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1061">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1062">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1063">326.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div id="i209d71ebb5944f1aadd70761506c49b3_223"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1064" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 20 &#8212; Subsequent Events</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Performance-Based and Time-Vested Restricted Stock Units</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2023 and pursuant to the Company's 2022 Employee and Director Equity Based Compensation Plan (the "Plan"), the Company granted approximately <ix:nonFraction unitRef="shares" contextRef="c-184" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1065">1.3</ix:nonFraction>&#160;million </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TVUs in connection with the Company's annual grant which </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">vest on a graded basis over a period of <ix:nonNumeric contextRef="c-184" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1066">three years</ix:nonNumeric>, subject to continuous service to the Company by the employee.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company also awarded approximately <ix:nonFraction unitRef="shares" contextRef="c-185" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1067">0.5</ix:nonFraction>&#160;million PSUs to certain executive officers and employees in connection with the Company's annual grant </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">which vest after <ix:nonNumeric contextRef="c-185" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1068">three years</ix:nonNumeric>, subject to continued employment of the recipients and the achievement of certain performance metric targets. The Company has identified certain performance metrics and targets that will be fully established at a future date. The Company has determined that the service inception date precedes the grant date for these awards as (a) the awards were authorized prior to establishing an accounting grant date, (b) the recipients began providing services prior to the grant date, and (c) there are performance conditions that, if not met by the accounting grant date, will result in the forfeiture of the awards.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:95.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollar amounts are in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75</span></div></td></tr></table></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_229"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_232"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9A. Controls and Procedures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">An evaluation was carried out by Embecta&#8217;s management, with the participation of Embecta&#8217;s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of Embecta&#8217;s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of September&#160;30, 2023. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were, as of the end of the period covered by this Annual Report on Form 10-K, effective and designed to ensure that material information relating to Embecta and its consolidated subsidiaries would be made known to them by others within these entities. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the TSA period, we will continue to rely on certain material processes and internal control over financial reporting performed by BD. There were no changes in our internal control over financial reporting during the fiscal quarter ended September&#160;30, 2023, that have materially affected, or are reasonably likely to materially affect, Embecta&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2022, the Company commenced on the process of building a new ERP system to replace the existing systems provided by BD. The ERP system is designed to accurately maintain the Company's financial records used to report operating results. The implementation of the ERP will occur in phases. The first phase of the ERP implementation began in the fourth quarter of 2023. The Company will evaluate each quarter whether there are changes that materially affect, or are reasonably likely to materially affect our internal control over financial reporting.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Reports of Management</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Management&#8217;s Responsibilities </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following financial statements have been prepared by management in conformity with U.S. generally accepted accounting principles and include, where required, amounts based on the best estimates and judgments of management. The integrity and objectivity of data in the financial statements and elsewhere in this Annual Report are the responsibility of management. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In fulfilling its responsibilities for the integrity of the data presented and to safeguard the Company&#8217;s assets, management employs a system of internal accounting controls designed to provide reasonable assurance, at appropriate cost, that the Company&#8217;s assets are protected and that transactions are appropriately authorized, recorded and summarized. This system of control is supported by the selection of qualified personnel, by organizational assignments that provide appropriate delegation of authority and division of responsibilities, and by the dissemination of written policies and procedures. This control structure is further reinforced by a program of internal audits, including a policy that requires responsive action by management. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Board of Directors monitors the internal control system, including internal accounting and financial reporting controls, through its Audit Committee, which consists of three independent Directors. The Audit Committee meets periodically with the independent registered public accounting firm, the internal auditors and management to review the work of each and to satisfy itself that they are properly discharging their responsibilities. The independent registered public accounting firm and the internal auditors have full and free access to the Audit Committee and meet with its members, with and without management present, to discuss the scope and results of their audits including internal control, auditing and financial reporting matters. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Management&#8217;s Report on Internal Control Over Financial Reporting </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Act of 1934, as amended. Management conducted an assessment of the effectiveness of internal control over financial reporting based on the criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Based on the Company's assessment of the effectiveness of internal control over financial reporting and the criteria noted above, management concluded that internal controls over financial reporting were effective as of September 30, 2023. The financial statements and internal control over financial reporting have been audited by Ernst &amp; Young LLP, an independent registered public accounting firm. Ernst &amp; Young&#8217;s reports with respect to fairness of the presentation of the financial statements, and the effectiveness of internal control over financial reporting, are included in Item 8. Financial Statements and Supplementary Data.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_235"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9B. Other Information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Not applicable. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_238"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Not applicable. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_241"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_244"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 10. Directors, Executive Officers and Corporate Governance.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta has a Code of Conduct applicable to all employees, including the principal executive officer, principal financial officer, principal accounting officer, and controller, and all directors. The Code of Conduct is available at https://investors.embecta.com/corporate-governance/documents-charters. To the extent required by the rules of the SEC or The Nasdaq Stock Market LLC, Embecta intends to satisfy the disclosure requirements regarding any amendment or waiver of our Code of Conduct by posting such information on our website.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additional information required by this item will be included in the 2024 Proxy Statement and is incorporated herein by reference.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_247"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 11. Executive Compensation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The information required by this item will be included in the 2024 Proxy Statement and is incorporated herein by reference.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_250"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The other information required by this item will be included in the 2024 Proxy Statement and is incorporated herein by reference.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_253"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 13. Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The information required by this item will be included in the 2024 Proxy Statement and is incorporated herein by reference.</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_256"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 14. Principal Accountant Fees and Services.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The information required by this item will be included in the 2024 Proxy Statement and is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_259"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i209d71ebb5944f1aadd70761506c49b3_262"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 15. Exhibits and Financial Statement Schedules.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:15.34pt">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Statements</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The following consolidated financial statements of Embecta are included in Item 8 of this Annual Report on Form 10-K:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Report of Independent Registered Public Accounting Firm (PCAOB ID <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-1069">42</ix:nonNumeric>)</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Consolidated Statements of Income &#8212; Fiscal years ended September 30, 2023, 2022 and 2021</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Consolidated Statements of Comprehensive Income &#8212; Fiscal years ended September 30, 2023, 2022 and 2021</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Consolidated Balance Sheets &#8212; September 30, 2023 and 2022</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Consolidated Statements of Equity &#8212; Fiscal years ended September 30, 2023, 2022 and 2021</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Consolidated Statements of Cash Flows &#8212; Fiscal years ended September 30, 2023, 2022 and 2021</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Notes to Consolidated Financial Statements</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Statement Schedules</span></div><div style="margin-top:3pt;padding-left:49.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See Note 19 to the Consolidated Financial Statements included in Item 8. Financial Statements and Supplementary Data.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">      </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:10.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.762%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit </span></div><div style="margin-bottom:0.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exhibit Description</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex21.htm">Separation and Distribution Agreement, dated as of March 31, 2022, by and between the Company and BD. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000094787123000814/ss2350753_0301.htm">Amended and Restated Bylaws of the Company adopted effective as of August 2, 2023. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on August 3, 2023.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex32.htm">Amended and Restated Bylaws of the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522035814/d669833dex41.htm">Indenture, dated February 10, 2022, by and between the Company and U.S. Bank Trust Company, National Association, as trustee and as notes collateral agent, including the form of 5.000% Senior Secured Notes due 2030. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on February 11, 2022.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex42.htm">First Supplemental Indenture, dated as of April 1, 2022, to the Indenture dated as of February 10, 2022, by and between the Company and U.S. Bank Trust Company, National Association, as trustee and as notes collateral agent. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:3.75pt;text-align:justify"><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex41.htm">Indenture, dated as of March 31, 2022, by and between</a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex41.htm"> </a></span><span style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex41.htm">the Company and U.S. Bank Trust Company, National Association, as trustee and as notes collateral agent, including the form of 6.750% Senior Secured Notes due 2030. (Incorporated by reference to the Company's Current Report on Form 8-K filed on April 6, 2022.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex44.htm">First Supplemental Indenture, dated as of April 1, 2022, to the Indenture dated as of March 31, 2022, by and between the Company and U.S. Bank Trust Company, National Association, as trustee and as notes collateral agent. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K on April 6, 2022.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit45.htm">Description of Securities. (Filed herewith.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex101.htm">Transition Services Agreement, dated as of March 31, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000187278922000024/embc-9302022x10kexhibit102.htm">Amendment No. 1 to Transition Services Agreement, dated as of July 1, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed on December 22, 2022.) **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex102.htm">Tax Matters Agreement, dated as of March 31, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex103.htm">Employee Matters Agreement, dated as of March 31, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex1015.htm">Embecta 2022 Employee and Director Equity Based Compensation Plan. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:10.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.762%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex1016.htm">Embecta Corp. Executive Severance and Change in Control Plan. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex1017.htm">Embecta Deferred Compensation Plan. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000187278922000024/embc-9302022x10kexhibit108.htm">Embecta Corp. Directors&#8217; Deferral Plan. (Incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed on December 22, 2022.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000187278922000024/embc-9302022x10kexhibit109.htm">Form of Founders Grants under the Embecta Corp. 2022 Employee and Director Equity-Based Compensation Plan Terms and Conditions of Awards (April 1, 2022) (Incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed on December 22, 2022) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000187278922000024/embc-9302022x10kexhibit1010.htm">Form of Non-Employee Directors RSU Award under the Embecta Corp. 2022 Employee and Director Equity-Based Compensation Plan Terms and Conditions of Awards (April 1, 2022) (Incorporated by reference to the Company&#8217;s Annual Report on Form 10-K filed on December 22, 2022) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1872789/000187278923000013/embc-03312023x10qexhibit101.htm">Form of Employee and Director PSU and RSU Awards under the 2022 Employee and Director Equity Based Compensation Plan and Conditions of Awards (November 26, 2022). (Incorporated by reference to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 12, 2023.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312521363615/d192319dex108.htm">Letter Agreement, dated as of January 25, 2021, by and between BD and Devdatt Kurdikar. (Incorporated by reference to the Company&#8217;s Information Statement on Form 10 filed December 21, 2021.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312521363615/d192319dex109.htm">Letter Agreement, dated as of April 9, 2021, by and between BD and Jacob Elguicze. (Incorporated by reference to the Company&#8217;s Information Statement on Form 10 filed December 21, 2021.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312521363615/d192319dex1010.htm">Letter Agreement, dated as of August 13, 2021, by and between BD and Shaun Curtis. (Incorporated by reference to the Company&#8217;s Information Statement on Form 10 filed December 21, 2021.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312521363615/d192319dex1011.htm">Letter Agreement, dated as of February 24, 2021, by and between BD and Ajay Kumar. (Incorporated by reference to the Company&#8217;s Information Statement on Form 10 filed December 21, 2021.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312521363615/d192319dex1012.htm">Letter Agreement, dated as of May 26, 2021, by and between BD and Jeff Mann. (Incorporated by reference to the Company&#8217;s Information Statement on Form 10 filed December 21, 2021.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312521363615/d192319dex1013.htm">Change in Control Employment Agreement, dated as of February 10, 2021, by and between BD and Devdatt Kurdikar. (Incorporated by reference to the Company&#8217;s Information Statement on Form 10 filed December 21, 2021.) (+)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex106.htm">Cannula Supply Agreement, dated as of March 31, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) *, **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex105.htm">Form of Contract Manufacturing Agreement, dated as of March 31, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex107.htm">Lease Agreement, dated as of March 31, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) *, **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex104.htm">Intellectual Property Matters Agreement, dated as of March 31, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) *, **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex108.htm">Logistics Services Agreement, dated as of January 1, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-20230930x10kex1023.htm">Amendment to Logistics Services Agreement, dated as of November 20, 2023, by and between BD and the Company. (Filed herewith.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex109.htm">Form of Distribution Agreement, dated as of March 31, 2022, by and between BD and the Company. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1872789/000119312522097622/d297684dex1010.htm">Credit Agreement, dated as of March 31, 2022, by and among the Company, the lenders and other parties from time to time party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, collateral agent and an L/C issuer. (Incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2022.) **</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-20230930x10kexhibit211.htm">List of Subsidiaries of Embecta Corp. (Filed herewith.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-20230930x10kexhibit231.htm">Consent of Ernst &amp; Young LLP. (Filed herewith.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="embc-20230930x10kexhibit311.htm">Certification of Chief Executive Officer, pursuant to SEC Rule 13a&#8211;14(a). (Filed herewith.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="embc-20230930x10kexhibit312.htm">Certification of Chief Financial Officer, pursuant to SEC Rule 13a&#8211;14(a). (Filed herewith.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="embc-20230930x10kexhibit321.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. (Furnished herewith.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="embc-20230930x10kexhibit322.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350. (Furnished herewith.)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">97.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="embc-9302023x10kexhibit971.htm">Embecta Corp. Do</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="embc-9302023x10kexhibit971.htm">dd-Frank Cl</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="embc-9302023x10kexhibit971.htm">awback Policy (Filed herewith</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="embc-9302023x10kexhibit971.htm">.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="embc-9302023x10kexhibit971.htm">)</a></span></div></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:10.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.762%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">97.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit972.htm">Embecta Corp.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit972.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit972.htm">Supplemental Policy Regarding the Recovery of Compensation</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit972.htm">, Effective </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit972.htm">December 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit972.htm">, 2023</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit972.htm"> (Filed herewith</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit972.htm">.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="embc-9302023x10kexhibit972.htm">)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The following materials from this Annual Report on Form 10-K, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Equity, (v) the Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements. (Filed herewith.)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File. (Formatted as Inline XBRL and contained in Exhibit 101.)</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:3.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(+) </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or compensatory plan or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain information contained in this document has been omitted because it is both (i) not material and (ii) is the type that the Company treats as private or confidential.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish a supplemental copy of any omitted schedule to the Securities and Exchange Commission upon request.</span></td></tr></table></div><div id="i209d71ebb5944f1aadd70761506c49b3_265"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 16. Form 10-K Summary.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta is not providing summary information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="i209d71ebb5944f1aadd70761506c49b3_268"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">EMBECTA CORP.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ DEVDATT KURDIKAR</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Devdatt Kurdikar</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Title:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: November&#160;29, 2023 </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.780%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ JACOB ELGUICZE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Jacob Elguicze</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Title:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Senior Vice President, Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Financial Officer)</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: November&#160;29, 2023</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.780%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ BRIAN CAPONE</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Brian Capone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Title:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vice President, Controller and Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Accounting Officer)</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: November&#160;29, 2023  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities and Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"></td><td style="width:37.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.879%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%;text-decoration:underline">Capacity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%;text-decoration:underline">Date</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ LTG (RET.) DAVID F. MELCHER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">LTG (Ret.) David F. Melcher</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">and Chairman of the Board</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ DAVID J. ALBRITTON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">David J. Albritton</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ CARRIE L. ANDERSON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Carrie L. Anderson</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ ROBERT (BOB) J. HOMBACH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Robert (Bob) J. Hombach</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ MILTON M. MORRIS, PH.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Milton M. Morris, Ph.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ CLAIRE POMEROY, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Claire Pomeroy, M.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ KAREN N. PRANGE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Karen N. Prange</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ CHRISTOPHER R. REIDY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Christopher R. Reidy</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ DEVDATT KURDIKAR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Devdatt Kurdikar</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">President and Chief Executive</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ JACOB ELGUICZE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Jacob Elguicze</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Senior Vice President, Chief</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">November 29, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">83</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>embc-9302023x10kexhibit45.htm
<DESCRIPTION>EX-4.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iea5fc8b5c3404136882f547895784076_1"></div><div style="min-height:76.32pt;width:100%"><div style="margin-bottom:6pt;text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 4.5</font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF&#160;EMBECTA&#160;CAPITAL STOCK</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embecta Corp.&#8217;s (&#8220;Embecta&#8221;) authorized capital stock consists of 250,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share. We do not have any preferred stock issued and outstanding. Embecta&#8217;s Board of Directors may establish the rights and preferences of the preferred stock from time to time.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Voting Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Each holder of Embecta common stock is entitled to one vote for each share on all matters to be voted upon by the holders of Embecta common stock, and there are no cumulative voting rights.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">Dividend Rights. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Subject to any preferential rights of any outstanding preferred stock, holders of Embecta common stock are entitled to receive ratably the dividends, if any, as may be declared from time to time by its Board of Directors out of funds legally available for that purpose.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">Right to Receive liquidation distributions. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If there is a liquidation, dissolution or winding up of Embecta, holders of its common stock would be entitled to ratable distribution of its assets remaining after the payment in full of liabilities and any preferential rights of any then-outstanding preferred stock.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">No preemptive or similar rights. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Holders of Embecta common stock have no preemptive or conversion rights or other subscription rights, and there are no redemption or sinking fund provisions applicable to the Embecta common stock. All outstanding shares of Embecta common stock are fully paid and non-assessable.  &#160;The rights, preferences and privileges of the holders of Embecta common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that Embecta may designate and issue in the future.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-Takeover Effects of Governance Provisions</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain provisions of Delaware law and Embecta&#8217;s amended and restated certificate of incorporation and bylaws may be deemed to have an anti-takeover effect and may delay, defer or prevent a tender offer or change in control of Embecta that a stockholder might consider to be in its best interests, including attempts that might result in a premium being paid over the market price for the shares held by stockholders. These provisions are intended to enhance the likelihood of continuity and stability in the composition of Embecta&#8217;s Board of Directors and in the policies formulated by Embecta&#8217;s Board of Directors and could discourage certain types of transactions that may involve an actual or threatened change of control.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Classified Board.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embecta&#8217;s amended and restated certificate of incorporation provides that, until the annual stockholder meeting in 2026, Embecta&#8217;s Board of Directors will be divided into three classes, with each class consisting, as nearly as reasonably possible, of&#160;one-third&#160;of the total number of directors. The first term of office for the Class&#160;I directors will expire at the 2023 annual meeting of stockholders. The first term of office for the Class II directors will expire at the 2024 annual meeting of stockholders. The first term of office for the Class III directors will expire at the 2025 annual meeting of stockholders. At the 2023 annual meeting of stockholders, the Class I directors will be elected for a term of office to expire at the 2026 annual meeting of stockholders. At the 2024 annual meeting of stockholders, the Class II directors will be elected for a term of office to expire at the 2026 annual meeting of stockholders. At the 2025 annual meeting of stockholders, the Class III directors will be elected for a term of office to expire at the 2026 annual meeting of stockholders. Commencing with the 2026 annual meeting of stockholders, all directors will be elected annually and for a term of office to expire at the next annual meeting of stockholders, and Embecta&#8217;s Board of Directors will thereafter no longer be divided into classes. Before Embecta&#8217;s Board of Directors is declassified, it would take at least two annual stockholders meetings to occur for any individual or group to gain control of Embecta&#8217;s Board of Directors. Accordingly, while the Board of Directors is divided into classes, these provisions could discourage a third-party from initiating a proxy contest, making a tender offer or otherwise attempting to control Embecta.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;padding-left:14.5pt">Removal and Vacancies.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embecta&#8217;s amended and restated certificate of incorporation and bylaws provide that (i)&#160;until the 2026 annual meeting of stockholders (or such other time as the Board of Directors is no longer classified under the Delaware General Corporation Law (the &#8220;DGCL&#8221;), Embecta stockholders may remove directors only for cause and (ii)&#160;from and including the 2026 annual meeting of stockholders (or such other time as the Board of Directors is no longer classified under the DGCL), Embecta stockholders may remove directors with or without cause. Removal will require the affirmative vote of holders of at least a majority of the voting power of Embecta stock outstanding and entitled to vote on such removal. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="margin-bottom:6pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vacancies occurring on the Board of Directors, whether due to death, resignation, removal, retirement, disqualification or for any other reason, and newly created directorships resulting from an increase in the authorized number of directors, shall be filled solely by a majority of the remaining members of Embecta&#8217;s Board of Directors or by a sole remaining director.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">Size of the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Embecta&#8217;s amended and restated certificate of incorporation and bylaws provide that Embecta&#8217;s Board of Directors has the sole authority to fix the number of directors on the Board.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">Blank Check Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Embecta&#8217;s amended and restated certificate of incorporation authorizes Embecta&#8217;s Board of Directors to designate and issue, without any further vote or action by the Embecta stockholders, shares of preferred stock from time to time in one or more series and, with respect to each such series, to fix the number of shares constituting the series and the designation of the series, the voting powers (if any) of the shares of the series, and the preferences and relative, participating, optional and other rights, if any, and any qualifications, limitations or restrictions, of the shares of such series. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">No Stockholder Action by Written Consent.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;Embecta&#8217;s amended and restated certificate of incorporation and bylaws expressly exclude the right of Embecta stockholders to act by written consent. Stockholder action must therefore take place at an annual meeting or at a special meeting of Embecta stockholders.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">No Stockholder Ability to Call Special Meetings&#160;of Stockholders.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;Embecta&#8217;s amended and restated certificate of incorporation and bylaws provide a special meeting of Embecta stockholders can only be called by the Chairman of the Board or a majority of the directors Embecta&#8217;s Board of Directors. Embecta stockholders are not be able to call a special meeting of stockholders.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">Requirements for Advance Notification of Stockholder Nominations and Proposals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Embecta&#8217;s amended and restated bylaws require stockholders seeking to nominate persons for election as directors at an annual or special meeting of stockholders, or to bring other business before an annual or special meeting (other than a proposal submitted under Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), to provide timely notice in writing. A stockholder&#8217;s notice to Embecta&#8217;s Corporate Secretary must be in proper written form and must set forth certain information, as required under Embecta&#8217;s amended and restated bylaws, related to the stockholder giving the notice, the beneficial owner (if any) on whose behalf the nomination is made as well as their control persons and information about the proposal or nominee for election to the Board of Directors.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">Amendments to Bylaws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Embecta&#8217;s amended and restated certificate of incorporation and bylaws provide that Embecta&#8217;s Board of Directors have the authority to amend and repeal the Embecta amended and restated bylaws without a stockholder vote.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">Exclusive Forum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">. Embecta&#8217;s amended and restated certificate of incorporation provides that, unless Embecta (through approval of the Board of Directors) consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (1) any derivative action or proceeding brought on behalf of Embecta, (2) any action or proceeding asserting a claim for or based on a breach of a fiduciary duty owed by any current or former director or officer or other employee of Embecta to Embecta or Embecta&#8217;s stockholders, including any claim alleging aiding and abetting of such a breach of fiduciary duty, (3) any action or proceeding asserting a claim against Embecta or any current or former director or officer or other employee of Embecta arising pursuant to, or seeking to enforce any right, obligation or remedy under, any provision of the DGCL or Embecta&#8217;s amended and restated certificate of incorporation or amended and restated bylaws (as either may be amended from time to time), (4) any action or proceeding asserting a claim related to or involving Embecta or any current or former director or officer or other employee of Embecta governed by the internal affairs doctrine, or (5) any action or proceeding as to which the DGCL (as it may be amended from time to time) confers jurisdiction </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="margin-bottom:6pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">on the Court of Chancery of the State of Delaware. If and only if the Court of Chancery of the State of Delaware dismisses any such action or proceeding for lack of subject matter jurisdiction, such action or proceeding may be brought in another state court located within the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal district court for the District of Delaware). These exclusive forum provisions apply to all covered actions, including any covered action in which the plaintiff chooses to assert a claim or claims under federal law in addition to a claim or claims under Delaware law. These exclusive forum provisions will not apply to actions asserting only federal law claims under the Securities Act of 1933, as amended, or the Exchange Act, regardless of whether the state courts in the State of Delaware have jurisdiction over those claims. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%;padding-left:14.5pt">Business Combinations with Interested Stockholder.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Embecta is subject to Section&#160;203 of the DGCL, which, subject to certain exceptions, prohibits a Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for three years following the time that such person or entity becomes an interested stockholder.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Limitation on Liability of Directors and Indemnification of Directors and Officers</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Delaware law permits a corporation to adopt a provision in its certificate of incorporation eliminating or limiting, with exceptions, the monetary liability of a director to the corporation or its shareholders for breach of the director&#8217;s fiduciary duties. Embecta&#8217;s amended and restated certificate of incorporation includes provisions that eliminate the liability of directors to Embecta or its shareholders for monetary damages for a breach of fiduciary duties as directors to the fullest extent permitted by Delaware law. Under Delaware law, such a provision may not eliminate or limit a director&#8217;s monetary liability for&#58; (i)&#160;breaches of the director&#8217;s duty of loyalty to the corporation or its shareholders&#59; (ii)&#160;acts or omissions not in good faith or involving intentional misconduct or knowing violation of law&#59; (iii)&#160;the payment of unlawful dividends or stock repurchases or redemptions&#59; or (iv)&#160;transactions in which the director received an improper personal benefit.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Embecta&#8217;s amended and restated bylaws generally provide indemnification and advancement of expenses for its directors and officers to the fullest extent permitted by the DGCL.</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Listing</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Embecta&#8217;s common stock is listed on The Nasdaq Global Select Market, under the ticker symbol &#8220;EMBC.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Transfer Agent and Registrar</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The transfer agent and registrar for Embecta common stock is Computershare Trust Company, N.A.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;text-indent:24.5pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.23
<SEQUENCE>3
<FILENAME>embc-20230930x10kex1023.htm
<DESCRIPTION>EX-10.23
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i46f76c68dd6c44268aba63ddd60e9add_39"></div><div style="min-height:49.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.23</font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Becton, Dickinson and Company</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1 Becton Drive <br>Franklin Lakes, New Jersey 07417</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">November 20, 2023</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Embecta Corp.<br>1 Becton Drive<br>Franklin Lakes, New Jersey 07417<br>Attention&#58;  &#160;&#160;&#160;&#160;Jeffrey Mann</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Senior Vice President</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">E-mail&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;jeff.mann&#64;embecta.com</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Re&#58;  Logistics Services Agreement</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dear Mr. Mann&#58; </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Reference is made to the Logistics Services Agreement, dated as of January 1, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LSA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by and between Embecta Corp. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Embecta</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and Becton, Dickinson and Company (together with Embecta, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the LSA.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In consideration of the mutual promises and covenants contained herein, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties agree to the following&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LSA Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  (i) The Term is extended until March 31, 2024, (ii) the monthly Administrative Fee for each of the Services under the LSA during the extension period from January 1, 2024 through March 31, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interim Extension Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall be equal to one and one quarter percent (1.25%) of New Revenue for such Service and (iii) each of the Factoring Fee and the Servicing Fee for each such Services during the Interim Extension Period shall be equal to one hundred twenty-five percent (125%) of the Factoring Fee or the Servicing Fee, respectively, for such Service during the term of the LSA prior to the Interim Extension Period. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as expressly set forth in this letter agreement, no amendment, alteration or modification of the LSA is otherwise made.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, each of the Parties has caused this letter agreement to be duly executed on its behalf by its officer thereunto duly authorized as of the day and year first above written.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BECTON, DICKINSON AND COMPANY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;By&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Christopher DelOrefice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58;  Christopher DelOrefice</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58;    EVP and Chief Financial Officer</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EMBECTA CORP.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;By&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> &#47;s&#47; Jeff Mann</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58;  Jeff Mann&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58;    SVP, General Counsel &#38; Head of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;       Business Development &#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>embc-20230930x10kexhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0405a5f9735641ef916e63e11aaddd65_45"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 21.1</font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">EMBECTA CORP.</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">LIST OF SUBSIDIARIES</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">  Name&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;       Jurisdiction of Incorporation</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Becton Dickinson Penel Irish Branch</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Becton Dickinson Penel Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cayman Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Arabia Limited Co.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saudi Arabia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Argentina S.R.L.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Argentina</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Australia Pty Ltd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia (Victoria)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Austria GmbH </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Belgium BV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Brasil Ltda.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embecta Canada Co.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Chile SpA</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Colombia S.A.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Croatia Ltd.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Croatian&#58; embecta Hrvatska d.o.o.)</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Croatia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Denmark ApS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Finland Oy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta France </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France (Paris)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta G.K.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Japanese&#58; </font><font style="color:#000000;font-family:'MS Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#12456;&#12512;&#12505;&#12463;&#12479;&#21512;&#21516;&#20250;&#31038;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan (Tokyo)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta GmbH</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany (Heidelberg)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Hong Kong Limited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta India Private Limited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta International Holdings I LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USA (Delaware)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta International Holdings II LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USA (Delaware)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Israel Ltd.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Italy S.r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Kenya LTD.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kenya</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Korea Ltd.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Korea</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Luxembourg I S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Luxembourg II S.&#224; r.l.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Malaysia Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Medical Devices (Shanghai) Co., Ltd.<br>(Chinese&#58; &#33521;&#20336;&#36798;&#21307;</font><font style="color:#000000;font-family:'Microsoft JhengHei',serif;font-size:10pt;font-weight:400;line-height:100%">&#30103;&#22120;&#26800;&#65288;&#19978;&#28023;&#65289;&#26377;&#38480;&#20844;&#21496;)</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China (Shanghai)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embecta Medical Devices (Shanghai) Co., Ltd.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beijing Branch</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Chinese&#58; &#33521;&#20336;&#36798;&#21307;</font><font style="color:#000000;font-family:'Microsoft JhengHei',serif;font-size:10pt;font-weight:400;line-height:100%">&#30103;&#22120;&#26800;&#65288;&#19978;&#28023;&#65289;&#26377;&#38480;&#20844;&#21496;</font><font style="color:#000000;font-family:'MS Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#21271;&#20140;&#20998;&#20844;&#21496;)</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China (Beijing)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Medical Devices (Shanghai) Co., Ltd.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pudong Branch</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Chinese&#58; </font><font style="color:#000000;font-family:'MS Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#33521;&#20336;&#36798;&#21307;</font><font style="color:#000000;font-family:'Microsoft JhengHei',serif;font-size:10pt;font-weight:400;line-height:100%">&#30103;&#22120;&#26800;&#65288;&#19978;&#28023;&#65289;&#26377;&#38480;&#20844;&#21496;&#28006;&#19996;&#20998;&#20844;</font><font style="color:#000000;font-family:'MS Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#21496;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China (Pudong)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Medical I LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USA (Delaware)</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 21.1</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Medical II LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USA (Delaware)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Medical Spain, S.L.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Mexico, S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Netherlands B.V.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands (Amsterdam)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Netherlands B.V. - Belgian Branch</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Netherlands B.V. &#8211; Representative Office</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Arab Emirates</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta New Zealand Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Norway AS</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norway</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embecta Nova Scotia Company <br>(French&#58; Compagnie embecta de la Nouvelle-&#201;cosse)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada (Nova Scotia)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Peru S.R.L.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peru</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Philippines Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Philippines</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Poland sp. z o.o.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Portugal, Unipessoal Lda</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Rus Limited Liability Company</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Singapore Pte. Ltd., Indonesia Rep Office</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indonesia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Singapore Pte. Ltd. Taiwan Branch</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Taiwanese&#58; &#26032;&#21152;&#22369;&#21830;&#33521;&#20336;&#36948;&#32929;&#20221;&#26377;&#38480;&#20844;&#21496;&#21488;&#28771;&#20998;&#20844;&#21496;)</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta South Africa Proprietary Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Sweden AB</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Switzerland Holdings S&#224;rl</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland (Vaud)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Switzerland S&#224;rl</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland (Vaud)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Turkey Medikal &#220;r&#252;n ve Cihazlar &#304;thalat &#304;hracat Sat&#305;&#351; Pazarlama ve Da&#287;&#305;t&#305;m Limited &#350;irketi</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta U.K. Irish Branch</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta U.K. Limited</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Uruguay SRL</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uruguay</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta US Holdings I LLC</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USA (Delaware)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta (Thailand) Ltd.<br>(Thai&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#3648;&#3629;&#3655;&#3617;&#3648;&#3610;&#3655;&#3588;&#3605;&#3657;&#3634;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#3611;&#3619;&#3632;&#3648;&#3607;&#3624;&#3652;&#3607;&#3618;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#3592;&#3635;&#3585;&#3633;&#3604;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">embecta Vietnam Co., Ltd.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Vietnamese&#58; C&#244;ng ty TNHH embecta Vietnam or C&#244;ng ty TNHH embecta Vi&#7879;t Nam)</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vietnam</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>embc-20230930x10kexhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibb7818c277b441cfaefd6a93261e6086_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:190%">Exhibit 23.1</font></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:190%">Consent of Independent Registered Public Accounting Firm</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:107%">We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-264164) pertaining to the 2022 Employee and Director Equity-Based Compensation Plan of Embecta Corp. of our reports dated November&#160;29, 2023, with respect to the consolidated financial statements of Embecta Corp., and the effectiveness of internal control over financial reporting of Embecta Corp., included in this Annual Report (Form 10-K) for the year ended September 30, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">New York, New York</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">November&#160;29, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>embc-20230930x10kexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2f28e6093f744ae493d37c0560b1bafd_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 31.1 </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">I, Devdatt Kurdikar, certify that&#58; </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%"> </font></div><div style="margin-top:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Embecta Corp.&#59; </font></div><div style="margin-top:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-top:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-top:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) &#91;language omitted in accordance with Exchange Act Rule 13a-14(a)&#93; for the registrant and have&#58; </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">&#91;paragraph omitted in accordance with Exchange Act Rule 13a-14(a)&#93;&#59;</font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-1-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%"> </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58; November&#160;29, 2023 </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#47;s&#47; Devdatt Kurdikar</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Devdatt Kurdikar</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">President and Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-2-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>embc-20230930x10kexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i43f31df0db8f4a70a02547d5d731c142_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">I, Jacob Elguicze, certify that&#58; </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%"> </font></div><div style="margin-top:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Embecta Corp.&#59; </font></div><div style="margin-top:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-top:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-top:8pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) &#91;language omitted in accordance with Exchange Act Rule 13a-14(a)&#93; for the registrant and have&#58; </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">&#91;paragraph omitted in accordance with Exchange Act Rule 13a-14(a)&#93;&#59;</font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-1-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:115%"> </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58; November&#160;29, 2023</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#47;s&#47; Jacob Elguicze</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Jacob Elguicze</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-2-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>embc-20230930x10kexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iaf95805270d24fc0bc58b4e2505621a8_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 32.1 </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-top:6pt;text-indent:24.48pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to 18 U.S.C. Section 1350, in connection with the Annual Report on Form 10-K of Embecta Corp. for the fiscal year ended September&#160;30, 2023 as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;). </font></div><div style="margin-top:12pt;text-indent:24.48pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">I, Devdatt Kurdikar, the Chief Executive Officer of Embecta Corp., certify that, to the best of my knowledge&#58; </font></div><div style="margin-top:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:15pt">such Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:15pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Embecta Corp. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58; November&#160;29, 2023</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Devdatt Kurdikar</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Devdatt Kurdikar</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-1-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>embc-20230930x10kexhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic45fa366e2aa4fa8b0faccb9e6634f7a_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 32.2 </font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-top:6pt;text-indent:24.48pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to 18 U.S.C. Section 1350, in connection with the Annual Report on Form 10-K of Embecta Corp. for the fiscal year ended September&#160;30, 2023 as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;). </font></div><div style="margin-top:12pt;text-indent:24.48pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">I, Jacob Elguicze, the Chief Financial Officer of Embecta Corp., certify that, to the best of my knowledge&#58; </font></div><div style="margin-top:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:15pt">such Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:15pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Embecta Corp. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58; November&#160;29, 2023</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#47;s&#47; Jacob Elguicze</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Jacob Elguicze</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-1-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>10
<FILENAME>embc-9302023x10kexhibit971.htm
<DESCRIPTION>EX-97.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8d98b01757cb411f8a87d71715015694_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:139%">Exhibit 97.1</font></div></div><div style="margin-bottom:12pt;padding-right:-0.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EMBECTA CORP.<br>DODD-FRANK CLAWBACK POLICY</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Board of Directors (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of Embecta Corp. (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) has adopted this Dodd-Frank Clawback Policy (this &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in accordance with the applicable provisions of the Nasdaq Stock Market LLC Listing Rules (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Clawback Rules</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), promulgated pursuant to the final rules adopted by the Securities and Exchange Commission enacting the clawback standards under Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act. The Compensation and Management Development Committee (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Committee</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is designated to administer this Policy. Capitalized terms not otherwise defined in this Policy have the meanings given to them under the Clawback Rules.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Recovery of Erroneously Awarded Incentive Compensation</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Company shall comply with the Clawback Rules and reasonably promptly recover Erroneously Awarded Compensation Received by current or former Executive Officers of the Company (&#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Individuals</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) as required by the Clawback Rules in the event the Company is required to prepare an accounting restatement due to the Company&#8217;s material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period. The Committee may determine to not recover Erroneously Awarded Compensation pursuant to this Policy in circumstances where non-enforcement is expressly permitted by the Clawback Rules, including where recovery would violate applicable home country laws in effect before November 28, 2022.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Covered Individuals</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Committee shall determine the Company&#8217;s Covered Individuals.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Covered Compensation</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Policy applies to the Incentive-Based Compensation Received by a Covered Individual&#58;  (1) after such Covered Individual began service as an Executive Officer&#59; (2) who served as an Executive Officer at any time during the performance period for that Incentive-Based Compensation&#59; (3) while the Company has a class of securities listed on a national securities exchange or a national securities association&#59; and (4) during the three completed fiscal years immediately preceding the date that the Company is required pursuant to the Clawback Rules to prepare an accounting restatement as described above (or during any transition period, that results from a change in the Company&#8217;s fiscal year, within or immediately following those three completed fiscal years, as determined in accordance with the Clawback Rules).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The amount of Incentive-Based Compensation subject to this Policy is the Erroneously Awarded Compensation, which is the amount of Incentive-Based Compensation Received by a Covered Individual that exceeds the amount of Incentive-Based Compensation that otherwise would have been Received by the Covered Individual had it been determined based on the restated amount (or otherwise determined in accordance with the Clawback Rules), and will be computed without regard to any taxes paid by the Covered Individual (or withheld from the Incentive-Based Compensation). The Committee shall make all determinations regarding the amount of Erroneously Awarded Compensation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Method of Recovery</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Committee shall determine, in its sole discretion, the manner in which any Erroneously Awarded Compensation shall be recovered. Methods of recovery may include, but are not limited to&#58; (1)&#160;seeking direct repayment from the Covered Individual&#59; (2)&#160;reducing (subject to applicable law and the terms and conditions of the applicable plan, program or arrangement pursuant to which the Incentive-Based Compensation was paid) the amount that would otherwise be payable to the Covered Individual under any compensation, bonus, incentive, equity and other benefit plan, agreement, policy or arrangement maintained by the Company or any of its affiliates&#59; (3)&#160;cancelling any award (whether cash- or equity-based) or portion thereof previously granted to the Covered Individual&#59; or (4)&#160;any combination of the foregoing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">No-Fault Basis</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Policy applies on a no-fault basis, and Covered Individuals will be subject to recovery under this Policy without regard to their personal culpability.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Other Company Arrangements</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Policy shall be in addition to, and not in lieu of, any other clawback, recovery or recoupment policy maintained by the Company from time to time, as well as any clawback, recovery or recoupment provision in any of the Company&#8217;s plans, awards or individual agreements (including the clawback, recovery and recoupment provisions in the Company&#8217;s equity award agreements) (collectively, &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Company Arrangement</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and any other rights or remedies available to the Company, including termination of employment&#59; provided, however, that there is no intention to, nor shall there be, any duplicative recoupment of the same compensation under more than one policy, plan, award or agreement. In addition, no Other Company Arrangement shall serve to restrict the scope or the recoverability of Erroneously Awarded Compensation under this Policy or in any way limit recovery in compliance with the Clawback Rules.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">No Indemnification</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary set forth in any policy, arrangement, bylaws, charter, certificate of incorporation or plan of the Company or any individual agreement between a Covered Individual and the Company or any of its affiliates, no Covered Individual shall be entitled to indemnification from the Company or any of its affiliates for the amount that is or may be recovered by the Company pursuant to this Policy&#59; provided, however, that to the extent expense advancement or reimbursement is available to a Covered Individual, this Policy shall not serve to prohibit such advancement or reimbursement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Administration&#59; Interpretation</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Committee shall</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">interpret and construe this Policy consistent with the Clawback Rules and applicable laws and regulations and shall make all determinations necessary, appropriate or advisable for the administration of this Policy. Any determinations made by the Committee shall be final, binding and conclusive on all Covered Individuals. As required by the Clawback Rules, the Company shall provide public disclosures related to this Policy and any applicable recoveries of Erroneously Awarded Compensation. To the extent this Policy conflicts or is inconsistent with the Clawback Rules, the Clawback Rules shall govern. In no event is this Policy intended to be broader than, or require recoupment in addition to, that required pursuant to the Clawback Rules.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment or Termination of this Policy</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Board reserves the right to amend this Policy at any time and for any reason, subject to applicable law and the Clawback Rules. To the extent that the Clawback Rules cease to be in force or cease to apply to the Company, this Policy shall also cease to be in force.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Effective&#58; December 1, 2023</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div><div id="i8d98b01757cb411f8a87d71715015694_42"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">COVERED INDIVIDUAL ACKNOWLEDGMENT</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">I, &#91;INSERT NAME&#93;, acknowledge that I have received a copy of the Policy and the Clawback Rules, and that I have read and understood the Policy and the Clawback Rules. I further understand that the Policy applies to my Incentive-Based Compensation, as defined in the Clawback Rules, and that I agree to take all actions necessary to assist the Company in complying with the Policy and the Clawback Rules.</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">COVERED INDIVIDUAL</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">_____________________</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Name&#58;</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Date&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.2
<SEQUENCE>11
<FILENAME>embc-9302023x10kexhibit972.htm
<DESCRIPTION>EX-97.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1e799d76564c4b62b2844b995fa1d23a_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 97.1</font></div></div><div style="padding-left:116.65pt;padding-right:116.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Embecta Corp.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Supplemental Policy Regarding the Recovery of Compensation (&#8220;Policy&#8221;)<br>Effective December 1, 2023</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event that any Incentive Compensation payout is made to a member of Embecta Corp. (&#8220;Embecta&#8221; or the &#8220;Company&#8221;) who is an executive officer or other direct report to the Chief Executive Officer (&#8220;Leadership Team&#8221;) based, in whole or in part, on Embecta&#8217;s financial results for any time period, and Embecta&#8217;s financial statements covering all or part of such period are subsequently restated as a result of such member&#8217;s misconduct, including but not limited to fraud or knowing illegal conduct, then the Compensation and Management Development Committee (the &#8220;Committee&#8221;) of the Board of Directors of Embecta (the &#8220;Board&#8221;) may, in its discretion, require the Leadership Team member to reimburse such compensation to Embecta to the extent permitted by applicable law.  In addition, in such instance, the Committee shall have the discretion to (i) cause Embecta to cancel any outstanding Incentive Compensation awards (or recover any payments under such awards) that were granted to such Leadership Team member with respect to the period or periods so restated, and (ii) require the Leadership Team member to reimburse Embecta for any profits realized on any sale of stock occurring after the public issuance of the financial statements that are subsequently restated.  Such actions shall be in addition to any other remedies available to Embecta under applicable law.  The Committee shall have sole discretion to determine whether a Leadership Team member&#8217;s conduct constitutes fraud or knowing illegal conduct for purposes of this Policy.  For purposes of this Policy, &#8220;Incentive Compensation&#8221; means an award based wholly or in part upon the attainment of a financial reporting measure, including but not limited to any award granted under the Form of Embecta Corp. 2022 Employee and Director Equity-Based Compensation Plan (the &#8220;Plan&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To the extent permitted by applicable law, the Committee shall also have the authority to require reimbursement from members of the Leadership Team who were not involved in such misconduct in the amount by which any Incentive Compensation payout exceeded the amount that would have been awarded or paid based on the restated results, as determined by the Committee at its sole discretion.  The Committee shall determine, at its sole discretion, the method for recouping Incentive Compensation in such instance, which may include (i) requiring reimbursement of Incentive Compensation previously paid&#59; (ii) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards&#59; (iii) deducting the amount to be recouped from any compensation otherwise owed by the Company to the Leadership Team member&#59; and&#47;or (iv) taking any other remedial and recovery action permitted by law, as determined by the Committee.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition, in the event that a member of the Leadership Team who holds an equity-based compensation award under the Plan, or any successor to such plan, that contains restrictive covenants in the applicable award agreement breaches such restrictive covenants, the Committee shall have the discretion to (i) cause Embecta to cancel such equity-based compensation awards to the extent then outstanding, and (ii) recover of any shares received upon the exercise or vesting of such awards (the &#8220;Distributed Shares&#8221;) or any gain realized on the sale, transfer, or other disposition of any Distributed Shares.  Such actions shall be in addition to any other remedies available to Embecta under applicable law.  The Committee shall have sole discretion to determine whether an individual has breached the applicable restrictive covenants for purposes of this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy shall only apply to Incentive Compensation and other equity-based compensation awards granted after the date of this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">There is no intention to, nor shall there be, any duplicative recoupment of the same compensation under more than one policy, plan, award or agreement, including this Policy and the Company&#8217;s Dodd-Frank Clawback Policy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Plan shall be amended to implement the terms of this Policy.  The terms of this Policy shall also be incorporated into the terms and conditions of any equity-based compensation award granted after the date hereof.  The Committee may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the date hereof shall, as a condition to the grant of any benefit thereunder, require a Leadership Team member or other individual to agree to abide by the terms of this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company shall not indemnify any Leadership Team member or other individual against the loss of any incorrectly awarded or otherwise recouped Incentive Compensation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary to reflect final regulations adopted by the Securities and Exchange Commission under Section 10D of the Exchange Act and to comply with any rules or standards adopted by a national securities exchange on which the Company&#8217;s securities are listed.  The Committee may terminate this Policy at any time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy shall be binding and enforceable against all Leadership Team members, and their heirs, executors, administrators or other legal representatives.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>embc-20230930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:4102c7ef-a746-4e09-abe6-45c91f406b23,g:4bb25894-924e-4e32-9a1d-8a6b6ed5cbfa-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:embc="http://www.embecta.com/20230930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.embecta.com/20230930">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="embc-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="embc-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="embc-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="embc-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.embecta.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.embecta.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.embecta.com/role/ConsolidatedStatementsofIncome">
        <link:definition>0000003 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.embecta.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquity" roleURI="http://www.embecta.com/role/ConsolidatedStatementsofEquity">
        <link:definition>0000007 - Statement - Consolidated Statements of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquityParenthetical" roleURI="http://www.embecta.com/role/ConsolidatedStatementsofEquityParenthetical">
        <link:definition>0000008 - Statement - Consolidated Statements of Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.embecta.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000009 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Background" roleURI="http://www.embecta.com/role/Background">
        <link:definition>0000010 - Disclosure - Background</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.embecta.com/role/BasisofPresentation">
        <link:definition>0000011 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofAccountingPolicies" roleURI="http://www.embecta.com/role/SummaryofAccountingPolicies">
        <link:definition>0000012 - Disclosure - Summary of Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ThirdPartyArrangementsandRelatedPartyDisclosures" roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosures">
        <link:definition>0000013 - Disclosure - Third Party Arrangements and Related Party Disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreement" roleURI="http://www.embecta.com/role/CollaborationAgreement">
        <link:definition>0000014 - Disclosure - Collaboration Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherOperatingExpenses" roleURI="http://www.embecta.com/role/OtherOperatingExpenses">
        <link:definition>0000015 - Disclosure - Other Operating Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.embecta.com/role/Contingencies">
        <link:definition>0000016 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenues" roleURI="http://www.embecta.com/role/Revenues">
        <link:definition>0000017 - Disclosure - Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicalData" roleURI="http://www.embecta.com/role/SegmentandGeographicalData">
        <link:definition>0000018 - Disclosure - Segment and Geographical Data</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.embecta.com/role/StockBasedCompensation">
        <link:definition>0000019 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>0000020 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.embecta.com/role/LongTermDebt">
        <link:definition>0000021 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShare" roleURI="http://www.embecta.com/role/EarningsperShare">
        <link:definition>0000022 - Disclosure - Earnings per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.embecta.com/role/IncomeTaxes">
        <link:definition>0000023 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurements" roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurements">
        <link:definition>0000024 - Disclosure - Financial Instruments and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipment" roleURI="http://www.embecta.com/role/PropertyPlantandEquipment">
        <link:definition>0000025 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.embecta.com/role/Leases">
        <link:definition>0000026 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.embecta.com/role/BenefitPlans">
        <link:definition>0000027 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformation" roleURI="http://www.embecta.com/role/SupplementalFinancialInformation">
        <link:definition>0000028 - Disclosure - Supplemental Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.embecta.com/role/SubsequentEvents">
        <link:definition>0000029 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofAccountingPoliciesPolicies" roleURI="http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Summary of Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ThirdPartyArrangementsandRelatedPartyDisclosuresTables" roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresTables">
        <link:definition>9954472 - Disclosure - Third Party Arrangements and Related Party Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicalDataTables" roleURI="http://www.embecta.com/role/SegmentandGeographicalDataTables">
        <link:definition>9954473 - Disclosure - Segment and Geographical Data (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.embecta.com/role/StockBasedCompensationTables">
        <link:definition>9954474 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>9954475 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.embecta.com/role/LongTermDebtTables">
        <link:definition>9954476 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareTables" roleURI="http://www.embecta.com/role/EarningsperShareTables">
        <link:definition>9954477 - Disclosure - Earnings per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.embecta.com/role/IncomeTaxesTables">
        <link:definition>9954478 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsTables" roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsTables">
        <link:definition>9954479 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentTables" roleURI="http://www.embecta.com/role/PropertyPlantandEquipmentTables">
        <link:definition>9954480 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.embecta.com/role/LeasesTables">
        <link:definition>9954481 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTables" roleURI="http://www.embecta.com/role/SupplementalFinancialInformationTables">
        <link:definition>9954482 - Disclosure - Supplemental Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundDetails" roleURI="http://www.embecta.com/role/BackgroundDetails">
        <link:definition>9954483 - Disclosure - Background (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofAccountingPoliciesDetails" roleURI="http://www.embecta.com/role/SummaryofAccountingPoliciesDetails">
        <link:definition>9954484 - Disclosure - Summary of Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails" roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails">
        <link:definition>9954485 - Disclosure - Third Party Arrangements and Related Party Disclosures - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails" roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails">
        <link:definition>9954486 - Disclosure - Third Party Arrangements and Related Party Disclosures - Allocation of General Corporate Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails" roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails">
        <link:definition>9954487 - Disclosure - Third Party Arrangements and Related Party Disclosures - Purchases from Parent (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails" roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails">
        <link:definition>9954488 - Disclosure - Third Party Arrangements and Related Party Disclosures - Net Transfers to Parent (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementDetails" roleURI="http://www.embecta.com/role/CollaborationAgreementDetails">
        <link:definition>9954489 - Disclosure - Collaboration Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherOperatingExpensesDetails" roleURI="http://www.embecta.com/role/OtherOperatingExpensesDetails">
        <link:definition>9954490 - Disclosure - Other Operating Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesDetails" roleURI="http://www.embecta.com/role/RevenuesDetails">
        <link:definition>9954491 - Disclosure - Revenues (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicalDataDetails" roleURI="http://www.embecta.com/role/SegmentandGeographicalDataDetails">
        <link:definition>9954492 - Disclosure - Segment and Geographical Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetails" roleURI="http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails">
        <link:definition>9954493 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockbasedCompensationExpenseDetails" roleURI="http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails">
        <link:definition>9954494 - Disclosure - Stock-Based Compensation - Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRestrictedStockUnitsActivityDetails" roleURI="http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails">
        <link:definition>9954495 - Disclosure - Stock-Based Compensation - Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails" roleURI="http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails">
        <link:definition>9954496 - Disclosure - Stock-Based Compensation - Weighted Average Grant Date Fair Value of Performance-Based and Time-Vested Restricted Stock Units Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails" roleURI="http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails">
        <link:definition>9954497 - Disclosure - Stock-Based Compensation - Total Fair Value of Time Vested Stock Units Vested (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationSARsValuationAssumptionsDetails" roleURI="http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails">
        <link:definition>9954498 - Disclosure - Stock-Based Compensation - SARs Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationSARsOutstandingandtheChangesDetails" roleURI="http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails">
        <link:definition>9954499 - Disclosure - Stock-Based Compensation - SARs Outstanding and the Changes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationSummaryofSARsExercisedDetails" roleURI="http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails">
        <link:definition>9954500 - Disclosure - Stock-Based Compensation - Summary of SARs Exercised (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsSummaryDetails" roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails">
        <link:definition>9954501 - Disclosure - Goodwill and Other Intangible Assets - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails">
        <link:definition>9954502 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtAdditionalInformationDetails" roleURI="http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails">
        <link:definition>9954503 - Disclosure - Long-Term Debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDebtOutstandingDetails" roleURI="http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails">
        <link:definition>9954504 - Disclosure - Long-Term Debt - Debt Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails" roleURI="http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails">
        <link:definition>9954505 - Disclosure - Long-Term Debt - Principal Payments Required on Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareAdditionalInformationDetails" roleURI="http://www.embecta.com/role/EarningsperShareAdditionalInformationDetails">
        <link:definition>9954506 - Disclosure - Earnings per Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareComputationofEarningsperShareDetails" roleURI="http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails">
        <link:definition>9954507 - Disclosure - Earnings per Share - Computation of Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeBeforeIncomeTaxesDetails" roleURI="http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails">
        <link:definition>9954508 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesProvisionBenefitforIncomeTaxesDetails" roleURI="http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails">
        <link:definition>9954509 - Disclosure - Income Taxes - Provision (Benefit) for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxRateReconciliationDetails" roleURI="http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails">
        <link:definition>9954510 - Disclosure - Income Taxes - Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredIncomeTaxesDetails" roleURI="http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails">
        <link:definition>9954511 - Disclosure - Income Taxes - Deferred Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>9954512 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>9954513 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesInterestandPenaltiesDetails" roleURI="http://www.embecta.com/role/IncomeTaxesInterestandPenaltiesDetails">
        <link:definition>9954514 - Disclosure - Income Taxes - Interest and Penalties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsCashandCashEquivalentsDetails" roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsCashandCashEquivalentsDetails">
        <link:definition>9954515 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails" roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails">
        <link:definition>9954516 - Disclosure - Financial Instruments and Fair Value Measurements - Notional Amounts of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails" roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>9954517 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails" roleURI="http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails">
        <link:definition>9954518 - Disclosure - Property, Plant and Equipment - Components of Property, Plant and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentAdditionalInformationDetails" roleURI="http://www.embecta.com/role/PropertyPlantandEquipmentAdditionalInformationDetails">
        <link:definition>9954519 - Disclosure - Property, Plant and Equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://www.embecta.com/role/LeasesAdditionalInformationDetails">
        <link:definition>9954520 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesBalanceSheetInformationDetails" roleURI="http://www.embecta.com/role/LeasesBalanceSheetInformationDetails">
        <link:definition>9954521 - Disclosure - Leases - Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>9954522 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>9954523 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>9954523 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_2" roleURI="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2">
        <link:definition>9954523 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansDetails" roleURI="http://www.embecta.com/role/BenefitPlansDetails">
        <link:definition>9954524 - Disclosure - Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTradeReceivablesNetDetails" roleURI="http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails">
        <link:definition>9954525 - Disclosure - Supplemental Financial Information - Trade Receivables, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationLongLivedAssetsDetails" roleURI="http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails">
        <link:definition>9954526 - Disclosure - Supplemental Financial Information - Long-Lived Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.embecta.com/role/SubsequentEventsDetails">
        <link:definition>9954527 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod" abstract="false" name="CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="embc_NetParentInvestmentMember" abstract="true" name="NetParentInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_SECSchedule1209AllowanceCashDiscountsMember" abstract="true" name="SECSchedule1209AllowanceCashDiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_ShippingAndHandlingPolicyPolicyTextBlock" abstract="false" name="ShippingAndHandlingPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="embc_NetParentInvestmentTaxesDeemedSettledWithParent" abstract="false" name="NetParentInvestmentTaxesDeemedSettledWithParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_BuildingLeaseSixYearExtensionOptionMember" abstract="true" name="BuildingLeaseSixYearExtensionOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" abstract="false" name="DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold" abstract="false" name="TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_LesseeLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LesseeLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized" abstract="false" name="ShareBasedPaymentArrangementPlanModificationExpenseRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_GeneralCorporateExpenses" abstract="false" name="GeneralCorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_LesseeLeaseLiability" abstract="false" name="LesseeLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_NetParentInvestmentNetTransfersToParent" abstract="false" name="NetParentInvestmentNetTransfersToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_SeparationAndStandupCosts" abstract="false" name="SeparationAndStandupCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_CommonStockShareIssuanceRatio" abstract="false" name="CommonStockShareIssuanceRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="embc_PerformanceStockUnitsPSUsMember" abstract="true" name="PerformanceStockUnitsPSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="embc_DebtInstrumentPeriodicPaymentPrincipalPercentage" abstract="false" name="DebtInstrumentPeriodicPaymentPrincipalPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="embc_ThirdPartyAndRelatedPartyTransactionsAbstract" abstract="true" name="ThirdPartyAndRelatedPartyTransactionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" abstract="false" name="IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_SeniorSecuredTermLoanBMaturingMarch2029Member" abstract="true" name="SeniorSecuredTermLoanBMaturingMarch2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum" abstract="false" name="TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage" abstract="false" name="DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="embc_OperatingLossCarryforwardsNotSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_DeferredIncomeTaxesAndOtherAssetsMember" abstract="true" name="DeferredIncomeTaxesAndOtherAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" abstract="false" name="CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="embc_LesseeFinanceLeaseAreaOfPremisesLeased" abstract="false" name="LesseeFinanceLeaseAreaOfPremisesLeased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage" abstract="false" name="DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_TaxMattersAgreementCovenantRestrictionsPeriod" abstract="false" name="TaxMattersAgreementCovenantRestrictionsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="embc_LesseeLeaseLiabilityToBePaidYearOne" abstract="false" name="LesseeLeaseLiabilityToBePaidYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_PaymentOfRevolvingCreditFacilityFees" abstract="false" name="PaymentOfRevolvingCreditFacilityFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_BectonDickinsonAndCompanyMember" abstract="true" name="BectonDickinsonAndCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum" abstract="false" name="CannulaSupplyAgreementTerminationNoticePeriodMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_NetParentInvestmentPensionExpense" abstract="false" name="NetParentInvestmentPensionExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_BuildingLeaseFourYearExtensionOptionMember" abstract="true" name="BuildingLeaseFourYearExtensionOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_PaymentForSpinoffTransactionFinancingActivities" abstract="false" name="PaymentForSpinoffTransactionFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_CustomerOneCustomerTwoAndCustomerThreeMember" abstract="true" name="CustomerOneCustomerTwoAndCustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="embc_NetParentInvestmentShareBasedCompensationExpense" abstract="false" name="NetParentInvestmentShareBasedCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_LesseeLeaseLiabilityToBePaidYearTwo" abstract="false" name="LesseeLeaseLiabilityToBePaidYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_HostingArrangementServiceContractAssetsInServiceUsefulLife" abstract="false" name="HostingArrangementServiceContractAssetsInServiceUsefulLife" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_NetTransfersToParentFinancingActivities" abstract="false" name="NetTransfersToParentFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ContractuallySpecifiedServicingFeesPercentage" abstract="false" name="ContractuallySpecifiedServicingFeesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember" abstract="true" name="A2022EmployeeAndDirectorEquityBasedCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_CustomerOneAndCustomerTwoMember" abstract="true" name="CustomerOneAndCustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_NetParentInvestmentConsiderationPaidForSeparation" abstract="false" name="NetParentInvestmentConsiderationPaidForSeparation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock" abstract="false" name="ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" abstract="false" name="NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_LesseeLeaseLiabilityToBePaidAbstract" abstract="true" name="LesseeLeaseLiabilityToBePaidAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="embc_LesseeLeaseLiabilityToBePaidYearFive" abstract="false" name="LesseeLeaseLiabilityToBePaidYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" abstract="false" name="LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_TimeVestedRestrictedStockUnitsMember" abstract="true" name="TimeVestedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="embc_NetParentInvestmentSeparationRelatedAdjustments" abstract="false" name="NetParentInvestmentSeparationRelatedAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" abstract="false" name="DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="embc_NetParentInvestmentRelatedPartyDebtIssued" abstract="false" name="NetParentInvestmentRelatedPartyDebtIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_CustomerRelationshipAndOtherMember" abstract="true" name="CustomerRelationshipAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" abstract="false" name="NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_LesseeLeaseLiabilityToBePaid" abstract="false" name="LesseeLeaseLiabilityToBePaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="embc_A675SeniorSecuredNotesDueFebruary2030Member" abstract="true" name="A675SeniorSecuredNotesDueFebruary2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_CollaborativeArrangementPrincipalRightsPercentage" abstract="false" name="CollaborativeArrangementPrincipalRightsPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="embc_DebtInstrumentDiscountPercentage" abstract="false" name="DebtInstrumentDiscountPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_LesseeLeaseLiabilityToBePaidYearThree" abstract="false" name="LesseeLeaseLiabilityToBePaidYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_PropertyPlantAndEquipmentNetMember" abstract="true" name="PropertyPlantAndEquipmentNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="embc_RevenueFromContractWithCustomerSalesDeductionsRecognized" abstract="false" name="RevenueFromContractWithCustomerSalesDeductionsRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="embc_A500SeniorSecuredNotesDueFebruary2030Member" abstract="true" name="A500SeniorSecuredNotesDueFebruary2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="embc_DebtInstrumentVariableRateFloor" abstract="false" name="DebtInstrumentVariableRateFloor" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="embc_LesseeLeaseLiabilityToBePaidYearFour" abstract="false" name="LesseeLeaseLiabilityToBePaidYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_LogisticsServicesAgreementMaximumTerm" abstract="false" name="LogisticsServicesAgreementMaximumTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" abstract="false" name="NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive" abstract="false" name="LesseeLeaseLiabilityToBePaidDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_HostingArrangementServiceContractPolicyTextBlock" abstract="false" name="HostingArrangementServiceContractPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="embc_PerformanceBasedRestrictedStockUnitsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" abstract="false" name="DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_DistributionAgreementDistributorAppointmentMaximumTerm" abstract="false" name="DistributionAgreementDistributorAppointmentMaximumTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_ShareBasedPaymentArrangementLiabilityAwardMember" abstract="true" name="ShareBasedPaymentArrangementLiabilityAwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities" abstract="false" name="NetParentInvestmentCashPoolingAndGeneralFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member" abstract="true" name="SeniorSecuredRevolvingCreditFacilityMaturing2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="embc_NetParentInvestmentOtherTransfersToFromParentNet" abstract="false" name="NetParentInvestmentOtherTransfersToFromParentNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="embc_DebtInstrumentDiscountGross" abstract="false" name="DebtInstrumentDiscountGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>embc-20230930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:4102c7ef-a746-4e09-abe6-45c91f406b23,g:4bb25894-924e-4e32-9a1d-8a6b6ed5cbfa-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_eea1b307-3bf9-4d70-8b55-139f7fdb932c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5dec7ffc-8fa3-4621-9c96-00097929f891" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_eea1b307-3bf9-4d70-8b55-139f7fdb932c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5dec7ffc-8fa3-4621-9c96-00097929f891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5f383a81-7541-4683-8aa9-9160e781e631" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_eea1b307-3bf9-4d70-8b55-139f7fdb932c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5f383a81-7541-4683-8aa9-9160e781e631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3b9cd3d0-f3af-4499-8048-af08a10c023a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3b1db0c9-5414-421e-8511-1fe34c93f1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3b9cd3d0-f3af-4499-8048-af08a10c023a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3b1db0c9-5414-421e-8511-1fe34c93f1eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a359af1c-4187-461d-ab9b-f49d3eb3da72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3b9cd3d0-f3af-4499-8048-af08a10c023a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a359af1c-4187-461d-ab9b-f49d3eb3da72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d127abca-5cdb-44b7-8d8c-f25f7f002775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1921be50-ad47-473d-82b2-7fc5c939208a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d127abca-5cdb-44b7-8d8c-f25f7f002775" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_1921be50-ad47-473d-82b2-7fc5c939208a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c1d721a2-5b4d-4f8f-bfc0-01a1e20d6da6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d127abca-5cdb-44b7-8d8c-f25f7f002775" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c1d721a2-5b4d-4f8f-bfc0-01a1e20d6da6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_0943a253-0c45-4905-b7ea-6181819cc25a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d127abca-5cdb-44b7-8d8c-f25f7f002775" xlink:to="loc_us-gaap_AssetImpairmentCharges_0943a253-0c45-4905-b7ea-6181819cc25a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralExpense_193feeb5-6ac0-449f-b061-ce59ead166f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d127abca-5cdb-44b7-8d8c-f25f7f002775" xlink:to="loc_us-gaap_OtherGeneralExpense_193feeb5-6ac0-449f-b061-ce59ead166f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e817a63c-8273-4ae6-8736-3a176637e4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d185103c-b8f1-42a9-aa46-6bef7798304d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e817a63c-8273-4ae6-8736-3a176637e4d5" xlink:to="loc_us-gaap_OperatingIncomeLoss_d185103c-b8f1-42a9-aa46-6bef7798304d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_d8632898-e234-4c61-936d-97d35baf9f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e817a63c-8273-4ae6-8736-3a176637e4d5" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_d8632898-e234-4c61-936d-97d35baf9f8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_436c5cad-38ce-46fc-baa9-81936662c7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e817a63c-8273-4ae6-8736-3a176637e4d5" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_436c5cad-38ce-46fc-baa9-81936662c7ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3d6dccda-5733-4b0b-aa70-f54fa666f049" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e84e6022-4a77-4706-b097-602146138962" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3d6dccda-5733-4b0b-aa70-f54fa666f049" xlink:to="loc_us-gaap_GrossProfit_e84e6022-4a77-4706-b097-602146138962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1e202b7a-8877-4c24-9367-adad14dd34e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3d6dccda-5733-4b0b-aa70-f54fa666f049" xlink:to="loc_us-gaap_OperatingExpenses_1e202b7a-8877-4c24-9367-adad14dd34e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8cc4ad5d-4f40-4ef7-8a30-fbe5ace1d343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3a97d335-aecf-43af-a681-b96c3fc99c23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8cc4ad5d-4f40-4ef7-8a30-fbe5ace1d343" xlink:to="loc_us-gaap_NetIncomeLoss_3a97d335-aecf-43af-a681-b96c3fc99c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_07c77a3f-1145-4ba9-91dd-6478d4d833ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8cc4ad5d-4f40-4ef7-8a30-fbe5ace1d343" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_07c77a3f-1145-4ba9-91dd-6478d4d833ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fc22f756-fb90-4ef8-a132-98fbd1dba137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4e9c6073-1ba9-4fef-9223-3969a700d6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fc22f756-fb90-4ef8-a132-98fbd1dba137" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4e9c6073-1ba9-4fef-9223-3969a700d6e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_82a8e4a9-4785-4c16-8b14-0f419aa65c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fc22f756-fb90-4ef8-a132-98fbd1dba137" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_82a8e4a9-4785-4c16-8b14-0f419aa65c2c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bb6069f3-d98e-4fcb-9549-c4c1407045c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a40f893e-cbf4-4628-98ba-639b21326229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bb6069f3-d98e-4fcb-9549-c4c1407045c7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a40f893e-cbf4-4628-98ba-639b21326229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cb7db966-74a5-4d64-9aae-9906c1cab60f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bb6069f3-d98e-4fcb-9549-c4c1407045c7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cb7db966-74a5-4d64-9aae-9906c1cab60f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5313e3ff-9e13-4024-9a12-22ec458dc69f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bb6069f3-d98e-4fcb-9549-c4c1407045c7" xlink:to="loc_us-gaap_InventoryNet_5313e3ff-9e13-4024-9a12-22ec458dc69f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_135fbece-dc5e-4678-9f67-ee42136f6a39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bb6069f3-d98e-4fcb-9549-c4c1407045c7" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_135fbece-dc5e-4678-9f67-ee42136f6a39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a4037364-21b6-4051-8d2e-e09b287177a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bb6069f3-d98e-4fcb-9549-c4c1407045c7" xlink:to="loc_us-gaap_OtherAssetsCurrent_a4037364-21b6-4051-8d2e-e09b287177a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d498e50a-4c41-43af-8b1e-21495466998a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b42bc19e-d832-4901-982f-165d84b91a17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d498e50a-4c41-43af-8b1e-21495466998a" xlink:to="loc_us-gaap_CommonStockValue_b42bc19e-d832-4901-982f-165d84b91a17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1b0833ef-1580-4603-8e59-cab485de0d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d498e50a-4c41-43af-8b1e-21495466998a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1b0833ef-1580-4603-8e59-cab485de0d41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_901e2324-085b-485f-bffb-31c5577d0f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d498e50a-4c41-43af-8b1e-21495466998a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_901e2324-085b-485f-bffb-31c5577d0f6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e9dcb999-34ff-4647-9e9a-43fc05ed517b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d498e50a-4c41-43af-8b1e-21495466998a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e9dcb999-34ff-4647-9e9a-43fc05ed517b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_457eceef-a31d-482d-bf04-98b5cb186c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fbe4f69c-cbc7-4ad0-960f-f3474e604327" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_457eceef-a31d-482d-bf04-98b5cb186c4f" xlink:to="loc_us-gaap_AssetsCurrent_fbe4f69c-cbc7-4ad0-960f-f3474e604327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d8a4770d-cfe8-482e-96ea-c105a477ab96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_457eceef-a31d-482d-bf04-98b5cb186c4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d8a4770d-cfe8-482e-96ea-c105a477ab96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_8c776f1a-effe-41e5-8990-22ff092b2532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_457eceef-a31d-482d-bf04-98b5cb186c4f" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_8c776f1a-effe-41e5-8990-22ff092b2532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9af2fa5e-042c-4570-9f6e-4808f9194134" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_457eceef-a31d-482d-bf04-98b5cb186c4f" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_9af2fa5e-042c-4570-9f6e-4808f9194134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3ac00574-bf3d-42f2-8203-62a8bf1d85ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_12871419-62d5-42df-ba63-081b4caf35e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ac00574-bf3d-42f2-8203-62a8bf1d85ed" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_12871419-62d5-42df-ba63-081b4caf35e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_24c88fea-7552-4b76-91a3-4c6cecea9978" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ac00574-bf3d-42f2-8203-62a8bf1d85ed" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_24c88fea-7552-4b76-91a3-4c6cecea9978" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent_2b0d7d60-92fd-4587-ac81-e72d21bac20b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ac00574-bf3d-42f2-8203-62a8bf1d85ed" xlink:to="loc_us-gaap_AccountsPayableOtherCurrent_2b0d7d60-92fd-4587-ac81-e72d21bac20b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_12cb3101-b230-4e60-957a-817da0e2767e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ac00574-bf3d-42f2-8203-62a8bf1d85ed" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_12cb3101-b230-4e60-957a-817da0e2767e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_9e328ff9-379a-4507-908d-f4034d872901" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ac00574-bf3d-42f2-8203-62a8bf1d85ed" xlink:to="loc_us-gaap_LongTermDebtCurrent_9e328ff9-379a-4507-908d-f4034d872901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d2a346ec-f822-4d37-8ed9-ca4bf911c87e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ac00574-bf3d-42f2-8203-62a8bf1d85ed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d2a346ec-f822-4d37-8ed9-ca4bf911c87e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_08c1a71e-7072-42d1-bb73-66dc72d17267" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3ac00574-bf3d-42f2-8203-62a8bf1d85ed" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_08c1a71e-7072-42d1-bb73-66dc72d17267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_dfba6e7f-7496-4836-aa2a-cd19c0c5062c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_792f6c50-c46c-4c48-b76a-6c0ea03048b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_dfba6e7f-7496-4836-aa2a-cd19c0c5062c" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_792f6c50-c46c-4c48-b76a-6c0ea03048b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_a6379535-fc19-42a7-8611-f8a96c2f5f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_dfba6e7f-7496-4836-aa2a-cd19c0c5062c" xlink:to="loc_us-gaap_InventoryWorkInProcess_a6379535-fc19-42a7-8611-f8a96c2f5f99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_4adf5ed9-2c94-42b9-afbf-590bca9b77f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_dfba6e7f-7496-4836-aa2a-cd19c0c5062c" xlink:to="loc_us-gaap_InventoryFinishedGoods_4adf5ed9-2c94-42b9-afbf-590bca9b77f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_afa9b280-2081-4e5c-a061-c1a44798aed8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_453f55a0-e61a-4527-a11d-4b27e221d2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afa9b280-2081-4e5c-a061-c1a44798aed8" xlink:to="loc_us-gaap_LiabilitiesCurrent_453f55a0-e61a-4527-a11d-4b27e221d2e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_24d251cd-a6a3-428c-8d62-6bcf339cb7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afa9b280-2081-4e5c-a061-c1a44798aed8" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_24d251cd-a6a3-428c-8d62-6bcf339cb7bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_970f6153-859c-466f-8b2a-03beaac276b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afa9b280-2081-4e5c-a061-c1a44798aed8" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_970f6153-859c-466f-8b2a-03beaac276b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_150b0d99-5314-443c-8c1e-deaed89d12f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afa9b280-2081-4e5c-a061-c1a44798aed8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_150b0d99-5314-443c-8c1e-deaed89d12f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_359b7e80-d5e2-4df2-a352-f59eaf575be1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afa9b280-2081-4e5c-a061-c1a44798aed8" xlink:to="loc_us-gaap_CommitmentsAndContingencies_359b7e80-d5e2-4df2-a352-f59eaf575be1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1136d02c-b0d7-4584-bfd8-7a3c128cd7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afa9b280-2081-4e5c-a061-c1a44798aed8" xlink:to="loc_us-gaap_StockholdersEquity_1136d02c-b0d7-4584-bfd8-7a3c128cd7d5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e21807f-ce58-410a-820f-c27f45bc5250" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_400cfc32-cd8d-4bd6-8890-987237c803ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e21807f-ce58-410a-820f-c27f45bc5250" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_400cfc32-cd8d-4bd6-8890-987237c803ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_6ab25bba-9d4f-46a4-b5cc-cd0af4656430" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e21807f-ce58-410a-820f-c27f45bc5250" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_6ab25bba-9d4f-46a4-b5cc-cd0af4656430" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2aea1169-10f7-43f2-beb4-1db26d0d594c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e497f007-c38b-44b3-b35b-97ceea94965a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2aea1169-10f7-43f2-beb4-1db26d0d594c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e497f007-c38b-44b3-b35b-97ceea94965a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_487b44da-2944-4df5-a19b-b4c4bc94194c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2aea1169-10f7-43f2-beb4-1db26d0d594c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_487b44da-2944-4df5-a19b-b4c4bc94194c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_93b2b42e-5c79-47bb-84f1-36a80a80f5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2aea1169-10f7-43f2-beb4-1db26d0d594c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_93b2b42e-5c79-47bb-84f1-36a80a80f5b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9d82546b-59c5-4b90-809a-82b071390cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2aea1169-10f7-43f2-beb4-1db26d0d594c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_9d82546b-59c5-4b90-809a-82b071390cd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_cb6a4692-2a18-4707-ba7e-6f129340b81e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_cb6a4692-2a18-4707-ba7e-6f129340b81e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_87d9ef19-6044-42b5-b3ff-d93799937227" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_87d9ef19-6044-42b5-b3ff-d93799937227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e1448e42-a32d-4279-acf8-82df34dc929f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e1448e42-a32d-4279-acf8-82df34dc929f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PaymentOfRevolvingCreditFacilityFees_af759fba-7a0d-4114-bb53-2c6a90816ea2" xlink:href="embc-20230930.xsd#embc_PaymentOfRevolvingCreditFacilityFees"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:to="loc_embc_PaymentOfRevolvingCreditFacilityFees_af759fba-7a0d-4114-bb53-2c6a90816ea2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_a6f0edbb-423f-4a3d-9230-5ff4c74f4e46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_a6f0edbb-423f-4a3d-9230-5ff4c74f4e46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_1e36b0bf-df0f-4227-885e-9b64c8f67995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_1e36b0bf-df0f-4227-885e-9b64c8f67995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PaymentForSpinoffTransactionFinancingActivities_3d8e3d0d-a50a-4322-a2aa-1e295645c455" xlink:href="embc-20230930.xsd#embc_PaymentForSpinoffTransactionFinancingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:to="loc_embc_PaymentForSpinoffTransactionFinancingActivities_3d8e3d0d-a50a-4322-a2aa-1e295645c455" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetTransfersToParentFinancingActivities_47eb5424-858e-4dd5-ae14-3ba33ed567ac" xlink:href="embc-20230930.xsd#embc_NetTransfersToParentFinancingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:to="loc_embc_NetTransfersToParentFinancingActivities_47eb5424-858e-4dd5-ae14-3ba33ed567ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1916ca91-f222-40ca-8a0f-1a35f836c2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44ed82ca-e2f3-46a4-9f4a-289998ae3bba" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1916ca91-f222-40ca-8a0f-1a35f836c2c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5fcb4707-e9c2-46db-9807-ba8d47b7c723" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_NetIncomeLoss_5fcb4707-e9c2-46db-9807-ba8d47b7c723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6609e53b-d032-4f54-b017-690343c3d31f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6609e53b-d032-4f54-b017-690343c3d31f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_2a4ab4a0-23c0-48b4-a8b6-2db2431d8532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_2a4ab4a0-23c0-48b4-a8b6-2db2431d8532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_ca2987fb-e65b-44b6-a000-dde4c8c08fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_ca2987fb-e65b-44b6-a000-dde4c8c08fd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c7a7a502-5d81-4543-9ef9-a5ab128ce02b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_ShareBasedCompensation_c7a7a502-5d81-4543-9ef9-a5ab128ce02b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fdace677-f04f-4c38-86f9-c52d861e18be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fdace677-f04f-4c38-86f9-c52d861e18be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e544b809-0e29-458d-85fc-cb9cf72ed9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e544b809-0e29-458d-85fc-cb9cf72ed9a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ed4ebb41-5879-42d1-aac7-25db4b4778ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ed4ebb41-5879-42d1-aac7-25db4b4778ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet_70ac2e3a-f7b8-4cbb-a33d-24e9a536a388" xlink:href="embc-20230930.xsd#embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet_70ac2e3a-f7b8-4cbb-a33d-24e9a536a388" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_01573701-0986-430c-97d8-de6136f8bfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_01573701-0986-430c-97d8-de6136f8bfa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7fb2d0de-2e12-42dd-b583-9f9f1f47bc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7fb2d0de-2e12-42dd-b583-9f9f1f47bc5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_0b692849-ee2f-4fd3-9dce-9d654b683be4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_0b692849-ee2f-4fd3-9dce-9d654b683be4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_889d7dc7-e0d1-4f9f-b5af-4253487a714d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea8ee887-22b6-40f0-9f51-641b84b7f21c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_889d7dc7-e0d1-4f9f-b5af-4253487a714d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_250a5413-b01d-4946-a7c7-3b00d240258f" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities_0f9fbab5-6bee-4de2-93b2-a53d32c6385f" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_250a5413-b01d-4946-a7c7-3b00d240258f" xlink:to="loc_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities_0f9fbab5-6bee-4de2-93b2-a53d32c6385f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation_738cc6f7-2f6b-4c23-894b-27888b8c8c4a" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_250a5413-b01d-4946-a7c7-3b00d240258f" xlink:to="loc_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation_738cc6f7-2f6b-4c23-894b-27888b8c8c4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentTaxesDeemedSettledWithParent_42b8cb6f-d43e-4ab6-b77c-f8683eea7f90" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentTaxesDeemedSettledWithParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_250a5413-b01d-4946-a7c7-3b00d240258f" xlink:to="loc_embc_NetParentInvestmentTaxesDeemedSettledWithParent_42b8cb6f-d43e-4ab6-b77c-f8683eea7f90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentSeparationRelatedAdjustments_ee4aec4b-ccfb-4d3b-917c-aa5e8387e447" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentSeparationRelatedAdjustments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_250a5413-b01d-4946-a7c7-3b00d240258f" xlink:to="loc_embc_NetParentInvestmentSeparationRelatedAdjustments_ee4aec4b-ccfb-4d3b-917c-aa5e8387e447" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentNetTransfersToParent_70a6ed9a-8b1c-496e-b772-3cd6303ae0c1" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentNetTransfersToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_b3c97b06-b52d-4d90-bb3f-4eb66b11e522" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentNetTransfersToParent_70a6ed9a-8b1c-496e-b772-3cd6303ae0c1" xlink:to="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_b3c97b06-b52d-4d90-bb3f-4eb66b11e522" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentShareBasedCompensationExpense_b2cb2fc1-552a-4b9d-a031-cacc5833bb62" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentNetTransfersToParent_70a6ed9a-8b1c-496e-b772-3cd6303ae0c1" xlink:to="loc_embc_NetParentInvestmentShareBasedCompensationExpense_b2cb2fc1-552a-4b9d-a031-cacc5833bb62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentPensionExpense_edb3f260-7d36-4079-b5b2-d994cab349f9" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentPensionExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentNetTransfersToParent_70a6ed9a-8b1c-496e-b772-3cd6303ae0c1" xlink:to="loc_embc_NetParentInvestmentPensionExpense_edb3f260-7d36-4079-b5b2-d994cab349f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentConsiderationPaidForSeparation_df5109a1-eaba-4530-a13d-f4e1e03c2fb4" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentConsiderationPaidForSeparation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentNetTransfersToParent_70a6ed9a-8b1c-496e-b772-3cd6303ae0c1" xlink:to="loc_embc_NetParentInvestmentConsiderationPaidForSeparation_df5109a1-eaba-4530-a13d-f4e1e03c2fb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentRelatedPartyDebtIssued_ba33b90e-995e-4cd5-a6fe-ad714955da33" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentRelatedPartyDebtIssued"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentNetTransfersToParent_70a6ed9a-8b1c-496e-b772-3cd6303ae0c1" xlink:to="loc_embc_NetParentInvestmentRelatedPartyDebtIssued_ba33b90e-995e-4cd5-a6fe-ad714955da33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentOtherTransfersToFromParentNet_5f4e3659-e109-412b-a7ed-26299a31f828" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentOtherTransfersToFromParentNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_NetParentInvestmentNetTransfersToParent_70a6ed9a-8b1c-496e-b772-3cd6303ae0c1" xlink:to="loc_embc_NetParentInvestmentOtherTransfersToFromParentNet_5f4e3659-e109-412b-a7ed-26299a31f828" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#GoodwillandOtherIntangibleAssetsSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_20663fc8-09fd-45df-87c6-39cb59468c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a45b600d-f91b-4a60-a8ea-921bdbffa64b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_20663fc8-09fd-45df-87c6-39cb59468c06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a45b600d-f91b-4a60-a8ea-921bdbffa64b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6a5292c4-962c-4485-ac19-e2d23524f1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_20663fc8-09fd-45df-87c6-39cb59468c06" xlink:to="loc_us-gaap_Goodwill_6a5292c4-962c-4485-ac19-e2d23524f1bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9beaa723-646b-44af-a3b0-18fc54d677f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fdb5f97c-f227-4d9d-96d8-7c83771ac9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9beaa723-646b-44af-a3b0-18fc54d677f4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fdb5f97c-f227-4d9d-96d8-7c83771ac9b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_776b2371-17e9-4ff7-9322-d0ec3398e63b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9beaa723-646b-44af-a3b0-18fc54d677f4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_776b2371-17e9-4ff7-9322-d0ec3398e63b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#EarningsperShareComputationofEarningsperShareDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c5f3ac26-5ea9-4716-b637-d18acb4217e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95e244e8-4b77-4d35-8d1f-1b5eb474c37a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c5f3ac26-5ea9-4716-b637-d18acb4217e3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95e244e8-4b77-4d35-8d1f-1b5eb474c37a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4fd9936d-0e91-4153-82fb-9c0840036791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c5f3ac26-5ea9-4716-b637-d18acb4217e3" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4fd9936d-0e91-4153-82fb-9c0840036791" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13ae702b-16ad-4f3c-afac-e8205d619aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ed31d8cf-5aa4-48e0-a320-9eaf84110f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13ae702b-16ad-4f3c-afac-e8205d619aa2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_ed31d8cf-5aa4-48e0-a320-9eaf84110f99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_76f0076b-9c42-4b42-b0b3-b77c86c5d0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13ae702b-16ad-4f3c-afac-e8205d619aa2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_76f0076b-9c42-4b42-b0b3-b77c86c5d0ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesProvisionBenefitforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_122ad6f5-3b1d-48ad-9667-9c4c36fdf458" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1aff944e-d50c-47ee-b2d9-07cd82e42196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_122ad6f5-3b1d-48ad-9667-9c4c36fdf458" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1aff944e-d50c-47ee-b2d9-07cd82e42196" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4def0817-e5e0-4a4b-9b13-12740e5ffc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_122ad6f5-3b1d-48ad-9667-9c4c36fdf458" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4def0817-e5e0-4a4b-9b13-12740e5ffc2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_83213484-dbb9-4440-839b-65873e895a69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_122ad6f5-3b1d-48ad-9667-9c4c36fdf458" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_83213484-dbb9-4440-839b-65873e895a69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_681c5695-b33f-4f70-a99c-8f5867f67294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4a1524da-3c6a-46d8-be0b-3c76009eb97c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_681c5695-b33f-4f70-a99c-8f5867f67294" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4a1524da-3c6a-46d8-be0b-3c76009eb97c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_8153a34a-8a74-4dc7-9699-e71706fd4cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_681c5695-b33f-4f70-a99c-8f5867f67294" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_8153a34a-8a74-4dc7-9699-e71706fd4cf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1c1e3e70-59b1-4e0b-8f9c-7284167a20b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_681c5695-b33f-4f70-a99c-8f5867f67294" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_1c1e3e70-59b1-4e0b-8f9c-7284167a20b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5a6830f0-e4aa-4730-aaff-895b12eb0684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d37633f9-9c80-443e-9aea-639c02349734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5a6830f0-e4aa-4730-aaff-895b12eb0684" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d37633f9-9c80-443e-9aea-639c02349734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6cceddfc-df79-463e-9ca6-788780fe0bda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5a6830f0-e4aa-4730-aaff-895b12eb0684" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6cceddfc-df79-463e-9ca6-788780fe0bda" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5bf73f30-8cf3-4cee-8abf-eac454cd4bce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5bf73f30-8cf3-4cee-8abf-eac454cd4bce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0c3f0f86-02bd-4db8-a232-f27cf3d7b01b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0c3f0f86-02bd-4db8-a232-f27cf3d7b01b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_ce9e95f1-a0b2-413d-9a97-aedfe8b7bcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_ce9e95f1-a0b2-413d-9a97-aedfe8b7bcb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_fbd9d9d3-72f6-484c-a2b5-59cdbd1f0d97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_fbd9d9d3-72f6-484c-a2b5-59cdbd1f0d97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent_08bb4ff5-b78a-4f62-9519-e68bd1789a19" xlink:href="embc-20230930.xsd#embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent_08bb4ff5-b78a-4f62-9519-e68bd1789a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_b736c6f1-3b69-4b2e-9d90-7e63b7777299" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_b736c6f1-3b69-4b2e-9d90-7e63b7777299" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_c2596950-50b2-4e17-bbe0-d46a744a92e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_c2596950-50b2-4e17-bbe0-d46a744a92e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_5f7a339b-24d5-45b1-b364-b05d401a45d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_5f7a339b-24d5-45b1-b364-b05d401a45d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_95c5dce9-b7ab-4942-b96e-8e9bcc932765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_95c5dce9-b7ab-4942-b96e-8e9bcc932765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_d2b1a6cf-9bdd-4df8-b655-1680aa42ef35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_d2b1a6cf-9bdd-4df8-b655-1680aa42ef35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_81e2768c-7ac7-40cb-9e15-bd169331a92d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_328959be-f78b-4980-a3cc-5766bb30aa1b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_81e2768c-7ac7-40cb-9e15-bd169331a92d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesDeferredIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_fe5ba334-2f9e-4c30-a201-947f0d5c8400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_32d12ff3-1a77-4a99-af6b-9411c73e0850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fe5ba334-2f9e-4c30-a201-947f0d5c8400" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_32d12ff3-1a77-4a99-af6b-9411c73e0850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_0d25a72c-5a31-412c-a0ac-d19f805cddcc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fe5ba334-2f9e-4c30-a201-947f0d5c8400" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_0d25a72c-5a31-412c-a0ac-d19f805cddcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1c443f21-b759-4a6f-bb56-9aa26e52a83b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9b27807f-abe4-4b2c-be6c-fc01486798cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_1c443f21-b759-4a6f-bb56-9aa26e52a83b" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_9b27807f-abe4-4b2c-be6c-fc01486798cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0eff524c-eecb-4f3d-821e-78066dad6627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_1c443f21-b759-4a6f-bb56-9aa26e52a83b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0eff524c-eecb-4f3d-821e-78066dad6627" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_a59a1e3f-d8a3-4af0-a046-cfb741bbc2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_a59a1e3f-d8a3-4af0-a046-cfb741bbc2c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_9df613b1-20da-4af8-9455-4c0097c2e073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_9df613b1-20da-4af8-9455-4c0097c2e073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_14d78efc-228f-4823-808c-c1275173242d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_14d78efc-228f-4823-808c-c1275173242d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_8ed08b85-ffa6-4acf-b795-63ab37ab4411" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_8ed08b85-ffa6-4acf-b795-63ab37ab4411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_99916952-c012-468d-bf87-afd3c7902ac7" xlink:href="embc-20230930.xsd#embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:to="loc_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_99916952-c012-468d-bf87-afd3c7902ac7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredTaxAssetsLeasingArrangements_a7ce4dca-79a9-49b9-9124-c5d66e507dae" xlink:href="embc-20230930.xsd#embc_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:to="loc_embc_DeferredTaxAssetsLeasingArrangements_a7ce4dca-79a9-49b9-9124-c5d66e507dae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards_140ed002-f238-43fa-9468-1653bf8e03f4" xlink:href="embc-20230930.xsd#embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:to="loc_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards_140ed002-f238-43fa-9468-1653bf8e03f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_eeaf34c5-1d89-4a3d-a9cf-9007bc727744" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_eeaf34c5-1d89-4a3d-a9cf-9007bc727744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_66f9c0d5-08b2-4c3e-a4d6-0150929846c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_95b2acf7-e743-4e48-8d9d-8d2c525a8a87" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_66f9c0d5-08b2-4c3e-a4d6-0150929846c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_87b0106d-5af7-4d24-8d8f-29458b982360" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e480eafc-2d65-4ec9-8c2f-f1f54388f54f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_87b0106d-5af7-4d24-8d8f-29458b982360" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_e480eafc-2d65-4ec9-8c2f-f1f54388f54f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5c64375f-bf03-49eb-9970-e8f0e17fea12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_87b0106d-5af7-4d24-8d8f-29458b982360" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5c64375f-bf03-49eb-9970-e8f0e17fea12" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_fa042d4b-9925-4109-80b7-8a9963be4cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_fc4d3d03-f719-4bd8-bd71-7c301ff76f33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_fa042d4b-9925-4109-80b7-8a9963be4cf4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_fc4d3d03-f719-4bd8-bd71-7c301ff76f33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_66b9c62b-5f4f-47a6-98b6-31300155b810" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_fa042d4b-9925-4109-80b7-8a9963be4cf4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_66b9c62b-5f4f-47a6-98b6-31300155b810" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesBalanceSheetInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/LeasesBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_9d123f0f-db72-48ac-accc-bdfff350d9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e1b9f2a7-fd12-44e6-a1cf-7f5a956f9193" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_9d123f0f-db72-48ac-accc-bdfff350d9f6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e1b9f2a7-fd12-44e6-a1cf-7f5a956f9193" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cd2da031-e46d-4cc6-b10d-4e48708bb303" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_9d123f0f-db72-48ac-accc-bdfff350d9f6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cd2da031-e46d-4cc6-b10d-4e48708bb303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f32855d5-0c61-4e12-b642-61f066d1cc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6a77a4f6-2a02-4f7e-a422-b970e4d3f009" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_f32855d5-0c61-4e12-b642-61f066d1cc3d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6a77a4f6-2a02-4f7e-a422-b970e4d3f009" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_37382bce-12ec-407f-afcc-fa6c255dc324" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_f32855d5-0c61-4e12-b642-61f066d1cc3d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_37382bce-12ec-407f-afcc-fa6c255dc324" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaid_d18f8467-a79a-4e13-a5e7-e1c1bd5d2722" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_0cda29ea-7869-4ed4-97b5-5bc08addbdcd" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_d18f8467-a79a-4e13-a5e7-e1c1bd5d2722" xlink:to="loc_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_0cda29ea-7869-4ed4-97b5-5bc08addbdcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiability_8bc9f63f-da01-462d-b41f-1314370f70ee" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_d18f8467-a79a-4e13-a5e7-e1c1bd5d2722" xlink:to="loc_embc_LesseeLeaseLiability_8bc9f63f-da01-462d-b41f-1314370f70ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d32d8bbb-b515-4a62-9cbb-a484b0504ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_97d947fe-45e3-4156-9aca-fc07ba041813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d32d8bbb-b515-4a62-9cbb-a484b0504ce4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_97d947fe-45e3-4156-9aca-fc07ba041813" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d8fe15ca-25d3-40b2-9cc9-31926a5b23f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d32d8bbb-b515-4a62-9cbb-a484b0504ce4" xlink:to="loc_us-gaap_OperatingLeaseLiability_d8fe15ca-25d3-40b2-9cc9-31926a5b23f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearTwo_85e08a47-98a7-422a-86c0-dc6128b60fe3" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7102a75c-cdc9-4329-ad89-13dab7f089fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearTwo_85e08a47-98a7-422a-86c0-dc6128b60fe3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7102a75c-cdc9-4329-ad89-13dab7f089fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5671180c-656c-4f38-8720-6610f2e9c3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearTwo_85e08a47-98a7-422a-86c0-dc6128b60fe3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5671180c-656c-4f38-8720-6610f2e9c3ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_2c38c647-6b1f-4bda-b088-97c9e8451289" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_c1fa83ce-7999-471d-9e36-fc0f096b544f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_2c38c647-6b1f-4bda-b088-97c9e8451289" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_c1fa83ce-7999-471d-9e36-fc0f096b544f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c6830bd3-48fa-4411-ae80-748f411b32cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_2c38c647-6b1f-4bda-b088-97c9e8451289" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c6830bd3-48fa-4411-ae80-748f411b32cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a4492dd2-92e4-4631-b9e3-7e5cf86d71e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f85bc8c5-0909-4bf3-9137-1fc868225d29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a4492dd2-92e4-4631-b9e3-7e5cf86d71e8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f85bc8c5-0909-4bf3-9137-1fc868225d29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ac380213-f3c1-4dda-a554-ae1abd5d2879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a4492dd2-92e4-4631-b9e3-7e5cf86d71e8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ac380213-f3c1-4dda-a554-ae1abd5d2879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_fd1254d4-1d87-444f-b636-8466d3c8e2da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a4492dd2-92e4-4631-b9e3-7e5cf86d71e8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_fd1254d4-1d87-444f-b636-8466d3c8e2da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_77698937-4280-499a-877e-55c741fd9ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a4492dd2-92e4-4631-b9e3-7e5cf86d71e8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_77698937-4280-499a-877e-55c741fd9ffe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_39304c9c-91ad-4524-9ca3-035653d11815" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a4492dd2-92e4-4631-b9e3-7e5cf86d71e8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_39304c9c-91ad-4524-9ca3-035653d11815" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_445df288-01db-42b3-876a-fe89a6d71223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a4492dd2-92e4-4631-b9e3-7e5cf86d71e8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_445df288-01db-42b3-876a-fe89a6d71223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_b34fb488-6c89-45e7-bd5d-f5e534f5e4f7" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6b7d0741-8609-4784-a201-e605878918d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_b34fb488-6c89-45e7-bd5d-f5e534f5e4f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6b7d0741-8609-4784-a201-e605878918d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0bb15681-0545-48b2-967a-6cd0f10f83ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_b34fb488-6c89-45e7-bd5d-f5e534f5e4f7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0bb15681-0545-48b2-967a-6cd0f10f83ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearThree_830031de-60aa-4a4e-af89-ca9287ab30ab" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_b539e4cf-1654-468a-969f-c0fa5301313d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearThree_830031de-60aa-4a4e-af89-ca9287ab30ab" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_b539e4cf-1654-468a-969f-c0fa5301313d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63dcc09c-2cc3-4cd4-b21d-93f2c28f0d89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearThree_830031de-60aa-4a4e-af89-ca9287ab30ab" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_63dcc09c-2cc3-4cd4-b21d-93f2c28f0d89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearFive_9a45fe69-dc64-4b79-9f59-a6dfd44c7d17" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_d0b4deb1-a573-4ad2-8006-764b72459175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearFive_9a45fe69-dc64-4b79-9f59-a6dfd44c7d17" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_d0b4deb1-a573-4ad2-8006-764b72459175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7b079b26-991a-40f5-804c-d14165f7c325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearFive_9a45fe69-dc64-4b79-9f59-a6dfd44c7d17" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7b079b26-991a-40f5-804c-d14165f7c325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiability_cf6c54c0-7835-47a8-90d3-7bb17c651394" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b1f4f581-49a5-4767-8583-745128ad2a01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiability_cf6c54c0-7835-47a8-90d3-7bb17c651394" xlink:to="loc_us-gaap_FinanceLeaseLiability_b1f4f581-49a5-4767-8583-745128ad2a01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e845da30-881f-4dbb-8c99-1509b77c0d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiability_cf6c54c0-7835-47a8-90d3-7bb17c651394" xlink:to="loc_us-gaap_OperatingLeaseLiability_e845da30-881f-4dbb-8c99-1509b77c0d9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearOne_5565833a-058d-4873-839b-6bf55819b027" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearOne"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f1929ef4-87b2-4fe2-bfce-30cfd492fe3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearOne_5565833a-058d-4873-839b-6bf55819b027" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f1929ef4-87b2-4fe2-bfce-30cfd492fe3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9a2b9880-6860-4c8f-9233-0332e490951e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearOne_5565833a-058d-4873-839b-6bf55819b027" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9a2b9880-6860-4c8f-9233-0332e490951e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearFour_bbc922f0-f4cb-49f3-a5b6-3759b057179c" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_c947ac65-cb76-4da8-b278-3446050abfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearFour_bbc922f0-f4cb-49f3-a5b6-3759b057179c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_c947ac65-cb76-4da8-b278-3446050abfa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e2d899f3-434b-426c-93de-bad4a2ea9ede" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearFour_bbc922f0-f4cb-49f3-a5b6-3759b057179c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e2d899f3-434b-426c-93de-bad4a2ea9ede" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0a16e498-082e-4f26-80cb-899e86df6842" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bb8366ba-4883-450b-b18e-22e1c9fead14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0a16e498-082e-4f26-80cb-899e86df6842" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bb8366ba-4883-450b-b18e-22e1c9fead14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_939d2c8a-ed4f-4cba-8217-6bae845a12a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0a16e498-082e-4f26-80cb-899e86df6842" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_939d2c8a-ed4f-4cba-8217-6bae845a12a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_94b74b11-36e4-44b6-8bc3-69a11a71820b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0a16e498-082e-4f26-80cb-899e86df6842" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_94b74b11-36e4-44b6-8bc3-69a11a71820b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_64ff91b6-8167-4468-9eeb-33c73b22f92e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0a16e498-082e-4f26-80cb-899e86df6842" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_64ff91b6-8167-4468-9eeb-33c73b22f92e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_33bb8df1-6901-4691-9f8b-14586c8f9a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0a16e498-082e-4f26-80cb-899e86df6842" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_33bb8df1-6901-4691-9f8b-14586c8f9a2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1ab9560e-f3c1-47c6-a03d-aa9e0b2da132" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0a16e498-082e-4f26-80cb-899e86df6842" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1ab9560e-f3c1-47c6-a03d-aa9e0b2da132" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e3cdaf2c-29fc-44c1-a0f8-e4046c537f26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_d3860ceb-8595-45ef-8e70-8168063007d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e3cdaf2c-29fc-44c1-a0f8-e4046c537f26" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_d3860ceb-8595-45ef-8e70-8168063007d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_e1f56606-57db-45d5-ab64-23408b2d8995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e3cdaf2c-29fc-44c1-a0f8-e4046c537f26" xlink:to="loc_us-gaap_FinanceLeaseLiability_e1f56606-57db-45d5-ab64-23408b2d8995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaid_297730da-72f5-4349-adeb-d020f3ed38a6" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearOne_5cd6a614-22de-408f-9bba-735d67e35653" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearOne"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_297730da-72f5-4349-adeb-d020f3ed38a6" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearOne_5cd6a614-22de-408f-9bba-735d67e35653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearTwo_f97601e0-6d0f-4e4a-ab31-80256116866e" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_297730da-72f5-4349-adeb-d020f3ed38a6" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearTwo_f97601e0-6d0f-4e4a-ab31-80256116866e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearThree_cc87e320-545f-4fae-92d3-0dbd812c9f71" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_297730da-72f5-4349-adeb-d020f3ed38a6" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearThree_cc87e320-545f-4fae-92d3-0dbd812c9f71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearFour_a1c18648-4451-49cc-9767-01f15fdff8c1" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_297730da-72f5-4349-adeb-d020f3ed38a6" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearFour_a1c18648-4451-49cc-9767-01f15fdff8c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearFive_299a23a8-3100-4dde-a0e8-2cedc37924c2" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_297730da-72f5-4349-adeb-d020f3ed38a6" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearFive_299a23a8-3100-4dde-a0e8-2cedc37924c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_7702e7c2-b74e-4955-9942-1386f1a39ef2" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_297730da-72f5-4349-adeb-d020f3ed38a6" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_7702e7c2-b74e-4955-9942-1386f1a39ef2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_2"/>
  <link:calculationLink xlink:role="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaid_9c20dd2f-7011-4f30-8992-2c715b25a57d" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a2751eaf-3505-423a-9555-f37a70ac2107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_9c20dd2f-7011-4f30-8992-2c715b25a57d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a2751eaf-3505-423a-9555-f37a70ac2107" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3cd8d796-b88b-4cad-8a5d-df97d9d85192" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid_9c20dd2f-7011-4f30-8992-2c715b25a57d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3cd8d796-b88b-4cad-8a5d-df97d9d85192" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>embc-20230930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:4102c7ef-a746-4e09-abe6-45c91f406b23,g:4bb25894-924e-4e32-9a1d-8a6b6ed5cbfa-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedStatementsofEquity"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1e1699f8-3acf-415f-bc25-efa31e15e823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1e1699f8-3acf-415f-bc25-efa31e15e823" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_80ecc135-5d78-4125-8d79-541a9cd8a610" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_80ecc135-5d78-4125-8d79-541a9cd8a610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84233f6e-1418-4ac2-b625-a80b15d5968e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_StockholdersEquity_84233f6e-1418-4ac2-b625-a80b15d5968e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments_1af94a68-7e3d-4af4-b9c4-270d0bb906a2" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments_1af94a68-7e3d-4af4-b9c4-270d0bb906a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c18d036e-3d4b-478e-8b59-08abf4c2d9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c18d036e-3d4b-478e-8b59-08abf4c2d9d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment_fb584bdb-b5b6-40ae-951b-50281da7a38d" xlink:href="embc-20230930.xsd#embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment_fb584bdb-b5b6-40ae-951b-50281da7a38d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentConsiderationPaidForSeparation_2d9c230f-089e-4867-92ee-d7b4e96c7ea6" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentConsiderationPaidForSeparation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_embc_NetParentInvestmentConsiderationPaidForSeparation_2d9c230f-089e-4867-92ee-d7b4e96c7ea6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_85c59271-d408-462d-8eee-ea8d92bfb8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_NetIncomeLoss_85c59271-d408-462d-8eee-ea8d92bfb8f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_49f748c4-a6df-499a-92e6-c04bc2ec6464" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_49f748c4-a6df-499a-92e6-c04bc2ec6464" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentNetTransfersToParent_37137210-730e-48db-8067-553297eb9771" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentNetTransfersToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_embc_NetParentInvestmentNetTransfersToParent_37137210-730e-48db-8067-553297eb9771" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e3098ccb-0228-41ba-ba43-608c626455b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e3098ccb-0228-41ba-ba43-608c626455b6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_950c234a-eb33-4632-ac13-e30b5cc01f82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_DividendsCommonStock_950c234a-eb33-4632-ac13-e30b5cc01f82" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_62f438e4-635a-4bcb-bdde-7d4732b99680" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_62f438e4-635a-4bcb-bdde-7d4732b99680" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_85770194-ad4d-478f-8bce-80d302ac8248" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_85770194-ad4d-478f-8bce-80d302ac8248" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f577b697-8034-4a1b-8782-1cd7c54b1f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_121de5a5-4bf0-4def-a015-3a56d15fe3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c7d0e14e-aa02-42ad-9324-f2523db8dc07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1e1699f8-3acf-415f-bc25-efa31e15e823" xlink:to="loc_us-gaap_StatementTable_c7d0e14e-aa02-42ad-9324-f2523db8dc07" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2366d4f0-a5c5-4e63-92a5-951288f76c18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c7d0e14e-aa02-42ad-9324-f2523db8dc07" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2366d4f0-a5c5-4e63-92a5-951288f76c18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2366d4f0-a5c5-4e63-92a5-951288f76c18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2366d4f0-a5c5-4e63-92a5-951288f76c18" xlink:to="loc_us-gaap_EquityComponentDomain_2366d4f0-a5c5-4e63-92a5-951288f76c18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2366d4f0-a5c5-4e63-92a5-951288f76c18" xlink:to="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5df5a255-66d2-4dee-9787-9696c620b38a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_us-gaap_CommonStockMember_5df5a255-66d2-4dee-9787-9696c620b38a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d7b172d7-74c1-4f1f-846e-0519967b23a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d7b172d7-74c1-4f1f-846e-0519967b23a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9786859c-c137-4364-87cc-23a71ab25faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_us-gaap_RetainedEarningsMember_9786859c-c137-4364-87cc-23a71ab25faa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentMember_abd5bbd2-d99b-45c6-b119-c0893ebcac3f" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_embc_NetParentInvestmentMember_abd5bbd2-d99b-45c6-b119-c0893ebcac3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_24181044-d91c-45de-be51-6d32fd336299" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_24181044-d91c-45de-be51-6d32fd336299" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/BackgroundDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#BackgroundDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/BackgroundDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_5b0d9bf2-7bdf-4d1d-b400-22ef58f56e79" xlink:href="embc-20230930.xsd#embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_bfe05e05-a667-4cd3-8a88-64b6b98b8650" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_5b0d9bf2-7bdf-4d1d-b400-22ef58f56e79" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_bfe05e05-a667-4cd3-8a88-64b6b98b8650" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CommonStockShareIssuanceRatio_3a1844a4-7d9b-4e6b-8b36-edfe0c8e1eca" xlink:href="embc-20230930.xsd#embc_CommonStockShareIssuanceRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_5b0d9bf2-7bdf-4d1d-b400-22ef58f56e79" xlink:to="loc_embc_CommonStockShareIssuanceRatio_3a1844a4-7d9b-4e6b-8b36-edfe0c8e1eca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_ce526d20-54a1-4065-b9eb-31f4c1da0860" xlink:href="embc-20230930.xsd#embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_5b0d9bf2-7bdf-4d1d-b400-22ef58f56e79" xlink:to="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_ce526d20-54a1-4065-b9eb-31f4c1da0860" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5009d3a5-703b-4e94-90eb-01c1ba2cd30c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_ce526d20-54a1-4065-b9eb-31f4c1da0860" xlink:to="loc_dei_LegalEntityAxis_5009d3a5-703b-4e94-90eb-01c1ba2cd30c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5009d3a5-703b-4e94-90eb-01c1ba2cd30c_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5009d3a5-703b-4e94-90eb-01c1ba2cd30c" xlink:to="loc_dei_EntityDomain_5009d3a5-703b-4e94-90eb-01c1ba2cd30c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d72ccae3-c8f7-4a5f-9ed6-76e642b598cc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5009d3a5-703b-4e94-90eb-01c1ba2cd30c" xlink:to="loc_dei_EntityDomain_d72ccae3-c8f7-4a5f-9ed6-76e642b598cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BectonDickinsonAndCompanyMember_f2a09b1b-f02d-443b-986b-5a500e82a087" xlink:href="embc-20230930.xsd#embc_BectonDickinsonAndCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d72ccae3-c8f7-4a5f-9ed6-76e642b598cc" xlink:to="loc_embc_BectonDickinsonAndCompanyMember_f2a09b1b-f02d-443b-986b-5a500e82a087" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SummaryofAccountingPoliciesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SummaryofAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/SummaryofAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_68ba5460-7dff-4648-b77d-c6dc35fdd2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_68ba5460-7dff-4648-b77d-c6dc35fdd2fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife_facd8e63-a978-46cd-9501-17d9accc9105" xlink:href="embc-20230930.xsd#embc_HostingArrangementServiceContractAssetsInServiceUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife_facd8e63-a978-46cd-9501-17d9accc9105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2829e6bb-5d41-4b9f-ace6-770b005105d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2829e6bb-5d41-4b9f-ace6-770b005105d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7e12c01a-8a33-487c-8008-613e5c5bb889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_Depreciation_7e12c01a-8a33-487c-8008-613e5c5bb889" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_7f6782ea-d9e8-4cb0-bd90-99f0f35a10ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_InterestPaidCapitalized_7f6782ea-d9e8-4cb0-bd90-99f0f35a10ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_b15b80fd-5bef-41d6-8b1f-ce91e00084fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_AdvertisingExpense_b15b80fd-5bef-41d6-8b1f-ce91e00084fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_50ac1f0f-d71f-48a2-acff-4828eb69e473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_NumberOfReportingUnits_50ac1f0f-d71f-48a2-acff-4828eb69e473" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d73f8ca3-29de-4d64-a19a-30382d478cab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d73f8ca3-29de-4d64-a19a-30382d478cab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_66750425-f2c9-4429-a3f1-9ae7cf1634a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_66750425-f2c9-4429-a3f1-9ae7cf1634a4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_3d030f03-a19a-49b2-b3d5-bd529ed772aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_NumberOfOperatingSegments_3d030f03-a19a-49b2-b3d5-bd529ed772aa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f07c5fdc-9bc4-479d-8b1b-e59d3531c554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_NumberOfReportableSegments_f07c5fdc-9bc4-479d-8b1b-e59d3531c554" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_9eb239a2-1765-4ce3-abb2-7f3966fcdb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_InterestPaidNet_9eb239a2-1765-4ce3-abb2-7f3966fcdb7a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_8e4dcd72-fa61-407a-b0d1-a9c2b86d984a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_8e4dcd72-fa61-407a-b0d1-a9c2b86d984a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_c67556e8-359f-4a6f-be90-9bba5c0be022" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_c67556e8-359f-4a6f-be90-9bba5c0be022" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_69168b7c-61eb-42be-99d9-998d29991557" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_srt_RangeAxis_69168b7c-61eb-42be-99d9-998d29991557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_69168b7c-61eb-42be-99d9-998d29991557_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_69168b7c-61eb-42be-99d9-998d29991557" xlink:to="loc_srt_RangeMember_69168b7c-61eb-42be-99d9-998d29991557_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_63b60081-900a-4e22-9bfe-bd8eab73d5a7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_69168b7c-61eb-42be-99d9-998d29991557" xlink:to="loc_srt_RangeMember_63b60081-900a-4e22-9bfe-bd8eab73d5a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_12beecf5-fc59-454b-b099-f9a48d006f8b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_63b60081-900a-4e22-9bfe-bd8eab73d5a7" xlink:to="loc_srt_MinimumMember_12beecf5-fc59-454b-b099-f9a48d006f8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ca07fbc2-380f-4088-9bda-f536bd77cdda" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_63b60081-900a-4e22-9bfe-bd8eab73d5a7" xlink:to="loc_srt_MaximumMember_ca07fbc2-380f-4088-9bda-f536bd77cdda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_734bd812-12b1-443f-80a4-83afd292ade7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_734bd812-12b1-443f-80a4-83afd292ade7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_734bd812-12b1-443f-80a4-83afd292ade7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_734bd812-12b1-443f-80a4-83afd292ade7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_734bd812-12b1-443f-80a4-83afd292ade7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_734bd812-12b1-443f-80a4-83afd292ade7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_b47bbe32-9438-4baf-badb-a759764ae61b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:to="loc_us-gaap_BuildingMember_b47bbe32-9438-4baf-badb-a759764ae61b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_06d1f7e6-8bcd-4469-8b48-1a9259b83002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_06d1f7e6-8bcd-4469-8b48-1a9259b83002" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_19475291-fafc-41a5-9dd9-a9a613669f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_19475291-fafc-41a5-9dd9-a9a613669f70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5ef3a3d4-163f-401d-8d33-7c6cc530cf26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5ef3a3d4-163f-401d-8d33-7c6cc530cf26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5ef3a3d4-163f-401d-8d33-7c6cc530cf26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5ef3a3d4-163f-401d-8d33-7c6cc530cf26" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5ef3a3d4-163f-401d-8d33-7c6cc530cf26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d050883a-99e1-46e6-94f0-386a10c0508c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5ef3a3d4-163f-401d-8d33-7c6cc530cf26" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d050883a-99e1-46e6-94f0-386a10c0508c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PropertyPlantAndEquipmentNetMember_6cf3aa7d-5f0d-4ab7-896e-4d4724423457" xlink:href="embc-20230930.xsd#embc_PropertyPlantAndEquipmentNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d050883a-99e1-46e6-94f0-386a10c0508c" xlink:to="loc_embc_PropertyPlantAndEquipmentNetMember_6cf3aa7d-5f0d-4ab7-896e-4d4724423457" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredIncomeTaxesAndOtherAssetsMember_48249c5f-c1ae-4cd7-966f-1fc61d8018a7" xlink:href="embc-20230930.xsd#embc_DeferredIncomeTaxesAndOtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d050883a-99e1-46e6-94f0-386a10c0508c" xlink:to="loc_embc_DeferredIncomeTaxesAndOtherAssetsMember_48249c5f-c1ae-4cd7-966f-1fc61d8018a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_595eca6b-e535-42a1-97e9-f45a45c720af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_595eca6b-e535-42a1-97e9-f45a45c720af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_595eca6b-e535-42a1-97e9-f45a45c720af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_595eca6b-e535-42a1-97e9-f45a45c720af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_595eca6b-e535-42a1-97e9-f45a45c720af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_595eca6b-e535-42a1-97e9-f45a45c720af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_f98be11d-1869-40ac-baba-3c10377939a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:to="loc_us-gaap_PatentsMember_f98be11d-1869-40ac-baba-3c10377939a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_36a54c1d-f5f4-4865-aa31-03501e960b17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:to="loc_us-gaap_CustomerRelationshipsMember_36a54c1d-f5f4-4865-aa31-03501e960b17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_97abe70d-db3d-4aee-a0d9-7db5e4331845" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_97abe70d-db3d-4aee-a0d9-7db5e4331845" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4c66b051-9167-4c78-aa01-e53304faa212" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_srt_ProductOrServiceAxis_4c66b051-9167-4c78-aa01-e53304faa212" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4c66b051-9167-4c78-aa01-e53304faa212_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4c66b051-9167-4c78-aa01-e53304faa212" xlink:to="loc_srt_ProductsAndServicesDomain_4c66b051-9167-4c78-aa01-e53304faa212_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c265b1cc-40dd-4519-ba04-d682ff1309db" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4c66b051-9167-4c78-aa01-e53304faa212" xlink:to="loc_srt_ProductsAndServicesDomain_c265b1cc-40dd-4519-ba04-d682ff1309db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_7f0c1488-4510-447f-a391-e7351b11d85e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c265b1cc-40dd-4519-ba04-d682ff1309db" xlink:to="loc_us-gaap_ShippingAndHandlingMember_7f0c1488-4510-447f-a391-e7351b11d85e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum_f45c308b-358b-4ab0-854f-e54772773d0e" xlink:href="embc-20230930.xsd#embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum_f45c308b-358b-4ab0-854f-e54772773d0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ContractuallySpecifiedServicingFeesPercentage_9841bdbc-7e02-4046-a990-e8f9dc5ff82c" xlink:href="embc-20230930.xsd#embc_ContractuallySpecifiedServicingFeesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_ContractuallySpecifiedServicingFeesPercentage_9841bdbc-7e02-4046-a990-e8f9dc5ff82c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DistributionAgreementDistributorAppointmentMaximumTerm_bc5baf06-3775-4f49-b3ec-36a300338d54" xlink:href="embc-20230930.xsd#embc_DistributionAgreementDistributorAppointmentMaximumTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_DistributionAgreementDistributorAppointmentMaximumTerm_bc5baf06-3775-4f49-b3ec-36a300338d54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue_43b61981-79f4-49de-bff5-9590c67432f0" xlink:href="embc-20230930.xsd#embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue_43b61981-79f4-49de-bff5-9590c67432f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum_9949b597-c81f-4dff-b06a-48cefb0a5046" xlink:href="embc-20230930.xsd#embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum_9949b597-c81f-4dff-b06a-48cefb0a5046" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum_745be9a0-d03a-41f4-ab5f-62329cf25725" xlink:href="embc-20230930.xsd#embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum_745be9a0-d03a-41f4-ab5f-62329cf25725" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod_0bb98e21-f368-4bc3-9083-9010dd387c0b" xlink:href="embc-20230930.xsd#embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod_0bb98e21-f368-4bc3-9083-9010dd387c0b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TaxMattersAgreementCovenantRestrictionsPeriod_e3f3897b-57de-4837-b176-6e407928f903" xlink:href="embc-20230930.xsd#embc_TaxMattersAgreementCovenantRestrictionsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_TaxMattersAgreementCovenantRestrictionsPeriod_e3f3897b-57de-4837-b176-6e407928f903" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold_3d239b33-3206-4809-9fce-b3a1024327b2" xlink:href="embc-20230930.xsd#embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold_3d239b33-3206-4809-9fce-b3a1024327b2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LogisticsServicesAgreementMaximumTerm_8e818a01-d367-4fad-8d0e-25e568076f39" xlink:href="embc-20230930.xsd#embc_LogisticsServicesAgreementMaximumTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_LogisticsServicesAgreementMaximumTerm_8e818a01-d367-4fad-8d0e-25e568076f39" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue_3e03b4ea-cca6-4c40-b911-c1ce5e1e6a2a" xlink:href="embc-20230930.xsd#embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue_3e03b4ea-cca6-4c40-b911-c1ce5e1e6a2a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_e03f27a4-3c8f-4229-b8bb-0a36d27f3ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_e03f27a4-3c8f-4229-b8bb-0a36d27f3ffa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent_7afcb4f7-8af3-482a-8cae-1f7401a68e66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_AccountsPayableOtherCurrent_7afcb4f7-8af3-482a-8cae-1f7401a68e66" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7089fa09-0d0c-44c3-adf1-b8a2b1c44f90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7089fa09-0d0c-44c3-adf1-b8a2b1c44f90" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_54097716-d272-46b3-9da0-289714ad4158" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_OtherAssetsCurrent_54097716-d272-46b3-9da0-289714ad4158" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartiesAmountInCostOfSales_37018d8d-344f-4654-a872-eaf5d4e7f83c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartiesAmountInCostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_RelatedPartiesAmountInCostOfSales_37018d8d-344f-4654-a872-eaf5d4e7f83c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3dd929ab-5013-44ff-9ee3-0bf86444dad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3dd929ab-5013-44ff-9ee3-0bf86444dad6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_432b5819-26b2-4874-85d2-2b2f6bbe9a86" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_srt_CounterpartyNameAxis_432b5819-26b2-4874-85d2-2b2f6bbe9a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_432b5819-26b2-4874-85d2-2b2f6bbe9a86_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_432b5819-26b2-4874-85d2-2b2f6bbe9a86" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_432b5819-26b2-4874-85d2-2b2f6bbe9a86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_390c02d4-472b-4be5-967c-9aea42dcaea4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_432b5819-26b2-4874-85d2-2b2f6bbe9a86" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_390c02d4-472b-4be5-967c-9aea42dcaea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BectonDickinsonAndCompanyMember_4cba1c34-ace4-48ca-aa4b-219b9fcca904" xlink:href="embc-20230930.xsd#embc_BectonDickinsonAndCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_390c02d4-472b-4be5-967c-9aea42dcaea4" xlink:to="loc_embc_BectonDickinsonAndCompanyMember_4cba1c34-ace4-48ca-aa4b-219b9fcca904" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6828d361-27a8-42a0-986d-da0df8f7e73c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_srt_RangeAxis_6828d361-27a8-42a0-986d-da0df8f7e73c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6828d361-27a8-42a0-986d-da0df8f7e73c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6828d361-27a8-42a0-986d-da0df8f7e73c" xlink:to="loc_srt_RangeMember_6828d361-27a8-42a0-986d-da0df8f7e73c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d7a25c64-1c8f-4b2c-8d7d-803e3e039e93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6828d361-27a8-42a0-986d-da0df8f7e73c" xlink:to="loc_srt_RangeMember_d7a25c64-1c8f-4b2c-8d7d-803e3e039e93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2397bf81-d755-4955-9c73-041d4699e495" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d7a25c64-1c8f-4b2c-8d7d-803e3e039e93" xlink:to="loc_srt_MinimumMember_2397bf81-d755-4955-9c73-041d4699e495" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d20d2c52-6ef8-46fb-9c95-5b0ac470e36c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d7a25c64-1c8f-4b2c-8d7d-803e3e039e93" xlink:to="loc_srt_MaximumMember_d20d2c52-6ef8-46fb-9c95-5b0ac470e36c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e7ae253e-c1af-4d1c-a2ee-4d6e45eef832" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_dei_LegalEntityAxis_e7ae253e-c1af-4d1c-a2ee-4d6e45eef832" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e7ae253e-c1af-4d1c-a2ee-4d6e45eef832_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e7ae253e-c1af-4d1c-a2ee-4d6e45eef832" xlink:to="loc_dei_EntityDomain_e7ae253e-c1af-4d1c-a2ee-4d6e45eef832_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7bdd3d4a-faea-4df9-ae42-75380de7ba43" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e7ae253e-c1af-4d1c-a2ee-4d6e45eef832" xlink:to="loc_dei_EntityDomain_7bdd3d4a-faea-4df9-ae42-75380de7ba43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BectonDickinsonAndCompanyMember_6e73e3d4-e410-4883-a352-c51d6955212c" xlink:href="embc-20230930.xsd#embc_BectonDickinsonAndCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_7bdd3d4a-faea-4df9-ae42-75380de7ba43" xlink:to="loc_embc_BectonDickinsonAndCompanyMember_6e73e3d4-e410-4883-a352-c51d6955212c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4a23e523-998a-4f35-907b-21c127e52521" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_us-gaap_DebtInstrumentAxis_4a23e523-998a-4f35-907b-21c127e52521" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4a23e523-998a-4f35-907b-21c127e52521_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a23e523-998a-4f35-907b-21c127e52521" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4a23e523-998a-4f35-907b-21c127e52521_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f974b744-ea86-4beb-aec4-e6ad079f57fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a23e523-998a-4f35-907b-21c127e52521" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f974b744-ea86-4beb-aec4-e6ad079f57fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_a4915e25-c7fb-43e1-bf92-52de3bf8408b" xlink:href="embc-20230930.xsd#embc_A675SeniorSecuredNotesDueFebruary2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f974b744-ea86-4beb-aec4-e6ad079f57fe" xlink:to="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_a4915e25-c7fb-43e1-bf92-52de3bf8408b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_84f38411-5598-48ab-a302-2a11644e5b74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_84f38411-5598-48ab-a302-2a11644e5b74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_84f38411-5598-48ab-a302-2a11644e5b74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_84f38411-5598-48ab-a302-2a11644e5b74" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_84f38411-5598-48ab-a302-2a11644e5b74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e9d26faa-3764-4205-9c6a-cc0de8344b78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_84f38411-5598-48ab-a302-2a11644e5b74" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e9d26faa-3764-4205-9c6a-cc0de8344b78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_42c4c101-fc4f-4c8f-a55a-f19639566689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e9d26faa-3764-4205-9c6a-cc0de8344b78" xlink:to="loc_us-gaap_SeniorNotesMember_42c4c101-fc4f-4c8f-a55a-f19639566689" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_86f5ef83-804e-42e5-a7a6-7cfee69ddd53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_86f5ef83-804e-42e5-a7a6-7cfee69ddd53" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_86f5ef83-804e-42e5-a7a6-7cfee69ddd53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_86f5ef83-804e-42e5-a7a6-7cfee69ddd53" xlink:to="loc_us-gaap_RelatedPartyDomain_86f5ef83-804e-42e5-a7a6-7cfee69ddd53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_017b4886-27e1-4c18-8094-ca10d701c778" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_86f5ef83-804e-42e5-a7a6-7cfee69ddd53" xlink:to="loc_us-gaap_RelatedPartyDomain_017b4886-27e1-4c18-8094-ca10d701c778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_6b9928e7-c5fd-44f5-ad39-e72391e8fca6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_017b4886-27e1-4c18-8094-ca10d701c778" xlink:to="loc_us-gaap_ParentMember_6b9928e7-c5fd-44f5-ad39-e72391e8fca6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_135243bd-da63-41ba-bf6e-abc80c3768db" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_srt_StatementScenarioAxis_135243bd-da63-41ba-bf6e-abc80c3768db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_135243bd-da63-41ba-bf6e-abc80c3768db_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_135243bd-da63-41ba-bf6e-abc80c3768db" xlink:to="loc_srt_ScenarioUnspecifiedDomain_135243bd-da63-41ba-bf6e-abc80c3768db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c99d4625-d9e0-4476-a9cb-aed4fc4bf7fb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_135243bd-da63-41ba-bf6e-abc80c3768db" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c99d4625-d9e0-4476-a9cb-aed4fc4bf7fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_0c8d02e1-9eb0-4014-b342-9a826f248e33" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_c99d4625-d9e0-4476-a9cb-aed4fc4bf7fb" xlink:to="loc_srt_ScenarioForecastMember_0c8d02e1-9eb0-4014-b342-9a826f248e33" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_44c0705c-258f-43fc-91f6-1d53ad56b81d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_GeneralCorporateExpenses_79338f88-47ad-4991-afe4-14181d5ca233" xlink:href="embc-20230930.xsd#embc_GeneralCorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_44c0705c-258f-43fc-91f6-1d53ad56b81d" xlink:to="loc_embc_GeneralCorporateExpenses_79338f88-47ad-4991-afe4-14181d5ca233" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1a29ecc0-2e7b-41c4-be64-3193083a0334" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_44c0705c-258f-43fc-91f6-1d53ad56b81d" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1a29ecc0-2e7b-41c4-be64-3193083a0334" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98a61977-0637-4f0e-837d-dfc0014fc8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1a29ecc0-2e7b-41c4-be64-3193083a0334" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98a61977-0637-4f0e-837d-dfc0014fc8d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_98a61977-0637-4f0e-837d-dfc0014fc8d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98a61977-0637-4f0e-837d-dfc0014fc8d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_98a61977-0637-4f0e-837d-dfc0014fc8d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98a61977-0637-4f0e-837d-dfc0014fc8d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e9c688b6-cc3e-4e01-aff1-38197228665d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:to="loc_us-gaap_CostOfSalesMember_e9c688b6-cc3e-4e01-aff1-38197228665d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2c3eb929-1a5d-4ee7-990a-e24f888aa21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2c3eb929-1a5d-4ee7-990a-e24f888aa21e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f79e19b6-36ca-40b1-bb67-0609826dca1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f79e19b6-36ca-40b1-bb67-0609826dca1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseMember_9330aef2-bd71-4955-b56f-6425b577f22a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseMember_9330aef2-bd71-4955-b56f-6425b577f22a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_41552eaa-584f-4fe8-b827-040700e56ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_8a4a3beb-43a0-41d3-a048-b9944babe12b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_41552eaa-584f-4fe8-b827-040700e56ad5" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_8a4a3beb-43a0-41d3-a048-b9944babe12b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c4a9f22d-a38e-4197-9abb-f283e7495cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_41552eaa-584f-4fe8-b827-040700e56ad5" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c4a9f22d-a38e-4197-9abb-f283e7495cd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_89a4bcbe-4f5c-48e0-9b63-4c83a1cbef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c4a9f22d-a38e-4197-9abb-f283e7495cd4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_89a4bcbe-4f5c-48e0-9b63-4c83a1cbef8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_89a4bcbe-4f5c-48e0-9b63-4c83a1cbef8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_89a4bcbe-4f5c-48e0-9b63-4c83a1cbef8e" xlink:to="loc_us-gaap_RelatedPartyDomain_89a4bcbe-4f5c-48e0-9b63-4c83a1cbef8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_89621a72-fd88-433f-bdbd-d5bbe4b678a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_89a4bcbe-4f5c-48e0-9b63-4c83a1cbef8e" xlink:to="loc_us-gaap_RelatedPartyDomain_89621a72-fd88-433f-bdbd-d5bbe4b678a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_73fef54e-b3b6-40bc-b1f2-39fea336bc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_89621a72-fd88-433f-bdbd-d5bbe4b678a3" xlink:to="loc_us-gaap_ParentMember_73fef54e-b3b6-40bc-b1f2-39fea336bc3f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/CollaborationAgreementDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#CollaborationAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/CollaborationAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dd2e1289-6ab2-4ebf-9678-cafa17f87906" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b6339c3e-5ee6-47c2-adea-07d56c2b4b17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dd2e1289-6ab2-4ebf-9678-cafa17f87906" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b6339c3e-5ee6-47c2-adea-07d56c2b4b17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CollaborativeArrangementPrincipalRightsPercentage_4d351b95-e13d-4fa3-9a79-ed2a3c26cb17" xlink:href="embc-20230930.xsd#embc_CollaborativeArrangementPrincipalRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dd2e1289-6ab2-4ebf-9678-cafa17f87906" xlink:to="loc_embc_CollaborativeArrangementPrincipalRightsPercentage_4d351b95-e13d-4fa3-9a79-ed2a3c26cb17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8eabed21-7586-46d6-86c7-d05e21c32170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dd2e1289-6ab2-4ebf-9678-cafa17f87906" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8eabed21-7586-46d6-86c7-d05e21c32170" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1bee285d-f95a-4b8b-afed-c5de7565e322" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8eabed21-7586-46d6-86c7-d05e21c32170" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1bee285d-f95a-4b8b-afed-c5de7565e322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1bee285d-f95a-4b8b-afed-c5de7565e322_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1bee285d-f95a-4b8b-afed-c5de7565e322" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1bee285d-f95a-4b8b-afed-c5de7565e322_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1f97f053-20fd-403b-9423-3e20b4b6267c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1bee285d-f95a-4b8b-afed-c5de7565e322" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1f97f053-20fd-403b-9423-3e20b4b6267c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3387d496-195a-47c5-9be7-083e2e48e6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1f97f053-20fd-403b-9423-3e20b4b6267c" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3387d496-195a-47c5-9be7-083e2e48e6ba" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SegmentandGeographicalDataDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SegmentandGeographicalDataDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/SegmentandGeographicalDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_def0323d-0743-4982-bb10-a3c288ae4787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a58da680-550c-4a53-953f-5ded447b2d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_def0323d-0743-4982-bb10-a3c288ae4787" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a58da680-550c-4a53-953f-5ded447b2d6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4480d1a0-98c1-43af-867c-9731019c2d17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_def0323d-0743-4982-bb10-a3c288ae4787" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4480d1a0-98c1-43af-867c-9731019c2d17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_17f04332-3a32-4424-aecc-71230063d6b2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4480d1a0-98c1-43af-867c-9731019c2d17" xlink:to="loc_srt_StatementGeographicalAxis_17f04332-3a32-4424-aecc-71230063d6b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_17f04332-3a32-4424-aecc-71230063d6b2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_17f04332-3a32-4424-aecc-71230063d6b2" xlink:to="loc_srt_SegmentGeographicalDomain_17f04332-3a32-4424-aecc-71230063d6b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_41433ca4-fb24-42a6-abb9-b015980693c9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_17f04332-3a32-4424-aecc-71230063d6b2" xlink:to="loc_srt_SegmentGeographicalDomain_41433ca4-fb24-42a6-abb9-b015980693c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a06a51d1-16a0-454a-891d-347c997de7cb" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_41433ca4-fb24-42a6-abb9-b015980693c9" xlink:to="loc_country_US_a06a51d1-16a0-454a-891d-347c997de7cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_233ca3fe-bca2-4305-a752-98ec0134f508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_41433ca4-fb24-42a6-abb9-b015980693c9" xlink:to="loc_us-gaap_NonUsMember_233ca3fe-bca2-4305-a752-98ec0134f508" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_964b2f0d-d125-444d-a1b3-31732848073a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_964b2f0d-d125-444d-a1b3-31732848073a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized_d491275d-e059-4471-ace2-1e6819a1fcea" xlink:href="embc-20230930.xsd#embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized_d491275d-e059-4471-ace2-1e6819a1fcea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b8d93e1c-33e1-4416-af2f-152b56215480" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b8d93e1c-33e1-4416-af2f-152b56215480" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_96872536-3011-40b7-964b-74df2452841c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_96872536-3011-40b7-964b-74df2452841c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e422232a-5182-4339-b676-80073141397c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e422232a-5182-4339-b676-80073141397c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1923f03-f2da-4f50-8e53-6e5af3bb8c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1923f03-f2da-4f50-8e53-6e5af3bb8c4c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_257ea1f9-acae-4f42-a804-783b46e6e4db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_257ea1f9-acae-4f42-a804-783b46e6e4db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_4442cbdb-63b3-454d-87b6-57b72963a6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_4442cbdb-63b3-454d-87b6-57b72963a6f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d00973d9-6cd9-4630-aadd-64277007b1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d00973d9-6cd9-4630-aadd-64277007b1ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_04cf9941-b15e-423b-8b76-cc3e0e38de00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_04cf9941-b15e-423b-8b76-cc3e0e38de00" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_39c3dd8f-77e4-42d4-b2fc-ee0398d0c6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_us-gaap_PlanNameAxis_39c3dd8f-77e4-42d4-b2fc-ee0398d0c6b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_39c3dd8f-77e4-42d4-b2fc-ee0398d0c6b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_39c3dd8f-77e4-42d4-b2fc-ee0398d0c6b9" xlink:to="loc_us-gaap_PlanNameDomain_39c3dd8f-77e4-42d4-b2fc-ee0398d0c6b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_95cfa4aa-bbbe-4bce-b8eb-f2ed515f89e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_39c3dd8f-77e4-42d4-b2fc-ee0398d0c6b9" xlink:to="loc_us-gaap_PlanNameDomain_95cfa4aa-bbbe-4bce-b8eb-f2ed515f89e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember_103cb40a-81f0-4558-9002-92111acb3ab2" xlink:href="embc-20230930.xsd#embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_95cfa4aa-bbbe-4bce-b8eb-f2ed515f89e3" xlink:to="loc_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember_103cb40a-81f0-4558-9002-92111acb3ab2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7343a866-b288-4272-afc8-78284ecc0342" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_us-gaap_AwardTypeAxis_7343a866-b288-4272-afc8-78284ecc0342" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7343a866-b288-4272-afc8-78284ecc0342_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7343a866-b288-4272-afc8-78284ecc0342" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7343a866-b288-4272-afc8-78284ecc0342_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7343a866-b288-4272-afc8-78284ecc0342" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_c3607086-2e9d-4264-aabd-d3ddf1b8fd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_c3607086-2e9d-4264-aabd-d3ddf1b8fd7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019167cc-08e7-4258-8962-bdcd05ba3a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019167cc-08e7-4258-8962-bdcd05ba3a92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_d08fc439-7c3f-43d1-bea3-c467853f3aa1" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_d08fc439-7c3f-43d1-bea3-c467853f3aa1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceStockUnitsPSUsMember_d201e30e-5dc1-4fa7-8f62-c23a1263c9a5" xlink:href="embc-20230930.xsd#embc_PerformanceStockUnitsPSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_embc_PerformanceStockUnitsPSUsMember_d201e30e-5dc1-4fa7-8f62-c23a1263c9a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_c342de73-190f-4160-bcc2-a02701bb7575" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_c342de73-190f-4160-bcc2-a02701bb7575" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4552de9b-d02e-4cf9-a8ee-dee5952a979a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_srt_RangeAxis_4552de9b-d02e-4cf9-a8ee-dee5952a979a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4552de9b-d02e-4cf9-a8ee-dee5952a979a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4552de9b-d02e-4cf9-a8ee-dee5952a979a" xlink:to="loc_srt_RangeMember_4552de9b-d02e-4cf9-a8ee-dee5952a979a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c4cd43d5-2036-4080-b685-30fd42651232" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4552de9b-d02e-4cf9-a8ee-dee5952a979a" xlink:to="loc_srt_RangeMember_c4cd43d5-2036-4080-b685-30fd42651232" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_99b62c26-868b-48e3-9464-3ec61ec285fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c4cd43d5-2036-4080-b685-30fd42651232" xlink:to="loc_srt_MinimumMember_99b62c26-868b-48e3-9464-3ec61ec285fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b776236f-8e14-4af8-b9a0-fd9bbc23cbb0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c4cd43d5-2036-4080-b685-30fd42651232" xlink:to="loc_srt_MaximumMember_b776236f-8e14-4af8-b9a0-fd9bbc23cbb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_9fe090bc-0cf4-4cba-af35-90a9abaf2f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_us-gaap_GranteeStatusAxis_9fe090bc-0cf4-4cba-af35-90a9abaf2f2d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_9fe090bc-0cf4-4cba-af35-90a9abaf2f2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_9fe090bc-0cf4-4cba-af35-90a9abaf2f2d" xlink:to="loc_us-gaap_GranteeStatusDomain_9fe090bc-0cf4-4cba-af35-90a9abaf2f2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_f63e5c40-4834-462c-b2cc-1879801dfdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_9fe090bc-0cf4-4cba-af35-90a9abaf2f2d" xlink:to="loc_us-gaap_GranteeStatusDomain_f63e5c40-4834-462c-b2cc-1879801dfdfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_e6d0b171-6297-49e2-86d6-12e408743409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_f63e5c40-4834-462c-b2cc-1879801dfdfb" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_e6d0b171-6297-49e2-86d6-12e408743409" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_95084d7b-efab-40ee-82b3-e848d2f57790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_f63e5c40-4834-462c-b2cc-1879801dfdfb" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_95084d7b-efab-40ee-82b3-e848d2f57790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_a73b05cc-8e31-43a6-9ea1-0c6542fe31e3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_srt_TitleOfIndividualAxis_a73b05cc-8e31-43a6-9ea1-0c6542fe31e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a73b05cc-8e31-43a6-9ea1-0c6542fe31e3_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_a73b05cc-8e31-43a6-9ea1-0c6542fe31e3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a73b05cc-8e31-43a6-9ea1-0c6542fe31e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_64efc797-1d34-4887-928d-0eb6c318b501" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_a73b05cc-8e31-43a6-9ea1-0c6542fe31e3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_64efc797-1d34-4887-928d-0eb6c318b501" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_89571fde-c421-4b57-a6ab-3ff24cfae841" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_64efc797-1d34-4887-928d-0eb6c318b501" xlink:to="loc_srt_ChiefExecutiveOfficerMember_89571fde-c421-4b57-a6ab-3ff24cfae841" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationStockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_95afbf5d-a71a-45fd-b0ae-0e2d8f17ba2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b4dc9b7-18ea-4e4f-ac2c-4cc9bb3d1d06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_95afbf5d-a71a-45fd-b0ae-0e2d8f17ba2f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b4dc9b7-18ea-4e4f-ac2c-4cc9bb3d1d06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9086d54c-861d-4452-8452-447d6a60b8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_95afbf5d-a71a-45fd-b0ae-0e2d8f17ba2f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9086d54c-861d-4452-8452-447d6a60b8f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbd9602a-5099-4f0d-9de2-950a4011f435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_95afbf5d-a71a-45fd-b0ae-0e2d8f17ba2f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbd9602a-5099-4f0d-9de2-950a4011f435" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_701e708a-0ed2-410c-b657-f573f729c30e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbd9602a-5099-4f0d-9de2-950a4011f435" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_701e708a-0ed2-410c-b657-f573f729c30e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_701e708a-0ed2-410c-b657-f573f729c30e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_701e708a-0ed2-410c-b657-f573f729c30e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_701e708a-0ed2-410c-b657-f573f729c30e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_701e708a-0ed2-410c-b657-f573f729c30e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_49d6fb48-25d3-4d55-bc2d-9a3e93049633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:to="loc_us-gaap_CostOfSalesMember_49d6fb48-25d3-4d55-bc2d-9a3e93049633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_22b13212-9c0e-42df-95b1-ad48e6f2a15b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_22b13212-9c0e-42df-95b1-ad48e6f2a15b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f96e83da-aa60-4bbc-b2c2-bb6310593d54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f96e83da-aa60-4bbc-b2c2-bb6310593d54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_23e087ac-8f40-4506-a3ed-85175dee818a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbd9602a-5099-4f0d-9de2-950a4011f435" xlink:to="loc_us-gaap_AwardTypeAxis_23e087ac-8f40-4506-a3ed-85175dee818a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23e087ac-8f40-4506-a3ed-85175dee818a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_23e087ac-8f40-4506-a3ed-85175dee818a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23e087ac-8f40-4506-a3ed-85175dee818a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_23e087ac-8f40-4506-a3ed-85175dee818a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4af8a454-086e-45f9-a437-f42b9c675c44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_us-gaap_StockCompensationPlanMember_4af8a454-086e-45f9-a437-f42b9c675c44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedPaymentArrangementLiabilityAwardMember_c66ccecd-bab3-4a0d-af2e-bad4017ae2f3" xlink:href="embc-20230930.xsd#embc_ShareBasedPaymentArrangementLiabilityAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_embc_ShareBasedPaymentArrangementLiabilityAwardMember_c66ccecd-bab3-4a0d-af2e-bad4017ae2f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_583c87d7-0f26-4ae9-b57a-ff921277c416" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_583c87d7-0f26-4ae9-b57a-ff921277c416" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_6071b592-05f9-4bf5-a44b-b3bf97b9ec4e" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_6071b592-05f9-4bf5-a44b-b3bf97b9ec4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_8e28b0aa-9806-4b92-acac-6a02ffbea648" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_8e28b0aa-9806-4b92-acac-6a02ffbea648" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dbb574d2-943b-404c-9ec7-83a972b26278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dbb574d2-943b-404c-9ec7-83a972b26278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eb5fab2d-7e3b-4d27-bc84-59a959e5e0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eb5fab2d-7e3b-4d27-bc84-59a959e5e0b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dedf722d-a979-4756-ba26-f68b551331ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dedf722d-a979-4756-ba26-f68b551331ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5cb6310d-d62e-4e32-ba5a-c38ac861c818" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5cb6310d-d62e-4e32-ba5a-c38ac861c818" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_01f3a418-4d08-4c5a-a933-84b03c33c82f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber_46ee2852-d484-48c8-9794-38e19b6f93a8" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber_46ee2852-d484-48c8-9794-38e19b6f93a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_04353dcf-8048-4afa-909b-20810c7f9dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_04353dcf-8048-4afa-909b-20810c7f9dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3d29018-036e-4e46-ab92-ec3ac3ac0d29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3d29018-036e-4e46-ab92-ec3ac3ac0d29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_25b750dc-15e3-4c99-a73a-8e123a44eea3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_25b750dc-15e3-4c99-a73a-8e123a44eea3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2c8b3a4a-b9ad-48c9-9833-8cd0606b9f72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2c8b3a4a-b9ad-48c9-9833-8cd0606b9f72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_df17b065-54cb-4bb5-829e-17e81bc4b278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_9e3b0f2c-e659-4eb6-8494-868d3dafb6fa" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_9e3b0f2c-e659-4eb6-8494-868d3dafb6fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fad03856-431e-4406-8c86-967722bf8ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fad03856-431e-4406-8c86-967722bf8ac7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91cd65f3-0366-4d9f-8bf9-3b22c2d506e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fad03856-431e-4406-8c86-967722bf8ac7" xlink:to="loc_us-gaap_AwardTypeAxis_91cd65f3-0366-4d9f-8bf9-3b22c2d506e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91cd65f3-0366-4d9f-8bf9-3b22c2d506e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_91cd65f3-0366-4d9f-8bf9-3b22c2d506e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91cd65f3-0366-4d9f-8bf9-3b22c2d506e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1457bb28-6883-453e-830e-bddfe930d9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_91cd65f3-0366-4d9f-8bf9-3b22c2d506e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1457bb28-6883-453e-830e-bddfe930d9cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_da4ad0d1-d13b-43ae-9c76-5e50e1d73542" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1457bb28-6883-453e-830e-bddfe930d9cc" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_da4ad0d1-d13b-43ae-9c76-5e50e1d73542" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_c07958b1-d00f-4b35-9eeb-bc6e2ca3c559" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1457bb28-6883-453e-830e-bddfe930d9cc" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_c07958b1-d00f-4b35-9eeb-bc6e2ca3c559" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_89689b5a-84ac-427c-b0ec-5f93f9f9c1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_887cb029-f882-4264-8ca5-ae2af4efdff2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_89689b5a-84ac-427c-b0ec-5f93f9f9c1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_887cb029-f882-4264-8ca5-ae2af4efdff2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32f39423-54b2-4ccc-9872-a3cc95967035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_89689b5a-84ac-427c-b0ec-5f93f9f9c1cd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32f39423-54b2-4ccc-9872-a3cc95967035" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81e298a7-f6f4-480b-8c78-36b34e5457e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32f39423-54b2-4ccc-9872-a3cc95967035" xlink:to="loc_us-gaap_AwardTypeAxis_81e298a7-f6f4-480b-8c78-36b34e5457e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81e298a7-f6f4-480b-8c78-36b34e5457e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_81e298a7-f6f4-480b-8c78-36b34e5457e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81e298a7-f6f4-480b-8c78-36b34e5457e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e550f59-758f-4c64-a39d-7fed0236abc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_81e298a7-f6f4-480b-8c78-36b34e5457e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e550f59-758f-4c64-a39d-7fed0236abc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_c5c0be6c-b337-4030-91f3-539cb68e74bf" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e550f59-758f-4c64-a39d-7fed0236abc8" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_c5c0be6c-b337-4030-91f3-539cb68e74bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_b87959ab-bb2f-4024-a12a-1c1fd3313bf3" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e550f59-758f-4c64-a39d-7fed0236abc8" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_b87959ab-bb2f-4024-a12a-1c1fd3313bf3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8c3c86e3-fa3e-476e-a16c-f946697f5607" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_19ecce78-c07d-4190-a93f-0a4b4ef35a89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8c3c86e3-fa3e-476e-a16c-f946697f5607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_19ecce78-c07d-4190-a93f-0a4b4ef35a89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe6a15b6-6d02-4c2e-af37-68f05d19d1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8c3c86e3-fa3e-476e-a16c-f946697f5607" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe6a15b6-6d02-4c2e-af37-68f05d19d1d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7f814fac-6d96-4d39-b1d7-38474cceb014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe6a15b6-6d02-4c2e-af37-68f05d19d1d9" xlink:to="loc_us-gaap_AwardTypeAxis_7f814fac-6d96-4d39-b1d7-38474cceb014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7f814fac-6d96-4d39-b1d7-38474cceb014_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7f814fac-6d96-4d39-b1d7-38474cceb014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7f814fac-6d96-4d39-b1d7-38474cceb014_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_084e09c6-707d-4d79-b46f-fd2e61fb1a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7f814fac-6d96-4d39-b1d7-38474cceb014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_084e09c6-707d-4d79-b46f-fd2e61fb1a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_3cb0bca5-fb61-4d72-bd0c-5b83b39e7942" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_084e09c6-707d-4d79-b46f-fd2e61fb1a7d" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_3cb0bca5-fb61-4d72-bd0c-5b83b39e7942" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationSARsValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d996f5b0-70ea-431a-8d57-88dab26e38f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d996f5b0-70ea-431a-8d57-88dab26e38f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7cb76960-895d-4872-906a-b93f1ad12fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7cb76960-895d-4872-906a-b93f1ad12fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d9eaa362-788b-4f5a-acfa-eae38cfabd33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d9eaa362-788b-4f5a-acfa-eae38cfabd33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8770db99-93d1-42fd-80d1-4b93e4c2b8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8770db99-93d1-42fd-80d1-4b93e4c2b8f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_286a3378-9b6c-43ce-8d22-93d14588f315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_286a3378-9b6c-43ce-8d22-93d14588f315" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d01170b-970c-4247-b2e2-7c560c2d3282" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d01170b-970c-4247-b2e2-7c560c2d3282" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2649de52-c192-4029-b44e-fadad19bb5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d01170b-970c-4247-b2e2-7c560c2d3282" xlink:to="loc_us-gaap_AwardTypeAxis_2649de52-c192-4029-b44e-fadad19bb5e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2649de52-c192-4029-b44e-fadad19bb5e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2649de52-c192-4029-b44e-fadad19bb5e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2649de52-c192-4029-b44e-fadad19bb5e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0faec46b-849d-4c29-888d-f42a17146b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2649de52-c192-4029-b44e-fadad19bb5e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0faec46b-849d-4c29-888d-f42a17146b8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_7ac61f86-9e3c-434d-a9a2-0e979ab12af1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0faec46b-849d-4c29-888d-f42a17146b8e" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_7ac61f86-9e3c-434d-a9a2-0e979ab12af1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationSARsOutstandingandtheChangesDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_682ab78b-8bdd-401f-8c0a-f27e9943928a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_682ab78b-8bdd-401f-8c0a-f27e9943928a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_bc6348af-6265-44bc-a4b1-c2086fc9e101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_bc6348af-6265-44bc-a4b1-c2086fc9e101" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_b0a5268d-a4d7-4e7d-9ff4-3dc8020920d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_b0a5268d-a4d7-4e7d-9ff4-3dc8020920d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_05ab8df6-4204-4a80-91b4-64720f227333" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_05ab8df6-4204-4a80-91b4-64720f227333" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e748ed31-c533-4343-9d55-2350bbd3516c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_7d7b80f2-5f32-4b05-b697-eabe08a48a71" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_7d7b80f2-5f32-4b05-b697-eabe08a48a71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_cea42b36-f779-4328-b096-0f870f1d47a2" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_cea42b36-f779-4328-b096-0f870f1d47a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6a4f8618-715b-4c5e-9312-490630477ca6" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6a4f8618-715b-4c5e-9312-490630477ca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_0acc8b20-ecee-4a7f-9d28-160971982cfa" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_0acc8b20-ecee-4a7f-9d28-160971982cfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_41ca14e8-d282-4393-ab72-f744b1aeb8ec" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_41ca14e8-d282-4393-ab72-f744b1aeb8ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_46b3d638-9b3c-45c4-9be1-6cac2f38aa45" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_46b3d638-9b3c-45c4-9be1-6cac2f38aa45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_9da73859-0ad4-4544-81d1-b5d21bb61546" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c787b631-84cf-4aa2-ae05-8b688f8c5b46" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c787b631-84cf-4aa2-ae05-8b688f8c5b46" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_b0ffc881-f6ce-41d6-9e86-2681fa314d8e" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_b0ffc881-f6ce-41d6-9e86-2681fa314d8e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_5a3a974d-ea27-4eac-b960-b35c8771ad14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_5a3a974d-ea27-4eac-b960-b35c8771ad14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_e22b59eb-6445-4997-8e79-618a1db36598" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_e22b59eb-6445-4997-8e79-618a1db36598" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_2b875086-7241-4159-802d-503af98e515f" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_2b875086-7241-4159-802d-503af98e515f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_810e5201-aaa1-4d9b-96eb-f02be1a9012b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_810e5201-aaa1-4d9b-96eb-f02be1a9012b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1bb3cd8d-c653-4119-9677-9a59e7b485c1" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1bb3cd8d-c653-4119-9677-9a59e7b485c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_daf7ee91-300d-4195-b486-85345dd94dd4" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_daf7ee91-300d-4195-b486-85345dd94dd4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c60eb561-3f5c-45cd-91ee-8dfc34637a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c60eb561-3f5c-45cd-91ee-8dfc34637a4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3a0fe592-33a7-4ce6-852a-c6698670cf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c60eb561-3f5c-45cd-91ee-8dfc34637a4b" xlink:to="loc_us-gaap_AwardTypeAxis_3a0fe592-33a7-4ce6-852a-c6698670cf0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a0fe592-33a7-4ce6-852a-c6698670cf0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3a0fe592-33a7-4ce6-852a-c6698670cf0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a0fe592-33a7-4ce6-852a-c6698670cf0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_559ae05d-d962-4b2f-809b-92dd244bcd44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3a0fe592-33a7-4ce6-852a-c6698670cf0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_559ae05d-d962-4b2f-809b-92dd244bcd44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_19d58174-36d5-4783-8ec4-ccff2521c5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_559ae05d-d962-4b2f-809b-92dd244bcd44" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_19d58174-36d5-4783-8ec4-ccff2521c5e8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationSummaryofSARsExercisedDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_256eed84-4ec3-4daf-a5d1-3a01bd3c8052" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue_0cac597a-898b-446c-9080-79b05c7c9636" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_256eed84-4ec3-4daf-a5d1-3a01bd3c8052" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue_0cac597a-898b-446c-9080-79b05c7c9636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue_ae84cba2-61ed-4e16-9310-f522f2d259ff" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_256eed84-4ec3-4daf-a5d1-3a01bd3c8052" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue_ae84cba2-61ed-4e16-9310-f522f2d259ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cd7e28c4-26ad-469c-b765-118bbcc34f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_256eed84-4ec3-4daf-a5d1-3a01bd3c8052" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cd7e28c4-26ad-469c-b765-118bbcc34f5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_99954896-95d4-46c8-b8fa-c7fc7e9c20b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cd7e28c4-26ad-469c-b765-118bbcc34f5c" xlink:to="loc_us-gaap_AwardTypeAxis_99954896-95d4-46c8-b8fa-c7fc7e9c20b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99954896-95d4-46c8-b8fa-c7fc7e9c20b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_99954896-95d4-46c8-b8fa-c7fc7e9c20b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99954896-95d4-46c8-b8fa-c7fc7e9c20b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_104033e9-0600-4c2d-bde1-767ec7a9fbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_99954896-95d4-46c8-b8fa-c7fc7e9c20b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_104033e9-0600-4c2d-bde1-767ec7a9fbc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_44f74b77-97c7-4342-8b96-860e6460b59b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_104033e9-0600-4c2d-bde1-767ec7a9fbc7" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_44f74b77-97c7-4342-8b96-860e6460b59b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#GoodwillandOtherIntangibleAssetsSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_041aa982-a139-43fe-be4d-94f69a17bb28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_041aa982-a139-43fe-be4d-94f69a17bb28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d847bbbf-97c9-4a3c-b3ac-aba0798cd1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d847bbbf-97c9-4a3c-b3ac-aba0798cd1d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_43c769f1-9b56-4d9e-af55-e2236f623c21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_43c769f1-9b56-4d9e-af55-e2236f623c21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b14559ad-5549-48a7-875a-f122c4126c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b14559ad-5549-48a7-875a-f122c4126c06" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cf9af560-47db-4435-b386-4da79944ce8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cf9af560-47db-4435-b386-4da79944ce8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b70b109-4311-4c43-aeb7-ebcb8e363c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cf9af560-47db-4435-b386-4da79944ce8e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b70b109-4311-4c43-aeb7-ebcb8e363c56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9b70b109-4311-4c43-aeb7-ebcb8e363c56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b70b109-4311-4c43-aeb7-ebcb8e363c56" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9b70b109-4311-4c43-aeb7-ebcb8e363c56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2d7d1c4-e0c1-4ceb-9edc-f31827897ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b70b109-4311-4c43-aeb7-ebcb8e363c56" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2d7d1c4-e0c1-4ceb-9edc-f31827897ff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_de22b940-5c16-4143-9437-5932e7827831" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2d7d1c4-e0c1-4ceb-9edc-f31827897ff7" xlink:to="loc_us-gaap_PatentsMember_de22b940-5c16-4143-9437-5932e7827831" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CustomerRelationshipAndOtherMember_627ffce7-41c9-41b7-b46e-a6e21a6148ff" xlink:href="embc-20230930.xsd#embc_CustomerRelationshipAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2d7d1c4-e0c1-4ceb-9edc-f31827897ff7" xlink:to="loc_embc_CustomerRelationshipAndOtherMember_627ffce7-41c9-41b7-b46e-a6e21a6148ff" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dc2310f3-5418-4de0-811b-b8bdec41e405" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dc2310f3-5418-4de0-811b-b8bdec41e405" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_16b616bd-709a-40e1-83d8-5a3822e5750a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_16b616bd-709a-40e1-83d8-5a3822e5750a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentDiscountGross_21776d60-ee2e-415d-a743-8303054251f0" xlink:href="embc-20230930.xsd#embc_DebtInstrumentDiscountGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_embc_DebtInstrumentDiscountGross_21776d60-ee2e-415d-a743-8303054251f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_acd64c3f-0982-4c4f-8298-f4ae8850dd00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_DebtInstrumentTerm_acd64c3f-0982-4c4f-8298-f4ae8850dd00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_88a02b55-71a1-4374-ae7d-1f58c7b4c057" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_88a02b55-71a1-4374-ae7d-1f58c7b4c057" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentVariableRateFloor_4cd249ce-0411-412e-9f96-048ddd24e8a0" xlink:href="embc-20230930.xsd#embc_DebtInstrumentVariableRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_embc_DebtInstrumentVariableRateFloor_4cd249ce-0411-412e-9f96-048ddd24e8a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentDiscountPercentage_59ac112d-5897-464b-9fe7-15f6e4636c2a" xlink:href="embc-20230930.xsd#embc_DebtInstrumentDiscountPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_embc_DebtInstrumentDiscountPercentage_59ac112d-5897-464b-9fe7-15f6e4636c2a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage_0d7f2aaf-c42e-4d4b-a09c-925b639d31f5" xlink:href="embc-20230930.xsd#embc_DebtInstrumentPeriodicPaymentPrincipalPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage_0d7f2aaf-c42e-4d4b-a09c-925b639d31f5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_336f600d-b9bb-4996-bd3f-1103d5181f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_336f600d-b9bb-4996-bd3f-1103d5181f8a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_763407b6-b546-462f-bbb6-79b95b61e9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_763407b6-b546-462f-bbb6-79b95b61e9ed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_34110743-d10f-4495-b579-332744f1b914" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_LineOfCredit_34110743-d10f-4495-b579-332744f1b914" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_423f5792-f471-441f-a8c3-4c0ad021c13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_LongTermDebtFairValue_423f5792-f471-441f-a8c3-4c0ad021c13e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3bec5389-ca64-4fbb-bd3d-8ba6104d8b18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_DebtInstrumentAxis_3bec5389-ca64-4fbb-bd3d-8ba6104d8b18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3bec5389-ca64-4fbb-bd3d-8ba6104d8b18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3bec5389-ca64-4fbb-bd3d-8ba6104d8b18" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3bec5389-ca64-4fbb-bd3d-8ba6104d8b18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3bec5389-ca64-4fbb-bd3d-8ba6104d8b18" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member_cefafcc2-36b7-4d4d-a0c4-506e1874ac16" xlink:href="embc-20230930.xsd#embc_A500SeniorSecuredNotesDueFebruary2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:to="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member_cefafcc2-36b7-4d4d-a0c4-506e1874ac16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_6a07d51f-afe9-4df7-aa12-c8a645c36020" xlink:href="embc-20230930.xsd#embc_A675SeniorSecuredNotesDueFebruary2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:to="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_6a07d51f-afe9-4df7-aa12-c8a645c36020" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_4468df66-2a50-41c8-8819-2639205590a6" xlink:href="embc-20230930.xsd#embc_SeniorSecuredTermLoanBMaturingMarch2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:to="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_4468df66-2a50-41c8-8819-2639205590a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member_d18d418c-fce9-4183-aaa8-18b8a663ee45" xlink:href="embc-20230930.xsd#embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:to="loc_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member_d18d418c-fce9-4183-aaa8-18b8a663ee45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dee3f93d-1d7c-4a07-bf00-a720eb0afdba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dee3f93d-1d7c-4a07-bf00-a720eb0afdba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dee3f93d-1d7c-4a07-bf00-a720eb0afdba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dee3f93d-1d7c-4a07-bf00-a720eb0afdba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dee3f93d-1d7c-4a07-bf00-a720eb0afdba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8d11802d-b703-41ea-897c-92932b611fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dee3f93d-1d7c-4a07-bf00-a720eb0afdba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8d11802d-b703-41ea-897c-92932b611fd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4c253d55-84e3-4539-9f4a-db9e7f5c6db3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8d11802d-b703-41ea-897c-92932b611fd2" xlink:to="loc_us-gaap_SeniorNotesMember_4c253d55-84e3-4539-9f4a-db9e7f5c6db3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_b7cb9556-f19f-4c60-934a-d0d44f9d91d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8d11802d-b703-41ea-897c-92932b611fd2" xlink:to="loc_us-gaap_SecuredDebtMember_b7cb9556-f19f-4c60-934a-d0d44f9d91d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f008810-95dd-4e5a-bf28-84843c895072" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f008810-95dd-4e5a-bf28-84843c895072" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_1f008810-95dd-4e5a-bf28-84843c895072_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f008810-95dd-4e5a-bf28-84843c895072" xlink:to="loc_us-gaap_RelatedPartyDomain_1f008810-95dd-4e5a-bf28-84843c895072_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d6d1a720-668a-4600-ad2b-11cb4b8bff59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f008810-95dd-4e5a-bf28-84843c895072" xlink:to="loc_us-gaap_RelatedPartyDomain_d6d1a720-668a-4600-ad2b-11cb4b8bff59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_a8ce5634-f496-4bf5-94b1-74677de90a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d6d1a720-668a-4600-ad2b-11cb4b8bff59" xlink:to="loc_us-gaap_ParentMember_a8ce5634-f496-4bf5-94b1-74677de90a3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ab72dd0d-e435-4b15-9b29-f8c98e573d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_VariableRateAxis_ab72dd0d-e435-4b15-9b29-f8c98e573d43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ab72dd0d-e435-4b15-9b29-f8c98e573d43_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ab72dd0d-e435-4b15-9b29-f8c98e573d43" xlink:to="loc_us-gaap_VariableRateDomain_ab72dd0d-e435-4b15-9b29-f8c98e573d43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_75852bcd-8d4e-485f-8d9b-99f04ea0facc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ab72dd0d-e435-4b15-9b29-f8c98e573d43" xlink:to="loc_us-gaap_VariableRateDomain_75852bcd-8d4e-485f-8d9b-99f04ea0facc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_0275a419-bbfa-4791-8ddc-e41ac88653bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_75852bcd-8d4e-485f-8d9b-99f04ea0facc" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_0275a419-bbfa-4791-8ddc-e41ac88653bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_64f031bd-278d-42d0-8a17-50654b72cedd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_CreditFacilityAxis_64f031bd-278d-42d0-8a17-50654b72cedd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_64f031bd-278d-42d0-8a17-50654b72cedd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_64f031bd-278d-42d0-8a17-50654b72cedd" xlink:to="loc_us-gaap_CreditFacilityDomain_64f031bd-278d-42d0-8a17-50654b72cedd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7be367c1-2375-4cbe-8cd9-53aef570ebc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_64f031bd-278d-42d0-8a17-50654b72cedd" xlink:to="loc_us-gaap_CreditFacilityDomain_7be367c1-2375-4cbe-8cd9-53aef570ebc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0a88cbd7-cb3f-4ff7-9eb8-ad25665dca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7be367c1-2375-4cbe-8cd9-53aef570ebc5" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0a88cbd7-cb3f-4ff7-9eb8-ad25665dca0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6040b7a7-7a53-4be8-811c-aed4a54e8389" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6040b7a7-7a53-4be8-811c-aed4a54e8389" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6040b7a7-7a53-4be8-811c-aed4a54e8389_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6040b7a7-7a53-4be8-811c-aed4a54e8389" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6040b7a7-7a53-4be8-811c-aed4a54e8389_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eee3f189-4a8e-427b-b73e-1fcbdd663ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6040b7a7-7a53-4be8-811c-aed4a54e8389" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eee3f189-4a8e-427b-b73e-1fcbdd663ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_75b6e88c-d359-4071-8abd-6235ab3cd84f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eee3f189-4a8e-427b-b73e-1fcbdd663ae9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_75b6e88c-d359-4071-8abd-6235ab3cd84f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_4e5d5be6-0f27-4e5a-947c-796bc0fe0cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_4e5d5be6-0f27-4e5a-947c-796bc0fe0cc7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4e5d5be6-0f27-4e5a-947c-796bc0fe0cc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4e5d5be6-0f27-4e5a-947c-796bc0fe0cc7" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4e5d5be6-0f27-4e5a-947c-796bc0fe0cc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7b1037d3-8685-41f4-a273-16a30cee6705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4e5d5be6-0f27-4e5a-947c-796bc0fe0cc7" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7b1037d3-8685-41f4-a273-16a30cee6705" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6d303bde-6499-4675-935e-36520856852f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7b1037d3-8685-41f4-a273-16a30cee6705" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6d303bde-6499-4675-935e-36520856852f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8ec8ed50-6ed8-46c5-bdb5-755bc9b5eaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6d303bde-6499-4675-935e-36520856852f" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8ec8ed50-6ed8-46c5-bdb5-755bc9b5eaa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_c3b3ad00-a1b4-45f2-9c04-8e80915efda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6d303bde-6499-4675-935e-36520856852f" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_c3b3ad00-a1b4-45f2-9c04-8e80915efda4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LongTermDebtDebtOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3935cdb6-f437-405f-863a-52031437bb93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3935cdb6-f437-405f-863a-52031437bb93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c82d205e-cb76-453f-bb83-9b8a99b02628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c82d205e-cb76-453f-bb83-9b8a99b02628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_82690f07-00f4-4820-8b2b-cce077a96419" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_LongTermDebtCurrent_82690f07-00f4-4820-8b2b-cce077a96419" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c1115a69-52fe-4fdb-ae2b-f524206c726e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c1115a69-52fe-4fdb-ae2b-f524206c726e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_354d471e-e59e-412f-98e2-ca5f71073aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_354d471e-e59e-412f-98e2-ca5f71073aa5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_511dd986-a147-42e0-bb73-540595108efa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_DebtInstrumentTable_511dd986-a147-42e0-bb73-540595108efa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_91ec198b-8b96-45e3-a45f-1e85524bc7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_511dd986-a147-42e0-bb73-540595108efa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_91ec198b-8b96-45e3-a45f-1e85524bc7f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_91ec198b-8b96-45e3-a45f-1e85524bc7f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_91ec198b-8b96-45e3-a45f-1e85524bc7f7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_91ec198b-8b96-45e3-a45f-1e85524bc7f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4732bd4b-8025-4782-8960-2685032c2d21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_91ec198b-8b96-45e3-a45f-1e85524bc7f7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4732bd4b-8025-4782-8960-2685032c2d21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_78f6cec1-2e96-44ab-80ba-eb5d29c10005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4732bd4b-8025-4782-8960-2685032c2d21" xlink:to="loc_us-gaap_SecuredDebtMember_78f6cec1-2e96-44ab-80ba-eb5d29c10005" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0e6f4a6e-d25e-4445-b076-3c326277cedd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4732bd4b-8025-4782-8960-2685032c2d21" xlink:to="loc_us-gaap_SeniorNotesMember_0e6f4a6e-d25e-4445-b076-3c326277cedd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_237a1d73-9c22-4099-b594-0c628e988d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_511dd986-a147-42e0-bb73-540595108efa" xlink:to="loc_us-gaap_DebtInstrumentAxis_237a1d73-9c22-4099-b594-0c628e988d1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_237a1d73-9c22-4099-b594-0c628e988d1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_237a1d73-9c22-4099-b594-0c628e988d1a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_237a1d73-9c22-4099-b594-0c628e988d1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_237a1d73-9c22-4099-b594-0c628e988d1a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_3e7cc8dc-71c1-4894-a9a5-081a29ed553c" xlink:href="embc-20230930.xsd#embc_SeniorSecuredTermLoanBMaturingMarch2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:to="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_3e7cc8dc-71c1-4894-a9a5-081a29ed553c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member_7ab2698f-3de6-4d70-8537-5cc1af1bdaa5" xlink:href="embc-20230930.xsd#embc_A500SeniorSecuredNotesDueFebruary2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:to="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member_7ab2698f-3de6-4d70-8537-5cc1af1bdaa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_1387f9a0-04c1-4ee8-b7d6-3800a33b9625" xlink:href="embc-20230930.xsd#embc_A675SeniorSecuredNotesDueFebruary2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:to="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_1387f9a0-04c1-4ee8-b7d6-3800a33b9625" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_37c6e35d-dd11-41ee-ad2a-ff3255d88a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_55e768bd-9246-42e8-be66-614b72196eec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_37c6e35d-dd11-41ee-ad2a-ff3255d88a5c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_55e768bd-9246-42e8-be66-614b72196eec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f0b001d5-3cbd-4fb0-9440-0e3c47d0ceda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_37c6e35d-dd11-41ee-ad2a-ff3255d88a5c" xlink:to="loc_us-gaap_DerivativeTable_f0b001d5-3cbd-4fb0-9440-0e3c47d0ceda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e9c698fd-8d11-4202-8e8c-f55b94fc6410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f0b001d5-3cbd-4fb0-9440-0e3c47d0ceda" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e9c698fd-8d11-4202-8e8c-f55b94fc6410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e9c698fd-8d11-4202-8e8c-f55b94fc6410_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e9c698fd-8d11-4202-8e8c-f55b94fc6410" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e9c698fd-8d11-4202-8e8c-f55b94fc6410_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_88525a76-3210-4fbf-afad-73fceb0f5a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e9c698fd-8d11-4202-8e8c-f55b94fc6410" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_88525a76-3210-4fbf-afad-73fceb0f5a9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_32f6ef82-256b-40ce-a0f8-af601a0838e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_88525a76-3210-4fbf-afad-73fceb0f5a9a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_32f6ef82-256b-40ce-a0f8-af601a0838e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d7e3f3ad-67a2-40c3-b01c-0a42fc620d55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_f0b001d5-3cbd-4fb0-9440-0e3c47d0ceda" xlink:to="loc_us-gaap_HedgingDesignationAxis_d7e3f3ad-67a2-40c3-b01c-0a42fc620d55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d7e3f3ad-67a2-40c3-b01c-0a42fc620d55_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d7e3f3ad-67a2-40c3-b01c-0a42fc620d55" xlink:to="loc_us-gaap_HedgingDesignationDomain_d7e3f3ad-67a2-40c3-b01c-0a42fc620d55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_149fe8ce-7bb0-4ec2-8af6-11185750a036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d7e3f3ad-67a2-40c3-b01c-0a42fc620d55" xlink:to="loc_us-gaap_HedgingDesignationDomain_149fe8ce-7bb0-4ec2-8af6-11185750a036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_504980bd-8cfb-477d-8b31-0cd7fecfc232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_149fe8ce-7bb0-4ec2-8af6-11185750a036" xlink:to="loc_us-gaap_NondesignatedMember_504980bd-8cfb-477d-8b31-0cd7fecfc232" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_9e95732a-c73b-468c-968f-ab425bcac557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:to="loc_us-gaap_InterestIncomeOther_9e95732a-c73b-468c-968f-ab425bcac557" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_74e5e460-2a92-47cb-b27f-563a71825e51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_74e5e460-2a92-47cb-b27f-563a71825e51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_900f6c32-f789-4aac-9e3d-563419e7d809" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_900f6c32-f789-4aac-9e3d-563419e7d809" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c38a9cc1-aab2-44fe-b792-a738fd07f4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c38a9cc1-aab2-44fe-b792-a738fd07f4f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_51c3146d-1873-480b-a56c-6ad6a4e2a82b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_51c3146d-1873-480b-a56c-6ad6a4e2a82b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_51c3146d-1873-480b-a56c-6ad6a4e2a82b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_51c3146d-1873-480b-a56c-6ad6a4e2a82b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_51c3146d-1873-480b-a56c-6ad6a4e2a82b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0f3db870-fbed-47cf-91d9-b604ac7d2a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_51c3146d-1873-480b-a56c-6ad6a4e2a82b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0f3db870-fbed-47cf-91d9-b604ac7d2a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_3cb2a9b0-2026-46b4-aa67-10e7d34ecd09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_0f3db870-fbed-47cf-91d9-b604ac7d2a44" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_3cb2a9b0-2026-46b4-aa67-10e7d34ecd09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3ebd2381-255f-4385-aebe-bb1f8a875836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3ebd2381-255f-4385-aebe-bb1f8a875836" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3ebd2381-255f-4385-aebe-bb1f8a875836_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3ebd2381-255f-4385-aebe-bb1f8a875836" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3ebd2381-255f-4385-aebe-bb1f8a875836_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d07f188a-c608-48f7-bccb-a21bbc1f4346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3ebd2381-255f-4385-aebe-bb1f8a875836" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d07f188a-c608-48f7-bccb-a21bbc1f4346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_7f4f8fe5-e054-480c-8878-f243b7d043c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d07f188a-c608-48f7-bccb-a21bbc1f4346" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_7f4f8fe5-e054-480c-8878-f243b7d043c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_b25f8dfd-daec-4d0b-bf9d-6bd8969f9559" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:to="loc_srt_MajorCustomersAxis_b25f8dfd-daec-4d0b-bf9d-6bd8969f9559" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b25f8dfd-daec-4d0b-bf9d-6bd8969f9559_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_b25f8dfd-daec-4d0b-bf9d-6bd8969f9559" xlink:to="loc_srt_NameOfMajorCustomerDomain_b25f8dfd-daec-4d0b-bf9d-6bd8969f9559_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d74e6a7b-ad22-4152-8883-ce7ce0793916" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_b25f8dfd-daec-4d0b-bf9d-6bd8969f9559" xlink:to="loc_srt_NameOfMajorCustomerDomain_d74e6a7b-ad22-4152-8883-ce7ce0793916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CustomerOneCustomerTwoAndCustomerThreeMember_ca8a68ea-e09f-48d6-9f7d-27aeeeeebb40" xlink:href="embc-20230930.xsd#embc_CustomerOneCustomerTwoAndCustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d74e6a7b-ad22-4152-8883-ce7ce0793916" xlink:to="loc_embc_CustomerOneCustomerTwoAndCustomerThreeMember_ca8a68ea-e09f-48d6-9f7d-27aeeeeebb40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CustomerOneAndCustomerTwoMember_0d73f1e8-cec3-4601-80fb-f17d92c09f49" xlink:href="embc-20230930.xsd#embc_CustomerOneAndCustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d74e6a7b-ad22-4152-8883-ce7ce0793916" xlink:to="loc_embc_CustomerOneAndCustomerTwoMember_0d73f1e8-cec3-4601-80fb-f17d92c09f49" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_48290183-30e6-42d0-9f2d-983af8736037" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_48290183-30e6-42d0-9f2d-983af8736037" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_86791a1f-5b64-44b0-adbe-0ff072328bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_86791a1f-5b64-44b0-adbe-0ff072328bfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_aadf8ae5-a6ad-44ed-9726-798dcc9a5a58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_aadf8ae5-a6ad-44ed-9726-798dcc9a5a58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d3f8752-5f29-4a1f-9c07-0758d2a242ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d3f8752-5f29-4a1f-9c07-0758d2a242ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4847a54e-13d9-4f9a-b5af-321fd67d3890" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d3f8752-5f29-4a1f-9c07-0758d2a242ae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4847a54e-13d9-4f9a-b5af-321fd67d3890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4847a54e-13d9-4f9a-b5af-321fd67d3890_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4847a54e-13d9-4f9a-b5af-321fd67d3890" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4847a54e-13d9-4f9a-b5af-321fd67d3890_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4847a54e-13d9-4f9a-b5af-321fd67d3890" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_2fec9565-75c3-49dd-a914-09e98e928859" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_LandMember_2fec9565-75c3-49dd-a914-09e98e928859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_37da85af-bcd1-4c9a-b26b-c83ed2f03c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_BuildingMember_37da85af-bcd1-4c9a-b26b-c83ed2f03c57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_9a18860d-a880-40ec-9089-0678db41b04b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_9a18860d-a880-40ec-9089-0678db41b04b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_62a3f5bb-6f12-446d-9d60-e29e33e1a731" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_62a3f5bb-6f12-446d-9d60-e29e33e1a731" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_a960db6e-788c-4df1-815a-5669a2ddb408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_ConstructionInProgressMember_a960db6e-788c-4df1-815a-5669a2ddb408" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeFinanceLeaseAreaOfPremisesLeased_37c1e587-f5bc-48ca-a1f8-3394020e03ad" xlink:href="embc-20230930.xsd#embc_LesseeFinanceLeaseAreaOfPremisesLeased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_embc_LesseeFinanceLeaseAreaOfPremisesLeased_37c1e587-f5bc-48ca-a1f8-3394020e03ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_279be175-0680-440b-8e03-05760f3819ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_279be175-0680-440b-8e03-05760f3819ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_63a50c01-b9f6-4f4d-90bf-db6c48ae5853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_63a50c01-b9f6-4f4d-90bf-db6c48ae5853" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_FinanceLeaseCost_0764001c-7062-4122-bcbf-ad3a7f81e87b" xlink:href="embc-20230930.xsd#embc_FinanceLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_embc_FinanceLeaseCost_0764001c-7062-4122-bcbf-ad3a7f81e87b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_348da7b3-8b7d-4401-b7db-5c603c9711aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_348da7b3-8b7d-4401-b7db-5c603c9711aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_be3d3e59-8dad-49aa-8959-d0484f620e17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_be3d3e59-8dad-49aa-8959-d0484f620e17" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8730c8bf-72cb-4bce-a4fc-280d54eb5b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8730c8bf-72cb-4bce-a4fc-280d54eb5b3c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b0bccf4d-5b31-4a50-bea8-c1625185711d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b0bccf4d-5b31-4a50-bea8-c1625185711d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_50ed9b08-afc7-469b-acdd-011899794883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_OperatingLeaseCost_50ed9b08-afc7-469b-acdd-011899794883" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_9115ed11-5193-4a63-9e76-3dc59b0e5ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_9115ed11-5193-4a63-9e76-3dc59b0e5ec6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_e8f66a7f-7361-4c5f-a5f6-bc64e2bbf45f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_9115ed11-5193-4a63-9e76-3dc59b0e5ec6" xlink:to="loc_us-gaap_LeaseContractualTermAxis_e8f66a7f-7361-4c5f-a5f6-bc64e2bbf45f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_e8f66a7f-7361-4c5f-a5f6-bc64e2bbf45f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_e8f66a7f-7361-4c5f-a5f6-bc64e2bbf45f" xlink:to="loc_us-gaap_LeaseContractualTermDomain_e8f66a7f-7361-4c5f-a5f6-bc64e2bbf45f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_0fd7d2f3-d03d-4be8-af3b-90bf85a4fcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_e8f66a7f-7361-4c5f-a5f6-bc64e2bbf45f" xlink:to="loc_us-gaap_LeaseContractualTermDomain_0fd7d2f3-d03d-4be8-af3b-90bf85a4fcdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BuildingLeaseSixYearExtensionOptionMember_46305dda-974e-4b4a-82e7-376a9ffa9eb0" xlink:href="embc-20230930.xsd#embc_BuildingLeaseSixYearExtensionOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_0fd7d2f3-d03d-4be8-af3b-90bf85a4fcdb" xlink:to="loc_embc_BuildingLeaseSixYearExtensionOptionMember_46305dda-974e-4b4a-82e7-376a9ffa9eb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BuildingLeaseFourYearExtensionOptionMember_84327573-bfb1-468c-997b-48cd01dca70d" xlink:href="embc-20230930.xsd#embc_BuildingLeaseFourYearExtensionOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_0fd7d2f3-d03d-4be8-af3b-90bf85a4fcdb" xlink:to="loc_embc_BuildingLeaseFourYearExtensionOptionMember_84327573-bfb1-468c-997b-48cd01dca70d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/BenefitPlansDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#BenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/BenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_79c3c015-b323-43cc-8bed-a7fe227fca1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_79c3c015-b323-43cc-8bed-a7fe227fca1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_eaaeabfa-21a3-4a08-92a6-5112b195769f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_eaaeabfa-21a3-4a08-92a6-5112b195769f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_406fa316-a356-4825-8203-b45f9d108a40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_406fa316-a356-4825-8203-b45f9d108a40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_da082ceb-dcba-46f0-80f3-a00e387c0703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_da082ceb-dcba-46f0-80f3-a00e387c0703" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage_458752f2-7b95-44e7-bc08-c9c073c1f6a7" xlink:href="embc-20230930.xsd#embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage_458752f2-7b95-44e7-bc08-c9c073c1f6a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage_0899b526-2e03-4633-862f-07204f01e426" xlink:href="embc-20230930.xsd#embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage_0899b526-2e03-4633-862f-07204f01e426" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_66f5bcb5-00c7-4740-9b20-dfddf04e9226" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_66f5bcb5-00c7-4740-9b20-dfddf04e9226" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7b3c2cc0-9715-4188-8d09-b5e9e71e0f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7b3c2cc0-9715-4188-8d09-b5e9e71e0f8b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_80c8fc11-d875-47c1-b734-bb0c7957424c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7b3c2cc0-9715-4188-8d09-b5e9e71e0f8b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_80c8fc11-d875-47c1-b734-bb0c7957424c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_80c8fc11-d875-47c1-b734-bb0c7957424c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_80c8fc11-d875-47c1-b734-bb0c7957424c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_80c8fc11-d875-47c1-b734-bb0c7957424c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_35fb30f4-dfa5-4bfd-a37d-3092e6f380ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_80c8fc11-d875-47c1-b734-bb0c7957424c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_35fb30f4-dfa5-4bfd-a37d-3092e6f380ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5b84f199-0cd7-4346-95a5-defc78692c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_35fb30f4-dfa5-4bfd-a37d-3092e6f380ef" xlink:to="loc_us-gaap_ForeignPlanMember_5b84f199-0cd7-4346-95a5-defc78692c8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_ba026c51-c77d-40cd-8871-aef23d5a9f6e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ForeignPlanMember_5b84f199-0cd7-4346-95a5-defc78692c8e" xlink:to="loc_country_CH_ba026c51-c77d-40cd-8871-aef23d5a9f6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b51b7974-b07e-467b-a159-f3be4558a8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7b3c2cc0-9715-4188-8d09-b5e9e71e0f8b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b51b7974-b07e-467b-a159-f3be4558a8c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b51b7974-b07e-467b-a159-f3be4558a8c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b51b7974-b07e-467b-a159-f3be4558a8c4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b51b7974-b07e-467b-a159-f3be4558a8c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a23e8578-42ba-4dd6-a0fe-42536ffeed60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b51b7974-b07e-467b-a159-f3be4558a8c4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a23e8578-42ba-4dd6-a0fe-42536ffeed60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseMember_b6ee9e14-3965-4229-a0a4-cdd4d7765eed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a23e8578-42ba-4dd6-a0fe-42536ffeed60" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseMember_b6ee9e14-3965-4229-a0a4-cdd4d7765eed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SupplementalFinancialInformationTradeReceivablesNetDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3e4acc90-cb35-45c2-b3cf-1fe30a28a478" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3e4acc90-cb35-45c2-b3cf-1fe30a28a478" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b4016aac-91fd-4777-8ede-b9fa0c19a651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b4016aac-91fd-4777-8ede-b9fa0c19a651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2b721d0b-5d17-4e6d-8a5e-66f97c24624e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2b721d0b-5d17-4e6d-8a5e-66f97c24624e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_b8ef4688-bbbb-469f-b938-8dcba01c3f05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_b8ef4688-bbbb-469f-b938-8dcba01c3f05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_5a192377-8f1d-4119-9852-0b6012835c90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_d2ef79d8-22d4-4ae7-a753-27dc16ee7125" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3e4acc90-cb35-45c2-b3cf-1fe30a28a478" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_d2ef79d8-22d4-4ae7-a753-27dc16ee7125" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_057d6057-993b-4591-b80f-5a650656b9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_d2ef79d8-22d4-4ae7-a753-27dc16ee7125" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_057d6057-993b-4591-b80f-5a650656b9e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_057d6057-993b-4591-b80f-5a650656b9e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_057d6057-993b-4591-b80f-5a650656b9e7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_057d6057-993b-4591-b80f-5a650656b9e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_dbc5ed9f-f2c5-45d6-9ed5-1a503f0f48e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_057d6057-993b-4591-b80f-5a650656b9e7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_dbc5ed9f-f2c5-45d6-9ed5-1a503f0f48e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_0cfb903b-67af-49c1-980e-c863bc729c75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_dbc5ed9f-f2c5-45d6-9ed5-1a503f0f48e7" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_0cfb903b-67af-49c1-980e-c863bc729c75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SECSchedule1209AllowanceCashDiscountsMember_9ebc425c-29ea-4fea-a6c4-03ed3e661e6d" xlink:href="embc-20230930.xsd#embc_SECSchedule1209AllowanceCashDiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_dbc5ed9f-f2c5-45d6-9ed5-1a503f0f48e7" xlink:to="loc_embc_SECSchedule1209AllowanceCashDiscountsMember_9ebc425c-29ea-4fea-a6c4-03ed3e661e6d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SupplementalFinancialInformationLongLivedAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_32ab8f78-bb55-41a1-8130-b2a4ef7be87d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_782e4f5a-40ec-4e3b-a8fd-3547b0331319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_32ab8f78-bb55-41a1-8130-b2a4ef7be87d" xlink:to="loc_us-gaap_NoncurrentAssets_782e4f5a-40ec-4e3b-a8fd-3547b0331319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8977fa81-a114-48ab-85e8-56d1b5449b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_32ab8f78-bb55-41a1-8130-b2a4ef7be87d" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8977fa81-a114-48ab-85e8-56d1b5449b7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_805074f9-40f9-4017-89dc-0e1e0643b112" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8977fa81-a114-48ab-85e8-56d1b5449b7f" xlink:to="loc_srt_StatementGeographicalAxis_805074f9-40f9-4017-89dc-0e1e0643b112" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_805074f9-40f9-4017-89dc-0e1e0643b112_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_805074f9-40f9-4017-89dc-0e1e0643b112" xlink:to="loc_srt_SegmentGeographicalDomain_805074f9-40f9-4017-89dc-0e1e0643b112_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_805074f9-40f9-4017-89dc-0e1e0643b112" xlink:to="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_85fe2aac-b51a-4c4d-82ca-2da6006867ca" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:to="loc_country_US_85fe2aac-b51a-4c4d-82ca-2da6006867ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_511d02d4-e03a-4ec8-912e-fac7815c52fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:to="loc_us-gaap_EMEAMember_511d02d4-e03a-4ec8-912e-fac7815c52fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_8d93bdc2-5b48-48f8-a9ac-17d9cbb556da" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:to="loc_srt_AsiaMember_8d93bdc2-5b48-48f8-a9ac-17d9cbb556da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OtherCountriesMember_d7043a6e-fd53-4d41-8227-5728ab30fc4e" xlink:href="embc-20230930.xsd#embc_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:to="loc_embc_OtherCountriesMember_d7043a6e-fd53-4d41-8227-5728ab30fc4e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.embecta.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_c19e3cad-7b7f-4851-833b-8dab9d0fd88f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_813975a1-ef11-42fd-9677-4432cbd359a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c19e3cad-7b7f-4851-833b-8dab9d0fd88f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_813975a1-ef11-42fd-9677-4432cbd359a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e9e11948-a9b8-4e00-8023-cfe1ebc549bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_c19e3cad-7b7f-4851-833b-8dab9d0fd88f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e9e11948-a9b8-4e00-8023-cfe1ebc549bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_4803a90c-688c-4618-b49f-0d9dfbc955a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_c19e3cad-7b7f-4851-833b-8dab9d0fd88f" xlink:to="loc_us-gaap_SubsequentEventTable_4803a90c-688c-4618-b49f-0d9dfbc955a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f25d4407-e92a-4732-9c04-212d9dc771e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_4803a90c-688c-4618-b49f-0d9dfbc955a0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f25d4407-e92a-4732-9c04-212d9dc771e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f25d4407-e92a-4732-9c04-212d9dc771e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f25d4407-e92a-4732-9c04-212d9dc771e8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f25d4407-e92a-4732-9c04-212d9dc771e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7cd5a0e8-40c7-4fc4-a8ab-7ff89441d9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f25d4407-e92a-4732-9c04-212d9dc771e8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7cd5a0e8-40c7-4fc4-a8ab-7ff89441d9b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4c9fb83b-55ee-4c62-be3d-5bee9a174b53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7cd5a0e8-40c7-4fc4-a8ab-7ff89441d9b0" xlink:to="loc_us-gaap_SubsequentEventMember_4c9fb83b-55ee-4c62-be3d-5bee9a174b53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7fafb72a-812a-4a6c-bec4-411c3720503d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_4803a90c-688c-4618-b49f-0d9dfbc955a0" xlink:to="loc_us-gaap_AwardTypeAxis_7fafb72a-812a-4a6c-bec4-411c3720503d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7fafb72a-812a-4a6c-bec4-411c3720503d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7fafb72a-812a-4a6c-bec4-411c3720503d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7fafb72a-812a-4a6c-bec4-411c3720503d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ed8cb5a-ed6b-4e5e-a0f4-e2025f2c4832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7fafb72a-812a-4a6c-bec4-411c3720503d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ed8cb5a-ed6b-4e5e-a0f4-e2025f2c4832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_dd53fd50-d2db-464c-bbf4-3c9d27315b5f" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ed8cb5a-ed6b-4e5e-a0f4-e2025f2c4832" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_dd53fd50-d2db-464c-bbf4-3c9d27315b5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_b364eb4e-d85f-4e54-aa1e-8d0b6e44e63f" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ed8cb5a-ed6b-4e5e-a0f4-e2025f2c4832" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_b364eb4e-d85f-4e54-aa1e-8d0b6e44e63f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>embc-20230930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:4102c7ef-a746-4e09-abe6-45c91f406b23,g:4bb25894-924e-4e32-9a1d-8a6b6ed5cbfa-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_embc_SeparationAndStandupCosts_71cc2b78-9c45-4768-af1a-de791ed0ef9d_terseLabel_en-US" xlink:label="lab_embc_SeparationAndStandupCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separation and stand-up costs</link:label>
    <link:label id="lab_embc_SeparationAndStandupCosts_label_en-US" xlink:label="lab_embc_SeparationAndStandupCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separation and Standup Costs</link:label>
    <link:label id="lab_embc_SeparationAndStandupCosts_documentation_en-US" xlink:label="lab_embc_SeparationAndStandupCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standup Costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeparationAndStandupCosts" xlink:href="embc-20230930.xsd#embc_SeparationAndStandupCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_SeparationAndStandupCosts" xlink:to="lab_embc_SeparationAndStandupCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_c596f72b-5617-4488-be5f-39f059e2ea0b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_ac739fec-2a00-499e-8dab-b192dab0db9b_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_12b835bc-5017-409b-b4a7-c6ef7c2d11ff_verboseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_b3705452-5776-4f9f-9bfc-1364244527d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonemployee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_5d930aa6-c8d5-415e-824b-a409326395fe_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f50517ef-97cc-4d4f-869f-fb2b74f7c8a2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_20e20fa9-02ae-4125-ad32-be9d58ea5de5_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ba68550c-c415-4413-ac51-53c6a8e4cd03_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bbbd84a3-f62c-4405-a5b6-cd9abb0faeca_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_845cc68a-a08e-4fa1-a70a-ff7482c89f04_terseLabel_en-US" xlink:label="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Table]</link:label>
    <link:label id="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_label_en-US" xlink:label="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Table]</link:label>
    <link:label id="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_documentation_en-US" xlink:label="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:href="embc-20230930.xsd#embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_6842001d-55ed-4fbf-b64a-b0360490b327_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ecbfc3c5-e1e7-410b-af16-78c609cee6ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_254f39a8-520b-455c-b8ad-79de87a94ce5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_563ffa5d-1ced-4556-8958-5468e0e9fd0d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOther_f3f8e4fd-10dc-4858-b2af-599f0b826d1f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOther_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther" xlink:to="lab_us-gaap_InterestIncomeOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_1ff5763f-af45-4046-a78e-3437a5c87d05_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DeferredIncomeTaxesAndOtherAssetsMember_52514630-5fc6-4cb5-b1f6-2d8eede28224_terseLabel_en-US" xlink:label="lab_embc_DeferredIncomeTaxesAndOtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets</link:label>
    <link:label id="lab_embc_DeferredIncomeTaxesAndOtherAssetsMember_label_en-US" xlink:label="lab_embc_DeferredIncomeTaxesAndOtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets [Member]</link:label>
    <link:label id="lab_embc_DeferredIncomeTaxesAndOtherAssetsMember_documentation_en-US" xlink:label="lab_embc_DeferredIncomeTaxesAndOtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredIncomeTaxesAndOtherAssetsMember" xlink:href="embc-20230930.xsd#embc_DeferredIncomeTaxesAndOtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DeferredIncomeTaxesAndOtherAssetsMember" xlink:to="lab_embc_DeferredIncomeTaxesAndOtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_058e37a7-8d6b-4401-8c55-f0f526fc1aa0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_23afe902-ac4f-4253-aa80-6f99baac8421_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of SAR's Outstanding and Changes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_356c58aa-b53f-414c-8ddd-24e96df1453e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested, Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5c38197a-4cc8-434c-88dc-5800947020c3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested, Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_2f8680e2-0819-451e-a719-1febb8e958bd_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_7c93621a-496c-46a8-bcbd-01d5651611ef_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_3672e520-5000-4066-98c4-cf02cb9d9157_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum_08ebb4e4-af4b-4307-9ed3-b1344f522783_terseLabel_en-US" xlink:label="lab_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannula Supply Agreement, minimum period from distribution date to terminate agreement</link:label>
    <link:label id="lab_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum_label_en-US" xlink:label="lab_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannula Supply Agreement, Termination, Period subsequent to Distribution Date, Minimum</link:label>
    <link:label id="lab_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum_documentation_en-US" xlink:label="lab_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannula Supply Agreement, Termination, Period subsequent to Distribution Date, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" xlink:href="embc-20230930.xsd#embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" xlink:to="lab_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_e5c47a2c-ca55-4320-b83a-55e0a2ae1fe5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_ae1cee58-64c0-4d02-bd28-86bfdc3721c3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_9a1b8b66-8132-4141-9e3c-1829010a504e_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum_6a38d622-2529-4542-bd20-2851fe8768df_terseLabel_en-US" xlink:label="lab_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannula Supply Agreement, minimum notice period to terminate agreement</link:label>
    <link:label id="lab_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum_label_en-US" xlink:label="lab_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannula Supply Agreement, Termination, Notice Period, Minimum</link:label>
    <link:label id="lab_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum_documentation_en-US" xlink:label="lab_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannula Supply Agreement, Termination, Notice Period, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum" xlink:href="embc-20230930.xsd#embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum" xlink:to="lab_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_d26197af-851a-404b-9bef-117c68e60782_terseLabel_en-US" xlink:label="lab_embc_SeniorSecuredTermLoanBMaturingMarch2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due March 2029</link:label>
    <link:label id="lab_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_label_en-US" xlink:label="lab_embc_SeniorSecuredTermLoanBMaturingMarch2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Term Loan B Maturing March 2029 [Member]</link:label>
    <link:label id="lab_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_documentation_en-US" xlink:label="lab_embc_SeniorSecuredTermLoanBMaturingMarch2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Term Loan B Maturing March 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member" xlink:href="embc-20230930.xsd#embc_SeniorSecuredTermLoanBMaturingMarch2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member" xlink:to="lab_embc_SeniorSecuredTermLoanBMaturingMarch2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_474f4434-8acc-4b7f-840e-82ce90542d39_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearOne_75a1a2a9-3d0d-4108-bc07-e96606f4134a_totalLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearOne_label_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year One</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearOne_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearOne" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearOne" xlink:to="lab_embc_LesseeLeaseLiabilityToBePaidYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized_06377bbb-4b1e-4b45-89bc-01907668b00d_terseLabel_en-US" xlink:label="lab_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates recorded</link:label>
    <link:label id="lab_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized_label_en-US" xlink:label="lab_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Sales Deductions Recognized</link:label>
    <link:label id="lab_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized_documentation_en-US" xlink:label="lab_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in rebate liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized" xlink:href="embc-20230930.xsd#embc_RevenueFromContractWithCustomerSalesDeductionsRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized" xlink:to="lab_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_30efa667-8c95-4012-bc11-b8ca52f2d423_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income and other net taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_a2e6db29-594a-4642-86ae-0aba95de32b7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_f03efb94-3c22-4a09-9bcb-1ac45bbc8d49_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d380a406-8b46-47d2-9776-c2044ac7df36_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal statutory tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_0e10b783-6210-4dcf-9e81-1d890f7ea1a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_b927eefe-d79e-4884-90ac-730dfd8fda0a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e88d45f5-dd2a-4ec4-b714-e392130dbcd9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_1348233f-449d-41b9-a533-812b89708b1d_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock_b8b85086-492b-4306-a177-bb845db68ede_terseLabel_en-US" xlink:label="lab_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of SARs Valuation Assumptions</link:label>
    <link:label id="lab_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Appreciation Rights, Valuation Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock" xlink:href="embc-20230930.xsd#embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock" xlink:to="lab_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_72e645b9-9ade-4d84-b105-9aaa5e47c8a3_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_76838e2f-1d18-4e35-a10c-469b5ff6a7dd_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_524a3fa0-0df2-4db8-bfb5-d2f2916a3825_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearTwo_f1e7c9cd-24b3-4eb2-a16c-304b487d2bfc_totalLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearTwo_label_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearTwo_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearTwo" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearTwo" xlink:to="lab_embc_LesseeLeaseLiabilityToBePaidYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_df0492b2-10f5-4ca1-8479-3a3cbb34aa75_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_749f6e64-96a7-44ef-84a3-02fd8aacdafa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Interest</link:label>
    <link:label id="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Capitalization, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestCapitalizationPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:to="lab_us-gaap_InterestCapitalizationPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentTaxesDeemedSettledWithParent_da350d65-616b-4a79-8f2d-18327890353c_negatedTerseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentTaxesDeemedSettledWithParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes deemed settled with BD</link:label>
    <link:label id="lab_embc_NetParentInvestmentTaxesDeemedSettledWithParent_label_en-US" xlink:label="lab_embc_NetParentInvestmentTaxesDeemedSettledWithParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Taxes Deemed Settled With Parent</link:label>
    <link:label id="lab_embc_NetParentInvestmentTaxesDeemedSettledWithParent_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentTaxesDeemedSettledWithParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Taxes Deemed Settled With Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentTaxesDeemedSettledWithParent" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentTaxesDeemedSettledWithParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentTaxesDeemedSettledWithParent" xlink:to="lab_embc_NetParentInvestmentTaxesDeemedSettledWithParent" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_GeneralCorporateExpenses_5186d9e3-574f-426e-adb8-756bd1e0a9ed_terseLabel_en-US" xlink:label="lab_embc_GeneralCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total General Corporate Expenses</link:label>
    <link:label id="lab_embc_GeneralCorporateExpenses_label_en-US" xlink:label="lab_embc_GeneralCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Corporate Expenses</link:label>
    <link:label id="lab_embc_GeneralCorporateExpenses_documentation_en-US" xlink:label="lab_embc_GeneralCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Corporate Expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_GeneralCorporateExpenses" xlink:href="embc-20230930.xsd#embc_GeneralCorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_GeneralCorporateExpenses" xlink:to="lab_embc_GeneralCorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidAbstract_11bfce03-2fcb-4355-bc38-bd83673b5695_terseLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidAbstract_label_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid [Abstract]</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidAbstract_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidAbstract" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract" xlink:to="lab_embc_LesseeLeaseLiabilityToBePaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_1dc855ce-009b-4871-8662-7ac7e0d8f7f7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_508d336b-24b8-45f4-9276-06cd9f2f7212_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearFive_4d9666da-9c92-4b51-9521-eadf0cf76789_totalLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearFive_label_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year Five</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearFive_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearFive" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearFive" xlink:to="lab_embc_LesseeLeaseLiabilityToBePaidYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_c353f5e3-8bc7-46e5-a4c6-c9b2611ea056_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_ffca4622-f50b-4011-ba02-3a25952257f4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_587a802e-8647-4975-972f-6c43b1e36c37_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_4bd79086-e037-4394-bd03-4b3ea56d63e1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_04494d8b-6a8f-42ac-be7a-ad6ea3e702c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_5b8b01ed-5e4e-4638-94b6-f7004c5f7d2d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_921efa22-d0cd-4a5e-b25f-4e0b2eb73dc5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a047c2d5-2ff1-428e-8dc5-2f682be22e25_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_aba2e26b-1434-4bd4-b7cd-b2a2fb6e2965_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share - Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_8c2e4bc5-c2f8-494f-ac05-ac2b42996810_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of tax holidays on diluted earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Income Tax Benefits Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:to="lab_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b0fc3ac4-006a-4547-b35d-edb5a7744f76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d1dcda44-273a-4024-b2c6-c6b799d114ec_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net (net of allowance for doubtful accounts of $1.0 million and $1.3 million as of September&#160;30, 2023 and September&#160;30, 2022, respectively)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_2812835e-44cd-4c53-b02a-98f013d3a2ad_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_PerformanceStockUnitsPSUsMember_02ab818f-5aa9-442e-bc66-d277500308b8_terseLabel_en-US" xlink:label="lab_embc_PerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_embc_PerformanceStockUnitsPSUsMember_label_en-US" xlink:label="lab_embc_PerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Units (PSUs) [Member]</link:label>
    <link:label id="lab_embc_PerformanceStockUnitsPSUsMember_documentation_en-US" xlink:label="lab_embc_PerformanceStockUnitsPSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Units (PSUs)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceStockUnitsPSUsMember" xlink:href="embc-20230930.xsd#embc_PerformanceStockUnitsPSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_PerformanceStockUnitsPSUsMember" xlink:to="lab_embc_PerformanceStockUnitsPSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_CommonStockShareIssuanceRatio_a95017ff-5546-43e2-ab4a-1fcf7d590aca_terseLabel_en-US" xlink:label="lab_embc_CommonStockShareIssuanceRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, distribution ratio</link:label>
    <link:label id="lab_embc_CommonStockShareIssuanceRatio_label_en-US" xlink:label="lab_embc_CommonStockShareIssuanceRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Share Issuance Ratio</link:label>
    <link:label id="lab_embc_CommonStockShareIssuanceRatio_documentation_en-US" xlink:label="lab_embc_CommonStockShareIssuanceRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Share Issuance Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CommonStockShareIssuanceRatio" xlink:href="embc-20230930.xsd#embc_CommonStockShareIssuanceRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_CommonStockShareIssuanceRatio" xlink:to="lab_embc_CommonStockShareIssuanceRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_23a9eba2-903c-41d7-87e6-f3d51227edac_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_SECSchedule1209AllowanceCashDiscountsMember_6bee30c1-c079-41c7-b9d4-c1576e69fe7b_terseLabel_en-US" xlink:label="lab_embc_SECSchedule1209AllowanceCashDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Cash Discounts</link:label>
    <link:label id="lab_embc_SECSchedule1209AllowanceCashDiscountsMember_label_en-US" xlink:label="lab_embc_SECSchedule1209AllowanceCashDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Cash Discounts [Member]</link:label>
    <link:label id="lab_embc_SECSchedule1209AllowanceCashDiscountsMember_documentation_en-US" xlink:label="lab_embc_SECSchedule1209AllowanceCashDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Cash Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SECSchedule1209AllowanceCashDiscountsMember" xlink:href="embc-20230930.xsd#embc_SECSchedule1209AllowanceCashDiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_SECSchedule1209AllowanceCashDiscountsMember" xlink:to="lab_embc_SECSchedule1209AllowanceCashDiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_fa122df7-91b6-4319-8114-6a3781d543cf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_b536a85c-fe05-47ea-a41c-903caf41ce8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_3ae5e011-a490-4a32-ae76-d56ddb9d5ef7_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5043662d-5a2b-470e-bbfb-b7de1b80dd50_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_93f983a9-a8c0-4b18-8a8c-ed1c147fd0b2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Diabetes Care Business/ Embecta Corp.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_67c84dd7-2da2-4a66-9076-6d7b54bbf9af_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income attributable to Embecta</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_8e2e86b1-f2b2-4129-be03-68ea3e806414_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated intangible asset amortization expense for subsequent years thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d28f9816-9d46-4708-8192-0b8513faca33_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_c7ca7c1b-8cf3-4ed8-b7cc-98038c1db3d4_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherGeneralExpense_257c1dec-b338-48f1-a403-766fa330e616_terseLabel_en-US" xlink:label="lab_us-gaap_OtherGeneralExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_us-gaap_OtherGeneralExpense_label_en-US" xlink:label="lab_us-gaap_OtherGeneralExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other General Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralExpense" xlink:to="lab_us-gaap_OtherGeneralExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_761512f5-b205-4a12-b081-4594737a2482_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_85c7dad7-ce3c-4a9f-8f1e-77298f2dc9c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_a0b6d103-be6b-48f7-928f-185cd252110b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1d780e41-878d-483b-b00d-11f52e6405af_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_b0ee8381-b74c-48da-ab7c-a5c55e31369e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_639ec33b-b916-421c-9496-b8a9ecda6f9e_verboseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_fbb96eae-1017-421e-bc63-17d38cd2dea4_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment and fixtures</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_50b9aa4b-999e-4e32-8eae-fcddc49a4609_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_271e1c10-37ad-4c8e-918f-26125ef72b11_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_4b05af4b-8f2a-41a1-83d1-e876e90bc1e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact related to tax holidays</link:label>
    <link:label id="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount_label_en-US" xlink:label="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Holiday, Aggregate Dollar Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:to="lab_us-gaap_IncomeTaxHolidayAggregateDollarAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a95475ab-7e0a-4de4-85f9-a5be0378c747_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7cf657f1-d14e-4108-ade1-5f051ee51f45_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_44afca62-8ca6-491c-9405-bd26c4485e90_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_95186b28-c0e6-4328-8845-38217e166626_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentSeparationRelatedAdjustments_b904c24e-1268-4409-937c-fc0c2341cd7a_terseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentSeparationRelatedAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Separation related adjustments, net</link:label>
    <link:label id="lab_embc_NetParentInvestmentSeparationRelatedAdjustments_label_en-US" xlink:label="lab_embc_NetParentInvestmentSeparationRelatedAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Separation Related Adjustments</link:label>
    <link:label id="lab_embc_NetParentInvestmentSeparationRelatedAdjustments_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentSeparationRelatedAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Separation Related Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentSeparationRelatedAdjustments" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentSeparationRelatedAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentSeparationRelatedAdjustments" xlink:to="lab_embc_NetParentInvestmentSeparationRelatedAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_4752726f-3a08-4ccf-876e-db2a4774fa9f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embecta Corp. Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_a43febc0-96e4-4bfc-80a9-5e1a67dd9ec2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_34946917-55f9-4abd-a15a-74814b5f5ec7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DistributionAgreementDistributorAppointmentMaximumTerm_b8ee1386-063d-42ed-9788-823a9a625d71_terseLabel_en-US" xlink:label="lab_embc_DistributionAgreementDistributorAppointmentMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Agreement, maximum term for distributor appointed</link:label>
    <link:label id="lab_embc_DistributionAgreementDistributorAppointmentMaximumTerm_label_en-US" xlink:label="lab_embc_DistributionAgreementDistributorAppointmentMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Agreement, Distributor Appointment, Maximum Term</link:label>
    <link:label id="lab_embc_DistributionAgreementDistributorAppointmentMaximumTerm_documentation_en-US" xlink:label="lab_embc_DistributionAgreementDistributorAppointmentMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Agreement, Distributor Appointment, Maximum Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DistributionAgreementDistributorAppointmentMaximumTerm" xlink:href="embc-20230930.xsd#embc_DistributionAgreementDistributorAppointmentMaximumTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DistributionAgreementDistributorAppointmentMaximumTerm" xlink:to="lab_embc_DistributionAgreementDistributorAppointmentMaximumTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e9e98726-0d74-422a-b5ef-6fafe85090ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_0c24763f-bfbf-4c6a-b913-e147c8070037_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4e61ea50-227d-4cb7-a6a5-19c804931f85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_ab990407-28fa-4af9-be3b-f991760ec607_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_PaymentForSpinoffTransactionFinancingActivities_6e9cc5e3-2c75-4c68-8662-0f31c79ba64d_negatedTerseLabel_en-US" xlink:label="lab_embc_PaymentForSpinoffTransactionFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net consideration paid to Becton, Dickinson and Company in connection with the Separation</link:label>
    <link:label id="lab_embc_PaymentForSpinoffTransactionFinancingActivities_label_en-US" xlink:label="lab_embc_PaymentForSpinoffTransactionFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Spinoff Transaction, Financing Activities</link:label>
    <link:label id="lab_embc_PaymentForSpinoffTransactionFinancingActivities_documentation_en-US" xlink:label="lab_embc_PaymentForSpinoffTransactionFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Spinoff Transaction, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PaymentForSpinoffTransactionFinancingActivities" xlink:href="embc-20230930.xsd#embc_PaymentForSpinoffTransactionFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_PaymentForSpinoffTransactionFinancingActivities" xlink:to="lab_embc_PaymentForSpinoffTransactionFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_20df4ff1-a24c-4f87-872b-9f35de13f7bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_83bc7335-47c1-455a-a254-468a1b417885_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0245e385-aefa-49f0-87ea-b2562250e319_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_c0b62032-97e7-4394-b348-4f733092f5e6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_3d8d1095-fc3c-4bef-8e9c-84bbcc9647cd_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_b68ee44b-5471-4df4-b08d-b31593e3d2b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plan net loss and prior service credit, net of amortization</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_ae5c2651-e12d-4b5a-bfa3-ed642cb02134_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_d05b282c-7988-4813-9abe-b27a46f7274c_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents &#8211; net</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d67f2d23-bc40-43bf-a287-418f28db6c9b_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d0569e1a-5c20-45c7-be3b-5653297e5742_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_b78e5c9b-d49d-476f-8731-987ff64a0c35_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_92e2f9f5-c5e3-45d4-bdd3-efa0d50f6692_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f8926926-2ea8-4a9a-b2e9-e041ff00e610_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_af37ca44-9cef-49d6-919e-7f6a0a3e4b19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized for future grant ( in shares )</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_c87decf6-73ea-4c28-86d0-ddfdf91e0c94_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShippingAndHandlingPolicyPolicyTextBlock_854e4f0d-61f6-44b1-b9d2-16a400cd1544_terseLabel_en-US" xlink:label="lab_embc_ShippingAndHandlingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling Costs</link:label>
    <link:label id="lab_embc_ShippingAndHandlingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_embc_ShippingAndHandlingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping And Handling, Policy [Policy Text Block]</link:label>
    <link:label id="lab_embc_ShippingAndHandlingPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_embc_ShippingAndHandlingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping And Handling, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShippingAndHandlingPolicyPolicyTextBlock" xlink:href="embc-20230930.xsd#embc_ShippingAndHandlingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShippingAndHandlingPolicyPolicyTextBlock" xlink:to="lab_embc_ShippingAndHandlingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_01df9c74-51c8-4b05-b1c0-31099b5e165c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_033b17d3-6822-4a99-9c9d-03703ede2c0d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_49b665d8-5b00-47ec-ad57-113d3159aaf4_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fd1a8277-8095-4957-8ad5-e84335719d59_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated intangible asset amortization expense for 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2a30e63e-3c5d-496b-8400-38bb0d1950b9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_78268f75-a822-4451-8206-1509cad77b45_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_807ef4a3-448a-4170-be52-cf4670e1e47b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_7f8cf86e-381a-4a20-b282-80eeab5ca0d8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_7c7b7951-a7dd-4d89-a7fb-7b05e2632faf_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_030884a4-f275-480e-b853-416b396f6993_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ebb88974-121e-4b6d-8e45-c27af9f1de87_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_8bced8f7-add5-4580-aa3f-5b4ed1e539b0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend declared</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_8c679bb7-eb93-4598-8656-76d0165f8f82_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense capitalized</link:label>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Capitalized, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidCapitalized" xlink:to="lab_us-gaap_InterestPaidCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_eff5eca3-82d2-4ce8-a226-2ff35520efc0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_OtherCountriesMember_19dbca4f-eb64-4093-93f2-81a6f1168a14_terseLabel_en-US" xlink:label="lab_embc_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_embc_OtherCountriesMember_label_en-US" xlink:label="lab_embc_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_embc_OtherCountriesMember_documentation_en-US" xlink:label="lab_embc_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OtherCountriesMember" xlink:href="embc-20230930.xsd#embc_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_OtherCountriesMember" xlink:to="lab_embc_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_5a41cc27-27f7-43f7-8b5c-037711aa1348_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_0c6143fa-3e56-4fa4-bb4a-c3d5b891787f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_7c031549-acbf-4b88-886c-8792ae450a53_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_5c2287eb-47b7-431b-9acd-e26d485fea8f_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_91749bf0-ef00-4764-946d-4db788877567_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes on unremitted foreign earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_9bea2f47-0929-484b-a092-7c79d333d98f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of long-term debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_87834cae-31c9-438c-9791-8781c8ad4b86_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_afc1e3ae-b206-46d2-8699-0928f01bd9d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ca678979-38a7-4cd7-abb3-b454e2ebe240_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_a7b6e42f-f614-4e32-8b24-5996a45ee2b5_terseLabel_en-US" xlink:label="lab_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="embc-20230930.xsd#embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ffa83522-41d8-44f8-a94a-b7d856079fd8_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_bccecc95-317f-4194-856d-4fcc885cad5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: debt issuance costs and discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_a798b4e6-6806-475c-8917-ca4c92285ca4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_76a592df-408c-4c25-931c-89ec629aa2b7_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_245d903a-ec62-471c-a3dc-2dd5c1ddc866_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1932ed01-e14c-43bb-b056-d30118f0d8cf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_7b39634d-c064-4173-bf0f-91dfa5b71f48_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected to vest (in dollars per share)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Weighted Average Grant Date Fair value</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Weighted Average Grant Date Fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments_d003805d-b518-46e6-a56b-29229ee6ef8a_negatedTerseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers to Becton, Dickinson and Company including Separation adjustments</link:label>
    <link:label id="lab_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments_label_en-US" xlink:label="lab_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Net Transfers to Parent, Including Separation Adjustments</link:label>
    <link:label id="lab_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Net Transfers to Parent, Including Separation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" xlink:to="lab_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ac8189b6-6bb0-4d85-b413-fd9b82b682a1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeFinanceLeaseAreaOfPremisesLeased_944a9a1f-f5e0-44d9-a52f-707d23111c13_terseLabel_en-US" xlink:label="lab_embc_LesseeFinanceLeaseAreaOfPremisesLeased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of space leased (in square feet)</link:label>
    <link:label id="lab_embc_LesseeFinanceLeaseAreaOfPremisesLeased_label_en-US" xlink:label="lab_embc_LesseeFinanceLeaseAreaOfPremisesLeased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Area of Premises Leased</link:label>
    <link:label id="lab_embc_LesseeFinanceLeaseAreaOfPremisesLeased_documentation_en-US" xlink:label="lab_embc_LesseeFinanceLeaseAreaOfPremisesLeased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Area of Premises Leased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeFinanceLeaseAreaOfPremisesLeased" xlink:href="embc-20230930.xsd#embc_LesseeFinanceLeaseAreaOfPremisesLeased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeFinanceLeaseAreaOfPremisesLeased" xlink:to="lab_embc_LesseeFinanceLeaseAreaOfPremisesLeased" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_CollaborativeArrangementPrincipalRightsPercentage_c49f33ff-7e08-413f-8cd5-a19699149665_terseLabel_en-US" xlink:label="lab_embc_CollaborativeArrangementPrincipalRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales percentage</link:label>
    <link:label id="lab_embc_CollaborativeArrangementPrincipalRightsPercentage_label_en-US" xlink:label="lab_embc_CollaborativeArrangementPrincipalRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Principal Rights, Percentage</link:label>
    <link:label id="lab_embc_CollaborativeArrangementPrincipalRightsPercentage_documentation_en-US" xlink:label="lab_embc_CollaborativeArrangementPrincipalRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Principal Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CollaborativeArrangementPrincipalRightsPercentage" xlink:href="embc-20230930.xsd#embc_CollaborativeArrangementPrincipalRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_CollaborativeArrangementPrincipalRightsPercentage" xlink:to="lab_embc_CollaborativeArrangementPrincipalRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_35130402-da34-4970-a9dc-7b2c4c9b3da4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0fc311d2-e324-49c2-9d2d-a41984b9b842_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1d9d4e0a-a22a-4496-9cce-3ddfe01d560a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals and reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_fe39d997-7863-4e90-ba89-81bc11ef807e_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_b699f086-1bd4-493b-9cd6-62c8257f5685_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_accb6872-dcad-4263-bb58-e2d6d5ac8ba0_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_3eddc58b-a4a0-4329-b62e-b64c7fa50b08_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1eed03d8-0f51-4038-b1bc-c9970911fc31_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_efa99636-282b-450b-8b02-42e2aa0cdbd8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_0c9cdd1f-d701-4108-9f21-982364a5ae56_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_25b3a985-60f2-428b-8602-e39a7edb2e37_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_78d39bee-f868-4705-a0e3-dfbc47381e74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fb127b8b-dac9-4dd5-9056-6c21642bb386_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_6c283989-edf2-4d23-8627-3d564b8a8f61_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_A675SeniorSecuredNotesDueFebruary2030Member_07eefd63-dec1-4f89-86cd-96032a56a19a_terseLabel_en-US" xlink:label="lab_embc_A675SeniorSecuredNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% Senior Secured Notes due 2030</link:label>
    <link:label id="lab_embc_A675SeniorSecuredNotesDueFebruary2030Member_cc0cbbcb-7551-4d6a-9aa8-a0b767723c93_verboseLabel_en-US" xlink:label="lab_embc_A675SeniorSecuredNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% Notes due February 2030</link:label>
    <link:label id="lab_embc_A675SeniorSecuredNotesDueFebruary2030Member_label_en-US" xlink:label="lab_embc_A675SeniorSecuredNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% Senior Secured Notes due February 2030 [Member]</link:label>
    <link:label id="lab_embc_A675SeniorSecuredNotesDueFebruary2030Member_documentation_en-US" xlink:label="lab_embc_A675SeniorSecuredNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% Senior Secured Notes due February 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member" xlink:href="embc-20230930.xsd#embc_A675SeniorSecuredNotesDueFebruary2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member" xlink:to="lab_embc_A675SeniorSecuredNotesDueFebruary2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_be872372-5d1e-4001-b1d0-028b7285855f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_28d95c3e-a9a1-4b4f-9eb3-d9d774bea2f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common dividends ($0.15 per share)</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_58ab368a-ae40-401a-9817-a303d3b51b13_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_3de17dec-dfc7-4c45-940a-e5af75cd3d8e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_f5cfca08-180b-4d12-af92-88cdda271f90_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_fa7bf6c3-8819-4960-a3a9-6a822f26d507_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6f36edf8-3a95-4e2c-b992-0a1d3ec0ed4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentOtherTransfersToFromParentNet_78386a1f-e516-4ee2-a3b8-93e619e0fa41_terseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentOtherTransfersToFromParentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other transfers to (from) BD, net</link:label>
    <link:label id="lab_embc_NetParentInvestmentOtherTransfersToFromParentNet_label_en-US" xlink:label="lab_embc_NetParentInvestmentOtherTransfersToFromParentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Other Transfers To (From) Parent, Net</link:label>
    <link:label id="lab_embc_NetParentInvestmentOtherTransfersToFromParentNet_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentOtherTransfersToFromParentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Other Transfers To (From) Parent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentOtherTransfersToFromParentNet" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentOtherTransfersToFromParentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentOtherTransfersToFromParentNet" xlink:to="lab_embc_NetParentInvestmentOtherTransfersToFromParentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e3ceaf64-ed0a-4eb3-be4a-c66a1c4520d8_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fda9e75a-90c2-4903-a0e8-c5a754924216_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amount representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2d4310d4-e4e4-45c7-b2ab-c6bc80344e0d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_edf7981a-0c1f-443f-9d05-b2636f111c5c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_29afba7e-7895-476c-adac-8a89fa0430ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Provision (Benefit) for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_6f708df3-a4a0-4248-babc-a42399dc33a1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c5723a84-d32d-4a3d-a222-3d76444eb071_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards_9181928d-14b7-4009-9d5e-7889bb37d2ab_terseLabel_en-US" xlink:label="lab_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax loss and credit carryforwards</link:label>
    <link:label id="lab_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards_label_en-US" xlink:label="lab_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards</link:label>
    <link:label id="lab_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards_documentation_en-US" xlink:label="lab_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" xlink:href="embc-20230930.xsd#embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" xlink:to="lab_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_e85ce685-86fc-493b-8987-706d7a9d9d20_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_de057010-f03a-421d-a532-33cfca5b8158_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_50df05b5-b188-45a0-abff-3531f62b7c94_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_69c8079a-37c9-4853-9501-cc683434ea1d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_3c4e1707-abb2-4063-922c-e39be01458d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease due to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_879f32b8-b556-439e-9484-aeb70f3475d3_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_ed8dfcef-7980-45e8-a005-786ecc093499_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartiesAmountInCostOfSales_93090e18-02b3-46df-ad03-b49528f87ab4_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartiesAmountInCostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold from related party inventory purchases</link:label>
    <link:label id="lab_us-gaap_RelatedPartiesAmountInCostOfSales_label_en-US" xlink:label="lab_us-gaap_RelatedPartiesAmountInCostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties Amount in Cost of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartiesAmountInCostOfSales" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartiesAmountInCostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartiesAmountInCostOfSales" xlink:to="lab_us-gaap_RelatedPartiesAmountInCostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_6e029869-8dd2-4c72-8383-bde57db3689a_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a8e1ed12-d217-46c0-ad39-6be4010fd6c2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_A500SeniorSecuredNotesDueFebruary2030Member_7a8fdda7-ce34-4a08-b764-7c671cacecd4_terseLabel_en-US" xlink:label="lab_embc_A500SeniorSecuredNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.00% Senior Secured Notes due 2030</link:label>
    <link:label id="lab_embc_A500SeniorSecuredNotesDueFebruary2030Member_bec91436-e6a9-4ffb-85ad-3ffbb88e1ec6_verboseLabel_en-US" xlink:label="lab_embc_A500SeniorSecuredNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.00% Notes due February 2030</link:label>
    <link:label id="lab_embc_A500SeniorSecuredNotesDueFebruary2030Member_label_en-US" xlink:label="lab_embc_A500SeniorSecuredNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.00% Senior Secured Notes due February 2030 [Member]</link:label>
    <link:label id="lab_embc_A500SeniorSecuredNotesDueFebruary2030Member_documentation_en-US" xlink:label="lab_embc_A500SeniorSecuredNotesDueFebruary2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.00% Senior Secured Notes due February 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member" xlink:href="embc-20230930.xsd#embc_A500SeniorSecuredNotesDueFebruary2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member" xlink:to="lab_embc_A500SeniorSecuredNotesDueFebruary2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_379f46f1-7f8c-41b9-9694-32b8157025aa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax reserves</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_02847ea0-1a41-4491-b87d-e03ba4e9caa0_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amortized intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_c7b00ce1-0d13-4e05-8069-98cd580e401a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ee573c08-efa8-46d3-944a-ffcf6e8ec52e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_ccbdbb80-1bda-48e7-a11d-7c37088f7c03_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and benefits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_BuildingLeaseFourYearExtensionOptionMember_44de2c83-acb9-4420-8ee7-1083b857fd3d_terseLabel_en-US" xlink:label="lab_embc_BuildingLeaseFourYearExtensionOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Lease, Four Year Extension Option</link:label>
    <link:label id="lab_embc_BuildingLeaseFourYearExtensionOptionMember_label_en-US" xlink:label="lab_embc_BuildingLeaseFourYearExtensionOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Lease, Four Year Extension Option [Member]</link:label>
    <link:label id="lab_embc_BuildingLeaseFourYearExtensionOptionMember_documentation_en-US" xlink:label="lab_embc_BuildingLeaseFourYearExtensionOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Lease, Four Year Extension Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BuildingLeaseFourYearExtensionOptionMember" xlink:href="embc-20230930.xsd#embc_BuildingLeaseFourYearExtensionOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_BuildingLeaseFourYearExtensionOptionMember" xlink:to="lab_embc_BuildingLeaseFourYearExtensionOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b23bc0db-e4ba-4ea9-b5d4-e638b2d31acc_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DebtInstrumentVariableRateFloor_f8786530-ee88-4a5d-89eb-84b70c64e237_terseLabel_en-US" xlink:label="lab_embc_DebtInstrumentVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate floor</link:label>
    <link:label id="lab_embc_DebtInstrumentVariableRateFloor_label_en-US" xlink:label="lab_embc_DebtInstrumentVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Floor</link:label>
    <link:label id="lab_embc_DebtInstrumentVariableRateFloor_documentation_en-US" xlink:label="lab_embc_DebtInstrumentVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate, Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentVariableRateFloor" xlink:href="embc-20230930.xsd#embc_DebtInstrumentVariableRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DebtInstrumentVariableRateFloor" xlink:to="lab_embc_DebtInstrumentVariableRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member_ee76af42-61ab-4bf2-b4de-4cd93074a1c1_terseLabel_en-US" xlink:label="lab_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member_label_en-US" xlink:label="lab_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Credit Facility Maturing 2027 [Member]</link:label>
    <link:label id="lab_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member_documentation_en-US" xlink:label="lab_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Revolving Credit Facility Maturing 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member" xlink:href="embc-20230930.xsd#embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member" xlink:to="lab_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_1b16486b-089b-40da-bbed-80e5994dc306_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a226a23a-1c8f-4d01-bcff-7d64ed22201b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b25e721d-dd8d-4c2c-9843-dd8a3c34f641_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6519fa3c-8de1-446c-b678-848dd48534b3_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - condensed combined statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ae59bdca-5d2e-4d9f-8a91-8d8026bb033f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized intangible assets - Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentShareBasedCompensationExpense_9ba12b01-aef4-49a7-8c84-494a89c67d1a_negatedTerseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_embc_NetParentInvestmentShareBasedCompensationExpense_label_en-US" xlink:label="lab_embc_NetParentInvestmentShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Share-Based Compensation Expense</link:label>
    <link:label id="lab_embc_NetParentInvestmentShareBasedCompensationExpense_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Share-Based Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentShareBasedCompensationExpense" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentShareBasedCompensationExpense" xlink:to="lab_embc_NetParentInvestmentShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife_c3dbb152-d1f4-4f6b-8258-e9130663f7df_terseLabel_en-US" xlink:label="lab_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cloud computing arrangement assets in-service useful lives</link:label>
    <link:label id="lab_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife_label_en-US" xlink:label="lab_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Assets In-Service, Useful Life</link:label>
    <link:label id="lab_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife_documentation_en-US" xlink:label="lab_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Assets In-Service, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife" xlink:href="embc-20230930.xsd#embc_HostingArrangementServiceContractAssetsInServiceUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife" xlink:to="lab_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_83958d9a-c5db-47f7-bb7f-537708604ac2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_881a54c8-ad06-4114-9bc1-f9d9f77611c6_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_f64b971d-58e5-4924-b75c-2655b954ebdb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_094b7fa2-026b-4c22-aec8-16c935756e0d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_f2ed2c0f-cf3d-4aae-83d5-99da10932a24_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_483b482e-bd60-41e9-af59-a600503143a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3e35109e-9574-4947-b478-d6a1a2f29b1f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributed (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_a07c42d0-8450-4fb3-bd5e-f02de2c89545_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_3695b3e4-faa9-4484-9fc9-51fd711fe616_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_08d273e7-126a-4591-935c-9c395bc33c37_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2673c50f-341b-4a8d-bc96-0c7a23d96c11_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0f525b5c-39cf-4df9-b097-42e6709bb7f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4e0384d8-5b75-4fb1-a6d2-35c67f82872f_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_46b60cb8-d094-4070-8731-ddedc39036d6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_f57b935a-fe4c-4801-970d-30130afccd11_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3fe17aa6-84bd-461b-8859-189fb41e0ed2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_e2b70d24-2352-4e15-9548-c6a3531da686_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, canceled or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_4b71ef75-fd40-42dd-9e79-e4e681c20a2b_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedPaymentArrangementLiabilityAwardMember_88eed9e3-4ace-4536-8622-b1e887bf6cb5_terseLabel_en-US" xlink:label="lab_embc_ShareBasedPaymentArrangementLiabilityAwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Awards</link:label>
    <link:label id="lab_embc_ShareBasedPaymentArrangementLiabilityAwardMember_label_en-US" xlink:label="lab_embc_ShareBasedPaymentArrangementLiabilityAwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Liability Award [Member]</link:label>
    <link:label id="lab_embc_ShareBasedPaymentArrangementLiabilityAwardMember_documentation_en-US" xlink:label="lab_embc_ShareBasedPaymentArrangementLiabilityAwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Liability Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedPaymentArrangementLiabilityAwardMember" xlink:href="embc-20230930.xsd#embc_ShareBasedPaymentArrangementLiabilityAwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedPaymentArrangementLiabilityAwardMember" xlink:to="lab_embc_ShareBasedPaymentArrangementLiabilityAwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_bb18735a-1a98-4349-9bb2-3f621432ae8e_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_508ce456-1187-4c45-8acd-58b609fb45a3_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_3854c67c-ab0c-4af1-b0b6-343e5046ed93_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and penalties expense (benefit) associated with unrecognized tax benefits on the Consolidated Statements of Income</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a3a03333-acdf-4dd0-b273-28621e44c475_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for recognition for unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f85b52ef-35fe-499f-9cfe-0b47188d2efd_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_f456ddee-8d3d-4284-a6cd-be7934cc69e3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_dc2e589e-bb6b-4aef-9d22-a81bf8894288_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_610b9f25-48b7-48c3-938d-8a05cc55d3a7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_d6886993-8766-4972-ad21-f6c015b66668_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember_ea0b4677-a827-4ed0-8f97-09581415447d_terseLabel_en-US" xlink:label="lab_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Employee and Director Equity Based Compensation Plan</link:label>
    <link:label id="lab_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember_label_en-US" xlink:label="lab_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Employee and Director Equity Based Compensation Plan [Member]</link:label>
    <link:label id="lab_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember_documentation_en-US" xlink:label="lab_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Employee and Director Equity Based Compensation Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember" xlink:href="embc-20230930.xsd#embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember" xlink:to="lab_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_90c675d9-eca4-4e06-80b3-40519a02e3ea_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded net pension obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_49c73614-46e5-4de8-8f3a-50fee105a249_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_a4082c73-72ec-4e58-b66c-3b74160791b0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_8fd0d2fa-c618-4ea0-b940-00ef1e77a2fd_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, Middle East, and Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_920f0062-e335-4f34-a191-59d93e2911ba_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_669319f2-6585-4304-8747-2bb33f23497a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_4fa3959d-7a77-4c6d-b9c5-3bab9f066364_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, canceled or expired (in dollars per share)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_72b04ae6-9a68-4ae2-aad7-5d9db0d0b5e6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_fdb67191-fe25-497b-b75f-37bafea621e6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_80220dc9-81b7-4b4c-a705-b1dc83f1b49f_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_c6cca2e2-1d6b-4f09-95e1-1bb3fd80f582_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_cf368d10-9ed9-4121-887e-11e8f2ef07fa_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CEO</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8436e167-c36d-4ac4-bde4-00c6f53443ce_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_6143dbb0-6e39-4a78-819e-dff747439c3f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e035ddee-4f5b-4461-a2aa-8f5a2aa0ccb4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_77c2d7c4-05df-492a-bfb0-208316b6d8c7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ef843f77-59f4-432f-9782-028ee1653b20_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_dcb97636-a9de-488c-9fe0-48fabcf41384_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_4d92ad2a-ea79-47f8-917f-0718b4043a3a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_f25873bf-8a94-41c0-859c-e7c324ed95a4_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_e94d860f-1de0-4db4-9d2e-80a9d67e1b6e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_91866fd9-d735-4390-9a97-8eb09ce77811_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_443a4a23-db81-438e-a5c2-e21e0bdb3b40_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Interest Carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_96f5fc6a-43e0-4f91-82df-017609559ff7_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_5f101c26-0d8a-4629-8121-999e2f69f19b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DebtInstrumentDiscountGross_92b72bd5-2bcd-4494-b17e-56cc94db77c7_terseLabel_en-US" xlink:label="lab_embc_DebtInstrumentDiscountGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_embc_DebtInstrumentDiscountGross_label_en-US" xlink:label="lab_embc_DebtInstrumentDiscountGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount, Gross</link:label>
    <link:label id="lab_embc_DebtInstrumentDiscountGross_documentation_en-US" xlink:label="lab_embc_DebtInstrumentDiscountGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentDiscountGross" xlink:href="embc-20230930.xsd#embc_DebtInstrumentDiscountGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DebtInstrumentDiscountGross" xlink:to="lab_embc_DebtInstrumentDiscountGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_348a1b22-3dd9-4a05-aafb-8e9946668dcd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c221705d-8a67-40dc-adf8-1e3aa675fa3a_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with the Separation and reclassification of Net Investment from Becton, Dickinson and Company (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3e21c9e7-5ff0-458e-b5ed-bcacecf2332d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares distributed</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d02e4723-e23e-483e-96c2-54c5a75c8e4a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage_6df5e866-1c9b-4d64-a206-86527a3c78de_terseLabel_en-US" xlink:label="lab_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum deferral percentage of base salary under deferred compensation plan</link:label>
    <link:label id="lab_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage_label_en-US" xlink:label="lab_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Base Salary Deferral Maximum, Percentage</link:label>
    <link:label id="lab_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage_documentation_en-US" xlink:label="lab_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Base Salary Deferral Maximum, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage" xlink:href="embc-20230930.xsd#embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage" xlink:to="lab_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_dfc8f610-fa24-4a4c-8f03-ccbb57e5face_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_351e15cf-da21-41aa-a952-27aadfaf263d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued balance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_449eb399-de66-42ff-ac05-794636c071c1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incremental cost to be recognized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseMember_fe668498-a061-43cd-97f4-90c3f9d2a843_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_237c377a-fb7b-417e-8a3a-767f4749f805_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of finance lease</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:to="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f5fef6ea-69b3-49ea-806f-b8b28fc1e6e0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested, Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_60ab3181-05a6-440e-a3de-a0ae9b38820e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested, Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e6340359-56fc-4495-b674-357900609e46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value per SAR (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ae8bd7b5-3a3f-4b5d-8e85-1a88e0e21568_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares related to stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_dae0b6df-9edf-4706-90c8-c222377749e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_BectonDickinsonAndCompanyMember_005b2e85-6bd4-42de-a303-7250f3ae0bd9_terseLabel_en-US" xlink:label="lab_embc_BectonDickinsonAndCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Becton, Dickinson and Company</link:label>
    <link:label id="lab_embc_BectonDickinsonAndCompanyMember_label_en-US" xlink:label="lab_embc_BectonDickinsonAndCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Becton, Dickinson and Company [Member]</link:label>
    <link:label id="lab_embc_BectonDickinsonAndCompanyMember_documentation_en-US" xlink:label="lab_embc_BectonDickinsonAndCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Becton, Dickinson and Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BectonDickinsonAndCompanyMember" xlink:href="embc-20230930.xsd#embc_BectonDickinsonAndCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_BectonDickinsonAndCompanyMember" xlink:to="lab_embc_BectonDickinsonAndCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_CustomerOneCustomerTwoAndCustomerThreeMember_f5cb12fb-9328-45bf-969f-04c822e6e478_terseLabel_en-US" xlink:label="lab_embc_CustomerOneCustomerTwoAndCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Customers in Aggregate</link:label>
    <link:label id="lab_embc_CustomerOneCustomerTwoAndCustomerThreeMember_label_en-US" xlink:label="lab_embc_CustomerOneCustomerTwoAndCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One, Customer Two and Customer Three [Member]</link:label>
    <link:label id="lab_embc_CustomerOneCustomerTwoAndCustomerThreeMember_documentation_en-US" xlink:label="lab_embc_CustomerOneCustomerTwoAndCustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One, Customer Two and Customer Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CustomerOneCustomerTwoAndCustomerThreeMember" xlink:href="embc-20230930.xsd#embc_CustomerOneCustomerTwoAndCustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_CustomerOneCustomerTwoAndCustomerThreeMember" xlink:to="lab_embc_CustomerOneCustomerTwoAndCustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet_0ca16a5c-1ae7-4d6f-927d-f1b979b610e0_negatedTerseLabel_en-US" xlink:label="lab_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from/due to Becton, Dickinson and Company</link:label>
    <link:label id="lab_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet_label_en-US" xlink:label="lab_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Other Receivables And Other Accounts Payable, Net</link:label>
    <link:label id="lab_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet_documentation_en-US" xlink:label="lab_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Other Receivables And Other Accounts Payable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" xlink:href="embc-20230930.xsd#embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" xlink:to="lab_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_46c7f3c9-fce7-4972-a064-04ef5fe73b81_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b49586c3-9171-4b11-9e47-fb85fe130bcc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_555670ad-0f3b-4579-b45e-43faa40d1438_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_61ce3a42-775a-44e1-bf29-eed6ee566c06_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_37da9a86-f98d-4f46-b669-893cb7521d69_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_15f223a8-c2e1-4137-95d6-c91279606ef0_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_1f1fb87f-a7e7-4186-a884-6c7cfaab70c4_totalLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_label_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Due after Year Five</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Due after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive" xlink:to="lab_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_ea98e07b-197a-4cbc-bad5-21afd69b22cb_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_5ea230c4-8b80-4381-9fbd-21f1c74cce51_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_5cce16aa-5689-4fc9-ad68-f78ec1b094ed_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_FinanceLeaseCost_47b8e9ec-ce2e-4f8c-bc0f-feb48edc4232_terseLabel_en-US" xlink:label="lab_embc_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_embc_FinanceLeaseCost_label_en-US" xlink:label="lab_embc_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:label id="lab_embc_FinanceLeaseCost_documentation_en-US" xlink:label="lab_embc_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_FinanceLeaseCost" xlink:href="embc-20230930.xsd#embc_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_FinanceLeaseCost" xlink:to="lab_embc_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_d191e674-2cfc-4d6f-b76f-4eff0eeb686c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_a3e45cd1-724c-4686-b8fa-919711fdadd7_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment_fcd6bd83-ee6a-452d-83c9-8296309d8d8c_terseLabel_en-US" xlink:label="lab_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with the Separation and reclassification of Net Investment from Becton, Dickinson and Company</link:label>
    <link:label id="lab_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment_label_en-US" xlink:label="lab_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues and Reclassification of Net Parent Investment</link:label>
    <link:label id="lab_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment_documentation_en-US" xlink:label="lab_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues and Reclassification of Net Parent Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" xlink:href="embc-20230930.xsd#embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" xlink:to="lab_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_CustomerRelationshipAndOtherMember_8531e775-1ef6-4652-882d-2d480fb85397_terseLabel_en-US" xlink:label="lab_embc_CustomerRelationshipAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships and Other &#8211; net</link:label>
    <link:label id="lab_embc_CustomerRelationshipAndOtherMember_label_en-US" xlink:label="lab_embc_CustomerRelationshipAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationship And Other [Member]</link:label>
    <link:label id="lab_embc_CustomerRelationshipAndOtherMember_documentation_en-US" xlink:label="lab_embc_CustomerRelationshipAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationship and other [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CustomerRelationshipAndOtherMember" xlink:href="embc-20230930.xsd#embc_CustomerRelationshipAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_CustomerRelationshipAndOtherMember" xlink:to="lab_embc_CustomerRelationshipAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentNetTransfersToParent_c4d01431-c3a3-4692-98d8-cb1f2b6a4680_negatedTerseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentNetTransfersToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers to Becton, Dickinson and Company</link:label>
    <link:label id="lab_embc_NetParentInvestmentNetTransfersToParent_bf5fbd4b-6036-47bc-ab8e-b1ed9fe6029c_totalLabel_en-US" xlink:label="lab_embc_NetParentInvestmentNetTransfersToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers to BD</link:label>
    <link:label id="lab_embc_NetParentInvestmentNetTransfersToParent_label_en-US" xlink:label="lab_embc_NetParentInvestmentNetTransfersToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Net Transfers to Parent</link:label>
    <link:label id="lab_embc_NetParentInvestmentNetTransfersToParent_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentNetTransfersToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Net Transfers to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentNetTransfersToParent" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentNetTransfersToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentNetTransfersToParent" xlink:to="lab_embc_NetParentInvestmentNetTransfersToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_34bbf4a9-d44a-4edf-96f8-4e6e72d9e6a1_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2783766c-42fc-497d-a61b-8ddb378c3878_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_fccdae47-844a-4169-801f-874115ef1ea3_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_67ccf89c-edfc-459c-9df4-654fc3b2dfbf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_e98177be-f055-4c70-a5b0-d0a08fcb0136_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9dc500c7-0c02-4fb6-b675-f3b9d0de2115_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f489ade2-799d-4ed4-ab3f-6ee74c9b6c00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f2b0ee73-a594-4b8a-b71b-825530291fc7_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_90e4cd4d-14a1-481f-af96-4c01faf837fd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition and Measurement of Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_c024d8b5-7c2d-4ab6-8cd5-ea3ccffb226e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b99d8c27-c680-4ce8-9b3c-a2bc58912782_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f66eed58-87bf-4c9b-830b-fe54e186f625_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_774d233c-d229-4930-915a-467233e04f72_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9a589d61-f31b-4ac2-bc0e-4a2d4ea24c34_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ff12b1c8-2468-4533-91d8-82fdaa1f2d2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6542c794-30db-42e4-9047-fe608b2cb50f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_468550fb-1e94-4575-8a8d-6aa01ec61176_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e96e01ce-7dc9-4239-93ff-322daeeb1eed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_07351708-b744-429b-bfd9-558e8481357e_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation_6eb95d31-f9b2-42cf-b383-f081909d703c_negatedTerseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and segment allocations, excluding non-cash stock-based compensation</link:label>
    <link:label id="lab_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation_label_en-US" xlink:label="lab_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Corporate And Segment Allocations, Excluding Non-Cash Share-Based Compensation</link:label>
    <link:label id="lab_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Corporate And Segment Allocations, Excluding Non-Cash Share-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" xlink:to="lab_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetTransfersToParentFinancingActivities_7a4606aa-ce04-4a41-8cb5-0f6d83998869_negatedLabel_en-US" xlink:label="lab_embc_NetTransfersToParentFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers to Becton, Dickinson and Company</link:label>
    <link:label id="lab_embc_NetTransfersToParentFinancingActivities_label_en-US" xlink:label="lab_embc_NetTransfersToParentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Transfers to Parent, Financing Activities</link:label>
    <link:label id="lab_embc_NetTransfersToParentFinancingActivities_documentation_en-US" xlink:label="lab_embc_NetTransfersToParentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Transfers to Parent, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetTransfersToParentFinancingActivities" xlink:href="embc-20230930.xsd#embc_NetTransfersToParentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetTransfersToParentFinancingActivities" xlink:to="lab_embc_NetTransfersToParentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_50ef2967-9ed9-470e-8ca1-ecae316ae9dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_AssetsAndLiabilitiesLesseeTableTextBlock_faf0395e-ae59-4d58-bc2a-29d187191a39_terseLabel_en-US" xlink:label="lab_embc_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Balance Sheet Information</link:label>
    <link:label id="lab_embc_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_embc_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_embc_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_embc_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="embc-20230930.xsd#embc_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_embc_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3dfa0678-3ac5-4cd4-99ae-0a26f9d71db8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated intangible asset amortization expense for 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_44587c3c-a531-4bc8-bc96-e8a96deb0304_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_8f0ba469-afd6-439f-9456-f227eaa6aa2c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f31feede-9d67-4f1a-80f1-9d2d95bb54c1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d3efe772-49e1-4ea6-8edd-17060c1771a1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_19fb9e34-9eeb-47e1-8e85-33a508b8c797_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_53997492-ee4a-4042-a2fa-d8f72f973ea6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_a046907a-92ef-4e68-98f0-ca723a7b19a2_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue_c2935ceb-33e4-463d-a6a4-f325c46b4914_terseLabel_en-US" xlink:label="lab_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Logistics Services Agreement, administrative fee as a percentage of net revenue</link:label>
    <link:label id="lab_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue_label_en-US" xlink:label="lab_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Logistics Services Agreement, Administrative Fee, Percentage of Net Revenue</link:label>
    <link:label id="lab_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue_documentation_en-US" xlink:label="lab_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Logistics Services Agreement, Administrative Fee, Percentage of Net Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" xlink:href="embc-20230930.xsd#embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" xlink:to="lab_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3feff24b-f73b-4262-ae53-09c1b9b5ff7b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8e8f69c8-01b5-47b8-af53-4fa660b04880_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5582bda8-8db8-4e5f-9ed6-21ecce2646e5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_54819adc-1bac-4ec3-9f46-f1a02521bbd0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used for Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_7770d8f5-d675-4dae-a48e-9dcc604b4f03_totalLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amount representing interest</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityUndiscountedExcessAmount" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_embc_LesseeLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_b8baa7c8-9891-4d55-a36f-c8fd6482bb04_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1fd1b930-3060-420d-8c89-b554978e3833_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7393008a-2cbe-4eee-887f-7bd2774442f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a86a9827-ab1f-437a-a1f2-66c3f2db0a83_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_6b2d6c39-55d4-4ba9-a609-7ec6a94aab11_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_249fa8ed-a5ba-4748-b713-55d4d2d51bd1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_0654fdac-1b3a-4c12-9a8a-e70ad7940802_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_298a51bf-ed55-4f5b-bd7b-0bbd89db6430_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_ceef0d1f-8c1e-4e3f-89dd-d6073af1a941_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Payments Required on Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_e3406649-1747-443d-b94d-9c75ea7e2543_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current total</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f6bd321b-36ce-426c-8f02-233cec4f961a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_87a992b4-ee73-473f-a4ff-3889f6a197eb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_547c1bee-dc97-4aae-b5ad-ed87ac03ae7f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_65dd6a23-3d09-49ef-8565-4546ea2dde1a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_1e420d6c-a8a4-4f83-a5d5-48a1b4608a18_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_96b30bda-950a-471a-9981-68199eaec77d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_e7db5ba6-cf1c-4325-ad20-ff1a4b8cc4e8_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_9ac379bd-9ddf-445b-82b3-257e29d63210_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_TaxMattersAgreementCovenantRestrictionsPeriod_4fba9488-12bd-48fd-8f8a-db480b32bac5_terseLabel_en-US" xlink:label="lab_embc_TaxMattersAgreementCovenantRestrictionsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matters Agreement, covenant restrictions period</link:label>
    <link:label id="lab_embc_TaxMattersAgreementCovenantRestrictionsPeriod_label_en-US" xlink:label="lab_embc_TaxMattersAgreementCovenantRestrictionsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matters Agreement, Covenant Restrictions, Period</link:label>
    <link:label id="lab_embc_TaxMattersAgreementCovenantRestrictionsPeriod_documentation_en-US" xlink:label="lab_embc_TaxMattersAgreementCovenantRestrictionsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matters Agreement, Covenant Restrictions, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TaxMattersAgreementCovenantRestrictionsPeriod" xlink:href="embc-20230930.xsd#embc_TaxMattersAgreementCovenantRestrictionsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_TaxMattersAgreementCovenantRestrictionsPeriod" xlink:to="lab_embc_TaxMattersAgreementCovenantRestrictionsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_b8a345ef-765e-4fa6-b4c9-a94d5b46ac53_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Performance Based Restricted Stock Units Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_2b5dca7d-1bb5-42a2-b520-d9d2c30fcb35_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_007e23af-479b-4e52-a586-c6e683f881ce_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_526927d6-16d0-4450-9cce-eb2fa52f45df_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit associated with stock-based compensation costs recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_63e3bb4e-b443-4cf6-b956-cd2672bab67a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_ba4509f0-ee05-4066-85f6-f64449b61981_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_aa58415f-56c0-4d8a-a72d-cbad122e03fb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_77e7c2eb-6808-4d50-b796-174d8b057cad_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_4eb5574a-32cd-47a3-8403-58823b4017c8_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_201ddff3-154b-4f4e-8f7f-bc621a6c2409_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_691fe3fb-b3c7-47a8-8c52-f44cea23abbf_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_bf4f01a1-b904-431a-9418-591b35e1d947_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Units (in thousands)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_454eebbc-87a2-4f0f-9c00-2a96b08af616_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SARs (in thousands)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_HostingArrangementServiceContractPolicyTextBlock_f1d58b41-a4a9-4154-b85e-d8a2017c2e7a_terseLabel_en-US" xlink:label="lab_embc_HostingArrangementServiceContractPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cloud Computing Arrangements</link:label>
    <link:label id="lab_embc_HostingArrangementServiceContractPolicyTextBlock_label_en-US" xlink:label="lab_embc_HostingArrangementServiceContractPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement Service Contract [Policy Text Block]</link:label>
    <link:label id="lab_embc_HostingArrangementServiceContractPolicyTextBlock_documentation_en-US" xlink:label="lab_embc_HostingArrangementServiceContractPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement Service Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_HostingArrangementServiceContractPolicyTextBlock" xlink:href="embc-20230930.xsd#embc_HostingArrangementServiceContractPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_HostingArrangementServiceContractPolicyTextBlock" xlink:to="lab_embc_HostingArrangementServiceContractPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue_0dd3adde-abea-4efa-b9b6-68565eac513c_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of SARs exercised</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Intrinsic Value</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_bb9ae7c5-0631-4cb8-9cdb-3b192879b50e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value Authorized - 250,000,000 Issued and outstanding - 57,333,353 as of September&#160;30, 2023 and 57,055,327 as of September&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_8520ae33-fe90-4287-a887-e6d2b7726770_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_cb335072-5d15-44f3-b947-a7ffb9a82505_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_1bb41665-1d35-4bd8-b64c-2178d60fa3e1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_0d981399-b9fd-4e5f-b485-67f211042854_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_e1db7d75-7007-497f-94a8-b1b52fbdcfc6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Data</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f3694233-9876-48f2-90f9-af93ec001aa8_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3ae3092-2e33-42b2-b0fa-41430dca2f77_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f62043e9-79c5-41c9-b960-f227b84009a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_3fd0ed36-4ac2-4bde-b26a-046b960d487e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_082cdfef-c2c9-4f13-96ce-f896d9c27b94_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from Finance Lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e8ff5bf2-4857-4d7c-82ab-e7b14b69a694_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plan expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_abc0bbd0-dbc1-410a-b1eb-08c98acb0c19_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Finance Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_61d2d80a-3534-485e-97f2-e3090c6f1288_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment expense</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_4dc1a244-cef0-42b5-afbe-7de2f2c2915e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_34a9e50f-e290-4279-a0ef-3ec2a9584dd3_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9ebbe483-41c2-4530-bd0e-2b06b98ba53e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_9bf3691c-867f-4bc0-a1d5-825aba73ff4c_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f81f94ba-be18-41f2-b5f6-de56cd26b2ce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7ce9845e-d120-495d-a12f-e69c3b6950d7_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_AuditInformationAbstract_label_en-US" xlink:label="lab_embc_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_embc_AuditInformationAbstract_documentation_en-US" xlink:label="lab_embc_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_AuditInformationAbstract" xlink:href="embc-20230930.xsd#embc_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_AuditInformationAbstract" xlink:to="lab_embc_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_cbfa0ec4-190d-406f-8e17-66931d54378a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_862fa17c-ff26-4c8f-86ee-505b47882101_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4db700d0-d29e-40a9-a770-2db5001ade34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_1559d26f-5339-451e-9fc9-3a2c06426e64_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_0b07bf04-83c4-4fd0-a2fc-e0925e1f83e9_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_3dd4f994-6a90-4724-a8d4-f209e9805133_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_604694c9-f2fa-4e8e-a520-b024e96ed896_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ce56f27c-bd5c-468a-92da-4bb0055178e6_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0b22b8ce-821f-4f22-8ccb-9f9962330033_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_f929fd63-ee73-4b5c-8436-1b20c48ef689_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated intangible asset amortization expense for 2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cfd20cad-e95f-4b1e-acda-db11a7799046_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dbb25044-9ea1-4509-a168-8dce7afada2c_netLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value of units granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_b491017e-25be-42e0-ab31-df2f130817a9_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_ccba5f4a-cc50-4dff-832d-932abd5b67ac_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_c6d7f82c-8654-4def-a930-e80e296da7e0_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Receivables</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b47fc6-ad4a-43d3-86af-f975f8c716f7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_65d79d23-a42d-4166-a765-69c3b710b1ea_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions and other</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_TimeVestedRestrictedStockUnitsMember_12f39ada-40ad-44d9-ad55-5ac9d529b60b_terseLabel_en-US" xlink:label="lab_embc_TimeVestedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time Vested Restricted Stock Units</link:label>
    <link:label id="lab_embc_TimeVestedRestrictedStockUnitsMember_92974e83-178f-4eed-95a9-d211bd7e49f8_verboseLabel_en-US" xlink:label="lab_embc_TimeVestedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-Vested Restricted Stock Units (TVUs)</link:label>
    <link:label id="lab_embc_TimeVestedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_embc_TimeVestedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time Vested Restricted Stock Units [Member]</link:label>
    <link:label id="lab_embc_TimeVestedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_embc_TimeVestedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time Vested Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_TimeVestedRestrictedStockUnitsMember" xlink:to="lab_embc_TimeVestedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentRelatedPartyDebtIssued_ed3cb0cb-2e5b-415c-83f3-a77a40d1a628_terseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentRelatedPartyDebtIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party senior secured notes</link:label>
    <link:label id="lab_embc_NetParentInvestmentRelatedPartyDebtIssued_label_en-US" xlink:label="lab_embc_NetParentInvestmentRelatedPartyDebtIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Related Party Debt Issued</link:label>
    <link:label id="lab_embc_NetParentInvestmentRelatedPartyDebtIssued_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentRelatedPartyDebtIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Related Party Debt Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentRelatedPartyDebtIssued" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentRelatedPartyDebtIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentRelatedPartyDebtIssued" xlink:to="lab_embc_NetParentInvestmentRelatedPartyDebtIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_19c3b210-adfb-4633-8c97-641d73c37fe2_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_a12abf85-5c69-4037-9a67-2372fb29b3df_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_3e08bc6a-90fa-4db7-aa01-5e9118044192_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Background</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_4d91b394-0eb5-4390-866f-bda2766c1d2d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_133cb09d-74e4-45a8-bbaa-72e5f6f9b118_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_76e5bdad-25b7-4401-bbd4-eda32a95aa20_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_197adac0-fc43-468e-815a-725b969b19cf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_6c171118-ce52-4705-a7a6-400053f64a88_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_7d3b6cb3-43b6-49c4-8325-6ac8b326b203_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0477f0e0-54b1-4e52-9a9a-5d17d3f910ff_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_79dbeacd-8f0c-41c6-9596-a801f56c78ad_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_da16fcc4-17f2-4717-b2f8-acb993b163c3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits including interest and penalties that would affect the effective tax rate if recognized</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7cbfd1c8-56a0-43ac-bce5-7db3deaee94d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_99f7d279-2350-4642-b549-791ad548c837_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_820b9f6b-6c9c-4ec6-a9ad-0258c32cb5f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_264710ee-32a8-4c34-8a0b-3ec1de45275c_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_5a5b88ee-a0c5-4ea8-850d-481796b05558_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US tax on foreign earnings</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de28abd4-1e47-4e51-a9f5-51f0a36d3913_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d658cea8-9ffa-42b7-99d9-c4f2e89ffd03_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_8b20e88e-ae98-40b1-81c1-1cdca4c3f3b4_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2c4218b0-eed0-415a-8bd1-1b243dc8b827_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_9241f1fa-5952-4603-8bed-419d327d8c11_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a3f9ca06-d723-41a0-82b6-cab56d2d6d32_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_267c0307-702e-41fc-bec9-b5c912a02cf5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_99e7b5c6-f192-4203-9860-af0f10cd7354_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_2542555c-3ce9-4652-b808-09747e74fdf4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_af1fcca6-0fe1-4474-8a43-67da3ef17bfd_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_1770ea95-adb2-4d38-aeac-adf5a17a2b7c_verboseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_204fc08a-ee50-4265-ba0b-98e4104c70c0_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undesignated</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8aac72cc-8f3d-4de6-bf74-e1213d8c70af_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_0e8bd5f1-2cad-4281-9edb-5ccc10213197_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_CustomerOneAndCustomerTwoMember_7c5ff4b2-7bdd-40df-b5d5-843c73da7faa_terseLabel_en-US" xlink:label="lab_embc_CustomerOneAndCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Customers in Aggregate</link:label>
    <link:label id="lab_embc_CustomerOneAndCustomerTwoMember_label_en-US" xlink:label="lab_embc_CustomerOneAndCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One and Customer Two [Member]</link:label>
    <link:label id="lab_embc_CustomerOneAndCustomerTwoMember_documentation_en-US" xlink:label="lab_embc_CustomerOneAndCustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One and Customer Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CustomerOneAndCustomerTwoMember" xlink:href="embc-20230930.xsd#embc_CustomerOneAndCustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_CustomerOneAndCustomerTwoMember" xlink:to="lab_embc_CustomerOneAndCustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b1f6dd1d-45da-4b7a-ba5f-6974740fe944_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod_c6e3d1ac-ce96-4c88-ae8a-0dc9a964b03e_terseLabel_en-US" xlink:label="lab_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannula Supply Agreement, termination related to yearly forecasted purchase minimum, wind-down period</link:label>
    <link:label id="lab_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod_label_en-US" xlink:label="lab_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannula Supply Agreement, Termination Related to Yearly Minimum Purchase Forecast, Wind-down Period</link:label>
    <link:label id="lab_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod_documentation_en-US" xlink:label="lab_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannula Supply Agreement, Termination Related to Yearly Minimum Purchase Forecast, Wind-down Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod" xlink:href="embc-20230930.xsd#embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod" xlink:to="lab_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5518ca71-210c-45f1-84b8-797b72023aaf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_de674682-7b66-4057-940f-1bc4cf1f3472_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Lived Assets by Geographic Area</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_75254f01-41ea-4368-bf7e-1073a12913c6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished products</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_348b4352-ad82-4755-be51-84eba28421ce_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax assets before valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_14936a50-499c-4ce4-8fdb-74d7d473e759_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_e6581425-797c-4ab0-b7d0-72ec8a77a30e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_941309ac-4a02-4cb4-8df2-d349ce495271_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage_d074978c-3191-4a8a-8714-997df3790f30_terseLabel_en-US" xlink:label="lab_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly payment as a percentage of principal</link:label>
    <link:label id="lab_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage_label_en-US" xlink:label="lab_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal, Percentage</link:label>
    <link:label id="lab_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage_documentation_en-US" xlink:label="lab_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage" xlink:href="embc-20230930.xsd#embc_DebtInstrumentPeriodicPaymentPrincipalPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage" xlink:to="lab_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_25ab264f-0719-4c4e-8a1b-d289a361b6b5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_36b62807-f417-445f-af4c-b0eb7fd8242a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities_2a85f788-414b-4071-89b8-1284dc2af800_terseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash pooling and general financing activities</link:label>
    <link:label id="lab_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities_label_en-US" xlink:label="lab_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Cash Pooling And General Financing Activities</link:label>
    <link:label id="lab_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Cash Pooling And General Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities" xlink:to="lab_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ab893e5b-2559-48b4-965e-c1479ad24559_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_372d0957-ecc1-4858-a17a-49fc325c8927_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_4582304b-2ca1-402c-8095-467f5c0cdb9b_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Awards</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8f77ca63-77a0-4971-bab8-f16a321a31d0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_06e605b7-5b2d-41ac-b566-7678bedb4ecb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Geographical Region</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_0a63d9fd-0131-4fde-a065-bece5d09c509_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_f9eabe70-a472-45d5-ba25-37ae20dc4408_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a297fc6b-18ca-4471-9e73-674036eb6be1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8ce4fc6c-f858-40cd-bc4b-1e26b11804e0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_42c87ba4-d9c1-43a9-bbee-3dada0103973_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d8339e9f-4d72-4665-9a1b-674e4b9959dd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_d2607dd9-243c-4d9b-b2bf-269dd472e4fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease due to lapse of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_2e2d7588-f757-4051-a17e-046bfc2aefbd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_bfe174c1-6c5c-40fb-8eeb-e319d8aadf50_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_96fb0311-6164-48b1-8f6a-a1308dadddc0_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_02938196-3222-47b1-b560-f65aa0dfbdb2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_ca1d6597-5162-4e6a-8751-5eb4c23d8a03_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_b85b428e-5290-4902-b9ec-d9753bf987b0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of operating lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_ab1166c6-8b8a-4765-ad0e-d145eec4301d_terseLabel_en-US" xlink:label="lab_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized research and development expenses</link:label>
    <link:label id="lab_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_label_en-US" xlink:label="lab_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs</link:label>
    <link:label id="lab_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_documentation_en-US" xlink:label="lab_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:href="embc-20230930.xsd#embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="lab_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_fa9e7271-6e40-4bef-bef9-6362672685d7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and penalties associated with unrecognized tax benefits on the Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_564508cf-f0f5-4dc0-ac9f-4e512ab919c1_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue_888ca5c7-3785-406c-a354-fbd53a6dc228_terseLabel_en-US" xlink:label="lab_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Agreement, fee paid as a percentage of net revenue for each territory</link:label>
    <link:label id="lab_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue_label_en-US" xlink:label="lab_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Agreement, Fee Paid per Territory, Percentage of Net Revenue</link:label>
    <link:label id="lab_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue_documentation_en-US" xlink:label="lab_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Agreement, Fee Paid per Territory, Percentage of Net Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" xlink:href="embc-20230930.xsd#embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" xlink:to="lab_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a69cff79-0676-40a0-8982-a99a82fbf292_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaMember_1544f6ca-3641-43ea-aade-76fbf240b220_terseLabel_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia</link:label>
    <link:label id="lab_srt_AsiaMember_label_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaMember" xlink:to="lab_srt_AsiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_db5d23a1-1916-48f2-8425-847764a18030_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_77cde589-95c3-494e-bbf2-8f6f3d300337_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ca644b6f-f3d8-41ef-9317-004ea4cb10a5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_14e8b537-eea0-4581-b75f-6b59cee6a4d1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e3ac06d9-97be-4455-bf0e-23a801145e2d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to tax withholding for stock-based compensation</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_890cf4e3-72e5-4b02-ac31-fe93d2aeeec6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_e13b0dd8-828f-4da5-9227-88ee86e26933_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_befcff1d-7bca-48b3-acd1-ded959bd78f3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_5ab2618d-56e8-4a0f-86a8-19e342d3821a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_OperatingLossCarryforwardsNotSubjectToExpiration_56c27a6a-1dce-4c20-9f03-548eca0f7465_terseLabel_en-US" xlink:label="lab_embc_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_embc_OperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_embc_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:label id="lab_embc_OperatingLossCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_embc_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="embc-20230930.xsd#embc_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_embc_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_075740f0-1b80-49cc-812f-c1679879aeed_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used for Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_0c3fa922-1939-465a-9c34-451bb638fe6f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DeferredTaxAssetsLeasingArrangements_3fb3fe68-4360-46ed-b5bf-2a99f2465caa_terseLabel_en-US" xlink:label="lab_embc_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_embc_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_embc_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_embc_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_embc_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredTaxAssetsLeasingArrangements" xlink:href="embc-20230930.xsd#embc_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_embc_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_3f508bca-2a42-4aef-bb09-673622c708c6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_612933c7-5491-41b4-b582-8fb84b8db595_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_30646fed-22fd-43c3-854a-575eaeaf3674_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a84e598a-63e1-4bf3-a1ca-de337b93a549_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f0aa0955-0207-4650-b179-1322bb84a675_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_6b44fe69-03c5-47cb-bbd3-28c16fb45878_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating Lease Assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_94222242-339b-40ea-93aa-2d7823b5491c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_544489e2-98ed-4c5f-8d98-dcee295fbf1c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_70f1efda-0609-4e02-afc7-8a17999a7202_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share - Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearFour_627a0a75-b6e5-43b7-8f83-1aff8b6cbc53_totalLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearFour_label_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year Four</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearFour_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearFour" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearFour" xlink:to="lab_embc_LesseeLeaseLiabilityToBePaidYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_e613de04-5511-424c-aa9c-58518e1af65e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_b5a2116e-1355-4a24-84ba-f57ac6de2662_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6b9186cc-3e40-4d78-9b2a-c4c94ca56d9c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_0cf969e4-bd4c-4fd0-be9e-6e457badf95b_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_PropertyPlantAndEquipmentNetMember_1165df65-f619-4b59-8d76-c9993deeb89d_terseLabel_en-US" xlink:label="lab_embc_PropertyPlantAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_embc_PropertyPlantAndEquipmentNetMember_label_en-US" xlink:label="lab_embc_PropertyPlantAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, And Equipment, Net [Member]</link:label>
    <link:label id="lab_embc_PropertyPlantAndEquipmentNetMember_documentation_en-US" xlink:label="lab_embc_PropertyPlantAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, And Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PropertyPlantAndEquipmentNetMember" xlink:href="embc-20230930.xsd#embc_PropertyPlantAndEquipmentNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_PropertyPlantAndEquipmentNetMember" xlink:to="lab_embc_PropertyPlantAndEquipmentNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_93e12d74-1e92-4793-9cbb-01fffe6907f4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearThree_66e73b1a-a395-4f61-a668-9356588bf5e7_totalLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearThree_label_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaidYearThree_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearThree" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidYearThree" xlink:to="lab_embc_LesseeLeaseLiabilityToBePaidYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_c7ede800-d6a7-4c33-8542-9c1439174bcd_totalLabel_en-US" xlink:label="lab_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers to BD as reflected in the Consolidated Statements of Cash Flows</link:label>
    <link:label id="lab_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_label_en-US" xlink:label="lab_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Transfers Reflected As Cash Flows From Financing Activities</link:label>
    <link:label id="lab_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Transfers Reflected As Cash Flows From Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" xlink:to="lab_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_438e339c-938b-4855-9c1c-cf9f3350f6e2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_76b6c458-eec8-4eee-9fcb-2bda303fab68_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b033f3af-878d-4459-bf6c-7c4ab40cc682_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_BuildingLeaseSixYearExtensionOptionMember_c3b8c5af-0737-4df0-b5d2-8575ef36e88f_terseLabel_en-US" xlink:label="lab_embc_BuildingLeaseSixYearExtensionOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Lease, Six Year Extension Option</link:label>
    <link:label id="lab_embc_BuildingLeaseSixYearExtensionOptionMember_label_en-US" xlink:label="lab_embc_BuildingLeaseSixYearExtensionOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Lease, Six Year Extension Option [Member]</link:label>
    <link:label id="lab_embc_BuildingLeaseSixYearExtensionOptionMember_documentation_en-US" xlink:label="lab_embc_BuildingLeaseSixYearExtensionOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Lease, Six Year Extension Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BuildingLeaseSixYearExtensionOptionMember" xlink:href="embc-20230930.xsd#embc_BuildingLeaseSixYearExtensionOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_BuildingLeaseSixYearExtensionOptionMember" xlink:to="lab_embc_BuildingLeaseSixYearExtensionOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_7b48b477-d448-425c-99b2-62b15877864f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_5d6195bc-edbd-42c2-a268-5d3e78dc3881_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0d9f2324-1907-46c3-be0c-96f5414bc50c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrent_ca747b01-712b-4eb7-8a9a-3053849c68bb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due to Becton, Dickinson and Company</link:label>
    <link:label id="lab_us-gaap_AccountsPayableOtherCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableOtherCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Other, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableOtherCurrent" xlink:to="lab_us-gaap_AccountsPayableOtherCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_42b56ee3-c174-47e1-b9bf-d8d627581e37_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_165235ca-d0a5-415f-a5d7-cdfb994ee52b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeAndExpenseTextBlock_563d7740-d366-4b55-8d60-3b0599824cf3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeAndExpenseTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeAndExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income and Expense [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeAndExpenseTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncomeAndExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeAndExpenseTextBlock" xlink:to="lab_us-gaap_OtherOperatingIncomeAndExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_db098216-1c80-4c6e-956e-90187c913bfc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentMember_08216b38-58b3-4994-bbcd-2e6cc41ad865_terseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment from Becton, Dickinson and Company</link:label>
    <link:label id="lab_embc_NetParentInvestmentMember_label_en-US" xlink:label="lab_embc_NetParentInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment [Member]</link:label>
    <link:label id="lab_embc_NetParentInvestmentMember_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentMember" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentMember" xlink:to="lab_embc_NetParentInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_dea7e188-25d9-40f8-9fc2-bba1a1ba937a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_0b15d29a-29eb-4786-8de9-4bcad2e01488_periodStartLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_dab8dd76-9620-4d41-bd8f-6197d90c797a_periodEndLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_ab197314-8ca1-41a6-bdf0-e602363864b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total principal debt issued</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e52f087-4df4-499f-a0f6-b40acfcadfa0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to net income to derive net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c693a108-03c9-4b8e-b7a2-b36cf6d50cee_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_c3a7916b-6ed4-4139-88ff-ce9884bb2aa8_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs capitalized for cloud computing arrangements</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_16c56958-a29a-475f-b922-02625dff683f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_82f8db53-cd1b-4208-8a3a-3078ca9e6c39_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a1f03562-1a67-4c08-8d26-764cafc9febd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of units vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_74958c33-2696-447f-8ee7-1cfe1cccc0bf_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent_51487143-9d59-4d4e-b43a-ea50882701f5_terseLabel_en-US" xlink:label="lab_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes on unremitted foreign earnings</link:label>
    <link:label id="lab_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent_label_en-US" xlink:label="lab_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Unremitted Foreign Earnings, Percent</link:label>
    <link:label id="lab_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent_documentation_en-US" xlink:label="lab_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Unremitted Foreign Earnings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" xlink:href="embc-20230930.xsd#embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" xlink:to="lab_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LogisticsServicesAgreementMaximumTerm_22b9fbdd-b99e-4536-8483-58661da19bc0_terseLabel_en-US" xlink:label="lab_embc_LogisticsServicesAgreementMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Logistics Services Agreement, maximum term</link:label>
    <link:label id="lab_embc_LogisticsServicesAgreementMaximumTerm_label_en-US" xlink:label="lab_embc_LogisticsServicesAgreementMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Logistics Services Agreement, Maximum Term</link:label>
    <link:label id="lab_embc_LogisticsServicesAgreementMaximumTerm_documentation_en-US" xlink:label="lab_embc_LogisticsServicesAgreementMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Logistics Services Agreement, Maximum Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LogisticsServicesAgreementMaximumTerm" xlink:href="embc-20230930.xsd#embc_LogisticsServicesAgreementMaximumTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LogisticsServicesAgreementMaximumTerm" xlink:to="lab_embc_LogisticsServicesAgreementMaximumTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_2ddaea10-5fd6-4451-9d32-e2392e53ef27_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7a995fde-4ee9-4051-89cb-1a020e001cc7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, canceled or expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_aedcd29f-8df1-464a-82cd-0e7bca9b03f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_d00225ed-aae8-4803-804e-bcac359a522c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_2be76914-3416-45d1-b590-181a731133eb_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred total</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_26b9bbe0-d4bb-4256-a2e4-881e36151b92_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b3b759b6-e250-40ce-b393-531a42500903_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized_46ec0cc5-aa6f-4ada-b73a-b8517ed7bc69_terseLabel_en-US" xlink:label="lab_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental cost recognized</link:label>
    <link:label id="lab_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized_label_en-US" xlink:label="lab_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Plan Modification, Expense Recognized</link:label>
    <link:label id="lab_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized_documentation_en-US" xlink:label="lab_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Plan Modification, Expense Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized" xlink:href="embc-20230930.xsd#embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized" xlink:to="lab_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_66f33fb2-c8f5-454a-a8f8-465eefcd43c6_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Finance Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_fefea11f-80d7-4a03-a73c-8436eed57455_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ac96e5b9-fe25-4395-9500-a389b39986d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_07003ce6-e918-4528-889a-311f53b2cec7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_d0eef568-a354-4d39-b17f-a00dec7a6b3c_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction Flag</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_b0f2eb23-9c06-4ebc-94e7-e02951521627_terseLabel_en-US" xlink:label="lab_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="embc-20230930.xsd#embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3c4aca14-67ce-4c95-bb99-67b11c47b969_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated intangible asset amortization expense for 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_db1a0ae2-a342-44bf-aebe-43129627a67c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_dcfe20e6-7439-4aa1-a24f-51452a6a25d1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_925a2893-e033-4909-ac35-e4858fdd2ec0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, canceled or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DebtInstrumentDiscountPercentage_e7127ab2-4692-40dd-9478-3eca9e28ca82_terseLabel_en-US" xlink:label="lab_embc_DebtInstrumentDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount percentage</link:label>
    <link:label id="lab_embc_DebtInstrumentDiscountPercentage_label_en-US" xlink:label="lab_embc_DebtInstrumentDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount, Percentage</link:label>
    <link:label id="lab_embc_DebtInstrumentDiscountPercentage_documentation_en-US" xlink:label="lab_embc_DebtInstrumentDiscountPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Discount, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentDiscountPercentage" xlink:href="embc-20230930.xsd#embc_DebtInstrumentDiscountPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DebtInstrumentDiscountPercentage" xlink:to="lab_embc_DebtInstrumentDiscountPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaid_5f5b2355-1148-41ba-9fc0-da3198798425_totalLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaid_label_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid</link:label>
    <link:label id="lab_embc_LesseeLeaseLiabilityToBePaid_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaid" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaid" xlink:to="lab_embc_LesseeLeaseLiabilityToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiability_b16175b0-4236-4e99-ae60-15cb5cb393d3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer rebate liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Refund Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiability" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_86245b26-3f82-4ed4-81b6-b5518d0863b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_874dac53-c88d-44b0-98ce-f08c6aa7541e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_7061c427-cdd1-4035-8ff7-031d2dfc885a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_04155ea1-7a1c-4408-8ace-42ac72bc5155_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_embc_ThirdPartyAndRelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party and Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_documentation_en-US" xlink:label="lab_embc_ThirdPartyAndRelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party and Related Party Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract" xlink:href="embc-20230930.xsd#embc_ThirdPartyAndRelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract" xlink:to="lab_embc_ThirdPartyAndRelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b8af79c2-1e16-4056-a710-d6c85ffd434f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares related to share-based compensation plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue_7da19f8f-f43e-4e4b-9751-7ff9dac4d991_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of SARs exercised</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Fair Value</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_17a7c2ee-bc26-4370-b4ac-7d9580860fbe_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4d3399d9-ae49-4a3c-9eeb-e00d973ffa26_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards and equity units (share equivalent) (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6e691d75-ffe6-40a6-8967-0033491a1819_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign income tax at rates other than 21%</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_25f82bc6-b8f2-458b-a344-1fe8059131bc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated intangible asset amortization expense for 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_ea0a0417-6876-4126-84f4-4b6eae3476ec_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_3c5c0653-a26f-4cfb-87f2-7cbd5c7b9103_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_b504efff-49e5-48ae-8a0d-311be82eab9e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_935c264f-1c45-4c6d-8b82-8102e406113f_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_e39502b7-204d-47e4-9ae4-99c2448c9d48_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_36cb5cd0-9ccb-47a5-8d92-2779a55a9239_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum_e82c3b24-925c-4d46-931b-e8f1bc6a1103_terseLabel_en-US" xlink:label="lab_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Services Agreement, maximum period</link:label>
    <link:label id="lab_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum_label_en-US" xlink:label="lab_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Period Of Continuing Involvement After Separation, Maximum</link:label>
    <link:label id="lab_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum_documentation_en-US" xlink:label="lab_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement, Period Of Continuing Involvement After Separation, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum" xlink:href="embc-20230930.xsd#embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum" xlink:to="lab_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_258234a5-f4ac-4e3a-8f25-8353af7059df_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_58b41e36-7ad3-4eb4-8a20-78155e0e96c5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_3702f64d-9514-4a0d-9255-10adb5e83506_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_48243081-7458-420b-afd5-60de0b951b0f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a8e6d610-ddfe-4281-925f-9c87ae8abe47_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_116904b5-7f5a-4dba-877f-f707e58599fd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Current Finance Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_7bd37cc3-478d-45c2-be72-91038d349d98_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allowance for Doubtful Accounts and Cash Discounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3ac7192a-5aba-443c-9390-083e3990c141_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_bc710ad7-385e-4bac-956a-0821a3d623f0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_f665140a-c01b-4c13-a75c-0be09d5001f5_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_f260f03f-4801-4034-a074-9968bda021d5_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_211bbf5b-5ff9-49e5-bec4-01968809363f_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_8ea56505-e968-4809-ae0a-05b607786ed7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized intangible assets - gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5cfb8f6a-9fef-4bc2-aa4f-305da7c96710_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_46015cd3-4c25-4305-8f5a-29ebc390432e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_08271f72-46be-4600-949c-88cfc9344408_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts accrued under the deferred compensation plan</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_cba61d92-8476-4e84-b78e-820d2c2948d4_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_b10d767b-cade-4364-aa56-2f71034852af_terseLabel_en-US" xlink:label="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Line Items]</link:label>
    <link:label id="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_label_en-US" xlink:label="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Line Items]</link:label>
    <link:label id="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_documentation_en-US" xlink:label="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:href="embc-20230930.xsd#embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="lab_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_69987eb4-6bd4-4034-b8a0-34df98eb5cf5_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining term of awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_b7225f30-3058-419a-be16-a9708fa926d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_ab7d1c8b-3579-48f9-b29e-eab0c1ed0f83_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Finance Lease Assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_cd61aeb6-fa70-4d48-aa09-9af21359c86d_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_cf3f4272-1bac-43e7-b100-1ff33885569e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries, wages and related items</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold_76f12a99-ca36-4a9a-95a9-5604dafaf869_terseLabel_en-US" xlink:label="lab_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matters Agreement, covenant restrictions, change in stock ownership threshold</link:label>
    <link:label id="lab_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold_label_en-US" xlink:label="lab_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matters Agreement, Covenant Restrictions, Change of Stock Ownership Threshold</link:label>
    <link:label id="lab_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold_documentation_en-US" xlink:label="lab_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Matters Agreement, Covenant Restrictions, Change of Stock Ownership Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold" xlink:href="embc-20230930.xsd#embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold" xlink:to="lab_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_39b32537-0d64-4932-9cb4-7d2b88061c59_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_d4ceef3e-a488-4ffc-934e-845fca5e0c47_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_5235d9a6-3cfd-455a-bc06-73463d50fe73_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_224b5e3f-321c-4c68-96d0-57ce7ff3f218_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cc3f08b6-9642-4acd-bb15-be6b74fd6cb7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_PerformanceBasedRestrictedStockUnitsMember_c00f0015-d960-4f59-a46d-99e7158ad123_terseLabel_en-US" xlink:label="lab_embc_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock Units</link:label>
    <link:label id="lab_embc_PerformanceBasedRestrictedStockUnitsMember_05584cde-b65f-4fe8-8e75-d3f6b5a75674_verboseLabel_en-US" xlink:label="lab_embc_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (PSUs)</link:label>
    <link:label id="lab_embc_PerformanceBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_embc_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_embc_PerformanceBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_embc_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_PerformanceBasedRestrictedStockUnitsMember" xlink:to="lab_embc_PerformanceBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4984f38b-fe2f-4811-8a22-fcfa0701bb61_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_24f70e73-4858-48ed-8244-f4f54ebbc07d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due from Becton, Dickinson and Company</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_117a6cd8-7f75-4e1e-a552-70cfcdbafc13_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_d77d2c4d-6813-49bd-b48e-99603f109661_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_0476eb22-b224-44a3-9919-db7e9a480821_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7265431f-6cb4-4204-b7c5-eef951561bdc_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_d420c45e-0f18-4073-a7b8-14525d2e478a_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_71ebec6b-8f8c-4f13-b3f3-d7c9793bf96e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_06360fe8-8218-489d-81a8-86932c552981_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0440cd15-6cef-42eb-84d9-8145c51db5d3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7b7beda3-072e-4705-877e-cde8dc81ab90_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - condensed combined balance sheets</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentPensionExpense_93b17153-6b7e-463d-a4a7-7675eef1c586_negatedLabel_en-US" xlink:label="lab_embc_NetParentInvestmentPensionExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension expense</link:label>
    <link:label id="lab_embc_NetParentInvestmentPensionExpense_label_en-US" xlink:label="lab_embc_NetParentInvestmentPensionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Pension Expense</link:label>
    <link:label id="lab_embc_NetParentInvestmentPensionExpense_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentPensionExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Pension Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentPensionExpense" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentPensionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentPensionExpense" xlink:to="lab_embc_NetParentInvestmentPensionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4fbf159d-934b-4e8d-a666-5849d19cc1af_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cd472d90-b58e-432e-8a4b-726a9079c6b5_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_0fe7f35f-2b5e-47e0-af72-e443acb7d3e4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest, net of interest capitalized</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock_5652a693-fe81-4ca8-98a4-a0973f75262b_terseLabel_en-US" xlink:label="lab_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party Arrangements and Related Party Disclosures</link:label>
    <link:label id="lab_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party and Related Party Transactions Disclosure [Text Block]</link:label>
    <link:label id="lab_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock_documentation_en-US" xlink:label="lab_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party and Related Party Transactions Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock" xlink:href="embc-20230930.xsd#embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_caa61bda-e0bf-4b6b-b894-bd4e790fba5d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a0dc164c-2d01-4707-b2a9-3df1b23b571a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_b80350e5-19bf-4026-932e-ea9a1d94388b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_3c311b7a-a827-47c6-ab43-a94c35066fc6_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_9b7c811a-2ae5-4569-82be-9455b0c0c3a1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_eba201f7-fa95-440d-b600-10e3e21e287c_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_4d22c847-1919-44fc-9465-f9c6728393f3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_8c4b20f3-eea0-434a-a643-2fd7c2b99131_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_8300a2c7-a614-4c0f-926c-43d9ad8d45c9_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_PaymentOfRevolvingCreditFacilityFees_a49b3818-abb9-4cba-9a19-3f9f789b2395_negatedTerseLabel_en-US" xlink:label="lab_embc_PaymentOfRevolvingCreditFacilityFees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of revolving credit facility fees</link:label>
    <link:label id="lab_embc_PaymentOfRevolvingCreditFacilityFees_label_en-US" xlink:label="lab_embc_PaymentOfRevolvingCreditFacilityFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Revolving Credit Facility Fees</link:label>
    <link:label id="lab_embc_PaymentOfRevolvingCreditFacilityFees_documentation_en-US" xlink:label="lab_embc_PaymentOfRevolvingCreditFacilityFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Revolving Credit Facility Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PaymentOfRevolvingCreditFacilityFees" xlink:href="embc-20230930.xsd#embc_PaymentOfRevolvingCreditFacilityFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_PaymentOfRevolvingCreditFacilityFees" xlink:to="lab_embc_PaymentOfRevolvingCreditFacilityFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_45b7605b-3b80-40eb-9808-ccde41605f93_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_bdf7cc5c-2e20-40b0-b81e-f3b48b87984d_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_8e0af2f8-6d45-4ba9-af87-80071143bc9d_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_943f1de3-1c70-4d6b-b95b-c58ab315cea0_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_01b05834-e379-4351-b1e4-aec438b015b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Time-Vested Restricted Stock Units Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_21dff48e-90a3-4112-939b-b12619d949b3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_d9912463-7550-4af0-95bb-d9e0e648916b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_7fe7c704-b48f-46e3-8812-78d1d5d50059_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amount representing interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_37928d6a-d346-4c8c-bec2-e4a8f39df0cc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_83d8d34b-6d95-4d4d-9166-2c0fd51d9520_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease due to settlements with tax authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ContractuallySpecifiedServicingFeesPercentage_eba1e1cf-3676-420f-b433-109ea7c6b6e3_terseLabel_en-US" xlink:label="lab_embc_ContractuallySpecifiedServicingFeesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Receivables Factoring Agreement Service fee as a percentage of annual revenue</link:label>
    <link:label id="lab_embc_ContractuallySpecifiedServicingFeesPercentage_label_en-US" xlink:label="lab_embc_ContractuallySpecifiedServicingFeesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractually Specified Servicing Fees, Percentage</link:label>
    <link:label id="lab_embc_ContractuallySpecifiedServicingFeesPercentage_documentation_en-US" xlink:label="lab_embc_ContractuallySpecifiedServicingFeesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractually Specified Servicing Fees, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ContractuallySpecifiedServicingFeesPercentage" xlink:href="embc-20230930.xsd#embc_ContractuallySpecifiedServicingFeesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ContractuallySpecifiedServicingFeesPercentage" xlink:to="lab_embc_ContractuallySpecifiedServicingFeesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a558111e-f29e-4da2-95db-14bcf2a1361d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c2afe5d3-bfc5-4315-a1ed-da598e9c7ff5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_f1a52649-690c-4834-afc3-d402476e0cc3_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber_3b84b568-f998-4778-b0c8-500fd2d5aaa2_terseLabel_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected to vest (in shares)</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Outstanding, Number</link:label>
    <link:label id="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber_documentation_en-US" xlink:label="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" xlink:to="lab_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_2bfa3ad8-6bbc-41a1-9153-d8de096fe6b0_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f932e549-f0fd-48cf-8ed5-97789bfbbc1f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_46e43715-8dde-4e8e-80b4-a937eb8dae83_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_bcbfb16b-f2d4-4ac6-90d5-eb773d3d7c55_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage_42490f4c-7959-47cc-880a-dafedf1f4ecc_terseLabel_en-US" xlink:label="lab_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum deferral percentage of bonus and other eligible cash compensation under deferred compensation plan</link:label>
    <link:label id="lab_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage_label_en-US" xlink:label="lab_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Bonus and other Eligible Cash Compensation Deferral Maximum, Percentage</link:label>
    <link:label id="lab_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage_documentation_en-US" xlink:label="lab_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Bonus and other Eligible Cash Compensation Deferral Maximum, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage" xlink:href="embc-20230930.xsd#embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage" xlink:to="lab_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_50b782c2-daf1-41c3-8788-c40beda2abc9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nontaxable items</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_9bc815c5-8f10-45a9-bdf1-55e63d4b20c8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f12206bc-f522-444c-b4d1-51fa4599c3fc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ef792bbf-363d-49df-97be-c1552db869eb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_403306b9-c93d-4c0f-9078-68c0f04d8668_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_ad48672b-5ed9-401b-ac40-6f338f2918eb_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_16ac8176-d1e5-43bf-92cf-02bc3c758744_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from Finance Lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_16978789-3625-4c8b-896e-db29d08f4d19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributed (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d88b6706-95b9-4bb4-987e-c2d6799f71ca_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_1cd29c20-7090-46c8-be6e-a3694e3d2f84_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_140dcd01-f7ec-49fe-beab-91504c7387b1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases from BD</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_13f3c639-afd2-4059-97c4-a4df166a2c06_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_28475e9c-587a-4835-a9b8-cf5a638d50bb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_286bf4b3-a17e-400e-abe0-fe478e486a13_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, depreciation of assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_06bd9d4d-ba3d-4f0d-8f83-af4c4b626188_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographical Data</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2675d940-d70b-45e4-855f-982ac95e71a0_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Change in Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_d7e2605d-b9a5-4a20-ba22-cf870ca632ef_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_9f390bfb-982b-4467-9460-7d8bf62e8f3d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_5e1b842d-5d9b-43bf-8255-0fe1aa1882b0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_2246e5e6-4e5e-4ed1-ad95-fb6eeff91aee_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cb5dcd11-f5c2-4df2-ab5b-8591e90df0db_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average number of shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_1000b6c3-37d7-4270-a703-24f6a652d550_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_cbf4ef8d-b80e-4701-955c-9d215a4a0db5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_d8fbe8c1-3eee-4b60-b028-0941934de8fa_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_35cf69fb-b3bd-4c69-a9d3-a5765d207f28_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_36b218ab-a675-4ff6-aa3d-f595230ce288_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_1e2e4feb-f4d0-4713-ae8a-72cff0ce98c9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_LesseeLeaseLiability_47143960-b2db-49b0-8acb-2f7de05d2682_totalLabel_en-US" xlink:label="lab_embc_LesseeLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_embc_LesseeLeaseLiability_label_en-US" xlink:label="lab_embc_LesseeLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability</link:label>
    <link:label id="lab_embc_LesseeLeaseLiability_documentation_en-US" xlink:label="lab_embc_LesseeLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiability" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_LesseeLeaseLiability" xlink:to="lab_embc_LesseeLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6f085a51-006f-4ea7-ab0f-20120a984e05_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_2af46442-ef86-452f-ba07-8acc64632814_terseLabel_en-US" xlink:label="lab_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="embc-20230930.xsd#embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_embc_NetParentInvestmentConsiderationPaidForSeparation_e547d6f1-2887-4fc9-9bf4-a0dc763de920_negatedTerseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentConsiderationPaidForSeparation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net consideration paid to Becton, Dickinson, and Company in connection with Separation</link:label>
    <link:label id="lab_embc_NetParentInvestmentConsiderationPaidForSeparation_12d023e9-49ed-4447-94b9-facef4c70a89_terseLabel_en-US" xlink:label="lab_embc_NetParentInvestmentConsiderationPaidForSeparation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net consideration paid to BD in connection with the Separation</link:label>
    <link:label id="lab_embc_NetParentInvestmentConsiderationPaidForSeparation_label_en-US" xlink:label="lab_embc_NetParentInvestmentConsiderationPaidForSeparation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Consideration Paid for Separation</link:label>
    <link:label id="lab_embc_NetParentInvestmentConsiderationPaidForSeparation_documentation_en-US" xlink:label="lab_embc_NetParentInvestmentConsiderationPaidForSeparation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment, Consideration Paid for Separation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentConsiderationPaidForSeparation" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentConsiderationPaidForSeparation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_embc_NetParentInvestmentConsiderationPaidForSeparation" xlink:to="lab_embc_NetParentInvestmentConsiderationPaidForSeparation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_c99bbabc-3767-4d8f-aa3d-f08bc83804ce_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_70489b3e-f2a1-48ea-9471-2aa5dfcc9bd6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_e68bfca6-b562-45e2-a959-dbd24f7804fe_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_a5d6286f-be41-4432-9025-7e6bcf056f6c_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_1ab96320-8b42-41b5-85f7-bde4e0ccfe99_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_ca43c913-8527-4b94-9719-6f4eb89949d3_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_fb7ac89f-23dc-4a4a-8939-0f1e94426e29_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_19483ed4-03e0-4011-8853-58a41d52c56f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f169d11e-95e9-466f-8222-3e0bb51b7125_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_b3ac74cb-1f73-4505-91e8-70626926012d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_fe5030ce-557e-47ce-acb2-421077eac2e3_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_589b1600-06ab-4478-bb15-5b3079a78210_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount drawn</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_61e223a1-678a-4085-8f6b-bb2781dd2526_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>embc-20230930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:4102c7ef-a746-4e09-abe6-45c91f406b23,g:4bb25894-924e-4e32-9a1d-8a6b6ed5cbfa-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.embecta.com/role/CoverPage" xlink:type="simple" xlink:href="embc-20230930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2b0bc08e-49d3-44ec-9708-43bd2c7d2f2c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_DocumentType_2b0bc08e-49d3-44ec-9708-43bd2c7d2f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_d234086c-1dfb-4902-b03a-6f382c6c4a6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_DocumentAnnualReport_d234086c-1dfb-4902-b03a-6f382c6c4a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2b5b34ee-5357-47e6-aee7-6ca30bcda0f9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_DocumentPeriodEndDate_2b5b34ee-5357-47e6-aee7-6ca30bcda0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_941675a0-7063-4e0f-97b9-5b70fea76e49" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_CurrentFiscalYearEndDate_941675a0-7063-4e0f-97b9-5b70fea76e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a75c7214-26c4-4704-a6d1-4f043d8695cf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_DocumentTransitionReport_a75c7214-26c4-4704-a6d1-4f043d8695cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bc013edf-6f8e-41b9-92dd-ba420e078f9d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityFileNumber_bc013edf-6f8e-41b9-92dd-ba420e078f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d37d3ea8-bf45-4796-a5c0-bbd9c9302599" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityRegistrantName_d37d3ea8-bf45-4796-a5c0-bbd9c9302599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_890f1f97-2c01-4473-82b2-3197ba15a23d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_890f1f97-2c01-4473-82b2-3197ba15a23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_11d79283-ae00-446e-a674-0c18f200b932" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityTaxIdentificationNumber_11d79283-ae00-446e-a674-0c18f200b932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_52d16f07-e0f0-498b-a1fe-26aa201dea07" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityAddressAddressLine1_52d16f07-e0f0-498b-a1fe-26aa201dea07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d64b7905-3e51-4d74-b301-102b6c6035f8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityAddressCityOrTown_d64b7905-3e51-4d74-b301-102b6c6035f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f96d7b59-5beb-4997-a92c-da15c0782693" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityAddressStateOrProvince_f96d7b59-5beb-4997-a92c-da15c0782693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d49b153d-317d-48b1-aaec-6e89009bf662" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityAddressPostalZipCode_d49b153d-317d-48b1-aaec-6e89009bf662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_94633cb2-e4c7-493f-a905-151ab828e6af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_CityAreaCode_94633cb2-e4c7-493f-a905-151ab828e6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d687dae3-f013-437a-be08-c6344f43279f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_LocalPhoneNumber_d687dae3-f013-437a-be08-c6344f43279f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_fe3749cc-e7bc-4055-93d1-5f2313ae338a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_Security12bTitle_fe3749cc-e7bc-4055-93d1-5f2313ae338a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_42435874-b26e-4907-861c-366638a028a8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_TradingSymbol_42435874-b26e-4907-861c-366638a028a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f834c6b0-65f1-4d8c-890f-083fcfcaabec" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_SecurityExchangeName_f834c6b0-65f1-4d8c-890f-083fcfcaabec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_d6d6cc42-54c0-42ea-8859-58f3bf5420fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_d6d6cc42-54c0-42ea-8859-58f3bf5420fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_277e8bd2-22fa-4a8a-9b38-45ca2d60f246" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityVoluntaryFilers_277e8bd2-22fa-4a8a-9b38-45ca2d60f246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_49a666a8-33c1-4c6d-ade0-bb69e861395e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityCurrentReportingStatus_49a666a8-33c1-4c6d-ade0-bb69e861395e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_6dc09d42-3cca-4a40-9d17-b72a9f3ee75d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityInteractiveDataCurrent_6dc09d42-3cca-4a40-9d17-b72a9f3ee75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_050fe3da-9a94-49a7-a719-e076d7a25aed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityFilerCategory_050fe3da-9a94-49a7-a719-e076d7a25aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3f1e2c4f-da1c-413d-a2b0-2d44a7506eb9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityEmergingGrowthCompany_3f1e2c4f-da1c-413d-a2b0-2d44a7506eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_eeb61271-3f2c-476d-964f-3802f464474d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntitySmallBusiness_eeb61271-3f2c-476d-964f-3802f464474d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_18e5c3f9-a296-48c9-983d-f453c3b217ae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_IcfrAuditorAttestationFlag_18e5c3f9-a296-48c9-983d-f453c3b217ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_7aed69e5-16d3-48c7-b447-338b251e0437" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_7aed69e5-16d3-48c7-b447-338b251e0437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a44aa112-b286-44a0-a1fe-988b8d2c0200" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityShellCompany_a44aa112-b286-44a0-a1fe-988b8d2c0200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_cdc6bd74-ec1c-4f8e-a0f3-1f186c450727" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityPublicFloat_cdc6bd74-ec1c-4f8e-a0f3-1f186c450727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_924a8eb4-837b-4628-97fb-87a9c44774c2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_924a8eb4-837b-4628-97fb-87a9c44774c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_41d0bb3c-3542-4b47-a68a-00f34fcf90fa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_41d0bb3c-3542-4b47-a68a-00f34fcf90fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_61d178c1-23e0-4ada-acc3-297d86ea12d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_EntityCentralIndexKey_61d178c1-23e0-4ada-acc3-297d86ea12d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_a359cb8b-92d2-4201-a824-b8c293d1aec9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_DocumentFiscalPeriodFocus_a359cb8b-92d2-4201-a824-b8c293d1aec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5c99e377-4aa4-49e8-a5a9-bb95b2b53e8f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_DocumentFiscalYearFocus_5c99e377-4aa4-49e8-a5a9-bb95b2b53e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5049e17e-1449-426c-b6a5-b2137d4914ff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7fe26ab-bbd2-4289-b186-784048f042bf" xlink:to="loc_dei_AmendmentFlag_5049e17e-1449-426c-b6a5-b2137d4914ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/AuditInformation" xlink:type="simple" xlink:href="embc-20230930.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_AuditInformationAbstract_1d1c08fe-e72a-4764-b1e3-9ba9f271d94e" xlink:href="embc-20230930.xsd#embc_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_2aea1237-55aa-402f-8462-8c406cf461e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_AuditInformationAbstract_1d1c08fe-e72a-4764-b1e3-9ba9f271d94e" xlink:to="loc_dei_AuditorName_2aea1237-55aa-402f-8462-8c406cf461e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_ef5e0c91-6b54-4e77-ab72-6b6e249bf227" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_AuditInformationAbstract_1d1c08fe-e72a-4764-b1e3-9ba9f271d94e" xlink:to="loc_dei_AuditorLocation_ef5e0c91-6b54-4e77-ab72-6b6e249bf227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_f3eadf9c-1718-4423-a193-4301e3368466" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_AuditInformationAbstract_1d1c08fe-e72a-4764-b1e3-9ba9f271d94e" xlink:to="loc_dei_AuditorFirmId_f3eadf9c-1718-4423-a193-4301e3368466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_44e6eefd-b719-4f25-9882-227f7ef4467e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_44e6eefd-b719-4f25-9882-227f7ef4467e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_88adb37e-b96b-4b78-bae2-fba02e0ed5be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_88adb37e-b96b-4b78-bae2-fba02e0ed5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_397267a4-7c9e-4252-a060-04a415d4d531" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_397267a4-7c9e-4252-a060-04a415d4d531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_22f199a1-a615-47dd-a7fa-09d4516f72e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_22f199a1-a615-47dd-a7fa-09d4516f72e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1cee0d3c-889b-4893-b1dd-7bb4312779a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_GrossProfit_1cee0d3c-889b-4893-b1dd-7bb4312779a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0bbc74e5-a805-4b1d-9bca-6dd16f969263" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0bbc74e5-a805-4b1d-9bca-6dd16f969263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_dd78ea68-bef4-47de-89d9-af7d1e762a51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bbc74e5-a805-4b1d-9bca-6dd16f969263" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_dd78ea68-bef4-47de-89d9-af7d1e762a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6f6656e4-e06d-4ef7-9545-fb5ce7d361e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bbc74e5-a805-4b1d-9bca-6dd16f969263" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6f6656e4-e06d-4ef7-9545-fb5ce7d361e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_132d43a4-f5eb-432d-90c3-bb4df72874ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bbc74e5-a805-4b1d-9bca-6dd16f969263" xlink:to="loc_us-gaap_AssetImpairmentCharges_132d43a4-f5eb-432d-90c3-bb4df72874ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralExpense_95d899cc-883c-4b28-8904-d20bbc09315c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherGeneralExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bbc74e5-a805-4b1d-9bca-6dd16f969263" xlink:to="loc_us-gaap_OtherGeneralExpense_95d899cc-883c-4b28-8904-d20bbc09315c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_5df1b499-c605-4511-86dc-593b21f3e638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bbc74e5-a805-4b1d-9bca-6dd16f969263" xlink:to="loc_us-gaap_OperatingExpenses_5df1b499-c605-4511-86dc-593b21f3e638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_332b2d53-0849-4e3a-bd7e-1fa366ed1079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_OperatingIncomeLoss_332b2d53-0849-4e3a-bd7e-1fa366ed1079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_8b3bbac9-c5ad-4991-be57-16211f9773e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_8b3bbac9-c5ad-4991-be57-16211f9773e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_acce78d0-9cdf-4db4-81d7-589d35a394ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_acce78d0-9cdf-4db4-81d7-589d35a394ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_53ffea9b-a85e-4f5c-afe3-37226fbef7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_53ffea9b-a85e-4f5c-afe3-37226fbef7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5ae7b4d0-0b89-4fb2-b8cf-036cfa822610" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5ae7b4d0-0b89-4fb2-b8cf-036cfa822610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea725a0a-c250-4e5c-a380-e76f4c377cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_NetIncomeLoss_ea725a0a-c250-4e5c-a380-e76f4c377cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a09153d8-7294-49b1-9d23-b0b9cb52dba0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1f51dd47-1417-4102-8c6e-bfdf4c18170e" xlink:to="loc_us-gaap_EarningsPerShareAbstract_a09153d8-7294-49b1-9d23-b0b9cb52dba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b3ad853d-b15c-432a-84cb-b1c1bc8c6f95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a09153d8-7294-49b1-9d23-b0b9cb52dba0" xlink:to="loc_us-gaap_EarningsPerShareBasic_b3ad853d-b15c-432a-84cb-b1c1bc8c6f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b0e542ab-e279-4793-be1c-c3b1961fe429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a09153d8-7294-49b1-9d23-b0b9cb52dba0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b0e542ab-e279-4793-be1c-c3b1961fe429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a41b5e90-28cc-41d0-be68-8d984e02ca74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2d4bfc12-5e01-4e24-8e5a-3cc7049a7bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a41b5e90-28cc-41d0-be68-8d984e02ca74" xlink:to="loc_us-gaap_NetIncomeLoss_2d4bfc12-5e01-4e24-8e5a-3cc7049a7bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_05720589-ddf5-43af-9df9-2ccb32b153c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a41b5e90-28cc-41d0-be68-8d984e02ca74" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_05720589-ddf5-43af-9df9-2ccb32b153c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2d0f2277-2f58-403e-8a24-e45e73b09a50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_05720589-ddf5-43af-9df9-2ccb32b153c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2d0f2277-2f58-403e-8a24-e45e73b09a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ceb6a874-2798-4c9b-ba3e-d825dda65d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_05720589-ddf5-43af-9df9-2ccb32b153c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ceb6a874-2798-4c9b-ba3e-d825dda65d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_24df2928-5a2e-440e-ac1c-39d7315e17f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_05720589-ddf5-43af-9df9-2ccb32b153c1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_24df2928-5a2e-440e-ac1c-39d7315e17f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_178b1140-d65a-4c32-83af-2cabbff033a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a41b5e90-28cc-41d0-be68-8d984e02ca74" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_178b1140-d65a-4c32-83af-2cabbff033a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2a4384cb-f787-46e5-9533-122cdf563793" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_23d24993-fc88-45be-b2a2-bc853873739f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2a4384cb-f787-46e5-9533-122cdf563793" xlink:to="loc_us-gaap_AssetsAbstract_23d24993-fc88-45be-b2a2-bc853873739f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_fd1da2c0-90bc-4d30-a6fb-3169823cb864" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23d24993-fc88-45be-b2a2-bc853873739f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_fd1da2c0-90bc-4d30-a6fb-3169823cb864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4076fb68-6ac1-4803-ba0f-b92e5199a1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fd1da2c0-90bc-4d30-a6fb-3169823cb864" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4076fb68-6ac1-4803-ba0f-b92e5199a1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_07738b8e-36e2-458b-bf9f-843e8c37e9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fd1da2c0-90bc-4d30-a6fb-3169823cb864" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_07738b8e-36e2-458b-bf9f-843e8c37e9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_0e3f80c1-eb97-4fd7-980c-40d513ad24a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fd1da2c0-90bc-4d30-a6fb-3169823cb864" xlink:to="loc_us-gaap_InventoryNetAbstract_0e3f80c1-eb97-4fd7-980c-40d513ad24a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_8888dfbe-d02d-40c9-bc43-64d2b4181617" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_0e3f80c1-eb97-4fd7-980c-40d513ad24a5" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_8888dfbe-d02d-40c9-bc43-64d2b4181617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_51aaecd1-2c6f-4759-a96b-c12d029c8df6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_0e3f80c1-eb97-4fd7-980c-40d513ad24a5" xlink:to="loc_us-gaap_InventoryWorkInProcess_51aaecd1-2c6f-4759-a96b-c12d029c8df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_e15f26eb-f21f-4ea3-b086-e39a7b5f1214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_0e3f80c1-eb97-4fd7-980c-40d513ad24a5" xlink:to="loc_us-gaap_InventoryFinishedGoods_e15f26eb-f21f-4ea3-b086-e39a7b5f1214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2f726ccd-44ca-4a0c-84e4-0011697b45d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_0e3f80c1-eb97-4fd7-980c-40d513ad24a5" xlink:to="loc_us-gaap_InventoryNet_2f726ccd-44ca-4a0c-84e4-0011697b45d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_a1657b3a-5735-4250-9831-016efefa75bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fd1da2c0-90bc-4d30-a6fb-3169823cb864" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_a1657b3a-5735-4250-9831-016efefa75bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_8c6a440f-4662-478b-accc-75b0c2397153" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fd1da2c0-90bc-4d30-a6fb-3169823cb864" xlink:to="loc_us-gaap_OtherAssetsCurrent_8c6a440f-4662-478b-accc-75b0c2397153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2291c35d-bab9-41a1-8e87-e6d3b74ae3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fd1da2c0-90bc-4d30-a6fb-3169823cb864" xlink:to="loc_us-gaap_AssetsCurrent_2291c35d-bab9-41a1-8e87-e6d3b74ae3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f8cb406c-cc70-4b57-be27-a1b2ba882bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23d24993-fc88-45be-b2a2-bc853873739f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f8cb406c-cc70-4b57-be27-a1b2ba882bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_3ed83b2c-1727-43b1-a42a-b5dfd0a86d35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23d24993-fc88-45be-b2a2-bc853873739f" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_3ed83b2c-1727-43b1-a42a-b5dfd0a86d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_4104ed2e-d5c8-476f-a226-3a4f264ef250" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23d24993-fc88-45be-b2a2-bc853873739f" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent_4104ed2e-d5c8-476f-a226-3a4f264ef250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8a907fa2-89eb-4005-8747-ae0e7f5cc987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23d24993-fc88-45be-b2a2-bc853873739f" xlink:to="loc_us-gaap_Assets_8a907fa2-89eb-4005-8747-ae0e7f5cc987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_28734ce1-9146-4e82-a061-018f52d020ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2a4384cb-f787-46e5-9533-122cdf563793" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_28734ce1-9146-4e82-a061-018f52d020ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_28734ce1-9146-4e82-a061-018f52d020ed" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_a68627bc-6020-4622-9e52-1ee9b7c02d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_a68627bc-6020-4622-9e52-1ee9b7c02d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_40b4e4df-3523-49b1-ae5b-0432b889d841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_40b4e4df-3523-49b1-ae5b-0432b889d841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent_71664370-e23e-4722-a587-94ac34c824d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:to="loc_us-gaap_AccountsPayableOtherCurrent_71664370-e23e-4722-a587-94ac34c824d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8f5161db-860b-4da8-a6fe-6d87cd79258e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8f5161db-860b-4da8-a6fe-6d87cd79258e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e5a03b38-d188-4783-b384-9f8cae605e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:to="loc_us-gaap_LongTermDebtCurrent_e5a03b38-d188-4783-b384-9f8cae605e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_135e69e6-62e9-4d76-8055-00d14024d4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_135e69e6-62e9-4d76-8055-00d14024d4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_836d9821-cf54-458f-baf5-b9b7bbbc252b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_836d9821-cf54-458f-baf5-b9b7bbbc252b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d4cf64c2-5c62-42c2-a49f-4a420e61c2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6cd88e00-c354-47da-8dc7-9f84072521b3" xlink:to="loc_us-gaap_LiabilitiesCurrent_d4cf64c2-5c62-42c2-a49f-4a420e61c2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_b2001741-fa14-47a0-b4bf-ecd3127f1bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_28734ce1-9146-4e82-a061-018f52d020ed" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_b2001741-fa14-47a0-b4bf-ecd3127f1bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c392eff7-1803-4df3-ba90-e1174da471b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_28734ce1-9146-4e82-a061-018f52d020ed" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c392eff7-1803-4df3-ba90-e1174da471b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_2d7fbddd-c410-46ed-823e-a2b8186fca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_28734ce1-9146-4e82-a061-018f52d020ed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_2d7fbddd-c410-46ed-823e-a2b8186fca4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7d31b121-1042-4abd-b59f-54fd62d50ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_28734ce1-9146-4e82-a061-018f52d020ed" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7d31b121-1042-4abd-b59f-54fd62d50ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_40e4d4f7-4a1b-4c05-8e7f-807a82ca3bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_28734ce1-9146-4e82-a061-018f52d020ed" xlink:to="loc_us-gaap_StockholdersEquityAbstract_40e4d4f7-4a1b-4c05-8e7f-807a82ca3bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9973f4e6-7a46-41c2-8cb3-bbca00b7ff2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_40e4d4f7-4a1b-4c05-8e7f-807a82ca3bdb" xlink:to="loc_us-gaap_CommonStockValue_9973f4e6-7a46-41c2-8cb3-bbca00b7ff2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_64d397cd-57d6-4ea4-862d-c3f2eab87285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_40e4d4f7-4a1b-4c05-8e7f-807a82ca3bdb" xlink:to="loc_us-gaap_AdditionalPaidInCapital_64d397cd-57d6-4ea4-862d-c3f2eab87285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_295698e9-f340-448e-8e28-31877e69d155" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_40e4d4f7-4a1b-4c05-8e7f-807a82ca3bdb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_295698e9-f340-448e-8e28-31877e69d155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_31fa9bda-44e1-4151-a08c-1143c8f00a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_40e4d4f7-4a1b-4c05-8e7f-807a82ca3bdb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_31fa9bda-44e1-4151-a08c-1143c8f00a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f5121fdf-7524-449d-ae0b-bcdc283c0c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_40e4d4f7-4a1b-4c05-8e7f-807a82ca3bdb" xlink:to="loc_us-gaap_StockholdersEquity_f5121fdf-7524-449d-ae0b-bcdc283c0c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0034216c-82bb-4cbd-8054-3201b8df54a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_28734ce1-9146-4e82-a061-018f52d020ed" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0034216c-82bb-4cbd-8054-3201b8df54a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_29012788-5bf6-4fdc-8d3f-c4c70659ef28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f653e641-2850-499b-87bd-7f084e43d97f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_29012788-5bf6-4fdc-8d3f-c4c70659ef28" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f653e641-2850-499b-87bd-7f084e43d97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4775ed59-1a23-4982-8221-6c49673367c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_29012788-5bf6-4fdc-8d3f-c4c70659ef28" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4775ed59-1a23-4982-8221-6c49673367c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6904fb11-d9e7-4afb-86a4-0fdb93b6c652" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_29012788-5bf6-4fdc-8d3f-c4c70659ef28" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6904fb11-d9e7-4afb-86a4-0fdb93b6c652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5380fa04-d3ec-49f9-8b32-cb0e22a7532f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_29012788-5bf6-4fdc-8d3f-c4c70659ef28" xlink:to="loc_us-gaap_CommonStockSharesIssued_5380fa04-d3ec-49f9-8b32-cb0e22a7532f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1caaa7b7-9d3e-4310-bee6-58cf325c8641" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_29012788-5bf6-4fdc-8d3f-c4c70659ef28" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1caaa7b7-9d3e-4310-bee6-58cf325c8641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedStatementsofEquity"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a8f4b775-a30c-4c3e-ab40-96d43fef0eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c7d0e14e-aa02-42ad-9324-f2523db8dc07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a8f4b775-a30c-4c3e-ab40-96d43fef0eaa" xlink:to="loc_us-gaap_StatementTable_c7d0e14e-aa02-42ad-9324-f2523db8dc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2366d4f0-a5c5-4e63-92a5-951288f76c18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c7d0e14e-aa02-42ad-9324-f2523db8dc07" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2366d4f0-a5c5-4e63-92a5-951288f76c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2366d4f0-a5c5-4e63-92a5-951288f76c18" xlink:to="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5df5a255-66d2-4dee-9787-9696c620b38a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_us-gaap_CommonStockMember_5df5a255-66d2-4dee-9787-9696c620b38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d7b172d7-74c1-4f1f-846e-0519967b23a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d7b172d7-74c1-4f1f-846e-0519967b23a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9786859c-c137-4364-87cc-23a71ab25faa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_us-gaap_RetainedEarningsMember_9786859c-c137-4364-87cc-23a71ab25faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentMember_abd5bbd2-d99b-45c6-b119-c0893ebcac3f" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_embc_NetParentInvestmentMember_abd5bbd2-d99b-45c6-b119-c0893ebcac3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_24181044-d91c-45de-be51-6d32fd336299" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e16b6f0-92c7-43ba-8412-d295dbb4efa9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_24181044-d91c-45de-be51-6d32fd336299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1e1699f8-3acf-415f-bc25-efa31e15e823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c7d0e14e-aa02-42ad-9324-f2523db8dc07" xlink:to="loc_us-gaap_StatementLineItems_1e1699f8-3acf-415f-bc25-efa31e15e823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1e1699f8-3acf-415f-bc25-efa31e15e823" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_80ecc135-5d78-4125-8d79-541a9cd8a610" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_80ecc135-5d78-4125-8d79-541a9cd8a610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84233f6e-1418-4ac2-b625-a80b15d5968e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_StockholdersEquity_84233f6e-1418-4ac2-b625-a80b15d5968e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments_1af94a68-7e3d-4af4-b9c4-270d0bb906a2" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments_1af94a68-7e3d-4af4-b9c4-270d0bb906a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c18d036e-3d4b-478e-8b59-08abf4c2d9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c18d036e-3d4b-478e-8b59-08abf4c2d9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment_fb584bdb-b5b6-40ae-951b-50281da7a38d" xlink:href="embc-20230930.xsd#embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment_fb584bdb-b5b6-40ae-951b-50281da7a38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentConsiderationPaidForSeparation_2d9c230f-089e-4867-92ee-d7b4e96c7ea6" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentConsiderationPaidForSeparation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_embc_NetParentInvestmentConsiderationPaidForSeparation_2d9c230f-089e-4867-92ee-d7b4e96c7ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_85c59271-d408-462d-8eee-ea8d92bfb8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_NetIncomeLoss_85c59271-d408-462d-8eee-ea8d92bfb8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_49f748c4-a6df-499a-92e6-c04bc2ec6464" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_49f748c4-a6df-499a-92e6-c04bc2ec6464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentNetTransfersToParent_37137210-730e-48db-8067-553297eb9771" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentNetTransfersToParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_embc_NetParentInvestmentNetTransfersToParent_37137210-730e-48db-8067-553297eb9771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e3098ccb-0228-41ba-ba43-608c626455b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e3098ccb-0228-41ba-ba43-608c626455b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_950c234a-eb33-4632-ac13-e30b5cc01f82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_DividendsCommonStock_950c234a-eb33-4632-ac13-e30b5cc01f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_62f438e4-635a-4bcb-bdde-7d4732b99680" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_62f438e4-635a-4bcb-bdde-7d4732b99680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_85770194-ad4d-478f-8bce-80d302ac8248" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_85770194-ad4d-478f-8bce-80d302ac8248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f577b697-8034-4a1b-8782-1cd7c54b1f42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f577b697-8034-4a1b-8782-1cd7c54b1f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_121de5a5-4bf0-4def-a015-3a56d15fe3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44337083-6f46-4c34-b8a7-0e6184d5edea" xlink:to="loc_us-gaap_StockholdersEquity_121de5a5-4bf0-4def-a015-3a56d15fe3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedStatementsofEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9d4cefbe-3463-4f26-931b-70c8e002d351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_474324ad-00c8-4dc0-ba53-f6309280d967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9d4cefbe-3463-4f26-931b-70c8e002d351" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_474324ad-00c8-4dc0-ba53-f6309280d967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="embc-20230930.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f41f39a1-5a74-4ff1-bb82-0d43e8f145f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_206068f2-4d3a-4964-8e50-b68f3c5c0373" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f41f39a1-5a74-4ff1-bb82-0d43e8f145f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_206068f2-4d3a-4964-8e50-b68f3c5c0373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_67575f26-4903-403c-85b8-edc0bd2cfd22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_206068f2-4d3a-4964-8e50-b68f3c5c0373" xlink:to="loc_us-gaap_NetIncomeLoss_67575f26-4903-403c-85b8-edc0bd2cfd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01bc63dc-4bfe-40f3-af31-741ad61b0c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_206068f2-4d3a-4964-8e50-b68f3c5c0373" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01bc63dc-4bfe-40f3-af31-741ad61b0c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0de655e6-12ce-4091-addd-31b4c531e4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01bc63dc-4bfe-40f3-af31-741ad61b0c5e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0de655e6-12ce-4091-addd-31b4c531e4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_a4889902-f4f6-4032-82cd-8e6a941afe42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01bc63dc-4bfe-40f3-af31-741ad61b0c5e" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_a4889902-f4f6-4032-82cd-8e6a941afe42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_bb50d678-eaef-4a9e-b014-2d5a8bbe5f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01bc63dc-4bfe-40f3-af31-741ad61b0c5e" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_bb50d678-eaef-4a9e-b014-2d5a8bbe5f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f2cc986e-7698-4d27-a813-1201f44d1702" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01bc63dc-4bfe-40f3-af31-741ad61b0c5e" xlink:to="loc_us-gaap_ShareBasedCompensation_f2cc986e-7698-4d27-a813-1201f44d1702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e6985a6e-284b-4541-bc7c-5f792226e90e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01bc63dc-4bfe-40f3-af31-741ad61b0c5e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e6985a6e-284b-4541-bc7c-5f792226e90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2586705-10cc-434f-b347-15c38d152877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01bc63dc-4bfe-40f3-af31-741ad61b0c5e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2586705-10cc-434f-b347-15c38d152877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c67a89b1-90da-4e74-b126-8486e417b267" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2586705-10cc-434f-b347-15c38d152877" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c67a89b1-90da-4e74-b126-8486e417b267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_243fa26d-7fbf-4ee0-8221-fedff2941de7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2586705-10cc-434f-b347-15c38d152877" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_243fa26d-7fbf-4ee0-8221-fedff2941de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet_5fdd1b03-4859-40b1-8150-74d84ad6cae7" xlink:href="embc-20230930.xsd#embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2586705-10cc-434f-b347-15c38d152877" xlink:to="loc_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet_5fdd1b03-4859-40b1-8150-74d84ad6cae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e44c2d6c-1210-4870-8cf4-5e80250c6e68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2586705-10cc-434f-b347-15c38d152877" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e44c2d6c-1210-4870-8cf4-5e80250c6e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f5e84dd8-f738-46c4-84c6-de6a25426cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2586705-10cc-434f-b347-15c38d152877" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f5e84dd8-f738-46c4-84c6-de6a25426cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_aa2d4342-5e3c-4fa8-a361-f8c84a3b2851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c2586705-10cc-434f-b347-15c38d152877" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_aa2d4342-5e3c-4fa8-a361-f8c84a3b2851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_c9dbc93d-0d1d-4182-9bdb-de267c22e1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_01bc63dc-4bfe-40f3-af31-741ad61b0c5e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_c9dbc93d-0d1d-4182-9bdb-de267c22e1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e7b21852-963b-4fd8-9891-3ee12c353a22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_206068f2-4d3a-4964-8e50-b68f3c5c0373" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e7b21852-963b-4fd8-9891-3ee12c353a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eff6005f-9450-436f-93b6-fc76ea20d9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f41f39a1-5a74-4ff1-bb82-0d43e8f145f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eff6005f-9450-436f-93b6-fc76ea20d9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cf858bd3-4b95-47c4-9543-7176743e133d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eff6005f-9450-436f-93b6-fc76ea20d9d7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cf858bd3-4b95-47c4-9543-7176743e133d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_97f10af6-82f1-4506-b42f-79b3a4196d13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eff6005f-9450-436f-93b6-fc76ea20d9d7" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_97f10af6-82f1-4506-b42f-79b3a4196d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e1faf00-3312-4e9d-9fc5-8ac03ccd8fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eff6005f-9450-436f-93b6-fc76ea20d9d7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e1faf00-3312-4e9d-9fc5-8ac03ccd8fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f41f39a1-5a74-4ff1-bb82-0d43e8f145f2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_521a3c31-0f8e-448a-a599-8042af10676d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_521a3c31-0f8e-448a-a599-8042af10676d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_fab07051-271d-4e67-b12e-05756b5d059f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_fab07051-271d-4e67-b12e-05756b5d059f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_7b5ee57c-d604-4a6b-a5ab-f7f49d0c2df7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_7b5ee57c-d604-4a6b-a5ab-f7f49d0c2df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PaymentOfRevolvingCreditFacilityFees_3517ac97-c350-4990-9c95-45a3afefe064" xlink:href="embc-20230930.xsd#embc_PaymentOfRevolvingCreditFacilityFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_embc_PaymentOfRevolvingCreditFacilityFees_3517ac97-c350-4990-9c95-45a3afefe064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4466896a-3ed4-408a-947f-2460bb573743" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4466896a-3ed4-408a-947f-2460bb573743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_93c76653-1219-4ba9-be4a-c2b1e946b6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_93c76653-1219-4ba9-be4a-c2b1e946b6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_7110dc5a-2182-4eb6-963e-a3b2145dc01f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_7110dc5a-2182-4eb6-963e-a3b2145dc01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PaymentForSpinoffTransactionFinancingActivities_0e897df9-3e4f-4478-854c-1dc3015412fb" xlink:href="embc-20230930.xsd#embc_PaymentForSpinoffTransactionFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_embc_PaymentForSpinoffTransactionFinancingActivities_0e897df9-3e4f-4478-854c-1dc3015412fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetTransfersToParentFinancingActivities_8eee8432-4d97-4237-9afc-9d6ad088c14f" xlink:href="embc-20230930.xsd#embc_NetTransfersToParentFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_embc_NetTransfersToParentFinancingActivities_8eee8432-4d97-4237-9afc-9d6ad088c14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec380f4e-7c28-4d52-b3da-e44905b52a83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_fdf73ec7-6369-4c89-904c-ec813dbd99b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec380f4e-7c28-4d52-b3da-e44905b52a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ca87402c-e0dd-4a86-b057-1d74e10839e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f41f39a1-5a74-4ff1-bb82-0d43e8f145f2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_ca87402c-e0dd-4a86-b057-1d74e10839e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab2aff6e-19ac-4ae3-8dd0-7f76f749d71d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f41f39a1-5a74-4ff1-bb82-0d43e8f145f2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab2aff6e-19ac-4ae3-8dd0-7f76f749d71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6e5e515-cfff-466f-aa4a-2da465eb2348" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f41f39a1-5a74-4ff1-bb82-0d43e8f145f2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e6e5e515-cfff-466f-aa4a-2da465eb2348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e61220d9-9b74-4177-ae29-9a101ea12c46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f41f39a1-5a74-4ff1-bb82-0d43e8f145f2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e61220d9-9b74-4177-ae29-9a101ea12c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/Background" xlink:type="simple" xlink:href="embc-20230930.xsd#Background"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/Background" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_228dd853-3f88-48bf-82ab-3a13bb24d56a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_22ddc0ed-e848-440a-9900-701ece173aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_228dd853-3f88-48bf-82ab-3a13bb24d56a" xlink:to="loc_us-gaap_NatureOfOperations_22ddc0ed-e848-440a-9900-701ece173aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/BasisofPresentation" xlink:type="simple" xlink:href="embc-20230930.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ff336cf1-0a18-4ee1-95b0-801abd06401e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_64da5c3a-587b-4072-9f09-7456486bf11b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ff336cf1-0a18-4ee1-95b0-801abd06401e" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_64da5c3a-587b-4072-9f09-7456486bf11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SummaryofAccountingPolicies" xlink:type="simple" xlink:href="embc-20230930.xsd#SummaryofAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SummaryofAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a1f4c287-29e4-41cb-8054-4761374c9e73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f8813644-c6dd-4005-8866-d3b579e70792" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a1f4c287-29e4-41cb-8054-4761374c9e73" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f8813644-c6dd-4005-8866-d3b579e70792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosures" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosures"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_dcc3a76f-3cb8-4585-90e7-f7b6352ee2bf" xlink:href="embc-20230930.xsd#embc_ThirdPartyAndRelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock_1c592455-9d99-4e77-b61c-c1a578ace16c" xlink:href="embc-20230930.xsd#embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_dcc3a76f-3cb8-4585-90e7-f7b6352ee2bf" xlink:to="loc_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock_1c592455-9d99-4e77-b61c-c1a578ace16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/CollaborationAgreement" xlink:type="simple" xlink:href="embc-20230930.xsd#CollaborationAgreement"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/CollaborationAgreement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b56cf6f1-2df9-450e-877b-cf2a142f6584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_1e3ecaca-72d8-428a-9031-5dfe40182bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b56cf6f1-2df9-450e-877b-cf2a142f6584" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_1e3ecaca-72d8-428a-9031-5dfe40182bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/OtherOperatingExpenses" xlink:type="simple" xlink:href="embc-20230930.xsd#OtherOperatingExpenses"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/OtherOperatingExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_c7d80aca-92ad-48b9-8702-b1930fdf71dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeAndExpenseTextBlock_1cc8191d-2e39-43af-a5e6-ed8ffabac423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncomeAndExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_c7d80aca-92ad-48b9-8702-b1930fdf71dd" xlink:to="loc_us-gaap_OtherOperatingIncomeAndExpenseTextBlock_1cc8191d-2e39-43af-a5e6-ed8ffabac423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/Contingencies" xlink:type="simple" xlink:href="embc-20230930.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d913d274-75b0-4fea-bad5-7690fee2593b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_c2feb426-3c11-4a1a-92e9-c27c93f806a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d913d274-75b0-4fea-bad5-7690fee2593b" xlink:to="loc_us-gaap_LossContingencyDisclosures_c2feb426-3c11-4a1a-92e9-c27c93f806a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/Revenues" xlink:type="simple" xlink:href="embc-20230930.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eadab3e8-132e-4055-ad1b-be2e6a44d2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_7326207e-c3c9-4b87-8b64-122bdbee712b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eadab3e8-132e-4055-ad1b-be2e6a44d2c4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_7326207e-c3c9-4b87-8b64-122bdbee712b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SegmentandGeographicalData" xlink:type="simple" xlink:href="embc-20230930.xsd#SegmentandGeographicalData"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SegmentandGeographicalData" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2a2ea415-78a6-48a9-bf6a-d8a2c052f96f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_7b993b8d-9e6b-43fd-a805-20dcebac2437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2a2ea415-78a6-48a9-bf6a-d8a2c052f96f" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_7b993b8d-9e6b-43fd-a805-20dcebac2437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_66f4fbe4-50ca-4217-b04c-4d390e6d1d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_17de906d-8d7d-469e-bdf2-8b21ad9fb232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_66f4fbe4-50ca-4217-b04c-4d390e6d1d8f" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_17de906d-8d7d-469e-bdf2-8b21ad9fb232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="embc-20230930.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ae6e5d00-150e-4cf9-a589-1b1d2643307b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a2877f2c-4781-4a37-a610-98f7463a5dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ae6e5d00-150e-4cf9-a589-1b1d2643307b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a2877f2c-4781-4a37-a610-98f7463a5dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LongTermDebt" xlink:type="simple" xlink:href="embc-20230930.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_279468f4-48ef-4267-afc1-bb414b671354" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_5ac22f85-7979-49df-9fa4-a1d67762ee34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_279468f4-48ef-4267-afc1-bb414b671354" xlink:to="loc_us-gaap_LongTermDebtTextBlock_5ac22f85-7979-49df-9fa4-a1d67762ee34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/EarningsperShare" xlink:type="simple" xlink:href="embc-20230930.xsd#EarningsperShare"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/EarningsperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4b798c74-65cb-4ed0-b81a-57f27fa71d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_b049671d-88dc-4cd6-ac69-aa9c24f79ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4b798c74-65cb-4ed0-b81a-57f27fa71d8c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_b049671d-88dc-4cd6-ac69-aa9c24f79ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxes" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5e5f7d14-124d-4eba-88b2-8b100288dcef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_381849fd-9d02-41a1-8ac6-ea2f6441a737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5e5f7d14-124d-4eba-88b2-8b100288dcef" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_381849fd-9d02-41a1-8ac6-ea2f6441a737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="simple" xlink:href="embc-20230930.xsd#FinancialInstrumentsandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cc8a69b7-2315-446c-a6e0-02d3989d5c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5b8e744c-dfbf-408e-b171-61d93b149804" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cc8a69b7-2315-446c-a6e0-02d3989d5c54" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5b8e744c-dfbf-408e-b171-61d93b149804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="embc-20230930.xsd#PropertyPlantandEquipment"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/PropertyPlantandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f9c5ad54-e259-415c-ac39-2a6389ce2110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_cf931310-3c44-4f69-8982-04686ab1d823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f9c5ad54-e259-415c-ac39-2a6389ce2110" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_cf931310-3c44-4f69-8982-04686ab1d823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/Leases" xlink:type="simple" xlink:href="embc-20230930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4fc7667b-b52e-4bdd-8400-8a9f8fb7fc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_634fcd74-e52f-4dad-8740-6a0d40be5fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4fc7667b-b52e-4bdd-8400-8a9f8fb7fc2c" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_634fcd74-e52f-4dad-8740-6a0d40be5fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_e8579563-bbd2-4cf6-a1cc-e44dacc268e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4fc7667b-b52e-4bdd-8400-8a9f8fb7fc2c" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_e8579563-bbd2-4cf6-a1cc-e44dacc268e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/BenefitPlans" xlink:type="simple" xlink:href="embc-20230930.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8b8563be-ce89-4f62-8fed-a8ebf28989c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_204d2bc8-9fab-4acc-a574-f95ee388606c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8b8563be-ce89-4f62-8fed-a8ebf28989c9" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_204d2bc8-9fab-4acc-a574-f95ee388606c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SupplementalFinancialInformation" xlink:type="simple" xlink:href="embc-20230930.xsd#SupplementalFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SupplementalFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c4bc8a81-b3c4-4536-9c49-eb16a1e780b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_87c429c9-bd91-4413-8344-864d7ccfb6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c4bc8a81-b3c4-4536-9c49-eb16a1e780b6" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_87c429c9-bd91-4413-8344-864d7ccfb6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SubsequentEvents" xlink:type="simple" xlink:href="embc-20230930.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0660d3db-13c1-402c-b175-fe7e29b4030e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_9d2c03e3-ba00-4fb6-8591-531d48ea454a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0660d3db-13c1-402c-b175-fe7e29b4030e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_9d2c03e3-ba00-4fb6-8591-531d48ea454a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies" xlink:type="simple" xlink:href="embc-20230930.xsd#SummaryofAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0f1d927f-bb96-4395-ba48-d35252c89710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0f1d927f-bb96-4395-ba48-d35252c89710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_5116c222-383c-4ac0-a2d5-34ef17659af2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_5116c222-383c-4ac0-a2d5-34ef17659af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_f7e0b648-34c4-485c-8fbb-5634cd691694" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_15ffac0a-170b-4f28-bb51-c7f3362a351b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_15ffac0a-170b-4f28-bb51-c7f3362a351b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_bdd8d71c-357c-4379-a3cd-99f79789477f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_bdd8d71c-357c-4379-a3cd-99f79789477f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_216af7c7-213c-4a55-bd76-234bb4229d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_216af7c7-213c-4a55-bd76-234bb4229d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_c7814269-9ee2-43f5-8c6d-bf7555d62329" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_c7814269-9ee2-43f5-8c6d-bf7555d62329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_HostingArrangementServiceContractPolicyTextBlock_67a4d2db-bf45-49a8-9113-b9a77e5fca47" xlink:href="embc-20230930.xsd#embc_HostingArrangementServiceContractPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_embc_HostingArrangementServiceContractPolicyTextBlock_67a4d2db-bf45-49a8-9113-b9a77e5fca47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d2209b58-13f2-496c-a68a-76acafaa740a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d2209b58-13f2-496c-a68a-76acafaa740a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_8887e718-a5da-4215-9b98-2418ed900fec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestCapitalizationPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_InterestCapitalizationPolicyPolicyTextBlock_8887e718-a5da-4215-9b98-2418ed900fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_05692302-639b-43c2-9223-f3f503bf9e38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_05692302-639b-43c2-9223-f3f503bf9e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_1982ca71-0a61-4a5c-95b8-6a87710e6aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_1982ca71-0a61-4a5c-95b8-6a87710e6aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cd65ac00-152f-44ee-ae56-c1d80b8adecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cd65ac00-152f-44ee-ae56-c1d80b8adecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShippingAndHandlingPolicyPolicyTextBlock_a6e19fc3-b560-4947-8c80-1b05e52e91f3" xlink:href="embc-20230930.xsd#embc_ShippingAndHandlingPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_embc_ShippingAndHandlingPolicyPolicyTextBlock_a6e19fc3-b560-4947-8c80-1b05e52e91f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0f79ccd2-500c-4a25-92d6-818cb3657446" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0f79ccd2-500c-4a25-92d6-818cb3657446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5b08f787-cada-4e7d-a303-161e6d84b02e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5b08f787-cada-4e7d-a303-161e6d84b02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_3acf2792-2c71-41f8-8fb1-3ab13d03e5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_3acf2792-2c71-41f8-8fb1-3ab13d03e5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_640b1ed0-82b4-4f82-a34f-7fa49eb014f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_640b1ed0-82b4-4f82-a34f-7fa49eb014f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_6dc8d451-8a64-4067-bc6b-c5b7a3d4b557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_6dc8d451-8a64-4067-bc6b-c5b7a3d4b557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_0fd5ff09-4ada-4def-94fe-d5efd66d2080" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_0fd5ff09-4ada-4def-94fe-d5efd66d2080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_e310a5b5-10b2-49a5-8a07-a58b57873f29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_e310a5b5-10b2-49a5-8a07-a58b57873f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_240d47ab-93ab-4cce-a9af-709bcc1b78c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_240d47ab-93ab-4cce-a9af-709bcc1b78c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_382f8865-57a4-415c-a12a-e91798028bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_UseOfEstimates_382f8865-57a4-415c-a12a-e91798028bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4e74aa27-324f-4fe0-a8d9-de74a4c7676a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_febdeecc-16d8-412e-b65a-4aac64a2c9e7" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4e74aa27-324f-4fe0-a8d9-de74a4c7676a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresTables" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosuresTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_61e124a3-25dd-4b69-bae8-b7e9faf21863" xlink:href="embc-20230930.xsd#embc_ThirdPartyAndRelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_fdeecf97-9042-41c9-9797-738321b06c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_61e124a3-25dd-4b69-bae8-b7e9faf21863" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_fdeecf97-9042-41c9-9797-738321b06c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SegmentandGeographicalDataTables" xlink:type="simple" xlink:href="embc-20230930.xsd#SegmentandGeographicalDataTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SegmentandGeographicalDataTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f80ad8ac-88bb-4105-8081-6ba52104ff1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_59582c36-4201-485e-83fa-57f721f66142" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f80ad8ac-88bb-4105-8081-6ba52104ff1b" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_59582c36-4201-485e-83fa-57f721f66142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7055612-ee7d-46fb-b8ca-acad98355f26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f7a8a220-e9ea-4adb-93b3-33f79d633c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7055612-ee7d-46fb-b8ca-acad98355f26" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f7a8a220-e9ea-4adb-93b3-33f79d633c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_4c1dbbed-6f97-435f-b48f-1716ed7222bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7055612-ee7d-46fb-b8ca-acad98355f26" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock_4c1dbbed-6f97-435f-b48f-1716ed7222bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_4b6a4ca9-eff5-458d-ad19-3e3b20baabc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7055612-ee7d-46fb-b8ca-acad98355f26" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock_4b6a4ca9-eff5-458d-ad19-3e3b20baabc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock_f2d35f6c-7769-43cf-8d4b-e687b2dc566c" xlink:href="embc-20230930.xsd#embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7055612-ee7d-46fb-b8ca-acad98355f26" xlink:to="loc_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock_f2d35f6c-7769-43cf-8d4b-e687b2dc566c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_b5ab524b-376f-4014-9cbe-655fac584e44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f7055612-ee7d-46fb-b8ca-acad98355f26" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock_b5ab524b-376f-4014-9cbe-655fac584e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="embc-20230930.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2b6e6539-6e41-47c0-96c9-458bbf92ca1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_1b1adaca-0a66-4c73-be25-e2b4f1f4151e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2b6e6539-6e41-47c0-96c9-458bbf92ca1c" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_1b1adaca-0a66-4c73-be25-e2b4f1f4151e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="embc-20230930.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_12800e15-737a-4328-a242-1e22c9124fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7238287f-bc4e-4e5b-88c4-15f5d434993c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_12800e15-737a-4328-a242-1e22c9124fb3" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7238287f-bc4e-4e5b-88c4-15f5d434993c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4a9c1933-1b88-4baf-b028-a0a0a74706c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_12800e15-737a-4328-a242-1e22c9124fb3" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4a9c1933-1b88-4baf-b028-a0a0a74706c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/EarningsperShareTables" xlink:type="simple" xlink:href="embc-20230930.xsd#EarningsperShareTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/EarningsperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6187063f-36ea-49f7-8863-f813a955b4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_846b32ae-9fbe-416f-9404-ad56e728d44f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6187063f-36ea-49f7-8863-f813a955b4a3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_846b32ae-9fbe-416f-9404-ad56e728d44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5673d871-0731-45f7-9f4f-5c913c2f8ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_ca6d2250-3e35-464a-a6a7-31ae01714f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5673d871-0731-45f7-9f4f-5c913c2f8ee2" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_ca6d2250-3e35-464a-a6a7-31ae01714f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_cf92a547-22a5-430a-b052-bf5e5a1f040d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5673d871-0731-45f7-9f4f-5c913c2f8ee2" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_cf92a547-22a5-430a-b052-bf5e5a1f040d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_eefcacd0-6c34-4746-be4d-4d0e26fe1ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5673d871-0731-45f7-9f4f-5c913c2f8ee2" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_eefcacd0-6c34-4746-be4d-4d0e26fe1ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6bbf3af0-0f23-4a8d-950b-72bf59c7d3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5673d871-0731-45f7-9f4f-5c913c2f8ee2" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6bbf3af0-0f23-4a8d-950b-72bf59c7d3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_3d3c32b8-9df3-411c-9fe4-79ee8082d377" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5673d871-0731-45f7-9f4f-5c913c2f8ee2" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_3d3c32b8-9df3-411c-9fe4-79ee8082d377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="simple" xlink:href="embc-20230930.xsd#FinancialInstrumentsandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5d3037c1-9881-42ad-82b4-77e23fc0aa99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_04a11c7e-5bf9-4574-a412-959312e0da82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5d3037c1-9881-42ad-82b4-77e23fc0aa99" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_04a11c7e-5bf9-4574-a412-959312e0da82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_38e4353e-248a-4d13-ac8f-0ffce9e3258e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5d3037c1-9881-42ad-82b4-77e23fc0aa99" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_38e4353e-248a-4d13-ac8f-0ffce9e3258e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="embc-20230930.xsd#PropertyPlantandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_acc4ad1a-c0fe-43bb-b18a-d7733b41ef03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_dbd08339-1b75-494f-8521-fe3810e62539" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_acc4ad1a-c0fe-43bb-b18a-d7733b41ef03" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_dbd08339-1b75-494f-8521-fe3810e62539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesTables" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_947bc290-7555-4a70-8d28-a1f93cee2e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_AssetsAndLiabilitiesLesseeTableTextBlock_1b135510-1ed8-4ef8-9d0a-a608b76e29fc" xlink:href="embc-20230930.xsd#embc_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_947bc290-7555-4a70-8d28-a1f93cee2e4a" xlink:to="loc_embc_AssetsAndLiabilitiesLesseeTableTextBlock_1b135510-1ed8-4ef8-9d0a-a608b76e29fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_9885700e-c27e-46c3-b12e-1bb7ce56f13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_947bc290-7555-4a70-8d28-a1f93cee2e4a" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_9885700e-c27e-46c3-b12e-1bb7ce56f13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_9988fa06-bc0d-4ffa-989f-b4951d2ed3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_947bc290-7555-4a70-8d28-a1f93cee2e4a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_9988fa06-bc0d-4ffa-989f-b4951d2ed3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d5e647d6-3358-4da1-8a43-301930ebeb36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_947bc290-7555-4a70-8d28-a1f93cee2e4a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d5e647d6-3358-4da1-8a43-301930ebeb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="embc-20230930.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_be0be24d-d61b-46b5-988c-bf838e1ca8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_7103197c-d4de-4b12-9a89-1630dc5f9b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_be0be24d-d61b-46b5-988c-bf838e1ca8b1" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_7103197c-d4de-4b12-9a89-1630dc5f9b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_4a5f5528-c536-45fb-a712-d031fcfc67f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_be0be24d-d61b-46b5-988c-bf838e1ca8b1" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_4a5f5528-c536-45fb-a712-d031fcfc67f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/BackgroundDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#BackgroundDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/BackgroundDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fd3b6986-42fd-4e90-88e0-5c0bbf6b88aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_ce526d20-54a1-4065-b9eb-31f4c1da0860" xlink:href="embc-20230930.xsd#embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fd3b6986-42fd-4e90-88e0-5c0bbf6b88aa" xlink:to="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_ce526d20-54a1-4065-b9eb-31f4c1da0860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5009d3a5-703b-4e94-90eb-01c1ba2cd30c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_ce526d20-54a1-4065-b9eb-31f4c1da0860" xlink:to="loc_dei_LegalEntityAxis_5009d3a5-703b-4e94-90eb-01c1ba2cd30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d72ccae3-c8f7-4a5f-9ed6-76e642b598cc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5009d3a5-703b-4e94-90eb-01c1ba2cd30c" xlink:to="loc_dei_EntityDomain_d72ccae3-c8f7-4a5f-9ed6-76e642b598cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BectonDickinsonAndCompanyMember_f2a09b1b-f02d-443b-986b-5a500e82a087" xlink:href="embc-20230930.xsd#embc_BectonDickinsonAndCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d72ccae3-c8f7-4a5f-9ed6-76e642b598cc" xlink:to="loc_embc_BectonDickinsonAndCompanyMember_f2a09b1b-f02d-443b-986b-5a500e82a087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_5b0d9bf2-7bdf-4d1d-b400-22ef58f56e79" xlink:href="embc-20230930.xsd#embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_ce526d20-54a1-4065-b9eb-31f4c1da0860" xlink:to="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_5b0d9bf2-7bdf-4d1d-b400-22ef58f56e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_bfe05e05-a667-4cd3-8a88-64b6b98b8650" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_5b0d9bf2-7bdf-4d1d-b400-22ef58f56e79" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_bfe05e05-a667-4cd3-8a88-64b6b98b8650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CommonStockShareIssuanceRatio_3a1844a4-7d9b-4e6b-8b36-edfe0c8e1eca" xlink:href="embc-20230930.xsd#embc_CommonStockShareIssuanceRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_5b0d9bf2-7bdf-4d1d-b400-22ef58f56e79" xlink:to="loc_embc_CommonStockShareIssuanceRatio_3a1844a4-7d9b-4e6b-8b36-edfe0c8e1eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SummaryofAccountingPoliciesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SummaryofAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SummaryofAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_98994bc1-7d69-466b-9c8c-174ac3a96e18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_98994bc1-7d69-466b-9c8c-174ac3a96e18" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_69168b7c-61eb-42be-99d9-998d29991557" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_srt_RangeAxis_69168b7c-61eb-42be-99d9-998d29991557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_63b60081-900a-4e22-9bfe-bd8eab73d5a7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_69168b7c-61eb-42be-99d9-998d29991557" xlink:to="loc_srt_RangeMember_63b60081-900a-4e22-9bfe-bd8eab73d5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_12beecf5-fc59-454b-b099-f9a48d006f8b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_63b60081-900a-4e22-9bfe-bd8eab73d5a7" xlink:to="loc_srt_MinimumMember_12beecf5-fc59-454b-b099-f9a48d006f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ca07fbc2-380f-4088-9bda-f536bd77cdda" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_63b60081-900a-4e22-9bfe-bd8eab73d5a7" xlink:to="loc_srt_MaximumMember_ca07fbc2-380f-4088-9bda-f536bd77cdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_734bd812-12b1-443f-80a4-83afd292ade7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_734bd812-12b1-443f-80a4-83afd292ade7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_734bd812-12b1-443f-80a4-83afd292ade7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_b47bbe32-9438-4baf-badb-a759764ae61b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:to="loc_us-gaap_BuildingMember_b47bbe32-9438-4baf-badb-a759764ae61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_06d1f7e6-8bcd-4469-8b48-1a9259b83002" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_06d1f7e6-8bcd-4469-8b48-1a9259b83002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_19475291-fafc-41a5-9dd9-a9a613669f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c03685c0-6710-4777-96f1-516d32870410" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_19475291-fafc-41a5-9dd9-a9a613669f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5ef3a3d4-163f-401d-8d33-7c6cc530cf26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5ef3a3d4-163f-401d-8d33-7c6cc530cf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d050883a-99e1-46e6-94f0-386a10c0508c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5ef3a3d4-163f-401d-8d33-7c6cc530cf26" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d050883a-99e1-46e6-94f0-386a10c0508c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PropertyPlantAndEquipmentNetMember_6cf3aa7d-5f0d-4ab7-896e-4d4724423457" xlink:href="embc-20230930.xsd#embc_PropertyPlantAndEquipmentNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d050883a-99e1-46e6-94f0-386a10c0508c" xlink:to="loc_embc_PropertyPlantAndEquipmentNetMember_6cf3aa7d-5f0d-4ab7-896e-4d4724423457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredIncomeTaxesAndOtherAssetsMember_48249c5f-c1ae-4cd7-966f-1fc61d8018a7" xlink:href="embc-20230930.xsd#embc_DeferredIncomeTaxesAndOtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d050883a-99e1-46e6-94f0-386a10c0508c" xlink:to="loc_embc_DeferredIncomeTaxesAndOtherAssetsMember_48249c5f-c1ae-4cd7-966f-1fc61d8018a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_595eca6b-e535-42a1-97e9-f45a45c720af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_595eca6b-e535-42a1-97e9-f45a45c720af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_595eca6b-e535-42a1-97e9-f45a45c720af" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_f98be11d-1869-40ac-baba-3c10377939a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:to="loc_us-gaap_PatentsMember_f98be11d-1869-40ac-baba-3c10377939a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_36a54c1d-f5f4-4865-aa31-03501e960b17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:to="loc_us-gaap_CustomerRelationshipsMember_36a54c1d-f5f4-4865-aa31-03501e960b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_97abe70d-db3d-4aee-a0d9-7db5e4331845" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e987b38a-0223-4429-9aa2-801379d651ec" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_97abe70d-db3d-4aee-a0d9-7db5e4331845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4c66b051-9167-4c78-aa01-e53304faa212" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_srt_ProductOrServiceAxis_4c66b051-9167-4c78-aa01-e53304faa212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c265b1cc-40dd-4519-ba04-d682ff1309db" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4c66b051-9167-4c78-aa01-e53304faa212" xlink:to="loc_srt_ProductsAndServicesDomain_c265b1cc-40dd-4519-ba04-d682ff1309db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_7f0c1488-4510-447f-a391-e7351b11d85e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c265b1cc-40dd-4519-ba04-d682ff1309db" xlink:to="loc_us-gaap_ShippingAndHandlingMember_7f0c1488-4510-447f-a391-e7351b11d85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_91f558ec-b24e-4597-ae0c-5f5bef16d74b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_68ba5460-7dff-4648-b77d-c6dc35fdd2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_68ba5460-7dff-4648-b77d-c6dc35fdd2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife_facd8e63-a978-46cd-9501-17d9accc9105" xlink:href="embc-20230930.xsd#embc_HostingArrangementServiceContractAssetsInServiceUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife_facd8e63-a978-46cd-9501-17d9accc9105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2829e6bb-5d41-4b9f-ace6-770b005105d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2829e6bb-5d41-4b9f-ace6-770b005105d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7e12c01a-8a33-487c-8008-613e5c5bb889" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_Depreciation_7e12c01a-8a33-487c-8008-613e5c5bb889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_7f6782ea-d9e8-4cb0-bd90-99f0f35a10ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_InterestPaidCapitalized_7f6782ea-d9e8-4cb0-bd90-99f0f35a10ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_b15b80fd-5bef-41d6-8b1f-ce91e00084fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_AdvertisingExpense_b15b80fd-5bef-41d6-8b1f-ce91e00084fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_50ac1f0f-d71f-48a2-acff-4828eb69e473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_NumberOfReportingUnits_50ac1f0f-d71f-48a2-acff-4828eb69e473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d73f8ca3-29de-4d64-a19a-30382d478cab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d73f8ca3-29de-4d64-a19a-30382d478cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_66750425-f2c9-4429-a3f1-9ae7cf1634a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_66750425-f2c9-4429-a3f1-9ae7cf1634a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_3d030f03-a19a-49b2-b3d5-bd529ed772aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_NumberOfOperatingSegments_3d030f03-a19a-49b2-b3d5-bd529ed772aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f07c5fdc-9bc4-479d-8b1b-e59d3531c554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_NumberOfReportableSegments_f07c5fdc-9bc4-479d-8b1b-e59d3531c554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_9eb239a2-1765-4ce3-abb2-7f3966fcdb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_InterestPaidNet_9eb239a2-1765-4ce3-abb2-7f3966fcdb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_8e4dcd72-fa61-407a-b0d1-a9c2b86d984a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_8e4dcd72-fa61-407a-b0d1-a9c2b86d984a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_c67556e8-359f-4a6f-be90-9bba5c0be022" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0419e28c-8f75-4ed5-a23b-be199fc973e5" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_c67556e8-359f-4a6f-be90-9bba5c0be022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_96c10f55-16d9-4fa0-a8c9-a32ee154ee16" xlink:href="embc-20230930.xsd#embc_ThirdPartyAndRelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_96c10f55-16d9-4fa0-a8c9-a32ee154ee16" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_432b5819-26b2-4874-85d2-2b2f6bbe9a86" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_srt_CounterpartyNameAxis_432b5819-26b2-4874-85d2-2b2f6bbe9a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_390c02d4-472b-4be5-967c-9aea42dcaea4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_432b5819-26b2-4874-85d2-2b2f6bbe9a86" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_390c02d4-472b-4be5-967c-9aea42dcaea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BectonDickinsonAndCompanyMember_4cba1c34-ace4-48ca-aa4b-219b9fcca904" xlink:href="embc-20230930.xsd#embc_BectonDickinsonAndCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_390c02d4-472b-4be5-967c-9aea42dcaea4" xlink:to="loc_embc_BectonDickinsonAndCompanyMember_4cba1c34-ace4-48ca-aa4b-219b9fcca904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6828d361-27a8-42a0-986d-da0df8f7e73c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_srt_RangeAxis_6828d361-27a8-42a0-986d-da0df8f7e73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d7a25c64-1c8f-4b2c-8d7d-803e3e039e93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6828d361-27a8-42a0-986d-da0df8f7e73c" xlink:to="loc_srt_RangeMember_d7a25c64-1c8f-4b2c-8d7d-803e3e039e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2397bf81-d755-4955-9c73-041d4699e495" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d7a25c64-1c8f-4b2c-8d7d-803e3e039e93" xlink:to="loc_srt_MinimumMember_2397bf81-d755-4955-9c73-041d4699e495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d20d2c52-6ef8-46fb-9c95-5b0ac470e36c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d7a25c64-1c8f-4b2c-8d7d-803e3e039e93" xlink:to="loc_srt_MaximumMember_d20d2c52-6ef8-46fb-9c95-5b0ac470e36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e7ae253e-c1af-4d1c-a2ee-4d6e45eef832" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_dei_LegalEntityAxis_e7ae253e-c1af-4d1c-a2ee-4d6e45eef832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7bdd3d4a-faea-4df9-ae42-75380de7ba43" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e7ae253e-c1af-4d1c-a2ee-4d6e45eef832" xlink:to="loc_dei_EntityDomain_7bdd3d4a-faea-4df9-ae42-75380de7ba43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BectonDickinsonAndCompanyMember_6e73e3d4-e410-4883-a352-c51d6955212c" xlink:href="embc-20230930.xsd#embc_BectonDickinsonAndCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_7bdd3d4a-faea-4df9-ae42-75380de7ba43" xlink:to="loc_embc_BectonDickinsonAndCompanyMember_6e73e3d4-e410-4883-a352-c51d6955212c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4a23e523-998a-4f35-907b-21c127e52521" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_us-gaap_DebtInstrumentAxis_4a23e523-998a-4f35-907b-21c127e52521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f974b744-ea86-4beb-aec4-e6ad079f57fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a23e523-998a-4f35-907b-21c127e52521" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f974b744-ea86-4beb-aec4-e6ad079f57fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_a4915e25-c7fb-43e1-bf92-52de3bf8408b" xlink:href="embc-20230930.xsd#embc_A675SeniorSecuredNotesDueFebruary2030Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f974b744-ea86-4beb-aec4-e6ad079f57fe" xlink:to="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_a4915e25-c7fb-43e1-bf92-52de3bf8408b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_84f38411-5598-48ab-a302-2a11644e5b74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_84f38411-5598-48ab-a302-2a11644e5b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e9d26faa-3764-4205-9c6a-cc0de8344b78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_84f38411-5598-48ab-a302-2a11644e5b74" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e9d26faa-3764-4205-9c6a-cc0de8344b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_42c4c101-fc4f-4c8f-a55a-f19639566689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e9d26faa-3764-4205-9c6a-cc0de8344b78" xlink:to="loc_us-gaap_SeniorNotesMember_42c4c101-fc4f-4c8f-a55a-f19639566689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_86f5ef83-804e-42e5-a7a6-7cfee69ddd53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_86f5ef83-804e-42e5-a7a6-7cfee69ddd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_017b4886-27e1-4c18-8094-ca10d701c778" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_86f5ef83-804e-42e5-a7a6-7cfee69ddd53" xlink:to="loc_us-gaap_RelatedPartyDomain_017b4886-27e1-4c18-8094-ca10d701c778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_6b9928e7-c5fd-44f5-ad39-e72391e8fca6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_017b4886-27e1-4c18-8094-ca10d701c778" xlink:to="loc_us-gaap_ParentMember_6b9928e7-c5fd-44f5-ad39-e72391e8fca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_135243bd-da63-41ba-bf6e-abc80c3768db" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_srt_StatementScenarioAxis_135243bd-da63-41ba-bf6e-abc80c3768db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c99d4625-d9e0-4476-a9cb-aed4fc4bf7fb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_135243bd-da63-41ba-bf6e-abc80c3768db" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c99d4625-d9e0-4476-a9cb-aed4fc4bf7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_0c8d02e1-9eb0-4014-b342-9a826f248e33" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_c99d4625-d9e0-4476-a9cb-aed4fc4bf7fb" xlink:to="loc_srt_ScenarioForecastMember_0c8d02e1-9eb0-4014-b342-9a826f248e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_137a0ccb-17d4-402d-be3e-3a399514a7cb" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum_f45c308b-358b-4ab0-854f-e54772773d0e" xlink:href="embc-20230930.xsd#embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum_f45c308b-358b-4ab0-854f-e54772773d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ContractuallySpecifiedServicingFeesPercentage_9841bdbc-7e02-4046-a990-e8f9dc5ff82c" xlink:href="embc-20230930.xsd#embc_ContractuallySpecifiedServicingFeesPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_ContractuallySpecifiedServicingFeesPercentage_9841bdbc-7e02-4046-a990-e8f9dc5ff82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DistributionAgreementDistributorAppointmentMaximumTerm_bc5baf06-3775-4f49-b3ec-36a300338d54" xlink:href="embc-20230930.xsd#embc_DistributionAgreementDistributorAppointmentMaximumTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_DistributionAgreementDistributorAppointmentMaximumTerm_bc5baf06-3775-4f49-b3ec-36a300338d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue_43b61981-79f4-49de-bff5-9590c67432f0" xlink:href="embc-20230930.xsd#embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue_43b61981-79f4-49de-bff5-9590c67432f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum_9949b597-c81f-4dff-b06a-48cefb0a5046" xlink:href="embc-20230930.xsd#embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum_9949b597-c81f-4dff-b06a-48cefb0a5046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum_745be9a0-d03a-41f4-ab5f-62329cf25725" xlink:href="embc-20230930.xsd#embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum_745be9a0-d03a-41f4-ab5f-62329cf25725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod_0bb98e21-f368-4bc3-9083-9010dd387c0b" xlink:href="embc-20230930.xsd#embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod_0bb98e21-f368-4bc3-9083-9010dd387c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TaxMattersAgreementCovenantRestrictionsPeriod_e3f3897b-57de-4837-b176-6e407928f903" xlink:href="embc-20230930.xsd#embc_TaxMattersAgreementCovenantRestrictionsPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_TaxMattersAgreementCovenantRestrictionsPeriod_e3f3897b-57de-4837-b176-6e407928f903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold_3d239b33-3206-4809-9fce-b3a1024327b2" xlink:href="embc-20230930.xsd#embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold_3d239b33-3206-4809-9fce-b3a1024327b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LogisticsServicesAgreementMaximumTerm_8e818a01-d367-4fad-8d0e-25e568076f39" xlink:href="embc-20230930.xsd#embc_LogisticsServicesAgreementMaximumTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_LogisticsServicesAgreementMaximumTerm_8e818a01-d367-4fad-8d0e-25e568076f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue_3e03b4ea-cca6-4c40-b911-c1ce5e1e6a2a" xlink:href="embc-20230930.xsd#embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue_3e03b4ea-cca6-4c40-b911-c1ce5e1e6a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_e03f27a4-3c8f-4229-b8bb-0a36d27f3ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_e03f27a4-3c8f-4229-b8bb-0a36d27f3ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableOtherCurrent_7afcb4f7-8af3-482a-8cae-1f7401a68e66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_AccountsPayableOtherCurrent_7afcb4f7-8af3-482a-8cae-1f7401a68e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7089fa09-0d0c-44c3-adf1-b8a2b1c44f90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7089fa09-0d0c-44c3-adf1-b8a2b1c44f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_54097716-d272-46b3-9da0-289714ad4158" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_OtherAssetsCurrent_54097716-d272-46b3-9da0-289714ad4158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartiesAmountInCostOfSales_37018d8d-344f-4654-a872-eaf5d4e7f83c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartiesAmountInCostOfSales"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_RelatedPartiesAmountInCostOfSales_37018d8d-344f-4654-a872-eaf5d4e7f83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3dd929ab-5013-44ff-9ee3-0bf86444dad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_eb620156-fc4a-4190-a103-84400df42c1b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3dd929ab-5013-44ff-9ee3-0bf86444dad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_846fe285-0f20-4cb3-bb10-6057547f4365" xlink:href="embc-20230930.xsd#embc_ThirdPartyAndRelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1a29ecc0-2e7b-41c4-be64-3193083a0334" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_846fe285-0f20-4cb3-bb10-6057547f4365" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1a29ecc0-2e7b-41c4-be64-3193083a0334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98a61977-0637-4f0e-837d-dfc0014fc8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1a29ecc0-2e7b-41c4-be64-3193083a0334" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98a61977-0637-4f0e-837d-dfc0014fc8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98a61977-0637-4f0e-837d-dfc0014fc8d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e9c688b6-cc3e-4e01-aff1-38197228665d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:to="loc_us-gaap_CostOfSalesMember_e9c688b6-cc3e-4e01-aff1-38197228665d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2c3eb929-1a5d-4ee7-990a-e24f888aa21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2c3eb929-1a5d-4ee7-990a-e24f888aa21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f79e19b6-36ca-40b1-bb67-0609826dca1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f79e19b6-36ca-40b1-bb67-0609826dca1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseMember_9330aef2-bd71-4955-b56f-6425b577f22a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2c124c95-0e07-4c33-84a8-5af7bb29ff1a" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseMember_9330aef2-bd71-4955-b56f-6425b577f22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_44c0705c-258f-43fc-91f6-1d53ad56b81d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1a29ecc0-2e7b-41c4-be64-3193083a0334" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_44c0705c-258f-43fc-91f6-1d53ad56b81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_GeneralCorporateExpenses_79338f88-47ad-4991-afe4-14181d5ca233" xlink:href="embc-20230930.xsd#embc_GeneralCorporateExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_44c0705c-258f-43fc-91f6-1d53ad56b81d" xlink:to="loc_embc_GeneralCorporateExpenses_79338f88-47ad-4991-afe4-14181d5ca233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_71aa7d23-ee0e-4cf7-a877-d310cd8e1100" xlink:href="embc-20230930.xsd#embc_ThirdPartyAndRelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c4a9f22d-a38e-4197-9abb-f283e7495cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_71aa7d23-ee0e-4cf7-a877-d310cd8e1100" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c4a9f22d-a38e-4197-9abb-f283e7495cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_89a4bcbe-4f5c-48e0-9b63-4c83a1cbef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c4a9f22d-a38e-4197-9abb-f283e7495cd4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_89a4bcbe-4f5c-48e0-9b63-4c83a1cbef8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_89621a72-fd88-433f-bdbd-d5bbe4b678a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_89a4bcbe-4f5c-48e0-9b63-4c83a1cbef8e" xlink:to="loc_us-gaap_RelatedPartyDomain_89621a72-fd88-433f-bdbd-d5bbe4b678a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_73fef54e-b3b6-40bc-b1f2-39fea336bc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_89621a72-fd88-433f-bdbd-d5bbe4b678a3" xlink:to="loc_us-gaap_ParentMember_73fef54e-b3b6-40bc-b1f2-39fea336bc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_41552eaa-584f-4fe8-b827-040700e56ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c4a9f22d-a38e-4197-9abb-f283e7495cd4" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_41552eaa-584f-4fe8-b827-040700e56ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_8a4a3beb-43a0-41d3-a048-b9944babe12b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_41552eaa-584f-4fe8-b827-040700e56ad5" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_8a4a3beb-43a0-41d3-a048-b9944babe12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:href="embc-20230930.xsd#embc_ThirdPartyAndRelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities_170dab1d-c3ae-4b32-ba9c-ad24ed970c6d" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities_170dab1d-c3ae-4b32-ba9c-ad24ed970c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation_fc1e0749-d8c5-4cb9-ab9a-21dba44dafc5" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation_fc1e0749-d8c5-4cb9-ab9a-21dba44dafc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentTaxesDeemedSettledWithParent_613ba87b-9d52-49f3-86e3-71466ddd7272" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentTaxesDeemedSettledWithParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentTaxesDeemedSettledWithParent_613ba87b-9d52-49f3-86e3-71466ddd7272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentSeparationRelatedAdjustments_54206066-0620-4e16-bfba-6edefdb727fd" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentSeparationRelatedAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentSeparationRelatedAdjustments_54206066-0620-4e16-bfba-6edefdb727fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_bbe39448-3049-4d68-9014-afd2f22b62da" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities_bbe39448-3049-4d68-9014-afd2f22b62da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentShareBasedCompensationExpense_e67ae145-0be6-4650-b21d-22c875d9d6dc" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentShareBasedCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentShareBasedCompensationExpense_e67ae145-0be6-4650-b21d-22c875d9d6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentPensionExpense_b266cfa0-64d4-4ad3-b5c6-77e3f22aa0da" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentPensionExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentPensionExpense_b266cfa0-64d4-4ad3-b5c6-77e3f22aa0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentConsiderationPaidForSeparation_cd6a509b-4b5e-40e6-9992-4599a0f0167e" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentConsiderationPaidForSeparation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentConsiderationPaidForSeparation_cd6a509b-4b5e-40e6-9992-4599a0f0167e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentRelatedPartyDebtIssued_3b04a10e-3910-43f5-b04d-5f362b6231b6" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentRelatedPartyDebtIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentRelatedPartyDebtIssued_3b04a10e-3910-43f5-b04d-5f362b6231b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentOtherTransfersToFromParentNet_cd5155a5-1e42-481d-9157-6cd409c2b5e2" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentOtherTransfersToFromParentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentOtherTransfersToFromParentNet_cd5155a5-1e42-481d-9157-6cd409c2b5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_NetParentInvestmentNetTransfersToParent_a74e67a0-0f50-485f-8364-42b67ac64c71" xlink:href="embc-20230930.xsd#embc_NetParentInvestmentNetTransfersToParent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ThirdPartyAndRelatedPartyTransactionsAbstract_9a3d5db3-7e22-404d-bfcd-f12b45716fe2" xlink:to="loc_embc_NetParentInvestmentNetTransfersToParent_a74e67a0-0f50-485f-8364-42b67ac64c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/CollaborationAgreementDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#CollaborationAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/CollaborationAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1d09be6-cc63-4e3a-91fd-dc2a3b3b9d08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8eabed21-7586-46d6-86c7-d05e21c32170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b1d09be6-cc63-4e3a-91fd-dc2a3b3b9d08" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8eabed21-7586-46d6-86c7-d05e21c32170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1bee285d-f95a-4b8b-afed-c5de7565e322" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8eabed21-7586-46d6-86c7-d05e21c32170" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1bee285d-f95a-4b8b-afed-c5de7565e322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1f97f053-20fd-403b-9423-3e20b4b6267c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1bee285d-f95a-4b8b-afed-c5de7565e322" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1f97f053-20fd-403b-9423-3e20b4b6267c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3387d496-195a-47c5-9be7-083e2e48e6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1f97f053-20fd-403b-9423-3e20b4b6267c" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3387d496-195a-47c5-9be7-083e2e48e6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dd2e1289-6ab2-4ebf-9678-cafa17f87906" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8eabed21-7586-46d6-86c7-d05e21c32170" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dd2e1289-6ab2-4ebf-9678-cafa17f87906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b6339c3e-5ee6-47c2-adea-07d56c2b4b17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dd2e1289-6ab2-4ebf-9678-cafa17f87906" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b6339c3e-5ee6-47c2-adea-07d56c2b4b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CollaborativeArrangementPrincipalRightsPercentage_4d351b95-e13d-4fa3-9a79-ed2a3c26cb17" xlink:href="embc-20230930.xsd#embc_CollaborativeArrangementPrincipalRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_dd2e1289-6ab2-4ebf-9678-cafa17f87906" xlink:to="loc_embc_CollaborativeArrangementPrincipalRightsPercentage_4d351b95-e13d-4fa3-9a79-ed2a3c26cb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/OtherOperatingExpensesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#OtherOperatingExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/OtherOperatingExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_23f60940-781c-4cf8-b27b-ad92b30ac62c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeparationAndStandupCosts_cff0d0d7-332c-410d-803b-8992bde8b5c8" xlink:href="embc-20230930.xsd#embc_SeparationAndStandupCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_23f60940-781c-4cf8-b27b-ad92b30ac62c" xlink:to="loc_embc_SeparationAndStandupCosts_cff0d0d7-332c-410d-803b-8992bde8b5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_4a73b285-2cb4-47cd-95e3-342709d3d0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_23f60940-781c-4cf8-b27b-ad92b30ac62c" xlink:to="loc_us-gaap_SeveranceCosts1_4a73b285-2cb4-47cd-95e3-342709d3d0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/RevenuesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#RevenuesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/RevenuesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2d15a564-7c59-4af5-8e62-3e18541e2c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiability_00c7595b-15d4-4cfa-a892-36f8155cad70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2d15a564-7c59-4af5-8e62-3e18541e2c3e" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiability_00c7595b-15d4-4cfa-a892-36f8155cad70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized_c7f0c41a-9d13-44ab-926d-7151a61fd124" xlink:href="embc-20230930.xsd#embc_RevenueFromContractWithCustomerSalesDeductionsRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2d15a564-7c59-4af5-8e62-3e18541e2c3e" xlink:to="loc_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized_c7f0c41a-9d13-44ab-926d-7151a61fd124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_338f9fe9-54a6-402c-a5e3-257564c36d42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2d15a564-7c59-4af5-8e62-3e18541e2c3e" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_338f9fe9-54a6-402c-a5e3-257564c36d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SegmentandGeographicalDataDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SegmentandGeographicalDataDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SegmentandGeographicalDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_37252c26-d43e-4fa4-89bb-0d7a73b24dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_42dbc546-c962-4bf9-a1b8-724e9ae430af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_37252c26-d43e-4fa4-89bb-0d7a73b24dd7" xlink:to="loc_us-gaap_NumberOfOperatingSegments_42dbc546-c962-4bf9-a1b8-724e9ae430af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4480d1a0-98c1-43af-867c-9731019c2d17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_37252c26-d43e-4fa4-89bb-0d7a73b24dd7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4480d1a0-98c1-43af-867c-9731019c2d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_17f04332-3a32-4424-aecc-71230063d6b2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4480d1a0-98c1-43af-867c-9731019c2d17" xlink:to="loc_srt_StatementGeographicalAxis_17f04332-3a32-4424-aecc-71230063d6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_41433ca4-fb24-42a6-abb9-b015980693c9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_17f04332-3a32-4424-aecc-71230063d6b2" xlink:to="loc_srt_SegmentGeographicalDomain_41433ca4-fb24-42a6-abb9-b015980693c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a06a51d1-16a0-454a-891d-347c997de7cb" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_41433ca4-fb24-42a6-abb9-b015980693c9" xlink:to="loc_country_US_a06a51d1-16a0-454a-891d-347c997de7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_233ca3fe-bca2-4305-a752-98ec0134f508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_41433ca4-fb24-42a6-abb9-b015980693c9" xlink:to="loc_us-gaap_NonUsMember_233ca3fe-bca2-4305-a752-98ec0134f508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_def0323d-0743-4982-bb10-a3c288ae4787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4480d1a0-98c1-43af-867c-9731019c2d17" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_def0323d-0743-4982-bb10-a3c288ae4787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a58da680-550c-4a53-953f-5ded447b2d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_def0323d-0743-4982-bb10-a3c288ae4787" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a58da680-550c-4a53-953f-5ded447b2d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88280eab-602a-4c24-bc63-8ead30e3f4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88280eab-602a-4c24-bc63-8ead30e3f4a3" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_39c3dd8f-77e4-42d4-b2fc-ee0398d0c6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_us-gaap_PlanNameAxis_39c3dd8f-77e4-42d4-b2fc-ee0398d0c6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_95cfa4aa-bbbe-4bce-b8eb-f2ed515f89e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_39c3dd8f-77e4-42d4-b2fc-ee0398d0c6b9" xlink:to="loc_us-gaap_PlanNameDomain_95cfa4aa-bbbe-4bce-b8eb-f2ed515f89e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember_103cb40a-81f0-4558-9002-92111acb3ab2" xlink:href="embc-20230930.xsd#embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_95cfa4aa-bbbe-4bce-b8eb-f2ed515f89e3" xlink:to="loc_embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember_103cb40a-81f0-4558-9002-92111acb3ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7343a866-b288-4272-afc8-78284ecc0342" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_us-gaap_AwardTypeAxis_7343a866-b288-4272-afc8-78284ecc0342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7343a866-b288-4272-afc8-78284ecc0342" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_c3607086-2e9d-4264-aabd-d3ddf1b8fd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_c3607086-2e9d-4264-aabd-d3ddf1b8fd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019167cc-08e7-4258-8962-bdcd05ba3a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019167cc-08e7-4258-8962-bdcd05ba3a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_d08fc439-7c3f-43d1-bea3-c467853f3aa1" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_d08fc439-7c3f-43d1-bea3-c467853f3aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceStockUnitsPSUsMember_d201e30e-5dc1-4fa7-8f62-c23a1263c9a5" xlink:href="embc-20230930.xsd#embc_PerformanceStockUnitsPSUsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_embc_PerformanceStockUnitsPSUsMember_d201e30e-5dc1-4fa7-8f62-c23a1263c9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_c342de73-190f-4160-bcc2-a02701bb7575" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8dac4cc2-41f4-47a1-af8e-b5476a1da6b8" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_c342de73-190f-4160-bcc2-a02701bb7575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4552de9b-d02e-4cf9-a8ee-dee5952a979a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_srt_RangeAxis_4552de9b-d02e-4cf9-a8ee-dee5952a979a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c4cd43d5-2036-4080-b685-30fd42651232" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4552de9b-d02e-4cf9-a8ee-dee5952a979a" xlink:to="loc_srt_RangeMember_c4cd43d5-2036-4080-b685-30fd42651232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_99b62c26-868b-48e3-9464-3ec61ec285fe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c4cd43d5-2036-4080-b685-30fd42651232" xlink:to="loc_srt_MinimumMember_99b62c26-868b-48e3-9464-3ec61ec285fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b776236f-8e14-4af8-b9a0-fd9bbc23cbb0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c4cd43d5-2036-4080-b685-30fd42651232" xlink:to="loc_srt_MaximumMember_b776236f-8e14-4af8-b9a0-fd9bbc23cbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_9fe090bc-0cf4-4cba-af35-90a9abaf2f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_us-gaap_GranteeStatusAxis_9fe090bc-0cf4-4cba-af35-90a9abaf2f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_f63e5c40-4834-462c-b2cc-1879801dfdfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_9fe090bc-0cf4-4cba-af35-90a9abaf2f2d" xlink:to="loc_us-gaap_GranteeStatusDomain_f63e5c40-4834-462c-b2cc-1879801dfdfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_e6d0b171-6297-49e2-86d6-12e408743409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_f63e5c40-4834-462c-b2cc-1879801dfdfb" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_e6d0b171-6297-49e2-86d6-12e408743409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_95084d7b-efab-40ee-82b3-e848d2f57790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_f63e5c40-4834-462c-b2cc-1879801dfdfb" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_95084d7b-efab-40ee-82b3-e848d2f57790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_a73b05cc-8e31-43a6-9ea1-0c6542fe31e3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_srt_TitleOfIndividualAxis_a73b05cc-8e31-43a6-9ea1-0c6542fe31e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_64efc797-1d34-4887-928d-0eb6c318b501" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_a73b05cc-8e31-43a6-9ea1-0c6542fe31e3" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_64efc797-1d34-4887-928d-0eb6c318b501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_89571fde-c421-4b57-a6ab-3ff24cfae841" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_64efc797-1d34-4887-928d-0eb6c318b501" xlink:to="loc_srt_ChiefExecutiveOfficerMember_89571fde-c421-4b57-a6ab-3ff24cfae841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b9d2ce86-844a-4708-bfde-c6b98f72f0d9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_964b2f0d-d125-444d-a1b3-31732848073a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_964b2f0d-d125-444d-a1b3-31732848073a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized_d491275d-e059-4471-ace2-1e6819a1fcea" xlink:href="embc-20230930.xsd#embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized_d491275d-e059-4471-ace2-1e6819a1fcea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b8d93e1c-33e1-4416-af2f-152b56215480" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b8d93e1c-33e1-4416-af2f-152b56215480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_96872536-3011-40b7-964b-74df2452841c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_96872536-3011-40b7-964b-74df2452841c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e422232a-5182-4339-b676-80073141397c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e422232a-5182-4339-b676-80073141397c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1923f03-f2da-4f50-8e53-6e5af3bb8c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1923f03-f2da-4f50-8e53-6e5af3bb8c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_257ea1f9-acae-4f42-a804-783b46e6e4db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_257ea1f9-acae-4f42-a804-783b46e6e4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_4442cbdb-63b3-454d-87b6-57b72963a6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_4442cbdb-63b3-454d-87b6-57b72963a6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d00973d9-6cd9-4630-aadd-64277007b1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d00973d9-6cd9-4630-aadd-64277007b1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_04cf9941-b15e-423b-8b76-cc3e0e38de00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7eac1af1-c525-4378-a5a3-32caa729a9f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_04cf9941-b15e-423b-8b76-cc3e0e38de00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6e669cec-1087-47aa-8a49-adce36e84832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbd9602a-5099-4f0d-9de2-950a4011f435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6e669cec-1087-47aa-8a49-adce36e84832" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbd9602a-5099-4f0d-9de2-950a4011f435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_701e708a-0ed2-410c-b657-f573f729c30e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbd9602a-5099-4f0d-9de2-950a4011f435" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_701e708a-0ed2-410c-b657-f573f729c30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_701e708a-0ed2-410c-b657-f573f729c30e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_49d6fb48-25d3-4d55-bc2d-9a3e93049633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:to="loc_us-gaap_CostOfSalesMember_49d6fb48-25d3-4d55-bc2d-9a3e93049633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_22b13212-9c0e-42df-95b1-ad48e6f2a15b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_22b13212-9c0e-42df-95b1-ad48e6f2a15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f96e83da-aa60-4bbc-b2c2-bb6310593d54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8c81ce05-9cd2-4e39-bd76-aa98049d2b70" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f96e83da-aa60-4bbc-b2c2-bb6310593d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_23e087ac-8f40-4506-a3ed-85175dee818a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbd9602a-5099-4f0d-9de2-950a4011f435" xlink:to="loc_us-gaap_AwardTypeAxis_23e087ac-8f40-4506-a3ed-85175dee818a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_23e087ac-8f40-4506-a3ed-85175dee818a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4af8a454-086e-45f9-a437-f42b9c675c44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_us-gaap_StockCompensationPlanMember_4af8a454-086e-45f9-a437-f42b9c675c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedPaymentArrangementLiabilityAwardMember_c66ccecd-bab3-4a0d-af2e-bad4017ae2f3" xlink:href="embc-20230930.xsd#embc_ShareBasedPaymentArrangementLiabilityAwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_embc_ShareBasedPaymentArrangementLiabilityAwardMember_c66ccecd-bab3-4a0d-af2e-bad4017ae2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_583c87d7-0f26-4ae9-b57a-ff921277c416" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_583c87d7-0f26-4ae9-b57a-ff921277c416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_6071b592-05f9-4bf5-a44b-b3bf97b9ec4e" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_6071b592-05f9-4bf5-a44b-b3bf97b9ec4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_8e28b0aa-9806-4b92-acac-6a02ffbea648" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a77604a-e2a3-49c8-8dc2-95a2b72f29ed" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_8e28b0aa-9806-4b92-acac-6a02ffbea648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_95afbf5d-a71a-45fd-b0ae-0e2d8f17ba2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_dbd9602a-5099-4f0d-9de2-950a4011f435" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_95afbf5d-a71a-45fd-b0ae-0e2d8f17ba2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b4dc9b7-18ea-4e4f-ac2c-4cc9bb3d1d06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_95afbf5d-a71a-45fd-b0ae-0e2d8f17ba2f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0b4dc9b7-18ea-4e4f-ac2c-4cc9bb3d1d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9086d54c-861d-4452-8452-447d6a60b8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_95afbf5d-a71a-45fd-b0ae-0e2d8f17ba2f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9086d54c-861d-4452-8452-447d6a60b8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f0f7fb02-5a99-491e-abd7-51ff51112594" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fad03856-431e-4406-8c86-967722bf8ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f0f7fb02-5a99-491e-abd7-51ff51112594" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fad03856-431e-4406-8c86-967722bf8ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91cd65f3-0366-4d9f-8bf9-3b22c2d506e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fad03856-431e-4406-8c86-967722bf8ac7" xlink:to="loc_us-gaap_AwardTypeAxis_91cd65f3-0366-4d9f-8bf9-3b22c2d506e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1457bb28-6883-453e-830e-bddfe930d9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_91cd65f3-0366-4d9f-8bf9-3b22c2d506e3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1457bb28-6883-453e-830e-bddfe930d9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_da4ad0d1-d13b-43ae-9c76-5e50e1d73542" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1457bb28-6883-453e-830e-bddfe930d9cc" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_da4ad0d1-d13b-43ae-9c76-5e50e1d73542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_c07958b1-d00f-4b35-9eeb-bc6e2ca3c559" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1457bb28-6883-453e-830e-bddfe930d9cc" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_c07958b1-d00f-4b35-9eeb-bc6e2ca3c559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fad03856-431e-4406-8c86-967722bf8ac7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dbb574d2-943b-404c-9ec7-83a972b26278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_dbb574d2-943b-404c-9ec7-83a972b26278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eb5fab2d-7e3b-4d27-bc84-59a959e5e0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_eb5fab2d-7e3b-4d27-bc84-59a959e5e0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dedf722d-a979-4756-ba26-f68b551331ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dedf722d-a979-4756-ba26-f68b551331ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5cb6310d-d62e-4e32-ba5a-c38ac861c818" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5cb6310d-d62e-4e32-ba5a-c38ac861c818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_01f3a418-4d08-4c5a-a933-84b03c33c82f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1cb8078e-1ff4-4706-a4cc-81d973b64c7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_01f3a418-4d08-4c5a-a933-84b03c33c82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber_46ee2852-d484-48c8-9794-38e19b6f93a8" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber_46ee2852-d484-48c8-9794-38e19b6f93a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_04353dcf-8048-4afa-909b-20810c7f9dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_04353dcf-8048-4afa-909b-20810c7f9dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3d29018-036e-4e46-ab92-ec3ac3ac0d29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3d29018-036e-4e46-ab92-ec3ac3ac0d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_25b750dc-15e3-4c99-a73a-8e123a44eea3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_25b750dc-15e3-4c99-a73a-8e123a44eea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2c8b3a4a-b9ad-48c9-9833-8cd0606b9f72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2c8b3a4a-b9ad-48c9-9833-8cd0606b9f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_df17b065-54cb-4bb5-829e-17e81bc4b278" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_689b1942-d204-4071-9ecb-f23f6979c657" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_df17b065-54cb-4bb5-829e-17e81bc4b278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_9e3b0f2c-e659-4eb6-8494-868d3dafb6fa" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6925217-aa8d-4779-bee3-3b171f4fdad6" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue_9e3b0f2c-e659-4eb6-8494-868d3dafb6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d1d3a48a-7e62-4cb4-98b0-881e5fc9b212" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32f39423-54b2-4ccc-9872-a3cc95967035" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d1d3a48a-7e62-4cb4-98b0-881e5fc9b212" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32f39423-54b2-4ccc-9872-a3cc95967035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81e298a7-f6f4-480b-8c78-36b34e5457e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32f39423-54b2-4ccc-9872-a3cc95967035" xlink:to="loc_us-gaap_AwardTypeAxis_81e298a7-f6f4-480b-8c78-36b34e5457e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e550f59-758f-4c64-a39d-7fed0236abc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_81e298a7-f6f4-480b-8c78-36b34e5457e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e550f59-758f-4c64-a39d-7fed0236abc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_c5c0be6c-b337-4030-91f3-539cb68e74bf" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e550f59-758f-4c64-a39d-7fed0236abc8" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_c5c0be6c-b337-4030-91f3-539cb68e74bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_b87959ab-bb2f-4024-a12a-1c1fd3313bf3" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e550f59-758f-4c64-a39d-7fed0236abc8" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_b87959ab-bb2f-4024-a12a-1c1fd3313bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_89689b5a-84ac-427c-b0ec-5f93f9f9c1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32f39423-54b2-4ccc-9872-a3cc95967035" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_89689b5a-84ac-427c-b0ec-5f93f9f9c1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_887cb029-f882-4264-8ca5-ae2af4efdff2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_89689b5a-84ac-427c-b0ec-5f93f9f9c1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_887cb029-f882-4264-8ca5-ae2af4efdff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f834c5c6-4222-403c-90c8-ee37652a28c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe6a15b6-6d02-4c2e-af37-68f05d19d1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f834c5c6-4222-403c-90c8-ee37652a28c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe6a15b6-6d02-4c2e-af37-68f05d19d1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7f814fac-6d96-4d39-b1d7-38474cceb014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe6a15b6-6d02-4c2e-af37-68f05d19d1d9" xlink:to="loc_us-gaap_AwardTypeAxis_7f814fac-6d96-4d39-b1d7-38474cceb014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_084e09c6-707d-4d79-b46f-fd2e61fb1a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7f814fac-6d96-4d39-b1d7-38474cceb014" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_084e09c6-707d-4d79-b46f-fd2e61fb1a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_3cb0bca5-fb61-4d72-bd0c-5b83b39e7942" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_084e09c6-707d-4d79-b46f-fd2e61fb1a7d" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_3cb0bca5-fb61-4d72-bd0c-5b83b39e7942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8c3c86e3-fa3e-476e-a16c-f946697f5607" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fe6a15b6-6d02-4c2e-af37-68f05d19d1d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8c3c86e3-fa3e-476e-a16c-f946697f5607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_19ecce78-c07d-4190-a93f-0a4b4ef35a89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8c3c86e3-fa3e-476e-a16c-f946697f5607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_19ecce78-c07d-4190-a93f-0a4b4ef35a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationSARsValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5dd16a35-f8a4-4e16-8862-08a2fd5a4591" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d01170b-970c-4247-b2e2-7c560c2d3282" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5dd16a35-f8a4-4e16-8862-08a2fd5a4591" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d01170b-970c-4247-b2e2-7c560c2d3282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2649de52-c192-4029-b44e-fadad19bb5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d01170b-970c-4247-b2e2-7c560c2d3282" xlink:to="loc_us-gaap_AwardTypeAxis_2649de52-c192-4029-b44e-fadad19bb5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0faec46b-849d-4c29-888d-f42a17146b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2649de52-c192-4029-b44e-fadad19bb5e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0faec46b-849d-4c29-888d-f42a17146b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_7ac61f86-9e3c-434d-a9a2-0e979ab12af1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0faec46b-849d-4c29-888d-f42a17146b8e" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_7ac61f86-9e3c-434d-a9a2-0e979ab12af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4d01170b-970c-4247-b2e2-7c560c2d3282" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d996f5b0-70ea-431a-8d57-88dab26e38f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d996f5b0-70ea-431a-8d57-88dab26e38f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7cb76960-895d-4872-906a-b93f1ad12fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7cb76960-895d-4872-906a-b93f1ad12fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d9eaa362-788b-4f5a-acfa-eae38cfabd33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d9eaa362-788b-4f5a-acfa-eae38cfabd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8770db99-93d1-42fd-80d1-4b93e4c2b8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8770db99-93d1-42fd-80d1-4b93e4c2b8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_286a3378-9b6c-43ce-8d22-93d14588f315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0c51a43e-97f6-4869-8fa5-6d75ddba3d94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_286a3378-9b6c-43ce-8d22-93d14588f315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationSARsOutstandingandtheChangesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_05159a17-157d-4537-b9b3-f2b515cae5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c60eb561-3f5c-45cd-91ee-8dfc34637a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_05159a17-157d-4537-b9b3-f2b515cae5c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c60eb561-3f5c-45cd-91ee-8dfc34637a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3a0fe592-33a7-4ce6-852a-c6698670cf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c60eb561-3f5c-45cd-91ee-8dfc34637a4b" xlink:to="loc_us-gaap_AwardTypeAxis_3a0fe592-33a7-4ce6-852a-c6698670cf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_559ae05d-d962-4b2f-809b-92dd244bcd44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3a0fe592-33a7-4ce6-852a-c6698670cf0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_559ae05d-d962-4b2f-809b-92dd244bcd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_19d58174-36d5-4783-8ec4-ccff2521c5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_559ae05d-d962-4b2f-809b-92dd244bcd44" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_19d58174-36d5-4783-8ec4-ccff2521c5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c60eb561-3f5c-45cd-91ee-8dfc34637a4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_682ab78b-8bdd-401f-8c0a-f27e9943928a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_682ab78b-8bdd-401f-8c0a-f27e9943928a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_bc6348af-6265-44bc-a4b1-c2086fc9e101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_bc6348af-6265-44bc-a4b1-c2086fc9e101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_b0a5268d-a4d7-4e7d-9ff4-3dc8020920d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_b0a5268d-a4d7-4e7d-9ff4-3dc8020920d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_05ab8df6-4204-4a80-91b4-64720f227333" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_05ab8df6-4204-4a80-91b4-64720f227333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e748ed31-c533-4343-9d55-2350bbd3516c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_2b5b2b6f-8275-4a4c-aece-9d9fe1198d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e748ed31-c533-4343-9d55-2350bbd3516c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_7d7b80f2-5f32-4b05-b697-eabe08a48a71" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_7d7b80f2-5f32-4b05-b697-eabe08a48a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_cea42b36-f779-4328-b096-0f870f1d47a2" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_cea42b36-f779-4328-b096-0f870f1d47a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6a4f8618-715b-4c5e-9312-490630477ca6" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6a4f8618-715b-4c5e-9312-490630477ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_0acc8b20-ecee-4a7f-9d28-160971982cfa" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_0acc8b20-ecee-4a7f-9d28-160971982cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_41ca14e8-d282-4393-ab72-f744b1aeb8ec" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_41ca14e8-d282-4393-ab72-f744b1aeb8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_46b3d638-9b3c-45c4-9be1-6cac2f38aa45" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_46b3d638-9b3c-45c4-9be1-6cac2f38aa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_9da73859-0ad4-4544-81d1-b5d21bb61546" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward_7e6f7b30-d1ea-4edb-b9e7-b8796b011847" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_9da73859-0ad4-4544-81d1-b5d21bb61546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c787b631-84cf-4aa2-ae05-8b688f8c5b46" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c787b631-84cf-4aa2-ae05-8b688f8c5b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_b0ffc881-f6ce-41d6-9e86-2681fa314d8e" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_b0ffc881-f6ce-41d6-9e86-2681fa314d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0f5c422e-f4e6-41c0-8b53-69b9b1fe30e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_5a3a974d-ea27-4eac-b960-b35c8771ad14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_5a3a974d-ea27-4eac-b960-b35c8771ad14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_e22b59eb-6445-4997-8e79-618a1db36598" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm_e22b59eb-6445-4997-8e79-618a1db36598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_2b875086-7241-4159-802d-503af98e515f" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm_2b875086-7241-4159-802d-503af98e515f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_810e5201-aaa1-4d9b-96eb-f02be1a9012b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_810e5201-aaa1-4d9b-96eb-f02be1a9012b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1bb3cd8d-c653-4119-9677-9a59e7b485c1" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1bb3cd8d-c653-4119-9677-9a59e7b485c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_daf7ee91-300d-4195-b486-85345dd94dd4" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_d8384dd5-8eca-4e2f-8d8f-3c8979c3127e" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_daf7ee91-300d-4195-b486-85345dd94dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#StockBasedCompensationSummaryofSARsExercisedDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e941db32-a107-48df-9cc8-ce58b08528eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cd7e28c4-26ad-469c-b765-118bbcc34f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e941db32-a107-48df-9cc8-ce58b08528eb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cd7e28c4-26ad-469c-b765-118bbcc34f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_99954896-95d4-46c8-b8fa-c7fc7e9c20b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cd7e28c4-26ad-469c-b765-118bbcc34f5c" xlink:to="loc_us-gaap_AwardTypeAxis_99954896-95d4-46c8-b8fa-c7fc7e9c20b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_104033e9-0600-4c2d-bde1-767ec7a9fbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_99954896-95d4-46c8-b8fa-c7fc7e9c20b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_104033e9-0600-4c2d-bde1-767ec7a9fbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_44f74b77-97c7-4342-8b96-860e6460b59b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_104033e9-0600-4c2d-bde1-767ec7a9fbc7" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_44f74b77-97c7-4342-8b96-860e6460b59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_256eed84-4ec3-4daf-a5d1-3a01bd3c8052" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cd7e28c4-26ad-469c-b765-118bbcc34f5c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_256eed84-4ec3-4daf-a5d1-3a01bd3c8052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue_0cac597a-898b-446c-9080-79b05c7c9636" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_256eed84-4ec3-4daf-a5d1-3a01bd3c8052" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue_0cac597a-898b-446c-9080-79b05c7c9636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue_ae84cba2-61ed-4e16-9310-f522f2d259ff" xlink:href="embc-20230930.xsd#embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_256eed84-4ec3-4daf-a5d1-3a01bd3c8052" xlink:to="loc_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue_ae84cba2-61ed-4e16-9310-f522f2d259ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#GoodwillandOtherIntangibleAssetsSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f90f00ac-49b1-4963-b2c8-003d9729a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cf9af560-47db-4435-b386-4da79944ce8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f90f00ac-49b1-4963-b2c8-003d9729a3d4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cf9af560-47db-4435-b386-4da79944ce8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b70b109-4311-4c43-aeb7-ebcb8e363c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cf9af560-47db-4435-b386-4da79944ce8e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b70b109-4311-4c43-aeb7-ebcb8e363c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2d7d1c4-e0c1-4ceb-9edc-f31827897ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9b70b109-4311-4c43-aeb7-ebcb8e363c56" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2d7d1c4-e0c1-4ceb-9edc-f31827897ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_de22b940-5c16-4143-9437-5932e7827831" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2d7d1c4-e0c1-4ceb-9edc-f31827897ff7" xlink:to="loc_us-gaap_PatentsMember_de22b940-5c16-4143-9437-5932e7827831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CustomerRelationshipAndOtherMember_627ffce7-41c9-41b7-b46e-a6e21a6148ff" xlink:href="embc-20230930.xsd#embc_CustomerRelationshipAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c2d7d1c4-e0c1-4ceb-9edc-f31827897ff7" xlink:to="loc_embc_CustomerRelationshipAndOtherMember_627ffce7-41c9-41b7-b46e-a6e21a6148ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cf9af560-47db-4435-b386-4da79944ce8e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_041aa982-a139-43fe-be4d-94f69a17bb28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_041aa982-a139-43fe-be4d-94f69a17bb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d847bbbf-97c9-4a3c-b3ac-aba0798cd1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d847bbbf-97c9-4a3c-b3ac-aba0798cd1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_43c769f1-9b56-4d9e-af55-e2236f623c21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_43c769f1-9b56-4d9e-af55-e2236f623c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b14559ad-5549-48a7-875a-f122c4126c06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_f76b41a7-f150-46c8-9152-9bf110e4d330" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b14559ad-5549-48a7-875a-f122c4126c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f844cfcf-0715-494b-95bf-6b9e23fabf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f90f00ac-49b1-4963-b2c8-003d9729a3d4" xlink:to="loc_us-gaap_Goodwill_f844cfcf-0715-494b-95bf-6b9e23fabf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_3d539361-6693-4ec5-be22-f3d85e514dba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f90f00ac-49b1-4963-b2c8-003d9729a3d4" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_3d539361-6693-4ec5-be22-f3d85e514dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_65d4f8b6-dd09-4324-a872-93a12ddda42b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_61ea4f83-ddc0-467d-99ae-d0a2ca6dcdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_65d4f8b6-dd09-4324-a872-93a12ddda42b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_61ea4f83-ddc0-467d-99ae-d0a2ca6dcdb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a7bedfb8-e6f6-4371-826b-1702d93c8400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_65d4f8b6-dd09-4324-a872-93a12ddda42b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a7bedfb8-e6f6-4371-826b-1702d93c8400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b29cfe94-6bf1-42b2-b7f2-4343b9eb5bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_65d4f8b6-dd09-4324-a872-93a12ddda42b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b29cfe94-6bf1-42b2-b7f2-4343b9eb5bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b339eda8-650f-40af-beb9-17523487575d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_65d4f8b6-dd09-4324-a872-93a12ddda42b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b339eda8-650f-40af-beb9-17523487575d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_13b024ad-f42a-4c53-80d7-e30365b1b3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_65d4f8b6-dd09-4324-a872-93a12ddda42b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_13b024ad-f42a-4c53-80d7-e30365b1b3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_388870fe-dea8-4cfa-8c89-3398fddc9fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_65d4f8b6-dd09-4324-a872-93a12ddda42b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_388870fe-dea8-4cfa-8c89-3398fddc9fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_94ad4fe5-c5fd-4b11-8e1b-eb0abacfa7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_65d4f8b6-dd09-4324-a872-93a12ddda42b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_94ad4fe5-c5fd-4b11-8e1b-eb0abacfa7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LongTermDebtAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_32dc9441-b1ab-4364-bd53-755c73350006" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_32dc9441-b1ab-4364-bd53-755c73350006" xlink:to="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3bec5389-ca64-4fbb-bd3d-8ba6104d8b18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_DebtInstrumentAxis_3bec5389-ca64-4fbb-bd3d-8ba6104d8b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3bec5389-ca64-4fbb-bd3d-8ba6104d8b18" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member_cefafcc2-36b7-4d4d-a0c4-506e1874ac16" xlink:href="embc-20230930.xsd#embc_A500SeniorSecuredNotesDueFebruary2030Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:to="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member_cefafcc2-36b7-4d4d-a0c4-506e1874ac16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_6a07d51f-afe9-4df7-aa12-c8a645c36020" xlink:href="embc-20230930.xsd#embc_A675SeniorSecuredNotesDueFebruary2030Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:to="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_6a07d51f-afe9-4df7-aa12-c8a645c36020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_4468df66-2a50-41c8-8819-2639205590a6" xlink:href="embc-20230930.xsd#embc_SeniorSecuredTermLoanBMaturingMarch2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:to="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_4468df66-2a50-41c8-8819-2639205590a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member_d18d418c-fce9-4183-aaa8-18b8a663ee45" xlink:href="embc-20230930.xsd#embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a2e2154-f29d-40d9-b91e-36331d8fa11b" xlink:to="loc_embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member_d18d418c-fce9-4183-aaa8-18b8a663ee45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dee3f93d-1d7c-4a07-bf00-a720eb0afdba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dee3f93d-1d7c-4a07-bf00-a720eb0afdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8d11802d-b703-41ea-897c-92932b611fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dee3f93d-1d7c-4a07-bf00-a720eb0afdba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8d11802d-b703-41ea-897c-92932b611fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4c253d55-84e3-4539-9f4a-db9e7f5c6db3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8d11802d-b703-41ea-897c-92932b611fd2" xlink:to="loc_us-gaap_SeniorNotesMember_4c253d55-84e3-4539-9f4a-db9e7f5c6db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_b7cb9556-f19f-4c60-934a-d0d44f9d91d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8d11802d-b703-41ea-897c-92932b611fd2" xlink:to="loc_us-gaap_SecuredDebtMember_b7cb9556-f19f-4c60-934a-d0d44f9d91d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f008810-95dd-4e5a-bf28-84843c895072" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f008810-95dd-4e5a-bf28-84843c895072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d6d1a720-668a-4600-ad2b-11cb4b8bff59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f008810-95dd-4e5a-bf28-84843c895072" xlink:to="loc_us-gaap_RelatedPartyDomain_d6d1a720-668a-4600-ad2b-11cb4b8bff59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_a8ce5634-f496-4bf5-94b1-74677de90a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d6d1a720-668a-4600-ad2b-11cb4b8bff59" xlink:to="loc_us-gaap_ParentMember_a8ce5634-f496-4bf5-94b1-74677de90a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ab72dd0d-e435-4b15-9b29-f8c98e573d43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_VariableRateAxis_ab72dd0d-e435-4b15-9b29-f8c98e573d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_75852bcd-8d4e-485f-8d9b-99f04ea0facc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ab72dd0d-e435-4b15-9b29-f8c98e573d43" xlink:to="loc_us-gaap_VariableRateDomain_75852bcd-8d4e-485f-8d9b-99f04ea0facc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_0275a419-bbfa-4791-8ddc-e41ac88653bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_75852bcd-8d4e-485f-8d9b-99f04ea0facc" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_0275a419-bbfa-4791-8ddc-e41ac88653bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_64f031bd-278d-42d0-8a17-50654b72cedd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_CreditFacilityAxis_64f031bd-278d-42d0-8a17-50654b72cedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7be367c1-2375-4cbe-8cd9-53aef570ebc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_64f031bd-278d-42d0-8a17-50654b72cedd" xlink:to="loc_us-gaap_CreditFacilityDomain_7be367c1-2375-4cbe-8cd9-53aef570ebc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0a88cbd7-cb3f-4ff7-9eb8-ad25665dca0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7be367c1-2375-4cbe-8cd9-53aef570ebc5" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0a88cbd7-cb3f-4ff7-9eb8-ad25665dca0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6040b7a7-7a53-4be8-811c-aed4a54e8389" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6040b7a7-7a53-4be8-811c-aed4a54e8389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eee3f189-4a8e-427b-b73e-1fcbdd663ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6040b7a7-7a53-4be8-811c-aed4a54e8389" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eee3f189-4a8e-427b-b73e-1fcbdd663ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_75b6e88c-d359-4071-8abd-6235ab3cd84f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eee3f189-4a8e-427b-b73e-1fcbdd663ae9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_75b6e88c-d359-4071-8abd-6235ab3cd84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_4e5d5be6-0f27-4e5a-947c-796bc0fe0cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_4e5d5be6-0f27-4e5a-947c-796bc0fe0cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7b1037d3-8685-41f4-a273-16a30cee6705" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4e5d5be6-0f27-4e5a-947c-796bc0fe0cc7" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7b1037d3-8685-41f4-a273-16a30cee6705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6d303bde-6499-4675-935e-36520856852f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7b1037d3-8685-41f4-a273-16a30cee6705" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6d303bde-6499-4675-935e-36520856852f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8ec8ed50-6ed8-46c5-bdb5-755bc9b5eaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6d303bde-6499-4675-935e-36520856852f" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_8ec8ed50-6ed8-46c5-bdb5-755bc9b5eaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_c3b3ad00-a1b4-45f2-9c04-8e80915efda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_6d303bde-6499-4675-935e-36520856852f" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_c3b3ad00-a1b4-45f2-9c04-8e80915efda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99c29a7f-6404-41d4-84a4-9cc1fb3de7f2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dc2310f3-5418-4de0-811b-b8bdec41e405" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_dc2310f3-5418-4de0-811b-b8bdec41e405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_16b616bd-709a-40e1-83d8-5a3822e5750a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_16b616bd-709a-40e1-83d8-5a3822e5750a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentDiscountGross_21776d60-ee2e-415d-a743-8303054251f0" xlink:href="embc-20230930.xsd#embc_DebtInstrumentDiscountGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_embc_DebtInstrumentDiscountGross_21776d60-ee2e-415d-a743-8303054251f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_acd64c3f-0982-4c4f-8298-f4ae8850dd00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_DebtInstrumentTerm_acd64c3f-0982-4c4f-8298-f4ae8850dd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_88a02b55-71a1-4374-ae7d-1f58c7b4c057" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_88a02b55-71a1-4374-ae7d-1f58c7b4c057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentVariableRateFloor_4cd249ce-0411-412e-9f96-048ddd24e8a0" xlink:href="embc-20230930.xsd#embc_DebtInstrumentVariableRateFloor"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_embc_DebtInstrumentVariableRateFloor_4cd249ce-0411-412e-9f96-048ddd24e8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentDiscountPercentage_59ac112d-5897-464b-9fe7-15f6e4636c2a" xlink:href="embc-20230930.xsd#embc_DebtInstrumentDiscountPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_embc_DebtInstrumentDiscountPercentage_59ac112d-5897-464b-9fe7-15f6e4636c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage_0d7f2aaf-c42e-4d4b-a09c-925b639d31f5" xlink:href="embc-20230930.xsd#embc_DebtInstrumentPeriodicPaymentPrincipalPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage_0d7f2aaf-c42e-4d4b-a09c-925b639d31f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_336f600d-b9bb-4996-bd3f-1103d5181f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_336f600d-b9bb-4996-bd3f-1103d5181f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_763407b6-b546-462f-bbb6-79b95b61e9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_763407b6-b546-462f-bbb6-79b95b61e9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_34110743-d10f-4495-b579-332744f1b914" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_LineOfCredit_34110743-d10f-4495-b579-332744f1b914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_423f5792-f471-441f-a8c3-4c0ad021c13e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d564489f-8699-4150-b137-b7501a764ad8" xlink:to="loc_us-gaap_LongTermDebtFairValue_423f5792-f471-441f-a8c3-4c0ad021c13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LongTermDebtDebtOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b6e8320c-8cbe-462c-93db-84d31b390a35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_511dd986-a147-42e0-bb73-540595108efa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b6e8320c-8cbe-462c-93db-84d31b390a35" xlink:to="loc_us-gaap_DebtInstrumentTable_511dd986-a147-42e0-bb73-540595108efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_91ec198b-8b96-45e3-a45f-1e85524bc7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_511dd986-a147-42e0-bb73-540595108efa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_91ec198b-8b96-45e3-a45f-1e85524bc7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4732bd4b-8025-4782-8960-2685032c2d21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_91ec198b-8b96-45e3-a45f-1e85524bc7f7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4732bd4b-8025-4782-8960-2685032c2d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_78f6cec1-2e96-44ab-80ba-eb5d29c10005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4732bd4b-8025-4782-8960-2685032c2d21" xlink:to="loc_us-gaap_SecuredDebtMember_78f6cec1-2e96-44ab-80ba-eb5d29c10005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0e6f4a6e-d25e-4445-b076-3c326277cedd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4732bd4b-8025-4782-8960-2685032c2d21" xlink:to="loc_us-gaap_SeniorNotesMember_0e6f4a6e-d25e-4445-b076-3c326277cedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_237a1d73-9c22-4099-b594-0c628e988d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_511dd986-a147-42e0-bb73-540595108efa" xlink:to="loc_us-gaap_DebtInstrumentAxis_237a1d73-9c22-4099-b594-0c628e988d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_237a1d73-9c22-4099-b594-0c628e988d1a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_3e7cc8dc-71c1-4894-a9a5-081a29ed553c" xlink:href="embc-20230930.xsd#embc_SeniorSecuredTermLoanBMaturingMarch2029Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:to="loc_embc_SeniorSecuredTermLoanBMaturingMarch2029Member_3e7cc8dc-71c1-4894-a9a5-081a29ed553c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member_7ab2698f-3de6-4d70-8537-5cc1af1bdaa5" xlink:href="embc-20230930.xsd#embc_A500SeniorSecuredNotesDueFebruary2030Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:to="loc_embc_A500SeniorSecuredNotesDueFebruary2030Member_7ab2698f-3de6-4d70-8537-5cc1af1bdaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_1387f9a0-04c1-4ee8-b7d6-3800a33b9625" xlink:href="embc-20230930.xsd#embc_A675SeniorSecuredNotesDueFebruary2030Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e32e790a-10ee-42ea-a706-5e80b91fe990" xlink:to="loc_embc_A675SeniorSecuredNotesDueFebruary2030Member_1387f9a0-04c1-4ee8-b7d6-3800a33b9625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_511dd986-a147-42e0-bb73-540595108efa" xlink:to="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3935cdb6-f437-405f-863a-52031437bb93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3935cdb6-f437-405f-863a-52031437bb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c82d205e-cb76-453f-bb83-9b8a99b02628" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c82d205e-cb76-453f-bb83-9b8a99b02628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_82690f07-00f4-4820-8b2b-cce077a96419" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_LongTermDebtCurrent_82690f07-00f4-4820-8b2b-cce077a96419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c1115a69-52fe-4fdb-ae2b-f524206c726e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c1115a69-52fe-4fdb-ae2b-f524206c726e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_354d471e-e59e-412f-98e2-ca5f71073aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cee505b2-d1df-4cd1-a288-32808bf32eb1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_354d471e-e59e-412f-98e2-ca5f71073aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e9684d67-fd2a-4464-af6a-2d1f605cc125" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_577e7fa7-8971-4858-aff1-a554b814c6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9684d67-fd2a-4464-af6a-2d1f605cc125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_577e7fa7-8971-4858-aff1-a554b814c6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3b7ee36a-1af8-4153-8f07-47360fc42877" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9684d67-fd2a-4464-af6a-2d1f605cc125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3b7ee36a-1af8-4153-8f07-47360fc42877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_20bf0cc6-693a-4622-b2de-20d9bc984cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9684d67-fd2a-4464-af6a-2d1f605cc125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_20bf0cc6-693a-4622-b2de-20d9bc984cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_54e112a4-4d33-46ac-ba6c-90aa0e65bb97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9684d67-fd2a-4464-af6a-2d1f605cc125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_54e112a4-4d33-46ac-ba6c-90aa0e65bb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_8f01b931-84ad-4e1d-9196-dfb40d8b6d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9684d67-fd2a-4464-af6a-2d1f605cc125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_8f01b931-84ad-4e1d-9196-dfb40d8b6d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e4e4ef51-0186-4a73-91a0-c445151dacf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9684d67-fd2a-4464-af6a-2d1f605cc125" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e4e4ef51-0186-4a73-91a0-c445151dacf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/EarningsperShareAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#EarningsperShareAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/EarningsperShareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_02967515-c6fa-45bd-bdab-fb255f7bf8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_81a3e27a-8127-4b85-87fa-5b911f8cc4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_02967515-c6fa-45bd-bdab-fb255f7bf8a3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_81a3e27a-8127-4b85-87fa-5b911f8cc4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_6fcc762b-e765-4bb4-a268-2c66eafc190d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_02967515-c6fa-45bd-bdab-fb255f7bf8a3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_6fcc762b-e765-4bb4-a268-2c66eafc190d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d62c7d3d-fe8f-46ad-a833-2e1074b2a70f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_02967515-c6fa-45bd-bdab-fb255f7bf8a3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d62c7d3d-fe8f-46ad-a833-2e1074b2a70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#EarningsperShareComputationofEarningsperShareDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2c037c15-3ef6-48d7-9c8a-7236dd93a3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea7c658f-1204-427c-8493-078870ea1bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2c037c15-3ef6-48d7-9c8a-7236dd93a3f5" xlink:to="loc_us-gaap_NetIncomeLoss_ea7c658f-1204-427c-8493-078870ea1bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b26d884-8711-48aa-9646-cce02b36fc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2c037c15-3ef6-48d7-9c8a-7236dd93a3f5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b26d884-8711-48aa-9646-cce02b36fc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5a3e4a60-7b8b-410d-9136-1b196b927441" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2c037c15-3ef6-48d7-9c8a-7236dd93a3f5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5a3e4a60-7b8b-410d-9136-1b196b927441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54515864-ab84-4587-9ada-d7fc9242fd20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2c037c15-3ef6-48d7-9c8a-7236dd93a3f5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54515864-ab84-4587-9ada-d7fc9242fd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4e887ec4-ae68-4846-8e0f-520b8027e1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2c037c15-3ef6-48d7-9c8a-7236dd93a3f5" xlink:to="loc_us-gaap_EarningsPerShareBasic_4e887ec4-ae68-4846-8e0f-520b8027e1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cd29b2b4-3405-45a7-b722-38c6847d99b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2c037c15-3ef6-48d7-9c8a-7236dd93a3f5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cd29b2b4-3405-45a7-b722-38c6847d99b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesIncomeBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e3aca509-ddcb-4889-a2eb-22ae5c39d54c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_576bea74-3107-4271-b5a5-29b5ca50c564" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3aca509-ddcb-4889-a2eb-22ae5c39d54c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_576bea74-3107-4271-b5a5-29b5ca50c564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0061eeff-166b-41e0-aee6-a01be2c7956b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3aca509-ddcb-4889-a2eb-22ae5c39d54c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0061eeff-166b-41e0-aee6-a01be2c7956b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4ca52ed6-a61b-4afc-b6fc-6462ac8826d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e3aca509-ddcb-4889-a2eb-22ae5c39d54c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4ca52ed6-a61b-4afc-b6fc-6462ac8826d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesProvisionBenefitforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b31f2d1c-2ecd-4aa2-9650-19f40c6593ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6ec886e5-fa79-4bde-b548-dbff85c589fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b31f2d1c-2ecd-4aa2-9650-19f40c6593ad" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6ec886e5-fa79-4bde-b548-dbff85c589fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d5bc5506-4904-404a-9336-17b8b66d95ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6ec886e5-fa79-4bde-b548-dbff85c589fb" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d5bc5506-4904-404a-9336-17b8b66d95ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4e9285c2-b754-47d1-99aa-01a4a91a3c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6ec886e5-fa79-4bde-b548-dbff85c589fb" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4e9285c2-b754-47d1-99aa-01a4a91a3c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7bc990ad-bf64-48d3-87e2-27ccb5f52611" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6ec886e5-fa79-4bde-b548-dbff85c589fb" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7bc990ad-bf64-48d3-87e2-27ccb5f52611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_81eed9dd-18bd-4ad7-a499-e43d10a4d813" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_6ec886e5-fa79-4bde-b548-dbff85c589fb" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_81eed9dd-18bd-4ad7-a499-e43d10a4d813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63bf52ab-22d0-4ab2-8292-3ef35dae00db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b31f2d1c-2ecd-4aa2-9650-19f40c6593ad" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63bf52ab-22d0-4ab2-8292-3ef35dae00db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_025a03b4-fb5f-4b54-8086-f9e20b7f05f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63bf52ab-22d0-4ab2-8292-3ef35dae00db" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_025a03b4-fb5f-4b54-8086-f9e20b7f05f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c27c067f-1440-44d9-909d-c8b8a639ef47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63bf52ab-22d0-4ab2-8292-3ef35dae00db" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c27c067f-1440-44d9-909d-c8b8a639ef47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_20793539-477d-4b32-9eee-2094a78d998a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63bf52ab-22d0-4ab2-8292-3ef35dae00db" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_20793539-477d-4b32-9eee-2094a78d998a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_99b9e5f1-da91-43b2-9c64-eb548d7c0f80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_63bf52ab-22d0-4ab2-8292-3ef35dae00db" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_99b9e5f1-da91-43b2-9c64-eb548d7c0f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0cff04fa-ad1b-4997-a72f-884ebd564b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b31f2d1c-2ecd-4aa2-9650-19f40c6593ad" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0cff04fa-ad1b-4997-a72f-884ebd564b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_84c12f50-cc71-4c57-a593-a4465d6d3e72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_84c12f50-cc71-4c57-a593-a4465d6d3e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2ee151be-59ff-4774-800f-c90beb61416d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2ee151be-59ff-4774-800f-c90beb61416d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c7253ae8-a987-475e-b7d8-841d15feecf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c7253ae8-a987-475e-b7d8-841d15feecf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_6a918b9e-3c37-4b89-81de-0c4735013ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_6a918b9e-3c37-4b89-81de-0c4735013ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent_39b484fb-5ca0-4af8-b09c-5201d9fc897b" xlink:href="embc-20230930.xsd#embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent_39b484fb-5ca0-4af8-b09c-5201d9fc897b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_b2ade95e-d5aa-449c-a3f8-73fffe17ba7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_b2ade95e-d5aa-449c-a3f8-73fffe17ba7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_820347f1-b0bd-4489-b271-227b43f161f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_820347f1-b0bd-4489-b271-227b43f161f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_c584abc8-cf3a-48e8-a60f-06534045fa29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_c584abc8-cf3a-48e8-a60f-06534045fa29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_d6ccc0fa-1c2e-4bac-af6f-63771f141511" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome_d6ccc0fa-1c2e-4bac-af6f-63771f141511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_68665b81-5e15-4537-97ef-fa482ea15563" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_68665b81-5e15-4537-97ef-fa482ea15563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_24c58d84-d88e-427a-9100-7bd064410a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_24c58d84-d88e-427a-9100-7bd064410a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ce9810ff-0a34-4c42-a2c6-24cab85d8771" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_958fbb01-a842-43ae-a117-2df251fd9ab0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_ce9810ff-0a34-4c42-a2c6-24cab85d8771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesDeferredIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8956c534-c1d7-4ef4-8e03-1285c9093084" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8956c534-c1d7-4ef4-8e03-1285c9093084" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_cd906311-a7c9-4320-a9b4-f8b5d1046f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_cd906311-a7c9-4320-a9b4-f8b5d1046f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e89d4192-4ce0-4fed-b20d-f8facf4a7fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e89d4192-4ce0-4fed-b20d-f8facf4a7fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_8d90c0d6-8994-4ccf-ad14-a4f77307f630" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_8d90c0d6-8994-4ccf-ad14-a4f77307f630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_34823440-f84f-451e-9d58-e7d99363bccf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_34823440-f84f-451e-9d58-e7d99363bccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_b7155190-1f53-4c61-b8bb-82a7d208bfaa" xlink:href="embc-20230930.xsd#embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts_b7155190-1f53-4c61-b8bb-82a7d208bfaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredTaxAssetsLeasingArrangements_8bf79e3c-3616-45cd-94f7-aa4c400a76e2" xlink:href="embc-20230930.xsd#embc_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_embc_DeferredTaxAssetsLeasingArrangements_8bf79e3c-3616-45cd-94f7-aa4c400a76e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_1ff692f5-0590-4f94-89ce-b566966c39a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_1ff692f5-0590-4f94-89ce-b566966c39a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards_bcffb389-ba32-420b-9906-43e6d77e92fa" xlink:href="embc-20230930.xsd#embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards_bcffb389-ba32-420b-9906-43e6d77e92fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_4390cb21-4522-4d2e-a2b9-a2d08a2ffa0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_4390cb21-4522-4d2e-a2b9-a2d08a2ffa0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7ec4001a-98ed-493a-ad0a-dc867925b387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_7ec4001a-98ed-493a-ad0a-dc867925b387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3a3ae9b9-18eb-41e8-8ea3-3623878e1e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3a3ae9b9-18eb-41e8-8ea3-3623878e1e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_312a7fc8-a6ad-448e-ba50-440a8a91cdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_8aa44748-f56e-49aa-a019-e270bb5e0db4" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_312a7fc8-a6ad-448e-ba50-440a8a91cdcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_af2c8ff8-79d8-4c5f-ad3a-6b175917bf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8956c534-c1d7-4ef4-8e03-1285c9093084" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_af2c8ff8-79d8-4c5f-ad3a-6b175917bf9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_29b70a21-0087-46a6-ae94-ad09e9c3f6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_af2c8ff8-79d8-4c5f-ad3a-6b175917bf9a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_29b70a21-0087-46a6-ae94-ad09e9c3f6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_610c0289-a39a-43cc-ac9c-b33c7d064d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_af2c8ff8-79d8-4c5f-ad3a-6b175917bf9a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_610c0289-a39a-43cc-ac9c-b33c7d064d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e48b58ff-65f7-47ee-ad59-20824e1e5468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_af2c8ff8-79d8-4c5f-ad3a-6b175917bf9a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e48b58ff-65f7-47ee-ad59-20824e1e5468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a034714f-78c7-49dd-908e-4aa0ffde4ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8956c534-c1d7-4ef4-8e03-1285c9093084" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a034714f-78c7-49dd-908e-4aa0ffde4ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_42d4d345-e7f3-46b0-8177-b647d89f62c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_cd604f74-1f1c-444e-a31f-c821d98aee96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_42d4d345-e7f3-46b0-8177-b647d89f62c5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_cd604f74-1f1c-444e-a31f-c821d98aee96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_db133876-b33e-472a-903f-cfc1f55c9373" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_42d4d345-e7f3-46b0-8177-b647d89f62c5" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_db133876-b33e-472a-903f-cfc1f55c9373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1251f72e-8797-4e5f-994c-b85a7ba983bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayAggregateDollarAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_42d4d345-e7f3-46b0-8177-b647d89f62c5" xlink:to="loc_us-gaap_IncomeTaxHolidayAggregateDollarAmount_1251f72e-8797-4e5f-994c-b85a7ba983bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_98c544e3-24fa-4070-bf06-8a47347f21b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_42d4d345-e7f3-46b0-8177-b647d89f62c5" xlink:to="loc_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare_98c544e3-24fa-4070-bf06-8a47347f21b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_54a18860-84b8-474d-8da2-b06eaa437157" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_42d4d345-e7f3-46b0-8177-b647d89f62c5" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_54a18860-84b8-474d-8da2-b06eaa437157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_040f371c-cc23-409a-90a9-9a450be10366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_42d4d345-e7f3-46b0-8177-b647d89f62c5" xlink:to="loc_us-gaap_OperatingLossCarryforwards_040f371c-cc23-409a-90a9-9a450be10366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OperatingLossCarryforwardsNotSubjectToExpiration_64561618-e759-4b02-bb45-b0603e2c37be" xlink:href="embc-20230930.xsd#embc_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_42d4d345-e7f3-46b0-8177-b647d89f62c5" xlink:to="loc_embc_OperatingLossCarryforwardsNotSubjectToExpiration_64561618-e759-4b02-bb45-b0603e2c37be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8fdb15a7-24f1-42ca-aa83-9fbe146a6fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_06bb4a3b-033a-4266-80c5-b01c9405dd41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8fdb15a7-24f1-42ca-aa83-9fbe146a6fcb" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_06bb4a3b-033a-4266-80c5-b01c9405dd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d60a1eee-96f0-4404-adb4-829561ddbd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_06bb4a3b-033a-4266-80c5-b01c9405dd41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d60a1eee-96f0-4404-adb4-829561ddbd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_8fadf767-0bca-469f-9dda-510b75007ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_06bb4a3b-033a-4266-80c5-b01c9405dd41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_8fadf767-0bca-469f-9dda-510b75007ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_a42b690c-1a3d-4272-8aab-4dfcf9afa635" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_06bb4a3b-033a-4266-80c5-b01c9405dd41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_a42b690c-1a3d-4272-8aab-4dfcf9afa635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_6d8745db-3e3a-4302-96a3-329eb22d72a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_06bb4a3b-033a-4266-80c5-b01c9405dd41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_6d8745db-3e3a-4302-96a3-329eb22d72a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_33221778-2143-4fae-a735-5c0362aa25c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_06bb4a3b-033a-4266-80c5-b01c9405dd41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_33221778-2143-4fae-a735-5c0362aa25c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ebea9b37-11aa-4eff-8945-d14af0e2c365" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_06bb4a3b-033a-4266-80c5-b01c9405dd41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ebea9b37-11aa-4eff-8945-d14af0e2c365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_efba0b7f-0d4a-4e49-8b61-faf732d25db6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_06bb4a3b-033a-4266-80c5-b01c9405dd41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_efba0b7f-0d4a-4e49-8b61-faf732d25db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_cc54ab9d-f3cd-484a-b7ca-e45d12ccce41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8fdb15a7-24f1-42ca-aa83-9fbe146a6fcb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_cc54ab9d-f3cd-484a-b7ca-e45d12ccce41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/IncomeTaxesInterestandPenaltiesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#IncomeTaxesInterestandPenaltiesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/IncomeTaxesInterestandPenaltiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ab58a703-53c6-4f5a-87cf-edee35f7e781" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_c8934b88-acb9-4066-a342-651ebd6f9b38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab58a703-53c6-4f5a-87cf-edee35f7e781" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_c8934b88-acb9-4066-a342-651ebd6f9b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_3e7e6bfb-7713-4ade-a85e-501380d80380" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ab58a703-53c6-4f5a-87cf-edee35f7e781" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_3e7e6bfb-7713-4ade-a85e-501380d80380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#FinancialInstrumentsandFairValueMeasurementsCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_233d91c4-3a7a-41a4-82c2-56561e4a4754" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_136d05e9-b812-47d4-9afc-e197ec0eea97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_233d91c4-3a7a-41a4-82c2-56561e4a4754" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_136d05e9-b812-47d4-9afc-e197ec0eea97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f837a6b6-c2b7-4c69-be71-2fa3d349ba76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_233d91c4-3a7a-41a4-82c2-56561e4a4754" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f837a6b6-c2b7-4c69-be71-2fa3d349ba76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0681fa58-c86a-49e6-b98e-0af39180037b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f0b001d5-3cbd-4fb0-9440-0e3c47d0ceda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0681fa58-c86a-49e6-b98e-0af39180037b" xlink:to="loc_us-gaap_DerivativeTable_f0b001d5-3cbd-4fb0-9440-0e3c47d0ceda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e9c698fd-8d11-4202-8e8c-f55b94fc6410" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f0b001d5-3cbd-4fb0-9440-0e3c47d0ceda" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e9c698fd-8d11-4202-8e8c-f55b94fc6410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_88525a76-3210-4fbf-afad-73fceb0f5a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e9c698fd-8d11-4202-8e8c-f55b94fc6410" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_88525a76-3210-4fbf-afad-73fceb0f5a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_32f6ef82-256b-40ce-a0f8-af601a0838e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_88525a76-3210-4fbf-afad-73fceb0f5a9a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_32f6ef82-256b-40ce-a0f8-af601a0838e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d7e3f3ad-67a2-40c3-b01c-0a42fc620d55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f0b001d5-3cbd-4fb0-9440-0e3c47d0ceda" xlink:to="loc_us-gaap_HedgingDesignationAxis_d7e3f3ad-67a2-40c3-b01c-0a42fc620d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_149fe8ce-7bb0-4ec2-8af6-11185750a036" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d7e3f3ad-67a2-40c3-b01c-0a42fc620d55" xlink:to="loc_us-gaap_HedgingDesignationDomain_149fe8ce-7bb0-4ec2-8af6-11185750a036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_504980bd-8cfb-477d-8b31-0cd7fecfc232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_149fe8ce-7bb0-4ec2-8af6-11185750a036" xlink:to="loc_us-gaap_NondesignatedMember_504980bd-8cfb-477d-8b31-0cd7fecfc232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_37c6e35d-dd11-41ee-ad2a-ff3255d88a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f0b001d5-3cbd-4fb0-9440-0e3c47d0ceda" xlink:to="loc_us-gaap_DerivativeLineItems_37c6e35d-dd11-41ee-ad2a-ff3255d88a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_55e768bd-9246-42e8-be66-614b72196eec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_37c6e35d-dd11-41ee-ad2a-ff3255d88a5c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_55e768bd-9246-42e8-be66-614b72196eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_efab5397-6170-4128-aa7c-f7d727c59d73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_efab5397-6170-4128-aa7c-f7d727c59d73" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_51c3146d-1873-480b-a56c-6ad6a4e2a82b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_51c3146d-1873-480b-a56c-6ad6a4e2a82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0f3db870-fbed-47cf-91d9-b604ac7d2a44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_51c3146d-1873-480b-a56c-6ad6a4e2a82b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0f3db870-fbed-47cf-91d9-b604ac7d2a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_3cb2a9b0-2026-46b4-aa67-10e7d34ecd09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_0f3db870-fbed-47cf-91d9-b604ac7d2a44" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_3cb2a9b0-2026-46b4-aa67-10e7d34ecd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3ebd2381-255f-4385-aebe-bb1f8a875836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3ebd2381-255f-4385-aebe-bb1f8a875836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d07f188a-c608-48f7-bccb-a21bbc1f4346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3ebd2381-255f-4385-aebe-bb1f8a875836" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d07f188a-c608-48f7-bccb-a21bbc1f4346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_7f4f8fe5-e054-480c-8878-f243b7d043c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d07f188a-c608-48f7-bccb-a21bbc1f4346" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_7f4f8fe5-e054-480c-8878-f243b7d043c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_b25f8dfd-daec-4d0b-bf9d-6bd8969f9559" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:to="loc_srt_MajorCustomersAxis_b25f8dfd-daec-4d0b-bf9d-6bd8969f9559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d74e6a7b-ad22-4152-8883-ce7ce0793916" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_b25f8dfd-daec-4d0b-bf9d-6bd8969f9559" xlink:to="loc_srt_NameOfMajorCustomerDomain_d74e6a7b-ad22-4152-8883-ce7ce0793916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CustomerOneCustomerTwoAndCustomerThreeMember_ca8a68ea-e09f-48d6-9f7d-27aeeeeebb40" xlink:href="embc-20230930.xsd#embc_CustomerOneCustomerTwoAndCustomerThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d74e6a7b-ad22-4152-8883-ce7ce0793916" xlink:to="loc_embc_CustomerOneCustomerTwoAndCustomerThreeMember_ca8a68ea-e09f-48d6-9f7d-27aeeeeebb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_CustomerOneAndCustomerTwoMember_0d73f1e8-cec3-4601-80fb-f17d92c09f49" xlink:href="embc-20230930.xsd#embc_CustomerOneAndCustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d74e6a7b-ad22-4152-8883-ce7ce0793916" xlink:to="loc_embc_CustomerOneAndCustomerTwoMember_0d73f1e8-cec3-4601-80fb-f17d92c09f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7094f466-b221-4ce9-a730-d859d7a3b611" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_9e95732a-c73b-468c-968f-ab425bcac557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:to="loc_us-gaap_InterestIncomeOther_9e95732a-c73b-468c-968f-ab425bcac557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_74e5e460-2a92-47cb-b27f-563a71825e51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_74e5e460-2a92-47cb-b27f-563a71825e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_900f6c32-f789-4aac-9e3d-563419e7d809" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_900f6c32-f789-4aac-9e3d-563419e7d809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c38a9cc1-aab2-44fe-b792-a738fd07f4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1964a03d-ac4a-4840-9f3a-e83ba2f4c244" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c38a9cc1-aab2-44fe-b792-a738fd07f4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_695c146f-e348-4a35-bdcb-b1ecc9266684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d3f8752-5f29-4a1f-9c07-0758d2a242ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_695c146f-e348-4a35-bdcb-b1ecc9266684" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d3f8752-5f29-4a1f-9c07-0758d2a242ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4847a54e-13d9-4f9a-b5af-321fd67d3890" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d3f8752-5f29-4a1f-9c07-0758d2a242ae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4847a54e-13d9-4f9a-b5af-321fd67d3890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4847a54e-13d9-4f9a-b5af-321fd67d3890" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_2fec9565-75c3-49dd-a914-09e98e928859" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_LandMember_2fec9565-75c3-49dd-a914-09e98e928859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_37da85af-bcd1-4c9a-b26b-c83ed2f03c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_BuildingMember_37da85af-bcd1-4c9a-b26b-c83ed2f03c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_9a18860d-a880-40ec-9089-0678db41b04b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_9a18860d-a880-40ec-9089-0678db41b04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_62a3f5bb-6f12-446d-9d60-e29e33e1a731" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_62a3f5bb-6f12-446d-9d60-e29e33e1a731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_a960db6e-788c-4df1-815a-5669a2ddb408" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d0b23675-e6f1-4b9d-890c-9e717053e62b" xlink:to="loc_us-gaap_ConstructionInProgressMember_a960db6e-788c-4df1-815a-5669a2ddb408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d3f8752-5f29-4a1f-9c07-0758d2a242ae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_48290183-30e6-42d0-9f2d-983af8736037" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_48290183-30e6-42d0-9f2d-983af8736037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_86791a1f-5b64-44b0-adbe-0ff072328bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_86791a1f-5b64-44b0-adbe-0ff072328bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_aadf8ae5-a6ad-44ed-9726-798dcc9a5a58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5ba9fc0e-b53b-44e0-80c8-1612d1b0fb21" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_aadf8ae5-a6ad-44ed-9726-798dcc9a5a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/PropertyPlantandEquipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#PropertyPlantandEquipmentAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/PropertyPlantandEquipmentAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_99d6b928-f2cf-4887-814d-5b6fcf23c913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_d447823a-bc53-4c90-807e-3c38321326b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_99d6b928-f2cf-4887-814d-5b6fcf23c913" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_d447823a-bc53-4c90-807e-3c38321326b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ab667d20-8ddd-4c90-ae82-a8ac967ff7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_9115ed11-5193-4a63-9e76-3dc59b0e5ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ab667d20-8ddd-4c90-ae82-a8ac967ff7c6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_9115ed11-5193-4a63-9e76-3dc59b0e5ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_e8f66a7f-7361-4c5f-a5f6-bc64e2bbf45f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_9115ed11-5193-4a63-9e76-3dc59b0e5ec6" xlink:to="loc_us-gaap_LeaseContractualTermAxis_e8f66a7f-7361-4c5f-a5f6-bc64e2bbf45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_0fd7d2f3-d03d-4be8-af3b-90bf85a4fcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_e8f66a7f-7361-4c5f-a5f6-bc64e2bbf45f" xlink:to="loc_us-gaap_LeaseContractualTermDomain_0fd7d2f3-d03d-4be8-af3b-90bf85a4fcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BuildingLeaseSixYearExtensionOptionMember_46305dda-974e-4b4a-82e7-376a9ffa9eb0" xlink:href="embc-20230930.xsd#embc_BuildingLeaseSixYearExtensionOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_0fd7d2f3-d03d-4be8-af3b-90bf85a4fcdb" xlink:to="loc_embc_BuildingLeaseSixYearExtensionOptionMember_46305dda-974e-4b4a-82e7-376a9ffa9eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_BuildingLeaseFourYearExtensionOptionMember_84327573-bfb1-468c-997b-48cd01dca70d" xlink:href="embc-20230930.xsd#embc_BuildingLeaseFourYearExtensionOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_0fd7d2f3-d03d-4be8-af3b-90bf85a4fcdb" xlink:to="loc_embc_BuildingLeaseFourYearExtensionOptionMember_84327573-bfb1-468c-997b-48cd01dca70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_9115ed11-5193-4a63-9e76-3dc59b0e5ec6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeFinanceLeaseAreaOfPremisesLeased_37c1e587-f5bc-48ca-a1f8-3394020e03ad" xlink:href="embc-20230930.xsd#embc_LesseeFinanceLeaseAreaOfPremisesLeased"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_embc_LesseeFinanceLeaseAreaOfPremisesLeased_37c1e587-f5bc-48ca-a1f8-3394020e03ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_279be175-0680-440b-8e03-05760f3819ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_279be175-0680-440b-8e03-05760f3819ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_63a50c01-b9f6-4f4d-90bf-db6c48ae5853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_63a50c01-b9f6-4f4d-90bf-db6c48ae5853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_FinanceLeaseCost_0764001c-7062-4122-bcbf-ad3a7f81e87b" xlink:href="embc-20230930.xsd#embc_FinanceLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_embc_FinanceLeaseCost_0764001c-7062-4122-bcbf-ad3a7f81e87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_348da7b3-8b7d-4401-b7db-5c603c9711aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_348da7b3-8b7d-4401-b7db-5c603c9711aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_be3d3e59-8dad-49aa-8959-d0484f620e17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_be3d3e59-8dad-49aa-8959-d0484f620e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8730c8bf-72cb-4bce-a4fc-280d54eb5b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_8730c8bf-72cb-4bce-a4fc-280d54eb5b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b0bccf4d-5b31-4a50-bea8-c1625185711d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b0bccf4d-5b31-4a50-bea8-c1625185711d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_50ed9b08-afc7-469b-acdd-011899794883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_738c2f10-d53f-4f88-934a-223c80bdbd42" xlink:to="loc_us-gaap_OperatingLeaseCost_50ed9b08-afc7-469b-acdd-011899794883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesBalanceSheetInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LeasesBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_69cb51ee-4e22-4f95-8768-2ef25408d73c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c8a9c79f-8ef1-47a5-9e4f-2f67fb3a21d8" xlink:href="embc-20230930.xsd#embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69cb51ee-4e22-4f95-8768-2ef25408d73c" xlink:to="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c8a9c79f-8ef1-47a5-9e4f-2f67fb3a21d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f784ed44-793d-4479-80c5-d193321fec8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c8a9c79f-8ef1-47a5-9e4f-2f67fb3a21d8" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f784ed44-793d-4479-80c5-d193321fec8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_06c39306-0905-4e48-9319-f087a94ec715" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c8a9c79f-8ef1-47a5-9e4f-2f67fb3a21d8" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_06c39306-0905-4e48-9319-f087a94ec715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c32fe440-b991-4a8b-a21e-e4d8a728fdd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c8a9c79f-8ef1-47a5-9e4f-2f67fb3a21d8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c32fe440-b991-4a8b-a21e-e4d8a728fdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_be8a0e79-7507-459d-ab1a-9cc4c10d7a68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c8a9c79f-8ef1-47a5-9e4f-2f67fb3a21d8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_be8a0e79-7507-459d-ab1a-9cc4c10d7a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_0daf0f81-e51b-4733-823c-358e04ca334b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c8a9c79f-8ef1-47a5-9e4f-2f67fb3a21d8" xlink:to="loc_us-gaap_FinanceLeaseLiability_0daf0f81-e51b-4733-823c-358e04ca334b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_4ac8aed0-c2fd-43c2-ae4d-324261b9c8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c8a9c79f-8ef1-47a5-9e4f-2f67fb3a21d8" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_4ac8aed0-c2fd-43c2-ae4d-324261b9c8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_9f010599-f272-411c-9b75-2006371a653d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_c8a9c79f-8ef1-47a5-9e4f-2f67fb3a21d8" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_9f010599-f272-411c-9b75-2006371a653d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:href="embc-20230930.xsd#embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69cb51ee-4e22-4f95-8768-2ef25408d73c" xlink:to="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_a0ad3e80-d403-495f-b517-dcde65f1bcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_a0ad3e80-d403-495f-b517-dcde65f1bcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a0eb06cf-47fa-4dab-a391-3e25a3b69bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a0eb06cf-47fa-4dab-a391-3e25a3b69bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_377f3878-d30c-404c-9df3-0753edf8a3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_377f3878-d30c-404c-9df3-0753edf8a3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e5b81d66-7ed3-42d1-99f6-d0caba8b856f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e5b81d66-7ed3-42d1-99f6-d0caba8b856f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_653616fc-953b-477a-8a3e-ce00e758e58d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_653616fc-953b-477a-8a3e-ce00e758e58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_af8db2c3-94d5-4306-9f55-7c1d03c3991a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_af8db2c3-94d5-4306-9f55-7c1d03c3991a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_32dca074-2fa0-49ce-9bc7-594081163102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:to="loc_us-gaap_OperatingLeaseLiability_32dca074-2fa0-49ce-9bc7-594081163102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8272baf4-5a28-4e46-ba69-4b8d81c72cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8272baf4-5a28-4e46-ba69-4b8d81c72cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1238fa25-b259-4d37-a3c1-5f127a3ab163" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_aa72c155-c418-4473-928a-c6def3e3036e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1238fa25-b259-4d37-a3c1-5f127a3ab163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_51190f8e-864c-489f-88fc-baf9957c48ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_39aac1b9-a6c5-453b-b55c-7ce9ae7f9300" xlink:href="embc-20230930.xsd#embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_51190f8e-864c-489f-88fc-baf9957c48ad" xlink:to="loc_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_39aac1b9-a6c5-453b-b55c-7ce9ae7f9300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ab3d643b-cf0f-44eb-aee5-6027054b20d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_39aac1b9-a6c5-453b-b55c-7ce9ae7f9300" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ab3d643b-cf0f-44eb-aee5-6027054b20d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_213eb19e-237c-4f54-a7ab-ec38e7d3f92c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_39aac1b9-a6c5-453b-b55c-7ce9ae7f9300" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_213eb19e-237c-4f54-a7ab-ec38e7d3f92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_835059b5-09e0-4291-b222-5a5ec951d22b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_51190f8e-864c-489f-88fc-baf9957c48ad" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_835059b5-09e0-4291-b222-5a5ec951d22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_361e4f35-53f9-4c98-ac9e-5bf0fefeb010" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_835059b5-09e0-4291-b222-5a5ec951d22b" xlink:to="loc_us-gaap_OperatingLeasePayments_361e4f35-53f9-4c98-ac9e-5bf0fefeb010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_37f784d9-6e91-44f6-8dc3-113f86be4415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_835059b5-09e0-4291-b222-5a5ec951d22b" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_37f784d9-6e91-44f6-8dc3-113f86be4415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_0f43ecf9-9e03-42a0-85cd-641c44e13ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_835059b5-09e0-4291-b222-5a5ec951d22b" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_0f43ecf9-9e03-42a0-85cd-641c44e13ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4fe9f3f6-c782-497b-a52f-a09e6c975754" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4fe9f3f6-c782-497b-a52f-a09e6c975754" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7fc8ac92-0ba7-4cfd-a891-bb170eb56ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7fc8ac92-0ba7-4cfd-a891-bb170eb56ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a2c19480-c4fd-4c65-bd91-36fe001923e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a2c19480-c4fd-4c65-bd91-36fe001923e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_003e77d6-008e-46a8-9ee0-c0c4edffce6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_003e77d6-008e-46a8-9ee0-c0c4edffce6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0f1e07ae-c794-492b-99d9-134e25137da9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0f1e07ae-c794-492b-99d9-134e25137da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_518ff6a2-4888-4c7d-a6f6-f10ca7e6cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_518ff6a2-4888-4c7d-a6f6-f10ca7e6cc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2e31ec8c-93ed-44d9-891a-66f3d373c0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2e31ec8c-93ed-44d9-891a-66f3d373c0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_993fb106-0ffd-424f-9ca2-f3a79b076a43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_993fb106-0ffd-424f-9ca2-f3a79b076a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1779de27-19fd-4e8e-a9f9-68081422a5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1779de27-19fd-4e8e-a9f9-68081422a5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5fe196cc-9ee0-4c57-b37a-765c887c79e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e59d04ca-b6d7-4e43-86b9-1163e66d1b6e" xlink:to="loc_us-gaap_FinanceLeaseLiability_5fe196cc-9ee0-4c57-b37a-765c887c79e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4fe9f3f6-c782-497b-a52f-a09e6c975754" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_64461f8e-70f4-4f97-921b-1f2cd700cb93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_64461f8e-70f4-4f97-921b-1f2cd700cb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c10d4c80-0ad4-4283-b87f-a3b3d46db89c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c10d4c80-0ad4-4283-b87f-a3b3d46db89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0b78635c-74d4-4724-86bd-149d0661a8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0b78635c-74d4-4724-86bd-149d0661a8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_da0df8bb-f7e1-4a3e-ae2b-ad11fb35db2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_da0df8bb-f7e1-4a3e-ae2b-ad11fb35db2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0b504046-712b-41e3-9233-4ced2196c72b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0b504046-712b-41e3-9233-4ced2196c72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_59447f74-4714-4253-ae25-97fe7a316633" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_59447f74-4714-4253-ae25-97fe7a316633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_52aa6baf-ccc3-45e2-b80b-2851f26a2ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_52aa6baf-ccc3-45e2-b80b-2851f26a2ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_29685162-d5fa-420e-abc8-7774e0a977cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_29685162-d5fa-420e-abc8-7774e0a977cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_91587ad9-9407-4834-bee0-59b4f1aebe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_5f8311e7-9402-4bec-abfe-621cc707a164" xlink:to="loc_us-gaap_OperatingLeaseLiability_91587ad9-9407-4834-bee0-59b4f1aebe3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4fe9f3f6-c782-497b-a52f-a09e6c975754" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearOne_8e24808e-53af-4e24-95f1-6f7b4138a70d" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearOne_8e24808e-53af-4e24-95f1-6f7b4138a70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearTwo_840edc5f-a135-4c42-8d6d-14d54dd7ffc7" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearTwo_840edc5f-a135-4c42-8d6d-14d54dd7ffc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearThree_6acfa3e0-b1d2-454c-9094-892956698e10" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearThree_6acfa3e0-b1d2-454c-9094-892956698e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearFour_08f0e05c-edbe-41db-9163-047270916c0a" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearFour_08f0e05c-edbe-41db-9163-047270916c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidYearFive_00e010ca-c326-4bc2-b124-19e78ac48b48" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidYearFive_00e010ca-c326-4bc2-b124-19e78ac48b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_79432bb5-3a6c-4d24-9ecc-4177766a7b22" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive_79432bb5-3a6c-4d24-9ecc-4177766a7b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityToBePaid_d731121e-0775-494d-9455-b2cae358de21" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityToBePaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:to="loc_embc_LesseeLeaseLiabilityToBePaid_d731121e-0775-494d-9455-b2cae358de21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_0feb98d4-1c7f-492e-a523-8ea8979d9af0" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:to="loc_embc_LesseeLeaseLiabilityUndiscountedExcessAmount_0feb98d4-1c7f-492e-a523-8ea8979d9af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_LesseeLeaseLiability_4303ce9b-0bd0-44f5-8534-c9fe3c15c3d4" xlink:href="embc-20230930.xsd#embc_LesseeLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_embc_LesseeLeaseLiabilityToBePaidAbstract_67d8495e-1e8d-48da-8d44-23e33439c88e" xlink:to="loc_embc_LesseeLeaseLiability_4303ce9b-0bd0-44f5-8534-c9fe3c15c3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2" xlink:type="simple" xlink:href="embc-20230930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_2"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.embecta.com/role/BenefitPlansDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#BenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/BenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_01efd59e-7547-4853-9c1d-0eedd2a5f223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7b3c2cc0-9715-4188-8d09-b5e9e71e0f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_01efd59e-7547-4853-9c1d-0eedd2a5f223" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7b3c2cc0-9715-4188-8d09-b5e9e71e0f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_80c8fc11-d875-47c1-b734-bb0c7957424c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7b3c2cc0-9715-4188-8d09-b5e9e71e0f8b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_80c8fc11-d875-47c1-b734-bb0c7957424c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_35fb30f4-dfa5-4bfd-a37d-3092e6f380ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_80c8fc11-d875-47c1-b734-bb0c7957424c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_35fb30f4-dfa5-4bfd-a37d-3092e6f380ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_5b84f199-0cd7-4346-95a5-defc78692c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_35fb30f4-dfa5-4bfd-a37d-3092e6f380ef" xlink:to="loc_us-gaap_ForeignPlanMember_5b84f199-0cd7-4346-95a5-defc78692c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_ba026c51-c77d-40cd-8871-aef23d5a9f6e" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignPlanMember_5b84f199-0cd7-4346-95a5-defc78692c8e" xlink:to="loc_country_CH_ba026c51-c77d-40cd-8871-aef23d5a9f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b51b7974-b07e-467b-a159-f3be4558a8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7b3c2cc0-9715-4188-8d09-b5e9e71e0f8b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b51b7974-b07e-467b-a159-f3be4558a8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a23e8578-42ba-4dd6-a0fe-42536ffeed60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b51b7974-b07e-467b-a159-f3be4558a8c4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a23e8578-42ba-4dd6-a0fe-42536ffeed60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseMember_b6ee9e14-3965-4229-a0a4-cdd4d7765eed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a23e8578-42ba-4dd6-a0fe-42536ffeed60" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseMember_b6ee9e14-3965-4229-a0a4-cdd4d7765eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7b3c2cc0-9715-4188-8d09-b5e9e71e0f8b" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_79c3c015-b323-43cc-8bed-a7fe227fca1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_79c3c015-b323-43cc-8bed-a7fe227fca1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_eaaeabfa-21a3-4a08-92a6-5112b195769f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_eaaeabfa-21a3-4a08-92a6-5112b195769f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_406fa316-a356-4825-8203-b45f9d108a40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_406fa316-a356-4825-8203-b45f9d108a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_da082ceb-dcba-46f0-80f3-a00e387c0703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_da082ceb-dcba-46f0-80f3-a00e387c0703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage_458752f2-7b95-44e7-bc08-c9c073c1f6a7" xlink:href="embc-20230930.xsd#embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage_458752f2-7b95-44e7-bc08-c9c073c1f6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage_0899b526-2e03-4633-862f-07204f01e426" xlink:href="embc-20230930.xsd#embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage_0899b526-2e03-4633-862f-07204f01e426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_66f5bcb5-00c7-4740-9b20-dfddf04e9226" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_007b9ffc-3faf-4368-9dae-1e89d00df203" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_66f5bcb5-00c7-4740-9b20-dfddf04e9226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SupplementalFinancialInformationTradeReceivablesNetDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e720f7b-08d1-48de-a128-264522829558" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_d2ef79d8-22d4-4ae7-a753-27dc16ee7125" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1e720f7b-08d1-48de-a128-264522829558" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_d2ef79d8-22d4-4ae7-a753-27dc16ee7125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_057d6057-993b-4591-b80f-5a650656b9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_d2ef79d8-22d4-4ae7-a753-27dc16ee7125" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_057d6057-993b-4591-b80f-5a650656b9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_dbc5ed9f-f2c5-45d6-9ed5-1a503f0f48e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_057d6057-993b-4591-b80f-5a650656b9e7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_dbc5ed9f-f2c5-45d6-9ed5-1a503f0f48e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_0cfb903b-67af-49c1-980e-c863bc729c75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_dbc5ed9f-f2c5-45d6-9ed5-1a503f0f48e7" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_0cfb903b-67af-49c1-980e-c863bc729c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_SECSchedule1209AllowanceCashDiscountsMember_9ebc425c-29ea-4fea-a6c4-03ed3e661e6d" xlink:href="embc-20230930.xsd#embc_SECSchedule1209AllowanceCashDiscountsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_dbc5ed9f-f2c5-45d6-9ed5-1a503f0f48e7" xlink:to="loc_embc_SECSchedule1209AllowanceCashDiscountsMember_9ebc425c-29ea-4fea-a6c4-03ed3e661e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3e4acc90-cb35-45c2-b3cf-1fe30a28a478" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_d2ef79d8-22d4-4ae7-a753-27dc16ee7125" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3e4acc90-cb35-45c2-b3cf-1fe30a28a478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_3e4acc90-cb35-45c2-b3cf-1fe30a28a478" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b4016aac-91fd-4777-8ede-b9fa0c19a651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b4016aac-91fd-4777-8ede-b9fa0c19a651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2b721d0b-5d17-4e6d-8a5e-66f97c24624e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2b721d0b-5d17-4e6d-8a5e-66f97c24624e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_b8ef4688-bbbb-469f-b938-8dcba01c3f05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_b8ef4688-bbbb-469f-b938-8dcba01c3f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_5a192377-8f1d-4119-9852-0b6012835c90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2248a94c-a205-4403-a024-4e363e439715" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_5a192377-8f1d-4119-9852-0b6012835c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SupplementalFinancialInformationLongLivedAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e50728b9-5427-486c-b386-70373b7c3df7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8977fa81-a114-48ab-85e8-56d1b5449b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e50728b9-5427-486c-b386-70373b7c3df7" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8977fa81-a114-48ab-85e8-56d1b5449b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_805074f9-40f9-4017-89dc-0e1e0643b112" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8977fa81-a114-48ab-85e8-56d1b5449b7f" xlink:to="loc_srt_StatementGeographicalAxis_805074f9-40f9-4017-89dc-0e1e0643b112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_805074f9-40f9-4017-89dc-0e1e0643b112" xlink:to="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_85fe2aac-b51a-4c4d-82ca-2da6006867ca" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:to="loc_country_US_85fe2aac-b51a-4c4d-82ca-2da6006867ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_511d02d4-e03a-4ec8-912e-fac7815c52fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:to="loc_us-gaap_EMEAMember_511d02d4-e03a-4ec8-912e-fac7815c52fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_8d93bdc2-5b48-48f8-a9ac-17d9cbb556da" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:to="loc_srt_AsiaMember_8d93bdc2-5b48-48f8-a9ac-17d9cbb556da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_OtherCountriesMember_d7043a6e-fd53-4d41-8227-5728ab30fc4e" xlink:href="embc-20230930.xsd#embc_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9b655392-9dbb-401c-9ed0-de90bca39ca0" xlink:to="loc_embc_OtherCountriesMember_d7043a6e-fd53-4d41-8227-5728ab30fc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_32ab8f78-bb55-41a1-8130-b2a4ef7be87d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_8977fa81-a114-48ab-85e8-56d1b5449b7f" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_32ab8f78-bb55-41a1-8130-b2a4ef7be87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_782e4f5a-40ec-4e3b-a8fd-3547b0331319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_32ab8f78-bb55-41a1-8130-b2a4ef7be87d" xlink:to="loc_us-gaap_NoncurrentAssets_782e4f5a-40ec-4e3b-a8fd-3547b0331319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.embecta.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="embc-20230930.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.embecta.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_e788860e-26c0-4a19-9499-a9b5ffabf1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_4803a90c-688c-4618-b49f-0d9dfbc955a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_e788860e-26c0-4a19-9499-a9b5ffabf1e9" xlink:to="loc_us-gaap_SubsequentEventTable_4803a90c-688c-4618-b49f-0d9dfbc955a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f25d4407-e92a-4732-9c04-212d9dc771e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_4803a90c-688c-4618-b49f-0d9dfbc955a0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f25d4407-e92a-4732-9c04-212d9dc771e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7cd5a0e8-40c7-4fc4-a8ab-7ff89441d9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f25d4407-e92a-4732-9c04-212d9dc771e8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7cd5a0e8-40c7-4fc4-a8ab-7ff89441d9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4c9fb83b-55ee-4c62-be3d-5bee9a174b53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7cd5a0e8-40c7-4fc4-a8ab-7ff89441d9b0" xlink:to="loc_us-gaap_SubsequentEventMember_4c9fb83b-55ee-4c62-be3d-5bee9a174b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7fafb72a-812a-4a6c-bec4-411c3720503d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_4803a90c-688c-4618-b49f-0d9dfbc955a0" xlink:to="loc_us-gaap_AwardTypeAxis_7fafb72a-812a-4a6c-bec4-411c3720503d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ed8cb5a-ed6b-4e5e-a0f4-e2025f2c4832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7fafb72a-812a-4a6c-bec4-411c3720503d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ed8cb5a-ed6b-4e5e-a0f4-e2025f2c4832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_TimeVestedRestrictedStockUnitsMember_dd53fd50-d2db-464c-bbf4-3c9d27315b5f" xlink:href="embc-20230930.xsd#embc_TimeVestedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ed8cb5a-ed6b-4e5e-a0f4-e2025f2c4832" xlink:to="loc_embc_TimeVestedRestrictedStockUnitsMember_dd53fd50-d2db-464c-bbf4-3c9d27315b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_embc_PerformanceBasedRestrictedStockUnitsMember_b364eb4e-d85f-4e54-aa1e-8d0b6e44e63f" xlink:href="embc-20230930.xsd#embc_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ed8cb5a-ed6b-4e5e-a0f4-e2025f2c4832" xlink:to="loc_embc_PerformanceBasedRestrictedStockUnitsMember_b364eb4e-d85f-4e54-aa1e-8d0b6e44e63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_c19e3cad-7b7f-4851-833b-8dab9d0fd88f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_4803a90c-688c-4618-b49f-0d9dfbc955a0" xlink:to="loc_us-gaap_SubsequentEventLineItems_c19e3cad-7b7f-4851-833b-8dab9d0fd88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_813975a1-ef11-42fd-9677-4432cbd359a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c19e3cad-7b7f-4851-833b-8dab9d0fd88f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_813975a1-ef11-42fd-9677-4432cbd359a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e9e11948-a9b8-4e00-8023-cfe1ebc549bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_c19e3cad-7b7f-4851-833b-8dab9d0fd88f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e9e11948-a9b8-4e00-8023-cfe1ebc549bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>embc-20230930_g1.jpg
<TEXT>
begin 644 embc-20230930_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0!H17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    1    3@
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( %,
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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MR4-&ECN:W+.!_>6+J+ZO@Z"^Q"51^M3E2OY^Y)_]O'145_(9YX44 %% !10
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M63DT:UEJ%AJ4/VC3KVTO[<L5$]E<PW4)8=5\V!W3<.XW9'>N;^(/_(A>-_\
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M\(:!:1L9FM?!GPF\*K/HNCZ7I%KL%]K4FFS:@]K;C4O$^NWURMQJ+_A?T2^
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ME^"JXBC'M"K/'XMSBM'[:=_B9X6,G+_6:AJ_=JX2*\HRA!M>C<I7]6?SJ?\
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M_$KP3H7B_P 6>-=5O8E\[4;O6=4U2064EU-</IVAVVDZ%:2)INDV4$/XB_\
M!W'\"/A3KG[%WP@_:+U#2M(T[XR^ ?CKX;^&OAWQ0L$$&M>(/!'CCPOXZU?7
M/!%U<HJ7&I6=GJ7AJQ\5Z5#<O.NC-8:\^GQVXUS56N/XB\,^(<XJ?21RS-YU
MJ[Q^;<<YKA\PO*3<\/FN(QV%QE"I&]G2HT*TN2FUR450I."C[*'+\I@:]5YY
M3JMOGJ8N<9^:J2E&2:[)/;I96V1^(/\ P;H_&+XD?#+X9_\ !85?!%YJ$$6B
M?\$\_B-\8M,%H\P%M\2/A9H'C(>!;RV\OB'4 OB?7/)>/;-+Y*XW?9UV?SE?
M"3Q_KWPI^*/P]^)WA71] U_Q/\/?&/A[QGX<TCQ3H,7BCPY?:[X:U.VU?2(M
M:\-W!^RZ]IRZA:6\MSI-VLEG?QH;:\AGMI)87_T&X;RC U/$'QLUE1GG"X,P
M^/JX>I[&O"FN$I8>,X58ZT:D:=6<Z=3>,_WFK/LZ%*+QN:]'5^JQDXZ22^K<
MNC6J=G=/OJ?T#?\ $3A_P6(_Z"OPN_\ # :?_P#':_"SX\_$+XG_ +17QD^(
M_P <_'?A&ST_QM\5/%.H^-/%T/@WP7-X8\.S^)=9<7&MZG8Z%9Q/;6$NLZB;
MC5]2$+;+C5+Z]NMJF<J#P]\'_#_PPS''9GPI/'4,1F6"6!Q<,9G#QE"I1C7I
MXB$O8SY4JU.=-J%2]XPJ58[388++,'@)SJ8?G4IPY)*53F35U):/JFM'V;[G
M[V_\' 'Q2^)7C3]G3_@BEH/CF358\_\ !/+P!\1=5AU%;B":]\?^-/"OP[TG
MQ5J6H03A7.I2V_A'2+AEN%,]G_:,Z#8;F;S/W1_X-%_@A\+]$_8M^-/[0>GZ
M=I5_\7O'OQ[U_P"&OB3Q&889=7T3P3X#\(^!-:\/^#(9V#SV%K<ZIXKU/Q3J
M,4#PIJS:AHC7L<_]BZ<\/\[^(]1Y)]%6C@LIER83'\48[!8B=!V4L)5XVSW'
MS3G#>%2OA:%*6MI0?LG>#<7XN-?LN'5"G\,Z\HR<=G%XJK/[FXI>FFQ_6?-!
M!<JJ7$$4Z)-!<(DT:2JL]M,EQ;3*KJP6:WN(HYX)  \4T:2QLKHK#G_&G_(G
M>+/^Q:UW_P!-=UZ\5_G]0;]M05W95H-*[LFYPN[=&TE=K5V79'QJW7JC_'8_
MX)]_\GZ_L1?]G>?LV?\ JYO!?KQ7]]G_  =>>,O$WA?_ ():Z=HN@S7,6E_$
M7]I[X2>#?&B0,ZQW'AFR\.?$CX@6T-X%(#6P\8>!?"<RK)E/M4-L<;PE?Z6>
M-5"EB/'[P!IUDG"./J5TGM[7#9GAL30>NEU7HTW'K=+R/NLU2EG&3IJZY[_.
M-2,E]S29_/\ _P#!IA\"/A5\4/VY/BY\3/'VE:3XA\7? ?X,P>)/A5I6KP6]
MVNC^)?%'BO3_  ]J/CS3[6=6_P")MX:TCSM&L+W:PTV3Q<;R+RM0CT^Y@_T0
M?%?A3PSXZ\,^(/!?C30-(\5>$?%>CZCX?\3>&O$&GVNK:'KVAZM:RV.IZ3JV
MF7L<UI?Z??V<TMM=6MQ%)#-#(Z.I!-?S7]+#-LQJ>,^*@Z]:DLCRG(*.52A.
M<'AXRPT<T=6@XM<E18[%UY^TC:7-".ON1MX?$56;S22NU[*G15/6W+[JJ7CV
M?/)N_='^-9^V=\,?!WP4_:__ &J/@Y\/+O[=X"^%/[1?QJ^'/@JZ-RUZTOA3
MP5\1_$GASP_YEZ[2&]ECTK3K6.:\\R1;J5'G221)%=BO]/<BQ=?'Y)DV.Q4>
M7$XW*LOQ>(C;EY:^(PE&M5CR]+5)R5NFQ][1DYTJ4Y;RIPD_644W^+/TA_X+
MH?\ !./XA_\ !/K]MKQ_XBTG0=4M_P!GSXY>-O$/Q1^ WCK3H+B/1]/.OZG+
MXBUOX:MJ, \O3/$WPXUB]N-.LK&6Y^WWOA6+P]XC1B=0N([7]??V5/\ @[M\
M>_#WX0>'_ _[4?[,DWQJ^(_A31;32$^*_@GXD6O@B?QV-/MTM;;4?&?AC5?!
M^OVUAXCNHX4GUS7-"U1M/U2_FGNK7POI"$6[?S-Q%X?Y=])3PJ\.\[PF=4\J
MSK 8"E4CCY89XZC#$U*&'P/$>68FA"O0J7CF&7QG1JJIS1EAHWI\F)E*/@UL
M'3SS+L%5C55.K""]_EYTI.,85Z<HW3^.%T[[Q721]X?\$I_^#E/7_P!MW]N'
M4OV=/V@/A=X)^#O@WXQP0Z?^S2/"5YK>OZEH7C;2+>]OKGP7\1/%&HFUM_$L
M_C?3DF.A^(=.\-^$K/3M=TFRT)M%N!XC2]T[M_\ @[T_Y1S? K_L]?P%_P"J
M+_:(K\!POA;3\)_I(^&N0X3%U\PR[&O*,RPF-Q,:<:U:J\)B\%F7/"G[M)2S
M+"8JO1HWFZ&%Q&'HRJUY0E6GX\<O_L[/,#1C*4X2=*<9RM=OEE&IMM^\C)I:
MVC**NVFW^;O_  9R?\EB_;C_ .R:?!C_ -2GQU7[._\ !TS_ ,HG/%W_ &7'
MX+]O^HSJ7Y?Y'>N_C_\ Y3&R3_LI> ?_ %5Y,7C/^2FI?]?\'_Z;I'\]'_!H
M-_RD!_:$_P"S.O%'_JZ_@A7]2'_!QM_RAD_;-_Z]O@)_ZU!\$Z?C!_REIP5_
MV47AC_ZM<N#,O^2CPO\ U_P'_IRF?Q_?\&J'_*52W_[-S^,/_I7X-KX[_P""
M_P#_ ,I@?VVO^QX\"_\ JG/AQ7])Y;_RE)Q#_P!F>P/_ *TN!/<A_P E!6_[
M%D?_ $_ ^I/^";?_  <A_M3_ + 7P:T;]GCQ)\-O!_[2/PB\&QW%O\.+/Q5X
MBUCP;XX\"Z9<3RW7_",6/C'3[#Q#;:IX1LKJ>>;2-*UCPU=ZCH\<QTS3M;@T
M*VTW2;#XW_X*A?\ !7_]IC_@JIXK\')\3=+\._#[X6_#ZZO;CX>?!GP$=3NM
M&LM;U>-+2\\3>(M6U*:74O%_C"XM%32K74)+?3M-TO3C/:Z#H6ERZKKEQJW5
MD?T>N$\@\4\=XH8?&XN=6O7Q^8X/(JE*C' Y=FV9PJPQ^.AB%+GJTG]8Q53"
MX65*$<)5K\\:LU1HQA=+)<-1S">/C*5VYSC2:7)"I-/GFGNUK)QC9<K=[NR2
M_LM_X-S?^"5>N_LK_L<?%;QU^TQX,FTGXF?MJZ7I]EXC^''B"VEM=8\)? JS
MT;6].\.^%?$UE*$N]%\1^,%\6>(O$'B71V:&\T_3;OPMI6LV]CK^CZC8V?\
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MHO9QFJ5/Q\TR?^S:.&J*JZKG4E3JR<5&*E92IJ$;MI<L9W;D[M7T6B_R6_\
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M\0Z#I.HC[#JEKYYM!:W7GV4UQ;3/BSC3B;-O$[+>*\PS+ZQG^ Q_#V(PF/\
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M@7^R_ $'BZ?2XM _X2?QC>[+%-26W6#^U=1\0W>M-B(E/-;4FF/WC(6^:O\
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2DVE&*5Y2IN4GW<FVWJVV?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>embc-20230930_g2.jpg
<TEXT>
begin 644 embc-20230930_g2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ?D"8,# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **Y'Q_\7O _PJMDG\9>+]$\+QR?ZO\
MM:_BMVDYQ\JLP+?@#7 :/^VU\!=<OC9VGQ;\*>?O$8%QJ4<"LQS@*TA53T['
MT]10![;14%C?6VJ6<-W9W$5W:3()(IX'#I(IZ,K#@@^HJ>@ HHKD?'_Q>\#_
M  JMDG\9>+]$\+QR?ZO^UK^*W:3G'RJS M^ - '745X=9_MP_ &^O'M8_BYX
M4616"EIM12*/)..';"D>X.*]CT77--\2:;#J&DZA:ZI83#,5U93+-$X]5=20
M?P- %ZBBL#Q7\0/"_@-;9O$OB32/#JW180'5K^*U$NW&[9YC#=C<N<=,CUH
MWZ*\_P#^&A/A9_T4OP?_ .#ZU_\ CE=\CK(JLK!E89#*<@CUH =15#7->TSP
MSI=QJ>L:C::3IMN 9KR^G6&&,$@ L[$ 9) Y/4BN._X:$^%G_12_!_\ X/K7
M_P".4 >@45G>'_$FD^+-*AU30]4LM9TR8L(KS3[A)X7VDJVUT)!P00<'@@US
M6J?'#X<Z'J-SI^H^/_"^GW]M(8I[6ZUFVBEB<'!5E9P5(/8B@#MJ*\__ .&A
M/A9_T4OP?_X/K7_XY5W2?C5\/->NUM=,\>>&=1NFP%AM-8MY7.3@857)ZT =
MG1110 45E>)/%6B^#=-.HZ_K%AH>GAQ&;O4KI+>(,>B[W(&3Z9K"T3XT?#[Q
M-JEOIFC^.O#6JZE<$K#9V.KV\TTA )(5%<D\ G@=J .RHHJ&\O+?3K.>[NYX
M[6U@C:66>9PB1HHRS,QX  !))Z8H FHKS_\ X:$^%G_12_!__@^M?_CE'_#0
MGPL_Z*7X/_\ !]:__'* /0**XO2_C7\/-<N1;Z;X\\,ZA<'I%:ZQ;ROSP.%<
MFNTH **KZAJ%KI&GW-]?7,-E8VL33SW-Q((XXHU!9G=B<*H ))/  KC]/^.G
MPVU?4+:QL?B#X5O;ZZE6""VM]:MI))9&(5410^68D@ #DDT =Q117+>._BEX
M-^%]@+WQAXJT;PQ:M]V35KZ*V#^R[V&X^PH ZFBO"[?]N?\ 9_N;XV:?%OPL
M)0<;I+]4C_[^-A?UKU_PUXKT3QII,>J>']8T_7=,D)"7NFW27$+$=0'0E3^=
M &K1110 45SWC7XB>%OAOI9U+Q9XCTKPUIXS_I.K7D=LAQV!<C)]AS7EH_;E
M^ #7IM?^%N>%?- W;OMZ^7_WW]W/MF@#W.BL;PKXS\/^.M)35/#6N:;XATU_
MNWFEW<=S"WT="1^M;- !165XD\6:)X-TW^T?$&LZ?H6G[Q']JU*Z2WBW'HN]
MR!DX/&>U9/AOXL^!_&6I?V=X?\9>']=U#89/LNFZI!<2[1U;8CDX&1SCO0!U
M=%%9/B;Q=H7@O3AJ'B'6M/T*P,@B%UJ=U';Q%R"0NYR!D@'C/8T :U%<UX6^
M)G@_QS=36WAOQ7H?B"YA3S)8=+U&&Y>-<XW,$8D#/&372T %%%% !117FGCK
M]ICX3_#/4'T_Q3\1O#.B:B@)>RNM3B6=<=<Q[MP_$<]J /2Z*\?\*_MA?!'Q
MM>PV>C_%3PK<WDQ(BMWU.*&20CLJN5)/L.M>O(ZR*K*P96&0RG((]: '445R
M7B+XO>!?!^J/INO>-?#NB:BBJS6>HZK!;S*I&02CN" 1TXH ZVBO/_\ AH3X
M6?\ 12_!_P#X/K7_ ..4?\-"?"S_ **7X/\ _!]:_P#QR@#T"BN5\,_%?P1X
MTU$Z?X>\8Z!KM^(S*;73-4@N)0@(!;:CDX!(Y]Q754 %%%% !16?KWB#2_"N
MCW>KZUJ5GH^E6<9EN;Z_G2""!!U9Y'(51[DUS?@GXV?#OXEZE-IWA#Q[X8\5
M:A#";B6TT36+>\ECC#!2[)&[$+EE&2,98#O0!VE%%% !17!ZK\?/ACH-\ECJ
M7Q&\):=>N2JVUUKEK%(Q'4!6D!/0UV&DZSI^O627FF7UMJ-HY(6XM)EEC)'!
M 9210!<HHHH **@OKZVTNQN+V]N(K2SMXVFFN)W"1Q(H)9V8\!0 22> !7#?
M\-"?"S_HI?@__P 'UK_\<H ] HK%\+^-/#WCBREO/#FO:9X@M(I/)DN-+O([
MF-'P#M+(Q ."#CK@BMJ@ HKB=4^.'PXT34;G3]1\?^%["_MI&BGM;K6;:.6)
MP<%65G!4@]0:N^&/BKX*\;:@UAX=\8:#KU\L9F:UTO4X+F4(" 7*HQ.T%@,]
M.1ZT =311535-6LM#T^:^U&\M]/LH%W2W-U*L4<:^K,Q  ^M %NBO$-3_;>^
M >DW0M[CXM^%#)O,?^CZBDRA@<'+(2 /<G%=Y\/_ (T> ?BLDC>#?&F@^*#'
MGS(]*U&*X>/']Y58E?Q'>@#LZ**BNKJ&QM9KFYFCM[:%&DEFE8*B*!DLQ/
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MAN1G!&00>1T(KH]$UW3?$VEV^IZ/J%KJNFW +0WEC.LT,@!()5U)!Y!'![4
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M?]%+\'_^#ZU_^.5I>'OC!X#\7:I'IFA>-O#NM:E(&9+/3]6@GF8*,L0B.2<
M$GCM0!UU%8/BKQ]X8\"1VTGB7Q'I/AY+DLL#:K?16HE*XW!3(PW8R,X]13/"
MGQ$\*>/&N5\->)]'\1-:A3.-)OXKHQ;L[=_EL=N=K8SUP?2@#H:**YSQ5\2/
M"7@6:WB\2^*=%\/2W"EH8]5U"&V:10<$J)&&0,CIZT ='16%X5\>>&?'4-Q+
MX:\1:3XABMV"S2:5?17*Q,1D!C&QP3@]?2D\5>/O#'@2.VD\2^(])\/)<EE@
M;5;Z*U$I7&X*9&&[&1G'J* -ZBO/_P#AH3X6?]%+\'_^#ZU_^.4?\-"?"S_H
MI?@__P 'UK_\<H ] HK#\-^.O#?C)6;0/$&E:XJKN+:;>Q7 "YQGY&/&:W*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *^$_^"DG[?4_[-VFP^!/ LL+_$+5+?SIKU@'72+=LA7VG@S/
M@[0>% W$'*@_=E?S0_M*_$ZZ^,GQ\\>>,+JX>Y&IZO</;-)U2V5RD"#V6)8U
M_"@#:^&'P/\ C#^V-XVU.YT#3]4\9ZNS"34M;U*Z_=QD]#-<RMC<0#A<EB <
M XKTOXE?\$O_ -H#X9^&Y]<G\+VVOV5M'YMPF@WJW4\2@9)\KAWQWV!NA/3F
MOV2_8[^#&F_ ?]G/P5X8L;9(+LZ?%>ZE(JX:>]F17F=CU/S':,]%11VKV>@#
M^>#]C_\ ;4\:?LH^-+.6TOKK5/!$\RC5?#<LFZ&2,GYGA#<1RC)(9<9( ;(K
M^@GPGXHTWQOX7T?Q%HUPMWI.K6<-]:7"])(9$#HWXJPKXO\ ''_!([X5_$3X
MQ>)/&NJZWK=GI^L79O1H&CB&VAAD91Y@WE&)5GWOA0N-V,\9/U[\+_AKH?P?
M\ Z-X-\-0SP:%I$)@M([FX>>15+%L%W)8\L<#. , 8  H ^*_P#@I;^W]>?L
M^P)\.?A_<)'X]U"W$U]J6T-_95NX.S8#QYS]1G[JX.,LI'Y3_#7X._%;]K'Q
MSJ"^&M*U;QQK\A$^H:E=7&X)NSAY[F9@JDX.-S9.TXSBL?X[_$VZ^,WQE\9^
M-KMY'?6]4GNXUD.3'"6(AC^B1A%'LHK^@3]CWX$:9^SO^S_X3\+6=FEOJ36<
M=YJ\VS#SWTB!IF8]3@_(,]%11VH _(K7O^"2?[1&BZ.;Z'0]'U>55+M8V&K1
MF<8/3#[5)QS@,?SXKQ?X1_';XK?L>_$6X.AWNH^&]3LKG9JGAS4DD6WG9>&C
MN;9B,G'&>&&?E(ZU_2-7YD?\%HO@/I=UX)\,_%K3[1(=;M+U-&U.6-0#<6\B
M.T+OZF-T*@]<2XZ*, 'VM^RI^TGH7[5'P?TWQIHR?8[HL;75-,9]S6-VH!>(
MG^)<,K*W=67@'('PM_P7*_Y!7P;_ .NVK?\ H-G7EG_!%[XGW/A_X]>)/!,L
M\G]F^(M(:Y2')*_:K9PRMCM^Z>;)]EKU/_@N5_R"O@W_ -=M6_\ 0;.@#\H=
MIV@XXZ9K^C3]A[XG?\+<_91^&WB!Y1->#2H]/NVSEC/;$V\C-Z%C%N_X$*_"
M_3_AO_;G[(NK>-88M\^@>,8;&9E'*P75H26/L)((Q]7^M?HW_P $3?B=_:OP
MS\>> KB;,VCZE%JMLC=?)N$V.%]E>#/UE]Z .M_X++?$S_A%?V;='\(PRE+K
MQ5K$:R1YQNMK8>:_Y2FW_.OQ3K[Y_P""ROQ._P"$L_:4TGPE!-OM?"FCQI)'
M_<NKD^<Y_&+[-^5?,'[0'PW_ .%86?PML)(O+O-2\%V>M7!(PS-=7%S,F?<1
MO&O_  &@#]F?^"5?_)CG@'_KMJ7_ *7W%?CM^VM_R=Q\7O\ L9K[_P!&M7[$
M_P#!*O\ Y,<\ _\ 7;4O_2^XK\=OVUO^3N/B]_V,U]_Z-:@#M_ ?_!-;X]_$
MKP7HOBK0/"]C=:+K%I'>V<SZO;1L\3J&4E6<$<'H17#?&C]C;XR?L^:.FK^.
M_ ]WI&CM((O[2AG@N[=6)(4.\#N$)(X#X)XK]U?V*?\ DT?X0_\ 8LV/_HI:
MI?MS>,?"7A#]E7XD_P#"7W5K%:ZCHEW86=O<,H>ZO)(6$"1 \E_,VL" =NW=
MT7- 'YP?\$N?VWO$GA/XH:/\)O&.M7&K>$=?D%GI4FH2M*^FWA&(HXV8DB*0
M@)Y?0,RD;<MG]EZ_F<_9OM;V\_:&^&$.G!S?MXGTSR/+&2'^U1X/X'G\*_I7
MUC5[/P_I%]JFH3I:V%E ]S<3R'"QQHI9V/L "?PH _*'_@M5\<O[0\0^#_A/
MI]QF'3X_[=U5%;CSG#1VZ'T*IYK8])5-?G'\.O'6I_#'Q[X>\7:-)Y6JZ)?P
MZA;-G@O&X8*WJIQ@CN"177_&#QYK7[3W[1.O>(8();K5O%FM"+3[,\N%=UBM
M8![J@B3\*^AO^"F'[)-C^S7K7PXO=!A7^QM1T&#3+J=%P)-0M(TCEE;T,J&-
MO<AS0!^U_P .O'6F?$[P%X>\7:+)YNE:W80ZA;-GD)(@8*WHPS@CL016#^T)
M_P D"^)?_8LZG_Z2R5\7_P#!&GXZ?\)A\&]<^&NH3[M1\)W7VFQ5CRUC<,S;
M1Z[)A)D]A*@K[0_:$_Y(%\2_^Q9U/_TEDH _FI\,^'K[Q=XCTK0M,C6;4M3N
MXK*UC9P@:61PB L>!EF')KZM_P"'3_[27_0H:?\ ^#NT_P#CE?/O[/\ (D/Q
MY^&TDC*B+XETUF9C@ "ZCR2:_I5_X2S0_P#H,Z?_ .!4?^- '\]'QF_85^-W
MP%\.2>(?%_@F:WT"(@2ZE8W4%Y%#D@ R>4[,@R0-S #) S7NG_!,O]M7Q1\,
MOB]X<^&WB/6;C4_ 7B&X33+>WO96D&F7+G; T).=B-(51DX7Y]W5>?TE_;:_
M:%^&WP]_9V\>V.O>(M+NK_6-&O-,LM'AN$FN+J>:!D11&I)"@LI+D84<YZ9_
M#S]EOPCJ/CK]H_X9Z+I<<LEW<>(;%BT():*-)EDDE^B(KN3V"F@#^@+]K'_D
MUGXR?]B9K/\ Z0S5^ /[)W_)TWP;_P"QST;_ -+H:_?[]K'_ )-9^,G_ &)F
ML_\ I#-7X _LG?\ )TWP;_['/1O_ $NAH _=C]MS]I+_ (99^ &K^,+6.*?7
MIY8],T:"=2T;W<@8@L!U5$220COLQWK\,/!_@;XN?MI_%BZCTY-2\=>+[M?M
M%Y?7MP-L$08#?)(Y"QQKN "C Z*HZ"OUF_X+ ?#75O'7[*\&JZ3#)<CPQK,.
MJ7L48R1;&*6%WQWVM*A/HNX]!7YB?L2_M@7_ .Q[\1[_ %R/1(_$.BZM;+9Z
ME8&7RI=JMN1XI,'#*<\$$$$C@X( /5-:_P""/G[0&DZ'+?P)X8U:X2,O_9ME
MJK"X8C^$&2-(\G_?QQUKYW^#7QO^(?[*'Q0.J>'KN[T35M/NC;ZGHUUO6&Y\
MM\26]S%D9&01SAE/(((!K]DOAG_P58_9]^(2PQWOB&^\&7TF!]G\0V+HH/?]
M[%YD8'NS"H/%G_!/O]GC]J#QOJWQ234[OQ =>D66:7P_K43V#R"-4+*8U/S'
M:&/S=6)[T ?2WP;^*&F?&KX6>%_'.CJT>GZ[8QWB0N06A8C#Q,1QN1PRG'=3
M7SS_ ,%"OVW8OV3/ UIIV@I#>_$/7D?^S89UWQ6<*G#W4B]\'Y44_>;/4*P/
MT%\&?A!X>^ WPWTGP-X56ZCT'2_.^S)>3F:1?,E>5@6/7YY&K\'?^"B7Q-NO
MBA^V%\1;J9Y#;:/J#:!:Q.<B*.T)A8+Z!I5E?ZN: /.]+TGXJ?M;?%!HK5-;
M^(GC2_!=WDD,KK&#U9V(2*)2P&251<@<<5]!R?\ !(S]HF/1_MJZ/H<ESC/]
MG+K$7G] <9.(^O'W^H].:_1O_@E[\"-,^$7[+GA[7!9HOB/QA"NLW]XR?O'B
M?)MHP>NQ8BK =-SN>]?7U '\UFE:]\6OV._BG-';S:U\/O&%@R_:+5\QB9,Y
M42)RDT3=1G<C=1GK7[>_L*?MCZ?^UY\,9KZY@@TOQIHS)!K>F0$^6"P/ESQ9
M)/ER!6X))5E923@,WF?_  5L^ ^E_$;]FN]\;QVB#Q-X-DCNH;I%'F26DDBQ
MSPL>ZC>).>AC./O'/YW_ /!+7XGW/PY_;"\*68GDCTWQ+'-HMY&I.'WH7AR/
M::.+GL": /T3_P""PO\ R9^__8P6/\I:_&;X0?%37?@E\2O#_C?PW/Y&KZ-=
M+<19)V2KR'B?'5'0LC#T8U^S/_!87_DS]_\ L8+'^4M?BMX=\!ZUXLT/Q'JV
ME6;7EIX>M4O=1\OEH8&E2+S,=U#R(#Z;L] 2 #^E#X)_%[0OCQ\+?#WCKPY+
MOTO6+83"-B"\$@)62%\?Q(X93[KQQ7R;_P %DO\ DT>S_P"QFLO_ $5<5\@?
M\$E_VLO^%3_$R3X7^([WR_"GBR=?L$DS82SU+&U/HLP"QG_:6/H-QKZ__P""
MR7_)H]G_ -C-9?\ HJXH ^8/^"(__):/B'_V+\?_ *4I7[$U^.W_  1'_P"2
MT?$/_L7X_P#TI2OV)H ***\0_;:^)MU\'_V4_B5XIL7DAO[?2S:6LT1PT4US
M(EM'(#ZJTRM_P&@#\U_^"A__  4>\0>/?%VK?#KX8:U<:+X-TV5[2_U?3Y&B
MN-5F4E9%613E8 <J OW\$DE2!7S-\!_V'_C)^T=I9UCP?X4=]!W,@UC4ITM+
M:1@2"(V<@R8(()0, 1@D5R_[,/PE7XZ?M >!? LQ<6>L:DB79CSO%L@,DY4C
MH?*1\'M7]).A:'I_AC1;'2-)LX=.TNQ@2VM;2W0)'#&@"JB@=   * /P,^+?
M_!,_X]_!_0+O7+WPO!K^D6:&2XN?#]VMVT2 9+F+ D*@9)(0@ $G JS^QG_P
M4$\<?LP^(M/TS4K^[\2_#B218KO0[J5I&LXL\R6A8_NV49.S[C<@@$AA^_-?
M@]_P52^ ^E_!7]IN:\T"T2QT3Q79+K*6T*A8X;@NZ3H@[ L@DQT'FX' Q0!^
MYOA?Q-I?C3PWI>OZ)>QZCH^J6T=Y9W</W)H9%#(P^H(Z\U^&O_!6S_D]+Q!_
MV#-/_P#1 K[K_P""./Q/N?&7[,^I>&;V>2>?PKK$EM;[R3MM9E$L:Y]I#.,=
M@!7PI_P5L_Y/2\0?]@S3_P#T0* //O@Y^P%\:?CUX!LO&7@WP[9ZAH%Y)+'#
M<3:G;P,S1N4?Y'<,,,I[5VW_  Z?_:2_Z%#3_P#P=VG_ ,<K[L_X)E_'_P"%
M_@+]D#PMHWB;XD>$?#NL0W=^TNGZMKMK:W"!KJ1E+1R2!@""",CD&OJC_AK'
MX(?]%D^'_P#X5%C_ /': /A/_@F_^PQ\8/V=?VA+CQ5XYT"UTW17T2YLEFAU
M*"X;S7DA91M1R>B-SCM7Z@U@^#?'OAGXC:0=5\)^(M)\3Z6LK0&^T:^BNX!(
M "4WQLR[@",C.>16]0 51US7=-\,Z1=ZKK%_:Z5I=G&9;B]O)EBAA0=6=V("
MCW)J]7YF?\%:/A3\2?C;\2OA?X5\!:'K/B-'L;J:>SL=WV6-_,0+),Q(CCXR
M [D>F: /%O\ @I-_P4/L/CK9R?#'X;SO+X(BG274]:*M&=4D0Y6.-3@B!6 ;
M+#+LJD8"Y9G_  1/_P"3DO&7_8I3?^EEK7+_ !^_X)U2?LP?LER>._&6J"^\
M?7>J6EJNGV+YM-/B<.64MC,LAVC+<*.0-W#5U'_!$_\ Y.2\9?\ 8I3?^EEK
M0!^S]?C]_P %7/VT/%5U\4-1^#OA'6+G1?#>CP1QZU)8R&.34;B1%D,3.#GR
MD1E78, L7W;@%Q^P-?A%_P %5/@CKOPU_:CUWQ3<VLC^'/&#)?Z??A3Y9D$:
M)-"3V=6&<?W74T 9'P;_ ."8?QK^-OPVL_&VDVVBZ3I5_#]HT^#6+YX;B\B/
MW715C8*K=07*Y'/0@GA?A'\;_BK^PS\9+NSMY;S2;O2K_P C7/"]S-FUO-AP
MZ2*"5)*_=E7) (*DCK^H/[+?_!2;X'6O[//@_3_%/BF/PGKWA_1[;3+S3+BT
MG<LT$21;X?+1@ZOM!"@Y&2".,U^7W[1'C*Y_;$_:Z\1ZSX%T.[N)O%6I0VND
MZ<L8\Z58X8X$=@.%++%YC9.%RV3@$T ?T*>"_%ECX\\&Z#XFTMF?3-:L+?4;
M5FZF*:-9$)_X"PK:KD/@[X%?X8?"7P5X.DG6ZD\/Z+9Z6\Z9VR-# D989[$J
M3^-=?0!YI^TU_P FV_%?_L4M6_\ 2.6OYH@I;@#/>OZ7?VFO^3;?BO\ ]BEJ
MW_I'+7\_O[)_@FV^)7[0G@_PG>;1:ZY--ILC,,[5FMY(\_ANS^% 'VU_P1)^
M)WV'QO\ $/X?W$H":E8PZS:(QQAX'\J4+ZEEFC/TC^M?J]XK\267@WPOK&OZ
MD_EZ=I5G-?7+C^&*)"[G_OE37\^O[#OCNY^!?[97@2YU$FR":NVAZE')T19]
MUL^[V1G#?5*_6_\ X*@_$[_A6O['/B](IO)OO$3PZ!;?[7G-F9?Q@CG% 'X/
M^,O%%YXX\7ZYXCU%M^H:O?3ZA<-G.9)9&=N?JQK[<_X(P_\ )U^M_P#8I7G_
M *56E?,OPR^&_P#;GP+^,GC6:+?!H%KI=C"S#A9[J_B(8>XC@D'T?Z5]-?\
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M/V8]!^(5K\0=)M]*FUBYLI+-8+V*YWK&DP?)C8XP77KZU^??_!6#_D]KQ?\
M]>6G?^DD5?O37X+?\%8/^3VO%_\ UY:=_P"DD5 'Z4_\$G_^3)?"'_7[J/\
MZ5RU]@5^<G_!.']K7X/_  H_9-\,^&_%WC_2-!UVVNKYYK&[=A(BO<R,I.%/
M52#^-?3?_#?G[//_ $5CP_\ ]_7_ /B: /QV_P""FG_)\?Q/_P"NUC_Z06U?
MKI_P3>_Y,E^%O_7E<?\ I7/7XV_M]>.] ^)G[7'Q!\2^%]5M];T&_EM&MK^U
M),<H6R@1L9'9E8?A7[)?\$WO^3)?A;_UY7'_ *5ST ?2M%%87CSQ5!X$\#^(
MO$MTNZVT;3KC495]4AB:1A^2F@#\Z/\ @I=_P43U;X=ZW>?";X7:B;#7(4 U
MWQ#;-^]M&89%M W\,F""T@Y7(488$C\_?@C^R/\ &/\ :LN-0U?PIH-SJUIY
MS?:]?U6Y$,#S'E@9I#F5^02%W$9!.,UYI$VM?&#XF1_;+IKWQ#XGU=1+<R\F
M6YN)L%C]7?-?TM?#'X=:+\)/A_H/@[P[:K::/HUHEI;QJ "0HY=O5F;+,>Y8
MGO0!^"?QN_X)W_&_X">&[GQ%KWAF+4O#]JI>ZU'1+I;M+=1U>1!B14 Y+E=H
M[D5VO[ O[?7B/]G/QKI?AGQ1JMSJOPOOIEM[BTNI#)_96X@"> GE%4\M&/E(
MW$#=@U^[-S;0WEO+;W$23P2H8Y(I%#*ZD8*D'@@CM7P3I/\ P1I^#\?BS5=6
MUC7/$.HV%Q>2W%KH]K)%:6]O$SEDA)"L[!5(7<&7.,XH ^^E8.H92&4C((Z&
MOY;?%G_(U:S_ -?LW_HQJ_J#\/Z':>%]!TW1K!9%L=.MHK2W6:5I7$<:!%W.
MQ+,< 99B2>I-?R^>+/\ D:M9_P"OV;_T8U ']1&D_P#(*LO^N*?^@BLKXA?\
MB#XF_P"P9<_^BFK5TG_D%67_ %Q3_P!!%97Q"_Y$'Q-_V#+G_P!%-0!_,O\
M#W_D?O#/_83MO_1JU_417\N_P]_Y'[PS_P!A.V_]&K7]1% '\L6JJ6U:\ &2
M9W  _P!XU]J_\$@?B=_PA/[5R^'YY0EGXLTJXT\*QPOGQ@7$;?7$4BC_ *Z5
M\I> 8TF^,GAR.15=&U^V5E89!!N%R"*[O5H[K]DW]L2X\A73_A"/%V^)>\MM
M#<[E_!XL?@U ']'5?S7_ +6'Q,_X7%^TE\1?%R2F:UO]8G6TD)SFVB/E0?\
MD*-*_>_]J;XMP?"_]E_Q[XYLKM08-#D;3KE#P9YU$5LP]C)+&:_!+]G?X;_\
M)]>?$"_EB\VS\,^"]8UJ4$?+N%N88OQ$DZ,/]R@#T7_@F7_R?'\,/^NU]_Z0
M7-?H_P#\%DO^31[/_L9K+_T5<5^<'_!,O_D^/X8?]=K[_P!(+FOT?_X+)?\
M)H]G_P!C-9?^BKB@#XU_X(P_\G7ZW_V*5Y_Z56E?MI7XE_\ !&'_ ).OUO\
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M!M=,T:>]2P2:'48+AC,Z.ZKM1R<;8WYZ<5_1=7P5_P %GO\ DU#1/^QML_\
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M?]D5J_\ !<;_ )%7X2?]?NI?^B[>@"W_ ,$/O^1!^*?_ &$[+_T5)6O\:_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW&DN,LMG)UEM&/\ L9RF>J$<DJQKZB_X)'?MF37,B? [QCJ!DVHTOA:[N&Y
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M]GZ_(W_@J?\ MU7.L^(-=^!WA.UL9-%L2(->U*[MH[AYKD ,88-P(C\O.#(
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M#]K?A/\ $S1OC)\-_#OC;P]*9=(UNS2[@W8W1Y&&C?' =&#(P[%3765\D_\
M!*W3;_3?V)/!'VX,J7$]_/;(XP1"UW+C\"0S#_>KZVH \T_::_Y-M^*__8I:
MM_Z1RU^$/[ ?_)Y/PG_[#2?^@-7[O?M-?\FV_%?_ +%+5O\ TCEK\(?V _\
MD\GX3_\ 8:3_ - :@#4_X*%?#Z7X3?ME?$*WM0UK#>Z@NNV<D?R_\?*K.Q7T
MVRM(O']VO>/^"HG[24?QC^&?P"L+2=3_ &GH*^*M0A4_=FF40HI Z%'CNE_&
MNR_X+=?#06OBKX<^/X(?^/VTGT2[D X#1.)H<^Y$TWX)7YGSW^H:U_9UI+--
M>?98A:6D1)8HAD9Q&H]-\CG'JQH ^]_#GPW_ .$._P""._C#Q#-%MNO%7B2W
MOE=AAC!%>0VZ+]-T4K#_ 'ZS_P#@C#_R=?K?_8I7G_I5:5]=_MV?#J+X1_\
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MJW_(5O?^NS_^A&OZD])_Y!5E_P!<4_\ 010!;K\%O^"L'_)[7B__ *\M._\
M22*OWIK\%O\ @K!_R>UXO_Z\M._])(J ,CX#?\$W_BQ^T5\--/\ '/A6X\.Q
MZ+?2311+J%])%-NCD:-LJ(F Y4XYKT'_ (<V_'O_ )_/!_\ X-)?_C%??_\
MP2?_ .3)?"'_ %^ZC_Z5RU]@4 ?S&_&KX0Z[\!?B=K?@/Q*]I)K>CM$ERUC*
M9(29(DE7:Q52?ED7L.<U^[O_  3>_P"3)?A;_P!>5Q_Z5SU^1?\ P4T_Y/C^
M)_\ UVL?_2"VK]=/^";W_)DOPM_Z\KC_ -*YZ /I6O+/VK()KK]E_P"+T5NV
MV9_"&K*N!U/V.7C\>GXUZG5/6-*MM=TF]TV]C\ZSO('MYXS_ !1NI5A^()H
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M974D,#Z@T ?G7_P6X_Y(O\//^Q@D_P#29Z\6_P""(ZM_PN;XB-M.T:!&"V.
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M3_TJDK]Z?V._^34/@]_V*6E_^DL=?@M^V)_R=?\ &'_L;=4_]*I*_>G]CO\
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M'X^_ZXZ;_P"D%O0!^G__  2K_P"3'/ /_7;4O_2^XKZUKY*_X)5_\F.> ?\
MKMJ7_I?<5]1>)O$6G^#_  WJNNZM<+::7I=I+>W<[=(X8T+NQ^BJ30!^2O\
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MDS^T1X<^"/QQUG1O%FH0:/I'BRQCM(M1NG"0PW43EHA(QX56#R+N/ 8KG@Y
M!^XU?D7_ ,%P?^1^^%G_ &#+W_T;'7ZX)<126ZSK*C0,N\2*P*E<9SGIC'>O
MQ!_X*X?';PW\8/CUHFE>%=5M];T[PQIAM+B^LY!)";N25FD1''#!5$8)!(W;
MA_": /H__@A^K?\ "OOBDVT[3JEF V."1%)D?J/SJG_P7&_Y%7X2?]?NI?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M /DG_@IY\+?%GQ@_9C;P_P"#-"NO$6L_VU:7'V.S4%_+42;FY(X&1^=?-O\
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M &0?V+_C?X%_:<^&OB#7_AMK6EZ-IVM07%W>3QJ$AC!Y9OFZ"OW*HH ****
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M_0BB@ KX)_X*$?\ !-Y_VD-5;X@?#^XM=.\>K L5]87;>7;ZJB+A&WX^28*
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MHH _/S_@KA\"?'_QP\._#6#P'X6O_$\NG75\]VEBH8PJZ0A"V2.I5ORKG/\
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M(/Y57_X)'_ GQ_\  _P[\2H/'GA:_P##$NHW5B]HE\H4S*B3!RN">A9?SK]
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M'POJ?B+Q#J,&DZ)IL#7-W>W#82*-1R3W/L!R20!DFOSOUC_@IU\5?C9XOO\
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M?5]<?LVZ#:>%_P!GOX::591+%;6OAO3T547&3]G0LQ]V8EB>Y)- 'Q3\,/\
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M[(MEI.D),ME:V2QQG[3<LSDX,CE<!D Q\S+\NZ7Q#_P4._:1_9K\4:1_PO\
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MNZ;!HM[)<6[:'/#$S-)=3*P?S89,C"C& * /V2_X6SX'_P"AR\/_ /@T@_\
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MXS3_ !7C\,P+\09XA#)K0GFWLHA\G&S?Y>?+ 7.W) 'I7PA\9/\ E,W\,/\
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M'O0!]%?"G]AK0_@_^U!XK^,6A>(KJW_X2!;A)?#L5JD=JBS%'<;@<G]ZF\<
M#.,=Z^3_ /@II_R?)^SE_P!=K#_TYBM?]CC]H+XP? ?]J!?V;?C;J<GB-;M&
M72-6N)VN9(W\MI8F2=AOEAD564!_F1@J_+AEK(_X*:?\GR?LY?\ 7:P_].8H
M _4JOGW]NKX!:/\ M ?LX^*],O;2%]:TJRFU31KQE_>6]U$A<!6ZA7"E&'3#
M9QD CZ"KD/C!XBL_"/PF\::YJ#K'8Z=HMY=3,XR-B0NQ&._3IWH ^1/^"/OQ
M8O?'W[,EWX<U*9Y[CPCJCV%N[G)%I(BRQ+G_ &6:50.RJH]J]*_X*0_'#_A1
M_P"RGXIN+6X\C6_$"C0-.*G#!YU82N.X*PK*P/9@OK7SO_P1#T*ZMOA5\2=9
M=&%E>:U;VD3$_*7A@+/@?2=/T]*\G_X*C?&"'XD?M8>#?AZFF:AXF\->"/*N
M=7TK2%,DUS+,T<MPB@ \B!8E!/W2[^] &C\3OV.;C0_^"57A'5H[,Q>+]!N/
M^$SNM@(E\FZPLJ>Q2#[,S=Q]G/TK[_\ V+?CHO[1'[-_@_Q=--YNL?9OL&K<
MY87L/R2L?3?@2 >D@KY=UW_@J%IWB3PYJ&@ZA^SQX\GTG4+22QN+4V^$>%T*
M.F-G0J2*\<_X(_\ QAF\ ?&/Q?\ !W5X[S3K77D.IZ7::E&8IX[J%,LA0XPT
MEOAS[0#% 'H__!8KXDZMJ4GPS^#.C7$D \2W8O;]5) FQ*L5LAQ]Y?,,C$>J
M(>W'WK\%?@WX:^ OPWT?P9X5L8K/3M/A5'D1 LEU+@;YY2/O.YY)/T'  K\X
M?^"J>[P3^V)\ _'-ZA&D0+:Y>;_4YM=0\Z0<\?=F3/L17ZK*P=0RD,I&01T-
M $=U:PWUM+;W$,=Q;S(8Y(95#(ZD8*D'@@CC!K\G_"^CK^P__P %4K+PKX>,
MEEX$\>>4B:7&W[M8KO>L2!>@$5VA"]PF1W.?UEK\J?VSY%\?_P#!6#X'Z)I'
M[^]T8Z&MZ(_OQF.^FO7Y]H&5_P : /U6HHHH _)GX$Z+%^VE_P %.O'?BOQ2
MG]I^&?!,D[V%A=8DA*V\PMK2/8> I;?<$="X.<[CG]9J_*S_ ()?_P#%!?MJ
M?'WP/J.8M3S=%!+]Y_L]^4;![Y$RM[CGM7ZIT ?/O[97['>@?MA>!M+T74=2
M_P"$>U?2[U;JRUN*T%Q+%&1B:':67*N,?Q<,B'!Q@^F>!]#MO@G\']*TO6O$
M<FH:?X7TE8KG7=4VQL8((^992.!A%Y/MDUJ^/OB!X=^%OA6]\2^*]7M]"T&S
M,8N+^Z)$<>]UC3.!W9E'XU\N_P#!1+XH:?X@_8#\;>(?!6M66NZ1JHM+1=4T
MNY6>%HGO8HY0'0D'HT9'8D@\B@#S"/\ X*%_&?\ :,\8:KI?[,_PEM=>T'36
M\F;Q#XG8QQDD\/CSHDCR/F"%W<CG:.5K5\'?\%%?'WPL^*6F>!/VF_AK!\/I
M]69$LM>TARUB"6"[GS+(ICR1N=)&*<;EP<CV3_@F[X0TSPA^QG\.AIL$,;ZE
M:R:G=RQ#F:>61BS.>[!0B>P0#H*\^_X*]>$-+U[]D.^UB\AB.HZ'JMG<6,S#
MYU,DHAD53Z%9"2.GR ]0* /=/VPOC=JG[.O[.?BWXB:)8V>IZGH_V/R;6_WF
M%_.O(8&W;&!X64D8/4"OE#1O^"@7QT_: \,Z1'\ _A%:^)=4AL8?^$AUK4PT
M.FV]\\8>2VM_,GB!*9'+R$D_PD89I?CWXDN_%G_!&>UU._:1[R3P[H$4DDQ+
M/(8[^SCWDGJ6V;L]\U[I_P $U-!M/#_[%'PU2UB5&N[>XO)G5<&222ZE8ECW
M.,+]% [4 ?/7PW_X*N:UX0UKQAX0^/G@%O#7CC18<VECH4$H:^N25"6OE.TA
M5G#HRR!RC+D\?+N@^(?[;'[8GP[T.3X@:U\!-%T7X=IB5X;HR2WEO"Q7!F*7
M.^-N0-SP*!GE:YWX]>&-/UG_ (+)?#2"YMXY(Y8+&^D#*"&EAAG>-B#W!AC_
M .^17Z#_ +14,=Q^S[\3HI462-_"^IJR,,@@VDN010!5_9O^/.C?M*?!W0?'
M^B6\EC!J*ND]C,X=[6=&*21%@!NPPX; RI4X&<5\F?'7_@IKJWP)_:C\>?#2
M]\'V^O:9I-E;+HL.GK+]OU"_GM[66.%FRRJN9Y.0A.$  ).#K_\ !&]V;]D:
MZ!8D+XEO0 3T'E6YP/Q)_.O+='\&Z;XN_P""VGBV34X8KA='L+?5+>.7D>>F
MDV:(P'<J9-P]"H/:@#IO%7[5W[:OPMT%O'GB[X&^&&\$0J+B\L;&5FOK2WY.
MYREU(R'!!9C$P4+\RIS7V'^S;^T/X9_:>^%>G>-O#!DBAF8V]Y83D&:RN5 W
MPOC@XR"&'WE93QG ],N[2&_M9K:YB2>WF1HY8I%#*ZD8*D'J"#BOR_\ ^"3=
M]<>"?B-^T=X3TW-WH^DW*S6D*DLN^&:ZB7!Z_.H4>^T4 >S?M!?\%$M6T7XP
M2?!_X&^!V^)?Q#MYC#>22%OL5K(O^LCPA4L4Z.Y=$0\$D@@<5XB_;@_:@_9Q
M:PUOX[?!+2%\$SS+'<:CX7GW26V_H"PN9T# G #[ Q& _P#%7-_\$5M$MM:L
M?BUXZOQ'=^)KW48+22\D&9A&P>:3GL'=@3ZF,>@K]"?C%X0TOQ]\*?%_AW6H
M8I]+U+2KBWG68?* 8VPWL5.&!'((!'2@!? /Q8\,?$SX9Z9X_P!"U)+CPQ?V
M1OH[MQMV1J#O#C^%D*LK#L5([5\/Z9^W-^T1^TIKFM3?LZ?";1[WP1IUT]F/
M$'BB4J9V4 AE!GA56(*GRP)"H9<D9K*_X(]LWC[]EGXE>"=4:9]);5I[8-O/
MRQ75HB2(GIC:S<=W)[UYIX'M_P!JS_@FQ)K7AO2/ R?$WX9/>O>175I9R7"<
MJH:93"QEMR0JAEE5E!4E<YW$ ]\^$7_!0+XB>'_COHWPC_:)^'%IX$\0ZZ\<
M6F:GI,A^RO)(Q6)2#)*&1V^02)(V&P"O4KWG[=?[8WB;]E;Q+\*--\/Z+I.K
M1>+[NZM[M]2$NZ%8GM54Q['7D_:&SG/W1[UY3\'_ /@HE\"/VDOB-X=T[XG_
M  YL_"GCNUE^SZ7?^(;6"_MK6<NI")<NBO Y=1@E% (^\#UYC_@L9_R/W[-O
M_83U+_T;IM '#_\ !9'Q)\3[R]T[1];\)Z?8?"^SU6-]!\1172-<WT[6:F9)
M(Q*64*[2@$QKG8.3G)^Z/V3_ !Y\9]>\)ZQ/\:O ^C> ;+3[:U;29["_BG6Y
M@\MS+)*5GDV;0L1YV_>/7''S)_P6X_Y(O\//^Q@D_P#29Z]R_;X\37?A3_@G
M[XVN[)I4GFT>QL2T1(Q'//;PR9([%)&!]<X[T >0S?\ !0KXP?M >-M;T/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6C0$Y(&<]:ZZ@#\R_P#@A]_R(/Q3_P"PG9?^BI*]J_X*V?\ )EOB#_L)Z?\
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MO#WC.TU?6YS;V\VHV5HD",$9LNR73,!A3T4U]0_\*G\#_P#0F^'_ /P5P?\
MQ%6=.^'/A/1[V*\L/"^BV5W"=T=Q;Z?#'(AZ9#!<C\* /SM_;"_Y2S_L]?\
M8,TS_P!+[^OT4^(7_(@^)O\ L&7/_HIJN7GA?1M1U:WU6[TBQNM4M@%@O9K9
M'FB )("N1N7!)/![FM*2-)HVCD571@596&00>H(H _.S_@B7_P D"\=?]C,?
M_26"LK_@LS_S0K_L-7?_ +;5^C&A^&](\,V\D&CZ79:5!(V]X[&W2%6;&,D*
M!DX Y]J36O#.C^)/(_M;2;'5/L[%H?MMLDWEDXR5W X/ Z>E 'GO[6/_ ":S
M\9/^Q,UG_P!(9J_-3_@G/^VQIG[+WPTA\+?%33]2TCP3KMU/JGA_Q/#;/<0E
M@XAN(&6,%L*\9;@%@6.1AE-?KU=VD&H6LUK=0QW-M,C1RPS(&21",%6!X(()
M!!K!U/X:^$=:\-_\(]J'A;1;_0-Q;^RKK3H9+7)))/E,I7.2>W>@#\S?VKOV
MB)/^"C'B3PS\#_@98W^K:!_:$6H:WXDN+1X8(T7**Y5P&2) [,2P5F8*J@_Q
M?6G[6O[)0^*G[&Z?"SPLS&_\,V-FV@I,5'G26<7EQQL> "\>Y,\ ,P)X!KZ'
M\*>"?#O@/3O[/\-:!I?AVPX_T72;..UBXZ?+&H%;= 'YN_LD_P#!23PA\*_A
MOIOPP^.JZIX#\8>#X4TAIKS3+B59H8EVQ!TC1I$D5%13N7#8# _,0*_B?]M?
MXF?M=?M">%_!7[,M[J6A>$]/DWZ[XJGTR%T:)F4/*R7$;!$1 VQ6 9W;&.!7
MZ ^,/A3X)^(1!\5>#] \3$ *#K&F07? .0/WBGH:U/#?A71?!VFC3] T>PT.
MP#%Q:Z;:I;Q;CU.Q !D^N* /DG_@J#^S+KO[07P+L+_PI!/J/BOPE=-?VUC
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M&(ZOPY_P5W^ .J>"(M8U74=7T76_)W2^'3IDT\XDP<HDJKY+#(X9G7((R%Y
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MXU"JJ@8  '0 5GS>%]&N-:BUB72+&75HAMCOWMD,Z#!&!(1N'!/?N: /A/\
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M\1^$K:7Q5I5Y;WD>IVS&&2X,+AD2<+\LR?* 0X)VC (% 'L]%%% 'YI_MU_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#^U9^T+:_LO_  5UCQ]<Z/-KILWBMX;&&41>9+*X1-SD':H)R2 3[5O?L_\
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MC?QC\)?BYIEO8?$;PLCRO<6\2P_:$CE6&99$4[-ZNZ$-'\K*V0!C+?;RJ%4
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MEH ^P*_)W2])@_9<_P""P%KI7AQ!8^'/&!VRZ? /+C5+R$L4 '&U;J,.!C
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MK]G#]IKXB7G[<7Q6^"7Q&U:WU"TTZ.:[\/LMG%;OY*R))&I**-Y:WG1CG/\
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MC^)6!'N,$<$5N_$O2]/UKX<^*=/U9$DTNZTJZANED0.IB:)@^0>",$U\&?\
M!$K4KN;X%>/;!Q_H4'B,31-G^-[:(./RC3\Z /+/V<?V]/VF_P!H[1+[P'X*
ML],USXARW+W<_B;4+6"WL](TX+$JG8H"M(96?[RMQC"OD[-KXI_'3]M#]B#4
MM'\2_$[6=!^)/@J\NQ#<&RMXA '(W&/S$MX987*AMI*E,J>#T.E_P0[TR&/P
MM\6M0"_Z1->Z=;LW^RB3L!^<AKW/_@K<JM^Q?KQ*@E=4T\@D=#YX&1^!/YT
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M5_\ X)U^#=0U3]G_ .,'QH\0QY\0_$F\U&]\Q@3_ *-&)@,$] 9GN.!QA4_
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M:3/J=Q89]J^:?^"W6CV$WPA^'6JNL?\ :=OKLMK"Q7Y_)DMV:0 ^FZ*+(^E
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M'P9EU6!O %G8K/#I_P!CB$@8Z9!<$^;MWG]Y(QZ]\=*\H_X)&_\ ):/VEO\
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M  6(^,04!0=-NR0..HLR?UI?^"GG_)WG[,/_ &$X?_3A;4 ?</[..B?%S0?
M=S;?&CQ!H7B3Q8U_(\-YX?C*6ZVI2,(A!AB^<.)2?EZ$<]AZI110!^6MY_RG
M.L/^N)_]1QZ]"_;B_;H\<_LN_M9>#O#^F+_:O@RY\-IJ%UH$-K$TU[=R2WL4
M:B4J70%XH =O0 X!)P?/;S_E.=8?]<3_ .HX]6_VUM,AU;_@J[^SS;W"[HQ8
MZ/-CU,>IWLB_JHH Z+Q-I/\ P4/UC19_&]IXA\,: 51KF/P/I\-K)<HF,^6!
M);R*[8&,-.6R>,&O:O\ @GC^V-J7[6'@#78?%-C;:=XW\,7,=MJ,=JC1QSQR
M!O*F"-RC$QRJRY(!3/ 8*/K.OS)_X)2J(_VCOVF$0!4&I( J\ 8O+S% 'HO[
M67[:WQ";XZ6?P!_9^TVUO_B!,%&H:U=(DL=@Q3S"J*_[L%(\.[N& SM"ENG#
M_$K7OVR_V9_ .M>(_B3K/AWXN^!+JQFM=7MM)C2&ZTQ9D9//5EMH3M5F7/#K
MC(P@^89/_!.N-=:_X* ?M*:MJA$FMPW6H11^:-SHC:D0X![ >7&OTP*_1KXF
M:/8>(?AQXJTO5%C?3;W2KJWN5F7<GEM$RMD=Q@F@#X:_X(G_ /)MOC+_ +&V
M;_TCM:O_ !R_;0^*_P 1OVA[[X(_LV:3IE[J^CAAK7B740LD-LZD+*%W'8B1
MLP1F8.S/E57CYL[_ ((JLR_LT^-61/,<>*YB%SC)^QVO&:^2?^"?^L?M'QZA
M\2];^"OA[PWK=]?7=N->DUZ1%EB?,[QA \R$!B\N>N2H]* /J+Q[XU_;<_9'
MT4>//&FN^%OB[X+LG635[+3[=(I;:)CAFW+;0NJ@G <!PO!9-H-?9GP_^*4/
M[2GP M?%WP]UHZ%=:YISM97DD4=PVG78!4I+&P*L4D!5E[@'!&0:^/O%EW^W
M[XV\*ZSX>U3P#X!ETS5K*:PNHUN(06BE0HX'^E==K&O6?^"9OP'^(G[.?P5U
M_P )?$/3(=-NGUV34+)8;R*Y!BD@A5AF-B!\T9.#_>- '%?L2_MF>//$'QJ\
M7_ [X[O;VWQ$L)W;3;B.W2W6Y"+F2$! %;Y )HV ^9"Q[+FI\;/VO/B7\4?V
MM=(^!W[/FHVEG_9CL/$_B*:RCO(K<JRB; <$!81\IZ%Y'V<8!/F__!833?#/
MAGQ=\,O%OAC4;O2OC8;E8[1-'!^T3VB$^7*Q4[E=)<+&0,MN=>=GR^C?\$==
M+^'_ /PH?6=7T*X:]^(%UJ#+XGDNL?:(B&8VZ+R3Y)0E@W\3F7/W<  ^][*&
M2ULX(9KA[N6.-4>XD55:5@,%R% 4$GG@ <\ 5/110 5X1^V9^U-IW[)7P<G\
M6SV:ZKK%U<+I^DZ:SE5GN65FRY'(C559F(ZX"Y!8&O=Z\&_;&^//PT_9_P#A
M>NM_$?1K;Q-%<3>1IN@RVL5Q)>3XY"K("JJJG+.>@XY)"D ^:/#.@_M\?&WP
MC8>*X?B#X-^'%OJ,:WEIHLEBHE"-AD\S-K.R#:1\I<MSAA5O]DW]L;XP:=^T
MU<_L^_'ZTL9_$[PR/8:Q9PI$\LBP^> WE 1/&\09E954@KM().%J:+^US^V)
M\9M/M[_X;?L^:3H6AWB+):WOB*=AF%A\KJ9)K<,",$$(01T!R*\-^'=G\4K3
M_@K%\.S\8;S2;SQI-:R2R_V*H%O#"=.NO+CX5<LHSD_-_O&@#ZB_X*0?M;^,
MOV5?%/P9F\.7ZVVA:Q>WKZ];+9PSRW-O ]F2D9D'R-LEE ((Y8<\5Q#7_P"W
ME\?M$C\>^$M5\,?"_P /7L:WND^&+@0O=RP,-T3.TEO+EF4@D2/&/]A>E<Q_
MP6@TZ+6/%?[/-A.,P75[JL$F/[K2:<I_0U^GJJ$4*H"J!@ =!0!\0?\ !/O]
MM#QM\:O%WC#X5_%K38-.^(WAA&F,L4 @>XC2013K+&/E61':/E,*P?@#;EM3
M]NC]MS7O@CXF\.?"WX7:-#XC^*WB79Y$<R^9'9)(YCB.S(#2.P; 8A5"[FR"
M ?%?V>5$?_!8CXQ!0%!TV[) XZBS)_6JW@^-=>_X+8>)VU<AY=.LF:PCF&[:
M1I<*KM]/DD=OQ- '7S1_MY? _1O^%@>(O$OA?XGZ38I]KU;P?:PPQW/D #S/
M+:.UB^=4!/R.W(R%DZ'A_P#@C+KB>)OB%\?]8CB:!-0N-/NUB8Y*"2:]<*3W
MQFOU'90ZE6 92,$'H:_-+_@DWI-EH'QU_:>TS31&NG66KV]M;"(801)=7ZI@
M=AM H _2ZOSH_P""P6C_ !4D^%\^I:?KNBQ?"".*QBU'1Y4/]HRZA]IDVRHW
ME$>7M,(QY@Y5OE]?T7KXU_X*V?\ )EOB#_L)Z?\ ^CQ0!5_X)O>'?CII_P .
M?"6H>-_%'AO4_A9<>%X/^$>TG3HBM_;,3$8O.;R$SB(2 _O&Y(Z]1\&_\$Y_
MBE\8]/T?Q?\ #GX(^'+&[\4ZY<P7]UXCU=Q]CTBUC5DW,I&"S,X SNZ'"-U7
M]6_V*?\ DT?X0_\ 8LV/_HI:^+O^"'=C G@_XL7HC N9+_3X6DQR56.8J/S=
MOSH I?%GXW?MH?L1WFD>+/B9KOAOXD^"+R\6VN8]/MHEAC=LMY>];>"6-RJM
MM;#(".03P?T<T7XI>'M8^%5C\1&O4LO"UUHZ:Z;RY(40VK0B8L_IA#S]#7S!
M_P %;E5OV+]>)4$KJFGD$CH?/ R/P)_.N"^+FI7NF_\ !&G3I;)6>5_"6BP.
M5/W8GN+9'/TVL1^- '/^$?VE/VI_VX?$&O7?P/70_AI\-[&Y:SAUW6H4DFE(
MP<$M'+NE*D-MCC"IN +YPQT!^U=^T)^QK\2?#NB?M))HWB_P+X@F6VA\8Z)&
MD0M7R S'9'&"%!W,C1J2,E&.T@^9_L>ZM^V1X?\ V=?"-M\*?!_@J_\  KI<
M36%W?SQ?:)=]Q(TADS<*=PD+KRHP% [5K?M%?"7]M_\ :?\  ">#_&?@/P:-
M+CO8[^.33[VWBF25%900S7+#&'8'CO0!^I<$\=U#'-#(LL,BATDC8,K*1D$$
M=014E>>_L\^'_$'A+X$_#_0?%4"VWB/2M"L]/OXTE64"6&%8V.]20V=N<@]Z
M]"H _++]O;3O%/[,?[<'@K]I&'0)?$G@Y8X(;DJ#L@E6)[>2%FP1&S1N'C8\
M%R?[IKZ=^&/_  5"_9[^)$=O'+XP;PEJ$P!-GXDM7MMA[@S#="/^_E>I^'?V
MC_A7\5OBEXE^$>GZO'K7BG28+C^UM&NM.G6)4CD2*5"TL8CD^:1>%+ @D\BO
M-OB7_P $R_V>OB6TTS^"%\,7TF3]J\-7#V6W/I",PC_OW0!T_P 2_P!F?X3_
M +5GBKP;\1KO49-8NO#V#IFI>']30P2;95E0LZ!@^UQD8./F.<YKWV2-)HVC
MD571@596&00>H(K\;OC7\%?&W_!*7XD>%_B!\//&5YKG@C6+W[-=:;>8C:;8
M"QMKE%^24,F\I*%!4@X"D GZK_X*?_M7:S\(/V??#4'@J\ETS5O'A9(M3C;;
M-;6:Q(\IC/\ #(PEC7<.5#,1@X( /CWP5\;M0_X)8?M,?$CP5$EIX[\&:@/-
MCL[._02QL YM2[ -Y4J[C'(C#."& ("9^J_V'/V>?'GCKXXZY^U)\6;>WTG6
M_$=MNT/0X&W&&"6)$29N3M @58T4G<0S%L'&7^$_^"2GP[7]F^Z\-ZP&G^)N
MJ6J7,WBR1F=K.]QN"1)G'DAB58?><9)(.W;\J>!_VV_B9^QG\)?B1\!O%UO=
M6GC?04^S>%M2*K+]B+R*'7+ AXO+=IH6P1_#]TJ% /VGK\M?^"/O_):/V@?^
MNUO_ .E-U7VU^Q9XD^(7C7]FWP?XD^)]\+_Q7K,#7[2?9([8BW=B;?*1JJY:
M+8YP!]_':OR:_9#_ &+]%_;&^*WQ9L]9\1W_ (>70;SSHVL84D,IEGG!#;NF
M/+'3UH _<^ZNX+"VDN+F:.WMXUW/+*P5%'J2> *_)?QQXDT?]HK_ (*Z>![S
MX<W$>JV&AR69U#5]-(D@G^R!Y9Y/,7(9-I6'=T)  )R,^C1?\$0_ JR(9/B3
MXB>/(W*MG I([@'G!_ U]9?LQ_L7_#3]D^RO/^$-L+FYUF^C$5YKFJRB:\FC
M!#>7E5543(!VHHR0"<D @ ]VHHK/\0:]8^%M!U+6M3F-OINFVTMY=3+&TA2*
M-"[L%4%FPH)PH)/8&@#\A/A%\5K[_@F)^U7\2M%^)/AK4K[PMXKG\RUUFRB#
M2RPI-(\-Q$6(612LS"1 VY6 ZE<']"?AI^WW\ OBL\4.C_$G2K.]DP!9ZT6T
MZ7=_='GA%8_[I-;G@?X@?!S]MGX?ZE/I<.F_$'PI:WS6$\>K:6P19UC1\K'<
M1JP.V1<. .<X/%>(?$[_ ()'_ 7QU'/)HEAJO@:_<$K+H]\TD(;U,4^\8_V5
M*_A0![-X+_9'^'?@_P"/6M_&?1!J"^*]=61KAENPUHZRJF\K&%Z,4#YR?F.?
M:OFK]MK]N3QS^S'^UUX)\.:;&^L^#+OP['?W7AZUM8FN+Z[DFO88T64J70,\
M< .W. #@$G!\J_9/UKX@_L/_ +:MI^SKXC\1/XF\#Z\A;3R2PBB+QO)#/%&Q
M)A+.C1O&#@DD_-@$[G[:6GPZI_P5?_9Y@N$#QBPTB7:?[R:E>NOZJ* -#XD7
MG_!0/1/!^K?$^;Q#X9T/3=.@?49O!NGV]K-<6]LJB208>!]^U5.1YY?@[>32
M_#/]NSX]?MB>$=*\*_!CPSI.A>-[.T\SQ7XLU3;_ &=8,6983;HV_F0(6PR2
M8Y 4A2P_0KXC1K-\/?%".H=&TNZ5E(X(,+<5\"_\$2+&&/X(_$"\5,7$OB)8
MG;U5+:,J/P+M^= '/V?[4G[3/[(/Q]\&>$OV@-1TGQGX0\4W*V\6K6-M$BHK
M2*CR0R1Q0DF-G1F21#\K#&,@C]'O'OC;2OAKX)UWQ7KL_P!FT?1;*:_NY ,D
M1QH6;:.[$# '<D"OSS_X+,_\T*/?^V;S_P!M:_07XD^*O#7@?P'KNO>,)[:W
M\,:?:O/J$EW'YD?E <@I@[L\ +@DD@ 9- 'Y_?#/XX?M??MM0ZMXG^&%]X7^
M%'P_2Z>ULKK4K=;B>;:1N"EXIO,<9 9@B)G('(-8'B;]J+]J+]AGXE>%++X[
M:GHOC_P%K4XA.JV%N@*1J4$IC>.*)_-17#;94(?D _Q#H?"/[?'Q;^*EO<V7
M[-7[.,,GA*UGDAM[_4E$%KYC$NV5C:*&-B6W,HE8_-DGFOFS_@HM-^TKJW@?
MP=JWQU@\,Z+IDNH31Z=H>AE6EAF\L%G=E,F1MX_UI^G>@#] /^"I\BS?L,>.
MW0[D:73&!'<&_MZZS]AG_DR'X9_]B_\ U>N*_P""GO\ R8/XQ_[A7_I=;UVO
M[#/_ "9#\,_^Q?\ ZO0!\P?\$0_^26?$O_L,V_\ Z(-<5XJTV/\ :D_X+ 1:
M%KR"\\->#-JI9ORICM(/.VD="&NI,L.ZDBNU_P""(?\ R2SXE_\ 89M__1!K
ME?![#X-?\%G=<M=3_P!%M/%?G"UG8@*_VJT69,9]9HS'_O<4 ?JI7"_&[X,^
M'/V@/ACK?@3Q5',VC:K&JO):LJ3PNK!TDB9E8*ZLH()!'8@@D5W5<_\ $#QU
MI'PQ\#Z]XMUZ=K?1M%LI;Z[D4;F\N-2Q"CNQQ@#N2!0!S7P3^#7AC]FOX76O
M@_P[<7J>'-,,UPLFJW7FO&&8R2$M@ +DLV  !DU\0^&_VL/VC_VU_'_B>U_9
M\'A_P-X T27[./$6OVXDEF)SM8[HY!O8#<(UC^4$;VY%?:?P=_:,^'W[0'PV
MOO&GA756NO#-H\MO?7&H6DEJL#1QK)(K^8H!"HZDLI*\]>#7QCI__!0;Q#XQ
M\4:[X=_9:^ *>)=+M;G==:T;?[+;3R'Y!*T<814#!!M:20,54948P #EOB]\
M8_VS?V&VTOQ3\0/$GASXH>![F\6VE\BVC14=MS>6S)!#+$S*K;6^= 0!S]T_
M=?Q ^,#77[)OB?XI>$)_)D;P5=^(])FFB#&-OL+SPED88.#MRI&.,5^;'[=&
MJ?M;>+/V>[O5?C'I/A+P?X+CU&U#Z+I+(]S+,6(C8%9)\ ').9%^AZ5]G:9_
MRBI?_LC\W_IH:@#YA_9]_:R_:L_;&\-V?A?X=7FC:!JFD*\OB/QWJME$(@SR
MN8((HA$Z ^4O:,L2"24 RW4:A^U%^T?^P[\2?#FF_M"W>E_$'X<ZY,+=/$ND
MVR1R6V  =I2.(ET!#LDB$L,[7X->H_\ !('2;#3_ -CVTNK18Q=7VMWTUXRJ
M QD5EC4,>_R(GYT[_@KYI]C>?L<WLUV%-Q::W8RV9903YI9D.#V_=O)0!]HV
M5[!J5G!=VLR7%K<1K+%-&P971AE6!'4$$&O ?^"@?CJY^'?[&_Q0U>RE:&ZD
MTU=.1T.&'VJ:.V)'N%F)_"MW]B^_O-2_9,^$=Q?.TERWAJQ4NYR658E5"3W^
M4+7GW_!4'2Y]6_8=^(ZVZ&1X!87!4#^!+^W+G\%R?PH ^9/V7?VQOA%^Q1^R
M?X#T"[BO_$7COQ DNLWVCZ#;H\XDFE81-.S,JJ3"L2@9+$*#MP17JW@G]MC]
MG#]NG4M,^'?CSPQ-I^K?:UEL-+\60H()KO#1A(9HW/[S#LH5PFXL  3@5!_P
M2#^#/ACPY^SC:_$**RMKGQ9XBN[I)]1=5>>W@BF:%;=6QE%/E[R!U+@G.%Q@
M_P#!8OX1Z"?A'HGQ2L;:'3/&FCZQ;VO]J6P$4]Q ZOA&88+,CHC(2<J ^.IH
M [7_ (*T:ZW@7]BN31-,7[-9:IJNGZ/Y:,?EA0/.%!]/]&4<]J]\_8[\(V_@
M?]E?X4Z1;HL83PY97,@7IYTT2S2G\9)'/XU\;_\ !1C5]1^*7_!-7X5>+[U6
MDO;B?0]9O9&&#OFT^56; ]7G'_?5?;_[,FJ0:U^SA\++ZV;=#/X6TQAST_T6
M/(/N#D?A0!\)?\%B]W@/QI\"/B5IJ^3K&DZA<#SD.';R9+>>$9_V6$O_ 'U6
MG_P6J\1W<WP]^%7A*TD'V?7-:GNV(;Y6:&)(X\^H_P!*)_ 5G_\ !:[.KZ;\
M&/#MJOFZEJ.IWWD1+R3\MO&!CW:5:9_P6ET_^S+'X&ZWY3&QTO4;Z!V!Y&X6
MKA?Q$#?E0!^DGA?P[:>$?#.D:%IZ".PTNSALK= ,!8XT"*/R45^;/[8C'X8_
M\%4/@'XJTW%M+KJZ=8W;JP7?YEU+9R,WMY,J+]%K]-H)X[J&.:)UDBD4.CJ<
MAE(R"*_,O]O2(>)O^"D_[-.AVZF:XMY=,NYT4\B+^TW=OIA87/TH _3BN4^+
M/_)*_&7_ &!;W_T0]=77*?%G_DE?C+_L"WO_ *(>@#\M?^"4_P"U/\*_@'\+
MO&FE^/\ QA;>&[^^UE+FVAG@GD,D8@52P,:,.H(YK[@_X>0_LV_]%2T__P
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M_P $WO#OQTT_X<^$M0\;^*/#>I_"RX\+P?\ "/:3IT16_MF)B,7G-Y"9Q$)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ\;:7XYTZ)+&=[2R3;>2HNW>RSR1-&[8R5 ;DDCTK/\ V6_ /CO]J']N:?\
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M?^%]9A_X+)>.M9DTB^32)--*IJ#6SBW8_P!G6HP),;3R".O4&OTAHH ****
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M1>*M:;2+Y='?345=0-LXMV/]C6RX$F-I^8$=>HQ7Z0T4 ?C7^T)JWQ"\-_\
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M*Y? 'QK\5/"'@+Q?X/TF?Q*OA&YNFO\ 1[>)II'BF$+"41#EU4P%6 R<.#C
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M//A_\.K_ ,"_#J2XBDU35-39U690V5,\Q55V*1N\F,,Q*@Y.,#[OT7]EK3O
M/[(6K_!/PG>M ;GP]?:6FJ3_ "-+=7$4@>>3:. 9)"<#.%PHZ"O=Z* /R._8
MW_:O?]@#PQKWPH^+_P ,_%6F7IUB2^MKW2[%)#.\D<:;2'= XQ"-LB,P8'&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR,C'RM)<E/T*U^MO[)W_ ":S\&_^Q,T;_P!(8:_,C_@HA\(?&'[-'[7>G?M
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M)/&7B&QO)9+>\U*^=+^)FQNMKCSP6 5LD'D@-MVX J+]@_X0^-/VM/VP;O\
M: \3Z5)IOABSU676FN?+*P3W?(@MH"P^<1':689P(P"0S"@#]D:*** .7\;>
M(/$FA_8O^$>\*?\ "3^;O\__ (F,5IY&-NW[X.[=ENG3;[UQ.N?&+QAX1TU]
M6\0?#:33M&@>,7-U%K=O.\:LZIE8P,L<L,#(]R!S7KU>8?M+_P#)$O$?_;M_
MZ4Q4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '+?%+P#9_%'X=^(_"E[Y"Q:OI]Q9+/<6XG6!Y(V190A(R5+;AR.G4=:
MY']EWX"6W[-/P4\/^ (=1BUN;3!-YVK1V0M&NV>:20,R!WP5#A>6/"CIT'J]
M% !52^TBQU38;VRM[LIG;Y\2OMSUQD<=!5NB@!D,*6\211(L<2*%5$& H'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5YA^TO\ \D2\1_\ ;M_Z4Q5Z?7F'[2__ "1+Q'_V[?\ I3%0!Z?1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>8?M+_ /)$O$?_ &[?^E,5>GUYA^TO
M_P D2\1_]NW_ *4Q4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2_P#R
M1+Q'_P!NW_I3%7I]>8?M+_\ )$O$?_;M_P"E,5 'I]%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!7Q"N?"WB?PM(;47&H2W2'44$=Q$T?[Q=@?YU4$LK,03DYYH _.[QIX?\8_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSE8_\M0.(V/WP-GWPOF 'Z;4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !17&?&3XLZ#\"_AEK_COQ/)-'HFBP":<6T>^5RSJB(BY&69W11D@989(&37
MY0_%K_@KA\6_B_JO_"-?![PM_P (N+QC%;M;P'4]7G_W%VE$)&>%1F'9N,T
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M(:A\-?%4=C%HJRB?19[^2S625BI2='4$%P!M^;&!T/)K[9HH _$^/PK_ ,%
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M!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7(=W)5!C:S+P#0!YO_P3<_;XA_:(\/P^ ?&]ZD/Q+TNWS%<2D*-;MT',J_\
M3=0/G3N/G7C>$^Z:_FD^)'P^\=?LF_&R?1;^6?0O%GAV[2XL]1LV*AP#NBN(
M6[HP (_$$9!%?MQ^P;^VKI/[6OP[\J^>#3_B)HT2IK.EK\HF'07< [Q.>HZH
MQVG@HS@'U'1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM\?M'?$_XK>"/'6DZ1+I2PB\;0M#TFVNC8ZG'&K&?S(S(?M110<L. 5. I&
M ?N=17R9^P-^W5;_ +8'AW5K+5]+M]!\<:(J27MI9LQMKF%S@3PAB64;AM*$
ML5RIW'=QY'^UE_P5"U?P#\6)_A=\%_"=OXU\5V=P;.[NKF&6ZC:Y ^:WMX(&
M5Y'4Y#'(PRD;3C- 'Z'T5^7'P2_X*T^,O#WQ/B\%_M!>#+?PNDLRP3:A!93V
M%QII< JUQ;S%B4Y!)&TA3G#5^HBS1O")5=6B*[A("-I7&<Y]* 'T5^/&M?\
M!;#XC0ZQ?QZ;X)\*2Z<MQ(MM),+K>T08["V)0,E<9P*]2_9(_P""IWQ _:$_
M:&\(?#[6?"7AO3=,UJ2X2:ZL1<><GEVTLPV[I".3&!R.A- 'Z:T444 %>8?M
M+_\ )$O$?_;M_P"E,5>GUYA^TO\ \D2\1_\ ;M_Z4Q4 >GT444 %%%% !7Y7
M?\%A/V??$6G^(O#WQY\.7EXT&GQV^FZAY,C!]-D25FMKB,@Y12[[3C&'V'JY
MK]4:Q_%_A+2/'OA;5O#FO6,>I:+JEM):7=I,/EEB=2K#VX/!'(.".: /S7U+
M0=(_X*M?LCV^N6:VEI\=_!,7V>?;MC-T^TGRVZ8BN I9">$E# ' ;/YK?"GX
MG^+_ -FSXMV'B?0VDTCQ-H-T\4UI=1E0V"4FMYD.#M(W*R\$=L$ C]IOV-_^
M"?%A^QW\2/&/BR#QO=:[8ZG9FQM+&:W%NMO;^:LI:=MY$D@V*H8!0 7./FPO
MS]_P5>_8F77;&Z^.?@6S62YAB5_$UC:KD3P@ +?(!U*C DQU4!_X7) /NG]F
M']I/PO\ M2?"VQ\8>')!#-Q#J6ER.&FT^Y ^:)_4=U;'S*0>#D#UNOYP_P!D
MK]J;Q)^R?\4K;Q-HQ:]TBXVP:QHS/MCOK?.2/]F1>2C]CQRI8'^@[X4_%3PU
M\:O .D^,?".HIJ>AZE$)(I%X=&_BCD7^%U.593T(H ZZBBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBO*_CE^U#\,/V;8]';XC>*4\._VN919+]CN
M+IIO+V[SM@C<@#>G) 'S4 >J45\J_P##T;]F+_HIG_E U3_Y&H_X>C?LQ?\
M13/_ "@:I_\ (U 'U517RK_P]&_9B_Z*9_Y0-4_^1J^D_"/BS2?'GA;2?$>@
MWJ:CHNK6L=[97<891+#(H9&PP!&01P0".A - &O1110 4444 %%%% !1110
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MLK_3+6!)?M$<;,5\F1C^X/S-G*N#P< YS]"_!?X!^ OV??"ZZ#X#\.6FA69
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M=> _#_Q,\)ZCX9\4Z3;:YH.H1^5<V-VNY)%R"/<$$ A@000"""* /G_X'_\
M!1[X&?')H;6T\5+X5UJ3 &E>* ME(2>@60L8G)[!7+>U?3B.LBJRL&5AD,IR
M"/6OS5^.G_!%OPMKWVC4/A3XIN/#%VV671]<W75F3V59A^]C'NPE->_?\$[_
M -F_XD_LS_"_6M ^(?B*WU7[1?"33=,M+E[B'3XE7:VUV QYAP=@&!M!ZL0
M#ZNHK\^-(_X+,?#4?$75] \1>$-?T'1+6[>UMM:0I<LX5BI>:W 5HAQT4R'V
MK[-^%?QR\ ?&[2?[1\"^+=+\36X7=(ME.#-#G'^LB.'C/(X=0>: .ZHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKX.:_P#'C]F?QEX/\,:A)8ZW<P)<6\:/L6\,3K)]F<^D@7;U R5SQD5\+_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&=N[[9C.* /TQ_:^\,Z/;_LJ_%Z6+2;&*5/"FILKI;(&4BVDP00.#4_[%/\
MR:/\(?\ L6;'_P!%+7Y7_$+_ (*[?$?XH?#/Q1X,USP;X6CMM?TJYTN>ZT\7
M,3QB:-HRZAY7' 8G!S]:]6_9F_X*[>$?A7\*_!O@7Q/X!UI8= TZWTUM2TJ\
MBN#,(UV^9Y3B/;G .W<>O7U /UEHKYN^&'_!1+]G_P"*WDPV'Q"L-&OY,#[%
MXA#:<X8]%WR@1L?]US7T9;7,-Y;Q3V\J3P2J'CEC8,KJ1D$$<$$=Z ):***
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M3R:]+H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /FWX^?\ !/;X
M*_M"7%WJ6L^&O["\1W3&237?#[BTN9')R7D7!CE8GJSHS>]>$?LU_P#!*W4/
MV<_VC-)\>V?Q,DU#0-+$S1V<5DUO=7.]"GDRD.4,?S9)'WMH^5<Y'Z$T4 ?#
MO[>G_!03Q3^R#\2/"F@Z3X$M]<TC4;$WUSJ.HR21).?-9#! Z\*Z!0S%@V/-
M3Y?6W\%/^"M7P3^)ZV]IXCN;SX<ZQ)A3%K2>9:%O1;F,$ ?[4BQ]*^OO%G@O
M0/'NBS:1XET33O$&E3?ZRRU2U2XA;W*.",U\:?%;_@D#\$O'U^;[P\^L> KA
MGW20:5<":U8=\1S!BI]-K!1_=H ^X+>XBO+>*>"5)X)5#QR1L&5U(R""."".
M]25X-\<](\<?!7]DV\T7X%:;)?\ B7P[I5MIVC02A;FX2WBV1LZ(XQ+*L0+!
M2#N(^ZW"G\Z?AS_P5Z^,?PKU9M"^+7@^V\32V[;+CS[8Z/J<9[[U">7Q_=\I
M?KZ '['T5X3^RC^V-X'_ &O/#NJW_A./4-/U#2'B34=*U.)5F@\P-Y;AE9E=
M&V/@@Y^4Y XKW:@ HHJAK^O6'A?0M1UG5;J.QTO3K:2[NKJ4X2**-2SN?8*"
M?PH OT5\C?L3?MV?\-5>)_&.A:MH*>%]0LC_ &GH=NV\/?:2SE%E.X\NK!0S
M+A3YBX'!KZYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH3Z] TNO1:CYD(F6( A(D"@DOSN)^3ISFOJ:OC6\_P"4L]A_V2P_^E[U]E4
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MWSFG\K)RP';(].O'_L3_ +4G[*_PD^%>C^#=#\>V6E:XZ+/K%_KEI/9/?WC
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@5]U_L1_\%(?"W[34%IX7\4"V\*_$H)M^QEMMIJ9 Y:V9CD-W,3'</X2X!(
M/L^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT_$8..":]$H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCX8_"?69=7\&^ O#_AG5)8#;/>:981PRM$65BFY1G:2JDC_9'I6+^T/^RO\
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M&729Y"I!< HC2$>6LC J5C+!R&4@$$4 >H4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFVL+6;[!I^O:F&2?2Y%;9]FO-WS>6#\H=N8\8;Y>4_6VOAW_ (*$?\$\]/\
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M!9Z'X=TBRT+1K-=EO8:=;K!!$"23M10 ,DDGU))K6HH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5\>_MY?\% M#_97T23P[X?-OKGQ-O8=UO8D[H=-1A\L]S@]>ZQ]6ZG"\G#_X
M*"?\%#=/_9JTV?P7X+EM]4^)MY#\S'$D.C1L.)91T:4@Y2,^S-QA7^6/V#?^
M"?>M?M">($^,GQK^V77A^\N/M]KI^I%C<:](QW>?.6Y$!/([R>R?> ,?]C?]
MA;QA^V5XTF^,'QHO=1D\)WUQ]J+W;LEWKSC^%#P8[< !=RXX 6/&-R_L=H.@
MZ;X6T6RTC1["WTO2K&)8+:SM(Q'%#&HPJJHX  JS:6D&GVL-K:PQVUM"BQQ0
MPH%2- ,!5 X     J:@ HHHH **** "BBB@ HHHH **** "BBB@ HKC/&'QJ
M^'OP]NOLOBKQYX9\,W/'[G6-8M[1^>GRR.#S@UO>&_%FB>,M/^WZ!K.GZY8[
MBOVK3;I+B+<.HW(2,T :M%%% !1110 45YE\<?VE/AQ^SCH]OJ/Q \36^AK=
M;_LEKL>:XN2N-PCB0%CC*@G&!D9(K\^_C5_P6PC"W%C\*? [,W*IK'BA\ =L
MK;1-SZ@M(/=>U 'LO_!2#]@?2OCQX9O_ (B>$HK72OB)I=N9;C>ZPPZO B_<
ME8X5954?)(2,@!6.-I3Y)_8S_P""J%Y^S_\ #>[\$_$'2=2\7V.EPA?#\UK*
M@GA ('V65G/^J ^ZPR4QMP5V[<"S^"_[87[?EW%?>)I]6MO#$SB2.?Q%(=,T
MJ,9R&BM54&3V=(VZ<MFNX^-'_!''7_AW\%;GQ%X7\52^-?&6G W-[H\-D((Y
M[<+EUMAN9GD7K@D;P"  V%8 S+K_ (*._M0_M-_$*STKX1:$-%CCG1TTO0]/
M6^;;NX-W<3*5"=<MB)<=?6OU8\6?&[PE\(-!\/2?$_Q;H'A+5=2CCC,=U>+%
M')<;5\WRMQR8U8_>/ !&2*_*#]E#_@J%!^SM^SMJG@K4/!T&H^)=,.- FLH(
M[:"YW9S]MV $M&>=X!:0$ E2"YP/V?\ ]F#XK?\ !2+XHW/Q'^(^L7UKX/,^
MRZUN5=IE52?]$L(S\H4<C<!L3))W-D$ ^^?V^/V'?$'[95_X%NM$\;6NA:=H
M_G)<6EY&\L+)*4/GQ!#S( N,' (Q\R\Y]O\ V;OV8_ _[+?@6/PYX.L-LLFU
M]0U:X :[U"4#[\K@=!D[4&%4$X'))]/TG2[;0]+L].LHO)L[.%+>"/).R-%"
MJ,GDX '6K= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5G^(/#^E^+-%O='UK3[75M)
MO8FAN;*\B66&9#U5D8$$?6M"B@#\C/VPO^"6WB#X6ZM)\1O@$^H7-G9R_;&\
M/6DKG4=.=3N$EFX.^50>BY\Q<#!?/R_<_P"P3\0/BG\1OV?;+4/B[HMWI/B>
MWO);2*;4+4VUQ?VRJA2XDB(&UB6=.@W>7NQSS]&44 %%4M8UK3_#NEW6IZK?
M6VF:;:QF6XO+R98884'5G=B H'J34/AOQ-H_C+1;76- U:QUS2+I2T&H:;<I
M<03 $@E)$)5AD$<'M0!IT444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MECP[\0_"M\VC>)]$'2WNTR-Z#)/EOM;&2<%7&6V[CH_%K]LCX,?!#SHO%OQ
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MOKETI'[E,8VVZ8"L5P %$:]&*?L_:VL-C:PVUM#';VT*+'%#$H5$4# 50.
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M2"00>#F@#Y?_ &$_VY]&_:\\*SV5Y;QZ-\0=(@635-+CSY,R9"_:8"<GRRQ
M*DDH2 2058_5->%? O\ 8K^%/[./CC7_ !7X&T2?3M5UB(V[^==/-';0EU=H
MH5;[JED4\DGY0,XXKW6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS#]I?_
M )(EXC_[=O\ TIBKT^O,/VE_^2)>(_\ MV_]*8J /3Z*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#G?B%\/] ^*G@O5_"?BG3H]6T#5H#;W=I*2
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M2,$A21(I#+DXS^C7[ ?[;VF_M8^ S8:O)!8?$C1H5_M6P7"+=1\*+N%?[C'
M91]QCCHRDQ_M[?L*Z1^UAX/_ +5TA+?2_B5I,##3M08!4O$'/V6X..5)SM;^
M!B3T+ @'U'X=\0Z9XLT+3]:T6^M]4TG4($N;6\M7#Q31,,JZL.H(-:-?B/\
ML,_ML>(_V,?B!>?"SXI6]];^"!>O;W=K<HS7'A^ZW8:5%ZF(GET7/7>F3D2?
MM=I>J6>MZ;::CIUW#?V%W$L]O=6T@DBFC8!E=&!PRD$$$<$&@"U1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5POQL^-'A;X ?#G5?&OB^^%EI-BGRHN#+<RD'9#$O\4C$8 ^I. "1L_$#Q]H
M'PN\&ZMXJ\4:E#I&@Z7 ;BZNYCPBC@ #JS$D *.22  2:_$_XH?$7XD_\%4/
MVE+#PUX8MIM.\*V;M_9]E,3Y&F6F0)+VZ(X,C#&<>JQKGJ0!-)TWXG?\%8/V
MG9;J[:31_"FGD>8ZY>UT+3RW$:9P))Y,'T+L"?E1/E_:7X4_"OPU\%? .D>#
MO".G)IFAZ9%Y<,2\L[=6D=OXG8Y9F/4FL#]G?]GWPK^S1\,M.\&>$[;;;P#S
M+N^D \^^N" 'GE(ZL<# Z*  .!7IE !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7@_[7G[(?A3]K;X?-H^L*NG>(K)6?1]>CC!ELY2/NG^_$V!N3//!&
M& (]XHH _#7X"_'_ .)__!,GXU:CX"\>Z5=7/A*></J&D!BT;H3M6_L7. 20
MOL'"[6VLH*?M1\/_ (@>'OBGX.TOQ5X5U2#6=!U.$36UY;G*L.A!'56!R"IP
M5(((!%>7_M:?LE^$OVM/AX^A:ZBV&N6@:31]>BC#36,Q'X;XVP \9." ",,%
M8?E)\%/CA\5/^"8/QPOO!'C?3+B[\)W,XDU'2%?=#<1$[5OK%S@;B![!MNQP
MK*"@!^YM%<U\.?B-X<^+7@O2_%GA/5(=9T'4HA+;W4!X/8JP/*LIR&4X((((
MR*Z6@ HHHH **** "BBB@ HHHH **** "BJNIZI9Z+IMUJ&H74-C86L33W%U
M<R".**-02SNQ.%4 $DG@8KY'U;_@HM9^+-8OM-^"OPL\7?&C["[1W&K:7 ;3
M2PX&=@N75N?J@!!RI:@#["HKXUD_X*$:]\.Y(IOC-\ _&GPST5I/*?7K9EU>
MQMVW8S+)&B;5Z?=#$]@>M?5G@;QWX?\ B9X5T_Q+X6U>UUW0K^/S+:^LY-Z.
M.A'J&!R"IP0000",4 ;U%%,FFCMX9)976**-2SR.0%50,DDGH* 'T5\^_$[]
MOKX"?"5I8=9^(^EWE]'D&RT4MJ,NX?PGR RH?]\K7RS\1/\ @MKX)TSS8O!'
MP^UK7Y!E5N-9N8K"+/\ >"IYK,/8[3]* /THHKX/_8 _X*!>.OVM_B9XGT#Q
M#X*T[3=&L;#[=;ZGHZ3!+=A(J"&=I'8,SAR5V[3^[;Y2,E?O"@#G/'?Q&\+?
M"_0SK/B_Q%IGAG2@XC^V:K=);QESG" L1EC@\#GBOF_QA_P5,_9Q\)^8D?C6
M?7[A,YAT?2[B7./21D6,Y]FK8_;:_8@T[]LS3?"D5SXKN_"EYX?FG:*:*U%U
M%+'-Y?F*T9=,-^Z7#@\<Y![>-^#?^"+_ ,&M%2-]?\0>*O$ER/OK]IAM8&_X
M D9<?]_* .>\7?\ !;?X>6'F#PS\/?$FM,N0IU.X@L%8]N4,QP?IGVKQ7Q5_
MP6V^(^H2,OAKX>^&=(5CA1J4UQ?./Q1H03^'X5]]>$?^"=/[.G@O8UG\+]+O
MI%Y+ZO+/?[CC&2L[NOX 8]J]K\*?#/P?X#14\->%-#\.HHPJZ3IT-J ,8P/+
M4=J /QX/[=/[;'Q4^7PMHNKPQR\#_A'?!OGC!ST>2*4@>^>,=:_13]@75OCG
MK'P?O;CX[V]Q#KQU)_[..H0107C6NQ/];'& %^?>!N ;'48VD_3%% !7XJ_\
M%C+'P@W[0=GJ.G>,9]6\6/I\-MJ7AY81)#I<: F,^=O^5GW;O)VDC)<D;U!^
MP?\ @H=_P4.L_P!G;3+KP)X$NH;_ .)EW%B:X7$D6B1L.'<=&F(.4C/3(9N-
MJO\ .G_!/3_@GI??%?5K?XS?&:WN+W2KJ;[?IFD:F6>75Y6;=]KNMW)B).X*
MW,AY/R?? .*_8P_X)6ZI\?/!R>-/B'JNH>#O#MZH;2K.TA7[;>QD<3G>"(XS
MQMRI+C)X&TM]<Z'_ ,$9_@3I>UKS4_&6L-_$MUJ4"*3C' C@4@9YZ_C7W<BK
M&JJJA548"J, #TIU 'R9HO\ P2Q_9JT?89/ 4VIRK@B2]UJ]/('=5F53GW&*
M[C2?V"_V>]%4+;_";PY( NW_ $NW-R>N?^6I;GWKWNB@"EHNB:=X;TFTTO2+
M"UTO3+2,0VUE90K##"@X"(B@*JCT Q5VBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBOSB_;F_X*H6'PU>]\#_  <O+76/%<9,5[XD"K/:
M:>PZI"#E9I1W)!1>GS'(4 ^UOVC/BI>_!+X'^,?'.FZ+)XAO]%L6N(-/C!/F
M.6"@MCG8N[>V.=JM7X^_!K]G?XR_\%,OBE-X\\=:M=6/A)9?+N->GCVPQQ@D
M_9+"$_*<=./E7)9BS'#?IK_P3^\0_&+Q7^S_ &VK_&@R/KMY>22Z<]W;+;W;
M6)5/+,T:JH!+>85R 2I4GUKZ0M[>*UA2&&-(8D&%CC4*JCT '2@#D/A#\(?"
MWP+^'^E^#/!VG#3=#T]2$0L7DD=CEY)&/+.QR2?P&  !V=%% !1110 4444
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MDC8,KJ1D$$<$$=Z )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K/\ $'B#3/">AW^LZS?6^F:380M<75Y=2!(H8U&69F/
M  J?4=1M-'T^YO[^YALK&UB::>YN'"1Q1J"6=F/ 4 $DG@ 5^,G[;?[8WB?]
MMKXDV/P<^$-K>7OA%[T00Q6H*RZ[<*>)GZ;;=,%E#8&!YCXP @!A_M3_ +2G
MCG_@HS\;M*^&OPSL;M_"$5V4TO3N8_M;+D-?77]U0N2 WW%S_$QK]3/V0_V3
M_#7[)?PQA\/:2$O]>NPL^M:VR8DOIP.W=8DR0B=@23EF8GG/V'_V+-!_9&\
M['\G5?'>J1JVLZTJY'8BWA)&1"I^A<C<<?*J_2] !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_NJ!7T;10!3TG1M/T&QCLM,L;;3K./A+>TA6*-?HJ@ 5<HHH **** "BBB@
MKX0_X*$?\%&-/_9^L+WP%X NH-2^)5Q'LN+M-LD.B*P^\XY#3X.5C/"Y#-QA
M6Y[_ (*&?\%*;;X1QZC\-_A;?17GCA@UOJ>M1$/%H_9HXST:X]>T??+<+YG_
M ,$]O^";]UXHO;3XO_&JRFN5N)?MVE^'=4!>2[=CN%W>!N2"3N6-N6^\W'#
M%#_@GK_P3QO/B9J5O\9OC3;3W]A>2F_TO1=4R\NJ2,=WVN[W<F,D[E5N9"=S
M?)@/^M**L:JJJ%51@*HP /2E50J@ 8 X %+0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 445%=74-C:S7-S*EO;PHTDDLC!510,EB3T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5YW\=_@'X-_:.^']YX1\:Z
M8+ZPF^>"XCPMS9S8^6:%\'8X_$$9# @D'T2B@#\+O$GA7XS?\$H_CI%JVESM
MJOA34'\N*[*,-.UJW!)\F90?W<RC)QG<IR5+*3G]:?V7?VL/!'[5W@==<\+7
M?V?4[=574]"N7'VJPD/9A_$AP=L@X;'8AE'H7Q&^&_AKXM^#=1\*^+M(M]<T
M'4(_+GM+E<CV93U5U/(92"" 00:_&G]HK]E'XH_\$Z?B9;?$SX9:O?W7A".?
M_1M:A7=):*S#_1;Y -K(W"[B-C\<*V!0!^WE%?)/[$__  4*\)?M6:=#H>IB
M#PO\1X8\SZ,\G[J]VC+2VC$Y88Y,9^=>?O ;J^MJ "BBB@ HHKXV_P""E'P?
M^.OQH\#^&=!^#]TS:3+<31^(=-M]1CL9;E&5!$6=V4/"O[W='NY+(=K8^4 N
M_M)_\%.?A'^S_)<Z5I]X?'_BN+*G2]#F4P0N/X9KGE$Y!!5=[ ]5%?GQXC_:
M._:G_P""A>O7/ASP997]CX;9]DVF>&]UI8PH>UW=L1NXP2KN%./E3/%?4'[,
M_P#P1R\+^$Q:ZU\8=3'BW51AQH&FN\6GQ'KB23Y9)CTZ;%Z@AA7Z'^&?"VC>
M"]#M=&\/Z39:)I%JNR"QT^W2"&)?144 #\J /R+D_P"",WCGP[\,Y?$+^(-)
M\2>-[1X[E?","R)9W<2G,D!NRZ-O8< @(,@C=R&'U5^RW^U=^S?X#T9O"K:!
MIW[/OB^T58=6\/>(+3[#*)0!DM=.H\X9Z-(P?')45]O5R'C[X/\ @7XJ0QQ>
M,O!VA>*5C&(SJ^G17+1_[K.I*_@10!X]\3/^"A7P+^'&GL\'C>Q\9ZM(1'::
M/X1D74[FZD.-J(8B4!)('S,!VZ\5QW[-/PG\>?%GXT7/[1/QCT@^'-5^QMI_
M@[P=*VYM$LWSNEER 1.ZLP.0&P[Y"_*J?07@/]G[X9?"Z\-YX1^'_AOPY?'@
MWFFZ7##/CT\P+NQ[9Q7?T %%%% !1110 4444 %%%4=<US3O#.CWNK:O?6^F
M:791-/<WEW*L44,:C+.[,0  .YH NLP522< <DFORZ_X*!?\%.A:MJ'PQ^"V
MI>??N6M=4\66+9\LYVM!9L.KGH9AP.B9/S+YW^VQ_P %%_$7[1FN-\)O@A%J
M!\/:A-]AFOK*)Q?:ZS';Y42 ;DA/I]YQUVKE3])?L#_\$T=,^ Z6'COXD06V
MM?$3"S6EAQ+:Z*>H*GI)..[]%/W,XWD \_\ ^">__!,H>'9-.^)_QCTT3ZV2
M+G2?"UXNX6IZK/=*>LO=8SPO!;YN$_3BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHJAKVO:;X6T6]U?6+^VTO2K*)I[F\O)5BBA
MC49+,S'  ]30!?K\W/\ @IQ^WWX;T'P)X@^#_@/5!JWBK5%-AK5_8N&@TZW)
MQ-!Y@.&E<?NRHR%5GR0P K[&7QUX6_:N^"?B^V^&/CRWE74;*ZTA-;TPDR6%
MP\14,R':RD;@V/E)!RI&0:_++X,_L,_%/]G_ .+E_JGBK]GE_C5;:9,5TP1>
M(K:STV5U8XN&21':8$8*HZJ!D[E)QM /N+_@E?JGC[5_V5[&U\<:+%IFCVDY
MMO#NZT%L]SI^Q2'9  &4NSXD(R^23G[S=5^V;^S+;>.OV?9XOA[I-KX?\8>$
M+L>)_#7]CVJ0%;V$[V1%0 ;I%! ]7$9/2N<7]JO]I!%"K^Q_?JH& !XXM,#_
M ,EZ7_AJW]I+_HT#4/\ PN+3_P",4 >V?LP?'.P_:-^!_A?QW9>7'/?VX2_M
M4/\ Q[7B?)/%CJ '!(SU4J>]>J5\,?L'^$?B[X'^-WQ5?Q!\*[GX;?#7Q5*=
M>M--N-7M[U;#4BR+(D1CVDK*&=ON *(HU[9/W/0 4444 %%%% !1110 4444
M %%%% !1110!^3O_  5F_9%N/"NNQ?'WP-#):*\\0\0I991K:Y# 0WRD?=W-
MM5B,8?8W)9B/L+_@G[^UQ;_M5?!J&;4IHU\<Z"([+7+=< RMC]W=*/[LH4DX
MX#JXZ 9^CO$GAO3/&'A[4M"UFRBU'2-2MY+2[M)AE)HG4JRD>A!-?A]KVG^+
M?^"6/[9\5W8BYU#PG.2\&XX&K:1(_P \3'IYL9&/9XU;&UAD _=.BL/P/XUT
M;XC^#]'\4>'KV/4=$U:U2[M+F/H\;C(R.Q'0@\@@@\BMR@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *C2"..221(U623!=E4 M@8&3WXJ2B@ H
MKF/B=;^)KKX;^*8?!ES#9^+I-,N5TBXN%5HX[LQ-Y+,&^7&_;UR/4$<5^5_[
M)_\ P4H\>?!OXHW_ ,.OVBKF_NK%KUK:;5-3B"WFBW&<$2A1F2$DC/4J,%<K
MQ0!^N]%5]/U"UU:QM[VQN8;RRN8UF@N+>021RHPRKJPX92"""."#5B@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^T5\"/'/_!+OXF^"/$O@?XB7&HPZT)I(I%@:U\QK=HC+!<PB1EEB82IU/<\
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M"VV>-CR5 X"D_A0!]!4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <M\4/AKH'QA^'^N>#?$]FM]H>L6S6UQ$<;AGE70_PNK!65NS*
M#VKY:_8/_8)UK]CSQIXYU2_\:1>(--UB*.TLK.TA>(-&CEEFG5B0) "5 4D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\=_M@?\ !2KP#^S4MYX?T,P^-OB"@*'2[67_ $:Q?IFZE'0C_GFN7XP=F0U
M'T+\:_CMX)_9[\%W'BCQSK4.D:='E88S\T]U)C(BAC'+N?0<#J2 ":_'GXU?
MM'?&+_@IE\4+?X?^ =(NK#PBLOF6^APR;8Q&I_X^]0F'R\<''W5. H9CEHOA
M7^S]\<?^"FOQ*?QOXTU:YL/":R&.37KN(K;01AN;:P@X#$>WR@Y+L6/S?K_\
M!/V=? O[-?@N/PUX&T=+"W.UKJ]EP]W?2 8\R>3&6;DX'"KG"@#B@#R?]C']
M@GP;^R;HL>HL(O$?Q!N8MM[X@FCXB!'S0VRG_5Q]B?O/W.,*OU'110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC9^Q7^WEJ'C#5M;U37/".M71O+/3I+EQ87VED[?LJIG8DD(.T'&0P#G(D^8
M_8BBN:^&WQ$T'XM>!-$\8>&+Y=0T+5[9;FVG7@X/!5A_"ZL"K+U#*0>E=+0
M51US0].\3:/>Z3J]C;ZGI=[$T%S9W<2R131L,,CJPPP([&KU% 'X^?MB_P#!
M-SQ9^S[XD;XJ? :74I-$L)?MK:;I\SG4M%8<F2%A\TL(Y[EU'7<,L/;/V(?^
M"JFD_$S^S_!/Q?N+70?%C;8;3Q%@166HMT"RC[L$I]>(V/38<*?T7KX$_;8_
MX):^'_C=->^,?AG]C\)^-Y-TUUI[+Y=AJC]22%'[F4_WP-K'[P!)>@#ZN_:
M_9V\$?M,> Y_"_C73%O+<AGM+Z'"W5C*1@2PR8.UNF1RK 88$<5^/GC'X?\
MQO\ ^"5?QCCU_0KQM1\)WTOE0ZDL;-INK1#YO(N8\_NY0,\9##YBC$9-=+^S
MW^W?\7/V'?%P^&7Q?T35-6\-:>PB?3-0_P"0AIT?0-:RL=LL6!\JEBA &QE'
M7]4?"'C[X3_MC_"N\33+O2_''A34(A#?Z=.N7A)&0DT1P\3@C() ((#*>AH
MYW]DW]LOP-^UIX4^V:#<#3/$MK&&U/PW=2 W-J>A93QYL6>DBCN P4\5[Y7X
M/_M:?LL?$#]@WXS+XU\"3ZG8>#C>>=H/B.RD+/9EAG[+<-V8?,OSY65!W^91
M]X_L0_\ !3SPY\>$L/!_Q$DM?"WQ!;$,%SGR['5FZ#RR3^ZE/_/,G#'[AYV
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYI_;6_8C\,?M<^#<
MOY6C>.].A8:1KP3IU/D3XY>$G/NA)9>K*WTM10!\ ?\ !+GX,_'GX#77C?PI
M\2-,ETOP/"$?3(+F\BN%%X6R[6VQVQ$R'+=!NVX^;?7W_12,P522< <DF@!:
M*K:=J=GK%G'=V%W!>VDF=D]O(LB-@X.&!P>0:LT %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %>8?M+_\D2\1_P#;M_Z4
MQ5Z?7F'[2_\ R1+Q'_V[?^E,5 'I]%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5XC^UY^R]H?[5WPAOO"FHF.RUB$FZT;5F
M3<UE= <$XY*,/E=>X.>JJ1[=10!\B_\ !-_]F/XA_LN?#3Q-X?\ 'NJV=R+S
M5?M.GZ=83M/#;($"O('*C!D(!VXXV ]6('UU7RG_ ,%+-%^)FJ?LQZE>?#'6
M+_2[_2;N/4=4CTF9X;NXL8U?S%C="&&UBDA4$96-OH?-?^"8/[<<WQY\+O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1^G\3&O1J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ ILDB0QM)(RHB@LS,<  =233J_)W_@I=^U9\2/'GQBO/V</AYINH6L)
M:"UODL4;[9K,DT*2B)<<K %D&<?>PQ)V<4 ?;GPZ_;R^#WQ6^-TWPM\,:]-J
M?B!5E\B[CMS]ANWB5FD2&;/SE55FSC:0I*LU<KX1_P"":?PC\+?'W5_BI/%J
M&O7]Y?2ZG;:/JCQR6-G=22&1I%4("^&)V!R0N<\D CF/V /^">6G_LOVL?C+
MQ9)%JOQ+O+<QGRFW6^E1N/FBB/\ '(1PTGU5>,EOM>@ HHHH **** "BBB@
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MH3X?V/C#P7J:ZCI=R-LD;86>UE !:&9,G9(N1D=""""003WU !1110 4444
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MQD8)?:_M/?';P!<3:,OQ.\=:/-8,UI)IMQK-VOV5D.&C,3O\A4@@C (QBOU
M_:.^.WPMU3]LS]ES5M'^(?A"\T#1)-:%_?6.MVKVM@KVT2QB5U?;$&((7<1G
M&!7SE_P5-U_X#_%3QIHE[\-M<TW6/B;.Q75M0TF\@&E3VJQ,5,]RS")IP555
M*,25!5N?+% '@_[,OPG_ &D_C=HOB.;X2:[K,6DK?>=JL=GXI73DDNG .^2'
MSD+,1_'MP=I&<C%>[^'?^".OQM\=7HU'QOXTT'2992/,DGNY]1O/Q^4*>O\
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MJ6K:;H.HR"[,=](QU76,]&);F&(C&&/S%0-J@$,/O3P'_P $W_@EX!^+E_\
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M$Z,VZ11&4"[%8K\X ^;D Y+P/_P5)\<_'+]KCPSX+^&W@RUO/A_>:@EI,MW
M[:A):[AYUXS*^V%43+A2#P"&))&W])#H.F-K*ZN=.M#JRQ>0+_R%\\1YSL\S
M&[;GG&<5XA^R'^QSX._9'\$_V?HR+JGB:]1?[6\0SQ@373#G8@Y\N('H@/N2
M3S7OU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)),\!@% &[CYL  ^NJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KS#]I?\ Y(EXC_[=O_2F*O3Z\P_:7_Y(EXC_ .W;_P!*8J /
M3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2__ "1+
MQ'_V[?\ I3%7I]>8?M+_ /)$O$?_ &[?^E,5 'I]%%% !1110 4444 %%%%
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M^C:?X>TNVTW2K&VTS3K5!'!9V<*Q0Q(.BHB@!1[ 5<H **** "BBB@ HHHH
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M&GQ!M/\ E\_O:?8MT;<.&<<$'^Y@2\/<_LT?#6/]OS3OA,?"EB_@1?A(;?\
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MS\288\0ZNJ8AO@HPL5T%&6&  ) "RC'W@-M 'U)>66A^//#9@NH-/\0Z!J<
M)CE1+FUNH7 (.#E70@@]P17Q#K7A4_\ !/']H'POK'A:::W^ _Q$U5=(UC09
M9&>#0M3D!\FX@R?D1\'(Z!4<'I&%R_\ @EY\-_V@_@SK'B[P5\2=)O-.^'VG
MP9TU;^:.58[TR+D6K!B3"R&1FQ\H8+C!+9]'_P""KLEM_P ,9^(H7YO[C4]-
MBT]5^^UQ]J0X3ONV"3ISUH ^P:*KZ>LZV%LMT0UR(E$I7H7P,X_'-6* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP?RKX$U/_@AWX>FW_P!G?%C4[7Y<+]JT6.;#>IVS)D>W'UKE-4_X(<:O#O\
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M$?R?!Q[U:C_;4^ LDBH/B]X.!8X&[6(0/Q); H ]IHKRK_AK'X(?]%D^'_\
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M_9VO+=9H_BOH:HV<"7S8VX..59 1^(K3L_VX_@#?0^;'\7/"JKG&)M02)O\
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M-)M3N_M;PQN2[2,'.VYL\MO3N0/,3 RV.E?MI10!^7G[,/\ P6.M+Z2V\/\
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MZS80:C:^<NU_*FC61-P[':PR*V: "BBB@ HHHH **** "BBB@ HHHH ****
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M=?\ A7O[0WQ5^*/_  D'V_\ X3I-/3^R?L7E_8?LT/E9\WS#YF[K]Q<=.>M
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M_#UW"\,^@Z9-$XPT<EG&RL/0@KS6:WPE\#.I5O!GAYE(P0=*@P?_ !RNLHH
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M9K9\9\N:,_-&_LP&>HR"#7=U^'OQ?_96^.O_  3C\:M\0/A_KEYJ'A6)]O\
MPD&F)\JQD\0W]L<C:3CD[HR=IRK$ ?=W[&'_  4P\'?M'K9>&/%GV;P;\1&
MC2UDDQ9:D_3-L['AR?\ EDQW<_*7YP ?:E%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7F'[2_P#R1+Q'_P!NW_I3%7I]>8?M+_\
M)$O$?_;M_P"E,5 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:S"_[L/S0C_OW0!ZC\,_VM/@Y\8/*7PE\1M!U.YE^Y8R70MKMO\ MA+LD_\
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MBV3TK]!?@G\#O!O[/G@.S\)>"=(CTO2X/FDD^]/=2X :::3J[G'4\
M W])\ ^&-!\1:GX@TSPYI.G:]J8 O]4M+&**ZNP#D"655#/S_>)K>HHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OF_\
M;T_99M_VJ/@9?:39PQCQAH^[4-!N&P#YX'SP$]EE4;3V#!&/W:^D** /R7_X
M)%_M3W'A/Q+?? ?QA-):17,TL^@B\RC6]V"3/9D'[N[#.JG&'5QU<5^M%?D!
M_P %6_V8K_X0_$S3/CSX&273K/4KV.34I;+*M8:HI#1W((^Z)=H.>TBDDYD
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M">#SAQE6P<'@@>MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5YA^TO\ \D2\1_\ ;M_Z4Q5Z?7F'[2__ "1+Q'_V[?\ I3%0!Z?1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **S?$GB32?!^
M@WVMZ[J5KI&D6,1FNKZ]E6*&%!U9F8X KXL\$_\ !5CP9\3/VE-#^&7A/PEJ
MFL:)JUW]@A\3"7RRTF#B1;4IN\D8)+LRL%R2O&* *7_!0#_@I);?LZW-[\/O
M <4>I?$4PJ;F^G4-;:0'4,I*G_63%2&"GY1D%L_=/A?_  3E_9#^)_CSXR:7
M^T3\1]3U+3H%DEOK-M0D8W^LR21-&)&SRD&US@G[P "C:=U?>7BO]B7X->./
MC0OQ2UWP=!J?BO,;R-<32-:S2HH5)9+?=Y;L%51R,' )!(S7N?3@<"@!:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-=CX3\:>'O'VCIJWAC7M,\1Z6[%5OM)O([J!B.H#QL5)'UH VJ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JG::/86$SS6UE;VTTG#R0Q*K-SGD@<\U<HH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!A^-O&VA?#?PGJGB;Q-J<&CZ#ID)N+N^N"=D2#C/ )))(
M  !))  )(%?FOX__ ."T.DP_%KP\/"'AZ_N?AW;F1=;.H6D:7]UU"-;8FVH
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M^@NVV4:IJ7VBS:2-HR7MKF7H5=U#,A4\[3D9H ^SJ*** "O,/VE_^2)>(_\
MMV_]*8J]/KS#]I?_ )(EXC_[=O\ TIBH ]/HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME JS Y R:^L?VYOVZH_V,U\'QKX-F\67/B![AN;W['%#%#Y>_P"?RWW.?-7
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M*?@UXN^,[?%+6O!=KJ?BQMC2-=2.]K)*@"K,]N3Y;.% &2,< XW#->X*H50
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3C_90^(]I\7O%'Q_^+]E/HWB+6A<&RTR\C\JY:2XDW3SRQ8S" !L1#@X9L@
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MI_M%?M0+^T!\7]&NM#TVWU(:U&E] UK+?7:8-LL,+_.L$16,AFX(C506^8@
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MZ^\)?';P;XT^"L7Q6T_4F7P4VFS:J][/$RM#!"',V].3N0QN"!GE3C->*_\
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M9EX20\\[6/W\5]KT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO_&OC>TUJYMK"TGO+6/Q/-]D,FU-YBM+( %&?: ,1HC$C+=Z_4W]@WQ-HOQ
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MD@=3M%M?%N1@C:)3R",/_> !^JM%(K!U#*0RD9!'0TM !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>8?M
M+_\ )$O$?_;M_P"E,5>GUYA^TO\ \D2\1_\ ;M_Z4Q4 >GT444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7F'[2__)$O$?\ V[?^E,5>GUYA^TO_
M ,D2\1_]NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7QK_P4K_Y!7P"_[*GH_P#Z#-7V57QK_P %*_\ D%?
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M495P<;B?N?\ X)/_ /)DOA#_ *_=1_\ 2N6@#[ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\P_:7_Y(EXC_P"W;_TI
MBKT^O,/VE_\ DB7B/_MV_P#2F*@#T^BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,/VE_^2)>(_\ MV_]
M*8J]/KS#]I?_ )(EXC_[=O\ TIBH ]/HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O,/VE_^2)>(_\ MV_]*8J]/KS#]I?_ )(EXC_[=O\ TIBH ]/HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\P_:7_Y(EXC_P"W;_TIBKT^O,/VE_\ DB7B/_MV_P#2F*@#T^BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_L4?M%>)/V!_V@];^%'Q/633O"EY?BUU2*5B8].NN!'?1GO$R[=Q'WD*-SL
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M,'[,&B?LW^%[M5NY?$?C76I/MGB+Q5?9:ZU*Y))8EB21&"3M7/<DY8DG\O\
M]CWPSXS_ &/_ !E\0?BSIFE1^.O"GA'7+_P/XLM[&)EO8+*.2%VOX%)P5#QJ
M64] O)P2Z?L1\/\ X@>'OBGX.TOQ5X5U2#6=!U.$36UY;G*L.A!'56!R"IP5
M(((!% '14444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2_P#R1+Q'
M_P!NW_I3%7I]>8?M+_\ )$O$?_;M_P"E,5 'I]%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KS#]I?\ Y(EXC_[=O_2F*O3Z\P_:7_Y(EXC_ .W;_P!*8J /3Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#@I9^SUKO[17[--SIGA:V:_P#$>AZC#K5G81X#W>Q)(Y(ER?O>7,[ =R@
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M[)_Q8T_]G[_@FIX'\9>/K:]N=&L;.7SX[&V\^3[/-?RI!E&(!4K)$.N,,.U
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *FK:39:_I5YI
MFI6D-]IUY"]O<VMP@>.:)U*NC*>"I!((/8U^(/[07PI\8_\ !,G]JC2/&O@9
MYI/"5W.]QH\LS,T4UN2//TZX/<@'&3R5*.#N!V_N37F_[0OP'\.?M(?"G6?
MWB:+_1;U-]M>(H,ME<J#Y<\?^TI/3N"RGAC0!8^ _P ;O#?[0WPNT7QSX6N/
M-T_4(_WEN[ RVDXXD@E Z.AX]",,,@@GT"OP[_9C^,_BW_@FS^T]K7P_^(*2
MIX2N[E;;6(4#-$%/^HU&W]1M()P,LA((W* /V\T_4+75M/MKZQN(KRRNHEG@
MN('#QRQL RNK#@@@@@CJ#0!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[JS=@9;*Y4#S()/]I21S_$I5APPJU\>/@EX<_:&^%NM>!O%%OYFGZC'^[N$
M\VTG',<\9/1T;GT(RIR"0?QV_9]^*WC'_@F1^U1J_@KQRDS^$KR9+?5XHE8Q
M3VY)\C4;<=\ DX')4NA 8#: ?N315/1]8L?$&DV6J:9=PW^FWL*7%M=6[AXY
MHG4,KJPX*D$$$>M7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,/VE_P#D
MB7B/_MV_]*8J]/KS#]I?_DB7B/\ [=O_ $IBH ]/HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'
M[2__ "1+Q'_V[?\ I3%7I]>8?M+_ /)$O$?_ &[?^E,5 'I]%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ@@@T :%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5YA^TO_P D2\1_]NW_ *4Q5Z?7
MF'[2_P#R1+Q'_P!NW_I3%0!Z?1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'[2__)$O$?\
MV[?^E,5>GUYA^TO_ ,D2\1_]NW_I3%0!Z?1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %1SP1W4,D,T:RPR*4>.10RLI&""#
MU!%244 ?B5^V=^SOXF_8!_:%T7XK?#%I+#PE=WYNM+FC!:.PN""9;&4=XF7?
MM!^]&67DH2?U9_9=_:0\._M1_"33/&>@LL$[?Z/J>FL^Z2PNU +Q-ZCD,K?Q
M*RG@Y ZOXO?"?P[\</ASK?@KQ59B\T75H#%(!@/$W5)8S_"Z, RGU ZCBOQ@
M^&?C+QO_ ,$LOVMK_0/$2SW_ (3NV2+48X5(CU/3F8^3>0@G'F)\Q SP1)&3
MR30!^Z%%9GAGQ+I?C+P[INNZ)?0ZGH^I6Z75I>6[;HYHG4,K ^A!%:= !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7F'[2__ "1+Q'_V[?\ I3%7I]>8?M+_ /)$O$?_ &[?^E,5
M 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "O,/VE_^2)>(_\ MV_]*8J]/KS#]I?_
M )(EXC_[=O\ TIBH ]/HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA^TO_P D2\1_
M]NW_ *4Q5Z?7F'[2_P#R1+Q'_P!NW_I3%0!Z?1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  2\_;:_X7EX+3X;^,=0W^/?#]N/LMU</\^JV2X ?)^]+'PK=V7:_)WD?>M
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M30]6MDNK2[A/#HPSTZ@CD%3R""#@@UNT %%%% !1110 4444 %%%% !1110
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M&_U1/F1,P&,JQ#9(4@ _::BBB@ KS#]I?_DB7B/_ +=O_2F*NG\;>/K;P/\
M8OM&EZMJ7VK?M_LNS,^S;MSOP>,[N/7!]*\=^.7Q>L?%'PMUO3(=!\0V4D_D
M8GOM.:*%=L\;?,Q/&<8'N10!]%4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM?\ !+']MK_A<'A*+X5^,K_?XUT*W_XEMW</\^IV2#&"3]Z6(<'NR8;DJYH
M_06BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS#]I?\ Y(EX
MC_[=O_2F*O3Z\P_:7_Y(EXC_ .W;_P!*8J /3Z*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7F'[2__ "1+Q'_V[?\ I3%7I]>8?M+_ /)$O$?_ &[?^E,5 'I]
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M (*@_!K7OC=^UM)I'A'2[6?6-(^'RZ_)!!%BYU!([N5'0$??=4(*CJ0FT9)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5YA^TO\ \D2\1_\ ;M_Z4Q5Z?7F'[2__ "1+Q'_V[?\ I3%0!Z?1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MS#]I?_DB7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_ -*8J /3Z*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KS#]I?_DB7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_
M -*8J /3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS#]I?_DB7B/_ +=O_2F*
MO3Z\P_:7_P"2)>(_^W;_ -*8J /3Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MS#]I?_DB7B/_ +=O_2F*O3Z\P_:7_P"2)>(_^W;_ -*8J /3Z*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7[+.EZE#9^%['P;%JNGZ]<ZF8X[&9KA92LS.QP1)O ;?C!R/NXH _4S]C_\
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MP:IX\\10SV[::\RW0@2=]UR]Q("4DDE/!"Y4*6Y)8A?J'_AD[X(?]$;^'_\
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M .6[;?\ Q5'_  @/Q)_Z*K_Y;MM_\57I]% 'F'_" _$G_HJO_ENVW_Q5'_"
M_$G_ **K_P"6[;?_ !5>GT4 >8?\(#\2?^BJ_P#ENVW_ ,51_P (#\2?^BJ_
M^6[;?_%5Z?10!YA_P@/Q)_Z*K_Y;MM_\51_P@/Q)_P"BJ_\ ENVW_P 57I]%
M 'F'_" _$G_HJO\ Y;MM_P#%4?\ " _$G_HJO_ENVW_Q5>GT4 >8?\(#\2?^
MBJ_^6[;?_%4?\(#\2?\ HJO_ );MM_\ %5Z?10!YA_P@/Q)_Z*K_ .6[;?\
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M(#Y@C7:GRE\# /8#/>O8Z* /,/\ A ?B3_T57_RW;;_XJC_A ?B3_P!%5_\
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MMO\ XJO3Z* /'/#?P;\;^$-'ATO2/B;]DL(69DB_L"!\%F+-RSD\DD]:U/\
MA ?B3_T57_RW;;_XJO3Z* /,/^$!^)/_ $57_P MVV_^*H_X0'XD_P#15?\
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M?10!YA_P@/Q)_P"BJ_\ ENVW_P 51_P@/Q)_Z*K_ .6[;?\ Q5>GT4 >8?\
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MBJ_^6[;?_%5Z?10!YA_P@/Q)_P"BJ_\ ENVW_P 51_P@/Q)_Z*K_ .6[;?\
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MP@/Q)_Z*K_Y;MM_\57I]% 'F'_" _$G_ **K_P"6[;?_ !5'_" _$G_HJO\
MY;MM_P#%5Z?10!YA_P (#\2?^BJ_^6[;?_%4?\(#\2?^BJ_^6[;?_%5Z?10!
MYA_P@/Q)_P"BJ_\ ENVW_P 51_P@/Q)_Z*K_ .6[;?\ Q5>GT4 >8?\ " _$
MG_HJO_ENVW_Q5'_" _$G_HJO_ENVW_Q5>GT4 >8?\(#\2?\ HJO_ );MM_\
M%4?\(#\2?^BJ_P#ENVW_ ,57I]% 'F'_  @/Q)_Z*K_Y;MM_\51_P@/Q)_Z*
MK_Y;MM_\57I]% ')?#?P(_@'1[ZWN-3DUB_U"_FU&\O'A6$2328R51>%&%'&
M3SGH" .MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH EHKEK[XJ>"M+\9VWA"\\8:#:>++H*T&@SZG E_*""04@+;VR 2,#L:ZF@
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ML?RH OT45BW'C7P]:ZH-,FU[3(=2;@6<EY&LQZ_P%L]CV[&@#:HHHH ****
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M?0V6I:WINGWDV#%;W5W'%(^3@;58@G)XXK75@ZAE(92,@CH: %HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_%OQ6_9T3XH7'C,CQGK5@VN6&@R6;3?:XW0R1K).SAA+*"#G:0"PSG)(V_\
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M ,$C?V4-6^$O@G5?B;XJM)M.UOQ3 EOIUA.NUX=/#!_,<'D&5@I /\**?XN
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MX*TX1PS&,Y32M+5V8[GZ&>4EL>K-TVH2/W L[.'3[."UMT$4$$:Q1HO1548
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M  4!L/ .A:W\'O -S'J'BW4H'LM;U*%MR:7"Z[7@4CK.RD@_\\P?[WW0#/\
M^"._[2GBOXAZ1XN^'?BG4KK7(= MX;_2KR[=I9XH&8QO 7).44A"@/(W,.F
M/&F_9/\ CQ^W?^TYX@O/BW;^(OAYX;MUENK6;4["1[>UM_,VPV=H,B(OC!8A
ML_*SMDGGZI_X)4?LH:M\ OA7JGBWQ9:3:=XJ\7F%_P"S;@;7L[./<8E=>JR.
M79V4\@; 0&#"OI?]IA?B-)\#_$\7PF3=\09HX8M+;? GEEIXUE?,Y\L;8C(W
M//' )Q0!^05M'XT_X)G_ +:6G>$]"\63>(-"NI[%[VU1&BBU*SG8*4E@W,%E
M7+[6!)! (X8K7[F5^%'@6:?]G?\ ;4L->_:VT'7M3U]IX=1@U*6]CN(4DW;8
MKMPH83Q(5&%C==ACQM;;L'[I6MU#?6L-S;2I<6\R+)'+&P974C(8$=00<YH
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M_ :]ZJ*UM8K&UAMK>-8H(46..-1@*H& ![ "I: /Q+_8-_Y2A7__ &$_$/\
MZ!<5]/\ _!:'QQ-#\)_ 'P_L-TFH^)=<-UY$9RTD=O'L"8]Y+F(CW3ZU]4>
M_P!BWX-?#'XH2?$7PUX._LWQE)+<3-J7]J7LN7G#"4^7),T?S;V_AXSQBK/Q
M<_9-\ ?'#XD^$/''BNVO[O6/"KQ2:='%=F.W#),)AOC ^;+ 9SU  H V]!AT
M/]F?]GG3HM4N%M]"\$^'8TNIU&28[:W =@.[-L.!U);WK\'OC3^TA+^UG^T'
M;>)?B=JFI:1X*%T8H;'2XQ<2:98 Y\J!&*J96 &YSU8Y(P H_H&^(WP[\/\
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M33-YW+'' '"C@ "OHW_AUQ^S%_T3/_ROZI_\DT?\.N/V8O\ HF?_ )7]4_\
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M^=%8]R<YZFND^%?PQT'X,_#W1/!?ABWDM="T>$P6L<KEWP6+DLQZDLS$GU-
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MM[]E?]DWX>QZ'H.G>+KS6[M4DUC7)M)A\Z^F _Z[_+$I)V(. "2<L68^J_\
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MW\!.4,8B1@KC.TJV,X# G)Q\K_LGIJ/[4W_!2Z7XA>']+N;+08=<NO$=U(P
M^RVHWB(2$<;Y&,:E1G)9NH!-?HYXX_X)H_L[>/O$DNN7O@&.PO)Y/-GCTF^N
M+."4_P#7*-PB>OR!<FO:?A+\$_ WP)\-#0/ ?AJR\-Z9G<Z6JEI)F&<-+*Y+
MR,,XR[$XXH [>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?=_B_P  ^'/B!X5N?#7B71;+7=!N(Q'+87\(EB8#H<-T(ZAAR",@YKYNT_\
MX):_LV:?KG]I+X!DG52&2RN-7O)+=&!SG:9<L/9B1@=* /FS_@B5\,=<TO1O
MB'X\O;>:UT+53:Z;I[-PET\32M,X'<(610W3+..JFOU#JEHNBZ?X<TFUTO2;
M&VTS3;2,16]G9PK%#"@Z*B* % ] *NT %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\5?F-_P2Y_9:^'?[3FO?$*U^(.DW&JPZ/;64EFL%[+;;&D>8/DQL,Y"+U]*
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MTRW\OZ8%P7_\=[5]8_!7X[>!_P!H3P<OB;P'KL.MZ7YAAEVJT<MO* "8Y8V
M9&P0>1R"",@@T =_117S7_P4'_:*O?V:OV;=8U[1I1!XEU2=-&TF;&?)GE5V
M:7'JD<<C#MN"YXH L_M!_M^?!O\ 9MU*71_$OB"74O$<2[I-#T*$75U'P"!)
M\RI&Q!!"NZD@YQCFO'O#?_!93X#:YJL5I>6'C'P_ YP;[4M+A:%.>X@GD?\
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MZ, 58>Q!%?F#_P %K/CC]DT?P;\)K"XQ+=N=>U55/(C3=';(?9F\YB#WC0T
M?4?[/_\ P4:^$?[2'Q&M_!'A<ZY9ZY<V\MQ;KJUFD,<WEKN9%*R-EMNYL8Z(
MW/%?45?S?6ND^-/V-_C!\-O%E[:FVU,6FG>++&(DKY]K,-QB?TR!)$P[?-7]
M%7A'Q3IWCCPKHWB/1YQ=:3JUG#?VDP_CAE0.A_%6% &O7RE\:O\ @IM\"?@G
MK5UHUSKUYXKUBU?R[BS\+VZW7E,#@J96=(MP(.5#DC&" :\[_P""MW[3&J_!
MGX/:1X,\-7LFG:]XSDFBGO(&Q)#81*OG!2#E6D:2-,_W?,'7!'RQ_P $[?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 'XK?\/J_C?_ -"M\/\ _P %U]_\F4?\/J_C?_T*WP__ /!=??\ R97[4T4
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M;W$6J:J9YX6A$Y9RSP%"Q=C\F-I4 '"UYC_P1$F1?BU\2(2P$K:' ZKW(%P
M3^&X?G0!^P5?FE_P6^><?#'X9*N?LQUBZ+\\;A"NW]"U?I;7S#_P46_9SO\
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M7_"#R0Z0MU_;'ANYD)*2VQ;$MI(?XMH9HF&<E&5N-U;'B;_E+A#_ -E,M/\
MTKCK]4/VXOV7;3]JGX&ZEH$4<4?BK3MU_H-V^!LNE7_5%NR2CY#V&5;G:* /
MRK_X*@?&'0OCWX^^%GCKP[)NTW5_!4$ODLP+VTHO+L20OC^)'#*?7&1P17[1
M_!'_ )(OX!_[%_3_ /TFCK^9C5K*^TB_N-,U&*:UN[&5[>6UN 5:"16(="I^
MZ0P.1ZU_0;\0/C1%^S_^PI:^-S(J7MAX1L8]/5L?/>2V\<< QW'F.I/^RK'M
M0!^5'_!1;XL?\-%?MFWNB6>IVMKH>AW,/A:RO+R=8K6)EDVW$\CL0JH)GDRY
M.-D:DG KZZ_;\A^!GC+]B[3/"O@KXF>!]1U?P#':2Z+9V?B&SEN+B*)!!+$J
MK(69FC)? !+-&O<U\1?L4?L4ZM^VQXE\6"3Q0WAC3]&@CGN=6DL#?--<3.=D
M>TRQ\D)*Q;<<;1Q\V1]:_P##C'_JMG_EJ?\ W;0!8_X(J_'3SK+QC\)-1N/G
MA/\ ;^DJ[?PG;'<H,^A\EPH_O2'UK]&_B]\)_#?QP^'>M>"O%EE]MT358?*D
M"D"2)ARDL;$':Z, RG'4#((R*_!WP^VM?\$^_P!MZUAU"Y>[_P"$2UE8;NXC
MB,?V[395 9Q'DX+V\NX+EMK$<G;FOTF_X*M#XA#X#^'?'GPR\4^(-,T[2[AC
MJW_"-ZG-;I/8W$:[9Y/*<>8BLJ#O@3$],F@#Y!^-/_!';XL^"+ZYN_A]?Z?X
M]TA7+00^>MEJ"KU&Y)"(R1ZK)DX^Z.!7E.C_ +0W[4W[&6NVFGZMJ?BK0H$/
M[K1_%D,ES8SH,96(397;ZM"P/N*^M_V O^"G7@[PK\+[;P-\9?$&I6.K:;-+
M]C\1WT<]\MY#)(7"2N@>0.K.P!8;=@7YAC%87_!3#]O3X2_&[X/1_#[P%<R>
M+;^;48;R35C9RV]O9"(MG8955G=L[<JNW:S?-T% 'WE^QK^U%I_[6GP9M?%T
M%FNEZQ;3MI^K:<C%E@N556)0GDHRNK+GIDCDJ37X[?L%?\I!/ W_ &&K[_TG
MN*^]?^",'P]UGPS\ _%'B/4H9+:P\1:NKZ<D@(\R*&/8TJY'W2Y9<]_+-?G!
M^RW\3?#_ ,&_VQO#OC+Q3=266@:5JUY)=W$<+2LBM%,@PB@L?F9>@[T ?T45
M^'/_  6)6 ?M?*80HD/AVR,V/[^^;&?^ [:^^-<_X*X?L[:7I=Q=6FMZSK-S
M&I*65IH\R22G' !E"(/Q85^94T?BC_@I+^VG-<V6FS6,.NWD33K&P<:5I4(2
M,N[XQE8P.<#=(P Y8"@#]O/V>;AH?V=?AG/?.L+IX5TQYWD8 *1:1EB3T '-
M?A[XZ\=:/^V#^W@^K^)-<L=$\%ZOKZ0&_P!6O$M+>WTBWX&9)&"HS0Q'C/,D
MF!R:_57_ (*/_&"V_9^_9!UJPTEUL=1UV)/#.E11'!C21")2.X"P)( 1T8IZ
MU^:'[$O_  3GU']L+P7K_BB;QC_PA>E:??+I]LYTG[<;N0('E_Y;1;0@>+GY
MLESTV\@'T3_P5OU+X3_%CX;^#_%7@GX@>#==\0^';HV$FFZ-K=I//)8S#@K'
M'(6(CD1, #@2N>U>Q_\ !'OXZ?\ "POV?[[P'?W'F:OX+NO+A5VRS6,Y:2(^
MIVN)D]E"#N*\A;_@AB=IQ\;,GMGPI_\ =M?,W[!_Q(U+]D_]M>ST'Q$WV"WN
MKZ;PCKL3-A(W:7RT<D\ ).D9W'^'=TS0!ZY_P6T:X_X7QX##?\>G_"-9CZ_?
M^U3;_P!-E?HE^P']C_X8V^$_V'_4_P!C)N_ZZ;W\S_Q_?7@O_!7;]FO5?B]\
M(]&\<^'+.2_UGP8\SW=I FZ26PE"F5P!RQC:-&Q_=:0]J^<O^"<?_!2#PW\#
M? Z_#/XH27EIX?M9Y)])UZ")[E;1)#N>"6) 7V;R[AE#'+D$8P: /V'K^?+X
MU20_\/&O$;:,3N'Q%^3'7SQ?+O\ _(FZO2KW_@HE\6?@5\8O$MWH?Q1TGXM^
M&M6N)[Q;:2WNOL5OYK%E6)9T22 ID8C1FC&,'=7/_P#!-?X17_[0G[7>G^)M
M:OXIX?#MW_PDVI2W4R^?=W(D+Q;5)RQ,V'8@8 4Y()7(!^\=?/G_  4!>>/]
MC/XKFWSYG]CD'!_A,B!O_'<U]!US?Q(\#6/Q.^'OB7PAJ99=/UW3;C39W4 L
MB2QLA9<]QNR/<"@#\H/^"(D=J?BW\2)'/^FKH<"Q=/\ 5FX&_P#41U^P=?S_
M 'P5^(?B[_@FW^UE?IXFT26Y:R672M6L$;9]MLI&5EF@8\$$I'(A/!QM.,G'
MZ<ZM_P %9OV=K'P=)K-KXDU+4=2$1>/08M(N$NV? ^0LR"$'D<^9CK@G% 'V
M17Y__P#!8SXW:M\._@;X?\&:/<R64OC2[FBO9HFVL]E B&6'UP[31 XZJ&4\
M,:^+OV9?B!\9?VJ/VWI-;\->(M=\-0ZYJXU77QH][(EM:Z<A4&-QG:P$2I"F
M\'+;>*^R?^"S'P>U7QQ\$?#'C/2K:2\'A"_F-]'$FYH[6Y5%:;_=5XH@?0/D
M\ T >>_\$VO^">_PU^(WP,L?B5\1]%_X2F^UZ:X&GV,]Q+';VEO%*T.XJC*6
MD9XY#EB0%V8 .2?GS_@I!^RSI/['7Q>\'>(OAO-=Z-HNM"2]L(/M#R2:=>6T
MD9;RI&RVW]Y"R[B6!W<XQ7T?_P $U/V_/AIX'^ ^G_#7XA:]%X3U/P_+/]BO
M+U'-O>6\LKS??4$*Z-(Z[6QE0A!/('SI_P %,OVJ-"_:S^*WA#P[\.UN-<T;
MP^LMK:7<4#AM1O+EXPPBC(W%1Y42KD LQ; Q@D ^O/VIOB[=?'C_ ())OXZO
MXXX]1U:UTQKP1+M0W$>I0Q3%1V4R1L0.P(%?-O\ P2?_ &2? WQ\O/&?BKQ_
MI0\0Z?H3V]I8:7<,PMVFD#.\L@4C>55$ 4Y7YR2#A<?2'[4/PFNO@;_P2._X
M0B_*G4M+M-+^V!3E5N)-2AFF4'N!)(P![XK$_P""(?\ R2SXE_\ 89M__1!H
M ^+?^"EGP3\+? 3]I^ZT;P78#1M%O=,M=3CL(G8QV\CET<)DDA28MV,\%B!@
M8 ^_O#__  3A^$&C_L9W"W_AJ+4?&=QX7?5)O$<TD@NH[TVYF5H_FPB(Q"A
M,%5&[<22?C[_ (+)?\G<6?\ V+-E_P"C;BOUTU;_ )-MO?\ L4G_ /2,T ?E
M)_P17UJZM?VF?%.FI*PLKSPK/)+#GY2\=U;;&(]0'<?\#-3_ /!;#_DY+P;_
M -BE#_Z67597_!&'_DZ_6_\ L4KS_P!*K2M7_@MA_P G)>#?^Q2A_P#2RZH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1TRK,0<<C'%?<%% %32M*LM!TNTTW3;.#3].LXE@MK2UC6.*&-0%5$10 J@
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MR&C;+;I&YSTQ0!XTO_!,?X-_M"?#'X>>*;V'5O"FO7?AS3)+VX\.SQ0I>/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^W?;/]6%._S/+CZ[NFWC'6O<*^(/^"/7_)GZ?]C!??RBK[?H X;XT?&CPG\
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M* "OSZ_:*_X+!>"/A7XJO_#?@?PW+\0+RQE,%QJ?VT6M@)%.&$3!':4 @C<
MJGJ"PYK[0^-UKK%]\%_'UMX=>2/Q!-X?U"/3FBSO%R;:01%<<YWE<8K\)OV
M/B!\'/AK\;YK_P"-6C6]_HKV+0V-Q?V)O;:RN_,0B22#:Q/RA@&VMM)!Q_$H
M!];^%?\ @N))_:$<?B7X3J+%I/GN-*UK,L4>3R(Y(<.V,?QH.#TS@?HG\"/C
MYX-_:/\ A_;^,/!&HM?:7)(T$L4R>7/:S+@M%*G\+ $'J00002"#7S]\8/@W
M\ OVX/A!J^B_#S4? ESXJ\CS=*U;2?(6YL9@0P$JQ#S5C;!#*R]&SC(%4_V
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MR ?4[<?C7\\_PSOKK]FSXS?!?X@,[)8W2V>OY;O;?:9;>X7/OY,X^AK];O\
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M[3WB2'PEJ.DS>!_&4ZEK6RNKE;BVO2!DK#-M4[\ G8RC('!8YQZK^V3^T_\
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M1/%-C +B\T'4MOF"/.TR1.IQ*@) )&"-PRHR,_1U?FO^SO\ \$K_ !I^S_\
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M9(6D7C*A,#."V00/!O#/_!<0OJ\*>(?A/Y.EL<2S:9K/F3I[JCPJK?0LOUH
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MDS74LLU]<6NX$PR1H@7!0M$Q+C().,&OT5^-OQJ\*_L^_#G5/&OC&]:TT>Q
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M:+^QSK'C.\UGPY?^(5UZ"UAC6QF2,Q&)I22V[KGS!T]* /WUK^?GX0$^(O\
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MEM??L@);P2J\UEK][#.H/*,1'( ?^ NI_&O@'_@FQ_RD,\-?]=M8_P#2.YH
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M\@G&#QS0!^\5%5]/OHM4T^VO(#N@N(EFC;U5@"/T-6* "BBB@ HHHH ****
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M/4/ $?A]M%L%O+C5K/4&F@=VD")%Y;1@H6'F,#O;B,U^<O\ P5@_Y/:\7_\
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MO:JJ+$;E86?8.BC=*Q Z"OTY_P""0W_)FVG?]AJ__P#0UK\]?VL_^4H6J?\
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M,DKAYI.N &BX 4#IBODO]D/6)-0_X*'>#]1CT4>%6N_%ES(=$C4H-/$AES;
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M?L0_MO#QUING%](GUL^)="GD4_9[A&D\R6V+8X*%VC(ZA2K?Q T >V_MV?\
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ML6-[;172X864!B@CD)Z$E+?)()&X, 3B@#]0/^"R7_)H]G_V,UE_Z*N*RO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M->+M&M=?T*Z9&FL;Q=T;E'#J>.X90?PKHZ* .$^%?P+\ _ ^UU"V\">%=/\
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M16N8F#J+LRW,600>8Y79#R.XKZ$HH CM[>*SMXH((D@@B4)''&H544#   X
M [5P7Q4_9]^&_P ;H84\=>"](\2O"-L5Q>6X\^,<\+*,.HYZ XKT&B@#PCP=
M^PK\ _ 6L6^JZ-\+]#BO[=Q)#-=(]WY;#HRB9G (Z@XX.#UKW;IP.!2T4 %(
MRAU*L RD8(/0TM% 'S]XR_8#_9[\>:A<7VK?"S15N9\F1].,MAN).2V+=T&X
MGOC-=)\+_P!D?X.?!C5%U/P=\/-%TC5%.8]0,)GN8^,'9+*6=/\ @)%>NT4
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M'##LPP1ZUX[HG_!/O]G?P_JT6HVGPJT5KF)@ZB[,MS%D$'F.5V0\CN*^A**
M([>WBL[>*"")(((E"1QQJ%5% P  .  .U>4R?LG?"&3XB#QVW@'26\7_ -H#
M5/[7V-YWVH/O$N=V-VX9Z5ZU10 C*'4JP#*1@@]#7@?BK]@G]GWQIK$VJ:G\
M+-#^VS$M(UDLEFKL3DL4A=%R3U.,FO?:* .3^&_PF\&_!_0SH_@KPSIGAG3F
M;>\.G6ZQ>8W]YV'+MSU8DXXKJ+BWBNH)()XTFAD4H\<BAE92,$$'J".U244
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MO$^Q<8\K,[8;JVP'HU?5L\\=K#)--(L4,:EWDD8*JJ!DDD] !0!)17PA?_\
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M) !](45\#ZU_P4$^-/PEM(?$7Q6_9JU30/ \DJ)-JFFZD)I;)&(&Z1-F,YX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB'C.Z\!_L8?%#4K*1HKF;3X].5E;:VVZN(K9\'_<E;\J^=OV=?\ E,#\?/\
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M1:KYU]?&Q@5[V[8#S9V_>]R  /X555[4 =W_ ,$6E6/X4_$Y54*J^)0 JC
M\A>*^D_V^_BC_P *C_9(^(NL12^5?7>GG2;,J<-YMT1!N7W579_^ 5^>W_!+
M?]KC1?A'=7GP_O?#&O:I?>-/%=K%;7]A$C6UH9C' #,2P( )W' /%?5_[>7_
M !=OX^?LZ_!"+]]:ZIK[>)M9@_Z=+120#QT9/M0YXRHZ\4 >U? /X2ZS\)?V
M/?#/@?P_)'I?BNU\,L(9;A?D@U.:)I69@5;@7$C$Y4\#H>E?GW^UM^P/!\$_
MV8/''Q/\>>+[_P"(OQ7O;FQ$NKW+N(+;?<QJXC#$LYVY7<_&WA46OUWKX_\
M^"L'_)DOB_\ Z_=._P#2N*@#VO\ 9._Y-9^#?_8F:-_Z0PUXC_P5&\67MO\
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M>G&X[I9Y#R\LK?Q.QY)^@    \^_:T_:^\&_LE^"5U/77_M+Q#?*RZ1X?MW
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MEM_E03>9G8@/,AYSVXKVW]NK_DS_ .+?_8OW'\J^"O''_*$OPA_U^K_Z=IZ
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M#Q%\;? OAGQ9\/)9Q%?:GX19EN;$N0$R2^T#)V@,@#$!?,4D$_:W_"XO"/\
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M5H]"FURW>WUS499/+6/30MLSJ6 +8>01(0@R0V#A2U?3O_!)_P")FDZ+X/\
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M?[ OQ,^''QA^#(D\)G4-1:RU;PY9S-]COE0*^WRR3A73>K*. 2C+M;D_0O\
MP5#\07FK?!GPC\+M'D*:U\2O$UCHD<>"&\D2K([>N!(( 1Z,: &_L._L[67B
M#]@:T\-^*Y+Y/^%B)<:UK$UK,89YENG&PA\?QP)#GCD,1WKV'1[CX1_L*?!W
M0/#.H>([7PKX7LS-'9S:Q.#/<R,[2R?=4&1\N3\JYQCTKT>ZU+PK\&? -JVJ
M:KI_ACPKHEK!9K>:I=1VUO!&H6*)6D<A1GY5'J2 .M8'BKX;_##]I+P[H.JZ
M[HFB>/M#\IKG2[FX5;F#9*JYDC/0[@J\^U 'P_\ LRR7G[3O_!1;Q/\ 'KP?
MI%W8?"_3[!]-36;J!H%U686R0 *#RQ)^?'\*HF[:S 5]B_M4?#/Q_P#%[X7C
MPK\//&(\":C?7T2:AK W>:ECM?S5CV#=O)\OHR9&1N SGX;\;^$8OV#?^"@/
MPLLOAA<W6G^"/B-<P6FI^%1.\MNAEN!;NRJ23A2Z2)W4HR@[3MK]1J /Q[^,
MW[)?A+]DG]IK]DO1/#D]YJ>H:EXKM;C5-7OF_>W<JZA9!<(/E15W-A1SR<EC
MS7["5^=7_!13_D]#]D#_ +&:#_TXV-?HK0!\1_'P_P#"Z/\ @HK\$?A\F9M*
M\"V%QXSU-5Y"S%@+?</59(H#])O>O9;K]D?P_?\ [6%O\>+S6+Z]URUL/L-K
MI5Q'&UK;#RO+#QG;N#8:4\D\R'I7C/["7_%W/VA/VB_C;)^_M=0UU?#&C3]C
M:6B@$CCHR"U/'<'J:^D?V@_VB/!G[,_P^N?%OC/4/LULI\JTLH0&N;Z;&1%"
MF>6/<G 4<D@4 8/[9GQ#\,_#7]F3XA:EXJ>W:QNM(N=/@LY\'[9<S1-'%"JG
MJ2Q!XZ ,W12:\1_X)E?#C5_^&#;?2=5N+S21XE?4I;*9%"S6UO/F-)4##')5
MI%)&#N!Y!KR?X8_!'XB?\%'?'VF?%?XV03>&OA%8OYWAOP5&[+]MC."';H=C
M #=*0&D'"!4P1^E-E96^FV<%I:01VMK;QK%#!"@1(T48554<     >E 'D?[
M*_[,?A_]E'X:R^#O#UY<:G!-?S7\M]>1HL\K/M #E  =JHJYQV[5\:_\%.M9
ML/B9^T5\ OAEX5"7WC^VU<74\EJH>6QBEDA\L.1TXC>4@_=5 QX;->P?MA_M
MU7/P]\21?"+X.Z<WC3XSZHPMDM[6,31:467.Z0=&E"_-L/RH!ND(48;7_8K_
M &(?^%#7-_\ $+Q_J9\7_&/7PTNH:M,YE6S\SEXHF/+,3]Z3C.-J@+G< ?6U
M?*7_  4&_:N\6_LH>"_!VK^$=.T74;G6=8_L^X76H)I46/RRV4$<L9#9'<D>
MU?5M?G5_P6B_Y)9\,/\ L9C_ .B&H ](_;B_;GUS]D;XI_#C3(=&T_5?"VM0
M7%SJJR02/?;8V4!+=A*J*S;L9=6&37"^+_C-^W5I_AVZ^(=K\-_!VF^'8+=[
MW_A%92US?Q6X!;,H$JN\@4<JA5NVP'BL;_@HII<&M?MN_LI6-RN^WFUB!9$(
MX9?[0M\C\>E?H\ZK(K*RAE88*L,@CTH \-_8U_:>M/VLO@K:>,X[!-(U2&YD
MT[5-/CD\Q(;E K'8QY*LCHXSR-V.<9/NE?G7_P $2V/_  H'QT,\?\).3C_M
MU@K]%* /E+]I[]J[Q;\%?VE/@=\/=#T[1;K1?'&H1VFI3ZA!,]Q$C7,41,+)
M*JJ=LA/S*W('TK@?VF/^"@GB_P" /[5D/PTL/"%CXKTN\TB"33K&TBE74KO4
M9RR00B7S-BQEPN?W9.,XR<5RO[?O_)]W[)?_ &&8?_2^WJI\0]+@U3_@M%\/
M%N%WI#H!N%4C^)+*]*G\#@_A0!/\3?V@OVW_ ('^&[KXB>*O O@>[\)VX2:_
MTFPW326$1(!+%)M^1G!<&15QDC K[.^!OQVT/XW? W0/B;;%=*TG4+%[NY2X
ME!6R:,LLZ._ PCHXW$#(7.!FJ?[6:K)^RO\ &0,H8?\ "&ZP<$9Y%E,0?SKX
MK_9YOKZQ_P""-GBR6P9A<#2-=3*D@B-KB99,?\ +T ;^@_MB_M#_ +6GB[7G
M_9V\)>'M,^'^BW7V7_A(O%@?-Y(,-CAOEW+@[%5BJNI9@6%> ?M(?&;XA?$'
M]J[]G#PK\5O!4'@[QWX7\4V[7+Z=(7T_4;>XOK/R;BV)9CMS!(I!9L%>H.Y5
M^U?^"5=I8VW[#_@62S"^=<3ZC+=D* 3+]NG7G'?8L8Y[ ?2O)/\ @I=I]E'^
MU!^R+?*J+J,OBCR9&"C<T2WNGE03Z!G?'^\?>@#ZS_:D_:6\-_LJ_"F[\:>(
M8I+YO-6TT_2[=PDM]<L"5C4GA0 K,S8.%4\$X!^8].^*?[>'B[0(_&VE_#[P
M%I6ER0FXM?"M^T@O9XC\R;LS##[<<%XSSRHZ#A_^"NJZWJ'Q:_9OTO35L1Y^
MJ7/V-M4+?9'NC/9*HGVC/EC*9QSM9J]=_P",]?\ JC__ )-T >E?LC_M<V_[
M5/@WQ!#_ &4W@[XA^')/L.LZ%J"-(+6XP0LH7*LT9=7!4E6!1E)Z,?/OV9OV
MT?&7B7]HGQ=\#_C5HVA^&?'.GL7T>718IHK;48U4LP42R2$EH\2H01E-V0"O
M.#^R/^RW\;?AW^UAXU^+7Q);PFD/BK2Y;>]M_#MS*5^TF2W976-TX'[ELG<>
M7/K7G7_!7B+P_!XD^%=UX5DU"+X]&]5-'700?M;V>YMN[9\X;SR/*QR290.^
M #V+6OVS/&_Q'_;"@^#?P7TK0=5T3103XL\3:Q;3W$=F5;$JP^5-&,KQ&-V=
MTC$<*A8_9M?#'_!(C_A7_P#PSE=GPRK#QI]O8>+#>8-T;C+>3[^3Y?W.V[S?
MXMU?<] !67XJU270_#&L:C J//9V<UQ&L@)4LB%@#@CC(]:U*Y_XA?\ (@^)
MO^P9<_\ HIJ /CWX'?MQ^._B9^PS\2OC/JFD^'8/%'AJXO(K.TM+:=;)Q#!!
M(OF(TS.23*V<.. .G?B/AC^V7^TW^UEX'LY_@_X$\,Z=)81>3KOB;6"T=F]]
M]XP6D32L<*C(26W\M_#\N[R[]DK_ )1'_';_ *_=4_\ 22TKZ_\ ^"7>EP:;
M^P[\.FA7#W7V^XE;'WF-_<#/Y*H_"@#A?V9/VU_B;J'[1EQ\"?CQX2TOPYXR
MDMFGTV^TG<D5R5C\W:07=7#1K(P=& RA4KG./5?VT?VQK']E3PUHUO8:.WBK
MQYXCG-KHF@QL1YC9"F23;EMH9E4*HW.S #'++\]?M#J(_P#@L%\!64;2WAE2
MQ'&?FU4<_AQ5/]HZ'^T?^"O7P*M=8 ?2X]&BGLTD&Y!(IOV1@#QN\Y%YZ_*O
MH* -KQ'\7/VZ_AWX3N?B%KW@OP)J&A6</VV_\-66\WEO;@;I"-LI.57.<.Y&
MW.T\Y[[XG_M":'^T[_P3>^(?CO0X7LENO#]U!>:?*P=[.Z0 21%@!N )!#8&
M593@9P/L::&.XADBEC66*12KQN 592,$$'J*^6?VDU^'D/[#/Q=A^&@\,IX?
M71;DM'X4%N+02;%'(@^7=M"^^ /:@#PKX7_'_P 0_LS_ /!)GP)XZ\+V>F7^
MKVLTEND.KQ220%9-4N%8E8Y$;.#Q\WYU]W_!_P 77GQ ^$G@CQ3J,4$.H:YH
M=CJ=S':JRQ))-;I(X0,20H+' ))QCDU^8GCC_E"7X0_Z_5_].T]?H_\ LQG/
M[-OPG(Y'_"):3_Z1Q4 >._#W]J[Q;XL_;\^(7P/O-.T6/PGX>T<:A:WD$$PO
MGD,=FV)',I0KFYDZ1@\+SP<Y_P"UY^VKKWPK^(GA[X0_";PS!XU^+>O*LB6M
MR2;:QC8,5,@5E)8JK/@LH5%WL<$9\F^"3K)_P61^-15@P_X1I1D'/(BTL$?G
M5+X $:M_P6&^-,^LG=?6FARBQ$@SM %A&FTGH?))Z=B>?4 J_M&_&7]J+X5_
M /QK9_&KP7X:UWPAXCT:\TEM<\(R,)M)N+F)HX/M"LVTQ;V5,A>_WR<*WLG_
M  35U270_P#@GKX9U&!4>>SAUBXC60$J62\N6 .".,CUKVS]KW3[+4OV5?B]
M#J"HUL/"FIR_O%!"NEK(Z,!ZAU4CW KP?_@G=_RC=T?_ *\M<_\ 2JZH I?
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M^$.T6=K*X\:>*F;RYY@>&A4,  1\P7;(VTJS!-P6O._V6OA[KF@_\$]_C_\
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ML^&'_8S'_P!$-79?\%8/A??:M\&/#_Q3\/;H?%'PXU6+4X;B-<NEN\B!R/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/NI1&9F<JTKIN9=P=E$G!WJ^<!E8J.'_ &C_  1^UE^V[\+[_3M0^'-G\.-
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M5G[.>D_M2?!?5_ NISBPN)62[T[4?+\PV5W'GRY=N1D89D89Y5V P>:]?HH
M_/'X?_$?]LK]G;PA8?#W4?@K9?$M-)C&GZ3XDL=514EMT&R(RX;)   RXB;
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M=J@>_6_QB_X*$-<1";X%^ $B+ .RWT.0N>3_ ,A7TK[[HH *^+_^"G7[/7Q
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\#7 ?'K]M3X0_LVZA%IGC;Q4EMK<D8E72;&"2ZN@A'#,J B,'MO*Y[5\,?\
M!3[]I;X;?M'_ +*_A?4/A]XGM]=6S\70+=6WEO!<VY-E=XWQ2*K@'D!L;20<
M$X- 'ZK1R+-&KH=R, P([@TZJFD_\@JR_P"N*?\ H(JW0 45XS\=?VPOA)^S
MA-#:>.O%]OIVJS+OCTJUBDNKLJ>C-%$K%%/.&?:#@X)-9/P/_;H^"W[0NM+H
MGA#QA&^OLF]=)U*WEL[B0=Q'YBA9",$D(S$ 9(QS0![Y17&?%OXP^$/@7X+N
M/%OCC5_[$\/V\L<,EY]FFN-KNVU!LB1V.3Z"O'/BA_P46^ OPEOK*QU?QE]L
MO[J"*Y^RZ79S7+PQ2('1I<+B,E6!V,0X!'RT ?2U%><_!/\ :(^'G[16@W.K
M_#[Q-;>(;6U=8[J-$DAGMV(.T212*KKG#8)&#M."<5Z-0 45Y_XX^/G@/X;^
M//#'@SQ)KZZ7XD\3;_[*LWM9W6?9]\F14,<8'J[+7B&K?\%1/V<]'\72:!+X
MWDG\J0POJ=KIUQ-9!@<'$JH=PS_$H*GJ#B@#ZOHKPOXR?MM?!KX%Z/H]_P")
MO&=K)_;-JE]IUKI:M>375NXRDRK&#B-AG#L0IP<$D5M? +]JCX9_M,Z??7/@
M#Q$FJS6!7[98S0O;W,&[[K-&X!*G!&Y<KD$9S0!ZU17%?%CXT>"/@9X8;Q!X
M\\2V7AO2@=J273$O,W7;%&H+R-CG:BDXYQ7A7@O_ (*>?LZ^./$4.C0>.&TN
MYN)1#!-J^GSVMO(QZ9E9-B#WD*C]* /JJBJEYJEK8Z7/J4TRBQAA:X>9<N/+
M"[BPQG(P,\5\^ZM_P4,^ .C_  [M/&K^/X9M%O+B6UM$CL;D75S)'C>$MVC$
MFT;ERY4)D@;J /HVFR2+%&SNP1%&69C@ >IKP?X%_MR?!G]HK6UT/P;XM67Q
M"T;2KI&H6LMK<.J@EMF]0LA !)",Q !)XKYI_P""P?Q\T'0_@_'\,++Q+<V'
MC;4+JUU"?2K>.X3S]-(G1M\JKY;(709C+9.T';WH ^]O$OC+1/!_A6]\3:SJ
M=O8:!96YN[C4)&S%'"!G?D9XQW%1^!?'>@?$SPK8>)?"VJV^MZ#?AFMK^U),
M<H5V1L9'9E8?A7QQXV_:$^'_ ,=/^">OQ,MO ^O_ -MS>'?!\-GJB_8[BW^S
MS&  +F6--W,;\KD<=>17.?LB?MC?"3]FS]B/X4V?CKQ9%8:O/:7TT.DVD$EU
M=NO]H7.&*1J=@/."Y4'!P3B@#]"**\=^ /[7'PL_:8CNT\!>)H]1U"SC$MSI
M=S"]M=PH2!N\MP"R@D LFY02!G)%>Q4 %%%>$?'+]N#X,_L[ZLVC^,O&$4.O
M+&)#I&GV\EW<J#R XC4B,D8($A7(((XH ]WHKR'X%_M:?"G]I#[5'X!\6V^K
M7UJ@>XTZ:*2VNHU/\7E2JK,HZ%ERH) SS6UX^_:#^'_PO\<>&/"'BCQ"FD>(
M?$I8:7:R6L[K/M(#$RJACC R.7910!Z)17R?K7_!4C]G'0_%$NBR^.)+D0L4
MDU*RTRYN+,,#@@2(A+C_ &D#*>QKZ5\%^--"^(GA?3_$?AG5;76]#U"/S;6^
MLY \<JY(.#Z@@@@\@@@X(H VZXWXH_&+P7\%=#MM8\<^(K/PUIES<"TANKYB
M$>8JSA!@'G:C'\#7 ?'K]M3X0_LVZA%IGC;Q4EMK<D8E72;&"2ZN@A'#,J B
M,'MO*Y[5\,?\%/OVEOAM^T?^ROX7U#X?>)[?75L_%T"W5MY;P7-N397>-\4B
MJX!Y ;&TD'!.#0!^JT<BS1JZ'<C ,".X-<;\3OC-X)^"^GV%]XW\267ANTOY
M_LUM+>L0)9<9V# /. 374Z3_ ,@JR_ZXI_Z"*_/7_@M%_P DL^&'_8S'_P!$
M-0!^BM%?,?C[_@I+^SY\-_&=QX8U7QSY^HVLQ@O)--L+B[@MG'4-)&A5L="(
M]Q!!!P017O?@'XA>&_BEX4L/$WA/6;37M"ODWP7MF^Y&]0>ZL#P58 @@@@&@
M#H:*\F^.7[57PM_9OBM?^%@>+;71;J[7?;V"1R7%U*N2-PBB5F"Y!&X@+D$9
MKRCP%_P5"_9Y\?>(H-&B\7SZ'<W#B.";6[&2VMW8GH92"B?5RH]Z /K"BLKQ
M+XJT?P;X=OM?US4[72=%L83<7-_=RB.&*,?Q,QXQ_/(KY9/_  58_9M76GL&
M\9WBPJ2/M_\ 8MVT!()'&(RYZ9SMQ@T ?6MY>0Z?9SW5S(L-O!&TLDC=%51D
MD_0"N7^&/Q:\'_&;P]+KO@CQ!9^)-(BN&M'N[)B46955F3D#D!U/XBC2_''A
M#XE_#>;Q#I6LVNN>$;ZRE9K^QD,D;0[6$G*\@@;@1]X$$8S7DW[%S? O1?@O
MJD_P.U%G\!0ZK<37EU>&ZC$=T(83*2;M5<*(Q$<_=Z\]: /H>BODO7/^"IO[
M..@^('TI_&L]Z(W,<E]8Z7<S6RD8Y#A/G'N@8''TS]!?"GXQ>"_CAX5C\2>!
M?$-GXCT=V\LSVI8-&X )22-@'C;!!VN <$<4 =E1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 <_\0O\ D0?$W_8,N?\
MT4U?GK_P22_Y,O\ BO\ ]AF__P#3=;U^A7Q"_P"1!\3?]@RY_P#135^>O_!)
M+_DR_P"*_P#V&;__ --UO0!A?\$;_P!G_P )>)?A[XI^(_B'0[/7-8CU=M&T
MYM2A2=;.*.&.5VB5@0K.UQ@MUPF!C+9O_M^?#SP]\'?VP/V9/&?@W2K7PYK&
MM:_]GOSIL*P).(;JS 9E4!2S+=2JS8R1@'.!7H?_  1A_P"34-;_ .QMO/\
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M$U*XOOA%)IUQXHT:&Z61&B:%H@RJ) &!\N4H2PR1 A).,GZF\&_MX_LR>*_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M% 8LQ/')8D]:\JO?V(_@)J&L?VG/\)?"K7>_S#MTY$C9LDY,8PAY/=:]NHH
MH66@Z9INBQZ/::=:6ND1P_9TL(8%2!(L8\L1@;0N.,8QBL_P7\/_  O\-])?
M2_"7AO2/"VF23&X>RT6QBLX6D( +E(U52Q"J,XSA1Z5OT4 >,^*OV-/@=XUU
MJ;5M9^%OAFZU&9S+-<+8K$TKG&6?9C<3CJ<]_4UZ?X5\(Z'X%T.VT7PYHUAH
M.D6PQ#8:;;);P1YY.$0 #)]JUZ* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885897872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Nov. 20, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EMBECTA CORP.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-1583942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Kimball Drive, Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Parsippany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">401-0000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EMBC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,334,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">The information required by Items 10, 11, 12, 13 and 14 of  Part III of this Annual Report on Form 10-K is incorporated by reference to the Registrant&#8217;s definitive proxy statement for its 2024 Annual Meeting of Stockholders (the &#8220;2024 Proxy Statement&#8221;), which will be filed pursuant to Regulation 14A with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) within 120 days after the end of the fiscal year to which this report relates.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001872789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881515312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">ERNST & YOUNG LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885915040">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,120.8<span></span>
</td>
<td class="nump">$ 1,129.5<span></span>
</td>
<td class="nump">$ 1,165.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Product [Member]<span></span>
</td>
<td class="text">Product [Member]<span></span>
</td>
<td class="text">Product [Member]<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 370.9<span></span>
</td>
<td class="nump">$ 354.6<span></span>
</td>
<td class="nump">$ 364.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Product [Member]<span></span>
</td>
<td class="text">Product [Member]<span></span>
</td>
<td class="text">Product [Member]<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 749.9<span></span>
</td>
<td class="nump">$ 774.9<span></span>
</td>
<td class="nump">$ 800.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">341.3<span></span>
</td>
<td class="nump">294.8<span></span>
</td>
<td class="nump">240.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85.2<span></span>
</td>
<td class="nump">66.9<span></span>
</td>
<td class="nump">63.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">58.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">99.4<span></span>
</td>
<td class="nump">44.7<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">528.4<span></span>
</td>
<td class="nump">465.3<span></span>
</td>
<td class="nump">308.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">221.5<span></span>
</td>
<td class="nump">309.6<span></span>
</td>
<td class="nump">492.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(107.0)<span></span>
</td>
<td class="num">(46.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8.8)<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Income Taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">105.7<span></span>
</td>
<td class="nump">256.6<span></span>
</td>
<td class="nump">494.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35.3<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
<td class="nump">80.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 70.4<span></span>
</td>
<td class="nump">$ 223.6<span></span>
</td>
<td class="nump">$ 414.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Income per common share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 3.92<span></span>
</td>
<td class="nump">$ 7.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 3.89<span></span>
</td>
<td class="nump">$ 7.28<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">For periods prior to the Separation, this income statement line includes cost of products sold from related party inventory purchases. Refer to Note 4 for further detail.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885684416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 70.4<span></span>
</td>
<td class="nump">$ 223.6<span></span>
</td>
<td class="nump">$ 414.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other Comprehensive Income (Loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Benefit plan net loss and prior service credit, net of amortization</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="num">(64.2)<span></span>
</td>
<td class="num">(8.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), net of tax</a></td>
<td class="nump">15.8<span></span>
</td>
<td class="num">(64.2)<span></span>
</td>
<td class="num">(8.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income</a></td>
<td class="nump">$ 86.2<span></span>
</td>
<td class="nump">$ 159.4<span></span>
</td>
<td class="nump">$ 405.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885919968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 326.5<span></span>
</td>
<td class="nump">$ 330.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables, net (net of allowance for doubtful accounts of $1.0 million and $1.3 million as of September&#160;30, 2023 and September&#160;30, 2022, respectively)</a></td>
<td class="nump">16.7<span></span>
</td>
<td class="nump">22.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSupplies', window );">Materials</a></td>
<td class="nump">32.1<span></span>
</td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">8.1<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished products</a></td>
<td class="nump">111.9<span></span>
</td>
<td class="nump">93.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total Inventories</a></td>
<td class="nump">152.1<span></span>
</td>
<td class="nump">122.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Amounts due from Becton, Dickinson and Company</a></td>
<td class="nump">142.4<span></span>
</td>
<td class="nump">110.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">111.4<span></span>
</td>
<td class="nump">77.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">749.1<span></span>
</td>
<td class="nump">664.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">300.2<span></span>
</td>
<td class="nump">301.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and Other Intangible Assets</a></td>
<td class="nump">24.7<span></span>
</td>
<td class="nump">24.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent', window );">Deferred Income Taxes and Other Assets</a></td>
<td class="nump">140.4<span></span>
</td>
<td class="nump">95.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">1,214.4<span></span>
</td>
<td class="nump">1,086.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">53.5<span></span>
</td>
<td class="nump">41.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">118.1<span></span>
</td>
<td class="nump">104.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Amounts due to Becton, Dickinson and Company</a></td>
<td class="nump">73.1<span></span>
</td>
<td class="nump">66.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salaries, wages and related items</a></td>
<td class="nump">62.1<span></span>
</td>
<td class="nump">48.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current finance lease liabilities</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes</a></td>
<td class="nump">33.6<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">353.5<span></span>
</td>
<td class="nump">301.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred Income Taxes and Other Liabilities</a></td>
<td class="nump">57.2<span></span>
</td>
<td class="nump">46.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-Term Debt</a></td>
<td class="nump">1,593.9<span></span>
</td>
<td class="nump">1,598.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Non Current Finance Lease Liabilities</a></td>
<td class="nump">31.5<span></span>
</td>
<td class="nump">32.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Embecta Corp. Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value Authorized - 250,000,000 Issued and outstanding - 57,333,353 as of September&#160;30, 2023 and 57,055,327 as of September&#160;30, 2022</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(541.1)<span></span>
</td>
<td class="num">(577.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(309.1)<span></span>
</td>
<td class="num">(324.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Equity</a></td>
<td class="num">(821.7)<span></span>
</td>
<td class="num">(891.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 1,214.4<span></span>
</td>
<td class="nump">$ 1,086.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885697712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Trade receivables, allowance for doubtful accounts</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">57,333,353<span></span>
</td>
<td class="nump">57,055,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">57,333,353<span></span>
</td>
<td class="nump">57,055,327<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885209424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Net Investment from Becton, Dickinson and Company</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 30, 2020</a></td>
<td class="nump">$ 572.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 833.8<span></span>
</td>
<td class="num">$ (261.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentConsiderationPaidForSeparation', window );">Net consideration paid to Becton, Dickinson, and Company in connection with Separation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Diabetes Care Business/ Embecta Corp.</a></td>
<td class="nump">414.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of taxes</a></td>
<td class="num">(8.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentNetTransfersToParent', window );">Net transfers to Becton, Dickinson and Company</a></td>
<td class="num">(383.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(383.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">594.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">864.8<span></span>
</td>
<td class="num">(270.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments', window );">Net transfers to Becton, Dickinson and Company including Separation adjustments</a></td>
<td class="num">(380.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(390.3)<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with the Separation and reclassification of Net Investment from Becton, Dickinson and Company (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,012,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment', window );">Issuance of common stock in connection with the Separation and reclassification of Net Investment from Becton, Dickinson and Company</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (613.7)<span></span>
</td>
<td class="nump">613.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentConsiderationPaidForSeparation', window );">Net consideration paid to Becton, Dickinson, and Company in connection with Separation</a></td>
<td class="num">(1,266.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,266.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Diabetes Care Business/ Embecta Corp.</a></td>
<td class="nump">223.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.2<span></span>
</td>
<td class="nump">178.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of taxes</a></td>
<td class="num">(64.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentNetTransfersToParent', window );">Net transfers to Becton, Dickinson and Company</a></td>
<td class="num">(1,712.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation plans</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common dividends ($0.15 per share)</a></td>
<td class="num">$ (8.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares related to share-based compensation plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="nump">57,055,327<span></span>
</td>
<td class="nump">57,055,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="num">$ (891.4)<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="num">(577.1)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">(324.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Diabetes Care Business/ Embecta Corp.</a></td>
<td class="nump">70.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of taxes</a></td>
<td class="nump">15.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation plans</a></td>
<td class="nump">21.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common dividends ($0.15 per share)</a></td>
<td class="num">(34.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of shares related to share-based compensation plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of shares related to stock-based compensation plans</a></td>
<td class="num">$ (3.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="nump">57,333,353<span></span>
</td>
<td class="nump">57,333,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="num">$ (821.7)<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 27.9<span></span>
</td>
<td class="num">$ (541.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (309.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentConsiderationPaidForSeparation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Consideration Paid for Separation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentConsiderationPaidForSeparation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentNetTransfersToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Net Transfers to Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentNetTransfersToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Net Transfers to Parent, Including Separation Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues and Reclassification of Net Parent Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885803200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend declared</a></td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884628896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 70.4<span></span>
</td>
<td class="nump">$ 223.6<span></span>
</td>
<td class="nump">$ 414.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to net income to derive net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">32.6<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment of property, plant and equipment</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">58.9<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">21.5<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="num">(26.5)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade receivables, net</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="nump">122.7<span></span>
</td>
<td class="num">(31.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(28.8)<span></span>
</td>
<td class="num">(23.4)<span></span>
</td>
<td class="num">(18.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet', window );">Due from/due to Becton, Dickinson and Company</a></td>
<td class="num">(23.2)<span></span>
</td>
<td class="num">(47.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="num">(14.2)<span></span>
</td>
<td class="num">(44.0)<span></span>
</td>
<td class="num">(11.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other current liabilities</a></td>
<td class="nump">7.9<span></span>
</td>
<td class="nump">76.9<span></span>
</td>
<td class="nump">40.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Income and other net taxes payable</a></td>
<td class="num">(12.6)<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet', window );">Other assets and liabilities, net</a></td>
<td class="num">(16.1)<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
<td class="nump">67.7<span></span>
</td>
<td class="nump">412.2<span></span>
</td>
<td class="nump">456.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(26.5)<span></span>
</td>
<td class="num">(23.6)<span></span>
</td>
<td class="num">(36.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Acquisition of intangible assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used for Investing Activities</a></td>
<td class="num">(26.5)<span></span>
</td>
<td class="num">(24.0)<span></span>
</td>
<td class="num">(39.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from the issuance of long-term debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1,450.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(9.5)<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of long-term debt issuance costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(33.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_PaymentOfRevolvingCreditFacilityFees', window );">Payment of revolving credit facility fees</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments related to tax withholding for stock-based compensation</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments on finance lease</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividend payments</a></td>
<td class="num">(34.4)<span></span>
</td>
<td class="num">(8.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_PaymentForSpinoffTransactionFinancingActivities', window );">Net consideration paid to Becton, Dickinson and Company in connection with the Separation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1,266.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetTransfersToParentFinancingActivities', window );">Net transfers to Becton, Dickinson and Company</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(177.9)<span></span>
</td>
<td class="num">(417.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Used for Financing Activities</a></td>
<td class="num">(48.7)<span></span>
</td>
<td class="num">(48.0)<span></span>
</td>
<td class="num">(417.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net Change in Cash and cash equivalents</a></td>
<td class="num">(4.4)<span></span>
</td>
<td class="nump">330.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Opening Cash and cash equivalents</a></td>
<td class="nump">330.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Closing Cash and cash equivalents</a></td>
<td class="nump">$ 326.5<span></span>
</td>
<td class="nump">$ 330.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Other Receivables And Other Accounts Payable, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetTransfersToParentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Transfers to Parent, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetTransfersToParentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_PaymentForSpinoffTransactionFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment for Spinoff Transaction, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_PaymentForSpinoffTransactionFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_PaymentOfRevolvingCreditFacilityFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of Revolving Credit Facility Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_PaymentOfRevolvingCreditFacilityFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143977542816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Background</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 1 &#8212; Background</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Embecta Corp. ("Embecta" or the "Company") is a leading global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a broad portfolio of marketed products, including a variety of pen needles, syringes and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The Company primarily sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022 (the "Separation Date"), Embecta and Becton, Dickinson and Company ("BD") entered into a Separation and Distribution Agreement (the "Separation and Distribution Agreement"). Pursuant to the Separation and Distribution Agreement, BD agreed to spin off its diabetes care business (the "Diabetes Care Business") into Embecta, a new, publicly traded company (the "Separation"). </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Separation occurred by means of a pro-rata distribution (the "Distribution") of all of Embecta&#8217;s issued and outstanding shares of common stock on the basis of one share of Embecta common stock, par value $0.01 per share, for every five shares of BD common stock, par value $1.00 per share, held as of the close of business on March 22, 2023, the record date for the distribution. Embecta is now a standalone publicly traded company and, on April 1, 2022, regular-way trading of Embecta common stock commenced on the Nasdaq Global Select Market under the ticker symbol "EMBC".</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, BD and Embecta entered into various agreements to provide a framework for the relationship between BD and Embecta after the Separation, including, but not limited to, a separation and distribution agreement, a transition services agreement, a tax matters agreement, an employee matters agreement, a cannula supply agreement, contract manufacturing agreements, an intellectual property matters agreement, a logistics services agreement, distribution agreements, factoring and receivables agreements, local support and service agreements and other transaction documents.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143888691520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 2 &#8212; Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, the Company became a standalone publicly traded company, and its financial statements are now presented on a consolidated basis. Prior to the Separation on April 1, 2022, the Company&#8217;s historical combined financial statements were prepared on a standalone basis and were derived from BD's consolidated financial statements and accounting records. The financial statements for all periods presented, including the historical results of the Company prior to April 1, 2022, are now referred to as "Consolidated Financial Statements", and have been prepared pursuant to the rules and regulations for reporting on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Prior to Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the Company was referred to as the Diabetes Care Business. The assets, liabilities, revenue and expenses of the Diabetes Care Business were reflected in the combined financial statements on a historical cost basis, as included in the consolidated financial statements of BD, using the historical accounting policies applied by BD. The Consolidated Financial Statements did not purport to reflect what the Company&#8217;s results of operations, comprehensive income, financial position, equity or cash flows would have been had the Company operated as a standalone public company during the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Diabetes Care Business had historically functioned together with the other businesses controlled by BD. Accordingly, the Diabetes Care Business relied on BD&#8217;s corporate and other support functions for its business. Therefore, for the period prior to the Separation, certain corporate and shared costs were allocated to the Diabetes Care Business based on a specific identification basis or, when specific identification was not practicable, a proportional cost allocation method, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt">expenses related to BD support functions, including expenses for facilities, executive oversight, treasury, finance, legal, human resources, shared services, compliance, procurement, information technology and other corporate functions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:9.96pt">certain manufacturing and supply costs incurred by BD, including facility management, distribution, logistics, planning and global quality.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.19pt">certain costs incurred by BD&#8217;s Medication Delivery Solutions organizational unit in relation to selling and marketing activities, and related administrative support functions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">iv.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt">certain costs incurred by BD for activities related to device research and development, as well as medical and regulatory affairs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">stock-based compensation expenses (see Note 10).</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">vi.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt">certain compensation expenses maintained on a centralized basis such as certain employee benefit expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management believes these cost allocations were a reasonable reflection of the utilization of services provided to, or the benefit derived by, the Diabetes Care Business during the period prior to the Separation, though the allocations may not be indicative of the actual costs that would have been incurred had the Diabetes Care Business operated as a standalone public company. Actual costs that may have been incurred if the Diabetes Care Business had been a standalone company would depend on a number of factors, including the chosen organizational structure, whether functions were outsourced or performed by Diabetes Care Business employees, and strategic decisions made in areas such as manufacturing, selling and marketing, research and development, information technology and infrastructure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BD utilized a centralized approach to cash management and the financing of its operations. Cash generated by the Diabetes Care Business was routinely transferred into accounts managed by BD&#8217;s centralized treasury function and cash disbursements related to operations prior to the Separation were funded as needed by BD. Balances held by the Diabetes Care Business with BD for cash transfers and loans were reflected as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due to Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> prior to the Separation. All other cash and cash equivalents and related transfers between BD and the Diabetes Care Business were generally held centrally through accounts controlled and maintained by BD and were not specifically identifiable to the Diabetes Care Business. Accordingly, such balances were accounted for through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. BD&#8217;s third-party debt and related interest expense were not attributed to the Diabetes Care Business because the business was not the legal obligor of the debt and the borrowings were not specifically identifiable to the business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the Diabetes Care Business, transactions with BD affiliates were included in the Consolidated Statements of Income and related balances were reflected as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due to Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Related Party Loans Payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Other balances between the Diabetes Care Business and BD were considered to be effectively settled in the Consolidated Financial Statements at the time the transactions were recorded.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As the separate legal entities that made up the Diabetes Care Business were not historically held by a single legal entity, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was shown in lieu of stockholders&#8217; equity in these Consolidated Financial Statements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> represented BD&#8217;s interest in the recorded assets of the Diabetes Care Business and the cumulative investment by BD through the date of the Separation, inclusive of operating results.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For periods prior to the Separation, income tax expense and tax balances in the Consolidated Financial Statements were calculated on a separate tax return basis. The separate tax return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company was a separate taxpayer and a standalone enterprise. Management believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provision for income taxes for the period prior to the Separation was calculated by applying an estimated effective income tax rate for the full year to ordinary income adjusted by the tax impact of discrete items.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">As of the Separation Date</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain assets and liabilities, including patents and unrecognized tax benefits that were included in the Consolidated Balance Sheet prior to the Separation, have been retained by BD post-Separation and therefore were transferred to BD through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Company's Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, additional pension assets, deferred tax assets, other compensation obligations, and certain other assets and liabilities were transferred to the Company through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and the Company recorded these in the Consolidated Balance Sheet. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As part of the Separation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">was reclassified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Common Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accumulated Deficit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Post Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following the Separation, certain functions continue to be provided by BD under the Transition Services Agreements or are being performed using Embecta&#8217;s own resources or third-party service providers. Additionally, under manufacturing and supply agreements, the Company manufactures certain products for BD, or its applicable affiliate and BD manufactures certain products for the Company. The Company incurred certain costs in its establishment as a standalone public company and expects to incur ongoing additional costs associated with operating as an independent, publicly traded company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All intercompany transactions and accounts within Embecta have been eliminated. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain reclassifications were made to conform the prior period Consolidated Financial Statements to the current period presentation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886730752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Accounting Policies</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 3 &#8212; Summary of Accounting Policies</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recognizes revenue from product sales and considers performance obligations satisfied when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement. The Company acts as the principal in its customer arrangements and therefore records revenue on a gross basis. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. The point in time upon which shipment or delivery occurs is the most faithful depiction of when control of the goods transfers to the customer. Variable consideration such as rebates, chargebacks, sales discounts, and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additional disclosures regarding the Company&#8217;s accounting for revenue recognition are provided in Note 8.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cash and Cash Equivalents</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash and cash equivalents include all highly liquid investments with a maturity of three months or less at the date of acquisition. Interest income on Cash and cash equivalents is recorded as earned.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Trade Receivables</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#8217;s estimate of probable credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Inventories</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cloud Computing Arrangements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company capitalizes costs incurred to implement cloud computing arrangements that are service contracts within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Prepaid expenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Company's Condensed Consolidated Balance Sheets. Implementation costs associated with cloud computing arrangements are capitalized when incurred during the application development phase. Once the implementation of a cloud computing arrangement is complete and ready for its intended use, the Company amortizes the costs over the expected term of the hosting arrangement using the straight-line method to the same income statement line as the associated cloud operating expenses. The total balance of capitalized costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">associated with these arrangements as of September&#160;30, 2023 is $38.0&#160;million which primarily relates to the implementation of the Company's new enterprise resource planning ("ERP") system. These capitalized costs are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Costs amortized during fiscal year ended September 30, 2023 were not material to the Company's consolidated financial results. As of September&#160;30, 2023, cloud computing arrangement assets in-service have useful lives which range from approximately <span style="-sec-ix-hidden:f-353">three</span> to nine years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2022, the Company commenced on the process of building a new ERP system to replace the existing systems provided by BD. The ERP system is designed to accurately maintain the Company's financial records used to report operating results. The implementation of the ERP will occur in phases. The first phase of the ERP system implementation began in the fourth quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is principally provided on the straight-line basis over estimated useful lives, which range from 20 to 45 years for buildings, 4 to 13 years for machinery and equipment and 1 to 20 years for leasehold improvements. Depreciation expense was $31.5&#160;million in 2023, $31.0&#160;million in 2022, and $37.2&#160;million in 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant and equipment are periodically reviewed when impairment indicators are present to assess recoverability or a decision has been made to abandon efforts associated with construction in progress assets. Recoverability is determined by comparing the carrying values of the assets or asset groups to the undiscounted cash flows to be generated from the use and eventual disposition of such assets or asset groups. If the asset&#8217;s or asset group&#8217;s carrying value exceeds such </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">undiscounted cash flows, the assets or asset groups are not recoverable and an impairment loss is recognized based on the amount by which the carrying value of the asset or asset group exceeds its calculated fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Capitalized Interest</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The interest cost on capital projects is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended September 30, 2023 and 2022, the Company capitalized $4.6 million and $5.2 million of interest expense, respectively, into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and capitalized $0.9 million of interest expense into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> during the year ended September 30, 2023. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Advertising Costs </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advertising costs are expensed as incurred and included in S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">elling and administrative expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company recorded advertising costs of $15.5&#160;million, $11.6&#160;million, and $9.3&#160;million in 2023, 2022 and 2021, respectively.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill represents the excess of the consideration transferred over the fair value of net assets of businesses acquired. The Company has one reporting unit. Goodwill is evaluated for impairment as of July 1 each year, or more frequently if impairment indicators exist, by first assessing qualitative factors to determine whether it is more likely than not that fair value is less than carrying value. If the Company concludes it is more likely than not that fair value is less than carrying value, a quantitative fair value test is performed. If carrying value is greater than fair value, a goodwill impairment charge will be recorded for the difference (up to the carrying value of goodwill). The Company completed the annual goodwill impairment test as of July 1, 2023 and concluded that no impairment to goodwill was necessary as the fair value of the Company's one reporting unit was significantly in excess of the carrying value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No goodwill impairments were identified during the years ended September 30, 2022, or 2021, and no accumulated impairment losses are recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortized intangible assets primarily consist of patents and customer relationships. Patents are generally amortized over 20 years using the straight-line method. Customer relationship assets are generally amortized over periods ranging from 10 to 15 years, using the straight-line method. Other intangibles with finite useful lives are amortized over periods principally ranging from 1 to 40 years, using the straight-line method. Finite-lived intangible assets are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#8217;s carrying value exceeds its calculated fair value.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Foreign Currency Translation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Generally, foreign subsidiaries&#8217; functional currency is the local currency of operations and the net assets of foreign operations are translated into United States dollars using current exchange rates. The United States dollar results that arise from such translation are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Shipping and Handling Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company considers its shipping and handling costs to be contract fulfillment costs and records them within selling and administrative expense. Shipping and handling costs were $36.9&#160;million, $27.4&#160;million, and $13.6&#160;million in 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contingencies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries). Additional disclosures regarding the Company&#8217;s accounting for contingencies are provided in Note 7.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Stock-Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, certain of the Company&#8217;s employees historically participated in BD&#8217;s stock-based compensation plans. Stock-based compensation expense was either allocated to the Company based on a proportionate cost allocation method or recorded based on specific identification. Effective April 1, 2022, the Company established the 2022 Employee and Director Equity Based Compensation Plan (the "Plan"). The Plan provides for the grant of various types of awards, including restricted stock unit ("RSU") awards, stock appreciation rights, stock options, performance-based awards and cash awards. Under the Plan, the exercise price of awards, if any, is set on the grant date and generally may not be less than </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the fair market value per share on that date. The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards. For awards that ultimately settle in cash, we treat them as liability awards and mark the award to market each reporting period and recognize any adjustment in our Consolidated Statements of Income. The Company recognizes stock-based compensation cost only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants. The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change (see Note 10).</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Benefit Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the defined benefit plans in which the Company participated related primarily to plans sponsored by BD and for which other businesses of BD also participate (the "Shared Plans"). The Company accounted for the Shared Plans as multiemployer plans and therefore the related assets and liabilities were not reflected in the Consolidated Balance Sheets. For such periods prior to the Separation, the Consolidated Statements of Income reflect a proportional allocation of net periodic benefit cost for the Shared Plans associated with the Company. The Company's participation in the defined pension and postretirement benefit plans sponsored by BD concluded upon the completion of the Separation on April 1, 2022. At and after Separation, Embecta became the plan sponsor for certain non-United States defined benefit pension plans (see Note 18).</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Research and Development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development costs are expensed as incurred.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax basis of assets and liabilities at the applicable tax rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, the Company engages in transactions in which tax consequences may be subject to uncertainty. The Company conducts business and files tax returns in numerous jurisdictions based on its interpretation of tax laws and regulations. In evaluating the Company&#8217;s tax provision, the Company establishes a reserve for uncertain tax positions unless such positions are determined to be more likely than not of being sustained upon examination based on the technical merits.  The Company&#8217;s policy is to recognize, when applicable, interest and penalties on uncertain tax positions as part of income tax expense.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Tax Cuts and Jobs Act was enacted on December 22, 2017 and introduced an additional United States tax on the earnings of non-United States subsidiaries which are referred to as Global Intangible Low Taxed Income (&#8220;GILTI&#8221;). The Company has elected to treat GILTI as a period cost. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the Company's operations were included in the tax returns of BD. Income taxes as presented in the Consolidated Financial Statements attribute current and deferred income tax assets and liabilities of BD to the Company in a manner that is systematic, rational, and consistent with the asset and liability method prescribed by the accounting guidance for income taxes. The Company's income tax provision prior to the Separation was prepared using the separate return method. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company were a separate taxpayer and a standalone enterprise. The Company believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additional disclosures regarding the Company's accounting for income taxes are provided in Note 14.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Segment Data</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company operates and reports its financial information as one segment. In making this determination, the Company (i) determines its Chief Operating Decision Maker (&#8220;CODM&#8221;), (ii) identifies and analyzes potential business components, (iii) </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">identifies its operating segments and (iv) determines whether there are multiple operating segments requiring presentation as reportable segments. The Company&#8217;s decision to report as one segment is based upon the following: (1) its internal organizational structure; (2) the manner in which its operations are managed; and (3) the criteria used by the Company&#8217;s President, its CODM, to evaluate performance of the Company&#8217;s business and allocate resources and capital.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Fair Value Measurements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#8217;s fair value measurements are provided in Note 15.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Level 1&#8212;Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Level 2&#8212;Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Level 3&#8212;Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Leases</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company determines whether an arrangement contains a lease at inception. If a lease is identified in an arrangement, the Company recognizes a right-of-use asset and liability in the Company's Consolidated Balance Sheets and determine whether the lease should be classified as a finance or operating lease. The Company does not recognize assets or liabilities for leases with lease terms of less than 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i) there is a transfer of ownership of the leased asset to Embecta by the end of the lease term, (ii) the Company holds an option to purchase the leased asset that the Company is reasonably certain to exercise, (iii) the lease term is for a major part of the remaining economic life of the leased asset, (iv) the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v) the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the implicit rate is not readily determinable, the Company utilizes its incremental borrowing rate at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease payments are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method over the shorter of the useful life of the related asset or the lease term. Finance lease payments are bifurcated into (i) a portion that is recorded as imputed interest expense and (ii) a portion that reduces the finance liability associated with the lease.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For lease arrangements that are recognized on the Company&#8217;s Consolidated Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. Variable lease payments are expensed as incurred. If a lease includes an option to extend or terminate the lease, the Company reflects the option in the lease term if it is reasonably certain the Company will exercise the option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Finance leases are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Current finance lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Non Current Finance Lease Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and operating leases are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Company's Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses, including determining the allocation of shared costs and expenses from BD, depreciable and amortizable lives, sales returns and allowances, rebate accruals, restructuring costs, inventory reserves and taxes on income as reflected in the Consolidated Financial Statements. Actual results could differ from these estimates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> represented BD&#8217;s interest in the recorded assets of the Company and the cumulative investment by BD in the Company through the date of the Separation, inclusive of operating results and the net effect of the transactions with and allocations from BD. See Notes 2 and 4 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Supplemental Disclosures Of Cash Flow Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash paid for interest related to debt during the year ended September 30, 2023 and 2022 was $111.0 million and $38.9 million, respectively. The Company did not have any debt outstanding during the year ended September 30, 2021. Cash paid for income taxes, net of refunds, for the years ended September 30, 2023 and 2022 was $30.4 million and $15.6 million, respectively. For the year ended September 30, 2021, the Company's current tax liabilities computed under the separate return method are considered to be effectively settled at the time the transaction is recorded, with the offset recorded against </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers, as if it had originated the contracts. The Company adopted this guidance at the beginning of fiscal year 2023 and it did not materially impact the Company's Condensed Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886620672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Third Party Arrangements and Related Party Disclosures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ThirdPartyAndRelatedPartyTransactionsAbstract', window );"><strong>Third Party and Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock', window );">Third Party Arrangements and Related Party Disclosures</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 4 &#8212; Third Party Arrangements and Related Party Disclosures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Separation, BD ceased to be a related party to Embecta and accordingly, no related party transactions or balances are reported subsequent to April 1, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, the Company entered into the Separation and Distribution Agreement, which contains provisions that, among other things, relate to (i) assets, liabilities and contracts to be transferred, assumed and assigned to each of Embecta and BD (including certain deferred assets and liabilities) as part of the Separation, (ii) cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of Embecta's business with Embecta and financial responsibility for the obligations and liabilities of BD&#8217;s remaining businesses with BD, (iii) procedures with respect to claims subject to indemnification and related matters, (iv) the allocation among Embecta and BD of rights and obligations under existing insurance policies with respect to occurrences prior to completion of the Separation, as well as the right to proceeds and the obligation to incur certain deductibles under certain insurance policies, and (v) procedures governing Embecta&#8217;s and BD&#8217;s obligations and allocations of liabilities with respect to ongoing litigation matters that may implicate each of BD&#8217;s business and Embecta&#8217;s business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Agreements that Embecta entered into with BD that govern aspects of Embecta's relationship with BD following the Separation include, but are not limited to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Transition Services Agreements ("TSA") - Pursuant to the TSA, Embecta and BD and their respective affiliates provide each other, on an interim, transitional basis, various services, including, but not limited to, information technology, human resources, procurement, quality and regulatory affairs, medical affairs, tax and treasury services. The agreed-upon charges for such services are generally intended to allow the servicing party to charge a price comprised of out-of-pocket costs and expenses and a predetermined profit in the form of a mark-up of such out-of-pocket costs and expenses. The services will terminate no later than 24 months following the Separation, subject to the Extension. The Extension is conditioned upon BD obtaining a supplemental private letter ruling. The service recipient may terminate any services by giving prior written notice to the provider of such services and paying any applicable wind-down charges.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Trade Receivables Factoring Agreements - Embecta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and BD entered into trade receivables factoring agreements (the "Factoring Agreements"), under which Embecta transfers certain net trade receivable assets to BD, and pays a service fee calculated as 0.1% of annual revenues related to countries subject to the Factoring Agreements in exchange for the services provided by BD. Per the terms of the Factoring Agreements, the Company and its relevant subsidiaries sell receivables to the corresponding BD subsidiary in the same jurisdiction and such BD subsidiary collects the receivables from Company's customers. The BD subsidiary assumes the credit risk in respect of the receivables, and accordingly deducts a factoring fee from the purchase price of such receivables. Accordingly, Embecta accounts for the transfer as sales of trade receivables by recognizing an increase to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and a decrease to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Trade Receivables, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Balance Sheets when proceeds from the transactions are received. The transfers are presented in the Consolidated Statements of Cash Flows as operating activities and the related service fee is presented as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other income (expense), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Statements of Income. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Distribution Agreements - Embecta and BD entered into distribution agreements for certain territories, principally in the Asia Pacific Region and Latin America, whereby a subsidiary of BD is appointed as a distributor of Embecta or its relevant subsidiaries to support certain commercial operations of the diabetes care business on a transitional basis in these regions for a maximum of two years. The distribution agreements will each continue </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">until either (1) certain governmental approvals needed to distribute products in the defined territory are obtained and order-to-cash processes and other services of the Company for such territory are migrated to an alternative commercial arrangement between the parties or (2) the applicable services are transitioned to a third-party distributor or independently performed by Embecta, but in any event no longer than the maximum term of two years, except certain such agreements may be extended in connection with the Extension. Embecta shall pay BD a return of 1.5% to 2.0% of net revenue for each territory.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Cannula Supply Agreement - Embecta and BD entered into a cannula supply agreement whereby BD sells to Embecta cannulas for incorporation into Embecta's existing syringes and pen needles, safety syringes and safety pen needles, and products currently under development. BD retains ownership of all cannula technology, cannula production activities and the intellectual property rights therein. Embecta is limited to a maximum number of cannulas that it can purchase under the cannula supply agreement, which will be an absolute upper limit of cannulas per year and yearly limits that vary with annual demand. The cannula supply agreement is terminable by Embecta without cause by providing at least 36 months&#8217; written notice; however, such termination can be effective no earlier than five years from the Separation. The cannula supply agreement will be terminable by BD without cause by providing at least 36 months&#8217; written notice; however, such termination can be effective no earlier than ten years from the Separation. However, in the event of a change of control of Embecta, BD has the right to terminate the cannula supply agreement in its sole discretion. The cannula supply agreement will also terminate automatically, subject to a 36-month wind-down period, if Embecta&#8217;s yearly forecast is below the required minimum purchase amount, and the parties have other customary termination rights for material breach or bankruptcy of the other party.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Tax Matters Agreement - Pursuant to the tax matters agreement, Embecta agreed to certain covenants that contain restrictions intended to preserve the tax-free status of the distribution and certain related transactions. Embecta may take certain actions prohibited by these covenants only if Embecta obtains and provides to BD an opinion from a United States tax counsel or accountant of recognized national standing, in either case satisfactory to BD, to the effect that such action would not jeopardize the tax-free status of the distribution and certain related transactions, or if Embecta obtains prior written consent of BD. Embecta is barred from taking any action, or failing to take any action, where such action or failure to act adversely affects or could reasonably be expected to adversely affect the tax-free status of the distribution and certain related transactions or result in certain other taxes to BD, for all relevant time periods. In addition, during the period ending two years after the Separation, these covenants include specific restrictions on Embecta&#8217;s (i) discontinuing the active conduct of Embecta&#8217;s trade or business; (ii) issuance or sale of stock or other securities (including securities convertible into Embecta stock, but excluding certain compensatory arrangements); (iii) liquidating, merging, or consolidating with any other person; (iv) amending Embecta&#8217;s certificate of incorporation (or other organizational documents) or taking any other action, whether through a stockholder vote or otherwise, affecting the voting rights of Embecta common stock; (v) sales of assets outside the ordinary course of business; and (vi) entering into any other corporate transaction which would cause Embecta to undergo a 50% or greater change in its stock ownership.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Logistics Services Agreement - Embecta and BD entered into a logistics services agreement whereby BD provides Embecta with certain order-to-cash and logistics services to support certain commercial operations for a maximum term of two years, which BD has agreed to extend through March 31, 2024. Embecta will pay BD</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (i) reimbursable costs, including all shipping costs, selling costs, general administration costs, costs of goods, research and development services costs, and other income and expenses related solely to the diabetes care business, that are incurred by BD directly, as allocated costs or as costs payable to a third party and (ii) a monthly administrative fee of 1.0% of net revenue (which will increase to 1.25% of net revenue after January 1, 2024).</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Other agreements that Embecta entered into with BD include, but are not limited to, the employee matters agreement ("EMA"), an intellectual property matters agreement, local support services agreements, certain other manufacturing arrangements and a process services agreement and lease agreement for a manufacturing facility located in Holdrege, Nebraska. See Note 17 for more information on the lease agreement for Holdrege. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As it pertains to the Distribution Agreements noted above, Embecta has determined it is the principal under these arrangements and is entitled to all the benefits, and is liable for all the risks, related to the inventory and receivables. Additionally, Embecta has latitude in pricing, has the ability to direct BD regarding decisions over inventory, and is responsible for all credit and collections risks and losses associated with the related receivables when there is no factoring agreement in place. As such, Embecta recognizes these sales on a gross basis.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount due from BD under the above agreements was $142.4&#160;million at September&#160;30, 2023 and is reflected in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The amount due to BD under these agreements was $73.1 million at September&#160;30, 2023 and is included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due to Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The closing of the transfers of certain assets and liabilities related to the Diabetes Care Business in certain jurisdictions, including China, Mexico, and Italy, as contemplated by the Separation and Distribution Agreement did not occur at </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Separation. The transfers of the remaining relevant local assets and liabilities for these deferred countries are expected to close at a future date. As of September&#160;30, 2023, the Company estimates that amounts due to BD related to certain assets and liabilities in deferred close jurisdictions is $29.7&#160;million and are reflected in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. As of September&#160;30, 2023, the Company estimates that amounts due from BD related to certain assets and liabilities in deferred close jurisdictions are $8.4&#160;million and is reflected in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Prepaid expenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the Company did not operate as a standalone business and the Consolidated Financial Statements were derived from the consolidated financial statements and accounting records of BD. The following disclosure summarizes activity between the Company and BD up to the Separation, including the affiliates of BD that were not part of the Separation.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the years ended September 30, 2022 and 2021, cost of products sold from related party inventory purchases were $28.0 million and $40.6 million, respectively. For the year ended September 30, 2023 there were no cost of products sold from related party inventory purchases.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Corporate and Medical Segment Allocations from BD</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, BD provided significant corporate, finance, human resources, information technology, facilities, and legal services, among others (collectively, &#8220;General Corporate Expenses&#8221;) to the Company. Some of these services continue to be provided by BD to the Company on a temporary basis under the TSA. For purposes of these Consolidated Financial Statements for the periods prior to the Separation, the General Corporate Expenses have been allocated to the Company. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocations of General Corporate Expenses are reflected in the Consolidated Statements of Income as follows: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.448%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">13.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling and administrative expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">98.3</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.2</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.6)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.3)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total General Corporate Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">53.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">115.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These expenses were allocated to the Company on a pro rata basis of global and regional revenues, headcount, research and development spend and other drivers. Management believes the assumptions underlying the Consolidated Financial Statements, including the assumptions regarding allocating General Corporate Expenses from BD, are reasonable. Nevertheless, the Consolidated Financial Statements for periods prior to the Separation may not include all of the actual expenses that would have been incurred and may not reflect the Company&#8217;s Consolidated results of operations, financial position and cash flows had it been a standalone public company during the periods presented. Actual costs that would have been incurred if the Company had been a standalone public company would depend on multiple factors, including organizational structure and strategic decisions made in various areas, including information technology and infrastructure. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Related party transactions  </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following transactions represent activity in the ordinary course of business between the Company and BD prior to the Separation for certain materials for use in production of certain medical products that were not at arm&#8217;s length. The following table summarizes such former related party purchases as follows: </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.447%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases from BD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">All significant intercompany transactions between the Company and BD prior to the Separation have been included in the Consolidated Financial Statements and are considered to be effectively settled for cash at the time the transaction is recorded. For the period prior to the Separation, the total net effect of the settlement of these intercompany transactions is reflected in the Consolidated Statements of Cash Flows as a financing activity and in the Consolidated Balance Sheets as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, net transfers to BD were included within&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#160;in the Consolidated Statements of Equity and represent the net effect of transactions between the Company and BD. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the components of the net transfers to BD as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.447%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cash pooling and general financing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">255.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">599.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Corporate and segment allocations, excluding non-cash stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(50.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(109.9)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Taxes deemed settled with BD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(72.5)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other Separation related adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(11.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net transfers to BD as reflected in the Consolidated Statements of Cash Flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">177.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">417.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(8.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(12.5)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Pension expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net consideration paid to BD in connection with the Separation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,266.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Related party senior secured notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">197.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other transfers to (from) BD, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">84.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(11.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net transfers to BD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,712.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">383.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:2pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">The nature of activities includes financing activities for capital transfers, cash sweeps and other treasury services. As part of this activity, cash balances were swept to BD on a daily basis under the BD Treasury function and the Company receives capital from BD for its cash needs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Related Party Senior Secured Notes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 31, 2022, Embecta issued $200.0 million of senior secured notes to BD</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (the "Related Party Notes"). </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Related Party Notes issued to BD were not issued for cash and instead were subject to a debt-for-debt exchange which occurred on April 1, 2022. As of April 1, 2022 t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">he Related Party Notes were reclassified to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Balance Sheets as the Related Party Notes are third party debt for periods post Separation.</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Refer to Note 12 for further information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ThirdPartyAndRelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Third Party and Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ThirdPartyAndRelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Third Party and Related Party Transactions Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886851520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration Agreement</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 5 &#8212; Collaboration Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2023, the Company entered into a collaboration agreement with a third-party to develop and commercialize an interoperable automated glycemic controller ("iAGC") to complement the Company's insulin patch pump currently in development. The Company believes that both parties are active participants in the operating activities of the collaboration and exposed to certain risks and rewards depending on commercial success. The transaction included an upfront payment of $2.5&#160;million for project costs, which was expensed to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Research and development expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> during the year ended September&#160;30, 2023. Upon successful commercialization of the iAGC, the Company will be responsible for the sales and marketing effort and would pay a royalty to the third-party based on future product sales to customers. The Company expects that it will be the principal in the end customer sale and 100% of product sales will be included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and any royalty payments and continued project costs after commercialization will be included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> as they are incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886892816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Operating Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeAndExpenseTextBlock', window );">Other Operating Expenses</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 6 &#8212; Other Operating Expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, the Company incurred separation and stand-up costs of approximately </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$92.7&#160;million, $44.7 million, and $4.8 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> during the years ended September&#160;30, 2023, 2022, and 2021, respectively. The costs incurred primarily consist of costs associated with accounting, auditing, legal services, supply chain, employee retention, the implementation of the Company's new ERP system, and certain other costs to establish certain stand-alone functions to assist with the transition to being a stand-alone entity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2023, the Company recorded approximately $5.6&#160;million of severance costs related to the optimization of certain business functions. These costs were primarily recorded in the U.S. and severance costs were not material to any comparable prior year periods presented. Liabilities for costs associated with these activities were not material to any period presented. For the years ended September 30, 2022, and 2021 severance costs were not material to the Company's Consolidated Statements of Income.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeAndExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other operating income and other operating expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeAndExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886675840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Contingencies</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 7 &#8212; Contingencies </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is subject to potential liabilities under government regulations and various claims and legal actions that are pending or may be asserted from time-to-time. These matters arise in the ordinary course and conduct of the Company&#8217;s business and include, for example, commercial, product liability, breach of contract and tort, intellectual property, product liability, environmental, securities and employment matters. The Company intends to continue to defend itself vigorously in such matters and when warranted, take legal action against others. Furthermore, the Company regularly assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in its financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">An estimated loss contingency is accrued in the Company&#8217;s Financial Statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company&#8217;s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company&#8217;s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.</span></div>The Company was not a party to any material legal proceedings at September&#160;30, 2023 or September&#160;30, 2022, nor is it a party to any material legal proceedings as of the date of issuance of these Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480102/450-20-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480102/450-20-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450-20/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450-30/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483049/450-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886851520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 8 &#8212; Revenues </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Measurement of Revenues </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Payment terms extended to the Company&#8217;s customers are based upon commercially reasonable terms for the markets in which the Company&#8217;s products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible. The allowance for doubtful accounts for trade receivables is not material to the Company&#8217;s consolidated financial results. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts, and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company&#8217;s agreements primarily with its end-user customers. Additional factors considered in the estimate of the Company&#8217;s rebate liability include the quantification of inventory that is either in stock at or in transit to the Company&#8217;s distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s liability attributed to variable consideration at September&#160;30, 2023 and September&#160;30, 2022 was $36.4 million and $43.8 million, respectively. Sales deductions recorded as a reduction of gross revenues for the years ended September&#160;30, 2023, 2022 and 2021 were $411.1 million, $336.4 million, and $298.7&#160;million respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Disaggregation of Revenues </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Disaggregation of revenue by geographic region is provided within Note 9. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Assets and Liabilities </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company does not have contract liabilities. Contract assets consist of the Company&#8217;s right to consideration that is conditional upon its future performance pursuant to private label agreements and are presented within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Prepaid expenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Balance Sheets. </span></div>The Company&#8217;s contract asset balance was $1.2 million as of each of September&#160;30, 2023 and 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886755840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographical Data<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographical Data</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 9 &#8212; Segment and Geographical Data </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating segments are identified as components of an enterprise in which discrete financial information is available for evaluation by the CODM in making decisions regarding assessing business performance and allocating resources and capital. Management has concluded that the Company operates in one segment based upon the information used by the CODM in evaluating the performance of the Company&#8217;s business and allocating resources and capital. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Disaggregation of Revenues </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has distribution agreements with regional or national distributors (including wholesalers and medical suppliers) to ensure broad availability of its products as well as a direct sales force in certain countries and regions around the world. In the United States and Canada, the Company utilizes its large and small key account managers that call on payers, retailers, wholesalers and institutional customers, and field-based territory managers that call on health care providers and pharmacies. In certain markets within Europe, the Company has dedicated sales representatives and in certain regions of the Middle East and Africa, the Company has distribution agreements. In Asia, the Company has distribution agreements and in China, the Company relies on its own commercial team to support sales execution. In Latin America, the Company maintains distribution agreements and direct sales representatives. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company disaggregates its revenue by geography as management believes this category best depicts how the nature, amount, and timing of revenues and cash flows are affected by economic factors. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues by geographic region are as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">601.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">600.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">609.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">519.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">529.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">555.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,120.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,129.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,165.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span>For the years ended September&#160;30, 2023, 2022, and 2021 no individual country outside of the United States generated net revenues that represented more than 10.0% of total revenues.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884219232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 10 &#8212; Stock-Based Compensation</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Prior to Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, certain of the Company's employees participated in stock-based compensation plans sponsored by BD. Under these plans BD granted time-vested restricted stock units ("TVUs"), stock appreciation rights ("SARs"), and performance share units ("PSUs") to certain management level employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation on April 1, 2022, share-based compensation expense in the Consolidated Statements of Income is representative of those employees who were dedicated to the Diabetes Care Business. Additionally, share-based compensation expense was allocated to the Diabetes Care Business for BD Corporate and Medical Segment employees who were not dedicated solely to the Diabetes Care Business. This stock-based compensation expense was allocated using a proportional cost allocation method and is included as a component of corporate allocations for periods prior to the Separation. The amounts presented for the periods prior to the Separation are not necessarily indicative of future awards and do not necessarily reflect the costs that the Company would have incurred as an independent company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">As of Separation Date and Periods Post Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, and in accordance with the EMA, Embecta's employees with outstanding former BD share-based awards received replacement share-based awards under the Plan. The ratio used to convert the BD share-based awards was designed to preserve the aggregate intrinsic value of the award immediately after the Separation when compared to the aggregate intrinsic value of the award immediately prior to Separation. As a result of the award modification, Embecta will incur $6.1&#160;million of incremental stock-based compensation expense. Of this amount, $1.8&#160;million and $2.3&#160;million was recognized during the year ended September 30, 2023 and 2022, respectively. $2.0&#160;million will be recognized at a future date over the awards' remaining vesting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective April 1, 2022, Embecta established the Plan. A total of 7,000,000 shares of common stock are authorized under the Plan. The Plan provides for the grant of various types of awards including RSU awards, SARs, stock options, performance-based awards and other stock-based awards. Under the Plan, the exercise price of awards, if any, is set on the grant date and may not be less than the fair market value per share on that date. Generally SARs have a term of ten years and a <span style="-sec-ix-hidden:f-502">three</span> or four year vesting period, subject to limited exceptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recognizes stock-based compensation cost only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants. The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, Embecta granted 48,192 potential shares to non-employee directors in the form of RSUs, which vest at the earlier of (i) the first anniversary of the grant date or (ii) the date of the first annual meeting of stockholders, subject to continued service of the recipients.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 4, 2022 and in connection with the Separation, Embecta granted 860,611 of potential shares to members of the Embecta leadership team as a one-time sign-on equity grant, subject to continued employment, comprised of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">172,787 grants of time-vested RSUs which cliff vest on the third anniversary after grant date;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">528,167 grants of SARs which cliff vest on the third anniversary after grant date and;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">27,653 of TVUs and 132,004 of SARs granted to the Embecta's chief executive officer which vest evenly over <span style="-sec-ix-hidden:f-510">three</span> and four years, respectively.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Stock-Based Compensation Expense </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total direct and allocated stock-based compensation expense for the years ended September&#160;30, 2023, 2022, and 2021 and the respective income tax benefits recognized by the Company in the Consolidated Statements of Income are as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.388%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">14.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Stock-Based Compensation Expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Tax benefit associated with stock-based compensation costs recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company's total stock-based compensation expense by classification of award:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:55.131%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Equity Awards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Liability Awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company's total stock-based compensation expense by award type for the years ended September&#160;30, 2023 and 2022, subsequent to the Separation:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:70.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Time-Vested Restricted Stock Units (TVUs)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Performance-Based Restricted Stock Units (PSUs)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock Appreciation Rights (SARs)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Time Vested Restricted Stock Units</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> ended September 30, 2023</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Embecta granted 680,281 RSUs in the form of TVUs to employees which vest ratably over three years, subject to continued employment of the recipients. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TVUs vest on a graded basis over a period of three years. The related stock-based compensation expense is recorded over the requisite service period, which is the vesting period or is based on retirement eligibility. The fair value of all TVUs is based on the market value of the Company&#8217;s stock on the date of grant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of TVUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stock Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at October 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">977.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">680.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">31.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Distributed*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(386.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(82.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,188.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected to vest at September 30</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,134.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.39&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">*The amounts distributed include shares withheld for taxes that are not formally issued to the market.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average grant date fair value of TVUs granted during the years 2023 and 2022 are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average grant date fair value of units granted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The total fair value of TVUs vested during the years 2023 and 2022 was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total fair value of units vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2023, the weighted average remaining vesting term of TVUs is 1.5 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Performance Based Restricted Stock Units</span></div><div style="text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> ended September 30, 2023</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Embecta awarded 244,192 RSUs in the form of PSUs to certain executive officers and employees which vest after three years, subject to continued employment of the recipients and the achievement of certain performance metric targets. For a portion of these awards, the Company has identified certain performance metrics and targets that will be fully established at a future date. The Company has determined that the service inception date precedes the grant date for these awards as (a) the awards were authorized prior to establishing an accounting grant date, (b) the recipients began providing services prior to the grant date, and (c) there are performance conditions that, if not met by the accounting grant date, will result in the forfeiture of the awards. As the service inception date precedes the accounting grant date, the Company recognizes stock-based compensation expense for each separately-vesting tranche over the requisite service period based on the fair value at each reporting date. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">PSUs cliff vest on the third anniversary after grant date. The related stock-based compensation expense is recorded over the requisite service period, which is the vesting period or is based on retirement eligibility. The fair value of all PSUs is based on the market value of the Company&#8217;s stock on the date of grant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of PSUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stock Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at October 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">30.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Distributed</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">30.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">30.24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected to vest at September 30</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">54.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">30.24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average grant date fair value of PSUs granted during 2023 is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average grant date fair value of units granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September 30, 2023, the weighted average remaining vesting term of PSUs is 2.2 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Stock Appreciation Rights</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">SARs represent the right to receive, upon exercise, shares of common stock having a value equal to the difference between the market price of common stock on the date of exercise and the exercise price on the date of grant. SARs generally vest over a period of <span style="-sec-ix-hidden:f-583">three</span> to four years and have a term of ten years. The fair value of awards are estimated on the date of grant using a Black-Scholes-Merton (&#8220;BSM&#8221;) model. The BSM assumptions include expected dividend yield, risk-free interest rate, volatility, and term of the SARs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the SARs granted during 2022, the Company used the BSM to determine the fair value of the SARs as of the grant date. In applying this model, the Company uses both historical data and current market data to estimate the fair value of its SARs. The expected dividend yield is based on forecasted patterns of dividend payments. The risk-free interest rate is based on the rate at grant date of zero-coupon United States Treasury Notes with a term equal to the expected term of the SAR. Expected volatility is estimated using historical volatility. Due to the lack of trading history of Embecta's stock at the time of valuation efforts, the historical component of expected volatility is based on historical monthly price changes of the peer group within the industry. BD's historical data for Embecta employees was used to estimate equity award exercise and employee termination behavior within the valuation model. The expected term represents the amount of time that SARs granted are expected to be outstanding based on historical and forecasted exercise behavior. The weighted average fair value of SARs was determined using the following assumptions:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:89.809%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">37.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected life</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Fair value per SAR</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of SARs outstanding as of September 30, 2023 and changes and changes during the year then ended is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">SARs (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Aggregate Intrinsic Value </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at October 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,916.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(25.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(59.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,831.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested and expected to vest at September 30</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,740.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.05&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">179.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26.96&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">*The amounts exercised include shares withheld for taxes that are not formally issued to the market.</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of SARs exercised during the years 2023 and 2022 is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total intrinsic value of SARs exercised</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total fair value of SARs exercised</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Unrecognized Compensation Expense and Other Stock Plans</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount of unrecognized compensation expense for all non-vested stock-based awards as of September 30, 2023, is approximately $28.2&#160;million, which is expected to be recognized over a weighted-average remaining life of approximately 1.8 years. At September 30, 2023, 3.4&#160;million shares were authorized for future grants under the Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886650208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 11 &#8212; Goodwill and Other Intangible Assets </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill and Other Intangible Assets consisted of: </span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Amortized intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Patents &#8211; gross</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Patents &#8211; net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Customer Relationships and Other &#8211; gross</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Customer Relationships and Other &#8211; net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">8.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Goodwill and Other Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">24.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">24.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intangible asset amortization expense was $1.2&#160;million for the year ended September 30, 2023, $0.7&#160;million for the year ended September 30, 2022 and $0.3&#160;million for the year ended September 30, 2021, respectively. The estimated intangible asset amortization expense for each of the fiscal years ended September 30, 2024 through 2028 is expected to approximate $1.1&#160;million per year and $3.6&#160;million for years subsequent thereafter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886695440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 12 &#8212; Long-Term Debt</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">5.00% Senior Secured Notes due 2030</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 10, 2022 Embecta issued $500.0&#160;million aggregate principal amount of 5.00% senior secured notes due February 15, 2030 (the &#8220;5.00% Notes&#8221;). </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Interest payments on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.00%</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes are due semi-annually in February and August until maturity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">6.75% Senior Secured Notes due 2030</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 31, 2022, Embecta issued $200.0&#160;million of 6.75% Related Party Notes at a discount of $3.0&#160;million. </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Related Party Notes issued to BD were not issued for cash and instead were subject to a debt-for-debt exchange which occurred on April 1, 2022. As such, the issuance of the Related Party Notes is a non-cash financing activity and is not presented in the Consolidated Statements of Cash Flows for the year ended September 30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, BD transferred the Related Party Notes with a notional value of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$200.0&#160;million</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> issued by Embecta to Morgan Stanley in exchange for certain notes of BD that were purchased by Morgan Stanley pursuant to a tender offer. Morgan Stanley then sold the senior secured notes to qualified institutional buyers in the United States pursuant to Rule 144A under the Securities Act of 1933, as amended. As of April 1, 2022, the 6.75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">senior secured notes (the "6.75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes")</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> became third party debt of Embecta. Interest payments on the 6.75% Notes are due semi-annually in February and August until maturity. The 6.75% Notes will mature on February 15, 2030.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 31, 2022, Embecta entered into a credit agreement (the &#8220;Credit Agreement&#8221;), providing for: </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:28pt">a Term Loan B Facility (the "Term Loan") in the amount of $950.0&#160;million, with a </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">seven</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-year </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">term that matures in March 2029. The interest rate is 300 basis points over the secured overnight financing rate (&#8220;SOFR&#8221;), with a 0.50% SOFR floor. The Term Loan was issued at a discount of 0.50%. Principal and interest payments on the Term Loan commenced on June 30, 2022. Such quarterly principal payments are calculated as 0.25% of the initial principal amount, with the remaining balance payable upon maturity;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:28pt">a Revolving Credit Facility (the "Revolving Credit Facility") in an aggregate principal amount of up to $500.0&#160;million, with a </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">five</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-year term that matures in 2027. </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Borrowings under the Revolving Credit Facility bear interest, at Embecta&#8217;s option, at an annual rate equal to (a) in the case of loans denominated in United States dollars (i) the SOFR or (ii) the alternate base rate or (b) in the case of loans denominated in Euros, the EURIBOR rate, in each case plus an applicable margin specified in the credit agreement. A commitment fee applies to the unused portion of the Revolving Credit Facility, equal to 0.25% per annum. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September&#160;30, 2023, no amount has been drawn on the Revolving Credit Facility. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The credit agreement and the senior secured notes are secured by substantially all assets of Embecta and each subsidiary guarantor, subject to certain exceptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Credit Agreement and the indentures for Embecta's outstanding 5.00% Notes and 6.75% Notes contain customary financial covenants, including a total net leverage ratio covenant, which measures the ratio of (i) consolidated total net debt to (ii) consolidated earnings before interest, taxes, depreciation and amortization, and subject to other adjustments, must meet certain defined limits which are tested on a quarterly basis in accordance with the terms of the Credit Agreement and the 5.00% Notes and </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes. In addition, the Credit Agreement contains covenants that will limit, among other things, Embecta&#8217;s ability to prepay, redeem or repurchase its subordinated and junior lien debt, incur additional debt, make acquisitions, merge with other entities, pay dividends or distributions, redeem or repurchase equity interests, and create or become subject to liens. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a summary of Embecta's total debt outstanding as of September&#160;30, 2023:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Term Loan due March 2029</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">935.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-align:justify;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.00% Notes due February 2030</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">500.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:10pt;text-align:justify;text-indent:-10pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"> Notes due February 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">200.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total principal debt issued</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,635.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(9.5)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(32.4)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,593.9</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The debt issuance costs on the Term Loan, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.00%</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes, 6.75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Notes </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and the discount on the Term Loan are reported in the Consolidated Balance Sheets as a reduction of debt and are amortized as a component of </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Interest expense, net</span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> over the term of the related debt using the effective interest method.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The schedule of principal payments required on long-term debt for the next five fiscal years and thereafter is as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:88.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair value of long-term debt (including current portion) at September&#160;30, 2023 was $1,474.2&#160;million compared with a carrying value (which includes a reduction for unamortized debt issuance costs and discounts) of $1,603.4&#160;million. Fair value was estimated using inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability and would be considered Level 2 in the fair value hierarchy.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886677072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Share</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 13 &#8212; Earnings per Share</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, the date of the Separation, 57,012,925 shares of Embecta's common stock, par value $0.01 per share, were distributed to BD shareholders of record as of March 22, 2022, the record date of the distribution. This share amount is utilized for the calculation of earnings per basic and diluted common share for all periods presented prior to the Separation.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, and in accordance with the EMA, Embecta's employees with outstanding former BD share-based awards received replacement share-based awards under the Plan. The ratio used to convert the BD share-based awards was designed to preserve the aggregate intrinsic value of the award immediately after the Separation when compared to the aggregate intrinsic value of the award immediately prior to the Separation (see Note 10 for additional details).</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The calculation of earnings per basic and diluted common share for the </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">years ended September 30, 2023, 2022 and 2021 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:68.399%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.459%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.459%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">($ in millions and shares in thousands, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income attributable to Embecta</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">70.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">223.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">414.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average number of shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,248</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock awards and equity units (share equivalent)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">510</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,758</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,461</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,013</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per common share - Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per common share - Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For periods prior to the Separation, it is assumed that there were no dilutive equity instruments as there were no equity awards of Embecta outstanding prior to the Separation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For periods subsequent to the Separation, diluted earnings per share is computed by giving effect to all potentially dilutive stock awards that are outstanding. The computation of earnings per diluted share excludes the effect of the potential exercise of stock-based awards, when the effect of the potential exercise would be anti-dilutive. For both 2023 and 2022, 1.8&#160;million of dilutive share equivalents issuable under stock-based compensation plans were excluded from the diluted shares outstanding calculation because the result would have been antidilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886708960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 14 &#8212; Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Income (Loss) Before Income Taxe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">s</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Before Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for the years ended September 30 consisted of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Provision (benefit) for Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provision (benefit) for income taxes for the years ended September 30 consisted of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's income tax provision for the first half of 2022 and the year ended September 30, 2021 were prepared using a separate return method. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company was a separate taxpayer and a standalone enterprise. The Company believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For a portion of fiscal year 2022 and all periods prior to the Separation, the Company&#8217;s domestic and foreign operations were included in BD&#8217;s domestic consolidated and foreign tax returns, and payments to all tax authorities were made by BD on the Company&#8217;s behalf. The Company filed its own foreign tax return and made its own foreign tax payments in Ireland. The Company&#8217;s current tax liabilities computed under the separate return method were considered to be effectively settled in the consolidated financial statements at the time the transaction was recorded, with the offset recorded against Net parent investment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Tax Rate Reconciliation</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A reconciliation of federal statutory tax rate to the Company's effective income tax rate was as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US tax on foreign earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes on unremitted foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nontaxable items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase in the Company's effective income tax rate for fiscal year 2023 as compared to fiscal year 2022 was primarily due to the establishment of a valuation allowance against interest expense carryforwards in the U.S., an increase in U.S. tax on foreign earnings primarily because of limitations on the utilization of foreign tax credits and higher withholding taxes on unremitted foreign earnings; partially offset by increased tax benefits from non-taxable items and change in geographical mix of earnings.  For fiscal year 2023, the Other, net included a tax benefit for the establishment of net deferred tax assets incurred in connection with the ongoing separation of the Diabetes Care Business from BD, partially offset by a return to provision adjustment from the prior year.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The decrease in the Company's effective income tax rate for fiscal year 2022 as compared to fiscal year 2021 was primarily due to the change in geographical mix of earnings and favorable unrecognized tax benefits recorded in fiscal year 2022; partially offset by tax expense that have been provided on undistributed earnings of foreign subsidiaries.    </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Deferred Income Taxes</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred income taxes at September 30 consisted of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross deferred tax assets before valuation allowance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes on unremitted foreign earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities) (i)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt">Net deferred tax assets are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and net deferred tax liabilities are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred tax assets and liabilities are netted in the Consolidated Balance Sheets by separate tax jurisdictions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2023 and September 30, 2022, the Company has recorded deferred taxes on undistributed earnings of foreign subsidiaries.  The vast majority of these taxes were accrued, in part, because the Company does not meet certain holding period requirements for stock ownership.  During fiscal year 2024, the Company anticipates that it will meet these requirements at which time approximately $18.0&#160;million of the accrued balance as of September 30, 2023 will be recorded as a reduction to income tax expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2023 the Company has recorded valuation allowances of $31.6&#160;million due to the uncertainty that exists regarding future realizability of certain deferred tax assets primarily for interest expense carryforwards in the U.S. related to limitations on the annual deductibility of such interest, state net operating losses, state tax credits and deferred tax assets related to certain foreign manufacturing operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September 30, 2022, the Company has recorded valuation allowances of $10.4&#160;million for deferred tax assets related to certain foreign manufacturing operations.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The approximate tax reduction related to a tax holiday in Switzerland in which the Company does business is $2.1&#160;million and $0.04 impact on diluted earnings per share in fiscal year 2023. The tax holiday will expire in 2026.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tax loss and credit carryforwards consist of approximately $1.0&#160;million of state income tax credit carryforwards and $5.6&#160;million net operating loss carryforwards in various jurisdictions.  Approximately $1.0&#160;million of net operating loss carryforwards will not expire and the remaining carryforwards expire in varying amounts from 2028 through 2042.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Unrecognized Tax Benefits</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at October 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase due to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase due to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease due to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease due to settlements with tax authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease due to lapse of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits including interest and penalties that would affect the effective tax rate if recognized</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For a portion of fiscal year 2022 and all periods prior to the Separation, the Company&#8217;s domestic and foreign operations were included in BD&#8217;s domestic consolidated and foreign tax returns, with the exception of Ireland.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company conducts business and files tax returns in numerous countries and currently has no tax audits in progress for the period after the Separation. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following were included for the years ended September 30 as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Statements of Income and the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and penalties expense (benefit) associated with unrecognized tax benefits on the Consolidated Statements of Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and penalties associated with unrecognized tax benefits on the Consolidated Balance Sheets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886730752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments and Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 15 &#8212; Financial Instruments and Fair Value Measurements </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following reconciles </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> reported within the Consolidated Balance Sheets as of September&#160;30, 2023 and September&#160;30, 2022, to the total amounts shown in the Consolidated Statements of Cash Flows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> includes cash held in money market funds and other cash equivalents. All cash and cash equivalents are Level 1 in the fair value hierarchy. Interest income on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was $9.4&#160;million for the year ended September&#160;30, 2023 and is included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Interest expense, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. For the years ended September 30, 2022 and 2021, interest income was not material to the Company's Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Foreign Currency Risks and Related Strategies</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has foreign currency exposures throughout Europe, Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other income (expense), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the </span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">hedging costs associated with the derivative instruments. Gains and losses recognized to date on these instruments were not material to the Company's Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Nonrecurring Fair Value Measurements </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Non-financial assets, including property, plant and equipment as well as intangible assets, are measured at fair value when there are indicators of impairment and these assets are recorded at fair value only when an impairment is recognized. These measurements of fair value are generally based upon Level 3 inputs, including values estimated using the income approach. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2023, the Company recorded impairment charges of $2.5&#160;million related to the abandonment of certain manufacturing equipment in China that is no longer in use that were inherited as part of the spin from BD. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Machinery, equipment and fixtures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Impairment expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2022, the Company recorded impairment charges of $58.9&#160;million related to the abandonment of certain manufacturing production lines in the United States that are no longer expected to be completed. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Construction in progress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Impairment expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2021, the Company recorded impairment charges related to certain construction in progress assets related to discontinued projects totaling $13.8&#160;million. The impairment charges were recorded to adjust the carrying amount of the assets to the assets&#8217; fair values, which were estimated through a discounted cash flow model that utilized Level 3 inputs. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Historically and prior to the Separation, the Company&#8217;s operations formed part of BD&#8217;s monitoring of concentrations of credit risk associated with financial institutions for which BD conducted business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of September&#160;30, 2023, the Company had transferred the majority of its trade receivables to BD under the Factoring Agreements (see Note 4). As a result, the Company is no longer exposed to credit risk associated with those transferred receivables and does not have material credit risk exposure associated with the remaining $16.7 million of trade receivables. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Three of the Company&#8217;s customers represented at least 10.0% of total gross revenues individually and, in the aggregate, represented approximately 40.2% and 40.1% for the years ended September&#160;30, 2023 and 2022, respectively. Two customers represented at least 10.0% of total revenues individually and, in the aggregate, represented approximately 30.7% of total revenues for the year ended September 30, 2021. </span></div>Substantially all of the Company&#8217;s trade receivables are due from public and private entities involved in the healthcare industry. The Company does not normally require collateral from its customers.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886695440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 16 &#8212; Property, Plant and Equipment</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, Plant and Equipment, Net consisted of: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">124.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">123.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">567.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">505.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">44.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">64.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">747.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">701.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(447.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(400.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Property, Plant and Equipment, Net</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">300.2&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">301.6&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2023, the Company recorded impairment charges of $2.5&#160;million related to the abandonment of certain manufacturing equipment in China that is no longer in use that were inherited as part of the spin from BD. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Machinery, equipment and fixtures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the year ended September 30, 2022, the Company recorded impairment charges of $58.9&#160;million related to the abandonment of certain manufacturing production lines in the United States that are no longer expected to be completed. These assets were previously included as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Construction in progress</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The impairment charges are recognized within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Impairment expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Consolidated Statements of Income.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886711552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 17 &#8212; Leases</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Finance Lease</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In conjunction with the Separation, we entered into a lease agreement with BD pursuant to which the Company would lease approximately 278,000 square feet of manufacturing space and equipment at BD's manufacturing facility in Holdrege, Nebraska for an initial term of ten years and an option for the Company to extend the lease term for an additional period of up to five years. This lease is classified as a finance lease.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2023, the Company recorded total finance lease costs of $4.8 million which is comprised of $2.4 million attributable to depreciation of assets and $2.4 million attributable to interest expense associated with the lease liability. The amounts are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Interest expense, net,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> respectively. For the year ended September 30, 2022, total finance lease costs were not material to the Company's Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Operating Leases</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's operating leases primarily relate to its real estate leases that are not classified as finance leases. The Company entered into a real estate lease for a new Corporate Headquarters located in Parsippany, NJ which commenced during the second quarter of fiscal year 2023 for an initial term of ten years. The Company has options to extend the lease for additional period of six years and to extend for a subsequent additional period of four years, after the expiration of the first extension period.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2023 operating lease costs were $4.5 million. For the years ended September 30, 2022, and 2021 total operating lease costs were not material to the Company's Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Aggregate Lease Information</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's leases are included in its Consolidated Balance Sheets as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:55.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.992%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Finance Lease</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-929"><span style="-sec-ix-hidden:f-930">Property, Plant, and Equipment, Net</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">33.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Finance Lease Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">33.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current finance lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non Current Finance Lease Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">32.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Finance Lease Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">13.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">14.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-945"><span style="-sec-ix-hidden:f-946">Deferred Income Taxes and Other Assets</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Lease Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">23.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-951"><span style="-sec-ix-hidden:f-952">Accrued expenses</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-955"><span style="-sec-ix-hidden:f-956">Deferred Income Taxes and Other Liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Lease Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Supplemental cash flow information related to leases was as follows as of September 30, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Right of use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finance Lease</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating Leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2021 right of use assets obtained in exchange for lease liabilities was not material.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.719%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash paid for amounts included in the measurement of lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flows from Operating Leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Financing cash flows from Finance Lease</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flows from Finance Lease</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the years ended September 30, 2022, and 2021 cash paid for amounts included in the measurement of lease liabilities were not material.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Maturities of the Company's finance and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:36.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">54.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">27.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">82.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">56.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 17 &#8212; Leases</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Finance Lease</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In conjunction with the Separation, we entered into a lease agreement with BD pursuant to which the Company would lease approximately 278,000 square feet of manufacturing space and equipment at BD's manufacturing facility in Holdrege, Nebraska for an initial term of ten years and an option for the Company to extend the lease term for an additional period of up to five years. This lease is classified as a finance lease.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2023, the Company recorded total finance lease costs of $4.8 million which is comprised of $2.4 million attributable to depreciation of assets and $2.4 million attributable to interest expense associated with the lease liability. The amounts are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Interest expense, net,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> respectively. For the year ended September 30, 2022, total finance lease costs were not material to the Company's Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Operating Leases</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's operating leases primarily relate to its real estate leases that are not classified as finance leases. The Company entered into a real estate lease for a new Corporate Headquarters located in Parsippany, NJ which commenced during the second quarter of fiscal year 2023 for an initial term of ten years. The Company has options to extend the lease for additional period of six years and to extend for a subsequent additional period of four years, after the expiration of the first extension period.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2023 operating lease costs were $4.5 million. For the years ended September 30, 2022, and 2021 total operating lease costs were not material to the Company's Consolidated Statements of Income.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Aggregate Lease Information</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's leases are included in its Consolidated Balance Sheets as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:55.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.992%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Finance Lease</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-929"><span style="-sec-ix-hidden:f-930">Property, Plant, and Equipment, Net</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">33.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Finance Lease Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">33.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current finance lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non Current Finance Lease Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">32.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Finance Lease Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">13.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">14.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-945"><span style="-sec-ix-hidden:f-946">Deferred Income Taxes and Other Assets</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Lease Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">23.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-951"><span style="-sec-ix-hidden:f-952">Accrued expenses</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-955"><span style="-sec-ix-hidden:f-956">Deferred Income Taxes and Other Liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Lease Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Supplemental cash flow information related to leases was as follows as of September 30, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Right of use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finance Lease</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating Leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2021 right of use assets obtained in exchange for lease liabilities was not material.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.719%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash paid for amounts included in the measurement of lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flows from Operating Leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Financing cash flows from Finance Lease</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flows from Finance Lease</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the years ended September 30, 2022, and 2021 cash paid for amounts included in the measurement of lease liabilities were not material.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Maturities of the Company's finance and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:36.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">54.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">27.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">82.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">56.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886741344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Benefit Plans</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 18 &#8212; Benefit Plans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Defined Benefit Plans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation on April 1, 2022, Embecta participated in BD's non-United States plans. BD has defined benefit pension plans covering eligible employees in certain of its international subsidiaries. The Company participated in BD's benefit plans as though it was a participant in a multi-employer plan with the other businesses of BD. The retirement benefits accounting guidance provides that liabilities beyond any contributions currently due and unpaid are not required to be reported. Accordingly, no assets or liabilities associated with plans where the Company was a participant in a multi-employer plan with the other businesses of BD have been reflected in the Company&#8217;s Consolidated Balance Sheets. The Consolidated Statements of Income include expense allocations for these benefits, which were determined using a proportional allocation method. Total benefit plan expense allocated to the Company for the years ended September 30, 2022 and 2021 was $3.6&#160;million and $9.0&#160;million, respectively. Except for deferred closing countries, the Company's participation in the defined pension and postretirement benefit plans sponsored by BD concluded upon the completion of the Separation on April 1, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of April 1, 2022, Embecta became the plan sponsor for certain global defined benefit pension plans. These Consolidated Financial Statements reflect the periodic benefit costs and funded status of such plans. The Company uses September 30 as the year-end measurement date for these plans. Net periodic benefit cost for the Company&#8217;s global defined benefit pension plans for the years ended September 30, 2023 and 2022 was $1.0&#160;million and $0.7&#160;million, respectively. Of the plans, the defined benefit pension plan covering employees in Switzerland (the "Swiss Plan") is the only defined benefit pension plan material to the Company's Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's Swiss Plan is a government-mandated retirement account balance plan. Companies within the Swiss regulatory environment have substantial freedom in setting their pension plan design (e.g. with regards to the salary covered, level of retirement benefits, or overall benefit design) provided the benefits are always at least equal to the minimum requirements as defined by law. Most employers provide higher benefits than those required by law, which is the case for Embecta. The minimum level of retirement benefit is expressed by a cash balance formula with age-related contribution rates (or "retirement credits") based on an insured salary defined by law, and a minimum required interest crediting rate which is set by the government (1.00% in 2023 and 2022). The sum of the Company's contributions should be at least equal to the sum of employee contributions. Contributions to the Swiss Plan are invested into a diversified fund managed by an investment fiduciary. As of September&#160;30, 2023 and 2022, the Swiss plan had an unfunded net pension obligation of $1.9&#160;million and $0.6&#160;million, respectively, and plan assets that totaled $14.1&#160;million and $8.0&#160;million, respectively. Since the Separation, the Company recognized net periodic benefit cost totaling $0.9 million and $0.2 million during the fiscal years ended September 30, 2023 and 2022, respectively, related to the Company's Swiss plan, of which $0.3 million and $0.1 million was included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other income (expense), net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">during the fiscal years ended September 30, 2023 and 2022, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Defined Contribution Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has various defined contribution savings plans that cover substantially all employees in the United States, Ireland, and Japan. The Company matches a certain percentage of each employee&#8217;s contributions as per the provisions of the plans. Total employer contributions by the Company to the plans were $14.1 million and $8.9 million for the fiscal years ended September 30, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Between April 1, 2022 and September 30, 2022, BD remained the defined benefit pension plan sponsor for certain Embecta employees in Ireland. The Company accounts for this plan as though it was a participant in a multi-employer plan with other businesses of BD.  The amount of contributions to BD for this plan are included in the amounts noted above. At the Separation Date, Embecta effectuated an Embecta sponsored defined contribution pension plan for certain other employees in Ireland. On October 1, 2022, any Embecta employees who remained participating in the BD defined benefit pension plan ceased participating and these employees began participating in an Embecta sponsored defined contribution pension plan that was effectuated at the Separation Date. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Deferred Compensation Plan</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On the date of the Separation, the Company established a Deferred Compensation Plan in which certain directors and employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation. A participant's deferrals are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator. The amounts accrued under this plan were $6.1 million and $3.7 million as of September&#160;30, 2023, and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886870592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Supplemental Financial Information</a></td>
<td class="text"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 19 &#8212; Supplemental Financial Information</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Trade Receivables, Net</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amounts recognized in fiscal years 2023, 2022 and 2021 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:43.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance for Doubtful Accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance for Cash Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deductions and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(a) Accounts written off</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(b) Amounts factored to BD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Long-Lived Assets</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Long-lived assets, which include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Goodwill and Other Intangibles, net,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> by geographic area where located at September 30, 2023 and 2022 is as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">109.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">109.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Europe, Middle East, and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">176.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">174.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">38.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">324.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">326.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886935168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Note 20 &#8212; Subsequent Events</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Performance-Based and Time-Vested Restricted Stock Units</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2023 and pursuant to the Company's 2022 Employee and Director Equity Based Compensation Plan (the "Plan"), the Company granted approximately 1.3&#160;million </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">TVUs in connection with the Company's annual grant which </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">vest on a graded basis over a period of three years, subject to continuous service to the Company by the employee.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company also awarded approximately 0.5&#160;million PSUs to certain executive officers and employees in connection with the Company's annual grant </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">which vest after three years, subject to continued employment of the recipients and the achievement of certain performance metric targets. The Company has identified certain performance metrics and targets that will be fully established at a future date. The Company has determined that the service inception date precedes the grant date for these awards as (a) the awards were authorized prior to establishing an accounting grant date, (b) the recipients began providing services prior to the grant date, and (c) there are performance conditions that, if not met by the accounting grant date, will result in the forfeiture of the awards.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884189504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2022, the Company became a standalone publicly traded company, and its financial statements are now presented on a consolidated basis. Prior to the Separation on April 1, 2022, the Company&#8217;s historical combined financial statements were prepared on a standalone basis and were derived from BD's consolidated financial statements and accounting records. The financial statements for all periods presented, including the historical results of the Company prior to April 1, 2022, are now referred to as "Consolidated Financial Statements", and have been prepared pursuant to the rules and regulations for reporting on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Prior to Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the Company was referred to as the Diabetes Care Business. The assets, liabilities, revenue and expenses of the Diabetes Care Business were reflected in the combined financial statements on a historical cost basis, as included in the consolidated financial statements of BD, using the historical accounting policies applied by BD. The Consolidated Financial Statements did not purport to reflect what the Company&#8217;s results of operations, comprehensive income, financial position, equity or cash flows would have been had the Company operated as a standalone public company during the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Diabetes Care Business had historically functioned together with the other businesses controlled by BD. Accordingly, the Diabetes Care Business relied on BD&#8217;s corporate and other support functions for its business. Therefore, for the period prior to the Separation, certain corporate and shared costs were allocated to the Diabetes Care Business based on a specific identification basis or, when specific identification was not practicable, a proportional cost allocation method, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt">expenses related to BD support functions, including expenses for facilities, executive oversight, treasury, finance, legal, human resources, shared services, compliance, procurement, information technology and other corporate functions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:9.96pt">certain manufacturing and supply costs incurred by BD, including facility management, distribution, logistics, planning and global quality.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.19pt">certain costs incurred by BD&#8217;s Medication Delivery Solutions organizational unit in relation to selling and marketing activities, and related administrative support functions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">iv.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt">certain costs incurred by BD for activities related to device research and development, as well as medical and regulatory affairs.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">stock-based compensation expenses (see Note 10).</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">vi.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt">certain compensation expenses maintained on a centralized basis such as certain employee benefit expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management believes these cost allocations were a reasonable reflection of the utilization of services provided to, or the benefit derived by, the Diabetes Care Business during the period prior to the Separation, though the allocations may not be indicative of the actual costs that would have been incurred had the Diabetes Care Business operated as a standalone public company. Actual costs that may have been incurred if the Diabetes Care Business had been a standalone company would depend on a number of factors, including the chosen organizational structure, whether functions were outsourced or performed by Diabetes Care Business employees, and strategic decisions made in areas such as manufacturing, selling and marketing, research and development, information technology and infrastructure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BD utilized a centralized approach to cash management and the financing of its operations. Cash generated by the Diabetes Care Business was routinely transferred into accounts managed by BD&#8217;s centralized treasury function and cash disbursements related to operations prior to the Separation were funded as needed by BD. Balances held by the Diabetes Care Business with BD for cash transfers and loans were reflected as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due to Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> prior to the Separation. All other cash and cash equivalents and related transfers between BD and the Diabetes Care Business were generally held centrally through accounts controlled and maintained by BD and were not specifically identifiable to the Diabetes Care Business. Accordingly, such balances were accounted for through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. BD&#8217;s third-party debt and related interest expense were not attributed to the Diabetes Care Business because the business was not the legal obligor of the debt and the borrowings were not specifically identifiable to the business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain reclassifications were made to conform the prior period Consolidated Financial Statements to the current period presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the Diabetes Care Business, transactions with BD affiliates were included in the Consolidated Statements of Income and related balances were reflected as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due to Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amounts due from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Related Party Loans Payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Other balances between the Diabetes Care Business and BD were considered to be effectively settled in the Consolidated Financial Statements at the time the transactions were recorded.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As the separate legal entities that made up the Diabetes Care Business were not historically held by a single legal entity, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was shown in lieu of stockholders&#8217; equity in these Consolidated Financial Statements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> represented BD&#8217;s interest in the recorded assets of the Diabetes Care Business and the cumulative investment by BD through the date of the Separation, inclusive of operating results.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For periods prior to the Separation, income tax expense and tax balances in the Consolidated Financial Statements were calculated on a separate tax return basis. The separate tax return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company was a separate taxpayer and a standalone enterprise. Management believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provision for income taxes for the period prior to the Separation was calculated by applying an estimated effective income tax rate for the full year to ordinary income adjusted by the tax impact of discrete items.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">As of the Separation Date</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain assets and liabilities, including patents and unrecognized tax benefits that were included in the Consolidated Balance Sheet prior to the Separation, have been retained by BD post-Separation and therefore were transferred to BD through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the Company's Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Separation, additional pension assets, deferred tax assets, other compensation obligations, and certain other assets and liabilities were transferred to the Company through </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and the Company recorded these in the Consolidated Balance Sheet. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As part of the Separation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">was reclassified as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Common Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accumulated Deficit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Periods Post Separation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following the Separation, certain functions continue to be provided by BD under the Transition Services Agreements or are being performed using Embecta&#8217;s own resources or third-party service providers. Additionally, under manufacturing and supply agreements, the Company manufactures certain products for BD, or its applicable affiliate and BD manufactures certain products for the Company. The Company incurred certain costs in its establishment as a standalone public company and expects to incur ongoing additional costs associated with operating as an independent, publicly traded company.</span></div>All intercompany transactions and accounts within Embecta have been eliminated.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Measurement of Revenues</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue Recognition</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recognizes revenue from product sales and considers performance obligations satisfied when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement. The Company acts as the principal in its customer arrangements and therefore records revenue on a gross basis. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. The point in time upon which shipment or delivery occurs is the most faithful depiction of when control of the goods transfers to the customer. Variable consideration such as rebates, chargebacks, sales discounts, and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Measurement of Revenues </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Payment terms extended to the Company&#8217;s customers are based upon commercially reasonable terms for the markets in which the Company&#8217;s products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#8217;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible. The allowance for doubtful accounts for trade receivables is not material to the Company&#8217;s consolidated financial results. </span></div>The Company&#8217;s gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts, and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company&#8217;s agreements primarily with its end-user customers. Additional factors considered in the estimate of the Company&#8217;s rebate liability include the quantification of inventory that is either in stock at or in transit to the Company&#8217;s distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cash and Cash Equivalents</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash and cash equivalents include all highly liquid investments with a maturity of three months or less at the date of acquisition. Interest income on Cash and cash equivalents is recorded as earned.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Trade Receivables</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Trade Receivables</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#8217;s estimate of probable credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Inventories</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_HostingArrangementServiceContractPolicyTextBlock', window );">Cloud Computing Arrangements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cloud Computing Arrangements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company capitalizes costs incurred to implement cloud computing arrangements that are service contracts within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Prepaid expenses and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Company's Condensed Consolidated Balance Sheets. Implementation costs associated with cloud computing arrangements are capitalized when incurred during the application development phase. Once the implementation of a cloud computing arrangement is complete and ready for its intended use, the Company amortizes the costs over the expected term of the hosting arrangement using the straight-line method to the same income statement line as the associated cloud operating expenses. The total balance of capitalized costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">associated with these arrangements as of September&#160;30, 2023 is $38.0&#160;million which primarily relates to the implementation of the Company's new enterprise resource planning ("ERP") system. These capitalized costs are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Costs amortized during fiscal year ended September 30, 2023 were not material to the Company's consolidated financial results. As of September&#160;30, 2023, cloud computing arrangement assets in-service have useful lives which range from approximately <span style="-sec-ix-hidden:f-353">three</span> to nine years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Property, Plant and Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is principally provided on the straight-line basis over estimated useful lives, which range from 20 to 45 years for buildings, 4 to 13 years for machinery and equipment and 1 to 20 years for leasehold improvements. Depreciation expense was $31.5&#160;million in 2023, $31.0&#160;million in 2022, and $37.2&#160;million in 2021.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, plant and equipment are periodically reviewed when impairment indicators are present to assess recoverability or a decision has been made to abandon efforts associated with construction in progress assets. Recoverability is determined by comparing the carrying values of the assets or asset groups to the undiscounted cash flows to be generated from the use and eventual disposition of such assets or asset groups. If the asset&#8217;s or asset group&#8217;s carrying value exceeds such </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">undiscounted cash flows, the assets or asset groups are not recoverable and an impairment loss is recognized based on the amount by which the carrying value of the asset or asset group exceeds its calculated fair value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestCapitalizationPolicyPolicyTextBlock', window );">Capitalized Interest</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Capitalized Interest</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The interest cost on capital projects is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended September 30, 2023 and 2022, the Company capitalized $4.6 million and $5.2 million of interest expense, respectively, into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, Net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and capitalized $0.9 million of interest expense into </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span> during the year ended September 30, 2023.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Advertising Costs </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advertising costs are expensed as incurred and included in S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">elling and administrative expense</span>.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill represents the excess of the consideration transferred over the fair value of net assets of businesses acquired. The Company has one reporting unit. Goodwill is evaluated for impairment as of July 1 each year, or more frequently if impairment indicators exist, by first assessing qualitative factors to determine whether it is more likely than not that fair value is less than carrying value. If the Company concludes it is more likely than not that fair value is less than carrying value, a quantitative fair value test is performed. If carrying value is greater than fair value, a goodwill impairment charge will be recorded for the difference (up to the carrying value of goodwill). The Company completed the annual goodwill impairment test as of July 1, 2023 and concluded that no impairment to goodwill was necessary as the fair value of the Company's one reporting unit was significantly in excess of the carrying value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No goodwill impairments were identified during the years ended September 30, 2022, or 2021, and no accumulated impairment losses are recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortized intangible assets primarily consist of patents and customer relationships. Patents are generally amortized over 20 years using the straight-line method. Customer relationship assets are generally amortized over periods ranging from 10 to 15 years, using the straight-line method. Other intangibles with finite useful lives are amortized over periods principally ranging from 1 to 40 years, using the straight-line method. Finite-lived intangible assets are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#8217;s carrying value exceeds its calculated fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Foreign Currency Translation</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Generally, foreign subsidiaries&#8217; functional currency is the local currency of operations and the net assets of foreign operations are translated into United States dollars using current exchange rates. The United States dollar results that arise from such translation are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accumulated other comprehensive loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShippingAndHandlingPolicyPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Shipping and Handling Costs</span></div>The Company considers its shipping and handling costs to be contract fulfillment costs and records them within selling and administrative expense.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contingencies</span></div>The Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries).<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Stock-Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, certain of the Company&#8217;s employees historically participated in BD&#8217;s stock-based compensation plans. Stock-based compensation expense was either allocated to the Company based on a proportionate cost allocation method or recorded based on specific identification. Effective April 1, 2022, the Company established the 2022 Employee and Director Equity Based Compensation Plan (the "Plan"). The Plan provides for the grant of various types of awards, including restricted stock unit ("RSU") awards, stock appreciation rights, stock options, performance-based awards and cash awards. Under the Plan, the exercise price of awards, if any, is set on the grant date and generally may not be less than </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the fair market value per share on that date. The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards. For awards that ultimately settle in cash, we treat them as liability awards and mark the award to market each reporting period and recognize any adjustment in our Consolidated Statements of Income. The Company recognizes stock-based compensation cost only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants. The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change (see Note 10).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Benefit Plans</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Benefit Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the defined benefit plans in which the Company participated related primarily to plans sponsored by BD and for which other businesses of BD also participate (the "Shared Plans"). The Company accounted for the Shared Plans as multiemployer plans and therefore the related assets and liabilities were not reflected in the Consolidated Balance Sheets. For such periods prior to the Separation, the Consolidated Statements of Income reflect a proportional allocation of net periodic benefit cost for the Shared Plans associated with the Company. The Company's participation in the defined pension and postretirement benefit plans sponsored by BD concluded upon the completion of the Separation on April 1, 2022. At and after Separation, Embecta became the plan sponsor for certain non-United States defined benefit pension plans (see Note 18).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Research and Development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax basis of assets and liabilities at the applicable tax rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, the Company engages in transactions in which tax consequences may be subject to uncertainty. The Company conducts business and files tax returns in numerous jurisdictions based on its interpretation of tax laws and regulations. In evaluating the Company&#8217;s tax provision, the Company establishes a reserve for uncertain tax positions unless such positions are determined to be more likely than not of being sustained upon examination based on the technical merits.  The Company&#8217;s policy is to recognize, when applicable, interest and penalties on uncertain tax positions as part of income tax expense.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Tax Cuts and Jobs Act was enacted on December 22, 2017 and introduced an additional United States tax on the earnings of non-United States subsidiaries which are referred to as Global Intangible Low Taxed Income (&#8220;GILTI&#8221;). The Company has elected to treat GILTI as a period cost. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prior to the Separation, the Company's operations were included in the tax returns of BD. Income taxes as presented in the Consolidated Financial Statements attribute current and deferred income tax assets and liabilities of BD to the Company in a manner that is systematic, rational, and consistent with the asset and liability method prescribed by the accounting guidance for income taxes. The Company's income tax provision prior to the Separation was prepared using the separate return method. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company were a separate taxpayer and a standalone enterprise. The Company believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Data</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Segment Data</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company operates and reports its financial information as one segment. In making this determination, the Company (i) determines its Chief Operating Decision Maker (&#8220;CODM&#8221;), (ii) identifies and analyzes potential business components, (iii) </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">identifies its operating segments and (iv) determines whether there are multiple operating segments requiring presentation as reportable segments. The Company&#8217;s decision to report as one segment is based upon the following: (1) its internal organizational structure; (2) the manner in which its operations are managed; and (3) the criteria used by the Company&#8217;s President, its CODM, to evaluate performance of the Company&#8217;s business and allocate resources and capital.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Fair Value Measurements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#8217;s fair value measurements are provided in Note 15.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Level 1&#8212;Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Level 2&#8212;Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Level 3&#8212;Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Leases</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company determines whether an arrangement contains a lease at inception. If a lease is identified in an arrangement, the Company recognizes a right-of-use asset and liability in the Company's Consolidated Balance Sheets and determine whether the lease should be classified as a finance or operating lease. The Company does not recognize assets or liabilities for leases with lease terms of less than 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i) there is a transfer of ownership of the leased asset to Embecta by the end of the lease term, (ii) the Company holds an option to purchase the leased asset that the Company is reasonably certain to exercise, (iii) the lease term is for a major part of the remaining economic life of the leased asset, (iv) the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v) the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the implicit rate is not readily determinable, the Company utilizes its incremental borrowing rate at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease payments are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method over the shorter of the useful life of the related asset or the lease term. Finance lease payments are bifurcated into (i) a portion that is recorded as imputed interest expense and (ii) a portion that reduces the finance liability associated with the lease.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For lease arrangements that are recognized on the Company&#8217;s Consolidated Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. Variable lease payments are expensed as incurred. If a lease includes an option to extend or terminate the lease, the Company reflects the option in the lease term if it is reasonably certain the Company will exercise the option.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Finance leases are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Current finance lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Non Current Finance Lease Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and operating leases are recorded in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accrued expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Company's Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses, including determining the allocation of shared costs and expenses from BD, depreciable and amortizable lives, sales returns and allowances, rebate accruals, restructuring costs, inventory reserves and taxes on income as reflected in the Consolidated Financial Statements. Actual results could differ from these estimates. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net Investment from Becton, Dickinson and Company &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Net investment from Becton, Dickinson and Company</span> represented BD&#8217;s interest in the recorded assets of the Company and the cumulative investment by BD in the Company through the date of the Separation, inclusive of operating results and the net effect of the transactions with and allocations from BD.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers, as if it had originated the contracts. The Company adopted this guidance at the beginning of fiscal year 2023 and it did not materially impact the Company's Condensed Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_HostingArrangementServiceContractPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Hosting Arrangement Service Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_HostingArrangementServiceContractPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShippingAndHandlingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shipping And Handling, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShippingAndHandlingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480598/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCapitalizationPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for interest capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 835<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCapitalizationPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481097/715-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 60<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 80<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480576/715-80-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886708960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Third Party Arrangements and Related Party Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ThirdPartyAndRelatedPartyTransactionsAbstract', window );"><strong>Third Party and Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Transactions</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The allocations of General Corporate Expenses are reflected in the Consolidated Statements of Income as follows: </span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.448%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">13.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling and administrative expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">98.3</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.2</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other (income) expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.6)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.3)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total General Corporate Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">53.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">115.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table>The following table summarizes such former related party purchases as follows: <div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.447%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases from BD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the components of the net transfers to BD as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.447%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cash pooling and general financing activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">255.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">599.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Corporate and segment allocations, excluding non-cash stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(50.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(109.9)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Taxes deemed settled with BD</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(72.5)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other Separation related adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(11.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net transfers to BD as reflected in the Consolidated Statements of Cash Flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">177.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">417.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(8.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(12.5)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Pension expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net consideration paid to BD in connection with the Separation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,266.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Related party senior secured notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">197.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other transfers to (from) BD, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">84.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(11.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net transfers to BD</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,712.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">383.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span>The nature of activities includes financing activities for capital transfers, cash sweeps and other treasury services. As part of this activity, cash balances were swept to BD on a daily basis under the BD Treasury function and the Company receives capital from BD for its cash needs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ThirdPartyAndRelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Third Party and Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ThirdPartyAndRelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886797504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographical Data (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenues by Geographical Region</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues by geographic region are as follows: </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Year ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">601.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">600.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">609.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">519.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">529.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">555.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,120.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,129.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,165.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span>For the years ended September&#160;30, 2023, 2022, and 2021 no individual country outside of the United States generated net revenues that represented more than 10.0% of total revenues.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885794352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total direct and allocated stock-based compensation expense for the years ended September&#160;30, 2023, 2022, and 2021 and the respective income tax benefits recognized by the Company in the Consolidated Statements of Income are as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.388%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">14.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Stock-Based Compensation Expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12.8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Tax benefit associated with stock-based compensation costs recognized</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company's total stock-based compensation expense by classification of award:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:55.131%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Equity Awards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Liability Awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes the Company's total stock-based compensation expense by award type for the years ended September&#160;30, 2023 and 2022, subsequent to the Separation:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:70.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Time-Vested Restricted Stock Units (TVUs)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">16.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Performance-Based Restricted Stock Units (PSUs)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock Appreciation Rights (SARs)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock', window );">Schedule of Time-Vested Restricted Stock Units Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of TVUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stock Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at October 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">977.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">680.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">31.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Distributed*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(386.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(82.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,188.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected to vest at September 30</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,134.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.39&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">*The amounts distributed include shares withheld for taxes that are not formally issued to the market.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average grant date fair value of TVUs granted during the years 2023 and 2022 are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average grant date fair value of units granted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The total fair value of TVUs vested during the years 2023 and 2022 was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total fair value of units vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock', window );">Schedule of Performance Based Restricted Stock Units Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of PSUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stock Units (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at October 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">30.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Distributed</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">30.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Nonvested at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">30.24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected to vest at September 30</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">54.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">30.24&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The weighted average grant date fair value of PSUs granted during 2023 is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average grant date fair value of units granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock', window );">Schedule of SARs Valuation Assumptions</a></td>
<td class="text">The weighted average fair value of SARs was determined using the following assumptions:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:89.809%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">37.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Expected life</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Fair value per SAR</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of SAR's Outstanding and Changes</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of SARs outstanding as of September 30, 2023 and changes and changes during the year then ended is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">SARs (in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Weighted Average Remaining Contractual Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Aggregate Intrinsic Value </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at October 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,916.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(25.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited, canceled or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(59.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,831.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested and expected to vest at September 30</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,740.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">29.05&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at September 30</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">179.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26.96&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">*The amounts exercised include shares withheld for taxes that are not formally issued to the market.</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of SARs exercised during the years 2023 and 2022 is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total intrinsic value of SARs exercised</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total fair value of SARs exercised</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Share-Based Payment Award, Stock Appreciation Rights, Valuation Assumptions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886853376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill and Other Intangible Assets consisted of: </span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.869%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Amortized intangible assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Patents &#8211; gross</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: accumulated amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Patents &#8211; net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Customer Relationships and Other &#8211; gross</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Customer Relationships and Other &#8211; net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">8.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Goodwill and Other Intangible Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">24.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">24.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884163072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Debt Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a summary of Embecta's total debt outstanding as of September&#160;30, 2023:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Term Loan due March 2029</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">935.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-align:justify;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.00% Notes due February 2030</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">500.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:10pt;text-align:justify;text-indent:-10pt"><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.75%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"> Notes due February 2030</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">200.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total principal debt issued</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,635.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: current debt obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(9.5)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(32.4)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,593.9</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Principal Payments Required on Long-Term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The schedule of principal payments required on long-term debt for the next five fiscal years and thereafter is as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:88.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,588.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886841552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The calculation of earnings per basic and diluted common share for the </span><span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">years ended September 30, 2023, 2022 and 2021 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:68.399%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.459%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.459%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">($ in millions and shares in thousands, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Income attributable to Embecta</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">70.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">223.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">414.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic weighted average number of shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,248</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock awards and equity units (share equivalent)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">510</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,758</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,461</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">57,013</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per common share - Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per common share - Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885765584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income Before Income Taxes</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Before Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for the years ended September 30 consisted of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">285.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Provision (Benefit) for Income Taxes</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The provision (benefit) for income taxes for the years ended September 30 consisted of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following were included for the years ended September 30 as a component of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Statements of Income and the Consolidated Balance Sheets.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and penalties expense (benefit) associated with unrecognized tax benefits on the Consolidated Statements of Income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and penalties associated with unrecognized tax benefits on the Consolidated Balance Sheets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A reconciliation of federal statutory tax rate to the Company's effective income tax rate was as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal statutory tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State and local income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US tax on foreign earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes on unremitted foreign earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nontaxable items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nondeductible compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred income taxes at September 30 consisted of:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross deferred tax assets before valuation allowance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes on unremitted foreign earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities) (i)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt">Net deferred tax assets are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and net deferred tax liabilities are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred Income Taxes and Other Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. </span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.417%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at October 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase due to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase due to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease due to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease due to settlements with tax authorities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease due to lapse of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at September 30</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits including interest and penalties that would affect the effective tax rate if recognized</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886960688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following reconciles </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> reported within the Consolidated Balance Sheets as of September&#160;30, 2023 and September&#160;30, 2022, to the total amounts shown in the Consolidated Statements of Cash Flows:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The notional amounts of the Company&#8217;s foreign currency-related derivative instruments were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hedge Designation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts (a)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Undesignated</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other income (expense), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the </span></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">hedging costs associated with the derivative instruments. Gains and losses recognized to date on these instruments were not material to the Company's Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886788528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property, Plant and Equipment, Net consisted of: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Buildings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">124.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">123.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">567.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">505.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">44.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">64.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">747.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">701.6&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(447.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(400.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Property, Plant and Equipment, Net</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">300.2&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">301.6&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885744544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Balance Sheet Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's leases are included in its Consolidated Balance Sheets as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:55.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.992%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Finance Lease</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-929"><span style="-sec-ix-hidden:f-930">Property, Plant, and Equipment, Net</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">33.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Finance Lease Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">33.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current finance lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non Current Finance Lease Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">32.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Finance Lease Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">13.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">14.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-945"><span style="-sec-ix-hidden:f-946">Deferred Income Taxes and Other Assets</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Lease Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">23.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-951"><span style="-sec-ix-hidden:f-952">Accrued expenses</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><span style="-sec-ix-hidden:f-955"><span style="-sec-ix-hidden:f-956">Deferred Income Taxes and Other Liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total Operating Lease Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Supplemental cash flow information related to leases was as follows as of September 30, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.265%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Right of use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finance Lease</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating Leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended September 30, 2021 right of use assets obtained in exchange for lease liabilities was not material.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.719%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash paid for amounts included in the measurement of lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flows from Operating Leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Financing cash flows from Finance Lease</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16pt;text-indent:-10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flows from Finance Lease</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Finance Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Maturities of the Company's finance and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:36.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">54.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">27.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">82.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">56.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Maturities of the Company's finance and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:36.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">9.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">54.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">27.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">82.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">35.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">56.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143887518944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Schedule of Allowance for Doubtful Accounts and Cash Discounts</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amounts recognized in fiscal years 2023, 2022 and 2021 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:43.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.161%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance for Doubtful Accounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allowance for Cash Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deductions and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additions charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deductions and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Balance at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(a) Accounts written off</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(b) Amounts factored to BD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-Lived Assets by Geographic Area</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Long-lived assets, which include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Property, Plant and Equipment, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Goodwill and Other Intangibles, net,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> by geographic area where located at September 30, 2023 and 2022 is as follows:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">109.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">109.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Europe, Middle East, and Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">176.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">174.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">38.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">42.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">324.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">326.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885229856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Background (Details)<br></strong></div></th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_CommonStockShareIssuanceRatio', window );">Common stock, distribution ratio</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=embc_BectonDickinsonAndCompanyMember', window );">Becton, Dickinson and Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_CommonStockShareIssuanceRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Share Issuance Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_CommonStockShareIssuanceRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization, Consolidation and Presentation of Financial Statements [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=embc_BectonDickinsonAndCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=embc_BectonDickinsonAndCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881306112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>reporting_unit </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization', window );">Costs capitalized for cloud computing arrangements</a></td>
<td class="nump">$ 38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">31,500,000<span></span>
</td>
<td class="nump">$ 31,000,000<span></span>
</td>
<td class="nump">$ 37,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">$ 15,500,000<span></span>
</td>
<td class="nump">11,600,000<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">$ 341,300,000<span></span>
</td>
<td class="nump">294,800,000<span></span>
</td>
<td class="nump">240,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest, net of interest capitalized</a></td>
<td class="nump">$ 111,000,000<span></span>
</td>
<td class="nump">38,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">30,400,000<span></span>
</td>
<td class="nump">15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expense</a></td>
<td class="nump">$ 36,900,000<span></span>
</td>
<td class="nump">27,400,000<span></span>
</td>
<td class="nump">$ 13,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents &#8211; net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=embc_PropertyPlantAndEquipmentNetMember', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Interest expense capitalized</a></td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=embc_DeferredIncomeTaxesAndOtherAssetsMember', window );">Deferred Income Taxes and Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Interest expense capitalized</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife', window );">Cloud computing arrangement assets in-service useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Other Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife', window );">Cloud computing arrangement assets in-service useful lives</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Other Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">45 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_HostingArrangementServiceContractAssetsInServiceUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Hosting Arrangement, Service Contract, Assets In-Service, Useful Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_HostingArrangementServiceContractAssetsInServiceUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 40<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482558/350-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=embc_PropertyPlantAndEquipmentNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=embc_PropertyPlantAndEquipmentNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=embc_DeferredIncomeTaxesAndOtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=embc_DeferredIncomeTaxesAndOtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884921888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Third Party Arrangements and Related Party Disclosures - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum', window );">Transaction Services Agreement, maximum period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Amounts due from Becton, Dickinson and Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142,400,000<span></span>
</td>
<td class="nump">$ 110,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Amounts due to Becton, Dickinson and Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,100,000<span></span>
</td>
<td class="nump">66,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,100,000<span></span>
</td>
<td class="nump">104,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,400,000<span></span>
</td>
<td class="nump">77,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartiesAmountInCostOfSales', window );">Cost of products sold from related party inventory purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 28,000,000<span></span>
</td>
<td class="nump">$ 40,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=embc_A675SeniorSecuredNotesDueFebruary2030Member', window );">6.75% Senior Secured Notes due 2030 | Senior Notes | Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=embc_BectonDickinsonAndCompanyMember', window );">Becton, Dickinson and Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum', window );">Cannula Supply Agreement, minimum notice period to terminate agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum', window );">Cannula Supply Agreement, minimum period from distribution date to terminate agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=embc_BectonDickinsonAndCompanyMember', window );">Becton, Dickinson and Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ContractuallySpecifiedServicingFeesPercentage', window );">Trade Receivables Factoring Agreement Service fee as a percentage of annual revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DistributionAgreementDistributorAppointmentMaximumTerm', window );">Distribution Agreement, maximum term for distributor appointed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum', window );">Cannula Supply Agreement, minimum notice period to terminate agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum', window );">Cannula Supply Agreement, minimum period from distribution date to terminate agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod', window );">Cannula Supply Agreement, termination related to yearly forecasted purchase minimum, wind-down period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_TaxMattersAgreementCovenantRestrictionsPeriod', window );">Tax Matters Agreement, covenant restrictions period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold', window );">Tax Matters Agreement, covenant restrictions, change in stock ownership threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LogisticsServicesAgreementMaximumTerm', window );">Logistics Services Agreement, maximum term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue', window );">Logistics Services Agreement, administrative fee as a percentage of net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Amounts due from Becton, Dickinson and Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Amounts due to Becton, Dickinson and Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=embc_BectonDickinsonAndCompanyMember', window );">Becton, Dickinson and Company | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue', window );">Logistics Services Agreement, administrative fee as a percentage of net revenue</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=embc_BectonDickinsonAndCompanyMember', window );">Becton, Dickinson and Company | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue', window );">Distribution Agreement, fee paid as a percentage of net revenue for each territory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=embc_BectonDickinsonAndCompanyMember', window );">Becton, Dickinson and Company | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue', window );">Distribution Agreement, fee paid as a percentage of net revenue for each territory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cannula Supply Agreement, Termination, Notice Period, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cannula Supply Agreement, Termination, Period subsequent to Distribution Date, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cannula Supply Agreement, Termination Related to Yearly Minimum Purchase Forecast, Wind-down Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ContractuallySpecifiedServicingFeesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractually Specified Servicing Fees, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ContractuallySpecifiedServicingFeesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DistributionAgreementDistributorAppointmentMaximumTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Distribution Agreement, Distributor Appointment, Maximum Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DistributionAgreementDistributorAppointmentMaximumTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Distribution Agreement, Fee Paid per Territory, Percentage of Net Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Logistics Services Agreement, Administrative Fee, Percentage of Net Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LogisticsServicesAgreementMaximumTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Logistics Services Agreement, Maximum Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LogisticsServicesAgreementMaximumTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Matters Agreement, Covenant Restrictions, Change of Stock Ownership Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_TaxMattersAgreementCovenantRestrictionsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Matters Agreement, Covenant Restrictions, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_TaxMattersAgreementCovenantRestrictionsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transition Services Agreement, Period Of Continuing Involvement After Separation, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartiesAmountInCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount included in cost of sales related to transactions with related parties incurred and recorded in the statement of operations for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartiesAmountInCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=embc_A675SeniorSecuredNotesDueFebruary2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=embc_A675SeniorSecuredNotesDueFebruary2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=embc_BectonDickinsonAndCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=embc_BectonDickinsonAndCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=embc_BectonDickinsonAndCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=embc_BectonDickinsonAndCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885654752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Third Party Arrangements and Related Party Disclosures - Allocation of General Corporate Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_GeneralCorporateExpenses', window );">Total General Corporate Expenses</a></td>
<td class="nump">$ 53.1<span></span>
</td>
<td class="nump">$ 115.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_GeneralCorporateExpenses', window );">Total General Corporate Expenses</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">13.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_GeneralCorporateExpenses', window );">Total General Corporate Expenses</a></td>
<td class="nump">47.9<span></span>
</td>
<td class="nump">98.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_GeneralCorporateExpenses', window );">Total General Corporate Expenses</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_NonoperatingIncomeExpenseMember', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_GeneralCorporateExpenses', window );">Total General Corporate Expenses</a></td>
<td class="num">$ (0.6)<span></span>
</td>
<td class="num">$ (1.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_GeneralCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General Corporate Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_GeneralCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_NonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_NonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886815680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Third Party Arrangements and Related Party Disclosures - Purchases from Parent (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ParentMember', window );">Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Purchases from BD</a></td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="nump">$ 40.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143880286608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Third Party Arrangements and Related Party Disclosures - Net Transfers to Parent (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ThirdPartyAndRelatedPartyTransactionsAbstract', window );"><strong>Third Party and Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities', window );">Cash pooling and general financing activities</a></td>
<td class="nump">$ 255.9<span></span>
</td>
<td class="nump">$ 599.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation', window );">Corporate and segment allocations, excluding non-cash stock-based compensation</a></td>
<td class="num">(50.4)<span></span>
</td>
<td class="num">(109.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentTaxesDeemedSettledWithParent', window );">Taxes deemed settled with BD</a></td>
<td class="num">(16.2)<span></span>
</td>
<td class="num">(72.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentSeparationRelatedAdjustments', window );">Other Separation related adjustments, net</a></td>
<td class="num">(11.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities', window );">Net transfers to BD as reflected in the Consolidated Statements of Cash Flows</a></td>
<td class="nump">177.9<span></span>
</td>
<td class="nump">417.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="num">(8.5)<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentPensionExpense', window );">Pension expense</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="num">(9.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentConsiderationPaidForSeparation', window );">Net consideration paid to BD in connection with the Separation</a></td>
<td class="nump">1,266.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentRelatedPartyDebtIssued', window );">Related party senior secured notes</a></td>
<td class="nump">197.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentOtherTransfersToFromParentNet', window );">Other transfers to (from) BD, net</a></td>
<td class="nump">84.1<span></span>
</td>
<td class="num">(11.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_NetParentInvestmentNetTransfersToParent', window );">Net transfers to BD</a></td>
<td class="nump">$ 1,712.9<span></span>
</td>
<td class="nump">$ 383.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Cash Pooling And General Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentConsiderationPaidForSeparation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Consideration Paid for Separation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentConsiderationPaidForSeparation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Corporate And Segment Allocations, Excluding Non-Cash Share-Based Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentNetTransfersToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Net Transfers to Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentNetTransfersToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentOtherTransfersToFromParentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Other Transfers To (From) Parent, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentOtherTransfersToFromParentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentPensionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Pension Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentPensionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentRelatedPartyDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Related Party Debt Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentRelatedPartyDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentSeparationRelatedAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Separation Related Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentSeparationRelatedAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Share-Based Compensation Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentTaxesDeemedSettledWithParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Taxes Deemed Settled With Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentTaxesDeemedSettledWithParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment, Transfers Reflected As Cash Flows From Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ThirdPartyAndRelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Third Party and Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ThirdPartyAndRelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143887544880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreement (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">$ 85.2<span></span>
</td>
<td class="nump">$ 66.9<span></span>
</td>
<td class="nump">$ 63.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_CollaborativeArrangementPrincipalRightsPercentage', window );">Product sales percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_CollaborativeArrangementPrincipalRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Principal Rights, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_CollaborativeArrangementPrincipalRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885508144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Operating Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_SeparationAndStandupCosts', window );">Separation and stand-up costs</a></td>
<td class="nump">$ 92.7<span></span>
</td>
<td class="nump">$ 44.7<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_SeparationAndStandupCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Standup Costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_SeparationAndStandupCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143887463056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiability', window );">Customer rebate liability</a></td>
<td class="nump">$ 36.4<span></span>
</td>
<td class="nump">$ 43.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized', window );">Rebates recorded</a></td>
<td class="nump">411.1<span></span>
</td>
<td class="nump">336.4<span></span>
</td>
<td class="nump">$ 298.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_RevenueFromContractWithCustomerSalesDeductionsRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in rebate liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_RevenueFromContractWithCustomerSalesDeductionsRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884772736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographical Data (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 1,120.8<span></span>
</td>
<td class="nump">$ 1,129.5<span></span>
</td>
<td class="nump">$ 1,165.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">601.4<span></span>
</td>
<td class="nump">600.3<span></span>
</td>
<td class="nump">609.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 519.4<span></span>
</td>
<td class="nump">$ 529.2<span></span>
</td>
<td class="nump">$ 555.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143880178464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 04, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition for unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember', window );">Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="nump">860,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">SARs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining term of awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">SARs | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="nump">528,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">SARs | Employee | CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="nump">132,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="nump">172,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Employee | CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="nump">27,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum | Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember', window );">Time Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">680,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining term of awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_PerformanceStockUnitsPSUsMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember', window );">Performance Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining term of awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember', window );">2022 Employee and Director Equity Based Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Total incremental cost to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized', window );">Incremental cost recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Authorized for future grant ( in shares )</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember', window );">2022 Employee and Director Equity Based Compensation Plan | SARs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember', window );">2022 Employee and Director Equity Based Compensation Plan | SARs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember', window );">2022 Employee and Director Equity Based Compensation Plan | SARs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Plan Modification, Expense Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_PerformanceStockUnitsPSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_PerformanceStockUnitsPSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881205280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-Based Compensation Expense</a></td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="nump">$ 21.9<span></span>
</td>
<td class="nump">$ 18.7<span></span>
</td>
<td class="nump">$ 12.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit associated with stock-based compensation costs recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Equity Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_ShareBasedPaymentArrangementLiabilityAwardMember', window );">Liability Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember', window );">Time-Vested Restricted Stock Units (TVUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-Based Compensation Expense</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember', window );">Performance-Based Restricted Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-Based Compensation Expense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-Based Compensation Expense</a></td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_ShareBasedPaymentArrangementLiabilityAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_ShareBasedPaymentArrangementLiabilityAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884876672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Stock Units Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember', window );">Time Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Stock Units (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Beginning Balance (in shares)</a></td>
<td class="nump">977,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">680,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Distributed (in shares)</a></td>
<td class="num">(386,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited, canceled or expired (in shares)</a></td>
<td class="num">(82,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Ending Balance (in shares)</a></td>
<td class="nump">1,188,800<span></span>
</td>
<td class="nump">977,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber', window );">Expected to vest (in shares)</a></td>
<td class="nump">1,134,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Beginning Balance (in dollars per share)</a></td>
<td class="nump">$ 28.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">31.00<span></span>
</td>
<td class="nump">$ 31.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Distributed (in dollars per share)</a></td>
<td class="nump">28.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, canceled or expired (in dollars per share)</a></td>
<td class="nump">29.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Ending Balance (in dollars per share)</a></td>
<td class="nump">29.42<span></span>
</td>
<td class="nump">$ 28.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue', window );">Expected to vest (in dollars per share)</a></td>
<td class="nump">$ 29.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember', window );">Performance Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Stock Units (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Beginning Balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">61,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Distributed (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited, canceled or expired (in shares)</a></td>
<td class="num">(3,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Ending Balance (in shares)</a></td>
<td class="nump">57,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber', window );">Expected to vest (in shares)</a></td>
<td class="nump">54,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Beginning Balance (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">30.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Distributed (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, canceled or expired (in dollars per share)</a></td>
<td class="nump">30.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Ending Balance (in dollars per share)</a></td>
<td class="nump">30.24<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue', window );">Expected to vest (in dollars per share)</a></td>
<td class="nump">$ 30.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Weighted Average Grant Date Fair value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143887465616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Weighted Average Grant Date Fair Value of Performance-Based and Time-Vested Restricted Stock Units Granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember', window );">Time Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of units granted</a></td>
<td class="nump">$ 31.00<span></span>
</td>
<td class="nump">$ 31.23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember', window );">Performance Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of units granted</a></td>
<td class="nump">$ 30.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143886874640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Total Fair Value of Time Vested Stock Units Vested (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember', window );">Time Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of units vested</a></td>
<td class="nump">$ 10.9<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885901776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - SARs Valuation Assumptions (Details) - SARs<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">37.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Fair value per SAR (in dollars per share)</a></td>
<td class="nump">$ 9.38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143879988224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - SARs Outstanding and the Changes (Details) - SARs<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>SARs (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, Beginning Balance (in shares) | shares</a></td>
<td class="nump">1,916,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(25,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations', window );">Forfeited, canceled or expired (in shares) | shares</a></td>
<td class="num">(59,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, Ending Balance (in shares) | shares</a></td>
<td class="nump">1,831,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares) | shares</a></td>
<td class="nump">1,740,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber', window );">Exercisable (in shares) | shares</a></td>
<td class="nump">179,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 28.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">21.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited, canceled or expired (in dollars per share) | $ / shares</a></td>
<td class="nump">29.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">29.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest, Weighted Average Exercise Price (in dollars per share) | $ / shares</a></td>
<td class="nump">29.05<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice', window );">Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 26.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract', window );"><strong>Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm', window );">Vested and expected to vest, Weighted Average Remaining Contractual Term</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm', window );">Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Outstanding, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest, Aggregate Intrinsic Value | $</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue', window );">Exercisable, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were either cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143888734096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of SARs Exercised (Details) - SARs - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue', window );">Total intrinsic value of SARs exercised</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue', window );">Total fair value of SARs exercised</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143879978352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total amortized intangible assets</a></td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">15.6<span></span>
</td>
<td class="nump">15.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total Goodwill and Other Intangible Assets</a></td>
<td class="nump">$ 24.7<span></span>
</td>
<td class="nump">24.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents &#8211; net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">12 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets - gross</a></td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortized intangible assets - Less: accumulated amortization</a></td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total amortized intangible assets</a></td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=embc_CustomerRelationshipAndOtherMember', window );">Customer Relationships and Other &#8211; net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets - gross</a></td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortized intangible assets - Less: accumulated amortization</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total amortized intangible assets</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=embc_CustomerRelationshipAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=embc_CustomerRelationshipAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143879952896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated intangible asset amortization expense for 2024</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated intangible asset amortization expense for 2025</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated intangible asset amortization expense for 2026</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated intangible asset amortization expense for 2027</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated intangible asset amortization expense for 2028</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Estimated intangible asset amortization expense for subsequent years thereafter</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881131712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Feb. 10, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,474,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Reported Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,603,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=embc_A500SeniorSecuredNotesDueFebruary2030Member', window );">5.00% Senior Secured Notes due 2030 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=embc_A675SeniorSecuredNotesDueFebruary2030Member', window );">6.75% Senior Secured Notes due 2030 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=embc_A675SeniorSecuredNotesDueFebruary2030Member', window );">6.75% Senior Secured Notes due 2030 | Senior Notes | Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DebtInstrumentDiscountGross', window );">Discount</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=embc_SeniorSecuredTermLoanBMaturingMarch2029Member', window );">Term Loan due March 2029 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DebtInstrumentDiscountPercentage', window );">Discount percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage', window );">Quarterly payment as a percentage of principal</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=embc_SeniorSecuredTermLoanBMaturingMarch2029Member', window );">Term Loan due March 2029 | Secured Debt | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DebtInstrumentVariableRateFloor', window );">Variable rate floor</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member', window );">Revolving Credit Facility | Secured Debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amount drawn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DebtInstrumentDiscountGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Discount, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DebtInstrumentDiscountGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DebtInstrumentDiscountPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Discount, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DebtInstrumentDiscountPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DebtInstrumentPeriodicPaymentPrincipalPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Principal, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DebtInstrumentPeriodicPaymentPrincipalPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DebtInstrumentVariableRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Rate, Floor</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DebtInstrumentVariableRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=embc_A500SeniorSecuredNotesDueFebruary2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=embc_A500SeniorSecuredNotesDueFebruary2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=embc_A675SeniorSecuredNotesDueFebruary2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=embc_A675SeniorSecuredNotesDueFebruary2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=embc_SeniorSecuredTermLoanBMaturingMarch2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=embc_SeniorSecuredTermLoanBMaturingMarch2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881267584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Debt Outstanding (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Feb. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal debt issued</a></td>
<td class="nump">$ 1,635.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current debt obligations</a></td>
<td class="num">(9.5)<span></span>
</td>
<td class="num">$ (9.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: debt issuance costs and discounts</a></td>
<td class="num">(32.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">1,593.9<span></span>
</td>
<td class="nump">$ 1,598.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Term Loan due March 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal debt issued</a></td>
<td class="nump">$ 935.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.00% Notes due February 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal debt issued</a></td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.75% Notes due February 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal debt issued</a></td>
<td class="nump">$ 200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=embc_SeniorSecuredTermLoanBMaturingMarch2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=embc_SeniorSecuredTermLoanBMaturingMarch2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=embc_A500SeniorSecuredNotesDueFebruary2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=embc_A500SeniorSecuredNotesDueFebruary2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=embc_A675SeniorSecuredNotesDueFebruary2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=embc_A675SeniorSecuredNotesDueFebruary2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885611456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Principal Payments Required on Long-Term Debt (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 9.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 1,588.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885676816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share - Additional Information (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares distributed</a></td>
<td class="nump">57,012,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884188976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share - Computation of Earnings per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income attributable to Embecta</a></td>
<td class="nump">$ 70.4<span></span>
</td>
<td class="nump">$ 223.6<span></span>
</td>
<td class="nump">$ 414.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average number of shares outstanding (in shares)</a></td>
<td class="nump">57,248<span></span>
</td>
<td class="nump">57,024<span></span>
</td>
<td class="nump">57,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock awards and equity units (share equivalent) (in shares)</a></td>
<td class="nump">510<span></span>
</td>
<td class="nump">437<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">57,758<span></span>
</td>
<td class="nump">57,461<span></span>
</td>
<td class="nump">57,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per common share - Basic (in dollars per share)</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 3.92<span></span>
</td>
<td class="nump">$ 7.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per common share - Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 3.89<span></span>
</td>
<td class="nump">$ 7.28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881516208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Before Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (100.9)<span></span>
</td>
<td class="num">$ (29.1)<span></span>
</td>
<td class="nump">$ 87.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">206.6<span></span>
</td>
<td class="nump">285.7<span></span>
</td>
<td class="nump">407.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Income Taxes</a></td>
<td class="nump">$ 105.7<span></span>
</td>
<td class="nump">$ 256.6<span></span>
</td>
<td class="nump">$ 494.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884400912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Provision (Benefit) for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 20.4<span></span>
</td>
<td class="nump">$ 19.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">19.2<span></span>
</td>
<td class="nump">35.7<span></span>
</td>
<td class="nump">59.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current total</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="nump">59.5<span></span>
</td>
<td class="nump">82.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="num">(31.1)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred total</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="num">(26.5)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">$ 35.3<span></span>
</td>
<td class="nump">$ 33.0<span></span>
</td>
<td class="nump">$ 80.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881188112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Tax Rate Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of federal tax benefit</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign income tax at rates other than 21%</a></td>
<td class="num">(17.30%)<span></span>
</td>
<td class="num">(7.00%)<span></span>
</td>
<td class="num">(6.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">US tax on foreign earnings</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent', window );">Taxes on unremitted foreign earnings</a></td>
<td class="nump">11.10%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies', window );">Tax reserves</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(1.80%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowances</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="num">(1.50%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome', window );">Nontaxable items</a></td>
<td class="num">(8.60%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">33.40%<span></span>
</td>
<td class="nump">12.90%<span></span>
</td>
<td class="nump">16.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Unremitted Foreign Earnings, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881401712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Compensation and benefits</a></td>
<td class="nump">$ 9.7<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals and reserves</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">24.6<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">11.7<span></span>
</td>
<td class="nump">19.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts', window );">Capitalized research and development expenses</a></td>
<td class="nump">16.6<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DeferredTaxAssetsLeasingArrangements', window );">Leases</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">Interest expense carryforwards</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards', window );">Tax loss and credit carryforwards</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets before valuation allowance</a></td>
<td class="nump">109.7<span></span>
</td>
<td class="nump">86.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(31.6)<span></span>
</td>
<td class="num">(10.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">78.1<span></span>
</td>
<td class="nump">76.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Taxes on unremitted foreign earnings</a></td>
<td class="num">(20.5)<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use asset</a></td>
<td class="num">(12.8)<span></span>
</td>
<td class="num">(9.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(33.3)<span></span>
</td>
<td class="num">(17.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 44.8<span></span>
</td>
<td class="nump">$ 58.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143880290384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued balance</a></td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowances</a></td>
<td class="nump">31.6<span></span>
</td>
<td class="nump">$ 10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount', window );">Tax impact related to tax holidays</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare', window );">Impact of tax holidays on diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_OperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_OperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Not Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_OperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayAggregateDollarAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayAggregateDollarAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885158224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="nump">$ 14.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase due to current year tax positions</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase due to prior year tax positions</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease due to prior year tax positions</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Decrease due to settlements with tax authorities</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Decrease due to lapse of statute of limitations</a></td>
<td class="num">(4.7)<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits including interest and penalties that would affect the effective tax rate if recognized</a></td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143888744336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Interest and Penalties (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense', window );">Interest and penalties expense (benefit) associated with unrecognized tax benefits on the Consolidated Statements of Income</a></td>
<td class="num">$ (1.2)<span></span>
</td>
<td class="num">$ (1.5)<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalties associated with unrecognized tax benefits on the Consolidated Balance Sheets</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885864112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Cash and Cash Equivalents (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents - condensed combined balance sheets</a></td>
<td class="nump">$ 326.5<span></span>
</td>
<td class="nump">$ 330.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - condensed combined statements of cash flows</a></td>
<td class="nump">$ 326.5<span></span>
</td>
<td class="nump">$ 330.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884846608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Notional Amounts of Derivative Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts | Undesignated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="nump">$ 5.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143880146384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">$ 9,400,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">58,900,000<span></span>
</td>
<td class="nump">$ 13,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 16,700,000<span></span>
</td>
<td class="nump">$ 22,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenues | Three Customers in Aggregate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">40.20%<span></span>
</td>
<td class="nump">40.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenues | Two Customers in Aggregate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=embc_CustomerOneCustomerTwoAndCustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=embc_CustomerOneCustomerTwoAndCustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=embc_CustomerOneAndCustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=embc_CustomerOneAndCustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885478704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment - Components of Property, Plant and Equipment, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 747.9<span></span>
</td>
<td class="nump">$ 701.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less: accumulated depreciation</a></td>
<td class="num">(447.7)<span></span>
</td>
<td class="num">(400.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total Property, Plant and Equipment, Net</a></td>
<td class="nump">300.2<span></span>
</td>
<td class="nump">301.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">124.5<span></span>
</td>
<td class="nump">123.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery, equipment and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">567.2<span></span>
</td>
<td class="nump">505.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 44.8<span></span>
</td>
<td class="nump">$ 64.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884163072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 58.9<span></span>
</td>
<td class="nump">$ 13.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143885659152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br> ft&#178; in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeFinanceLeaseAreaOfPremisesLeased', window );">Area of space leased (in square feet) | ft&#178;</a></td>
<td class="nump">278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Term of finance lease</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRenewalTerm1', window );">Finance lease renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_FinanceLeaseCost', window );">Finance lease cost</a></td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease, depreciation of assets</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest expense</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=embc_BuildingLeaseSixYearExtensionOptionMember', window );">Building Lease, Six Year Extension Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease renewal term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=embc_BuildingLeaseFourYearExtensionOptionMember', window );">Building Lease, Four Year Extension Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease renewal term</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeFinanceLeaseAreaOfPremisesLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Finance Lease, Area of Premises Leased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeFinanceLeaseAreaOfPremisesLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=embc_BuildingLeaseSixYearExtensionOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=embc_BuildingLeaseSixYearExtensionOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=embc_BuildingLeaseFourYearExtensionOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=embc_BuildingLeaseFourYearExtensionOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881124064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property, Plant and Equipment, Net<span></span>
</td>
<td class="text">Property, Plant and Equipment, Net<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Total Finance Lease Assets</a></td>
<td class="nump">$ 33.1<span></span>
</td>
<td class="nump">$ 35.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current finance lease liabilities</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Non Current Finance Lease Liabilities</a></td>
<td class="nump">31.5<span></span>
</td>
<td class="nump">32.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total Finance Lease Liabilities</a></td>
<td class="nump">$ 35.1<span></span>
</td>
<td class="nump">$ 36.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (years)</a></td>
<td class="text">13 years 6 months<span></span>
</td>
<td class="text">14 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">6.80%<span></span>
</td>
<td class="nump">6.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Deferred Income Taxes and Other Assets<span></span>
</td>
<td class="text">Deferred Income Taxes and Other Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Total Operating Lease Assets</a></td>
<td class="nump">$ 23.0<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued expenses<span></span>
</td>
<td class="text">Accrued expenses<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Deferred Income Taxes and Other Liabilities<span></span>
</td>
<td class="text">Deferred Income Taxes and Other Liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Deferred Income Taxes and Other Liabilities</a></td>
<td class="nump">$ 15.4<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total Operating Lease Liabilities</a></td>
<td class="nump">$ 21.3<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (years)</a></td>
<td class="text">7 years 3 months 18 days<span></span>
</td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">6.90%<span></span>
</td>
<td class="nump">5.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884887840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>Right of use assets obtained in exchange for lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance Lease</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 36.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating Leases</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from Operating Leases</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from Finance Lease</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from Finance Lease</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Asset Obtained In Exchange For Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884317504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">36.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">54.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: amount representing interest</a></td>
<td class="nump">19.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">35.1<span></span>
</td>
<td class="nump">$ 36.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">27.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: amount representing interest</a></td>
<td class="nump">6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">21.3<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiabilityToBePaidAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiabilityToBePaidYearOne', window );">2024</a></td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiabilityToBePaidYearTwo', window );">2025</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiabilityToBePaidYearThree', window );">2026</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiabilityToBePaidYearFour', window );">2027</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiabilityToBePaidYearFive', window );">2028</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">47.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiabilityToBePaid', window );">Total lease payments</a></td>
<td class="nump">82.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiabilityUndiscountedExcessAmount', window );">Less: amount representing interest</a></td>
<td class="nump">26.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_LesseeLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 56.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiabilityToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability, to be Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiabilityToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiabilityToBePaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability, to be Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiabilityToBePaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability, to be Paid, Due after Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiabilityToBePaidYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability, to be Paid, Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiabilityToBePaidYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiabilityToBePaidYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability, to be Paid, Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiabilityToBePaidYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiabilityToBePaidYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability, to be Paid, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiabilityToBePaidYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiabilityToBePaidYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability, to be Paid, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiabilityToBePaidYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiabilityToBePaidYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability, to be Paid, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiabilityToBePaidYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_LesseeLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_LesseeLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143880694400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Benefit plan expense</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Total employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.1<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage', window );">Maximum deferral percentage of base salary under deferred compensation plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage', window );">Maximum deferral percentage of bonus and other eligible cash compensation under deferred compensation plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent', window );">Amounts accrued under the deferred compensation plan</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Swiss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Benefit plan expense</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Unfunded net pension obligation</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Plan assets</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH', window );">Swiss | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Benefit plan expense</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement with Individual, Base Salary Deferral Maximum, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Arrangement with Individual, Bonus and other Eligible Cash Compensation Deferral Maximum, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>embc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_NonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_NonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143884833248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information - Trade Receivables, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="num">$ (1.4)<span></span>
</td>
<td class="num">$ (6.2)<span></span>
</td>
<td class="num">$ (6.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions charged to costs and expenses</a></td>
<td class="num">(18.9)<span></span>
</td>
<td class="num">(18.4)<span></span>
</td>
<td class="num">(16.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions and other</a></td>
<td class="nump">19.3<span></span>
</td>
<td class="nump">23.2<span></span>
</td>
<td class="nump">16.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowance for Doubtful Accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions charged to costs and expenses</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions and other</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=embc_SECSchedule1209AllowanceCashDiscountsMember', window );">Allowance for Cash Discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions charged to costs and expenses</a></td>
<td class="num">(18.7)<span></span>
</td>
<td class="num">(18.1)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions and other</a></td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="num">$ (3.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=embc_SECSchedule1209AllowanceCashDiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=embc_SECSchedule1209AllowanceCashDiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143881170816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Information - Long-Lived Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 324.9<span></span>
</td>
<td class="nump">$ 326.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">109.2<span></span>
</td>
<td class="nump">109.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East, and Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">176.9<span></span>
</td>
<td class="nump">174.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">38.4<span></span>
</td>
<td class="nump">42.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=embc_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=embc_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=embc_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140143880245776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 28, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember', window );">Time Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">680,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember', window );">Performance Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Time Vested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Performance Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_TimeVestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=embc_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>embc-20230930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:embc="http://www.embecta.com/20230930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="embc-20230930.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">embc:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">embc:PropertyPlantAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">embc:PropertyPlantAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">embc:DeferredIncomeTaxesAndOtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-01</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">embc:BectonDickinsonAndCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:NonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:NonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A675SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">embc:A2022EmployeeAndDirectorEquityBasedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:ShareBasedPaymentArrangementLiabilityAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:ShareBasedPaymentArrangementLiabilityAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:ShareBasedPaymentArrangementLiabilityAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceStockUnitsPSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">embc:CustomerRelationshipAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">embc:CustomerRelationshipAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">embc:CustomerRelationshipAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A500SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-10</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A675SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A675SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredTermLoanBMaturingMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredTermLoanBMaturingMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredTermLoanBMaturingMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredRevolvingCreditFacilityMaturing2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredRevolvingCreditFacilityMaturing2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredRevolvingCreditFacilityMaturing2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:SeniorSecuredTermLoanBMaturingMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A500SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">embc:A675SeniorSecuredNotesDueFebruary2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">embc:CustomerOneCustomerTwoAndCustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">embc:CustomerOneCustomerTwoAndCustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">embc:CustomerOneAndCustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">embc:BuildingLeaseSixYearExtensionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">embc:BuildingLeaseFourYearExtensionOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:NonoperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:NonoperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">embc:SECSchedule1209AllowanceCashDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">embc:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">embc:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:TimeVestedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-28</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872789</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">embc:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-28</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>embc:reporting_unit</measure>
    </unit>
    <unit id="segment">
        <measure>embc:segment</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-32">0001872789</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-33">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-34">2023</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-35">false</dei:AmendmentFlag>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList contextRef="c-4" id="f-38">http://fasb.org/us-gaap/2023#ProductMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList contextRef="c-1" id="f-39">http://fasb.org/us-gaap/2023#ProductMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList contextRef="c-5" id="f-40">http://fasb.org/us-gaap/2023#ProductMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList contextRef="c-5" id="f-44">http://fasb.org/us-gaap/2023#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList contextRef="c-1" id="f-45">http://fasb.org/us-gaap/2023#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList contextRef="c-4" id="f-46">http://fasb.org/us-gaap/2023#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <embc:CommonStockShareIssuanceRatio
      contextRef="c-36"
      decimals="INF"
      id="f-342"
      unitRef="number">0.2</embc:CommonStockShareIssuanceRatio>
    <embc:HostingArrangementServiceContractAssetsInServiceUsefulLife contextRef="c-37" id="f-353">P3Y</embc:HostingArrangementServiceContractAssetsInServiceUsefulLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-86" id="f-502">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-92" id="f-510">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-86" id="f-583">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-119" id="f-620">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-90" id="f-621">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-91" id="f-622">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-6" id="f-929">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-7" id="f-930">http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-6" id="f-945">http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList contextRef="c-7" id="f-946">http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-6" id="f-951">http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-7" id="f-952">http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-6" id="f-955">http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-7" id="f-956">http://fasb.org/us-gaap/2023#DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-09-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--09-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-41186</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">EMBECTA CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">87-1583942</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">300 Kimball Drive, Suite 300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Parsippany</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">07054</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">862</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">401-0000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">EMBC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-24">false</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-25">false</dei:EntitySmallBusiness>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-26">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-27">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-28">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-8" id="f-29" unitRef="usd">1600000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-30" unitRef="shares">57334621</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-31">The information required by Items 10, 11, 12, 13 and 14 of  Part III of this Annual Report on Form 10-K is incorporated by reference to the Registrant&#x2019;s definitive proxy statement for its 2024 Annual Meeting of Stockholders (the &#x201c;2024 Proxy Statement&#x201d;), which will be filed pursuant to Regulation 14A with the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) within 120 days after the end of the fiscal year to which this report relates.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName contextRef="c-1" id="f-36">ERNST &amp; YOUNG LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-37">New York, New York</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-41" unitRef="usd">1120800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-5" id="f-42" unitRef="usd">1129500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-43" unitRef="usd">1165300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-47" unitRef="usd">370900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-4" decimals="-5" id="f-48" unitRef="usd">354600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-5" id="f-49" unitRef="usd">364900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-5" id="f-50" unitRef="usd">749900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-4" decimals="-5" id="f-51" unitRef="usd">774900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-5" decimals="-5" id="f-52" unitRef="usd">800400000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-53" unitRef="usd">341300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-4" decimals="-5" id="f-54" unitRef="usd">294800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-5" id="f-55" unitRef="usd">240300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-56" unitRef="usd">85200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-4" decimals="-5" id="f-57" unitRef="usd">66900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-5" id="f-58" unitRef="usd">63300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="-5" id="f-59" unitRef="usd">2500000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-4" decimals="-5" id="f-60" unitRef="usd">58900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-5" decimals="-5" id="f-61" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:OtherGeneralExpense contextRef="c-1" decimals="-5" id="f-62" unitRef="usd">99400000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense contextRef="c-4" decimals="-5" id="f-63" unitRef="usd">44700000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense contextRef="c-5" decimals="-5" id="f-64" unitRef="usd">4800000</us-gaap:OtherGeneralExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-5" id="f-65" unitRef="usd">528400000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-4" decimals="-5" id="f-66" unitRef="usd">465300000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-5" decimals="-5" id="f-67" unitRef="usd">308400000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-68" unitRef="usd">221500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-4" decimals="-5" id="f-69" unitRef="usd">309600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-5" id="f-70" unitRef="usd">492000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-1" decimals="-5" id="f-71" unitRef="usd">-107000000.0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-4" decimals="-5" id="f-72" unitRef="usd">-46200000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-5" decimals="-5" id="f-73" unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-74" unitRef="usd">-8800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-4" decimals="-5" id="f-75" unitRef="usd">-6800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-5" id="f-76" unitRef="usd">2900000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-77" unitRef="usd">105700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-78" unitRef="usd">256600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-79" unitRef="usd">494900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-80" unitRef="usd">35300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-81" unitRef="usd">33000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-82" unitRef="usd">80100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-83" unitRef="usd">70400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-84" unitRef="usd">223600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-85" unitRef="usd">414800000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-86"
      unitRef="usdPerShare">1.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-4"
      decimals="2"
      id="f-87"
      unitRef="usdPerShare">3.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-88"
      unitRef="usdPerShare">7.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-89"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-4"
      decimals="2"
      id="f-90"
      unitRef="usdPerShare">3.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-91"
      unitRef="usdPerShare">7.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-92" unitRef="usd">70400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-93" unitRef="usd">223600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-94" unitRef="usd">414800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-95" unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-96" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-97" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-98" unitRef="usd">17400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-99" unitRef="usd">-64200000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-100" unitRef="usd">-8900000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-101" unitRef="usd">15800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-102" unitRef="usd">-64200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-103" unitRef="usd">-8900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-5" id="f-104" unitRef="usd">86200000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-4" decimals="-5" id="f-105" unitRef="usd">159400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-5" id="f-106" unitRef="usd">405900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-5" id="f-107" unitRef="usd">326500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-5" id="f-108" unitRef="usd">330900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-6" decimals="-5" id="f-109" unitRef="usd">1000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-7" decimals="-5" id="f-110" unitRef="usd">1300000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-6" decimals="-5" id="f-111" unitRef="usd">16700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-7" decimals="-5" id="f-112" unitRef="usd">22200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryRawMaterialsAndSupplies contextRef="c-6" decimals="-5" id="f-113" unitRef="usd">32100000</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryRawMaterialsAndSupplies contextRef="c-7" decimals="-5" id="f-114" unitRef="usd">23400000</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryWorkInProcess contextRef="c-6" decimals="-5" id="f-115" unitRef="usd">8100000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="c-7" decimals="-5" id="f-116" unitRef="usd">5600000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods contextRef="c-6" decimals="-5" id="f-117" unitRef="usd">111900000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="c-7" decimals="-5" id="f-118" unitRef="usd">93800000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet contextRef="c-6" decimals="-5" id="f-119" unitRef="usd">152100000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-7" decimals="-5" id="f-120" unitRef="usd">122800000</us-gaap:InventoryNet>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-6" decimals="-5" id="f-121" unitRef="usd">142400000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-7" decimals="-5" id="f-122" unitRef="usd">110900000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-6" decimals="-5" id="f-123" unitRef="usd">111400000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-7" decimals="-5" id="f-124" unitRef="usd">77900000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-6" decimals="-5" id="f-125" unitRef="usd">749100000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-7" decimals="-5" id="f-126" unitRef="usd">664700000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-127" unitRef="usd">300200000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-128" unitRef="usd">301600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-6" decimals="-5" id="f-129" unitRef="usd">24700000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-7" decimals="-5" id="f-130" unitRef="usd">24600000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent contextRef="c-6" decimals="-5" id="f-131" unitRef="usd">140400000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent contextRef="c-7" decimals="-5" id="f-132" unitRef="usd">95500000</us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-6" decimals="-5" id="f-133" unitRef="usd">1214400000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-7" decimals="-5" id="f-134" unitRef="usd">1086400000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-6" decimals="-5" id="f-135" unitRef="usd">53500000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-7" decimals="-5" id="f-136" unitRef="usd">41400000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-137" unitRef="usd">118100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-7" decimals="-5" id="f-138" unitRef="usd">104300000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-6" decimals="-5" id="f-139" unitRef="usd">73100000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-7" decimals="-5" id="f-140" unitRef="usd">66500000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-141" unitRef="usd">62100000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-7" decimals="-5" id="f-142" unitRef="usd">48500000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-6" decimals="-5" id="f-143" unitRef="usd">9500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-7" decimals="-5" id="f-144" unitRef="usd">9500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-6" decimals="-5" id="f-145" unitRef="usd">3600000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-7" decimals="-5" id="f-146" unitRef="usd">3600000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-6" decimals="-5" id="f-147" unitRef="usd">33600000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-7" decimals="-5" id="f-148" unitRef="usd">27200000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-149" unitRef="usd">353500000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-7" decimals="-5" id="f-150" unitRef="usd">301000000.0</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="c-6" decimals="-5" id="f-151" unitRef="usd">57200000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="c-7" decimals="-5" id="f-152" unitRef="usd">46100000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-6" decimals="-5" id="f-153" unitRef="usd">1593900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-7" decimals="-5" id="f-154" unitRef="usd">1598100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-6" decimals="-5" id="f-155" unitRef="usd">31500000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-7" decimals="-5" id="f-156" unitRef="usd">32600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:CommitmentsAndContingencies contextRef="c-6" id="f-157" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-7" id="f-158" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-7"
      decimals="INF"
      id="f-159"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-160"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-7" decimals="INF" id="f-161" unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="INF" id="f-162" unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-163" unitRef="shares">57333353</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="INF" id="f-164" unitRef="shares">57333353</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-7" decimals="INF" id="f-165" unitRef="shares">57055327</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-7" decimals="INF" id="f-166" unitRef="shares">57055327</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-6" decimals="-5" id="f-167" unitRef="usd">600000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-7" decimals="-5" id="f-168" unitRef="usd">600000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-6" decimals="-5" id="f-169" unitRef="usd">27900000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-7" decimals="-5" id="f-170" unitRef="usd">10000000.0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-6" decimals="-5" id="f-171" unitRef="usd">-541100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-7" decimals="-5" id="f-172" unitRef="usd">-577100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-5" id="f-173" unitRef="usd">-309100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-5" id="f-174" unitRef="usd">-324900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-5" id="f-175" unitRef="usd">-821700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-5" id="f-176" unitRef="usd">-891400000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-6" decimals="-5" id="f-177" unitRef="usd">1214400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-7" decimals="-5" id="f-178" unitRef="usd">1086400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-5" id="f-179" unitRef="usd">833800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-5" id="f-180" unitRef="usd">-261600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-5" id="f-181" unitRef="usd">572200000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-5" id="f-182" unitRef="usd">414800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-183" unitRef="usd">414800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-12" decimals="-5" id="f-184" unitRef="usd">-8900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-5" id="f-185" unitRef="usd">-8900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <embc:NetParentInvestmentNetTransfersToParent contextRef="c-11" decimals="-5" id="f-186" unitRef="usd">383800000</embc:NetParentInvestmentNetTransfersToParent>
    <embc:NetParentInvestmentNetTransfersToParent contextRef="c-5" decimals="-5" id="f-187" unitRef="usd">383800000</embc:NetParentInvestmentNetTransfersToParent>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-5" id="f-188" unitRef="usd">864800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-14" decimals="-5" id="f-189" unitRef="usd">-270500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-5" id="f-190" unitRef="usd">594300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-5" id="f-191" unitRef="usd">864800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-14" decimals="-5" id="f-192" unitRef="usd">-270500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-5" id="f-193" unitRef="usd">594300000</us-gaap:StockholdersEquity>
    <embc:NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments contextRef="c-16" decimals="-5" id="f-194" unitRef="usd">390300000</embc:NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments>
    <embc:NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments contextRef="c-17" decimals="-5" id="f-195" unitRef="usd">-9800000</embc:NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments>
    <embc:NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments contextRef="c-4" decimals="-5" id="f-196" unitRef="usd">380500000</embc:NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-18"
      decimals="INF"
      id="f-197"
      unitRef="shares">57012925</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment contextRef="c-18" decimals="-5" id="f-198" unitRef="usd">600000</embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment>
    <embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment contextRef="c-19" decimals="-5" id="f-199" unitRef="usd">-613700000</embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment>
    <embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment contextRef="c-16" decimals="-5" id="f-200" unitRef="usd">613100000</embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment>
    <embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment contextRef="c-4" decimals="-5" id="f-201" unitRef="usd">0</embc:StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment>
    <embc:NetParentInvestmentConsiderationPaidForSeparation contextRef="c-16" decimals="-5" id="f-202" unitRef="usd">1266000000</embc:NetParentInvestmentConsiderationPaidForSeparation>
    <embc:NetParentInvestmentConsiderationPaidForSeparation contextRef="c-4" decimals="-5" id="f-203" unitRef="usd">1266000000</embc:NetParentInvestmentConsiderationPaidForSeparation>
    <us-gaap:NetIncomeLoss contextRef="c-19" decimals="-5" id="f-204" unitRef="usd">45200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-16" decimals="-5" id="f-205" unitRef="usd">178400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-206" unitRef="usd">223600000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-17" decimals="-5" id="f-207" unitRef="usd">-64200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-4" decimals="-5" id="f-208" unitRef="usd">-64200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-20" decimals="-5" id="f-209" unitRef="usd">10000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-4" decimals="-5" id="f-210" unitRef="usd">10000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-4"
      decimals="INF"
      id="f-211"
      unitRef="usdPerShare">0.15</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-19" decimals="-5" id="f-212" unitRef="usd">8600000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock contextRef="c-4" decimals="-5" id="f-213" unitRef="usd">8600000</us-gaap:DividendsCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-18"
      decimals="INF"
      id="f-214"
      unitRef="shares">42402</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-21"
      decimals="INF"
      id="f-215"
      unitRef="shares">57055327</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-5" id="f-216" unitRef="usd">600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-5" id="f-217" unitRef="usd">10000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-5" id="f-218" unitRef="usd">-577100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-5" id="f-219" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-5" id="f-220" unitRef="usd">-324900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-5" id="f-221" unitRef="usd">-891400000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-21"
      decimals="INF"
      id="f-222"
      unitRef="shares">57055327</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-5" id="f-223" unitRef="usd">600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-5" id="f-224" unitRef="usd">10000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-5" id="f-225" unitRef="usd">-577100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-5" id="f-226" unitRef="usd">-324900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-5" id="f-227" unitRef="usd">-891400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-26" decimals="-5" id="f-228" unitRef="usd">70400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-229" unitRef="usd">70400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-27" decimals="-5" id="f-230" unitRef="usd">15800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-231" unitRef="usd">15800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-28" decimals="-5" id="f-232" unitRef="usd">21500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-5" id="f-233" unitRef="usd">21500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="INF"
      id="f-234"
      unitRef="usdPerShare">0.15</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock contextRef="c-26" decimals="-5" id="f-235" unitRef="usd">34400000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock contextRef="c-1" decimals="-5" id="f-236" unitRef="usd">34400000</us-gaap:DividendsCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-29"
      decimals="INF"
      id="f-237"
      unitRef="shares">278026</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-28" decimals="-5" id="f-238" unitRef="usd">-3600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-5" id="f-239" unitRef="usd">-3600000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-30"
      decimals="INF"
      id="f-240"
      unitRef="shares">57333353</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-5" id="f-241" unitRef="usd">600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-5" id="f-242" unitRef="usd">27900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-5" id="f-243" unitRef="usd">-541100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-5" id="f-244" unitRef="usd">-309100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-5" id="f-245" unitRef="usd">-821700000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-246" unitRef="usd">70400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-247" unitRef="usd">223600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-248" unitRef="usd">414800000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-5" id="f-249" unitRef="usd">32600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-4" decimals="-5" id="f-250" unitRef="usd">31700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-5" decimals="-5" id="f-251" unitRef="usd">38300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-5" id="f-252" unitRef="usd">6400000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-4" decimals="-5" id="f-253" unitRef="usd">3200000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-5" decimals="-5" id="f-254" unitRef="usd">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-1" decimals="-5" id="f-255" unitRef="usd">2500000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-4" decimals="-5" id="f-256" unitRef="usd">58900000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-5" decimals="-5" id="f-257" unitRef="usd">13800000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-258" unitRef="usd">21500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-4" decimals="-5" id="f-259" unitRef="usd">18700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-5" id="f-260" unitRef="usd">12800000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-261" unitRef="usd">14300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-262" unitRef="usd">-26500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-263" unitRef="usd">-2800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-5" id="f-264" unitRef="usd">-7000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-4" decimals="-5" id="f-265" unitRef="usd">-122700000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-5" decimals="-5" id="f-266" unitRef="usd">31800000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-5" id="f-267" unitRef="usd">28800000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-4" decimals="-5" id="f-268" unitRef="usd">23400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-5" decimals="-5" id="f-269" unitRef="usd">18000000.0</us-gaap:IncreaseDecreaseInInventories>
    <embc:IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet contextRef="c-1" decimals="-5" id="f-270" unitRef="usd">23200000</embc:IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet>
    <embc:IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet contextRef="c-4" decimals="-5" id="f-271" unitRef="usd">47000000.0</embc:IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet>
    <embc:IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet contextRef="c-5" decimals="-5" id="f-272" unitRef="usd">0</embc:IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-5" id="f-273" unitRef="usd">14200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-4" decimals="-5" id="f-274" unitRef="usd">44000000.0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-5" decimals="-5" id="f-275" unitRef="usd">11500000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-5" id="f-276" unitRef="usd">7900000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-4" decimals="-5" id="f-277" unitRef="usd">76900000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-5" decimals="-5" id="f-278" unitRef="usd">40200000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable contextRef="c-1" decimals="-5" id="f-279" unitRef="usd">-12600000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable contextRef="c-4" decimals="-5" id="f-280" unitRef="usd">10300000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable contextRef="c-5" decimals="-5" id="f-281" unitRef="usd">0</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet contextRef="c-1" decimals="-5" id="f-282" unitRef="usd">16100000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet contextRef="c-4" decimals="-5" id="f-283" unitRef="usd">-7100000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet contextRef="c-5" decimals="-5" id="f-284" unitRef="usd">-500000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-285" unitRef="usd">67700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-4" decimals="-5" id="f-286" unitRef="usd">412200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-5" id="f-287" unitRef="usd">456300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-288" unitRef="usd">26500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-4" decimals="-5" id="f-289" unitRef="usd">23600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-5" decimals="-5" id="f-290" unitRef="usd">36800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-1" decimals="-5" id="f-291" unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-4" decimals="-5" id="f-292" unitRef="usd">400000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c-5" decimals="-5" id="f-293" unitRef="usd">2400000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-294" unitRef="usd">-26500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-4" decimals="-5" id="f-295" unitRef="usd">-24000000.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="-5" id="f-296" unitRef="usd">-39200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-1" decimals="-5" id="f-297" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-4" decimals="-5" id="f-298" unitRef="usd">1450000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-5" decimals="-5" id="f-299" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-1" decimals="-5" id="f-300" unitRef="usd">9500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-4" decimals="-5" id="f-301" unitRef="usd">4800000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-5" decimals="-5" id="f-302" unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-1" decimals="-5" id="f-303" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-4" decimals="-5" id="f-304" unitRef="usd">33300000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-5" decimals="-5" id="f-305" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <embc:PaymentOfRevolvingCreditFacilityFees contextRef="c-1" decimals="-5" id="f-306" unitRef="usd">0</embc:PaymentOfRevolvingCreditFacilityFees>
    <embc:PaymentOfRevolvingCreditFacilityFees contextRef="c-4" decimals="-5" id="f-307" unitRef="usd">5600000</embc:PaymentOfRevolvingCreditFacilityFees>
    <embc:PaymentOfRevolvingCreditFacilityFees contextRef="c-5" decimals="-5" id="f-308" unitRef="usd">0</embc:PaymentOfRevolvingCreditFacilityFees>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-5" id="f-309" unitRef="usd">3600000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-4" decimals="-5" id="f-310" unitRef="usd">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-5" decimals="-5" id="f-311" unitRef="usd">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-5" id="f-312" unitRef="usd">1200000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-4" decimals="-5" id="f-313" unitRef="usd">1800000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-5" decimals="-5" id="f-314" unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-1" decimals="-5" id="f-315" unitRef="usd">34400000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-4" decimals="-5" id="f-316" unitRef="usd">8600000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-5" decimals="-5" id="f-317" unitRef="usd">0</us-gaap:PaymentsOfDividendsCommonStock>
    <embc:PaymentForSpinoffTransactionFinancingActivities contextRef="c-1" decimals="-5" id="f-318" unitRef="usd">0</embc:PaymentForSpinoffTransactionFinancingActivities>
    <embc:PaymentForSpinoffTransactionFinancingActivities contextRef="c-4" decimals="-5" id="f-319" unitRef="usd">1266000000</embc:PaymentForSpinoffTransactionFinancingActivities>
    <embc:PaymentForSpinoffTransactionFinancingActivities contextRef="c-5" decimals="-5" id="f-320" unitRef="usd">0</embc:PaymentForSpinoffTransactionFinancingActivities>
    <embc:NetTransfersToParentFinancingActivities contextRef="c-1" decimals="-5" id="f-321" unitRef="usd">0</embc:NetTransfersToParentFinancingActivities>
    <embc:NetTransfersToParentFinancingActivities contextRef="c-4" decimals="-5" id="f-322" unitRef="usd">177900000</embc:NetTransfersToParentFinancingActivities>
    <embc:NetTransfersToParentFinancingActivities contextRef="c-5" decimals="-5" id="f-323" unitRef="usd">417100000</embc:NetTransfersToParentFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-324" unitRef="usd">-48700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-4" decimals="-5" id="f-325" unitRef="usd">-48000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-5" id="f-326" unitRef="usd">-417100000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-1" decimals="-5" id="f-327" unitRef="usd">3100000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-4" decimals="-5" id="f-328" unitRef="usd">-9300000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-5" decimals="-5" id="f-329" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-330" unitRef="usd">-4400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-4" decimals="-5" id="f-331" unitRef="usd">330900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-5" id="f-332" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-333" unitRef="usd">330900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-15" decimals="-5" id="f-334" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-10" decimals="-5" id="f-335" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-5" id="f-336" unitRef="usd">326500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-337" unitRef="usd">330900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-15" decimals="-5" id="f-338" unitRef="usd">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-339">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 1 &#x2014; Background&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Embecta Corp. ("Embecta" or the "Company") is a leading global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a broad portfolio of marketed products, including a variety of pen needles, syringes and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The Company primarily sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2022 (the "Separation Date"), Embecta and Becton, Dickinson and Company ("BD") entered into a Separation and Distribution Agreement (the "Separation and Distribution Agreement"). Pursuant to the Separation and Distribution Agreement, BD agreed to spin off its diabetes care business (the "Diabetes Care Business") into Embecta, a new, publicly traded company (the "Separation"). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Separation occurred by means of a pro-rata distribution (the "Distribution") of all of Embecta&#x2019;s issued and outstanding shares of common stock on the basis of one share of Embecta common stock, par value $0.01 per share, for every five shares of BD common stock, par value $1.00 per share, held as of the close of business on March 22, 2023, the record date for the distribution. Embecta is now a standalone publicly traded company and, on April 1, 2022, regular-way trading of Embecta common stock commenced on the Nasdaq Global Select Market under the ticker symbol "EMBC".&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the Separation, BD and Embecta entered into various agreements to provide a framework for the relationship between BD and Embecta after the Separation, including, but not limited to, a separation and distribution agreement, a transition services agreement, a tax matters agreement, an employee matters agreement, a cannula supply agreement, contract manufacturing agreements, an intellectual property matters agreement, a logistics services agreement, distribution agreements, factoring and receivables agreements, local support and service agreements and other transaction documents.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-34"
      decimals="INF"
      id="f-340"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-35"
      decimals="INF"
      id="f-341"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-343">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 2 &#x2014; Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2022, the Company became a standalone publicly traded company, and its financial statements are now presented on a consolidated basis. Prior to the Separation on April 1, 2022, the Company&#x2019;s historical combined financial statements were prepared on a standalone basis and were derived from BD's consolidated financial statements and accounting records. The financial statements for all periods presented, including the historical results of the Company prior to April 1, 2022, are now referred to as "Consolidated Financial Statements", and have been prepared pursuant to the rules and regulations for reporting on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Periods Prior to Separation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, the Company was referred to as the Diabetes Care Business. The assets, liabilities, revenue and expenses of the Diabetes Care Business were reflected in the combined financial statements on a historical cost basis, as included in the consolidated financial statements of BD, using the historical accounting policies applied by BD. The Consolidated Financial Statements did not purport to reflect what the Company&#x2019;s results of operations, comprehensive income, financial position, equity or cash flows would have been had the Company operated as a standalone public company during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Diabetes Care Business had historically functioned together with the other businesses controlled by BD. Accordingly, the Diabetes Care Business relied on BD&#x2019;s corporate and other support functions for its business. Therefore, for the period prior to the Separation, certain corporate and shared costs were allocated to the Diabetes Care Business based on a specific identification basis or, when specific identification was not practicable, a proportional cost allocation method, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt"&gt;expenses related to BD support functions, including expenses for facilities, executive oversight, treasury, finance, legal, human resources, shared services, compliance, procurement, information technology and other corporate functions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:9.96pt"&gt;certain manufacturing and supply costs incurred by BD, including facility management, distribution, logistics, planning and global quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;iii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.19pt"&gt;certain costs incurred by BD&#x2019;s Medication Delivery Solutions organizational unit in relation to selling and marketing activities, and related administrative support functions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;iv.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt"&gt;certain costs incurred by BD for activities related to device research and development, as well as medical and regulatory affairs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;v.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt"&gt;stock-based compensation expenses (see Note 10).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;vi.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt"&gt;certain compensation expenses maintained on a centralized basis such as certain employee benefit expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Management believes these cost allocations were a reasonable reflection of the utilization of services provided to, or the benefit derived by, the Diabetes Care Business during the period prior to the Separation, though the allocations may not be indicative of the actual costs that would have been incurred had the Diabetes Care Business operated as a standalone public company. Actual costs that may have been incurred if the Diabetes Care Business had been a standalone company would depend on a number of factors, including the chosen organizational structure, whether functions were outsourced or performed by Diabetes Care Business employees, and strategic decisions made in areas such as manufacturing, selling and marketing, research and development, information technology and infrastructure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;BD utilized a centralized approach to cash management and the financing of its operations. Cash generated by the Diabetes Care Business was routinely transferred into accounts managed by BD&#x2019;s centralized treasury function and cash disbursements related to operations prior to the Separation were funded as needed by BD. Balances held by the Diabetes Care Business with BD for cash transfers and loans were reflected as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Amounts due to Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; prior to the Separation. All other cash and cash equivalents and related transfers between BD and the Diabetes Care Business were generally held centrally through accounts controlled and maintained by BD and were not specifically identifiable to the Diabetes Care Business. Accordingly, such balances were accounted for through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. BD&#x2019;s third-party debt and related interest expense were not attributed to the Diabetes Care Business because the business was not the legal obligor of the debt and the borrowings were not specifically identifiable to the business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the Diabetes Care Business, transactions with BD affiliates were included in the Consolidated Statements of Income and related balances were reflected as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Amounts due to Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Amounts due from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Related Party Loans Payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Other balances between the Diabetes Care Business and BD were considered to be effectively settled in the Consolidated Financial Statements at the time the transactions were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As the separate legal entities that made up the Diabetes Care Business were not historically held by a single legal entity, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; was shown in lieu of stockholders&#x2019; equity in these Consolidated Financial Statements. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; represented BD&#x2019;s interest in the recorded assets of the Diabetes Care Business and the cumulative investment by BD through the date of the Separation, inclusive of operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For periods prior to the Separation, income tax expense and tax balances in the Consolidated Financial Statements were calculated on a separate tax return basis. The separate tax return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company was a separate taxpayer and a standalone enterprise. Management believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The provision for income taxes for the period prior to the Separation was calculated by applying an estimated effective income tax rate for the full year to ordinary income adjusted by the tax impact of discrete items.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;As of the Separation Date&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain assets and liabilities, including patents and unrecognized tax benefits that were included in the Consolidated Balance Sheet prior to the Separation, have been retained by BD post-Separation and therefore were transferred to BD through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;in the Company's Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the Separation, additional pension assets, deferred tax assets, other compensation obligations, and certain other assets and liabilities were transferred to the Company through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and the Company recorded these in the Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As part of the Separation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;was reclassified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Common Stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accumulated Deficit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Periods Post Separation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Following the Separation, certain functions continue to be provided by BD under the Transition Services Agreements or are being performed using Embecta&#x2019;s own resources or third-party service providers. Additionally, under manufacturing and supply agreements, the Company manufactures certain products for BD, or its applicable affiliate and BD manufactures certain products for the Company. The Company incurred certain costs in its establishment as a standalone public company and expects to incur ongoing additional costs associated with operating as an independent, publicly traded company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;All intercompany transactions and accounts within Embecta have been eliminated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain reclassifications were made to conform the prior period Consolidated Financial Statements to the current period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c-1" id="f-344">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2022, the Company became a standalone publicly traded company, and its financial statements are now presented on a consolidated basis. Prior to the Separation on April 1, 2022, the Company&#x2019;s historical combined financial statements were prepared on a standalone basis and were derived from BD's consolidated financial statements and accounting records. The financial statements for all periods presented, including the historical results of the Company prior to April 1, 2022, are now referred to as "Consolidated Financial Statements", and have been prepared pursuant to the rules and regulations for reporting on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Periods Prior to Separation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, the Company was referred to as the Diabetes Care Business. The assets, liabilities, revenue and expenses of the Diabetes Care Business were reflected in the combined financial statements on a historical cost basis, as included in the consolidated financial statements of BD, using the historical accounting policies applied by BD. The Consolidated Financial Statements did not purport to reflect what the Company&#x2019;s results of operations, comprehensive income, financial position, equity or cash flows would have been had the Company operated as a standalone public company during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Diabetes Care Business had historically functioned together with the other businesses controlled by BD. Accordingly, the Diabetes Care Business relied on BD&#x2019;s corporate and other support functions for its business. Therefore, for the period prior to the Separation, certain corporate and shared costs were allocated to the Diabetes Care Business based on a specific identification basis or, when specific identification was not practicable, a proportional cost allocation method, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt"&gt;expenses related to BD support functions, including expenses for facilities, executive oversight, treasury, finance, legal, human resources, shared services, compliance, procurement, information technology and other corporate functions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:9.96pt"&gt;certain manufacturing and supply costs incurred by BD, including facility management, distribution, logistics, planning and global quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;iii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.19pt"&gt;certain costs incurred by BD&#x2019;s Medication Delivery Solutions organizational unit in relation to selling and marketing activities, and related administrative support functions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;iv.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt"&gt;certain costs incurred by BD for activities related to device research and development, as well as medical and regulatory affairs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;v.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt"&gt;stock-based compensation expenses (see Note 10).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;vi.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:7.73pt"&gt;certain compensation expenses maintained on a centralized basis such as certain employee benefit expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Management believes these cost allocations were a reasonable reflection of the utilization of services provided to, or the benefit derived by, the Diabetes Care Business during the period prior to the Separation, though the allocations may not be indicative of the actual costs that would have been incurred had the Diabetes Care Business operated as a standalone public company. Actual costs that may have been incurred if the Diabetes Care Business had been a standalone company would depend on a number of factors, including the chosen organizational structure, whether functions were outsourced or performed by Diabetes Care Business employees, and strategic decisions made in areas such as manufacturing, selling and marketing, research and development, information technology and infrastructure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;BD utilized a centralized approach to cash management and the financing of its operations. Cash generated by the Diabetes Care Business was routinely transferred into accounts managed by BD&#x2019;s centralized treasury function and cash disbursements related to operations prior to the Separation were funded as needed by BD. Balances held by the Diabetes Care Business with BD for cash transfers and loans were reflected as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Amounts due to Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; prior to the Separation. All other cash and cash equivalents and related transfers between BD and the Diabetes Care Business were generally held centrally through accounts controlled and maintained by BD and were not specifically identifiable to the Diabetes Care Business. Accordingly, such balances were accounted for through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. BD&#x2019;s third-party debt and related interest expense were not attributed to the Diabetes Care Business because the business was not the legal obligor of the debt and the borrowings were not specifically identifiable to the business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain reclassifications were made to conform the prior period Consolidated Financial Statements to the current period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-345">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the Diabetes Care Business, transactions with BD affiliates were included in the Consolidated Statements of Income and related balances were reflected as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Amounts due to Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Amounts due from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Related Party Loans Payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Other balances between the Diabetes Care Business and BD were considered to be effectively settled in the Consolidated Financial Statements at the time the transactions were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As the separate legal entities that made up the Diabetes Care Business were not historically held by a single legal entity, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; was shown in lieu of stockholders&#x2019; equity in these Consolidated Financial Statements. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; represented BD&#x2019;s interest in the recorded assets of the Diabetes Care Business and the cumulative investment by BD through the date of the Separation, inclusive of operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For periods prior to the Separation, income tax expense and tax balances in the Consolidated Financial Statements were calculated on a separate tax return basis. The separate tax return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company was a separate taxpayer and a standalone enterprise. Management believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The provision for income taxes for the period prior to the Separation was calculated by applying an estimated effective income tax rate for the full year to ordinary income adjusted by the tax impact of discrete items.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;As of the Separation Date&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Certain assets and liabilities, including patents and unrecognized tax benefits that were included in the Consolidated Balance Sheet prior to the Separation, have been retained by BD post-Separation and therefore were transferred to BD through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;in the Company's Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the Separation, additional pension assets, deferred tax assets, other compensation obligations, and certain other assets and liabilities were transferred to the Company through &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and the Company recorded these in the Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As part of the Separation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;was reclassified as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Common Stock &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accumulated Deficit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Periods Post Separation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Following the Separation, certain functions continue to be provided by BD under the Transition Services Agreements or are being performed using Embecta&#x2019;s own resources or third-party service providers. Additionally, under manufacturing and supply agreements, the Company manufactures certain products for BD, or its applicable affiliate and BD manufactures certain products for the Company. The Company incurred certain costs in its establishment as a standalone public company and expects to incur ongoing additional costs associated with operating as an independent, publicly traded company.&lt;/span&gt;&lt;/div&gt;All intercompany transactions and accounts within Embecta have been eliminated.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-346">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 3 &#x2014; Summary of Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company recognizes revenue from product sales and considers performance obligations satisfied when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement. The Company acts as the principal in its customer arrangements and therefore records revenue on a gross basis. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. The point in time upon which shipment or delivery occurs is the most faithful depiction of when control of the goods transfers to the customer. Variable consideration such as rebates, chargebacks, sales discounts, and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Additional disclosures regarding the Company&#x2019;s accounting for revenue recognition are provided in Note 8.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash and cash equivalents include all highly liquid investments with a maturity of three months or less at the date of acquisition. Interest income on Cash and cash equivalents is recorded as earned.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Trade Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#x2019;s estimate of probable credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Cloud Computing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company capitalizes costs incurred to implement cloud computing arrangements that are service contracts within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Prepaid expenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Company's Condensed Consolidated Balance Sheets. Implementation costs associated with cloud computing arrangements are capitalized when incurred during the application development phase. Once the implementation of a cloud computing arrangement is complete and ready for its intended use, the Company amortizes the costs over the expected term of the hosting arrangement using the straight-line method to the same income statement line as the associated cloud operating expenses. The total balance of capitalized costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;associated with these arrangements as of September&#160;30, 2023 is $38.0&#160;million which primarily relates to the implementation of the Company's new enterprise resource planning ("ERP") system. These capitalized costs are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Costs amortized during fiscal year ended September 30, 2023 were not material to the Company's consolidated financial results. As of September&#160;30, 2023, cloud computing arrangement assets in-service have useful lives which range from approximately &lt;span style="-sec-ix-hidden:f-353"&gt;three&lt;/span&gt; to nine years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In 2022, the Company commenced on the process of building a new ERP system to replace the existing systems provided by BD. The ERP system is designed to accurately maintain the Company's financial records used to report operating results. The implementation of the ERP will occur in phases. The first phase of the ERP system implementation began in the fourth quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is principally provided on the straight-line basis over estimated useful lives, which range from 20 to 45 years for buildings, 4 to 13 years for machinery and equipment and 1 to 20 years for leasehold improvements. Depreciation expense was $31.5&#160;million in 2023, $31.0&#160;million in 2022, and $37.2&#160;million in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, plant and equipment are periodically reviewed when impairment indicators are present to assess recoverability or a decision has been made to abandon efforts associated with construction in progress assets. Recoverability is determined by comparing the carrying values of the assets or asset groups to the undiscounted cash flows to be generated from the use and eventual disposition of such assets or asset groups. If the asset&#x2019;s or asset group&#x2019;s carrying value exceeds such &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;undiscounted cash flows, the assets or asset groups are not recoverable and an impairment loss is recognized based on the amount by which the carrying value of the asset or asset group exceeds its calculated fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Capitalized Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The interest cost on capital projects is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended September 30, 2023 and 2022, the Company capitalized $4.6 million and $5.2 million of interest expense, respectively, into &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment, Net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and capitalized $0.9 million of interest expense into &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; during the year ended September 30, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Advertising Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advertising costs are expensed as incurred and included in S&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;elling and administrative expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The Company recorded advertising costs of $15.5&#160;million, $11.6&#160;million, and $9.3&#160;million in 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Goodwill represents the excess of the consideration transferred over the fair value of net assets of businesses acquired. The Company has one reporting unit. Goodwill is evaluated for impairment as of July 1 each year, or more frequently if impairment indicators exist, by first assessing qualitative factors to determine whether it is more likely than not that fair value is less than carrying value. If the Company concludes it is more likely than not that fair value is less than carrying value, a quantitative fair value test is performed. If carrying value is greater than fair value, a goodwill impairment charge will be recorded for the difference (up to the carrying value of goodwill). The Company completed the annual goodwill impairment test as of July 1, 2023 and concluded that no impairment to goodwill was necessary as the fair value of the Company's one reporting unit was significantly in excess of the carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;No goodwill impairments were identified during the years ended September 30, 2022, or 2021, and no accumulated impairment losses are recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Amortized intangible assets primarily consist of patents and customer relationships. Patents are generally amortized over 20 years using the straight-line method. Customer relationship assets are generally amortized over periods ranging from 10 to 15 years, using the straight-line method. Other intangibles with finite useful lives are amortized over periods principally ranging from 1 to 40 years, using the straight-line method. Finite-lived intangible assets are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#x2019;s carrying value exceeds its calculated fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Generally, foreign subsidiaries&#x2019; functional currency is the local currency of operations and the net assets of foreign operations are translated into United States dollars using current exchange rates. The United States dollar results that arise from such translation are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company considers its shipping and handling costs to be contract fulfillment costs and records them within selling and administrative expense. Shipping and handling costs were $36.9&#160;million, $27.4&#160;million, and $13.6&#160;million in 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries). Additional disclosures regarding the Company&#x2019;s accounting for contingencies are provided in Note 7.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, certain of the Company&#x2019;s employees historically participated in BD&#x2019;s stock-based compensation plans. Stock-based compensation expense was either allocated to the Company based on a proportionate cost allocation method or recorded based on specific identification. Effective April 1, 2022, the Company established the 2022 Employee and Director Equity Based Compensation Plan (the "Plan"). The Plan provides for the grant of various types of awards, including restricted stock unit ("RSU") awards, stock appreciation rights, stock options, performance-based awards and cash awards. Under the Plan, the exercise price of awards, if any, is set on the grant date and generally may not be less than &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;the fair market value per share on that date. The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards. For awards that ultimately settle in cash, we treat them as liability awards and mark the award to market each reporting period and recognize any adjustment in our Consolidated Statements of Income. The Company recognizes stock-based compensation cost only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants. The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change (see Note 10).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, the defined benefit plans in which the Company participated related primarily to plans sponsored by BD and for which other businesses of BD also participate (the "Shared Plans"). The Company accounted for the Shared Plans as multiemployer plans and therefore the related assets and liabilities were not reflected in the Consolidated Balance Sheets. For such periods prior to the Separation, the Consolidated Statements of Income reflect a proportional allocation of net periodic benefit cost for the Shared Plans associated with the Company. The Company's participation in the defined pension and postretirement benefit plans sponsored by BD concluded upon the completion of the Separation on April 1, 2022. At and after Separation, Embecta became the plan sponsor for certain non-United States defined benefit pension plans (see Note 18).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax basis of assets and liabilities at the applicable tax rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;From time to time, the Company engages in transactions in which tax consequences may be subject to uncertainty. The Company conducts business and files tax returns in numerous jurisdictions based on its interpretation of tax laws and regulations. In evaluating the Company&#x2019;s tax provision, the Company establishes a reserve for uncertain tax positions unless such positions are determined to be more likely than not of being sustained upon examination based on the technical merits.  The Company&#x2019;s policy is to recognize, when applicable, interest and penalties on uncertain tax positions as part of income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Tax Cuts and Jobs Act was enacted on December 22, 2017 and introduced an additional United States tax on the earnings of non-United States subsidiaries which are referred to as Global Intangible Low Taxed Income (&#x201c;GILTI&#x201d;). The Company has elected to treat GILTI as a period cost. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, the Company's operations were included in the tax returns of BD. Income taxes as presented in the Consolidated Financial Statements attribute current and deferred income tax assets and liabilities of BD to the Company in a manner that is systematic, rational, and consistent with the asset and liability method prescribed by the accounting guidance for income taxes. The Company's income tax provision prior to the Separation was prepared using the separate return method. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company were a separate taxpayer and a standalone enterprise. The Company believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Additional disclosures regarding the Company's accounting for income taxes are provided in Note 14.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Segment Data&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company operates and reports its financial information as one segment. In making this determination, the Company (i) determines its Chief Operating Decision Maker (&#x201c;CODM&#x201d;), (ii) identifies and analyzes potential business components, (iii) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;identifies its operating segments and (iv) determines whether there are multiple operating segments requiring presentation as reportable segments. The Company&#x2019;s decision to report as one segment is based upon the following: (1) its internal organizational structure; (2) the manner in which its operations are managed; and (3) the criteria used by the Company&#x2019;s President, its CODM, to evaluate performance of the Company&#x2019;s business and allocate resources and capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#x2019;s fair value measurements are provided in Note 15.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Level 1&#x2014;Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Level 2&#x2014;Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Level 3&#x2014;Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company determines whether an arrangement contains a lease at inception. If a lease is identified in an arrangement, the Company recognizes a right-of-use asset and liability in the Company's Consolidated Balance Sheets and determine whether the lease should be classified as a finance or operating lease. The Company does not recognize assets or liabilities for leases with lease terms of less than 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i) there is a transfer of ownership of the leased asset to Embecta by the end of the lease term, (ii) the Company holds an option to purchase the leased asset that the Company is reasonably certain to exercise, (iii) the lease term is for a major part of the remaining economic life of the leased asset, (iv) the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v) the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the implicit rate is not readily determinable, the Company utilizes its incremental borrowing rate at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease payments are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method over the shorter of the useful life of the related asset or the lease term. Finance lease payments are bifurcated into (i) a portion that is recorded as imputed interest expense and (ii) a portion that reduces the finance liability associated with the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For lease arrangements that are recognized on the Company&#x2019;s Consolidated Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. Variable lease payments are expensed as incurred. If a lease includes an option to extend or terminate the lease, the Company reflects the option in the lease term if it is reasonably certain the Company will exercise the option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Finance leases are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment, Net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Non Current Finance Lease Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and operating leases are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Company's Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses, including determining the allocation of shared costs and expenses from BD, depreciable and amortizable lives, sales returns and allowances, rebate accruals, restructuring costs, inventory reserves and taxes on income as reflected in the Consolidated Financial Statements. Actual results could differ from these estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; represented BD&#x2019;s interest in the recorded assets of the Company and the cumulative investment by BD in the Company through the date of the Separation, inclusive of operating results and the net effect of the transactions with and allocations from BD. See Notes 2 and 4 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Supplemental Disclosures Of Cash Flow Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash paid for interest related to debt during the year ended September 30, 2023 and 2022 was $111.0 million and $38.9 million, respectively. The Company did not have any debt outstanding during the year ended September 30, 2021. Cash paid for income taxes, net of refunds, for the years ended September 30, 2023 and 2022 was $30.4 million and $15.6 million, respectively. For the year ended September 30, 2021, the Company's current tax liabilities computed under the separate return method are considered to be effectively settled at the time the transaction is recorded, with the offset recorded against &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers, as if it had originated the contracts. The Company adopted this guidance at the beginning of fiscal year 2023 and it did not materially impact the Company's Condensed Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-347">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company recognizes revenue from product sales and considers performance obligations satisfied when the customer obtains control of the product, which is generally upon shipment or delivery, depending on the delivery terms specified in the sales agreement. The Company acts as the principal in its customer arrangements and therefore records revenue on a gross basis. When arrangements include multiple performance obligations, the total transaction price of the contract is allocated to each performance obligation based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. The point in time upon which shipment or delivery occurs is the most faithful depiction of when control of the goods transfers to the customer. Variable consideration such as rebates, chargebacks, sales discounts, and sales returns are estimated and treated as a reduction of revenue in the same period the related revenue is recognized. These estimates are based on contractual terms, historical practices and current trends, and are adjusted as new information becomes available. Revenues exclude any taxes that the Company collects from customers and remits to tax authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Measurement of Revenues &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Payment terms extended to the Company&#x2019;s customers are based upon commercially reasonable terms for the markets in which the Company&#x2019;s products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#x2019;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible. The allowance for doubtful accounts for trade receivables is not material to the Company&#x2019;s consolidated financial results. &lt;/span&gt;&lt;/div&gt;The Company&#x2019;s gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts, and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company&#x2019;s agreements primarily with its end-user customers. Additional factors considered in the estimate of the Company&#x2019;s rebate liability include the quantification of inventory that is either in stock at or in transit to the Company&#x2019;s distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-348">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Cash and cash equivalents include all highly liquid investments with a maturity of three months or less at the date of acquisition. Interest income on Cash and cash equivalents is recorded as earned.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c-1" id="f-349">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Trade Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The allowance for doubtful accounts represents the Company&#x2019;s estimate of probable credit losses relating to trade receivables and is determined based on historical experience, current conditions, reasonable and supportable forecasts and other specific account data. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-350">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Inventories are stated at the lower of approximate cost or net realizable value determined on the first-in, first-out basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <embc:HostingArrangementServiceContractPolicyTextBlock contextRef="c-1" id="f-351">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Cloud Computing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company capitalizes costs incurred to implement cloud computing arrangements that are service contracts within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Prepaid expenses and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Company's Condensed Consolidated Balance Sheets. Implementation costs associated with cloud computing arrangements are capitalized when incurred during the application development phase. Once the implementation of a cloud computing arrangement is complete and ready for its intended use, the Company amortizes the costs over the expected term of the hosting arrangement using the straight-line method to the same income statement line as the associated cloud operating expenses. The total balance of capitalized costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;associated with these arrangements as of September&#160;30, 2023 is $38.0&#160;million which primarily relates to the implementation of the Company's new enterprise resource planning ("ERP") system. These capitalized costs are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Costs amortized during fiscal year ended September 30, 2023 were not material to the Company's consolidated financial results. As of September&#160;30, 2023, cloud computing arrangement assets in-service have useful lives which range from approximately &lt;span style="-sec-ix-hidden:f-353"&gt;three&lt;/span&gt; to nine years.&lt;/span&gt;&lt;/div&gt;</embc:HostingArrangementServiceContractPolicyTextBlock>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization contextRef="c-6" decimals="-5" id="f-352" unitRef="usd">38000000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization>
    <embc:HostingArrangementServiceContractAssetsInServiceUsefulLife contextRef="c-38" id="f-354">P9Y</embc:HostingArrangementServiceContractAssetsInServiceUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-355">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is principally provided on the straight-line basis over estimated useful lives, which range from 20 to 45 years for buildings, 4 to 13 years for machinery and equipment and 1 to 20 years for leasehold improvements. Depreciation expense was $31.5&#160;million in 2023, $31.0&#160;million in 2022, and $37.2&#160;million in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, plant and equipment are periodically reviewed when impairment indicators are present to assess recoverability or a decision has been made to abandon efforts associated with construction in progress assets. Recoverability is determined by comparing the carrying values of the assets or asset groups to the undiscounted cash flows to be generated from the use and eventual disposition of such assets or asset groups. If the asset&#x2019;s or asset group&#x2019;s carrying value exceeds such &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;undiscounted cash flows, the assets or asset groups are not recoverable and an impairment loss is recognized based on the amount by which the carrying value of the asset or asset group exceeds its calculated fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-39" id="f-356">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-40" id="f-357">P45Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-41" id="f-358">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-42" id="f-359">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-43" id="f-360">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-44" id="f-361">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-362" unitRef="usd">31500000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-4" decimals="-5" id="f-363" unitRef="usd">31000000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-5" id="f-364" unitRef="usd">37200000</us-gaap:Depreciation>
    <us-gaap:InterestCapitalizationPolicyPolicyTextBlock contextRef="c-1" id="f-365">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Capitalized Interest&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The interest cost on capital projects is capitalized and included in the cost of the project. Capitalization commences with the first expenditure for the project and continues until the project is substantially complete and ready for its intended use. When no debt is incurred specifically for a project, interest is capitalized on project expenditures using the weighted average cost of the Company's outstanding borrowings. For the years ended September 30, 2023 and 2022, the Company capitalized $4.6 million and $5.2 million of interest expense, respectively, into &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment, Net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and capitalized $0.9 million of interest expense into &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt; during the year ended September 30, 2023.</us-gaap:InterestCapitalizationPolicyPolicyTextBlock>
    <us-gaap:InterestPaidCapitalized contextRef="c-45" decimals="-5" id="f-366" unitRef="usd">4600000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidCapitalized contextRef="c-46" decimals="-5" id="f-367" unitRef="usd">5200000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidCapitalized contextRef="c-47" decimals="-5" id="f-368" unitRef="usd">900000</us-gaap:InterestPaidCapitalized>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="c-1" id="f-369">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Advertising Costs &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advertising costs are expensed as incurred and included in S&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;elling and administrative expense&lt;/span&gt;.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense contextRef="c-1" decimals="-5" id="f-370" unitRef="usd">15500000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-4" decimals="-5" id="f-371" unitRef="usd">11600000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-5" decimals="-5" id="f-372" unitRef="usd">9300000</us-gaap:AdvertisingExpense>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c-1" id="f-373">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Goodwill represents the excess of the consideration transferred over the fair value of net assets of businesses acquired. The Company has one reporting unit. Goodwill is evaluated for impairment as of July 1 each year, or more frequently if impairment indicators exist, by first assessing qualitative factors to determine whether it is more likely than not that fair value is less than carrying value. If the Company concludes it is more likely than not that fair value is less than carrying value, a quantitative fair value test is performed. If carrying value is greater than fair value, a goodwill impairment charge will be recorded for the difference (up to the carrying value of goodwill). The Company completed the annual goodwill impairment test as of July 1, 2023 and concluded that no impairment to goodwill was necessary as the fair value of the Company's one reporting unit was significantly in excess of the carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;No goodwill impairments were identified during the years ended September 30, 2022, or 2021, and no accumulated impairment losses are recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Amortized intangible assets primarily consist of patents and customer relationships. Patents are generally amortized over 20 years using the straight-line method. Customer relationship assets are generally amortized over periods ranging from 10 to 15 years, using the straight-line method. Other intangibles with finite useful lives are amortized over periods principally ranging from 1 to 40 years, using the straight-line method. Finite-lived intangible assets are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset&#x2019;s carrying value exceeds its calculated fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="c-1"
      decimals="INF"
      id="f-374"
      unitRef="reporting_unit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:NumberOfReportingUnits
      contextRef="c-1"
      decimals="INF"
      id="f-375"
      unitRef="reporting_unit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-48" id="f-376">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-49" id="f-377">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-50" id="f-378">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-51" id="f-379">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-52" id="f-380">P40Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-381">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Generally, foreign subsidiaries&#x2019; functional currency is the local currency of operations and the net assets of foreign operations are translated into United States dollars using current exchange rates. The United States dollar results that arise from such translation are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <embc:ShippingAndHandlingPolicyPolicyTextBlock contextRef="c-1" id="f-382">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;/div&gt;The Company considers its shipping and handling costs to be contract fulfillment costs and records them within selling and administrative expense.</embc:ShippingAndHandlingPolicyPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-53" decimals="-5" id="f-383" unitRef="usd">36900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-54" decimals="-5" id="f-384" unitRef="usd">27400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-55" decimals="-5" id="f-385" unitRef="usd">13600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c-1" id="f-386">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;The Company establishes accruals for future losses which are both probable and can be reasonably estimated (and in the case of environmental matters, without considering possible third-party recoveries).</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-387">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, certain of the Company&#x2019;s employees historically participated in BD&#x2019;s stock-based compensation plans. Stock-based compensation expense was either allocated to the Company based on a proportionate cost allocation method or recorded based on specific identification. Effective April 1, 2022, the Company established the 2022 Employee and Director Equity Based Compensation Plan (the "Plan"). The Plan provides for the grant of various types of awards, including restricted stock unit ("RSU") awards, stock appreciation rights, stock options, performance-based awards and cash awards. Under the Plan, the exercise price of awards, if any, is set on the grant date and generally may not be less than &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;the fair market value per share on that date. The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards. For awards that ultimately settle in cash, we treat them as liability awards and mark the award to market each reporting period and recognize any adjustment in our Consolidated Statements of Income. The Company recognizes stock-based compensation cost only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants. The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change (see Note 10).&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy contextRef="c-1" id="f-388">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, the defined benefit plans in which the Company participated related primarily to plans sponsored by BD and for which other businesses of BD also participate (the "Shared Plans"). The Company accounted for the Shared Plans as multiemployer plans and therefore the related assets and liabilities were not reflected in the Consolidated Balance Sheets. For such periods prior to the Separation, the Consolidated Statements of Income reflect a proportional allocation of net periodic benefit cost for the Shared Plans associated with the Company. The Company's participation in the defined pension and postretirement benefit plans sponsored by BD concluded upon the completion of the Separation on April 1, 2022. At and after Separation, Embecta became the plan sponsor for certain non-United States defined benefit pension plans (see Note 18).&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-389">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-390">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax basis of assets and liabilities at the applicable tax rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;From time to time, the Company engages in transactions in which tax consequences may be subject to uncertainty. The Company conducts business and files tax returns in numerous jurisdictions based on its interpretation of tax laws and regulations. In evaluating the Company&#x2019;s tax provision, the Company establishes a reserve for uncertain tax positions unless such positions are determined to be more likely than not of being sustained upon examination based on the technical merits.  The Company&#x2019;s policy is to recognize, when applicable, interest and penalties on uncertain tax positions as part of income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;While the Company believes it has identified all reasonable exposures and the reserve it has established is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Tax Cuts and Jobs Act was enacted on December 22, 2017 and introduced an additional United States tax on the earnings of non-United States subsidiaries which are referred to as Global Intangible Low Taxed Income (&#x201c;GILTI&#x201d;). The Company has elected to treat GILTI as a period cost. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, the Company's operations were included in the tax returns of BD. Income taxes as presented in the Consolidated Financial Statements attribute current and deferred income tax assets and liabilities of BD to the Company in a manner that is systematic, rational, and consistent with the asset and liability method prescribed by the accounting guidance for income taxes. The Company's income tax provision prior to the Separation was prepared using the separate return method. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company were a separate taxpayer and a standalone enterprise. The Company believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-391">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Segment Data&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company operates and reports its financial information as one segment. In making this determination, the Company (i) determines its Chief Operating Decision Maker (&#x201c;CODM&#x201d;), (ii) identifies and analyzes potential business components, (iii) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;identifies its operating segments and (iv) determines whether there are multiple operating segments requiring presentation as reportable segments. The Company&#x2019;s decision to report as one segment is based upon the following: (1) its internal organizational structure; (2) the manner in which its operations are managed; and (3) the criteria used by the Company&#x2019;s President, its CODM, to evaluate performance of the Company&#x2019;s business and allocate resources and capital.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-392"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-393"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-394"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-395">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A fair value hierarchy is applied to prioritize inputs used in measuring fair value. The three levels of inputs used to measure fair value are detailed below. Additional disclosures regarding the Company&#x2019;s fair value measurements are provided in Note 15.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Level 1&#x2014;Inputs to the valuation methodology which represent unadjusted quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Level 2&#x2014;Inputs to the valuation methodology which include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Level 3&#x2014;Inputs to the valuation methodology which are unobservable and significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-396">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company determines whether an arrangement contains a lease at inception. If a lease is identified in an arrangement, the Company recognizes a right-of-use asset and liability in the Company's Consolidated Balance Sheets and determine whether the lease should be classified as a finance or operating lease. The Company does not recognize assets or liabilities for leases with lease terms of less than 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A lease qualifies as a finance lease if any of the following criteria are met at the inception of the lease: (i) there is a transfer of ownership of the leased asset to Embecta by the end of the lease term, (ii) the Company holds an option to purchase the leased asset that the Company is reasonably certain to exercise, (iii) the lease term is for a major part of the remaining economic life of the leased asset, (iv) the present value of the sum of lease payments equals or exceeds substantially all of the fair value of the leased asset, or (v) the nature of the leased asset is specialized to the point that it is expected to provide the lessor no alternative use at the end of the lease term. All other leases are recorded as operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Finance and operating lease assets and liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term using the discount rate implicit in the lease. If the implicit rate is not readily determinable, the Company utilizes its incremental borrowing rate at the lease commencement date. Operating lease assets are further adjusted for prepaid or accrued lease payments. Operating lease payments are expensed using the straight-line method as an operating expense over the lease term. Finance lease assets are amortized to depreciation expense using the straight-line method over the shorter of the useful life of the related asset or the lease term. Finance lease payments are bifurcated into (i) a portion that is recorded as imputed interest expense and (ii) a portion that reduces the finance liability associated with the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For lease arrangements that are recognized on the Company&#x2019;s Consolidated Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. Variable lease payments are expensed as incurred. If a lease includes an option to extend or terminate the lease, the Company reflects the option in the lease term if it is reasonably certain the Company will exercise the option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Finance leases are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment, Net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Non Current Finance Lease Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and operating leases are recorded in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Company's Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-397">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses, including determining the allocation of shared costs and expenses from BD, depreciable and amortizable lives, sales returns and allowances, rebate accruals, restructuring costs, inventory reserves and taxes on income as reflected in the Consolidated Financial Statements. Actual results could differ from these estimates. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net investment from Becton, Dickinson and Company&lt;/span&gt; represented BD&#x2019;s interest in the recorded assets of the Company and the cumulative investment by BD in the Company through the date of the Separation, inclusive of operating results and the net effect of the transactions with and allocations from BD.</us-gaap:UseOfEstimates>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-5" id="f-398" unitRef="usd">111000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-4" decimals="-5" id="f-399" unitRef="usd">38900000</us-gaap:InterestPaidNet>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount contextRef="c-15" decimals="INF" id="f-400" unitRef="usd">0</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-5" id="f-401" unitRef="usd">30400000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-4" decimals="-5" id="f-402" unitRef="usd">15600000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-403">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In October 2021, the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers, as if it had originated the contracts. The Company adopted this guidance at the beginning of fiscal year 2023 and it did not materially impact the Company's Condensed Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <embc:ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-404">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 4 &#x2014; Third Party Arrangements and Related Party Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Pursuant to the Separation, BD ceased to be a related party to Embecta and accordingly, no related party transactions or balances are reported subsequent to April 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the Separation, the Company entered into the Separation and Distribution Agreement, which contains provisions that, among other things, relate to (i) assets, liabilities and contracts to be transferred, assumed and assigned to each of Embecta and BD (including certain deferred assets and liabilities) as part of the Separation, (ii) cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of Embecta's business with Embecta and financial responsibility for the obligations and liabilities of BD&#x2019;s remaining businesses with BD, (iii) procedures with respect to claims subject to indemnification and related matters, (iv) the allocation among Embecta and BD of rights and obligations under existing insurance policies with respect to occurrences prior to completion of the Separation, as well as the right to proceeds and the obligation to incur certain deductibles under certain insurance policies, and (v) procedures governing Embecta&#x2019;s and BD&#x2019;s obligations and allocations of liabilities with respect to ongoing litigation matters that may implicate each of BD&#x2019;s business and Embecta&#x2019;s business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Agreements that Embecta entered into with BD that govern aspects of Embecta's relationship with BD following the Separation include, but are not limited to:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Transition Services Agreements ("TSA") - Pursuant to the TSA, Embecta and BD and their respective affiliates provide each other, on an interim, transitional basis, various services, including, but not limited to, information technology, human resources, procurement, quality and regulatory affairs, medical affairs, tax and treasury services. The agreed-upon charges for such services are generally intended to allow the servicing party to charge a price comprised of out-of-pocket costs and expenses and a predetermined profit in the form of a mark-up of such out-of-pocket costs and expenses. The services will terminate no later than 24 months following the Separation, subject to the Extension. The Extension is conditioned upon BD obtaining a supplemental private letter ruling. The service recipient may terminate any services by giving prior written notice to the provider of such services and paying any applicable wind-down charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Trade Receivables Factoring Agreements - Embecta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and BD entered into trade receivables factoring agreements (the "Factoring Agreements"), under which Embecta transfers certain net trade receivable assets to BD, and pays a service fee calculated as 0.1% of annual revenues related to countries subject to the Factoring Agreements in exchange for the services provided by BD. Per the terms of the Factoring Agreements, the Company and its relevant subsidiaries sell receivables to the corresponding BD subsidiary in the same jurisdiction and such BD subsidiary collects the receivables from Company's customers. The BD subsidiary assumes the credit risk in respect of the receivables, and accordingly deducts a factoring fee from the purchase price of such receivables. Accordingly, Embecta accounts for the transfer as sales of trade receivables by recognizing an increase to&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and a decrease to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Trade Receivables, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Consolidated Balance Sheets when proceeds from the transactions are received. The transfers are presented in the Consolidated Statements of Cash Flows as operating activities and the related service fee is presented as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other income (expense), net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Consolidated Statements of Income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Distribution Agreements - Embecta and BD entered into distribution agreements for certain territories, principally in the Asia Pacific Region and Latin America, whereby a subsidiary of BD is appointed as a distributor of Embecta or its relevant subsidiaries to support certain commercial operations of the diabetes care business on a transitional basis in these regions for a maximum of two years. The distribution agreements will each continue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;until either (1) certain governmental approvals needed to distribute products in the defined territory are obtained and order-to-cash processes and other services of the Company for such territory are migrated to an alternative commercial arrangement between the parties or (2) the applicable services are transitioned to a third-party distributor or independently performed by Embecta, but in any event no longer than the maximum term of two years, except certain such agreements may be extended in connection with the Extension. Embecta shall pay BD a return of 1.5% to 2.0% of net revenue for each territory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Cannula Supply Agreement - Embecta and BD entered into a cannula supply agreement whereby BD sells to Embecta cannulas for incorporation into Embecta's existing syringes and pen needles, safety syringes and safety pen needles, and products currently under development. BD retains ownership of all cannula technology, cannula production activities and the intellectual property rights therein. Embecta is limited to a maximum number of cannulas that it can purchase under the cannula supply agreement, which will be an absolute upper limit of cannulas per year and yearly limits that vary with annual demand. The cannula supply agreement is terminable by Embecta without cause by providing at least 36 months&#x2019; written notice; however, such termination can be effective no earlier than five years from the Separation. The cannula supply agreement will be terminable by BD without cause by providing at least 36 months&#x2019; written notice; however, such termination can be effective no earlier than ten years from the Separation. However, in the event of a change of control of Embecta, BD has the right to terminate the cannula supply agreement in its sole discretion. The cannula supply agreement will also terminate automatically, subject to a 36-month wind-down period, if Embecta&#x2019;s yearly forecast is below the required minimum purchase amount, and the parties have other customary termination rights for material breach or bankruptcy of the other party.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Tax Matters Agreement - Pursuant to the tax matters agreement, Embecta agreed to certain covenants that contain restrictions intended to preserve the tax-free status of the distribution and certain related transactions. Embecta may take certain actions prohibited by these covenants only if Embecta obtains and provides to BD an opinion from a United States tax counsel or accountant of recognized national standing, in either case satisfactory to BD, to the effect that such action would not jeopardize the tax-free status of the distribution and certain related transactions, or if Embecta obtains prior written consent of BD. Embecta is barred from taking any action, or failing to take any action, where such action or failure to act adversely affects or could reasonably be expected to adversely affect the tax-free status of the distribution and certain related transactions or result in certain other taxes to BD, for all relevant time periods. In addition, during the period ending two years after the Separation, these covenants include specific restrictions on Embecta&#x2019;s (i) discontinuing the active conduct of Embecta&#x2019;s trade or business; (ii) issuance or sale of stock or other securities (including securities convertible into Embecta stock, but excluding certain compensatory arrangements); (iii) liquidating, merging, or consolidating with any other person; (iv) amending Embecta&#x2019;s certificate of incorporation (or other organizational documents) or taking any other action, whether through a stockholder vote or otherwise, affecting the voting rights of Embecta common stock; (v) sales of assets outside the ordinary course of business; and (vi) entering into any other corporate transaction which would cause Embecta to undergo a 50% or greater change in its stock ownership.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Logistics Services Agreement - Embecta and BD entered into a logistics services agreement whereby BD provides Embecta with certain order-to-cash and logistics services to support certain commercial operations for a maximum term of two years, which BD has agreed to extend through March 31, 2024. Embecta will pay BD&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (i) reimbursable costs, including all shipping costs, selling costs, general administration costs, costs of goods, research and development services costs, and other income and expenses related solely to the diabetes care business, that are incurred by BD directly, as allocated costs or as costs payable to a third party and (ii) a monthly administrative fee of 1.0% of net revenue (which will increase to 1.25% of net revenue after January 1, 2024).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;Other agreements that Embecta entered into with BD include, but are not limited to, the employee matters agreement ("EMA"), an intellectual property matters agreement, local support services agreements, certain other manufacturing arrangements and a process services agreement and lease agreement for a manufacturing facility located in Holdrege, Nebraska. See Note 17 for more information on the lease agreement for Holdrege. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As it pertains to the Distribution Agreements noted above, Embecta has determined it is the principal under these arrangements and is entitled to all the benefits, and is liable for all the risks, related to the inventory and receivables. Additionally, Embecta has latitude in pricing, has the ability to direct BD regarding decisions over inventory, and is responsible for all credit and collections risks and losses associated with the related receivables when there is no factoring agreement in place. As such, Embecta recognizes these sales on a gross basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amount due from BD under the above agreements was $142.4&#160;million at September&#160;30, 2023 and is reflected in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Amounts due from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The amount due to BD under these agreements was $73.1 million at September&#160;30, 2023 and is included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Amounts due to Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The closing of the transfers of certain assets and liabilities related to the Diabetes Care Business in certain jurisdictions, including China, Mexico, and Italy, as contemplated by the Separation and Distribution Agreement did not occur at &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Separation. The transfers of the remaining relevant local assets and liabilities for these deferred countries are expected to close at a future date. As of September&#160;30, 2023, the Company estimates that amounts due to BD related to certain assets and liabilities in deferred close jurisdictions is $29.7&#160;million and are reflected in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Accrued expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. As of September&#160;30, 2023, the Company estimates that amounts due from BD related to certain assets and liabilities in deferred close jurisdictions are $8.4&#160;million and is reflected in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, the Company did not operate as a standalone business and the Consolidated Financial Statements were derived from the consolidated financial statements and accounting records of BD. The following disclosure summarizes activity between the Company and BD up to the Separation, including the affiliates of BD that were not part of the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the years ended September 30, 2022 and 2021, cost of products sold from related party inventory purchases were $28.0 million and $40.6 million, respectively. For the year ended September 30, 2023 there were no cost of products sold from related party inventory purchases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Corporate and Medical Segment Allocations from BD&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, BD provided significant corporate, finance, human resources, information technology, facilities, and legal services, among others (collectively, &#x201c;General Corporate Expenses&#x201d;) to the Company. Some of these services continue to be provided by BD to the Company on a temporary basis under the TSA. For purposes of these Consolidated Financial Statements for the periods prior to the Separation, the General Corporate Expenses have been allocated to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The allocations of General Corporate Expenses are reflected in the Consolidated Statements of Income as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;47.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;98.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total General Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;115.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;These expenses were allocated to the Company on a pro rata basis of global and regional revenues, headcount, research and development spend and other drivers. Management believes the assumptions underlying the Consolidated Financial Statements, including the assumptions regarding allocating General Corporate Expenses from BD, are reasonable. Nevertheless, the Consolidated Financial Statements for periods prior to the Separation may not include all of the actual expenses that would have been incurred and may not reflect the Company&#x2019;s Consolidated results of operations, financial position and cash flows had it been a standalone public company during the periods presented. Actual costs that would have been incurred if the Company had been a standalone public company would depend on multiple factors, including organizational structure and strategic decisions made in various areas, including information technology and infrastructure. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Related party transactions  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following transactions represent activity in the ordinary course of business between the Company and BD prior to the Separation for certain materials for use in production of certain medical products that were not at arm&#x2019;s length. The following table summarizes such former related party purchases as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.447%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Year ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Purchases from BD&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;All significant intercompany transactions between the Company and BD prior to the Separation have been included in the Consolidated Financial Statements and are considered to be effectively settled for cash at the time the transaction is recorded. For the period prior to the Separation, the total net effect of the settlement of these intercompany transactions is reflected in the Consolidated Statements of Cash Flows as a financing activity and in the Consolidated Balance Sheets as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, net transfers to BD were included within&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Net Investment from Becton, Dickinson and Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&#160;in the Consolidated Statements of Equity and represent the net effect of transactions between the Company and BD. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the components of the net transfers to BD as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.839%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.447%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Cash pooling and general financing activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;255.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;599.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Corporate and segment allocations, excluding non-cash stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(50.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(109.9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Taxes deemed settled with BD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(16.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(72.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other Separation related adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(11.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Net transfers to BD as reflected in the Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;177.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;417.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(8.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Pension expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net consideration paid to BD in connection with the Separation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,266.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Related party senior secured notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;197.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Other transfers to (from) BD, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;84.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(11.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net transfers to BD&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,712.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;383.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt"&gt;The nature of activities includes financing activities for capital transfers, cash sweeps and other treasury services. As part of this activity, cash balances were swept to BD on a daily basis under the BD Treasury function and the Company receives capital from BD for its cash needs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Related Party Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On March 31, 2022, Embecta issued $200.0 million of senior secured notes to BD&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (the "Related Party Notes"). &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Related Party Notes issued to BD were not issued for cash and instead were subject to a debt-for-debt exchange which occurred on April 1, 2022. As of April 1, 2022 t&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;he Related Party Notes were reclassified to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Consolidated Balance Sheets as the Related Party Notes are third party debt for periods post Separation.&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Refer to Note 12 for further information.&lt;/span&gt;&lt;/div&gt;</embc:ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock>
    <embc:TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum contextRef="c-36" id="f-405">P24M</embc:TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum>
    <embc:ContractuallySpecifiedServicingFeesPercentage
      contextRef="c-56"
      decimals="INF"
      id="f-406"
      unitRef="number">0.001</embc:ContractuallySpecifiedServicingFeesPercentage>
    <embc:DistributionAgreementDistributorAppointmentMaximumTerm contextRef="c-56" id="f-407">P2Y</embc:DistributionAgreementDistributorAppointmentMaximumTerm>
    <embc:DistributionAgreementDistributorAppointmentMaximumTerm contextRef="c-56" id="f-408">P2Y</embc:DistributionAgreementDistributorAppointmentMaximumTerm>
    <embc:DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue
      contextRef="c-57"
      decimals="INF"
      id="f-409"
      unitRef="number">0.015</embc:DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue>
    <embc:DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue
      contextRef="c-58"
      decimals="INF"
      id="f-410"
      unitRef="number">0.020</embc:DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue>
    <embc:CannulaSupplyAgreementTerminationNoticePeriodMinimum contextRef="c-56" id="f-411">P36M</embc:CannulaSupplyAgreementTerminationNoticePeriodMinimum>
    <embc:CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum contextRef="c-56" id="f-412">P5Y</embc:CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum>
    <embc:CannulaSupplyAgreementTerminationNoticePeriodMinimum contextRef="c-59" id="f-413">P36M</embc:CannulaSupplyAgreementTerminationNoticePeriodMinimum>
    <embc:CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum contextRef="c-59" id="f-414">P10Y</embc:CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum>
    <embc:CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod contextRef="c-56" id="f-415">P36M</embc:CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod>
    <embc:TaxMattersAgreementCovenantRestrictionsPeriod contextRef="c-56" id="f-416">P2Y</embc:TaxMattersAgreementCovenantRestrictionsPeriod>
    <embc:TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold
      contextRef="c-56"
      decimals="INF"
      id="f-417"
      unitRef="number">0.50</embc:TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold>
    <embc:LogisticsServicesAgreementMaximumTerm contextRef="c-56" id="f-418">P2Y</embc:LogisticsServicesAgreementMaximumTerm>
    <embc:LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue
      contextRef="c-56"
      decimals="INF"
      id="f-419"
      unitRef="number">0.010</embc:LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue>
    <embc:LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue
      contextRef="c-60"
      decimals="INF"
      id="f-420"
      unitRef="number">0.0125</embc:LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-61" decimals="-5" id="f-421" unitRef="usd">142400000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c-61" decimals="-5" id="f-422" unitRef="usd">73100000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-61" decimals="-5" id="f-423" unitRef="usd">29700000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-61" decimals="-5" id="f-424" unitRef="usd">8400000</us-gaap:OtherAssetsCurrent>
    <us-gaap:RelatedPartiesAmountInCostOfSales contextRef="c-4" decimals="-5" id="f-425" unitRef="usd">28000000</us-gaap:RelatedPartiesAmountInCostOfSales>
    <us-gaap:RelatedPartiesAmountInCostOfSales contextRef="c-5" decimals="-5" id="f-426" unitRef="usd">40600000</us-gaap:RelatedPartiesAmountInCostOfSales>
    <us-gaap:RelatedPartiesAmountInCostOfSales contextRef="c-1" decimals="INF" id="f-427" unitRef="usd">0</us-gaap:RelatedPartiesAmountInCostOfSales>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c-1" id="f-428">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The allocations of General Corporate Expenses are reflected in the Consolidated Statements of Income as follows: &lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;47.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;98.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total General Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;115.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;The following table summarizes such former related party purchases as follows: &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.447%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Year ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Purchases from BD&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the components of the net transfers to BD as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.839%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.447%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Cash pooling and general financing activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;255.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;599.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Corporate and segment allocations, excluding non-cash stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(50.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(109.9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Taxes deemed settled with BD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(16.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(72.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Other Separation related adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(11.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Net transfers to BD as reflected in the Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;177.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;417.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(8.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Pension expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net consideration paid to BD in connection with the Separation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,266.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Related party senior secured notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;197.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Other transfers to (from) BD, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;84.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(11.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net transfers to BD&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,712.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;383.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;The nature of activities includes financing activities for capital transfers, cash sweeps and other treasury services. As part of this activity, cash balances were swept to BD on a daily basis under the BD Treasury function and the Company receives capital from BD for its cash needs.</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <embc:GeneralCorporateExpenses contextRef="c-62" decimals="-5" id="f-429" unitRef="usd">2300000</embc:GeneralCorporateExpenses>
    <embc:GeneralCorporateExpenses contextRef="c-63" decimals="-5" id="f-430" unitRef="usd">13000000.0</embc:GeneralCorporateExpenses>
    <embc:GeneralCorporateExpenses contextRef="c-64" decimals="-5" id="f-431" unitRef="usd">47900000</embc:GeneralCorporateExpenses>
    <embc:GeneralCorporateExpenses contextRef="c-65" decimals="-5" id="f-432" unitRef="usd">98300000</embc:GeneralCorporateExpenses>
    <embc:GeneralCorporateExpenses contextRef="c-66" decimals="-5" id="f-433" unitRef="usd">3500000</embc:GeneralCorporateExpenses>
    <embc:GeneralCorporateExpenses contextRef="c-67" decimals="-5" id="f-434" unitRef="usd">5200000</embc:GeneralCorporateExpenses>
    <embc:GeneralCorporateExpenses contextRef="c-68" decimals="-5" id="f-435" unitRef="usd">-600000</embc:GeneralCorporateExpenses>
    <embc:GeneralCorporateExpenses contextRef="c-69" decimals="-5" id="f-436" unitRef="usd">-1300000</embc:GeneralCorporateExpenses>
    <embc:GeneralCorporateExpenses contextRef="c-4" decimals="-5" id="f-437" unitRef="usd">53100000</embc:GeneralCorporateExpenses>
    <embc:GeneralCorporateExpenses contextRef="c-5" decimals="-5" id="f-438" unitRef="usd">115200000</embc:GeneralCorporateExpenses>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="c-70" decimals="-5" id="f-439" unitRef="usd">28000000.0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty contextRef="c-71" decimals="-5" id="f-440" unitRef="usd">40600000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <embc:NetParentInvestmentCashPoolingAndGeneralFinancingActivities contextRef="c-4" decimals="-5" id="f-441" unitRef="usd">255900000</embc:NetParentInvestmentCashPoolingAndGeneralFinancingActivities>
    <embc:NetParentInvestmentCashPoolingAndGeneralFinancingActivities contextRef="c-5" decimals="-5" id="f-442" unitRef="usd">599500000</embc:NetParentInvestmentCashPoolingAndGeneralFinancingActivities>
    <embc:NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation contextRef="c-4" decimals="-5" id="f-443" unitRef="usd">50400000</embc:NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation>
    <embc:NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation contextRef="c-5" decimals="-5" id="f-444" unitRef="usd">109900000</embc:NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation>
    <embc:NetParentInvestmentTaxesDeemedSettledWithParent contextRef="c-4" decimals="-5" id="f-445" unitRef="usd">16200000</embc:NetParentInvestmentTaxesDeemedSettledWithParent>
    <embc:NetParentInvestmentTaxesDeemedSettledWithParent contextRef="c-5" decimals="-5" id="f-446" unitRef="usd">72500000</embc:NetParentInvestmentTaxesDeemedSettledWithParent>
    <embc:NetParentInvestmentSeparationRelatedAdjustments contextRef="c-4" decimals="-5" id="f-447" unitRef="usd">-11400000</embc:NetParentInvestmentSeparationRelatedAdjustments>
    <embc:NetParentInvestmentSeparationRelatedAdjustments contextRef="c-5" decimals="-5" id="f-448" unitRef="usd">0</embc:NetParentInvestmentSeparationRelatedAdjustments>
    <embc:NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities contextRef="c-4" decimals="-5" id="f-449" unitRef="usd">177900000</embc:NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities>
    <embc:NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities contextRef="c-5" decimals="-5" id="f-450" unitRef="usd">417100000</embc:NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities>
    <embc:NetParentInvestmentShareBasedCompensationExpense contextRef="c-4" decimals="-5" id="f-451" unitRef="usd">8500000</embc:NetParentInvestmentShareBasedCompensationExpense>
    <embc:NetParentInvestmentShareBasedCompensationExpense contextRef="c-5" decimals="-5" id="f-452" unitRef="usd">12500000</embc:NetParentInvestmentShareBasedCompensationExpense>
    <embc:NetParentInvestmentPensionExpense contextRef="c-4" decimals="-5" id="f-453" unitRef="usd">3600000</embc:NetParentInvestmentPensionExpense>
    <embc:NetParentInvestmentPensionExpense contextRef="c-5" decimals="-5" id="f-454" unitRef="usd">9400000</embc:NetParentInvestmentPensionExpense>
    <embc:NetParentInvestmentConsiderationPaidForSeparation contextRef="c-4" decimals="-5" id="f-455" unitRef="usd">1266000000</embc:NetParentInvestmentConsiderationPaidForSeparation>
    <embc:NetParentInvestmentConsiderationPaidForSeparation contextRef="c-5" decimals="-5" id="f-456" unitRef="usd">0</embc:NetParentInvestmentConsiderationPaidForSeparation>
    <embc:NetParentInvestmentRelatedPartyDebtIssued contextRef="c-4" decimals="-5" id="f-457" unitRef="usd">197000000.0</embc:NetParentInvestmentRelatedPartyDebtIssued>
    <embc:NetParentInvestmentRelatedPartyDebtIssued contextRef="c-5" decimals="-5" id="f-458" unitRef="usd">0</embc:NetParentInvestmentRelatedPartyDebtIssued>
    <embc:NetParentInvestmentOtherTransfersToFromParentNet contextRef="c-4" decimals="-5" id="f-459" unitRef="usd">84100000</embc:NetParentInvestmentOtherTransfersToFromParentNet>
    <embc:NetParentInvestmentOtherTransfersToFromParentNet contextRef="c-5" decimals="-5" id="f-460" unitRef="usd">-11400000</embc:NetParentInvestmentOtherTransfersToFromParentNet>
    <embc:NetParentInvestmentNetTransfersToParent contextRef="c-4" decimals="-5" id="f-461" unitRef="usd">1712900000</embc:NetParentInvestmentNetTransfersToParent>
    <embc:NetParentInvestmentNetTransfersToParent contextRef="c-5" decimals="-5" id="f-462" unitRef="usd">383800000</embc:NetParentInvestmentNetTransfersToParent>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-72" decimals="INF" id="f-463" unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-464">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 5 &#x2014; Collaboration Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In March 2023, the Company entered into a collaboration agreement with a third-party to develop and commercialize an interoperable automated glycemic controller ("iAGC") to complement the Company's insulin patch pump currently in development. The Company believes that both parties are active participants in the operating activities of the collaboration and exposed to certain risks and rewards depending on commercial success. The transaction included an upfront payment of $2.5&#160;million for project costs, which was expensed to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Research and development expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; during the year ended September&#160;30, 2023. Upon successful commercialization of the iAGC, the Company will be responsible for the sales and marketing effort and would pay a royalty to the third-party based on future product sales to customers. The Company expects that it will be the principal in the end customer sale and 100% of product sales will be included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and any royalty payments and continued project costs after commercialization will be included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; as they are incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-73" decimals="-5" id="f-465" unitRef="usd">2500000</us-gaap:ResearchAndDevelopmentExpense>
    <embc:CollaborativeArrangementPrincipalRightsPercentage
      contextRef="c-73"
      decimals="INF"
      id="f-466"
      unitRef="number">1</embc:CollaborativeArrangementPrincipalRightsPercentage>
    <us-gaap:OtherOperatingIncomeAndExpenseTextBlock contextRef="c-1" id="f-467">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 6 &#x2014; Other Operating Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the Separation, the Company incurred separation and stand-up costs of approximately &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$92.7&#160;million, $44.7 million, and $4.8 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; during the years ended September&#160;30, 2023, 2022, and 2021, respectively. The costs incurred primarily consist of costs associated with accounting, auditing, legal services, supply chain, employee retention, the implementation of the Company's new ERP system, and certain other costs to establish certain stand-alone functions to assist with the transition to being a stand-alone entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the year ended September 30, 2023, the Company recorded approximately $5.6&#160;million of severance costs related to the optimization of certain business functions. These costs were primarily recorded in the U.S. and severance costs were not material to any comparable prior year periods presented. Liabilities for costs associated with these activities were not material to any period presented. For the years ended September 30, 2022, and 2021 severance costs were not material to the Company's Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherOperatingIncomeAndExpenseTextBlock>
    <embc:SeparationAndStandupCosts contextRef="c-1" decimals="-5" id="f-468" unitRef="usd">92700000</embc:SeparationAndStandupCosts>
    <embc:SeparationAndStandupCosts contextRef="c-4" decimals="-5" id="f-469" unitRef="usd">44700000</embc:SeparationAndStandupCosts>
    <embc:SeparationAndStandupCosts contextRef="c-5" decimals="-5" id="f-470" unitRef="usd">4800000</embc:SeparationAndStandupCosts>
    <us-gaap:SeveranceCosts1 contextRef="c-1" decimals="-5" id="f-471" unitRef="usd">5600000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-5" decimals="-5" id="f-472" unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-4" decimals="-5" id="f-473" unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:LossContingencyDisclosures contextRef="c-1" id="f-474">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 7 &#x2014; Contingencies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is subject to potential liabilities under government regulations and various claims and legal actions that are pending or may be asserted from time-to-time. These matters arise in the ordinary course and conduct of the Company&#x2019;s business and include, for example, commercial, product liability, breach of contract and tort, intellectual property, product liability, environmental, securities and employment matters. The Company intends to continue to defend itself vigorously in such matters and when warranted, take legal action against others. Furthermore, the Company regularly assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;An estimated loss contingency is accrued in the Company&#x2019;s Financial Statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company&#x2019;s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company&#x2019;s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.&lt;/span&gt;&lt;/div&gt;The Company was not a party to any material legal proceedings at September&#160;30, 2023 or September&#160;30, 2022, nor is it a party to any material legal proceedings as of the date of issuance of these Consolidated Financial Statements.</us-gaap:LossContingencyDisclosures>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-475">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 8 &#x2014; Revenues &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Measurement of Revenues &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Payment terms extended to the Company&#x2019;s customers are based upon commercially reasonable terms for the markets in which the Company&#x2019;s products are sold. Because the Company generally expects to receive payment within one year or less from when control of a product is transferred to the customer, the Company does not generally adjust its revenues for the effects of a financing component. The Company&#x2019;s allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of its trade receivables. Such estimated credit losses are determined based on historical loss experiences, customer specific credit risk, and reasonable and supportable forward-looking information, such as country or regional risks that are not captured in the historical loss information. Amounts are written off against the allowances for doubtful accounts when the Company determines that a customer account is uncollectible. The allowance for doubtful accounts for trade receivables is not material to the Company&#x2019;s consolidated financial results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s gross revenues are subject to a variety of deductions which are recorded in the same period that the underlying revenues are recognized. Such variable consideration includes rebates, sales discounts, and sales returns. Because these deductions represent estimates of the related obligations, judgment is required when determining the impact of these revenue deductions on gross revenues for a reporting period. Rebates provided by the Company are based upon prices determined under the Company&#x2019;s agreements primarily with its end-user customers. Additional factors considered in the estimate of the Company&#x2019;s rebate liability include the quantification of inventory that is either in stock at or in transit to the Company&#x2019;s distributors, as well as the estimated lag time between the sale of product and the payment of corresponding rebates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s liability attributed to variable consideration at September&#160;30, 2023 and September&#160;30, 2022 was $36.4 million and $43.8 million, respectively. Sales deductions recorded as a reduction of gross revenues for the years ended September&#160;30, 2023, 2022 and 2021 were $411.1 million, $336.4 million, and $298.7&#160;million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Disaggregation of Revenues &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Disaggregation of revenue by geographic region is provided within Note 9. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contract Assets and Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company does not have contract liabilities. Contract assets consist of the Company&#x2019;s right to consideration that is conditional upon its future performance pursuant to private label agreements and are presented within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;The Company&#x2019;s contract asset balance was $1.2 million as of each of September&#160;30, 2023 and 2022.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ContractWithCustomerRefundLiability contextRef="c-6" decimals="-5" id="f-476" unitRef="usd">36400000</us-gaap:ContractWithCustomerRefundLiability>
    <us-gaap:ContractWithCustomerRefundLiability contextRef="c-7" decimals="-5" id="f-477" unitRef="usd">43800000</us-gaap:ContractWithCustomerRefundLiability>
    <embc:RevenueFromContractWithCustomerSalesDeductionsRecognized contextRef="c-1" decimals="-5" id="f-478" unitRef="usd">411100000</embc:RevenueFromContractWithCustomerSalesDeductionsRecognized>
    <embc:RevenueFromContractWithCustomerSalesDeductionsRecognized contextRef="c-4" decimals="-5" id="f-479" unitRef="usd">336400000</embc:RevenueFromContractWithCustomerSalesDeductionsRecognized>
    <embc:RevenueFromContractWithCustomerSalesDeductionsRecognized contextRef="c-5" decimals="-5" id="f-480" unitRef="usd">298700000</embc:RevenueFromContractWithCustomerSalesDeductionsRecognized>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-7" decimals="-5" id="f-481" unitRef="usd">1200000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-6" decimals="-5" id="f-482" unitRef="usd">1200000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-483">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 9 &#x2014; Segment and Geographical Data &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating segments are identified as components of an enterprise in which discrete financial information is available for evaluation by the CODM in making decisions regarding assessing business performance and allocating resources and capital. Management has concluded that the Company operates in one segment based upon the information used by the CODM in evaluating the performance of the Company&#x2019;s business and allocating resources and capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Disaggregation of Revenues &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has distribution agreements with regional or national distributors (including wholesalers and medical suppliers) to ensure broad availability of its products as well as a direct sales force in certain countries and regions around the world. In the United States and Canada, the Company utilizes its large and small key account managers that call on payers, retailers, wholesalers and institutional customers, and field-based territory managers that call on health care providers and pharmacies. In certain markets within Europe, the Company has dedicated sales representatives and in certain regions of the Middle East and Africa, the Company has distribution agreements. In Asia, the Company has distribution agreements and in China, the Company relies on its own commercial team to support sales execution. In Latin America, the Company maintains distribution agreements and direct sales representatives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company disaggregates its revenue by geography as management believes this category best depicts how the nature, amount, and timing of revenues and cash flows are affected by economic factors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Revenues by geographic region are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.994%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Year ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;601.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;600.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;609.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;519.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;529.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;555.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,120.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,129.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,165.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;For the years ended September&#160;30, 2023, 2022, and 2021 no individual country outside of the United States generated net revenues that represented more than 10.0% of total revenues.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-484"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c-1" id="f-485">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Revenues by geographic region are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.994%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Year ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;601.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;600.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;609.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;519.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;529.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;555.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,120.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,129.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,165.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;For the years ended September&#160;30, 2023, 2022, and 2021 no individual country outside of the United States generated net revenues that represented more than 10.0% of total revenues.</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-74" decimals="-5" id="f-486" unitRef="usd">601400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-75" decimals="-5" id="f-487" unitRef="usd">600300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-76" decimals="-5" id="f-488" unitRef="usd">609400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-77" decimals="-5" id="f-489" unitRef="usd">519400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-78" decimals="-5" id="f-490" unitRef="usd">529200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-79" decimals="-5" id="f-491" unitRef="usd">555900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-492" unitRef="usd">1120800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-5" id="f-493" unitRef="usd">1129500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-5" id="f-494" unitRef="usd">1165300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-495">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 10 &#x2014; Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Periods Prior to Separation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation, certain of the Company's employees participated in stock-based compensation plans sponsored by BD. Under these plans BD granted time-vested restricted stock units ("TVUs"), stock appreciation rights ("SARs"), and performance share units ("PSUs") to certain management level employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation on April 1, 2022, share-based compensation expense in the Consolidated Statements of Income is representative of those employees who were dedicated to the Diabetes Care Business. Additionally, share-based compensation expense was allocated to the Diabetes Care Business for BD Corporate and Medical Segment employees who were not dedicated solely to the Diabetes Care Business. This stock-based compensation expense was allocated using a proportional cost allocation method and is included as a component of corporate allocations for periods prior to the Separation. The amounts presented for the periods prior to the Separation are not necessarily indicative of future awards and do not necessarily reflect the costs that the Company would have incurred as an independent company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;As of Separation Date and Periods Post Separation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the Separation, and in accordance with the EMA, Embecta's employees with outstanding former BD share-based awards received replacement share-based awards under the Plan. The ratio used to convert the BD share-based awards was designed to preserve the aggregate intrinsic value of the award immediately after the Separation when compared to the aggregate intrinsic value of the award immediately prior to Separation. As a result of the award modification, Embecta will incur $6.1&#160;million of incremental stock-based compensation expense. Of this amount, $1.8&#160;million and $2.3&#160;million was recognized during the year ended September 30, 2023 and 2022, respectively. $2.0&#160;million will be recognized at a future date over the awards' remaining vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Effective April 1, 2022, Embecta established the Plan. A total of 7,000,000 shares of common stock are authorized under the Plan. The Plan provides for the grant of various types of awards including RSU awards, SARs, stock options, performance-based awards and other stock-based awards. Under the Plan, the exercise price of awards, if any, is set on the grant date and may not be less than the fair market value per share on that date. Generally SARs have a term of ten years and a &lt;span style="-sec-ix-hidden:f-502"&gt;three&lt;/span&gt; or four year vesting period, subject to limited exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company recognizes stock-based compensation cost only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants. The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2022, Embecta granted 48,192 potential shares to non-employee directors in the form of RSUs, which vest at the earlier of (i) the first anniversary of the grant date or (ii) the date of the first annual meeting of stockholders, subject to continued service of the recipients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 4, 2022 and in connection with the Separation, Embecta granted 860,611 of potential shares to members of the Embecta leadership team as a one-time sign-on equity grant, subject to continued employment, comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;172,787 grants of time-vested RSUs which cliff vest on the third anniversary after grant date;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;528,167 grants of SARs which cliff vest on the third anniversary after grant date and;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;27,653 of TVUs and 132,004 of SARs granted to the Embecta's chief executive officer which vest evenly over &lt;span style="-sec-ix-hidden:f-510"&gt;three&lt;/span&gt; and four years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Stock-Based Compensation Expense &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total direct and allocated stock-based compensation expense for the years ended September&#160;30, 2023, 2022, and 2021 and the respective income tax benefits recognized by the Company in the Consolidated Statements of Income are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Stock-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Tax benefit associated with stock-based compensation costs recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the Company's total stock-based compensation expense by classification of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.131%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.033%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.033%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.559%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Equity Awards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Liability Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the Company's total stock-based compensation expense by award type for the years ended September&#160;30, 2023 and 2022, subsequent to the Separation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.024%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.033%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Time-Vested Restricted Stock Units (TVUs)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Performance-Based Restricted Stock Units (PSUs)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Stock Appreciation Rights (SARs)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Time Vested Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the year&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; ended September 30, 2023&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, Embecta granted 680,281 RSUs in the form of TVUs to employees which vest ratably over three years, subject to continued employment of the recipients. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;TVUs vest on a graded basis over a period of three years. The related stock-based compensation expense is recorded over the requisite service period, which is the vesting period or is based on retirement eligibility. The fair value of all TVUs is based on the market value of the Company&#x2019;s stock on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A summary of TVUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Stock Units (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Nonvested at October 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;977.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;28.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;680.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;31.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Distributed*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(386.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;28.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Nonvested at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected to vest at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,134.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;*The amounts distributed include shares withheld for taxes that are not formally issued to the market.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The weighted average grant date fair value of TVUs granted during the years 2023 and 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.163%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average grant date fair value of units granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The total fair value of TVUs vested during the years 2023 and 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total fair value of units vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;At September 30, 2023, the weighted average remaining vesting term of TVUs is 1.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Performance Based Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the year&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; ended September 30, 2023&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, Embecta awarded 244,192 RSUs in the form of PSUs to certain executive officers and employees which vest after three years, subject to continued employment of the recipients and the achievement of certain performance metric targets. For a portion of these awards, the Company has identified certain performance metrics and targets that will be fully established at a future date. The Company has determined that the service inception date precedes the grant date for these awards as (a) the awards were authorized prior to establishing an accounting grant date, (b) the recipients began providing services prior to the grant date, and (c) there are performance conditions that, if not met by the accounting grant date, will result in the forfeiture of the awards. As the service inception date precedes the accounting grant date, the Company recognizes stock-based compensation expense for each separately-vesting tranche over the requisite service period based on the fair value at each reporting date. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;PSUs cliff vest on the third anniversary after grant date. The related stock-based compensation expense is recorded over the requisite service period, which is the vesting period or is based on retirement eligibility. The fair value of all PSUs is based on the market value of the Company&#x2019;s stock on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A summary of PSUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Stock Units (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Nonvested at October 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Distributed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Nonvested at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected to vest at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The weighted average grant date fair value of PSUs granted during 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average grant date fair value of units granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;At September 30, 2023, the weighted average remaining vesting term of PSUs is 2.2 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Stock Appreciation Rights&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;SARs represent the right to receive, upon exercise, shares of common stock having a value equal to the difference between the market price of common stock on the date of exercise and the exercise price on the date of grant. SARs generally vest over a period of &lt;span style="-sec-ix-hidden:f-583"&gt;three&lt;/span&gt; to four years and have a term of ten years. The fair value of awards are estimated on the date of grant using a Black-Scholes-Merton (&#x201c;BSM&#x201d;) model. The BSM assumptions include expected dividend yield, risk-free interest rate, volatility, and term of the SARs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the SARs granted during 2022, the Company used the BSM to determine the fair value of the SARs as of the grant date. In applying this model, the Company uses both historical data and current market data to estimate the fair value of its SARs. The expected dividend yield is based on forecasted patterns of dividend payments. The risk-free interest rate is based on the rate at grant date of zero-coupon United States Treasury Notes with a term equal to the expected term of the SAR. Expected volatility is estimated using historical volatility. Due to the lack of trading history of Embecta's stock at the time of valuation efforts, the historical component of expected volatility is based on historical monthly price changes of the peer group within the industry. BD's historical data for Embecta employees was used to estimate equity award exercise and employee termination behavior within the valuation model. The expected term represents the amount of time that SARs granted are expected to be outstanding based on historical and forecasted exercise behavior. The weighted average fair value of SARs was determined using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:89.809%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.991%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Fair value per SAR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A summary of SARs outstanding as of September 30, 2023 and changes and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;SARs (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Aggregate Intrinsic Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at October 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,916.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;28.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercised*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(25.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(59.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,831.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Vested and expected to vest at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,740.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercisable at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;179.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;26.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;*The amounts exercised include shares withheld for taxes that are not formally issued to the market.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A summary of SARs exercised during the years 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total intrinsic value of SARs exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total fair value of SARs exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Unrecognized Compensation Expense and Other Stock Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amount of unrecognized compensation expense for all non-vested stock-based awards as of September 30, 2023, is approximately $28.2&#160;million, which is expected to be recognized over a weighted-average remaining life of approximately 1.8 years. At September 30, 2023, 3.4&#160;million shares were authorized for future grants under the Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost contextRef="c-80" decimals="-5" id="f-496" unitRef="usd">6100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <embc:ShareBasedPaymentArrangementPlanModificationExpenseRecognized contextRef="c-81" decimals="-5" id="f-497" unitRef="usd">1800000</embc:ShareBasedPaymentArrangementPlanModificationExpenseRecognized>
    <embc:ShareBasedPaymentArrangementPlanModificationExpenseRecognized contextRef="c-82" decimals="-5" id="f-498" unitRef="usd">2300000</embc:ShareBasedPaymentArrangementPlanModificationExpenseRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-83" decimals="-5" id="f-499" unitRef="usd">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-84"
      decimals="INF"
      id="f-500"
      unitRef="shares">7000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-85" id="f-501">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-87" id="f-503">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-88"
      decimals="INF"
      id="f-504"
      unitRef="shares">48192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-89"
      decimals="INF"
      id="f-505"
      unitRef="shares">860611</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-90"
      decimals="INF"
      id="f-506"
      unitRef="shares">172787</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-91"
      decimals="INF"
      id="f-507"
      unitRef="shares">528167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-92"
      decimals="INF"
      id="f-508"
      unitRef="shares">27653</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-93"
      decimals="INF"
      id="f-509"
      unitRef="shares">132004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-93" id="f-511">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-512">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total direct and allocated stock-based compensation expense for the years ended September&#160;30, 2023, 2022, and 2021 and the respective income tax benefits recognized by the Company in the Consolidated Statements of Income are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Selling and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Stock-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Tax benefit associated with stock-based compensation costs recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the Company's total stock-based compensation expense by classification of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.131%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.033%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.033%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.559%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Equity Awards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Liability Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes the Company's total stock-based compensation expense by award type for the years ended September&#160;30, 2023 and 2022, subsequent to the Separation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.024%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.033%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Time-Vested Restricted Stock Units (TVUs)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Performance-Based Restricted Stock Units (PSUs)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Stock Appreciation Rights (SARs)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-94" decimals="-5" id="f-513" unitRef="usd">2200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-62" decimals="-5" id="f-514" unitRef="usd">2300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-63" decimals="-5" id="f-515" unitRef="usd">2700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-95" decimals="-5" id="f-516" unitRef="usd">18100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-64" decimals="-5" id="f-517" unitRef="usd">14600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-65" decimals="-5" id="f-518" unitRef="usd">7800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-96" decimals="-5" id="f-519" unitRef="usd">1600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-66" decimals="-5" id="f-520" unitRef="usd">1800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-67" decimals="-5" id="f-521" unitRef="usd">2300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-522" unitRef="usd">21900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-4" decimals="-5" id="f-523" unitRef="usd">18700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-5" id="f-524" unitRef="usd">12800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-1" decimals="-5" id="f-525" unitRef="usd">2700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-4" decimals="-5" id="f-526" unitRef="usd">2900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-5" decimals="-5" id="f-527" unitRef="usd">2800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-97" decimals="-5" id="f-528" unitRef="usd">21500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-98" decimals="-5" id="f-529" unitRef="usd">18700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-99" decimals="-5" id="f-530" unitRef="usd">12800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-100" decimals="-5" id="f-531" unitRef="usd">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-101" decimals="-5" id="f-532" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-102" decimals="-5" id="f-533" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-534" unitRef="usd">21900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-4" decimals="-5" id="f-535" unitRef="usd">18700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-5" id="f-536" unitRef="usd">12800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-103" decimals="-5" id="f-537" unitRef="usd">16200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-104" decimals="-5" id="f-538" unitRef="usd">6600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-105" decimals="-5" id="f-539" unitRef="usd">1000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-106" decimals="-5" id="f-540" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-107" decimals="-5" id="f-541" unitRef="usd">4700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-108" decimals="-5" id="f-542" unitRef="usd">3700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-543" unitRef="usd">21900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-109" decimals="-5" id="f-544" unitRef="usd">10300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-103"
      decimals="INF"
      id="f-545"
      unitRef="shares">680281</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-103" id="f-546">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-103" id="f-547">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock contextRef="c-1" id="f-548">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A summary of TVUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Stock Units (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Nonvested at October 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;977.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;28.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;680.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;31.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Distributed*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(386.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;28.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Nonvested at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected to vest at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,134.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;*The amounts distributed include shares withheld for taxes that are not formally issued to the market.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The weighted average grant date fair value of TVUs granted during the years 2023 and 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.163%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average grant date fair value of units granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The total fair value of TVUs vested during the years 2023 and 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total fair value of units vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-110"
      decimals="-2"
      id="f-549"
      unitRef="shares">977500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-110"
      decimals="2"
      id="f-550"
      unitRef="usdPerShare">28.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-103"
      decimals="-2"
      id="f-551"
      unitRef="shares">680300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-103"
      decimals="2"
      id="f-552"
      unitRef="usdPerShare">31.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-103"
      decimals="-2"
      id="f-553"
      unitRef="shares">386600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-103"
      decimals="2"
      id="f-554"
      unitRef="usdPerShare">28.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-103"
      decimals="-2"
      id="f-555"
      unitRef="shares">82400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-103"
      decimals="2"
      id="f-556"
      unitRef="usdPerShare">29.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-111"
      decimals="-2"
      id="f-557"
      unitRef="shares">1188800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-111"
      decimals="2"
      id="f-558"
      unitRef="usdPerShare">29.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber
      contextRef="c-111"
      decimals="-2"
      id="f-559"
      unitRef="shares">1134600</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue
      contextRef="c-111"
      decimals="2"
      id="f-560"
      unitRef="usdPerShare">29.39</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-103"
      decimals="2"
      id="f-561"
      unitRef="usdPerShare">31.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-112"
      decimals="2"
      id="f-562"
      unitRef="usdPerShare">31.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-103" decimals="-5" id="f-563" unitRef="usd">10900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-112" decimals="-5" id="f-564" unitRef="usd">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-103" id="f-565">P1Y6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-113"
      decimals="INF"
      id="f-566"
      unitRef="shares">244192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-113" id="f-567">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock contextRef="c-1" id="f-568">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A summary of PSUs outstanding as of September 30, 2023 and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:69.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.993%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Stock Units (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Nonvested at October 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Distributed&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Nonvested at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected to vest at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The weighted average grant date fair value of PSUs granted during 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.203%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average grant date fair value of units granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-114"
      decimals="-2"
      id="f-569"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-114"
      decimals="2"
      id="f-570"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-105"
      decimals="-2"
      id="f-571"
      unitRef="shares">61000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-105"
      decimals="2"
      id="f-572"
      unitRef="usdPerShare">30.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-105"
      decimals="-2"
      id="f-573"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-105"
      decimals="2"
      id="f-574"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-105"
      decimals="-2"
      id="f-575"
      unitRef="shares">3200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-105"
      decimals="2"
      id="f-576"
      unitRef="usdPerShare">30.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-115"
      decimals="-2"
      id="f-577"
      unitRef="shares">57800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-115"
      decimals="2"
      id="f-578"
      unitRef="usdPerShare">30.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber
      contextRef="c-115"
      decimals="-2"
      id="f-579"
      unitRef="shares">54600</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue
      contextRef="c-115"
      decimals="2"
      id="f-580"
      unitRef="usdPerShare">30.24</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-105"
      decimals="2"
      id="f-581"
      unitRef="usdPerShare">30.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-105" id="f-582">P2Y2M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-87" id="f-584">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-85" id="f-585">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <embc:ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-586">The weighted average fair value of SARs was determined using the following assumptions:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:89.809%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.991%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;37.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Fair value per SAR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</embc:ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-116" decimals="3" id="f-587" unitRef="number">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-116" decimals="3" id="f-588" unitRef="number">0.378</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-116" decimals="3" id="f-589" unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-116" id="f-590">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-117"
      decimals="2"
      id="f-591"
      unitRef="usdPerShare">9.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock contextRef="c-1" id="f-592">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A summary of SARs outstanding as of September 30, 2023 and changes and changes during the year then ended is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;SARs (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Aggregate Intrinsic Value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at October 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,916.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;28.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercised*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(25.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(59.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,831.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Vested and expected to vest at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,740.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;29.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercisable at September 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;179.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;26.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"&gt;*The amounts exercised include shares withheld for taxes that are not formally issued to the market.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A summary of SARs exercised during the years 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total intrinsic value of SARs exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total fair value of SARs exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-117"
      decimals="-2"
      id="f-593"
      unitRef="shares">1916700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="c-117"
      decimals="2"
      id="f-594"
      unitRef="usdPerShare">28.98</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-107"
      decimals="-2"
      id="f-595"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-107"
      decimals="2"
      id="f-596"
      unitRef="usdPerShare">0</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="c-107"
      decimals="-2"
      id="f-597"
      unitRef="shares">25100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-107"
      decimals="2"
      id="f-598"
      unitRef="usdPerShare">21.98</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
      contextRef="c-107"
      decimals="-2"
      id="f-599"
      unitRef="shares">59900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-107"
      decimals="2"
      id="f-600"
      unitRef="usdPerShare">29.53</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c-118"
      decimals="-2"
      id="f-601"
      unitRef="shares">1831700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="c-118"
      decimals="2"
      id="f-602"
      unitRef="usdPerShare">29.06</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-107" id="f-603">P7Y8M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="c-118" decimals="-5" id="f-604" unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-118"
      decimals="-2"
      id="f-605"
      unitRef="shares">1740800</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-118"
      decimals="2"
      id="f-606"
      unitRef="usdPerShare">29.05</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm contextRef="c-107" id="f-607">P7Y8M12D</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-118" decimals="-5" id="f-608" unitRef="usd">0</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="c-118"
      decimals="-2"
      id="f-609"
      unitRef="shares">179100</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
      contextRef="c-118"
      decimals="2"
      id="f-610"
      unitRef="usdPerShare">26.96</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm contextRef="c-107" id="f-611">P6Y3M18D</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue contextRef="c-118" decimals="-5" id="f-612" unitRef="usd">0</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue contextRef="c-107" decimals="-5" id="f-613" unitRef="usd">300000</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue contextRef="c-116" decimals="-5" id="f-614" unitRef="usd">100000</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue contextRef="c-107" decimals="-5" id="f-615" unitRef="usd">600000</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue>
    <embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue contextRef="c-116" decimals="-5" id="f-616" unitRef="usd">6100000</embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-6" decimals="-5" id="f-617" unitRef="usd">28200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-618">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-83" decimals="-5" id="f-619" unitRef="shares">3400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-623">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 11 &#x2014; Goodwill and Other Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Goodwill and Other Intangible Assets consisted of: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Patents &#x2013; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Patents &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Customer Relationships and Other &#x2013; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Customer Relationships and Other &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Intangible asset amortization expense was $1.2&#160;million for the year ended September 30, 2023, $0.7&#160;million for the year ended September 30, 2022 and $0.3&#160;million for the year ended September 30, 2021, respectively. The estimated intangible asset amortization expense for each of the fiscal years ended September 30, 2024 through 2028 is expected to approximate $1.1&#160;million per year and $3.6&#160;million for years subsequent thereafter.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="c-1" id="f-624">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Goodwill and Other Intangible Assets consisted of: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.873%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Patents &#x2013; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Patents &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Customer Relationships and Other &#x2013; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Customer Relationships and Other &#x2013; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Goodwill and Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-120" id="f-625">P12Y2M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-48" decimals="-5" id="f-626" unitRef="usd">10600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-121" decimals="-5" id="f-627" unitRef="usd">9400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-48" decimals="-5" id="f-628" unitRef="usd">4500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-121" decimals="-5" id="f-629" unitRef="usd">3900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-48" decimals="-5" id="f-630" unitRef="usd">6100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-121" decimals="-5" id="f-631" unitRef="usd">5500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-122" id="f-632">P5Y9M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-123" decimals="-5" id="f-633" unitRef="usd">5400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-124" decimals="-5" id="f-634" unitRef="usd">5200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-123" decimals="-5" id="f-635" unitRef="usd">2400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-124" decimals="-5" id="f-636" unitRef="usd">1800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-123" decimals="-5" id="f-637" unitRef="usd">3000000.0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-124" decimals="-5" id="f-638" unitRef="usd">3400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-6" decimals="-5" id="f-639" unitRef="usd">9100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-7" decimals="-5" id="f-640" unitRef="usd">8900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill contextRef="c-6" decimals="-5" id="f-641" unitRef="usd">15600000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-7" decimals="-5" id="f-642" unitRef="usd">15700000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-6" decimals="-5" id="f-643" unitRef="usd">24700000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="c-7" decimals="-5" id="f-644" unitRef="usd">24600000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-645" unitRef="usd">1200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-4" decimals="-5" id="f-646" unitRef="usd">700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-5" decimals="-5" id="f-647" unitRef="usd">300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-6" decimals="-5" id="f-648" unitRef="usd">1100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-6" decimals="-5" id="f-649" unitRef="usd">1100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-6" decimals="-5" id="f-650" unitRef="usd">1100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-6" decimals="-5" id="f-651" unitRef="usd">1100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-6" decimals="-5" id="f-652" unitRef="usd">1100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-6" decimals="-5" id="f-653" unitRef="usd">3600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:LongTermDebtTextBlock contextRef="c-1" id="f-654">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 12 &#x2014; Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;5.00% Senior Secured Notes due 2030&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On February 10, 2022 Embecta issued $500.0&#160;million aggregate principal amount of 5.00% senior secured notes due February 15, 2030 (the &#x201c;5.00% Notes&#x201d;). &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Interest payments on the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00%&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Notes are due semi-annually in February and August until maturity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;6.75% Senior Secured Notes due 2030&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On March 31, 2022, Embecta issued $200.0&#160;million of 6.75% Related Party Notes at a discount of $3.0&#160;million. &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Related Party Notes issued to BD were not issued for cash and instead were subject to a debt-for-debt exchange which occurred on April 1, 2022. As such, the issuance of the Related Party Notes is a non-cash financing activity and is not presented in the Consolidated Statements of Cash Flows for the year ended September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2022, BD transferred the Related Party Notes with a notional value of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$200.0&#160;million&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; issued by Embecta to Morgan Stanley in exchange for certain notes of BD that were purchased by Morgan Stanley pursuant to a tender offer. Morgan Stanley then sold the senior secured notes to qualified institutional buyers in the United States pursuant to Rule 144A under the Securities Act of 1933, as amended. As of April 1, 2022, the 6.75%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;senior secured notes (the "6.75%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Notes")&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; became third party debt of Embecta. Interest payments on the 6.75% Notes are due semi-annually in February and August until maturity. The 6.75% Notes will mature on February 15, 2030.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On March 31, 2022, Embecta entered into a credit agreement (the &#x201c;Credit Agreement&#x201d;), providing for: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:28pt"&gt;a Term Loan B Facility (the "Term Loan") in the amount of $950.0&#160;million, with a &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;seven&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;-year &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;term that matures in March 2029. The interest rate is 300 basis points over the secured overnight financing rate (&#x201c;SOFR&#x201d;), with a 0.50% SOFR floor. The Term Loan was issued at a discount of 0.50%. Principal and interest payments on the Term Loan commenced on June 30, 2022. Such quarterly principal payments are calculated as 0.25% of the initial principal amount, with the remaining balance payable upon maturity;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:49.5pt;text-align:justify;text-indent:-31.5pt"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:28pt"&gt;a Revolving Credit Facility (the "Revolving Credit Facility") in an aggregate principal amount of up to $500.0&#160;million, with a &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;five&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;-year term that matures in 2027. &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Borrowings under the Revolving Credit Facility bear interest, at Embecta&#x2019;s option, at an annual rate equal to (a) in the case of loans denominated in United States dollars (i) the SOFR or (ii) the alternate base rate or (b) in the case of loans denominated in Euros, the EURIBOR rate, in each case plus an applicable margin specified in the credit agreement. A commitment fee applies to the unused portion of the Revolving Credit Facility, equal to 0.25% per annum. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of September&#160;30, 2023, no amount has been drawn on the Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The credit agreement and the senior secured notes are secured by substantially all assets of Embecta and each subsidiary guarantor, subject to certain exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Credit Agreement and the indentures for Embecta's outstanding 5.00% Notes and 6.75% Notes contain customary financial covenants, including a total net leverage ratio covenant, which measures the ratio of (i) consolidated total net debt to (ii) consolidated earnings before interest, taxes, depreciation and amortization, and subject to other adjustments, must meet certain defined limits which are tested on a quarterly basis in accordance with the terms of the Credit Agreement and the 5.00% Notes and &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.75%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Notes. In addition, the Credit Agreement contains covenants that will limit, among other things, Embecta&#x2019;s ability to prepay, redeem or repurchase its subordinated and junior lien debt, incur additional debt, make acquisitions, merge with other entities, pay dividends or distributions, redeem or repurchase equity interests, and create or become subject to liens. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following is a summary of Embecta's total debt outstanding as of September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.809%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.991%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Term Loan due March 2029&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;935.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-align:justify;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.00% Notes due February 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;500.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-top:6pt;padding-left:10pt;text-align:justify;text-indent:-10pt"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.75%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt; Notes due February 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;200.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total principal debt issued&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,635.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(9.5)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: debt issuance costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(32.4)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,593.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The debt issuance costs on the Term Loan, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00%&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Notes, 6.75%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; Notes &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;and the discount on the Term Loan are reported in the Consolidated Balance Sheets as a reduction of debt and are amortized as a component of &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Interest expense, net&lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; over the term of the related debt using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The schedule of principal payments required on long-term debt for the next five fiscal years and thereafter is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:88.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.916%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,588.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The estimated fair value of long-term debt (including current portion) at September&#160;30, 2023 was $1,474.2&#160;million compared with a carrying value (which includes a reduction for unamortized debt issuance costs and discounts) of $1,603.4&#160;million. Fair value was estimated using inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability and would be considered Level 2 in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-125"
      decimals="INF"
      id="f-655"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-125" decimals="-5" id="f-656" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-125"
      decimals="INF"
      id="f-657"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-125"
      decimals="INF"
      id="f-658"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-125"
      decimals="INF"
      id="f-659"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-126"
      decimals="INF"
      id="f-660"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-72" decimals="-5" id="f-661" unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-72"
      decimals="INF"
      id="f-662"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <embc:DebtInstrumentDiscountGross contextRef="c-72" decimals="-5" id="f-663" unitRef="usd">3000000</embc:DebtInstrumentDiscountGross>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-127" decimals="-5" id="f-664" unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-126"
      decimals="INF"
      id="f-665"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-126"
      decimals="INF"
      id="f-666"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-126"
      decimals="INF"
      id="f-667"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-126"
      decimals="INF"
      id="f-668"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-128" decimals="-5" id="f-669" unitRef="usd">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm contextRef="c-129" id="f-670">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-130"
      decimals="INF"
      id="f-671"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <embc:DebtInstrumentVariableRateFloor
      contextRef="c-130"
      decimals="INF"
      id="f-672"
      unitRef="number">0.0050</embc:DebtInstrumentVariableRateFloor>
    <embc:DebtInstrumentDiscountPercentage contextRef="c-128" decimals="4" id="f-673" unitRef="number">0.0050</embc:DebtInstrumentDiscountPercentage>
    <embc:DebtInstrumentPeriodicPaymentPrincipalPercentage
      contextRef="c-129"
      decimals="INF"
      id="f-674"
      unitRef="number">0.0025</embc:DebtInstrumentPeriodicPaymentPrincipalPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-131" decimals="-5" id="f-675" unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-132" id="f-676">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-132"
      decimals="INF"
      id="f-677"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCredit contextRef="c-133" decimals="INF" id="f-678" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-125"
      decimals="INF"
      id="f-679"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-126"
      decimals="INF"
      id="f-680"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-125"
      decimals="INF"
      id="f-681"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-126"
      decimals="INF"
      id="f-682"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-683">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following is a summary of Embecta's total debt outstanding as of September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.809%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.991%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Term Loan due March 2029&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;935.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-align:justify;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.00% Notes due February 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;500.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-top:6pt;padding-left:10pt;text-align:justify;text-indent:-10pt"&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.75%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt; Notes due February 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;200.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total principal debt issued&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,635.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(9.5)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: debt issuance costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(32.4)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,593.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-134" decimals="-5" id="f-684" unitRef="usd">935800000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-135"
      decimals="INF"
      id="f-685"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-135" decimals="-5" id="f-686" unitRef="usd">500000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-136"
      decimals="INF"
      id="f-687"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-136" decimals="-5" id="f-688" unitRef="usd">200000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-6" decimals="-5" id="f-689" unitRef="usd">1635800000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent contextRef="c-6" decimals="-5" id="f-690" unitRef="usd">9500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-6" decimals="-5" id="f-691" unitRef="usd">32400000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-6" decimals="-5" id="f-692" unitRef="usd">1593900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-125"
      decimals="INF"
      id="f-693"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-126"
      decimals="INF"
      id="f-694"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-695">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The schedule of principal payments required on long-term debt for the next five fiscal years and thereafter is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:88.884%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.916%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,588.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-6" decimals="-5" id="f-696" unitRef="usd">9500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-6" decimals="-5" id="f-697" unitRef="usd">9500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-6" decimals="-5" id="f-698" unitRef="usd">9500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-6" decimals="-5" id="f-699" unitRef="usd">9500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="c-6" decimals="-5" id="f-700" unitRef="usd">9500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive contextRef="c-6" decimals="-5" id="f-701" unitRef="usd">1588300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LongTermDebtFairValue contextRef="c-137" decimals="-5" id="f-702" unitRef="usd">1474200000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-138" decimals="-5" id="f-703" unitRef="usd">1603400000</us-gaap:LongTermDebtFairValue>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-704">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 13 &#x2014; Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2022, the date of the Separation, 57,012,925 shares of Embecta's common stock, par value $0.01 per share, were distributed to BD shareholders of record as of March 22, 2022, the record date of the distribution. This share amount is utilized for the calculation of earnings per basic and diluted common share for all periods presented prior to the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In connection with the Separation, and in accordance with the EMA, Embecta's employees with outstanding former BD share-based awards received replacement share-based awards under the Plan. The ratio used to convert the BD share-based awards was designed to preserve the aggregate intrinsic value of the award immediately after the Separation when compared to the aggregate intrinsic value of the award immediately prior to the Separation (see Note 10 for additional details).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The calculation of earnings per basic and diluted common share for the &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;years ended September 30, 2023, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.399%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in millions and shares in thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Income attributable to Embecta&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;70.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;414.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic weighted average number of shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,248&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,013&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock awards and equity units (share equivalent)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;510&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,758&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,461&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,013&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings per common share - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings per common share - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For periods prior to the Separation, it is assumed that there were no dilutive equity instruments as there were no equity awards of Embecta outstanding prior to the Separation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For periods subsequent to the Separation, diluted earnings per share is computed by giving effect to all potentially dilutive stock awards that are outstanding. The computation of earnings per diluted share excludes the effect of the potential exercise of stock-based awards, when the effect of the potential exercise would be anti-dilutive. For both 2023 and 2022, 1.8&#160;million of dilutive share equivalents issuable under stock-based compensation plans were excluded from the diluted shares outstanding calculation because the result would have been antidilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-36"
      decimals="INF"
      id="f-705"
      unitRef="shares">57012925</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-34"
      decimals="INF"
      id="f-706"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-707">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The calculation of earnings per basic and diluted common share for the &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;years ended September 30, 2023, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:68.399%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.463%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in millions and shares in thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net Income attributable to Embecta&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;70.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;414.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic weighted average number of shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,248&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,013&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock awards and equity units (share equivalent)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;510&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,758&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,461&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;57,013&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings per common share - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings per common share - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-708" unitRef="usd">70400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-709" unitRef="usd">223600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-710" unitRef="usd">414800000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-711" unitRef="shares">57248000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-4" decimals="-3" id="f-712" unitRef="shares">57024000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-3" id="f-713" unitRef="shares">57013000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-3" id="f-714" unitRef="shares">510000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-4" decimals="-3" id="f-715" unitRef="shares">437000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-5" decimals="-3" id="f-716" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-717" unitRef="shares">57758000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-4" decimals="-3" id="f-718" unitRef="shares">57461000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-3" id="f-719" unitRef="shares">57013000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-720"
      unitRef="usdPerShare">1.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-4"
      decimals="2"
      id="f-721"
      unitRef="usdPerShare">3.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-722"
      unitRef="usdPerShare">7.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-723"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-4"
      decimals="2"
      id="f-724"
      unitRef="usdPerShare">3.89</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-725"
      unitRef="usdPerShare">7.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-4" decimals="-5" id="f-726" unitRef="shares">1800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-5" id="f-727" unitRef="shares">1800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-728">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 14 &#x2014; Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Income (Loss) Before Income Taxe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;s&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income Before Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; for the years ended September 30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;494.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Provision (benefit) for Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The provision (benefit) for income taxes for the years ended September 30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's income tax provision for the first half of 2022 and the year ended September 30, 2021 were prepared using a separate return method. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if the Company was a separate taxpayer and a standalone enterprise. The Company believes the assumptions supporting the allocation and presentation of income taxes on a separate return basis are reasonable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For a portion of fiscal year 2022 and all periods prior to the Separation, the Company&#x2019;s domestic and foreign operations were included in BD&#x2019;s domestic consolidated and foreign tax returns, and payments to all tax authorities were made by BD on the Company&#x2019;s behalf. The Company filed its own foreign tax return and made its own foreign tax payments in Ireland. The Company&#x2019;s current tax liabilities computed under the separate return method were considered to be effectively settled in the consolidated financial statements at the time the transaction was recorded, with the offset recorded against Net parent investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Tax Rate Reconciliation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A reconciliation of federal statutory tax rate to the Company's effective income tax rate was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US tax on foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes on unremitted foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nontaxable items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The increase in the Company's effective income tax rate for fiscal year 2023 as compared to fiscal year 2022 was primarily due to the establishment of a valuation allowance against interest expense carryforwards in the U.S., an increase in U.S. tax on foreign earnings primarily because of limitations on the utilization of foreign tax credits and higher withholding taxes on unremitted foreign earnings; partially offset by increased tax benefits from non-taxable items and change in geographical mix of earnings.  For fiscal year 2023, the Other, net included a tax benefit for the establishment of net deferred tax assets incurred in connection with the ongoing separation of the Diabetes Care Business from BD, partially offset by a return to provision adjustment from the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The decrease in the Company's effective income tax rate for fiscal year 2022 as compared to fiscal year 2021 was primarily due to the change in geographical mix of earnings and favorable unrecognized tax benefits recorded in fiscal year 2022; partially offset by tax expense that have been provided on undistributed earnings of foreign subsidiaries.    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Deferred income taxes at September 30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.839%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes on unremitted foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets (liabilities) (i)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt"&gt;Net deferred tax assets are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and net deferred tax liabilities are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Deferred tax assets and liabilities are netted in the Consolidated Balance Sheets by separate tax jurisdictions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of September 30, 2023 and September 30, 2022, the Company has recorded deferred taxes on undistributed earnings of foreign subsidiaries.  The vast majority of these taxes were accrued, in part, because the Company does not meet certain holding period requirements for stock ownership.  During fiscal year 2024, the Company anticipates that it will meet these requirements at which time approximately $18.0&#160;million of the accrued balance as of September 30, 2023 will be recorded as a reduction to income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of September 30, 2023 the Company has recorded valuation allowances of $31.6&#160;million due to the uncertainty that exists regarding future realizability of certain deferred tax assets primarily for interest expense carryforwards in the U.S. related to limitations on the annual deductibility of such interest, state net operating losses, state tax credits and deferred tax assets related to certain foreign manufacturing operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of September 30, 2022, the Company has recorded valuation allowances of $10.4&#160;million for deferred tax assets related to certain foreign manufacturing operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The approximate tax reduction related to a tax holiday in Switzerland in which the Company does business is $2.1&#160;million and $0.04 impact on diluted earnings per share in fiscal year 2023. The tax holiday will expire in 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Tax loss and credit carryforwards consist of approximately $1.0&#160;million of state income tax credit carryforwards and $5.6&#160;million net operating loss carryforwards in various jurisdictions.  Approximately $1.0&#160;million of net operating loss carryforwards will not expire and the remaining carryforwards expire in varying amounts from 2028 through 2042.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at October 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase due to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase due to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease due to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease due to settlements with tax authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease due to lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits including interest and penalties that would affect the effective tax rate if recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For a portion of fiscal year 2022 and all periods prior to the Separation, the Company&#x2019;s domestic and foreign operations were included in BD&#x2019;s domestic consolidated and foreign tax returns, with the exception of Ireland.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company conducts business and files tax returns in numerous countries and currently has no tax audits in progress for the period after the Separation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following were included for the years ended September 30 as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income tax provision&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Consolidated Statements of Income and the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest and penalties expense (benefit) associated with unrecognized tax benefits on the Consolidated Statements of Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest and penalties associated with unrecognized tax benefits on the Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-729">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income Before Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; for the years ended September 30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;285.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;256.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;494.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-5" id="f-730" unitRef="usd">-100900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-4" decimals="-5" id="f-731" unitRef="usd">-29100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-5" decimals="-5" id="f-732" unitRef="usd">87500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-5" id="f-733" unitRef="usd">206600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-4" decimals="-5" id="f-734" unitRef="usd">285700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-5" decimals="-5" id="f-735" unitRef="usd">407400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-736" unitRef="usd">105700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-4" decimals="-5" id="f-737" unitRef="usd">256600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-738" unitRef="usd">494900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-739">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The provision (benefit) for income taxes for the years ended September 30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following were included for the years ended September 30 as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income tax provision&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Consolidated Statements of Income and the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest and penalties expense (benefit) associated with unrecognized tax benefits on the Consolidated Statements of Income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest and penalties associated with unrecognized tax benefits on the Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-740" unitRef="usd">2600000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-741" unitRef="usd">20400000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-742" unitRef="usd">19200000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-743" unitRef="usd">-800000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-744" unitRef="usd">3400000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-745" unitRef="usd">4300000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-746" unitRef="usd">19200000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-747" unitRef="usd">35700000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-748" unitRef="usd">59400000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-749" unitRef="usd">21000000.0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-750" unitRef="usd">59500000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-751" unitRef="usd">82900000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-752" unitRef="usd">5900000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-753" unitRef="usd">-31100000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-754" unitRef="usd">-1300000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-755" unitRef="usd">700000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-756" unitRef="usd">-4600000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-757" unitRef="usd">-300000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-758" unitRef="usd">7700000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-759" unitRef="usd">9200000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-760" unitRef="usd">-1200000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-761" unitRef="usd">14300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-762" unitRef="usd">-26500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-763" unitRef="usd">-2800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-764" unitRef="usd">35300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-4" decimals="-5" id="f-765" unitRef="usd">33000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-5" id="f-766" unitRef="usd">80100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-767">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;A reconciliation of federal statutory tax rate to the Company's effective income tax rate was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US tax on foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes on unremitted foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nontaxable items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Nondeductible compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="INF" id="f-768" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-4" decimals="INF" id="f-769" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-5" decimals="INF" id="f-770" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-771" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-4" decimals="3" id="f-772" unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-5" decimals="3" id="f-773" unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="3" id="f-774" unitRef="number">-0.173</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-4" decimals="3" id="f-775" unitRef="number">-0.070</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c-5" decimals="3" id="f-776" unitRef="number">-0.061</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings contextRef="c-1" decimals="3" id="f-777" unitRef="number">0.125</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings contextRef="c-4" decimals="3" id="f-778" unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings contextRef="c-5" decimals="3" id="f-779" unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <embc:EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent contextRef="c-1" decimals="3" id="f-780" unitRef="number">0.111</embc:EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent>
    <embc:EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent contextRef="c-4" decimals="3" id="f-781" unitRef="number">0.032</embc:EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent>
    <embc:EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent contextRef="c-5" decimals="3" id="f-782" unitRef="number">0</embc:EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies contextRef="c-1" decimals="3" id="f-783" unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies contextRef="c-4" decimals="3" id="f-784" unitRef="number">-0.018</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies contextRef="c-5" decimals="3" id="f-785" unitRef="number">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="3" id="f-786" unitRef="number">0.140</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="3" id="f-787" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="3" id="f-788" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="c-1" decimals="3" id="f-789" unitRef="number">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="c-4" decimals="3" id="f-790" unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="c-5" decimals="3" id="f-791" unitRef="number">0.004</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="c-1" decimals="3" id="f-792" unitRef="number">0.086</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="c-4" decimals="3" id="f-793" unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome contextRef="c-5" decimals="3" id="f-794" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxExemptIncome>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="INF" id="f-795" unitRef="number">0.025</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-4" decimals="INF" id="f-796" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-5" decimals="INF" id="f-797" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-1" decimals="3" id="f-798" unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-4" decimals="3" id="f-799" unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-5" decimals="3" id="f-800" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-801" unitRef="number">0.334</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-4" decimals="3" id="f-802" unitRef="number">0.129</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-5" decimals="3" id="f-803" unitRef="number">0.162</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-804">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Deferred income taxes at September 30 consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.839%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes on unremitted foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets (liabilities) (i)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.73pt"&gt;Net deferred tax assets are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and net deferred tax liabilities are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; in the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="c-6" decimals="-5" id="f-805" unitRef="usd">9700000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="c-7" decimals="-5" id="f-806" unitRef="usd">8600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c-6" decimals="-5" id="f-807" unitRef="usd">9100000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c-7" decimals="-5" id="f-808" unitRef="usd">10300000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c-6" decimals="-5" id="f-809" unitRef="usd">24600000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c-7" decimals="-5" id="f-810" unitRef="usd">26200000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-6" decimals="-5" id="f-811" unitRef="usd">11700000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-7" decimals="-5" id="f-812" unitRef="usd">19000000.0</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <embc:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts contextRef="c-6" decimals="-5" id="f-813" unitRef="usd">16600000</embc:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <embc:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts contextRef="c-7" decimals="-5" id="f-814" unitRef="usd">7000000.0</embc:DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <embc:DeferredTaxAssetsLeasingArrangements contextRef="c-6" decimals="-5" id="f-815" unitRef="usd">12900000</embc:DeferredTaxAssetsLeasingArrangements>
    <embc:DeferredTaxAssetsLeasingArrangements contextRef="c-7" decimals="-5" id="f-816" unitRef="usd">9700000</embc:DeferredTaxAssetsLeasingArrangements>
    <us-gaap:DeferredTaxAssetInterestCarryforward contextRef="c-6" decimals="-5" id="f-817" unitRef="usd">16400000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetInterestCarryforward contextRef="c-7" decimals="-5" id="f-818" unitRef="usd">0</us-gaap:DeferredTaxAssetInterestCarryforward>
    <embc:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards contextRef="c-6" decimals="-5" id="f-819" unitRef="usd">6600000</embc:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards>
    <embc:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards contextRef="c-7" decimals="-5" id="f-820" unitRef="usd">500000</embc:DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-6" decimals="-5" id="f-821" unitRef="usd">2100000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-7" decimals="-5" id="f-822" unitRef="usd">5400000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-6" decimals="-5" id="f-823" unitRef="usd">109700000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-7" decimals="-5" id="f-824" unitRef="usd">86700000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-5" id="f-825" unitRef="usd">31600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="-5" id="f-826" unitRef="usd">10400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-6" decimals="-5" id="f-827" unitRef="usd">78100000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-7" decimals="-5" id="f-828" unitRef="usd">76300000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-6" decimals="-5" id="f-829" unitRef="usd">20500000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-7" decimals="-5" id="f-830" unitRef="usd">8200000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-6" decimals="-5" id="f-831" unitRef="usd">12800000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-7" decimals="-5" id="f-832" unitRef="usd">9500000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-6" decimals="-5" id="f-833" unitRef="usd">33300000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-7" decimals="-5" id="f-834" unitRef="usd">17700000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-6" decimals="-5" id="f-835" unitRef="usd">44800000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-7" decimals="-5" id="f-836" unitRef="usd">58600000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-6" decimals="-5" id="f-837" unitRef="usd">18000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-5" id="f-838" unitRef="usd">31600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="-5" id="f-839" unitRef="usd">10400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxHolidayAggregateDollarAmount contextRef="c-1" decimals="-5" id="f-840" unitRef="usd">2100000</us-gaap:IncomeTaxHolidayAggregateDollarAmount>
    <us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare
      contextRef="c-1"
      decimals="2"
      id="f-841"
      unitRef="usdPerShare">0.04</us-gaap:IncomeTaxHolidayIncomeTaxBenefitsPerShare>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-6" decimals="-5" id="f-842" unitRef="usd">1000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:OperatingLossCarryforwards contextRef="c-6" decimals="-5" id="f-843" unitRef="usd">5600000</us-gaap:OperatingLossCarryforwards>
    <embc:OperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-6" decimals="-5" id="f-844" unitRef="usd">1000000</embc:OperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-845">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.417%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at October 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase due to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase due to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease due to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease due to settlements with tax authorities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease due to lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at September 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits including interest and penalties that would affect the effective tax rate if recognized&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-7" decimals="-5" id="f-846" unitRef="usd">5700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-15" decimals="-5" id="f-847" unitRef="usd">16000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-10" decimals="-5" id="f-848" unitRef="usd">14500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-5" id="f-849" unitRef="usd">5000000.0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-4" decimals="-5" id="f-850" unitRef="usd">1000000.0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-5" decimals="-5" id="f-851" unitRef="usd">1300000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-5" id="f-852" unitRef="usd">3700000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-4" decimals="-5" id="f-853" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-5" decimals="-5" id="f-854" unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-5" id="f-855" unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-4" decimals="-5" id="f-856" unitRef="usd">6700000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-5" decimals="-5" id="f-857" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-1" decimals="-5" id="f-858" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-4" decimals="-5" id="f-859" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities contextRef="c-5" decimals="-5" id="f-860" unitRef="usd">100000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-1" decimals="-5" id="f-861" unitRef="usd">4700000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-4" decimals="-5" id="f-862" unitRef="usd">4600000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-5" decimals="-5" id="f-863" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-6" decimals="-5" id="f-864" unitRef="usd">9400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-7" decimals="-5" id="f-865" unitRef="usd">5700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-15" decimals="-5" id="f-866" unitRef="usd">16000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-6" decimals="-5" id="f-867" unitRef="usd">7200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-7" decimals="-5" id="f-868" unitRef="usd">7200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-15" decimals="-5" id="f-869" unitRef="usd">20000000.0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense contextRef="c-1" decimals="-5" id="f-870" unitRef="usd">-1200000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense contextRef="c-4" decimals="-5" id="f-871" unitRef="usd">-1500000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense contextRef="c-5" decimals="-5" id="f-872" unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-1" decimals="-5" id="f-873" unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-4" decimals="-5" id="f-874" unitRef="usd">1500000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-5" decimals="-5" id="f-875" unitRef="usd">4000000.0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-876">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 15 &#x2014; Financial Instruments and Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following reconciles &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; reported within the Consolidated Balance Sheets as of September&#160;30, 2023 and September&#160;30, 2022, to the total amounts shown in the Consolidated Statements of Cash Flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.416%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; includes cash held in money market funds and other cash equivalents. All cash and cash equivalents are Level 1 in the fair value hierarchy. Interest income on &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; was $9.4&#160;million for the year ended September&#160;30, 2023 and is included as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Interest expense, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. For the years ended September 30, 2022 and 2021, interest income was not material to the Company's Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Foreign Currency Risks and Related Strategies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has foreign currency exposures throughout Europe, Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The notional amounts of the Company&#x2019;s foreign currency-related derivative instruments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.293%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Undesignated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt"&gt;Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other income (expense), net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;hedging costs associated with the derivative instruments. Gains and losses recognized to date on these instruments were not material to the Company's Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Nonrecurring Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Non-financial assets, including property, plant and equipment as well as intangible assets, are measured at fair value when there are indicators of impairment and these assets are recorded at fair value only when an impairment is recognized. These measurements of fair value are generally based upon Level 3 inputs, including values estimated using the income approach. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the year ended September 30, 2023, the Company recorded impairment charges of $2.5&#160;million related to the abandonment of certain manufacturing equipment in China that is no longer in use that were inherited as part of the spin from BD. These assets were previously included as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The impairment charges are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Impairment expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;in the Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the year ended September 30, 2022, the Company recorded impairment charges of $58.9&#160;million related to the abandonment of certain manufacturing production lines in the United States that are no longer expected to be completed. These assets were previously included as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Construction in progress&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The impairment charges are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Impairment expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;in the Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the year ended September 30, 2021, the Company recorded impairment charges related to certain construction in progress assets related to discontinued projects totaling $13.8&#160;million. The impairment charges were recorded to adjust the carrying amount of the assets to the assets&#x2019; fair values, which were estimated through a discounted cash flow model that utilized Level 3 inputs. The impairment charges are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cost of products sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;in the Consolidated Statements of Income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Historically and prior to the Separation, the Company&#x2019;s operations formed part of BD&#x2019;s monitoring of concentrations of credit risk associated with financial institutions for which BD conducted business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of September&#160;30, 2023, the Company had transferred the majority of its trade receivables to BD under the Factoring Agreements (see Note 4). As a result, the Company is no longer exposed to credit risk associated with those transferred receivables and does not have material credit risk exposure associated with the remaining $16.7 million of trade receivables. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Three of the Company&#x2019;s customers represented at least 10.0% of total gross revenues individually and, in the aggregate, represented approximately 40.2% and 40.1% for the years ended September&#160;30, 2023 and 2022, respectively. Two customers represented at least 10.0% of total revenues individually and, in the aggregate, represented approximately 30.7% of total revenues for the year ended September 30, 2021. &lt;/span&gt;&lt;/div&gt;Substantially all of the Company&#x2019;s trade receivables are due from public and private entities involved in the healthcare industry. The Company does not normally require collateral from its customers.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-877">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following reconciles &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; reported within the Consolidated Balance Sheets as of September&#160;30, 2023 and September&#160;30, 2022, to the total amounts shown in the Consolidated Statements of Cash Flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.416%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;326.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-5" id="f-878" unitRef="usd">326500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-5" id="f-879" unitRef="usd">330900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestIncomeOther contextRef="c-1" decimals="-5" id="f-880" unitRef="usd">9400000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther contextRef="c-5" decimals="INF" id="f-881" unitRef="usd">0</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther contextRef="c-4" decimals="INF" id="f-882" unitRef="usd">0</us-gaap:InterestIncomeOther>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock contextRef="c-1" id="f-883">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The notional amounts of the Company&#x2019;s foreign currency-related derivative instruments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.293%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.418%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Hedge Designation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Undesignated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt"&gt;Represent hedges of transactional foreign exchange exposures resulting primarily from intercompany payables and receivables. Gains and losses on these instruments are recognized immediately in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other income (expense), net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. These gains and losses are largely offset by gains and losses on the underlying hedged items, as well as the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;hedging costs associated with the derivative instruments. Gains and losses recognized to date on these instruments were not material to the Company's Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount contextRef="c-139" decimals="-5" id="f-884" unitRef="usd">6700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-140" decimals="-5" id="f-885" unitRef="usd">5100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-1" decimals="-5" id="f-886" unitRef="usd">2500000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-4" decimals="-5" id="f-887" unitRef="usd">58900000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-5" decimals="-5" id="f-888" unitRef="usd">13800000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-6" decimals="-5" id="f-889" unitRef="usd">16700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-141" decimals="3" id="f-890" unitRef="number">0.402</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-142" decimals="3" id="f-891" unitRef="number">0.401</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-143" decimals="3" id="f-892" unitRef="number">0.307</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-893">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 16 &#x2014; Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment, Net consisted of: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;124.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;123.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;567.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;505.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;64.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;747.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;701.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(447.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(400.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Property, Plant and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;300.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;301.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the year ended September 30, 2023, the Company recorded impairment charges of $2.5&#160;million related to the abandonment of certain manufacturing equipment in China that is no longer in use that were inherited as part of the spin from BD. These assets were previously included as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the year ended September 30, 2022, the Company recorded impairment charges of $58.9&#160;million related to the abandonment of certain manufacturing production lines in the United States that are no longer expected to be completed. These assets were previously included as a component of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Construction in progress&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. The impairment charges are recognized within &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Impairment expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;in the Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-894">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment, Net consisted of: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;124.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;123.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;567.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;505.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;64.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;747.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;701.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(447.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(400.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Property, Plant and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;300.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;301.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-144" decimals="-5" id="f-895" unitRef="usd">2300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-145" decimals="-5" id="f-896" unitRef="usd">1400000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-146" decimals="-5" id="f-897" unitRef="usd">124500000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-147" decimals="-5" id="f-898" unitRef="usd">123700000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-148" decimals="-5" id="f-899" unitRef="usd">567200000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-149" decimals="-5" id="f-900" unitRef="usd">505100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-150" decimals="-5" id="f-901" unitRef="usd">9100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-151" decimals="-5" id="f-902" unitRef="usd">6500000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-152" decimals="-5" id="f-903" unitRef="usd">44800000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-153" decimals="-5" id="f-904" unitRef="usd">64900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-905" unitRef="usd">747900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-906" unitRef="usd">701600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-907" unitRef="usd">447700000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-908" unitRef="usd">400000000.0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-909" unitRef="usd">300200000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-910" unitRef="usd">301600000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-1" decimals="-5" id="f-911" unitRef="usd">2500000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-4" decimals="-5" id="f-912" unitRef="usd">58900000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-914">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 17 &#x2014; Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In conjunction with the Separation, we entered into a lease agreement with BD pursuant to which the Company would lease approximately 278,000 square feet of manufacturing space and equipment at BD's manufacturing facility in Holdrege, Nebraska for an initial term of ten years and an option for the Company to extend the lease term for an additional period of up to five years. This lease is classified as a finance lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the year ended September 30, 2023, the Company recorded total finance lease costs of $4.8 million which is comprised of $2.4 million attributable to depreciation of assets and $2.4 million attributable to interest expense associated with the lease liability. The amounts are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Interest expense, net,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; respectively. For the year ended September 30, 2022, total finance lease costs were not material to the Company's Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's operating leases primarily relate to its real estate leases that are not classified as finance leases. The Company entered into a real estate lease for a new Corporate Headquarters located in Parsippany, NJ which commenced during the second quarter of fiscal year 2023 for an initial term of ten years. The Company has options to extend the lease for additional period of six years and to extend for a subsequent additional period of four years, after the expiration of the first extension period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the year ended September 30, 2023 operating lease costs were $4.5 million. For the years ended September 30, 2022, and 2021 total operating lease costs were not material to the Company's Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Aggregate Lease Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's leases are included in its Consolidated Balance Sheets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.994%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-929"&gt;&lt;span style="-sec-ix-hidden:f-930"&gt;Property, Plant, and Equipment, Net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Finance Lease Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Non Current Finance Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Finance Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;13.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;14.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-945"&gt;&lt;span style="-sec-ix-hidden:f-946"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Operating Lease Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-951"&gt;&lt;span style="-sec-ix-hidden:f-952"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-955"&gt;&lt;span style="-sec-ix-hidden:f-956"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Operating Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Supplemental cash flow information related to leases was as follows as of September 30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.265%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Right of use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the year ended September 30, 2021 right of use assets obtained in exchange for lease liabilities was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.719%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flows from Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Financing cash flows from Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flows from Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the years ended September 30, 2022, and 2021 cash paid for amounts included in the measurement of lease liabilities were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Maturities of the Company's finance and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;82.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;56.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-913">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 17 &#x2014; Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In conjunction with the Separation, we entered into a lease agreement with BD pursuant to which the Company would lease approximately 278,000 square feet of manufacturing space and equipment at BD's manufacturing facility in Holdrege, Nebraska for an initial term of ten years and an option for the Company to extend the lease term for an additional period of up to five years. This lease is classified as a finance lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the year ended September 30, 2023, the Company recorded total finance lease costs of $4.8 million which is comprised of $2.4 million attributable to depreciation of assets and $2.4 million attributable to interest expense associated with the lease liability. The amounts are included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Cost of products sold&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Interest expense, net,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; respectively. For the year ended September 30, 2022, total finance lease costs were not material to the Company's Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's operating leases primarily relate to its real estate leases that are not classified as finance leases. The Company entered into a real estate lease for a new Corporate Headquarters located in Parsippany, NJ which commenced during the second quarter of fiscal year 2023 for an initial term of ten years. The Company has options to extend the lease for additional period of six years and to extend for a subsequent additional period of four years, after the expiration of the first extension period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the year ended September 30, 2023 operating lease costs were $4.5 million. For the years ended September 30, 2022, and 2021 total operating lease costs were not material to the Company's Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Aggregate Lease Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's leases are included in its Consolidated Balance Sheets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.994%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-929"&gt;&lt;span style="-sec-ix-hidden:f-930"&gt;Property, Plant, and Equipment, Net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Finance Lease Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Non Current Finance Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Finance Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;13.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;14.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-945"&gt;&lt;span style="-sec-ix-hidden:f-946"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Operating Lease Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-951"&gt;&lt;span style="-sec-ix-hidden:f-952"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-955"&gt;&lt;span style="-sec-ix-hidden:f-956"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Operating Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Supplemental cash flow information related to leases was as follows as of September 30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.265%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Right of use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the year ended September 30, 2021 right of use assets obtained in exchange for lease liabilities was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.719%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flows from Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Financing cash flows from Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flows from Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the years ended September 30, 2022, and 2021 cash paid for amounts included in the measurement of lease liabilities were not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Maturities of the Company's finance and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;82.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;56.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <embc:LesseeFinanceLeaseAreaOfPremisesLeased contextRef="c-6" decimals="-3" id="f-915" unitRef="sqft">278000</embc:LesseeFinanceLeaseAreaOfPremisesLeased>
    <us-gaap:LesseeFinanceLeaseTermOfContract1 contextRef="c-6" id="f-916">P10Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeFinanceLeaseRenewalTerm1 contextRef="c-6" id="f-917">P5Y</us-gaap:LesseeFinanceLeaseRenewalTerm1>
    <embc:FinanceLeaseCost contextRef="c-1" decimals="-5" id="f-918" unitRef="usd">4800000</embc:FinanceLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-5" id="f-919" unitRef="usd">2400000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-1" decimals="-5" id="f-920" unitRef="usd">2400000</us-gaap:FinanceLeaseInterestExpense>
    <embc:FinanceLeaseCost contextRef="c-4" decimals="INF" id="f-921" unitRef="usd">0</embc:FinanceLeaseCost>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-2" id="f-922">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-154" id="f-923">P6Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-155" id="f-924">P4Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-5" id="f-925" unitRef="usd">4500000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="INF" id="f-926" unitRef="usd">0</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-4" decimals="INF" id="f-927" unitRef="usd">0</us-gaap:OperatingLeaseCost>
    <embc:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="c-1" id="f-928">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's leases are included in its Consolidated Balance Sheets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.956%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.992%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.994%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-929"&gt;&lt;span style="-sec-ix-hidden:f-930"&gt;Property, Plant, and Equipment, Net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Finance Lease Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Non Current Finance Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Finance Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;13.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;14.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-945"&gt;&lt;span style="-sec-ix-hidden:f-946"&gt;Deferred Income Taxes and Other Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Operating Lease Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-951"&gt;&lt;span style="-sec-ix-hidden:f-952"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&lt;span style="-sec-ix-hidden:f-955"&gt;&lt;span style="-sec-ix-hidden:f-956"&gt;Deferred Income Taxes and Other Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total Operating Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</embc:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-6" decimals="-5" id="f-931" unitRef="usd">33100000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-7" decimals="-5" id="f-932" unitRef="usd">35500000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-6" decimals="-5" id="f-933" unitRef="usd">33100000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-7" decimals="-5" id="f-934" unitRef="usd">35500000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-6" decimals="-5" id="f-935" unitRef="usd">3600000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-7" decimals="-5" id="f-936" unitRef="usd">3600000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-6" decimals="-5" id="f-937" unitRef="usd">31500000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-7" decimals="-5" id="f-938" unitRef="usd">32600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability contextRef="c-6" decimals="-5" id="f-939" unitRef="usd">35100000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-7" decimals="-5" id="f-940" unitRef="usd">36200000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-6" id="f-941">P13Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-7" id="f-942">P14Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-6" decimals="3" id="f-943" unitRef="number">0.068</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-7" decimals="3" id="f-944" unitRef="number">0.068</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-6" decimals="-5" id="f-947" unitRef="usd">23000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-7" decimals="-5" id="f-948" unitRef="usd">6300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-6" decimals="-5" id="f-949" unitRef="usd">23000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-7" decimals="-5" id="f-950" unitRef="usd">6300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-6" decimals="-5" id="f-953" unitRef="usd">5900000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-7" decimals="-5" id="f-954" unitRef="usd">2000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-6" decimals="-5" id="f-957" unitRef="usd">15400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-7" decimals="-5" id="f-958" unitRef="usd">4300000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c-6" decimals="-5" id="f-959" unitRef="usd">21300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-7" decimals="-5" id="f-960" unitRef="usd">6300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-6" id="f-961">P7Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-7" id="f-962">P3Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-6" decimals="3" id="f-963" unitRef="number">0.069</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-7" decimals="3" id="f-964" unitRef="number">0.059</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-965">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Supplemental cash flow information related to leases was as follows as of September 30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.557%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.265%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Right of use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the year ended September 30, 2021 right of use assets obtained in exchange for lease liabilities was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.719%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:10pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flows from Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Financing cash flows from Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:16pt;text-indent:-10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flows from Finance Lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-5" id="f-966" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-4" decimals="-5" id="f-967" unitRef="usd">36700000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-968" unitRef="usd">19000000.0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-4" decimals="-5" id="f-969" unitRef="usd">2800000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-5" id="f-970" unitRef="usd">2900000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-5" id="f-971" unitRef="usd">1200000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-5" id="f-972" unitRef="usd">2400000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-974">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Maturities of the Company's finance and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;82.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;56.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-973">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Maturities of the Company's finance and operating lease liabilities as of September&#160;30, 2023 by fiscal year are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;47.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;54.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;82.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;56.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-6" decimals="-5" id="f-975" unitRef="usd">3600000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-6" decimals="-5" id="f-976" unitRef="usd">5600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <embc:LesseeLeaseLiabilityToBePaidYearOne contextRef="c-6" decimals="-5" id="f-977" unitRef="usd">9200000</embc:LesseeLeaseLiabilityToBePaidYearOne>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-6" decimals="-5" id="f-978" unitRef="usd">3700000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-6" decimals="-5" id="f-979" unitRef="usd">3600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <embc:LesseeLeaseLiabilityToBePaidYearTwo contextRef="c-6" decimals="-5" id="f-980" unitRef="usd">7300000</embc:LesseeLeaseLiabilityToBePaidYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-6" decimals="-5" id="f-981" unitRef="usd">3700000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-6" decimals="-5" id="f-982" unitRef="usd">2800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <embc:LesseeLeaseLiabilityToBePaidYearThree contextRef="c-6" decimals="-5" id="f-983" unitRef="usd">6500000</embc:LesseeLeaseLiabilityToBePaidYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-6" decimals="-5" id="f-984" unitRef="usd">3800000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-6" decimals="-5" id="f-985" unitRef="usd">2200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <embc:LesseeLeaseLiabilityToBePaidYearFour contextRef="c-6" decimals="-5" id="f-986" unitRef="usd">6000000.0</embc:LesseeLeaseLiabilityToBePaidYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive contextRef="c-6" decimals="-5" id="f-987" unitRef="usd">3900000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-6" decimals="-5" id="f-988" unitRef="usd">2100000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <embc:LesseeLeaseLiabilityToBePaidYearFive contextRef="c-6" decimals="-5" id="f-989" unitRef="usd">6000000.0</embc:LesseeLeaseLiabilityToBePaidYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-6" decimals="-5" id="f-990" unitRef="usd">36200000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-6" decimals="-5" id="f-991" unitRef="usd">11200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <embc:LesseeLeaseLiabilityToBePaidDueAfterYearFive contextRef="c-6" decimals="-5" id="f-992" unitRef="usd">47400000</embc:LesseeLeaseLiabilityToBePaidDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-6" decimals="-5" id="f-993" unitRef="usd">54900000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-6" decimals="-5" id="f-994" unitRef="usd">27500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <embc:LesseeLeaseLiabilityToBePaid contextRef="c-6" decimals="-5" id="f-995" unitRef="usd">82400000</embc:LesseeLeaseLiabilityToBePaid>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-6" decimals="-5" id="f-996" unitRef="usd">19800000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-6" decimals="-5" id="f-997" unitRef="usd">6200000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <embc:LesseeLeaseLiabilityUndiscountedExcessAmount contextRef="c-6" decimals="-5" id="f-998" unitRef="usd">26000000.0</embc:LesseeLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability contextRef="c-6" decimals="-5" id="f-999" unitRef="usd">35100000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-6" decimals="-5" id="f-1000" unitRef="usd">21300000</us-gaap:OperatingLeaseLiability>
    <embc:LesseeLeaseLiability contextRef="c-6" decimals="-5" id="f-1001" unitRef="usd">56400000</embc:LesseeLeaseLiability>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c-1" id="f-1002">&lt;div style="margin-top:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 18 &#x2014; Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prior to the Separation on April 1, 2022, Embecta participated in BD's non-United States plans. BD has defined benefit pension plans covering eligible employees in certain of its international subsidiaries. The Company participated in BD's benefit plans as though it was a participant in a multi-employer plan with the other businesses of BD. The retirement benefits accounting guidance provides that liabilities beyond any contributions currently due and unpaid are not required to be reported. Accordingly, no assets or liabilities associated with plans where the Company was a participant in a multi-employer plan with the other businesses of BD have been reflected in the Company&#x2019;s Consolidated Balance Sheets. The Consolidated Statements of Income include expense allocations for these benefits, which were determined using a proportional allocation method. Total benefit plan expense allocated to the Company for the years ended September 30, 2022 and 2021 was $3.6&#160;million and $9.0&#160;million, respectively. Except for deferred closing countries, the Company's participation in the defined pension and postretirement benefit plans sponsored by BD concluded upon the completion of the Separation on April 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of April 1, 2022, Embecta became the plan sponsor for certain global defined benefit pension plans. These Consolidated Financial Statements reflect the periodic benefit costs and funded status of such plans. The Company uses September 30 as the year-end measurement date for these plans. Net periodic benefit cost for the Company&#x2019;s global defined benefit pension plans for the years ended September 30, 2023 and 2022 was $1.0&#160;million and $0.7&#160;million, respectively. Of the plans, the defined benefit pension plan covering employees in Switzerland (the "Swiss Plan") is the only defined benefit pension plan material to the Company's Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company's Swiss Plan is a government-mandated retirement account balance plan. Companies within the Swiss regulatory environment have substantial freedom in setting their pension plan design (e.g. with regards to the salary covered, level of retirement benefits, or overall benefit design) provided the benefits are always at least equal to the minimum requirements as defined by law. Most employers provide higher benefits than those required by law, which is the case for Embecta. The minimum level of retirement benefit is expressed by a cash balance formula with age-related contribution rates (or "retirement credits") based on an insured salary defined by law, and a minimum required interest crediting rate which is set by the government (1.00% in 2023 and 2022). The sum of the Company's contributions should be at least equal to the sum of employee contributions. Contributions to the Swiss Plan are invested into a diversified fund managed by an investment fiduciary. As of September&#160;30, 2023 and 2022, the Swiss plan had an unfunded net pension obligation of $1.9&#160;million and $0.6&#160;million, respectively, and plan assets that totaled $14.1&#160;million and $8.0&#160;million, respectively. Since the Separation, the Company recognized net periodic benefit cost totaling $0.9 million and $0.2 million during the fiscal years ended September 30, 2023 and 2022, respectively, related to the Company's Swiss plan, of which $0.3 million and $0.1 million was included in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Other income (expense), net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;during the fiscal years ended September 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has various defined contribution savings plans that cover substantially all employees in the United States, Ireland, and Japan. The Company matches a certain percentage of each employee&#x2019;s contributions as per the provisions of the plans. Total employer contributions by the Company to the plans were $14.1 million and $8.9 million for the fiscal years ended September 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Between April 1, 2022 and September 30, 2022, BD remained the defined benefit pension plan sponsor for certain Embecta employees in Ireland. The Company accounts for this plan as though it was a participant in a multi-employer plan with other businesses of BD.  The amount of contributions to BD for this plan are included in the amounts noted above. At the Separation Date, Embecta effectuated an Embecta sponsored defined contribution pension plan for certain other employees in Ireland. On October 1, 2022, any Embecta employees who remained participating in the BD defined benefit pension plan ceased participating and these employees began participating in an Embecta sponsored defined contribution pension plan that was effectuated at the Separation Date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On the date of the Separation, the Company established a Deferred Compensation Plan in which certain directors and employees of the Company may defer the payment and taxation of up to 75% of their base salary and up to 100% of bonus amounts and other eligible cash compensation. A participant's deferrals are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator. The amounts accrued under this plan were $6.1 million and $3.7 million as of September&#160;30, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-4" decimals="-5" id="f-1003" unitRef="usd">3600000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-5" decimals="-5" id="f-1004" unitRef="usd">9000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-1" decimals="-5" id="f-1005" unitRef="usd">1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-109" decimals="-5" id="f-1006" unitRef="usd">700000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-156" decimals="-5" id="f-1007" unitRef="usd">-1900000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-157" decimals="-5" id="f-1008" unitRef="usd">-600000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-156" decimals="-5" id="f-1009" unitRef="usd">14100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-157" decimals="-5" id="f-1010" unitRef="usd">8000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-158" decimals="-5" id="f-1011" unitRef="usd">900000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-159" decimals="-5" id="f-1012" unitRef="usd">200000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-160" decimals="-5" id="f-1013" unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-161" decimals="-5" id="f-1014" unitRef="usd">100000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-1" decimals="-5" id="f-1015" unitRef="usd">14100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-4" decimals="-5" id="f-1016" unitRef="usd">8900000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <embc:DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage
      contextRef="c-1"
      decimals="INF"
      id="f-1017"
      unitRef="number">0.75</embc:DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage>
    <embc:DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage
      contextRef="c-1"
      decimals="INF"
      id="f-1018"
      unitRef="number">1</embc:DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-6" decimals="-5" id="f-1019" unitRef="usd">6100000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent contextRef="c-7" decimals="-5" id="f-1020" unitRef="usd">3700000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock contextRef="c-1" id="f-1021">&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 19 &#x2014; Supplemental Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Trade Receivables, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amounts recognized in fiscal years 2023, 2022 and 2021 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.161%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.161%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.164%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance for Cash Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(18.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(a) Accounts written off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(b) Amounts factored to BD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Long-lived assets, which include &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Goodwill and Other Intangibles, net,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; by geographic area where located at September 30, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.507%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;109.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;109.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Europe, Middle East, and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;176.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;174.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;42.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;326.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="c-1" id="f-1022">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amounts recognized in fiscal years 2023, 2022 and 2021 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.161%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.161%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.164%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allowance for Cash Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(16.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(18.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Additions charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Deductions and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;18.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(a) Accounts written off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(b) Amounts factored to BD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-162" decimals="-5" id="f-1023" unitRef="usd">3900000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-163" decimals="-5" id="f-1024" unitRef="usd">2200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-10" decimals="-5" id="f-1025" unitRef="usd">6100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-164" decimals="-5" id="f-1026" unitRef="usd">300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-165" decimals="-5" id="f-1027" unitRef="usd">16000000.0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-5" decimals="-5" id="f-1028" unitRef="usd">16300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-164" decimals="-5" id="f-1029" unitRef="usd">1100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-165" decimals="-5" id="f-1030" unitRef="usd">15100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-5" decimals="-5" id="f-1031" unitRef="usd">16200000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-166" decimals="-5" id="f-1032" unitRef="usd">3100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-167" decimals="-5" id="f-1033" unitRef="usd">3100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-15" decimals="-5" id="f-1034" unitRef="usd">6200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-168" decimals="-5" id="f-1035" unitRef="usd">300000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-169" decimals="-5" id="f-1036" unitRef="usd">18100000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-4" decimals="-5" id="f-1037" unitRef="usd">18400000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-168" decimals="-5" id="f-1038" unitRef="usd">2100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-169" decimals="-5" id="f-1039" unitRef="usd">21100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-4" decimals="-5" id="f-1040" unitRef="usd">23200000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-170" decimals="-5" id="f-1041" unitRef="usd">1300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-171" decimals="-5" id="f-1042" unitRef="usd">100000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-7" decimals="-5" id="f-1043" unitRef="usd">1400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-172" decimals="-5" id="f-1044" unitRef="usd">200000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-173" decimals="-5" id="f-1045" unitRef="usd">18700000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-1" decimals="-5" id="f-1046" unitRef="usd">18900000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-172" decimals="-5" id="f-1047" unitRef="usd">500000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-173" decimals="-5" id="f-1048" unitRef="usd">18800000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-1" decimals="-5" id="f-1049" unitRef="usd">19300000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-174" decimals="-5" id="f-1050" unitRef="usd">1000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-175" decimals="-5" id="f-1051" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-6" decimals="-5" id="f-1052" unitRef="usd">1000000.0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock contextRef="c-1" id="f-1053">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Long-lived assets, which include &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Property, Plant and Equipment, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Goodwill and Other Intangibles, net,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; by geographic area where located at September 30, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.021%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.507%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;109.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;109.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Europe, Middle East, and Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;176.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;174.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;42.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17pt;text-align:left;text-indent:-10pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;326.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets contextRef="c-176" decimals="-5" id="f-1054" unitRef="usd">109200000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-177" decimals="-5" id="f-1055" unitRef="usd">109300000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-178" decimals="-5" id="f-1056" unitRef="usd">176900000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-179" decimals="-5" id="f-1057" unitRef="usd">174500000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-180" decimals="-5" id="f-1058" unitRef="usd">38400000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-181" decimals="-5" id="f-1059" unitRef="usd">42300000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-182" decimals="-5" id="f-1060" unitRef="usd">400000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-183" decimals="-5" id="f-1061" unitRef="usd">100000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-6" decimals="-5" id="f-1062" unitRef="usd">324900000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-7" decimals="-5" id="f-1063" unitRef="usd">326200000</us-gaap:NoncurrentAssets>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1064">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Note 20 &#x2014; Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Performance-Based and Time-Vested Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In November 2023 and pursuant to the Company's 2022 Employee and Director Equity Based Compensation Plan (the "Plan"), the Company granted approximately 1.3&#160;million &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;TVUs in connection with the Company's annual grant which &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;vest on a graded basis over a period of three years, subject to continuous service to the Company by the employee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company also awarded approximately 0.5&#160;million PSUs to certain executive officers and employees in connection with the Company's annual grant &lt;/span&gt;&lt;span style="color:#2b2a29;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;which vest after three years, subject to continued employment of the recipients and the achievement of certain performance metric targets. The Company has identified certain performance metrics and targets that will be fully established at a future date. The Company has determined that the service inception date precedes the grant date for these awards as (a) the awards were authorized prior to establishing an accounting grant date, (b) the recipients began providing services prior to the grant date, and (c) there are performance conditions that, if not met by the accounting grant date, will result in the forfeiture of the awards.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-184"
      decimals="INF"
      id="f-1065"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-184" id="f-1066">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-185"
      decimals="INF"
      id="f-1067"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-185" id="f-1068">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:AuditorFirmId contextRef="c-1" id="f-1069">42</dei:AuditorFirmId>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc xlink:href="#f-48" xlink:label="f-48" xlink:type="locator"/>
        <link:loc xlink:href="#f-49" xlink:label="f-49" xlink:type="locator"/>
        <link:loc xlink:href="#f-47" xlink:label="f-47" xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">For periods prior to the Separation, this income statement line includes cost of products sold from related party inventory purchases. Refer to Note 4 for further detail.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-48"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-49"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-47"
          xlink:to="fn-1"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>106
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MO8<[""IW$-AK^O'H[A$-\YA*QM%02@(^70]3WB7XV4C-KM<T(VH/:PWM/0Q
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MOQTOR9HR<OAR_XJ?!Q91J,4 W4E_M2\-9F@2Z%-/-_.C0;T*6]$"K=OZ@9/
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MUFR7$"Z7D.&@HCH08B0K#VHEH/@I/?;2F[*?8+N3$AY+R>2 6[(F9=>?J2#
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M6<J5,8#?EU+JQP_F2=KAR>G\/U!+ P04    " #S@WU7WM1%+.("   7"
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M$0K9FNYB\2Y[^IE5#;(+O""+>?D?/55EC1$*=EQD264L:Y!$Z?Z5?JHZHF&
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M5?;"FIB=$&O=#@TQ))@+">;U.V,^Z^?N?JDQ<8R)K1ZNBT/L%M]P?[" W!]
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ME&\WC(8L+PK(W]=9)IX_%(\K'QZQO_X74$L#!!0    ( /.#?5<1N*E]7P(
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M*2FAM92DF:LLK+0RC=/=(["/ Z]:44"-KH%P AY0,KBQU2<+0"U2/FK*MH5
M4"*UIR)-1X^:(?1[KYNQFQQU,_(&41XH#,%YMOZQ1D7L3HB559(,1*9=>TY?
MHT4+C"H./N9_*69C9TS)+8,R)I6!&6?KH_!O!_=RG"VRS23S"SO4]W "%R9_
M-E%]Z% U(KN]].1'-7]2NF5<6U^_@/:!6&JSB%NJA9@X.(SE:A)21\$S3X-:
M4^D!.[G>E)%$5.@F@SWED)A7SN=:,'+"VYSW[@%Z"7]"R1.R?Y^JW7X&Y^(_
M.J?1Y/E $,@X.F;=[[:A6QWBW5;S^8$[N"T];MOQRV-FOK7\&::&Z+\F'F[9
MQ/_@T+W5&];5B?I%VK',7XZ@(P8E\E 02T+-.)2?!@VHZF:Y-#Q<AE6"B;$Y
MH+&]/75JFZ-MQ5VV#2.:HPBA?O1*AAI!\D;V(G(#AI.IEJ-P#?V3>8#\::N!
MS1D2Y9RB<8LZ0O//1QSY>UB[!T(4"AAO8&A&P'3M&N@OI'#,';ZH+#Q#:2=?
MP(TWT]RQR 1CL">#966GZ= 3HY\<K-70\IB+1QDC5Y(F<\KB"">K)9(E<N1
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MG)\7_R*$#%; -O6^LL46RL?M:GL*JS,&JV][@ 0&;[P190A ::"@D;&*%X1
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M,M&>;T1\W[.JI#<_\Y@;L&0?!4UA_QM4#YB)UJ.C-A[N7\4X?FEJEHUW%%\
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M ,!W@+^ATSVX>/W+VXN'A3_ B]@&AV7B4)T-5I.M[_T$ _(NLY78D2-7\ R
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MRX>:4O**'RJ/49)66DA\(7?XGDBLD1)"6286H_>[\+F!&AA-J:*?5_+EIN_
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M3@T<'8$F&D$1N"IWI1N" \P=/"*-!7C#E!&;LNRL8U1XL:M*A*)9KUV3*G!
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M+&E=:DE[XR"W)FW)5]P=B 3=5;-:IRV&Z;=,.WY6U$=#O5N A,+*#@X%-_E
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M;LD?*4TU-3V ^S.' X0OM$'ZZR1O_@]02P,$%     @ \X-]5YU]*W8;!
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MCM*+LP1LG+1QXTP;IEMA',_*L*SYYP2M%^#O*\/WWF[C#?2_.XMO4$L#!!0
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M[#CB1]7U+6X*- Z[ @+,J'<VHNV5V,THQPHL&L%'J-@W$2M8%V9 #-@S$')
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MD;Z\Q5=Y-FHC2^:X#Q&JP><:8<:%IS=I;3@(I^%-7X>RCG.G<AQEJ!J"?"/
M/[;4EZ,B(E2L5*JD[#)^+)C+D^4:-=ZWKD^IC;VT;_51/&D+WU"%DY.7-9G2
M\A)35HHZ3#^/RY$=^E3*7E7(*O6T5*U7+NA"AA-K%PL:]KM([[2F,8+AN)HQ
MY6.G8K4>R3@_]6U;')Q%L#_K>.**)$U(QY+IZ72HNTMGF2?S="+\J%R-Q8-E
M5,%U.;]\G9%+IZQT$VP?3S:Y#3@GQ<L&!U-V8H#WE<6F&&\DP'347?\'4$L#
M!!0    ( /.#?5>17+1B:@8  (X/   9    >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;(5736_<-A#]*\3&R,G9[\1.8ANPG18MT!1&G+:'H@>N--(RID2%
MI+S>_OJ^&4J[LK-V+_:*X@S?O'DS0YUMG+\+:Z*H'BI;A_/1.L;FPV02LC55
M.HQ=0S7>%,Y7.N+1EY/0>-*Y&%5V,I].WTTJ;>K1Q9FLW?B+,]=&:VJZ\2JT
M5:7]]HJLVYR/9J-^X8LIUY$7)A=GC2[IEN(?S8W'TV3G)3<5U<&X6GDJSD>7
MLP]72]XO&_XTM F#WXHC63EWQP^_YN>C*0,B2UED#QK_[NF:K&5'@/&]\SG:
M'<F&P]^]]Y\E=L2RTH&NG?W+Y'%]/CH=J9P*W=KXQ6U^H2Z>M^PO<S;(7[5)
M>Y<G(Y6U(;JJ,P:"RM3IOW[H>!@8G$Z?,9AW!G/!G0X2E)]TU!=GWFV4Y]WP
MQC\D5+$&.%-S4FZCQUL#NWCQA>ZI;BF<32*\\=HDZRRODN7\&<O97'UV=5P'
M]5.=4_[8P00P=ECF/9:K^8L>;ZD9J\7T6,VG\\4+_A:[V!;B;_%R;*KPKE+7
MP.JA ? ;U^I:F"6O_KY<!5G_YQ #R?_RL'^NEP^AT1F=CU 0@?P]C2Y>OYJ]
MFWY\ ?URAW[YDO<7,_.BY6%<O[M(ZE2]?G4ZG\T_JMZ[^DPZM)Y09U&Y8K]^
MH[>R%LE70=%#),ZRBD[%-8'-JM'U5KR=? R=4LD'I3U)F>2J;5!UF:NPG!EM
M[19%K(.K]<I2YQ9-1=RA']Q1#,K4:K,VV?K@&8UW>9O%=$1P-A^K*\IT&VBX
M7954DY?CZ*$AW@_,GC)"]:NFBXI%@,-<36I+VBO@L!1"DLIF30P<>D$Y@A/=
M'ZT,G'E=AX*\WY/1!W_\"$?NP&+MX@"0SK]AJS+ Y'N>>PJH* 2LG%>86M>9
MJ4OF#S0"\EA]/< )W+H-MI+XR5V[BD5KT>LRU]9R3&$3!X(3J!$\A6C0SXC/
MRA"'B<JZ$"ATC*7(5H1TB$FNW#TEE-848L8A@(F<.F8YIV&L;EODKG>?/W'.
M:<N)$P^]YIU(()&U 7W>9-K*3@'A#2&H<+SC5@4@,X7)>J?>A+MCI>M\J"I^
M#&W3.!_E&:1LM,_?6$P%9M/4:8QA'AQC(\!J:)>I\EO6@*<2KP"$O3-I.@IL
M3F.FF]@R&= -4_$4]L#W6%U6B7\VWG@343V@#:DM,2<A 7:PRUUX)GFBPT>2
MZMGKH>WIZ8Q8H6V-H2!3#Q0DV?R?3$2$3]/)OCAPSJ5' 3];^ZY&-9I<4MXI
MERFD@,D8#NNV]$S9K@BDHMO5-X#F4[2ZUU! W++4T'5:F>"AZPV\&3"=S_?)
M"+I"<0.FRQ,UO-BB8WF[Y<0_.HF-R]K\2WFG6#Y-],*A&!A)%EG^MLV)<:X0
M'-08-/.2FY!X2_I+BYZ@CCH\ZDF!AN@]23<>%*!4.R/U9(4]M[*FE,/A^UN;
ME]*L#-M^;PV+3S31ZX C8W,#<K/8.0O41SL\'.$\X9QSKAD4BH4=)?;&F  2
M+/>\>\,4K[:/1/BDP3<H >9D7]A"^T&EZ-*33!KV#@:\05.4><S]! /F#8CS
M^V&".LI1ZZDD"X3H?-CE:)_\83\[=&Q*'WJ77AEKH*HNL;+Y>ZOKR(TEY9Q[
M6PV&<-0V*0GL$R "%XX#L.Q.8=7)HPP#$Y^K# @E>K-J&?<QMYH-;I_\?X@Z
M5U8CC;CIHN7&#5&O:"L!]:.'E<;K_03CWNW0G .2D">)2]X.U]L^=AT3I-3D
MGU$^ L1E+%*U0MC]C4P@_+ \5QL$=+1X-U[B?FJMF&/CT7(Q/NU7CKD;\&C!
M#+9;5%VJHV%M=/4,7RS*[@5'>4"VS ./;=$,'0"UZ* Q$/R8@7BH]F@YFXUG
M>TQ'BR'J5,Q'\_>GXY-=)(]A?S)!E]!PN=/*[KKTXZN^"%=\)7&EUPVZ5S=A
M6%2[^NKN(G)!>S_>7U0O,35YA #5;UWZ#$[Z>NB.L=;WE*XL;&GWVP?^=/(G
MF0[QV6+ASQB6QF-%]*60L=JZBI3ZY\HM6IZ,W$%D!/*<:5H?N++8$VK]7@I0
MK\@.FP"'QNVDZXM[+F[0EK3)Y2I0R]T!.UU?A GV8.A<:2N'WO)G$$(^=/N>
M#+Z1T%M*^1+LAG_Z7-JM[CXV+],WUGY[^E+]K'V)*8X;8P'3Z?CD[2C1UC]$
MU\@7U\I%-#+YN<8',WG>@/>%0ZZ[!SY@]PE^\1]02P,$%     @ \X-]5_<)
M 3XL!0  U@L  !D   !X;"]W;W)K<VAE971S+W-H965T,3@N>&ULE59M;]LV
M$/XKA#L4+9#Y18[3O!I(TFX+L*Q%TFX8AGV@I9-$A"(UDHKK_?H]1\J.DR5>
M]T7BV]T]=_?<D:=+Z^Y\313$UT8;?S:H0VB/1R.?U]1(/[0M&>R4UC4R8.JJ
MD6\=R2(*-7J4C<<'HT8J,YB?QK5/;GYJNZ"5H4].^*YII%M=D+;+L\%DL%ZX
M454=>&$T/VUE1;<4OK2?'&:CC99"-62\LD8X*L\&YY/CBWT^'P_\JFCIM\:"
M/5E8>\>3J^)L,&9 I"D/K$'B=T^7I#4K HR_>IV#C4D6W!ZOM?\0?8<O"^GI
MTNK?5!'JL\'A0!14RDZ'&[O\B7I_9JPOM]K'KUBFL]/Q0.2=#[;IA8&@42;]
MY=<^#EL"AR\)9+U %G$G0Q'E>QGD_-39I7!\&MIX$%V-T@"G#"?E-CCL*LB%
M^2U5"'$0TA3B1[*5DVVM<JD%:SL=!9C@@Z.\5W>1U&4OJ)MDXMJ:4'OQP114
M/%8P K8-P&P-\"+;J?&6VJ&8CO=$-LZF._1--PY/H[[I?SA\0ZUU09E*_'&^
M\,&!'G\^YV_2MO^\-BZ98]_*G,X&J E/[IX&\]>O)@?CDQU8]S=8]W=I___)
MV:WN%QM('(G7KPZS278B=FH7'UMR,L;'IW->2$="%1BJ4E$AI!>Y;5IKXJ8M
MH4A@2*YURN.D$4OHJT6A?.X(IDMEI,D5+"B3V@G7I8+B>ZFT7&@<L4[0O=1=
MVENL1*A)7'Y\?\WZ&GG'@ K*%3<%CZY025?PFO2>O.?1HL,/8P$'HA634_11
M:FWSY!)293N7DX\;N6Q5D'HHKJ5!(XI!J:-W)M<=: P0,B0D<%B:E; Q.I '
M*@1@':/8( K1(2CQ^+:?'>\\<6CM*B#Q\C9BQ'/+8,S9NQ/_X-VW>?1>>5E5
M'*:( 4IOZ)Y,AW.?M]QA;Y&FX-2B2\T2,I2ROE2AYD!C&9E#?DS4A?%&PCHO
MWJ@8+,:RK*TF+S6YA*:A(O+*=VVK%5;?BF!!%=^!4 MG9;%F@-(JK!BE@N'6
MV:++F7< @;;-?PFC#@U=L'K/=,DCTW)R0?+?=@:8^C DU$Q<+!<QGK@C=#$4
M5RD_7XP*R,IMB+EDD4M0H)![CY*-D&CU-R<;8+1T5>*3;Q!_<4<K7"W1+OC)
M_('7D2\Y;R.6K5QA;0]H %''X=,(*>.#"ET?U]3VXT'>1+'IXOO$+%274XCW
MZ@5;-4F-=.5<JHC?/<JU-]'6$LS*$9KH_3I@N(GOJ,\RIA\Z!VH_=C^2(Z:0
M8Y4"[RBV.X/ X5)=.['1N@Y\3^)K510H[@_2IVYS7CIH>\;*\Q2,@,^]^G:)
M-9Y+^/1$RI%F>G#CX:ZU9,XT"';L2X%DP]QDIN)VZ)VEKY1'"Q'(SUQPXAPB
M__*!'T'L_VY<CQC\))##1V59/%1OSSZ7JI?[2-6W[!771?/0N1;L(.<$"44/
M@VC%?%D0@E]0J[BB:MQ##!REC!H$S1KF;Z);4 T7,5+GUJTBM11?BQ)ON'0/
MR+*$$ZFC$1JE;50N2ERBZ 7#AR:SA1/[B19)GHM7L[IC\3M)='U^+^!.:@,U
M"W*;*Y\_&7\F3ZKU.W$PG@SWXW\\G,;_$>97? 5M>M2;R5LQF_#Z+#L:9F(V
MFPV/Q&>+[@B)R=XD&P\/^]'1<)9&!S/H@^1S5_AHZZT%#E3Q1>E3XTG/KLWJ
MYM%ZGMYJ#\?3B_<:K83)HJF$Z'CX;C80+KTBTR38-K[<%C:@(<0A"APES0>P
M7UK<Z/V$#6R>\O-_ %!+ P04    " #S@WU7+UY<]HL/  "2,   &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q.2YX;6S56VMO([FQ_2N$,S>Q UF66K(DSPNP
M9V:3!>YDC;%W%Q<7^4!W4Q(S_4H_['%^?4Y5D2VV'K9WDGP(L&.UU&2Q6,]3
M1>[;AZ+Z6J^-:=2W+,WK=T?KIBE?GYW5\=IDNAX6I<GQ9EE4F6[PM5J=U65E
M=,*3LO0L&HUF9YFV^='[M_S;=?7^;=$VJ<W-=:7J-LMT]7AETN+AW='XR/_P
MQ:[6#?UP]OYMJ5?FQC0_E]<5OIUU5!*;F;RV1:XJLWQW=#E^?36E\3S@%VL>
MZN!9T4[NBN(K??DQ>7<T(H9,:N*&*&A\W)L/)DV)$-CXNZ-YU"U)$\-G3_T'
MWCOV<J=K\Z%(?[5)LWYWM#A2B5GJ-FV^% ]_-FX_YT0O+M*:_ZH'&3N='*FX
MK9LB<Y/!069S^=3?G!R""8O1@0F1FQ QW[(0<_E1-_K]VZIX4!6-!C5ZX*WR
M;#!G<U+*35/AK<6\YOU-4\1?3Z^PKT1]*#+HNM8DKK=G#:C3F+/84;H22M$!
M2N-(?2[R9EVK3WEBDCZ!,[#5\19YWJZB)RG>F'*H)J.!BD;1Y EZDVZO$Z8W
M.41OK2OC]GJM'V%:C;JL*IVO##___^5=W52PD[_NV[W0GNZG3;[SNBYU;-X=
MP3EJ4]V;H_>__]UX-GKS!.?3CO/I4]1_DY:>IO27HC%J/%*__]TB&D=OU"'*
MZMI4MDAJ=8V/2C6%@C9TY=[YWYJU"7X?J-A4#0*!*I;\B@CJ_/$/M3)9F1:/
MQM0*@QL;VU(W6!%#:V;@CAF(0P;*5.>UJLLBKXL*+^\>U=7'H?H9QE41]=JX
M(5<?U0I*)'H-XL7IO:GI&5IH*AO3(Z^AVMPVM3H^NOWEY_KH9.!^U27T%5M9
MLR(?IC$WEU]XC,X359J*@U\>&U63"764KF^($@G";QRCM+.FU-R;=+/QX2&I
M*?QW658V56.V]&@@J^R3B?E&SX;D)O*%;%*;L"QO&GS0RC6)_\<<$S&PAAS8
M('.\1OP3U12@L5')P[I0#P;[@MO:F(DY+C]:?6<:#/E V[YJ:UA3C:U<)HDE
MAG2:/KZ W0==*PPM7D!;0=2DT0]%5180D&$5?&;&4DAMQ;+=PWM>- '_$(M)
M'Y_;QNT:\CEH@/NYI\DKI559%6!0A(!Y=>/'T-3,0,8)LXX5;!ZG+7A31(C7
M*'+:!501;[;9S189E,[_ROU60\QC4E:TI'"G82Q!4VGD,].5=B++30Q1:)C?
M(_AD\3DK6;9-BT'Z05>@0UM)BITI2*&47YDZ":'&DVY"YT=6;M-$K?4]F6W<
M5I431$[K&8@X(5G$,AJFQ>8;</K1&T$7D4C8P8 ?<\S.<Y?F'VRSWHE+K B"
M )!WPH[<#?OT^7*@/F5WF*Y[@8I' ,;4#6:3SBD(&#;.T."=?!!## 1'80=1
M*980L&=<Z\.7ND;P$BTRES L\0WLY1[1A,?L7XL,,C&U7>4RPR<<GJ)7J\JL
M2&8V1_P#>HK5O4Y;XX,R$U$VR^ L& 8EZF7C> JD^K VN6BEVOCL=Q O=_,'
M*UE3@ 9TZL_,BL0N;>S4YM0"5:2I&(]Z-1N.@8/2E"/GDGZM6-CPPN<\>:A^
MHK7@D>(W _5J/%QTU,A(7D7#2?<#R1EZ+5:Y_0=()FU%9D#,/AI=*;+<A+:%
ML'L' 7JDPH0DD&.+I6'<F<*T07RT(4Y[NC/A G <[=V.8KHJ[IU>1/%_P&#"
MV<0%)3GZ%#\?JD_+I2RTG4N\##%>WZ462#$)S.\2FB'109+SP6@THG]B<K6$
MIRPK<I\I*1JT"&P5<[O/DNF)(N.]A7UVL8BS,Y&[1] H6L2(QU+H.X.6 $G;
M^7+SL_MQH"@'^RQ=E!P9!V$R[CL%";W :E7/#.1E@!J8Q0$_F6^FBBW!", $
MLV%GH"P><R0VR@ZHBXH\V$;BPU&F'SD<0H<I)2X$/AFWU+;"V^HKIHISE,05
M(P<FI87*4/W)Y*:B',I[E1BI%9PQ8Z^  Y*AR=[P^[HRAL7L0VMG.T]D,4Y-
M18XU1!V4^G<E)%P1AV17F<_3\$_^@MED<)U!8H.5^7MK:PMA4.PA 8HI#I30
M=4+K[)2,HN;LYAR>L@WLI(7UL61K,:&XS=I4DI!AFR9*G#8@?(9C'%!\?B.M
MJ7A-&-ZCHLT.L..EL>Q/G&-MSY_AW;N2 @V(G%RL]O1D*<^VK(50LH/:O*=Y
M,#I=#,87D2J!N//&4GP2OVHHC>:G/M.HQ(*IIJBZ!<G :3DX XSQ86WCM8C?
M958PF%HH D..[8E,L16]SW/(K4)N?O3L!D8+J1U;-UY^6/;GDBHR%)*D+[QC
M*UD7*3R'_+"]^QMG>LY0&-,2S'*J=Y0(2)?6L"X[^4Q%/CX'/Y>JMZ6XF(T&
ML_&8EM@GR8QC;V=4?G9J-+&]MB7<2&>"O("Z3JE"4)0Z3RDOP(2;1UGJP Y%
M2Y1@!FPME67C=I(K -H>(*[77$]%LS=J/(\&\\7<F30/#&H2TJA3:)S:Y=)Y
ME:@=F:E*>CJ4Q+Q1X9MNF?,(QC4+E^$(\OVD23T;\M%\,#N?$%DJEEAUXTF$
MY##MENI*KB(4/!!4O+9F2<$U;AV41$+'6H$=HS*B@.2B"46U@V7H)P?";SE-
MB:M(/.P0^;, WN<A"::'TK9W8Y>]Q_P@5NV3."4JJJH:_0UA/S=+*@.#B((2
M-42^+Z[2.+/6SISJUX(BV&F8D0\<PI<40Y,VQDR0 U11T3#BOQ/^.\>> "VH
M."'Q)!F  K4S))0Z48P7@$_CZ7"FYD ^7X ;=06M,+JG>K4HI;[RPS&0(!*M
M(1IX5E%@93R\P >6FM-'A/FW&X%AHW5!]38(< !X,G/UQ"N[I+\7_'?!":-S
M0D4 Q[CV(B?%?@]"D,ZSU@(EQBF8['!HAPQV%/-)XL>EI%#>^?G6SO\7I:=-
M@U&CX;1KOOA/$>U^R?UG=BAHFW#8"[TC +6(DS4B)]G)3ET9BNB6 M\O+O!M
MFC%L00!DW$*A\')">YVQ+<]@;]<!PA,[.S29VB\GL,^M;A;R3M#2^>):.A2T
M3M04DIW@W[;$1V3@E!J>YO?C2TN W3PV6XP&T6(L*6 KT7.0A2S#MD87+"%8
M:+T7+5E5SR:L?5F95_*9@9FC#<!6 (UX =V#.]UBKE UZ<LBK@-:%1'OBIC#
MB%%V:^L^8G1\5/2BPY05X(D4?,JD=F7%N80]!MY=.8H$(=L-I],"/6C>[U2R
M'<W?U+[JR'M@B55)-9,[P>A4%W8)M.]?[',@ 8_U3BG94+$MQD35:9 *>@;/
M9H,""J1@R[_RB0.F7$+"&OCW3YS-N5_R XGB%][A7ZB?P$8-^/@3@"9Q-587
M\SD'JV@QG$QEJE@I/&$"GQJICY0^[%V+W_^HCB<+..<)#1_-U0\"K UT%Y.C
MIH85!?5;ZA8<+Z+A%&,OAM-Y?_U0+D#.X\4",>X5CXPXA<0.4WB\NSUA0KF+
M)TPNU!_#'EBR8==WW#Q.I#RS-JGKCNEO)JAWJ(3C>$-EF*WK=H-IQ%#$MAZ\
ML+43=@"=^G;'%N&]?DO1=3^6/I'X?WWQ>M*,]@N^<LKC3Q CWB4M[.'2Z>49
M)KG_N9?)VSV$A1U'F2,K!UAH[;+9B[J:?=+=;73XJMB[-*5:%YJ"C*&>S!C?
M$;XY46)0-)UR-;<O?%,>"@\!=K"O(.B]T=WWWOZ5L-XA54W8^][X49Z?\  C
M,R08.$&U,I00X,D4\Z63[4C7INN$A'!V#2.PU*P%,J+ ?Y"Z8TB6$$_SW:YE
M2VX6]J*VFU[#7H=CS:U.TKWE9J=O+OL, D<WW!H2SZ"\;Q*'BT*/*:K>QLB>
MC_5)T%N30X2@O=7U+3MF!5IS$[G-V28W*PS4\=W)MEKNS*IKA]%PQ_164SXD
M0G([CIE0)65!*%U8@QR[B%"Y3T7A"U+WI<<!YEC\KM^Z,5[?&PD[L#4W9U\J
MX@/+A5;SDAY56*@9&#'69D!ITL?3SO]!/UZ;Y^%$/]D'P0FFP\0KP^8.FF)O
M[+[?4S/_EX(BWN]_%!3Q"O^-H,C7$:^ZIPX849DQ&0VC:8B+=BJYYX#19!B=
M.#*'<='YG$&1#'L6%)T+(I+1OPVJL)ZVH JK94O>_P(88:[^/9G?VRVU/5SF
M/USO<8^J._H65Z,W)$9W5C=0;<GN*<< @T/G'FM]+T>^LDLX+$"/"]X)H@9"
M-47G.],\&-/SINY@H4=ORX&Z8PB?Q;?/)?;ZF_3@NO.#37=^MX [=#X:=O$V
MRH_ZX5M.)>DH\N8S;;I+QMO1U<4,IJJ[?FP8+,&'+LOT49P<BLR*Q*0[RR$P
M%6 1 QJD8CKUQW0MD<(= SCQ\N^2H;GAOX<EZTQ!8J'QOL0G#P@MZM%261 &
M0^0@$VOVRU(WV*R<6'0S2KDXY"MB6W\]79*4+>18N7K=[(17.>)O>NWXI?J'
MJ8I39% R0XIFOC]8J]O*Z+I%-*7[.NXLVIT,]>ROVU%W:"0Z&&[BQGU!QRG<
M@@)7F\,1N<@0B'DS< BD;/P2J2:;75("3C8S.,YOFK[NA% <C7OL?-R7MBX%
M+B'6QN')8,G>70BSG^-.CL&\C"Z:R>%R;+H$XK9?&L[2$"O+S>$=FR<MXC;V
M=O41#&^;%T&/[JAT ]1AR?Y<OK,R=VH@+;2>]W9'.N(CLO<[0P$$Y -F-I)A
M']BR3M9E%[L<TN(JUY\G"!#N>3"?W06Y F [S,#[I$@L!^;>;<5S?*#R[7N8
MG#OT8;J85N^$A-J^;2:GN*^E>OQRP'<B5';_L]=^)Y08@U=;;DQ]X> M$)U1
M,Q#[8<,PG<2"8V2FB^%DT4<MO)/?C%J^$\'06L]!ET]>(==LYCOOOW2I\@/\
M@2XN4F2X)>LY_C]*D"?JLKNP\6-W84,0T)5.N:CHX9_QX&(\DQ[[8GBQZ-#/
M-LSQG%%C*#H?CD^XD;IX%OZ<7PPO3J1]<SX)6=AJ\RPF8^'B8CBBHXIY@,A<
MAY;][?F&T7PZ\AVFT?D6);<+[JGOS)Q?#,<T;S:\F,&*)L&\7MO)>\V_N^FT
M:YJ;E9YIV-BG^S5[KNYLT7^E1KSA$42PK\>S9_B,N_=CI+'@P&;O 1&Q^1-?
MU!#T=LV7.&][,:X-J1PL%:F8H9-T!Z/WW&HXY,%\M8-N?A;?_/V&5[#XR-_.
M":JOK9@:\.7@EH^/I[L(EB,055V]E>A S>'7 \!X,IQV]X2\-6VU)VC_KFOB
MSH"W[N/LNW5\%MP3STRUXMOP= L"8I<KX]VOW87[2[EGOADNM_4_ZVH%(U*I
M66+J:#@_/Q* [;\T1<FWS@'FFB+CQS4?RM, O%\60#;N"RW0_6\([_\)4$L#
M!!0    ( /.#?5=[(777@P,  .((   9    >&PO=V]R:W-H965T<R]S:&5E
M=#(P+GAM;)U6VV[;.!#]E8$:% D0Z$+)7L>Q#3CI7@JT72/I;E$L]H&6QA91
M2E1)*D[Z]1U2MN-L'*_;%U*\S#EGAAR.1BNEOY@2T<)])6LS#DIKFV$4F;S$
MBIM0-5C3RD+IBEL:ZF5D&HV\\$:5C%@<]Z.*BSJ8C/S<3$]&JK52U#C38-JJ
MXOKA"J5:C8,DV$S<B&5IW40T&35\B;=H_VIFFD;1%J40%=9&J!HT+L;!-!E>
M96Z_W_"WP)79^0;GR5RI+V[PMA@'L1.$$G/K$#AU=WB-4CH@DO%UC1EL*9WA
M[O<&_3?O._DRYP:OE?PD"EN.@T$ !2YX*^V-6OV!:W]Z#B]7TO@65MW>7AI
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MK%Q>]"['9U=3M@\&ORNY<9UGXD@6QGSAEP_%16_$A*26N6<$@7]W\JW4FH%
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MHV!O$&]ILSDOSM$F%R8LKVWL")+'F'52\9XBSP6D)DGOGL<[T TWRE&!Z3I
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MC2+'=D5J$'LK[OMBK@R(D.=K@EV:F+VD\AWM4GO**!)H7F?K!:F9(5PR[=8
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M,2[(-OSX(+QX4_(7_G/CO<GY<85#J;)$@/V%P?6X?B$%S2] +O\$4$L#!!0
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M\5$$.CP8PL"JSE_2:V7IRO?=AMY8J)T K5>*CMIAX SL7FV+?P!02P,$%
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M-P4_]!K+&(U?')]7U<;6@M"=!I<C7.BR$FKSF^60""[+JM ;1!_[11K:C]K
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M,+]"D^R28*$MT7.5[4!4P$Q=NR]>77WA<\BGMPR#3:2GSI9M5\'^W@'4DP-
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M-4GTH'=[YIK\8!AS*"C0+;_DV(YG\:G,A-Q 5K68-$#@P^%.<8ALE?GQJBC
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M--%F,2XX/7/,M.$,T?CAA,B'S,C4P"8MZI/#VSN<8]NB*(83"H%V$E1L6<V
M('8=\"T[&NCLT:DS-4R=?=&".@ :='Q<>Q3_&P-\#189DH4+>0"BP1&Y,: Q
M5A9B%GS&R^)OIN, BE([HTKCO9U=8Q@ E,G.=%OX4+['C!P1%]IUY(]+$)F^
M9*.6[=F(8J(>,&]#=![DXA  5RH*I+L/ABV[8K6<DSSF(Q-SCMK'M7CE<-)*
M)QCO)TY9I'4!DBA5?I= #@#:5+(IG"Q8MQ1<O<EBV*#K (\P_H-Q-5ON*L]
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M4ZH+V)-J*64S@+1M1_0BXN%MOMS(EKWE1$#0824P*04WR18* 5$MCI#<'H:
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M//^$T?X0\NU0U8>?VH/DU9/J2SD[GB/69/#G)8@Q+7K'72Q$@V'UF[>QY#1
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MAF?!AA9%.D669R6N8*OSN>*ZTJ3&8_K=U$0;\591>A^$@K>;L=R87![F>"
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MD..:M=PLY/8;[OI)+%\FN79?V':UPZ$'6:N-K'=@4E!7HAO9\^X<#@!7X1N
M> >(G>YN(Z?R$S,LG2JY!66KB<T&KE6')G&5L)>R-(I6*\*9=(D%';$!)G+X
MBK)0K"FKC'&P;'#^P%8<]<4T,+271039CG?>\<9O\$8QW$EA2@V?18[Y:X*
M1/9*X[W2>7R2<8F-#X/P$N(P'IS@&_2=#QS?X#^=+["1RE2B@%_7*VT4_2>_
MC_7;L0V/LUGO3'3#,IQY9 Z-:H->^OY=- H_GM Z[+4.3[&G2_)BWG($N2:]
M&Q0M:EB]O+ZQ!1;TGQ^3?IK\D+#H"<EQA;.-0F :UI*3?_4$?B)3@/9.@6[$
M8+U"U5^+_<3V$\&CJ(RM,<P0]1F,PL@?NC'T!VX<4WXK#"K!K$&I@_/H I+(
MSB?QV(\A21)_# _2T-H91)=1'/I7NVCL)UTT2HB/D,>..3@P1HVJ</;7D,E6
MF,XC_6S_PEQWQOI7WCU/=TP5E=# <4W0T/^0>* ZRW>)D8VSV4H:,JT+2WHE
M4=D"6E]+:?:)W:!_=]._4$L#!!0    ( /.#?5?A4"E.  <  +85   9
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M%4CUZ1(N[B%9D4(7X_9OB ,G OB<^I _4E.#<=P3<F49]4*6P6YB3.'6Q]1
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M5&@4@.<CI>SB!A>H/M6>_P502P,$%     @ \X-]5T[PWNKS @  )P<  !D
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MDZ%V"G2^4,IN!.=@^S=._@%02P,$%     @ \X-]5X3V!(0] P  >@<  !D
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MBPIK;F/=H*(_.VUJ[FAI]HEM#/(R@&J9L#2]26HN5+1:!-NC62UTZZ10^&C
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MNM!X!_J_T]H=%C[ ^!BN_@502P,$%     @ \X-]5]=D615.!P  M!0  !D
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MY&7#1^)W6=0^2I*<2AEGJ<2$+7M73(IR1OGJDQ^R)J>-Q ^8B^0##58B!VQ
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M^G1K_55Z$'$!=<Q&@V.6#M+1 ;Q1YXV1QQN]YHT=YQMA,ZF)MF7_7"[1-YA
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M D,"N%]H[;834M ]RF;_ U!+ P04    " #S@WU7>H/:JLH"  !-!@  &0
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MISD6-.]1.P5ZWRAE#X)ST/U!TC]02P,$%     @ \X-]5QTGU<GQ!   F@\
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M64D[U&^;T=VP=TO!+E2:\VS]BV%)&06N!9-9E!3(%1Z8M 9"F5&)C+G%6L,
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MM32-?$KZ<()LEDI+)W.^IOISG7Q8MO()X _8E/)^)0R<*.L7#<3%-'/VRPS
MPEAB'UD$FTGI32G!'GA2B/:BKF=DU=9'X^X"F]0%-OF'!=8Q7=I*K%/-_R7V
M7RJQ_M9Y*17ZWIT*#7/_#<JC4[U:'SS/RO/6DWAY:KWF^EYF]/=Z@:T#;X(I
MKLN38/EB5>Y.7W-E<99SCTL<GH4F 7Q?*&4W+Z2@/H[/_@)02P,$%     @
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MG];XH..&!/!\K;7;+LC [HDX^Q]02P,$%     @ \X-]5\*4"#[9 @  /0L
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MH#7 JE!%LU8,C,Q=^S*7!ILA][K"_A:4-<#UA93F>6 [HJICCOX 4$L#!!0
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M4B'>"HM)8U@T6UAC$@+8)%SO#%([H9XR2BUN?R*,7'7MW'%@'+BF5O@"7RN
M<00![ B8>!!5)9;D>FL&?JW-0!-?OZBU-N&7S<#GE +U_C4JC6'1;%&-JPBB
M/M,5U6J@TA@6S1;66(T OLGMG:Z']ZB=E3!\6F^1^K -@;$- 6P;;K11R#:9
M4P^PI7=H8=(8%LU6S?B0X*S/G$6U)Z@TAD6SA37V)(#OZ\^/+]WMRNHD_[8^
M;[(0IL)^%.Y9!SY9>+S"AEMZB]J'-0F,-0E@*]'F./F/S)O]"'JF?B_29O%/
MKI/2+1VFQ9BCTA@6S5[&-X8E'/6YD(]J7%!I#(MF"VN,2PBO3WA;Z!,\"EAH
MN*FW<'T8D] 8DQ V)B;!MW7XGI#'2W*8Z1V(J,L96#1;S[V=.KUNU<'=JX.[
M6:</KQ,:KQ/"*RC^&0[S:)/@3ME0G0P6S9;-.)D0=C(FOZ\V25JO3[HS&G5U
M!)7&L&BV@L;FA.,^,QK5":'2&!;-%M8XH?#$BDPG;-D)*SIA3V4WS(9N@<--
MO47LP_6$QO6$L!$Q^7W#%VO]R^JC':%.\5#78E!I#(MFZVD,3SCM,]M1K0\J
MC6'1[-VVQOI$+UVK>46VGV!'QY,=;NF]\;8/EQ,9EQ/!KL0D^T^"2[$NTB5)
MLK(J'H$=RJB+,J@TAD6SY33>)PIZS/4(U02ATA@6S1;6F* (7NSYO%R'V<?K
M=KBAMX2]_''"WE\GP/;DAC\?N[D.M_0./%2W@T6S53-N)^ISBUB$:H)0:0R+
M9@MK3% $K_7@WEP_<;(I,)VC&B LFBVJ,4 1;%+:'/>ZN0XCO6,4U0IAT6PY
MC16*^MR?%J%Z(E0:PZ+9PAI/%"'O3SO!HS&0X*B>!XMF_Z6<\3PQ[$M,@GO<
M7(>9OH&(2F-8-%M/XW_B/K>GQ:A.")7&L&BVL,8)Q2>WI_EE^ E>!-Q^@YMZ
M"]>'TXF-TXEA-V(R'+R]#E.\0P_5Z&#1; 6-T8G[W,,6HWHA5!K#HMG"[OV=
M-KSR\UDF_ 0[ F9PN*FWB'WXGMCXGOC$'K<NOSUNK\-,[Z!$M3Q8-%M/8WGB
M/G>_Q:CF!Y7&L&BVL,;\Q/ ZT.=E.\RFP&XWN*FWB'T8G=@8G?C$;K<NVU]^
M?QU&>L<DJOW!HMF/US#V9]SG;K<QJ@]"I3$LFBVL\4%C>!WHLY+]!!M:.8>;
M>HN(ZGF&>\_!RD2U:IXG)DGS6*OM8Z:Z3[MGEETV3^KZY/,K^HYMGSQF,-L'
MH=WP:I7DDJ3B02-';\]T;5)MGRVV?:.*LGG:UGVA5)$U+]>"+T55'Z!__U 4
M:O>F/D'WA+?9_U!+ P04    " #S@WU7M ?CJB<)   .60  &0   'AL+W=O
M<FMS:&5E=',O<VAE970T-"YX;6R]G%MOX[@=Q;\*X6Z+76 VUL6QDVEB((DN
MG<6F"":S[4/1!T9B;&%D44O)R028#U]2DBW3IIFH>[+S,+%E\D?2_V->CBA>
M/'/QM5HR5I-OJ[RH+D?+NBX_CL=5LF0K6IWPDA7RDT<N5K26;\5B7)6"T;3)
MM,K'GN-,QRN:%:/Y17/M3LPO^+K.LX+="5*M5RLJ7JY9SI\O1^YH<^%SMEC6
MZL)X?E'2!;MG]6_EG9#OQEM*FJU8466\(((]7HZNW(_QQ%$9FA3_RMASM?.:
MJ*8\</Y5O?F47HX<52.6LZ16""K_/+$;EN>*).OQ>P<=;<M4&7=?;^A1TWC9
MF =:L1N>_SM+Z^7EZ&Q$4O9(UWG]F3__@W4-.E6\A.=5\S]Y[M(Z(Y*LJYJO
MNLRR!JNL:/_2;]T7L9/!G1S)X'49O+=F\+L,_GZ&Z9$,DR[#Y*TEG'893M^:
M8=IEF+XUPZS+,&N"U7Z[36@"6M/YA>#/1*C4DJ9>-/%M<LN(9(62XGTMY*>9
MS%?/ORPSD9([*NH7<B4$+19,"JVN""U2\IGEM&:;CX.L2G)>K06KR,_D*DTS
M)2::DT]%^Y-0TOHQ8#7-\NHGF>2W^X#\^,-/%^-:5E05-TZZ2@5MI;PCE7(]
M<LN+>EF1L$A9J@/&LH7;9GJ;9EY[5N(OM#@ACON!>(XW,53HQI[]JA3;[)ZI
M/?;L]ZP\(;[39/<-V<.W9S>5'KT]NVO('MNSWU+9=M_8=BT4_E9Q?L/SC_!T
M47V1DJMHVRW]YU>9E'RJV:KZKZ&>URUW8N:J/OMC5=*$78YDIUPQ\<1&\[_]
MQ9TZ?S<%' D+D+ 0"8N0L!@$TV0SV<IF8J//=X5R+]E9(KNAJX5@37_U0?6)
MV6J](B43&4]-\K'RA\K'7EEO0E9-!V82"[(>(1(6(6$Q"*:)Y70KEE/K]W^U
MXFLUB*5K1AX%7Y%K.?/AQ0<YAB5?LZ)2<R YOMWP54F+%Y-8K/RA8D'"@A9V
MWL#41/-I[DZ\B:/^78R?=K5A2.DZYX:4$;*",0BF!7ZZ#?STS8&O^?"P6^E#
MPXZ$!2ULNA/,F>^:HGZ8<#H]-04=6;T8!-."/ML&?68/>I*(M9Q1L&]R@58Q
M4Z=[;24,#2P2%LP.XN6Z9\;(&E(Z$]\46F0%8Q!,"^W9-K1GUM#>"5;2K ]M
M\_OE]9()4Y"MK*%!1L*",T.076.G?9AR-C/VV<CZQ2"8%N/S;8S/K3&^X55-
M^",I!4_7B>R\*YZG[; MNK5"V:P5LN))3O6X>"'E6B1+>N2G;BUMJ J0L.#\
M(+;[T3\_&+*],\<4_<.$$V=J2!B#&J!%UG5Z=\&QQG9Z,CO]JYRO%QD7\D^R
M%C*:_^0U:X=HS_$=\GWS>7O]NUH9RCB;0FLO;6ALH;0 2@NAM A*BU$T75,[
MCI7[3@9"!T;)!TD+H+002HN@M!A%T^7C]?+QK%U2)-&$-NL$HT:LN0=KQ#OL
MT!W'U*,'T()#*"V"TN(W?2EZ='MST;6:4//!*SX[;W"\H;8BE!9":1&4%J-H
MNFIZ;]&=O->0 G45H;0 2@NAM A*BU$T73Z]V^C:[<8;6A3KG)+[=5GF+YHK
MG16-*UWP.I/#3FM.*V>J9D)^)D5'Z":U45Y0'_*59OA3BVL-K4D(I4506HRB
MZ6+J'4S7;F&^+J9.1<T*.<VJ6F0/ZZ:S2I6>!H@+ZG:^TBS7(2^,"K.VD!4)
MH;0(2HM1-%U;O5'JVIW2X;,CJ&\*I0506@BE15!:C*+IJND]6/?LO69'4$<6
M2@N@M!!*BZ"T&$73Y=/;NZ[=WY6"21GYS!*6/=&'G%5$+L%K+K)BT8]NFWOZ
MY)')4:LB5(URB?R +I@RA]6@2',BV!,KULRH-:COV]&4U=6;M2>.X^ZOVI&E
MAE!:!*7%*)J^?ZMWDCV[DQSL3G0,^S[4G(<\<M'/B.1K6I8\*^K]+63=CC&H
MF?Q*];WCLQ]H/4(H+8+28A1-EU!O''M69_$=EVGV@@=+R=X,ZS(-6I,02HN@
MM!A%T\74V\B>W4;^\Y9I]HH,%I>]6:>6?@IJ4$-I$906HVBZM'H/V[-[V,>E
MM5%,^QQ .RN70E(ADPGEZ,<26C4WS+L;Y!LQ?B#/69'^G/+GPK)#TEZOP4JS
MM]+>C4&=;R@M@M)B%$W76N]\>U9K=/Z%?B.WM);"TG;3)ES.LZF<ELLR9<?5
MK/8JFW*@-O@K=;;-I:"6-Y0606DQBJ;KIK>\/;M7/$0W\O)2/5A"LH)4-4^^
M$MD-R8S+K"3U4J9<\MRL*JC[W=%<5UO2G>XMZ*!EAE!:!*7%*)JNH-[G]NR&
M\*]\(2=%65)9M_.K$<\H#:AW_4I5;1T.U+J&TB(H+4;1=+GTUK5GMZ[M<J&I
MFNC(+H>J)QN/F4@%JVT.DKT&@S4U,W4W!P82M- 02HN@M!A%TP74N]B>?2OQ
M'W\FQ%[ 8'U W6S/L,/XR&,AT((C*"U&T72-]%:U9[>J_^CC(W;\8(5 -Q][
MA[N/CSQ! BTW@M)B%$U_=+5WH7V[C?N61TWLB*$B@-*"CK8K N]\9A(!M-P(
M2HM1-%T$O8_LVPW880^EV&&#Y0#==-S1=G=BGAG'#&BQ$906HVBZ&GHCV+<[
MIM9!@GPG4>?*&;4!M7:AM !*"Z&T"$J+431=0#OG(;S;@0C8$Q&P1R)@ST3
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MU;Q<,IHRH1+(SQ\YKS=O5 ';(Y#G_P-02P,$%     @ \X-]5V6:J.:Z P
MQ!   !D   !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULM5A=;]LV%/TKA%8,
M"=#JTQ]Q9AM(G'8KL*!!G&X/PQX8Z=HB2I$:2=OIOQ])R;)DRT)3*"^V*-U[
M?.[AD72OISLNOLD40*&7C#(Y<U*E\FO/DW$*&98NSX'I*RLN,JST4JP]F0O
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MI!*(PD)1NO90R>--16LZDM7FCI\SJ3Y]TRS43P!P':#F%XS);4<OT/U6)'\
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M-[C0,8FB22P&BN>V;5IRI9LP>[G5C34(8Z"?KSE7QX&9H&K5H^]02P,$%
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M$AAK@PUQP@(GM.+(W6U!(CWN9FJLQ1*+,D!>UA$[3AA6"4/4K0!:76@(."@
M!Z=.++EAG#&K!A4V",,PK,!5RQW,OI+;T#-;K6=U_,O+FNB57U"@"([YFYLK
M.^QWJ\/-WF[#<, ]"0&M"_POK94DU\V6,*G]@%X;@-0C!'S%$0./.-Z06D+8
MYFK?EK5R-R#3#>A]"_Z<QC%F'*P)R\)>'_6LE7 OZBCL^-W#F%N=:0IK) VT
M:YK]Y?]$+K\RFOW#;2 O$Y;*=)2&JYUY1H% ZTY?6>)/]#@S"E$Y%%[_T.M+
MR QH= :T"XT3%OP3>7LUO(-.M\)["=T!C?" =N5A7_]/1 WJ4=$A:G!D,I89
MC.2 =LU1NQ6<Z'J_ZM*@XP\./;^$!H%&A$"["KDC3)\QJ+!DV>7IF8_=]-F[
MPB6T"C1B!0Y:S'Z@5?J<C=Z2M7(2;O0.LNN=]V1 J*I]#E6/O?6F=$;U(*N<
M.#4!RJV4,B#H522<O;&F,$:[(+MV.2,'RBU9(W,);8*,-D%V;?*^# A5=<J5
MCZH!N\21"C**!MD53>,D*+>[C]?K5W.@FF)OY#_("!5D%RKGYC^H>@S2J\E^
M[*TVC821(RBX4/:#6CKUR+OA$F<HR"@:9%<T+64_>2L#V^IR"66#C+)!=F5S
M?N:3&RR)3=_KH,.4SMYP4S"C5)#]7*59DH2JIR65@%U"AOA&AOAV&=):?I2W
M<S2.=G^:\AIAXMN%21OY4=[$<51HF:YE_XT6\>U:Y!VYD5\].ZGUNE5]XN[=
MOB6$+?6E) <SNDE%=F=5O"TN/F_T==_!^PF\GF;7E\9,=IOZ'3.YI'(0DX4T
MZ77Z<LMCV05E]B#H6M_Q/5$A:*)_K@B>$Z8*R.\+2L7K@VJ@N"8>_P]02P,$
M%     @ \X-]5V1D'9,+ P  > H  !D   !X;"]W;W)K<VAE971S+W-H965T
M-34N>&ULQ591;]HP$/XKIVR:-FF0D%!@'40"NFZ55@FU:_LP[<$D1Q(UB3/;
M0/OO=W9"!BU$K82VE\2^^#[?]_G.N>&:BWL9(RIXR-)<CJQ8J>+4MF408\9D
MFQ>8TY<%%QE3-!61+0N!+#1.66J[CM.S,Y;DEC\TMIGPAWRITB3'F0"YS#(F
M'B>8\O7(ZE@;PU42Q4H;;']8L BO4=T4,T$SNT8)DPQSF? <!"Y&UKAS.AWH
M]6;!;8)KN34&S63.^;V>7(0CR]$!88J!T@B,7BN<8IIJ( KC=X5IU5MJQ^WQ
M!OW<<"<N<R9QRM.[)%3QR!I8$.*"+5-UQ=??L.)SHO$"GDKSA'6UUK$@6$K%
ML\J9(LB2O'RSATJ'+8=.[X"#6SFX3QVZ!QR\RL$S1,O(#*TSII@_%'P-0J\F
M-#TPVAAO8I/D^A2OE:"O"?DI_UKQX+XU(2%"F/*,DD,RHV\+[HP$9!^O4-")
MPE?!<@6T#<(Y2P3<LG2)P!<P0V'R*0^P@F)Y"#_HM%NW*#7$%;U$$NBAV1%N
M\D3)$I%L[\]0L225'VC;MV"#C)E .;05,=1QVD'%9E*R<0^PZ;APR7,52_B2
MAQCN M@D3:V/N]%GXC8B7F/1!L_Y"*[C>GL"FK[<W6T(QZN/RS-XW0-X6E-H
MU'2?:(V8^IXXE04+<&3112!1K-#RW[WI])S/^P@?"6R'?K>FWS7HWB$Y=5ZT
MYL^S=2PHDR*DZT7!_!&VU\W8HS&/UTR$\/,[0<*%PDS^VB=5]YA2'0EL1ZJ3
M6JJ3QDRIJY=5U1N9Z@UU]2YT]:XVU;LTI1B5I;A/DW*C3V8C_5=8^5YG:*^V
MF99+!CM+VKI@5GLH]&H*O48*6]<*E-?*RU.^$?FUYW@DL!T1^K4(_?^<\OUC
M2G4DL!VI!K54@W^5\H/G^>RTW>Z3K&\,Y[5D[:V?>(8B,KV-A( O<U7^KVIK
MW3Z-3=?PQ#ZAMJKL@O["E#W9)1-1DDM(<4&03KM/92O*/J><*%Z85F'.%34>
M9AA3:XA"+Z#O"\[59J(WJ)M-_P]02P,$%     @ \X-]5X(#8H*K @  %P<
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M&;4^DB)=C>%J8U7I)]E<69J+?IG3GPNU2Z#G"Z7L=N->T/P+DS]02P,$%
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MX%F NKY@3.Y/LAN4GU_"[U!+ P04    " #S@WU7:SCWA4D#  !&#@  &0
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M,S\)>S8D@T/>*C4D+ :"=:1V[$-)9/_ G0K*./K )!'*G7S3MG]N6MJ?5 '
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ML[4YPLR?LE!"[Q*=I](?G&UN'T$4: I+A6[13!"6D1)3-,-O^O251'-XJ8B
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MHM<;:051]Z]ZHGAI>\:2*]V![##7+1^$"=#[:\[5?F+:4/L12?\"4$L#!!0
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MO7.S?])75M_1HG*U9BFTJ5RN69J/$9 VP+Q?":%W'3M!^WF3_0502P,$%
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MQ/O3A'4MPC!RA^>J95<5![$[:E1GB(,&<7 5<8X53='!7HXD0WA/)-SUB)?
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M"]W!01B WI]QKC83<T#[GR#]"U!+ P04    " #S@WU7M.NF\)8#  #'#0
M&0   'AL+W=O<FMS:&5E=',O<VAE970V."YX;6RM5UV/FS@4_2L6K:H9:<-W
M2)A-D)K0:OLPTJAIN\^><).@ J:VD\S^^[6!,( =-!J%AP2;<Z[/N<87>W$F
M]#<[ '#TDF<%6QH'SLL'RV+; ^28F:2$0CS9$9IC+IIT;[&2 DXJ4IY9KFT'
M5H[3PH@65=\3C1;DR+.T@">*V#'/,?UO!1DY+PW'N'1\3_<'+CNL:%'B/6R
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M3RJ.?RNG7KVG!IZOW[Q_,N05F341\,CRO[)$;J?>V$,)I&2?RV=V^ TJ0B;
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M>E1HO)R/RQO)=F9B7#.IYD^SW )1C:8V4+^GC,FW&[U!_5^*V7]02P,$%
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M-N7V&!*SI0:5;,DS0M=KU*ZX @3<$/6K0U,4:\S6Y&63WAR%G;X^&43'.;K
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MJ%<8)*]?=4^B]VUJO239Y(7(=I3L-TKVGV)/=MYTV;QIO*>Y03B<H<0YMT?
MC%$I9Q8S^@AM#DNI,54+R7_1CJ5$U)8&J&#9'.&"7KX2//.0J:6!"J([GD.5
MOK8D5<X.O+.N**^2XVZ''MQJ6_Q6H\&NT>2A4=0Y;6QVM!HT6@W^1:O_4V;,
M!),IPM15J=92,6B)9%^2AS8/%:EL3K=L^GMZA%NELD"]\"W'0*J6TE:EIMEM
MNMJY+^9[^V/J=E5S^D-3M<HKIA=<&A X)\JH\Y:\TE7[J196E;X@SY2E\NZG
M.75LU,Z SN=*V<W"7=#\!TA^ U!+ P04    " #S@WU7R;7)**P"  "4"
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M#+YB$*J^ ^N.D:4K\DMI\,IPS0W^-H"R )Q?26G>.O;>:']$DK]02P,$%
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MCQ2PH"MN;N7F![1Z!I8OEUR[)]FTL8%'\I4VLFK!F$'%1/.FCVT==@#AV1N
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M[':&J)7R@ZQ?&%FZT6XA#0Z*[C''V1^4-<#W2RG-T\(&J/]-)'\ 4$L#!!0
M   ( /.#?5<=XP,<3 0  +<:   9    >&PO=V]R:W-H965T<R]S:&5E=#@R
M+GAM;+69_6^;.!C'_Q6+FTZ;= /\$"#I)9%NK::=U.JJ=;O[V4V<! UP#CO)
M]M^?>2DFF+H]+^2'%@C/X\_7O'R2,#^QXAO?42K0]RS-^<+9";&_\CR^VM&,
M<)?M:2[?V; B(T*N%EN/[PM*UE51EGK@^Y&7D21WEO-JVWVQG+.#2).<WA>(
M'[*,%#\^T)2=%@YVGC9\3K8[46[PEO,]V=('*K[N[PNYYK5=UDE&<YZP'!5T
MLW#^P%?70550[?%W0D^\LXS**(^,?2M7_EPO'+\DHBE=B;(%D?^.])JF:=E)
M<OS;-'7:,<O"[O)3]X]5>!GFD7!ZS=)_DK78+9RI@]9T0PZI^,Q.GV@3*"S[
MK5C*J[_H5.\;APY:';A@65,L";(DK_^3[\U$= KPY)D": K@M05!4Q!406NR
M*M8-$60Y+]@)%>7>LENY4,U-52W3)'EY&!]$(=]-9)U8WE(Y!QR]1W=$'(I$
M)'*%;5"U&=TFY#%)ZXUO;Z@@2<K?R7V_/MR@MV_>H3<HR=%=DJ;R@/"Y)R1/
MV=5;-6-_J,>&9\9^H'L7!?YO"'P(!LJO7U\.Y^6>G(5V*J"="JCZ!<_T^YCD
M)%_1.OM@G+I^,EQ?7G!7?$]6=.'(*XK3XDB=Y:^_X,C_?2C<A9J=10W:J(&I
M^U+.V&0H8%T55E7E#>"X#-QH[AV[W,;.EMR3EGOR$G<XQ%U7Q6?<<8_;V-F2
M.VRYPY>XHR'N\!7<QLZ6W%'+';W$'0]Q1P/<TQZWL;,E=]QRQR]Q3X>XXP'N
M68_;V-F2>]IR3XW<7W94NG@C:#%$/]7I(Q=Z^,8!+/%G+?[,C,\$25%:N6-/
M?DC;B\'[Z$P+$DZTXV <RC((]I46?6.46\KY%2(9.^1"?ERIQLA%DF^E\N3A
MH5P,^L[7DN&9=F68A[:-UC$^-D:[K[.@(TD/M)1]?<!2)?O!:%@_^T(7]Z-A
MW2#=<_0<69D9F]7\UYX6I)K]Y^6,+VKG2W4[#ZS\C.T$W92=73J:H<V];=F5
MH[&=I/&0I37V,32-E:>QG:BQ;FK0K^LQ5(V5J[&=K+%N:]"T8>YMRZY\C>V$
MC75C@W[3&4/96#D;_XRTL6YMC/7I'T/;6'D;7T;<6#<WQ&[8#S.&ND&I&\90
M-^CJUC]<F4>V3:;,#6.8&W1S W:#?C3=W%%GIW/BSE=JL[BK$VL0ZK+?I<>P
M-2A;@YVM0;?US,6SLU?_,(SA;E#N!CMW@^[N6#^%QG W*'>#G;M!=W>DW;/,
MO6W9E;O!SMU-6=1E[Y./86Y0Y@8[<S=E1O(QO W*V_ SW@;=VY/8G?0CC.%M
M4-Z&RW@;=&]/P9WXG5?_0Y5Y9-O?)Y7$@S$DWC3MGG2@_7XYAL,#Y?!@#(<'
MNIW#2#L;S4/_WVA>YZE"^4CGCA3;).<2>"/;^V[Y#*2HGY+4*X+MJP<-CTP(
MEE6+.TK6M"AWD.]O&!-/*^6SB_99U?(_4$L#!!0    ( /.#?5>N(?L-@@0
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MQZWG]^J$O3C$/<"4Q_,/F&UCPE$"&PFI>F,+L?+$N[P1-"N.=%=4")H6ESO
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M;]KA.3];_CQQ\PM02P$"% ,4    " #S@WU7!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /.#?5>7
M&('*[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( /.#?5>97)PC$ 8  )PG   3              "  <L!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ \X-]5QQ3OJ-."
M6C$  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( /.#?5?IW!1@.@(  +H%   8              " @9 0
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #S@WU7#$NO
M;PD&  "-&0  &               @($ $P  >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ \X-]5P&NM])B P  <PL  !@
M ("!/QD  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( /.#
M?5=:7^F#X@8  $4=   8              " @=<<  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    " #S@WU7WM1%+.("   7"   &
M        @('O(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ \X-]5Z!*P-\D"   ;C\  !@              ("!!R<  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( /.#?5<1N*E]7P(  +<%   8
M              " @6$O  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    " #S@WU7]>+U NP'  !^)0  &               @('V,0  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ \X-]5[FP')O<!0
M;PT  !D              ("!&#H  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    " #S@WU7U)UW;-<+  "?(P  &0              @($K
M0   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( /.#?5<
MV/(.4AT  !I:   9              " @3E,  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ \X-]5]H/?\;W%@  J40  !D
M     ("!PFD  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M" #S@WU7G7TK=AL$   G"0  &0              @('P@   >&PO=V]R:W-H
M965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( /.#?5>=*<-=R@,  /H(   9
M              " @4*%  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L!
M A0#%     @ \X-]5S--8FCE!   ]@H  !D              ("!0XD  'AL
M+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #S@WU7D5RT8FH&
M  ".#P  &0              @(%?C@  >&PO=V]R:W-H965T<R]S:&5E=#$W
M+GAM;%!+ 0(4 Q0    ( /.#?5?W"0$^+ 4  -8+   9              "
M@0"5  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ \X-]
M5R]>7/:+#P  DC   !D              ("!8YH  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    " #S@WU7>R%UUX,#  #B"   &0
M        @($EJ@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( /.#?5<,M!W$\PD  "@9   9              " @=^M  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ \X-]5R5 .WY=!0  ,PT
M !D              ("!";@  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    " #S@WU7"&%DNTT,  #^(P  &0              @(&=O0
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( /.#?5<C"S73
M<P@  -\7   9              " @2'*  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ \X-]5V1>?Q'3 P  D D  !D
M ("!R](  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " #S
M@WU7C=CSU1X'   -(@  &0              @('5U@  >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( /.#?5<CNF'H# D  %(9   9
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M970S,2YX;6Q02P$"% ,4    " #S@WU7S"-C*(L"  "#!0  &0
M    @(%=&0$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M /.#?5?A4"E.  <  +85   9              " @1\< 0!X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ \X-]5T[PWNKS @  )P<  !D
M             ("!5B,! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    " #S@WU7A/8$A#T#  !Z!P  &0              @(& )@$ >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( /.#?5<.3%CY, ,
M !@'   9              " @?0I 0!X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ \X-]5]=D615.!P  M!0  !D              ("!
M6RT! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " #S@WU7
M--]!7 H$  "@"0  &0              @('@- $ >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    ( /.#?5=Z@]JJR@(  $T&   9
M      " @2$Y 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ \X-]5QTGU<GQ!   F@\  !D              ("!(CP! 'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " #S@WU7RX!,\4P$   N"@
M&0              @(%*00$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    ( /.#?5?"E @^V0(  #T+   9              " @<U% 0!X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ \X-]5_Z+DV&C
M"   [4T  !D              ("!W4@! 'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    " #S@WU7M ?CJB<)   .60  &0
M@(&W40$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( /.#
M?5=EFJCFN@,  ,00   9              " @15; 0!X;"]W;W)K<VAE971S
M+W-H965T-#4N>&UL4$L! A0#%     @ \X-]5WWT;9Z* @  Q 8  !D
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M=#4P+GAM;%!+ 0(4 Q0    ( /.#?5?N5XXS<P,  +8/   9
M  " @6)O 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @
M\X-]5X#V])B "0  K60  !D              ("!#',! 'AL+W=O<FMS:&5E
M=',O<VAE970U,BYX;6Q02P$"% ,4    " #S@WU73("LAM<%   @+@  &0
M            @('#? $ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4
M Q0    ( /.#?5>IHH(/'P4  #(>   9              " @=&" 0!X;"]W
M;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ \X-]5V1D'9,+ P
M> H  !D              ("!)X@! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX
M;6Q02P$"% ,4    " #S@WU7@@-B@JL"   7!P  &0              @(%I
MBP$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( /.#?5<=
M7IB3U@(  "@'   9              " @4N. 0!X;"]W;W)K<VAE971S+W-H
M965T-3<N>&UL4$L! A0#%     @ \X-]5YD,%$]T!   QA(  !D
M     ("!6)$! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /.#?5?AQ@><700  ,T;   9              "
M@4NG 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ \X-]
M5\:V:%IA @  4 8  !D              ("!WZL! 'AL+W=O<FMS:&5E=',O
M<VAE970V-"YX;6Q02P$"% ,4    " #S@WU7Y%E0,_("  #J"   &0
M        @(%WK@$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0
M   ( /.#?5<A](+MFP,  (T+   9              " @:"Q 0!X;"]W;W)K
M<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ \X-]5RC7"0F_ @  'P@
M !D              ("!<K4! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q0
M2P$"% ,4    " #S@WU7M.NF\)8#  #'#0  &0              @(%HN $
M>&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( /.#?5>K"/B"
M4@0  +$0   9              " @36\ 0!X;"]W;W)K<VAE971S+W-H965T
M-CDN>&UL4$L! A0#%     @ \X-]5Q&#E71 !   &1   !D
M ("!OL ! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " #S
M@WU7WD>?S%X#  #7"@  &0              @($UQ0$ >&PO=V]R:W-H965T
M<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( /.#?5>CKIWIY@,   <-   9
M          " @<K( 0!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#
M%     @ \X-]5Y:Z!ES8 @  #P@  !D              ("!Y\P! 'AL+W=O
M<FMS:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    " #S@WU7R;7)**P"  "4
M"   &0              @('VSP$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM
M;%!+ 0(4 Q0    ( /.#?5=:\BM=:@(  $$&   9              " @=G2
M 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ \X-]5P?Z
M/9ZZ P  C1   !D              ("!>M4! 'AL+W=O<FMS:&5E=',O<VAE
M970W-BYX;6Q02P$"% ,4    " #S@WU7>1KBS^8#   \%   &0
M    @(%KV0$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    (
M /.#?5?3M>6F?@(  *\&   9              " @8C= 0!X;"]W;W)K<VAE
M971S+W-H965T-S@N>&UL4$L! A0#%     @ \X-]5_NM*IQP!   ;AL  !D
M             ("!/> ! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"
M% ,4    " #S@WU7JL4_X&T$  !"$P  &0              @('DY $ >&PO
M=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( /.#?5?\)DCM3 ,
M %D,   9              " @8CI 0!X;"]W;W)K<VAE971S+W-H965T.#$N
M>&UL4$L! A0#%     @ \X-]5QWC QQ,!   MQH  !D              ("!
M"^T! 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q02P$"% ,4    " #S@WU7
MKB'[#8($  "#&   &0              @(&.\0$ >&PO=V]R:W-H965T<R]S
M:&5E=#@S+GAM;%!+ 0(4 Q0    ( /.#?5=P7 )Z<@0  #(5   9
M      " @4?V 0!X;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%
M  @ \X-]5^_RYB)6 P   1   !D              ("!\/H! 'AL+W=O<FMS
M:&5E=',O<VAE970X-2YX;6Q02P$"% ,4    " #S@WU7".MRBG #   >$@
M&0              @(%]_@$ >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+
M 0(4 Q0    ( /.#?5>$^N P,P,  ,@3   -              "  20" @!X
M;"]S='EL97,N>&UL4$L! A0#%     @ \X-]5Y>*NQS     $P(   L
M         ( !@@4" %]R96QS+RYR96QS4$L! A0#%     @ \X-]5P%,X!I-
M!@  83@   \              ( !:P8" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( /.#?5=2-<:CB@(  +DR   :              "  >4, @!X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /.#?5>#T:P!+@(
M $0Q   3              "  :</ @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@    !> %X R1D   82 @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>185</ContextCount>
  <ElementCount>448</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>67</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ConsolidatedStatementsofEquity</Role>
      <ShortName>Consolidated Statements of Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ConsolidatedStatementsofEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Background</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/Background</Role>
      <ShortName>Background</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Summary of Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SummaryofAccountingPolicies</Role>
      <ShortName>Summary of Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Third Party Arrangements and Related Party Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosures</Role>
      <ShortName>Third Party Arrangements and Related Party Disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Collaboration Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/CollaborationAgreement</Role>
      <ShortName>Collaboration Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Other Operating Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/OtherOperatingExpenses</Role>
      <ShortName>Other Operating Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/Revenues</Role>
      <ShortName>Revenues</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Segment and Geographical Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SegmentandGeographicalData</Role>
      <ShortName>Segment and Geographical Data</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Earnings per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/EarningsperShare</Role>
      <ShortName>Earnings per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Financial Instruments and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurements</Role>
      <ShortName>Financial Instruments and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/PropertyPlantandEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Supplemental Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SupplementalFinancialInformation</Role>
      <ShortName>Supplemental Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Summary of Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.embecta.com/role/SummaryofAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Third Party Arrangements and Related Party Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresTables</Role>
      <ShortName>Third Party Arrangements and Related Party Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosures</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Segment and Geographical Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SegmentandGeographicalDataTables</Role>
      <ShortName>Segment and Geographical Data (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/SegmentandGeographicalData</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/StockBasedCompensation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/LongTermDebt</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Earnings per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/EarningsperShareTables</Role>
      <ShortName>Earnings per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/EarningsperShare</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/IncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsTables</Role>
      <ShortName>Financial Instruments and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurements</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/PropertyPlantandEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/PropertyPlantandEquipment</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/Leases</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Supplemental Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SupplementalFinancialInformationTables</Role>
      <ShortName>Supplemental Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.embecta.com/role/SupplementalFinancialInformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Background (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/BackgroundDetails</Role>
      <ShortName>Background (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.embecta.com/role/Background</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Summary of Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SummaryofAccountingPoliciesDetails</Role>
      <ShortName>Summary of Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Third Party Arrangements and Related Party Disclosures - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails</Role>
      <ShortName>Third Party Arrangements and Related Party Disclosures - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Third Party Arrangements and Related Party Disclosures - Allocation of General Corporate Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails</Role>
      <ShortName>Third Party Arrangements and Related Party Disclosures - Allocation of General Corporate Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Third Party Arrangements and Related Party Disclosures - Purchases from Parent (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails</Role>
      <ShortName>Third Party Arrangements and Related Party Disclosures - Purchases from Parent (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Third Party Arrangements and Related Party Disclosures - Net Transfers to Parent (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails</Role>
      <ShortName>Third Party Arrangements and Related Party Disclosures - Net Transfers to Parent (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Collaboration Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/CollaborationAgreementDetails</Role>
      <ShortName>Collaboration Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.embecta.com/role/CollaborationAgreement</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Other Operating Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/OtherOperatingExpensesDetails</Role>
      <ShortName>Other Operating Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.embecta.com/role/OtherOperatingExpenses</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Revenues (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/RevenuesDetails</Role>
      <ShortName>Revenues (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.embecta.com/role/Revenues</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Segment and Geographical Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SegmentandGeographicalDataDetails</Role>
      <ShortName>Segment and Geographical Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.embecta.com/role/SegmentandGeographicalDataTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Stock-Based Compensation - Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Stock-Based Compensation - Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Stock-Based Compensation - Weighted Average Grant Date Fair Value of Performance-Based and Time-Vested Restricted Stock Units Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails</Role>
      <ShortName>Stock-Based Compensation - Weighted Average Grant Date Fair Value of Performance-Based and Time-Vested Restricted Stock Units Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Stock-Based Compensation - Total Fair Value of Time Vested Stock Units Vested (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails</Role>
      <ShortName>Stock-Based Compensation - Total Fair Value of Time Vested Stock Units Vested (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Stock-Based Compensation - SARs Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails</Role>
      <ShortName>Stock-Based Compensation - SARs Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Stock-Based Compensation - SARs Outstanding and the Changes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails</Role>
      <ShortName>Stock-Based Compensation - SARs Outstanding and the Changes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Stock-Based Compensation - Summary of SARs Exercised (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of SARs Exercised (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Goodwill and Other Intangible Assets - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Long-Term Debt - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails</Role>
      <ShortName>Long-Term Debt - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Long-Term Debt - Debt Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails</Role>
      <ShortName>Long-Term Debt - Debt Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Long-Term Debt - Principal Payments Required on Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt - Principal Payments Required on Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Earnings per Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/EarningsperShareAdditionalInformationDetails</Role>
      <ShortName>Earnings per Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Earnings per Share - Computation of Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails</Role>
      <ShortName>Earnings per Share - Computation of Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Income Taxes - Income Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Income Taxes - Provision (Benefit) for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Provision (Benefit) for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Income Taxes - Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Income Taxes - Deferred Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Deferred Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Income Taxes - Interest and Penalties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/IncomeTaxesInterestandPenaltiesDetails</Role>
      <ShortName>Income Taxes - Interest and Penalties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsCashandCashEquivalentsDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - Financial Instruments and Fair Value Measurements - Notional Amounts of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Notional Amounts of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954518 - Disclosure - Property, Plant and Equipment - Components of Property, Plant and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails</Role>
      <ShortName>Property, Plant and Equipment - Components of Property, Plant and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954519 - Disclosure - Property, Plant and Equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/PropertyPlantandEquipmentAdditionalInformationDetails</Role>
      <ShortName>Property, Plant and Equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954520 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954521 - Disclosure - Leases - Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LeasesBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9954522 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9954523 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9954524 - Disclosure - Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/BenefitPlansDetails</Role>
      <ShortName>Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.embecta.com/role/BenefitPlans</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9954525 - Disclosure - Supplemental Financial Information - Trade Receivables, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails</Role>
      <ShortName>Supplemental Financial Information - Trade Receivables, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9954526 - Disclosure - Supplemental Financial Information - Long-Lived Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails</Role>
      <ShortName>Supplemental Financial Information - Long-Lived Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="embc-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9954527 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.embecta.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.embecta.com/role/SubsequentEvents</ParentRole>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="embc-20230930.htm">embc-20230930.htm</File>
    <File>embc-20230930.xsd</File>
    <File>embc-20230930_cal.xml</File>
    <File>embc-20230930_def.xml</File>
    <File>embc-20230930_lab.xml</File>
    <File>embc-20230930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>embc-20230930_g1.jpg</File>
    <File>embc-20230930_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="894">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>112
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "embc-20230930.htm": {
   "nsprefix": "embc",
   "nsuri": "http://www.embecta.com/20230930",
   "dts": {
    "inline": {
     "local": [
      "embc-20230930.htm"
     ]
    },
    "schema": {
     "local": [
      "embc-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "embc-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "embc-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "embc-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "embc-20230930_pre.xml"
     ]
    }
   },
   "keyStandard": 370,
   "keyCustom": 78,
   "axisStandard": 32,
   "axisCustom": 0,
   "memberStandard": 46,
   "memberCustom": 20,
   "hidden": {
    "total": 26,
    "http://fasb.org/us-gaap/2023": 20,
    "http://www.embecta.com/20230930": 2,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 185,
   "entityCount": 1,
   "segmentCount": 67,
   "elementCount": 669,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 894,
    "http://xbrl.sec.gov/dei/2023": 38
   },
   "report": {
    "R1": {
     "role": "http://www.embecta.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.embecta.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.embecta.com/role/ConsolidatedStatementsofIncome",
     "longName": "0000003 - Statement - Consolidated Statements of Income",
     "shortName": "Consolidated Statements of Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Income",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.embecta.com/role/ConsolidatedBalanceSheets",
     "longName": "0000005 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:InventoryRawMaterialsAndSupplies",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "0000006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.embecta.com/role/ConsolidatedStatementsofEquity",
     "longName": "0000007 - Statement - Consolidated Statements of Equity",
     "shortName": "Consolidated Statements of Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.embecta.com/role/ConsolidatedStatementsofEquityParenthetical",
     "longName": "0000008 - Statement - Consolidated Statements of Equity (Parenthetical)",
     "shortName": "Consolidated Statements of Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "0000009 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.embecta.com/role/Background",
     "longName": "0000010 - Disclosure - Background",
     "shortName": "Background",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.embecta.com/role/BasisofPresentation",
     "longName": "0000011 - Disclosure - Basis of Presentation",
     "shortName": "Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.embecta.com/role/SummaryofAccountingPolicies",
     "longName": "0000012 - Disclosure - Summary of Accounting Policies",
     "shortName": "Summary of Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosures",
     "longName": "0000013 - Disclosure - Third Party Arrangements and Related Party Disclosures",
     "shortName": "Third Party Arrangements and Related Party Disclosures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "embc:ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "embc:ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.embecta.com/role/CollaborationAgreement",
     "longName": "0000014 - Disclosure - Collaboration Agreement",
     "shortName": "Collaboration Agreement",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.embecta.com/role/OtherOperatingExpenses",
     "longName": "0000015 - Disclosure - Other Operating Expenses",
     "shortName": "Other Operating Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.embecta.com/role/Contingencies",
     "longName": "0000016 - Disclosure - Contingencies",
     "shortName": "Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LossContingencyDisclosures",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LossContingencyDisclosures",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.embecta.com/role/Revenues",
     "longName": "0000017 - Disclosure - Revenues",
     "shortName": "Revenues",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.embecta.com/role/SegmentandGeographicalData",
     "longName": "0000018 - Disclosure - Segment and Geographical Data",
     "shortName": "Segment and Geographical Data",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.embecta.com/role/StockBasedCompensation",
     "longName": "0000019 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.embecta.com/role/GoodwillandOtherIntangibleAssets",
     "longName": "0000020 - Disclosure - Goodwill and Other Intangible Assets",
     "shortName": "Goodwill and Other Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.embecta.com/role/LongTermDebt",
     "longName": "0000021 - Disclosure - Long-Term Debt",
     "shortName": "Long-Term Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.embecta.com/role/EarningsperShare",
     "longName": "0000022 - Disclosure - Earnings per Share",
     "shortName": "Earnings per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.embecta.com/role/IncomeTaxes",
     "longName": "0000023 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurements",
     "longName": "0000024 - Disclosure - Financial Instruments and Fair Value Measurements",
     "shortName": "Financial Instruments and Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.embecta.com/role/PropertyPlantandEquipment",
     "longName": "0000025 - Disclosure - Property, Plant and Equipment",
     "shortName": "Property, Plant and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.embecta.com/role/Leases",
     "longName": "0000026 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.embecta.com/role/BenefitPlans",
     "longName": "0000027 - Disclosure - Benefit Plans",
     "shortName": "Benefit Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.embecta.com/role/SupplementalFinancialInformation",
     "longName": "0000028 - Disclosure - Supplemental Financial Information",
     "shortName": "Supplemental Financial Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.embecta.com/role/SubsequentEvents",
     "longName": "0000029 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Summary of Accounting Policies (Policies)",
     "shortName": "Summary of Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresTables",
     "longName": "9954472 - Disclosure - Third Party Arrangements and Related Party Disclosures (Tables)",
     "shortName": "Third Party Arrangements and Related Party Disclosures (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.embecta.com/role/SegmentandGeographicalDataTables",
     "longName": "9954473 - Disclosure - Segment and Geographical Data (Tables)",
     "shortName": "Segment and Geographical Data (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.embecta.com/role/StockBasedCompensationTables",
     "longName": "9954474 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsTables",
     "longName": "9954475 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.embecta.com/role/LongTermDebtTables",
     "longName": "9954476 - Disclosure - Long-Term Debt (Tables)",
     "shortName": "Long-Term Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.embecta.com/role/EarningsperShareTables",
     "longName": "9954477 - Disclosure - Earnings per Share (Tables)",
     "shortName": "Earnings per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.embecta.com/role/IncomeTaxesTables",
     "longName": "9954478 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsTables",
     "longName": "9954479 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)",
     "shortName": "Financial Instruments and Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.embecta.com/role/PropertyPlantandEquipmentTables",
     "longName": "9954480 - Disclosure - Property, Plant and Equipment (Tables)",
     "shortName": "Property, Plant and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.embecta.com/role/LeasesTables",
     "longName": "9954481 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "embc:AssetsAndLiabilitiesLesseeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "embc:AssetsAndLiabilitiesLesseeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.embecta.com/role/SupplementalFinancialInformationTables",
     "longName": "9954482 - Disclosure - Supplemental Financial Information (Tables)",
     "shortName": "Supplemental Financial Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.embecta.com/role/BackgroundDetails",
     "longName": "9954483 - Disclosure - Background (Details)",
     "shortName": "Background (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-34",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:NatureOfOperations",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-35",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:NatureOfOperations",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails",
     "longName": "9954484 - Disclosure - Summary of Accounting Policies (Details)",
     "shortName": "Summary of Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "embc:HostingArrangementServiceContractPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "embc:HostingArrangementServiceContractPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails",
     "longName": "9954485 - Disclosure - Third Party Arrangements and Related Party Disclosures - Additional Information (Details)",
     "shortName": "Third Party Arrangements and Related Party Disclosures - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-36",
      "name": "embc:TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "embc:ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-36",
      "name": "embc:TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "embc:ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails",
     "longName": "9954486 - Disclosure - Third Party Arrangements and Related Party Disclosures - Allocation of General Corporate Expenses (Details)",
     "shortName": "Third Party Arrangements and Related Party Disclosures - Allocation of General Corporate Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "embc:GeneralCorporateExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "embc:GeneralCorporateExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails",
     "longName": "9954487 - Disclosure - Third Party Arrangements and Related Party Disclosures - Purchases from Parent (Details)",
     "shortName": "Third Party Arrangements and Related Party Disclosures - Purchases from Parent (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-70",
      "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-70",
      "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails",
     "longName": "9954488 - Disclosure - Third Party Arrangements and Related Party Disclosures - Net Transfers to Parent (Details)",
     "shortName": "Third Party Arrangements and Related Party Disclosures - Net Transfers to Parent (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "embc:NetParentInvestmentCashPoolingAndGeneralFinancingActivities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "embc:NetParentInvestmentCashPoolingAndGeneralFinancingActivities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.embecta.com/role/CollaborationAgreementDetails",
     "longName": "9954489 - Disclosure - Collaboration Agreement (Details)",
     "shortName": "Collaboration Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-73",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.embecta.com/role/OtherOperatingExpensesDetails",
     "longName": "9954490 - Disclosure - Other Operating Expenses (Details)",
     "shortName": "Other Operating Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "embc:SeparationAndStandupCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OtherOperatingIncomeAndExpenseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "embc:SeparationAndStandupCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OtherOperatingIncomeAndExpenseTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.embecta.com/role/RevenuesDetails",
     "longName": "9954491 - Disclosure - Revenues (Details)",
     "shortName": "Revenues (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ContractWithCustomerRefundLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ContractWithCustomerRefundLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.embecta.com/role/SegmentandGeographicalDataDetails",
     "longName": "9954492 - Disclosure - Segment and Geographical Data (Details)",
     "shortName": "Segment and Geographical Data (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-74",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
     "longName": "9954493 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
     "longName": "9954494 - Disclosure - Stock-Based Compensation - Stock-based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Stock-based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-109",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-109",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
     "longName": "9954495 - Disclosure - Stock-Based Compensation - Restricted Stock Units Activity (Details)",
     "shortName": "Stock-Based Compensation - Restricted Stock Units Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-110",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-103",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails",
     "longName": "9954496 - Disclosure - Stock-Based Compensation - Weighted Average Grant Date Fair Value of Performance-Based and Time-Vested Restricted Stock Units Granted (Details)",
     "shortName": "Stock-Based Compensation - Weighted Average Grant Date Fair Value of Performance-Based and Time-Vested Restricted Stock Units Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-103",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R56": {
     "role": "http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails",
     "longName": "9954497 - Disclosure - Stock-Based Compensation - Total Fair Value of Time Vested Stock Units Vested (Details)",
     "shortName": "Stock-Based Compensation - Total Fair Value of Time Vested Stock Units Vested (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-103",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-103",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails",
     "longName": "9954498 - Disclosure - Stock-Based Compensation - SARs Valuation Assumptions (Details)",
     "shortName": "Stock-Based Compensation - SARs Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-116",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-116",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails",
     "longName": "9954499 - Disclosure - Stock-Based Compensation - SARs Outstanding and the Changes (Details)",
     "shortName": "Stock-Based Compensation - SARs Outstanding and the Changes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-117",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-117",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails",
     "longName": "9954500 - Disclosure - Stock-Based Compensation - Summary of SARs Exercised (Details)",
     "shortName": "Stock-Based Compensation - Summary of SARs Exercised (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-107",
      "name": "embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "embc:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails",
     "longName": "9954501 - Disclosure - Goodwill and Other Intangible Assets - Summary (Details)",
     "shortName": "Goodwill and Other Intangible Assets - Summary (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails",
     "longName": "9954502 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)",
     "shortName": "Goodwill and Other Intangible Assets - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
     "longName": "9954503 - Disclosure - Long-Term Debt - Additional Information (Details)",
     "shortName": "Long-Term Debt - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails",
     "longName": "9954504 - Disclosure - Long-Term Debt - Debt Outstanding (Details)",
     "shortName": "Long-Term Debt - Debt Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails",
     "longName": "9954505 - Disclosure - Long-Term Debt - Principal Payments Required on Long-Term Debt (Details)",
     "shortName": "Long-Term Debt - Principal Payments Required on Long-Term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.embecta.com/role/EarningsperShareAdditionalInformationDetails",
     "longName": "9954506 - Disclosure - Earnings per Share - Additional Information (Details)",
     "shortName": "Earnings per Share - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-36",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-36",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails",
     "longName": "9954507 - Disclosure - Earnings per Share - Computation of Earnings per Share (Details)",
     "shortName": "Earnings per Share - Computation of Earnings per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails",
     "longName": "9954508 - Disclosure - Income Taxes - Income Before Income Taxes (Details)",
     "shortName": "Income Taxes - Income Before Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails",
     "longName": "9954509 - Disclosure - Income Taxes - Provision (Benefit) for Income Taxes (Details)",
     "shortName": "Income Taxes - Provision (Benefit) for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails",
     "longName": "9954510 - Disclosure - Income Taxes - Tax Rate Reconciliation (Details)",
     "shortName": "Income Taxes - Tax Rate Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails",
     "longName": "9954511 - Disclosure - Income Taxes - Deferred Income Taxes (Details)",
     "shortName": "Income Taxes - Deferred Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails",
     "longName": "9954512 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "longName": "9954513 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.embecta.com/role/IncomeTaxesInterestandPenaltiesDetails",
     "longName": "9954514 - Disclosure - Income Taxes - Interest and Penalties (Details)",
     "shortName": "Income Taxes - Interest and Penalties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsCashandCashEquivalentsDetails",
     "longName": "9954515 - Disclosure - Financial Instruments and Fair Value Measurements - Cash and Cash Equivalents (Details)",
     "shortName": "Financial Instruments and Fair Value Measurements - Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R75": {
     "role": "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails",
     "longName": "9954516 - Disclosure - Financial Instruments and Fair Value Measurements - Notional Amounts of Derivative Instruments (Details)",
     "shortName": "Financial Instruments and Fair Value Measurements - Notional Amounts of Derivative Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-139",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-139",
      "name": "us-gaap:DerivativeNotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails",
     "longName": "9954517 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Details)",
     "shortName": "Financial Instruments and Fair Value Measurements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestIncomeOther",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestIncomeOther",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails",
     "longName": "9954518 - Disclosure - Property, Plant and Equipment - Components of Property, Plant and Equipment, Net (Details)",
     "shortName": "Property, Plant and Equipment - Components of Property, Plant and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.embecta.com/role/PropertyPlantandEquipmentAdditionalInformationDetails",
     "longName": "9954519 - Disclosure - Property, Plant and Equipment - Additional Information (Details)",
     "shortName": "Property, Plant and Equipment - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:TangibleAssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R79": {
     "role": "http://www.embecta.com/role/LeasesAdditionalInformationDetails",
     "longName": "9954520 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "embc:LesseeFinanceLeaseAreaOfPremisesLeased",
      "unitRef": "sqft",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "embc:LesseeFinanceLeaseAreaOfPremisesLeased",
      "unitRef": "sqft",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails",
     "longName": "9954521 - Disclosure - Leases - Balance Sheet Information (Details)",
     "shortName": "Leases - Balance Sheet Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "embc:AssetsAndLiabilitiesLesseeTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "embc:AssetsAndLiabilitiesLesseeTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails",
     "longName": "9954522 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
     "longName": "9954523 - Disclosure - Leases - Maturities of Lease Liabilities (Details)",
     "shortName": "Leases - Maturities of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.embecta.com/role/BenefitPlansDetails",
     "longName": "9954524 - Disclosure - Benefit Plans (Details)",
     "shortName": "Benefit Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-109",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-109",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails",
     "longName": "9954525 - Disclosure - Supplemental Financial Information - Trade Receivables, Net (Details)",
     "shortName": "Supplemental Financial Information - Trade Receivables, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails",
     "longName": "9954526 - Disclosure - Supplemental Financial Information - Long-Lived Assets (Details)",
     "shortName": "Supplemental Financial Information - Long-Lived Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.embecta.com/role/SubsequentEventsDetails",
     "longName": "9954527 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-103",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-184",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "embc-20230930.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited, canceled or expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax benefit associated with stock-based compensation costs recognized",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US tax on foreign earnings",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r895"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undesignated",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested, Beginning Balance (in shares)",
        "periodEndLabel": "Nonvested, Ending Balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r477"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other, net",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r895"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited, canceled or expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations",
        "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards granted (in shares)",
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails",
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails",
      "http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails",
      "http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails",
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r464",
      "r465",
      "r466",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "netLabel": "Weighted average grant date fair value of units granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r895"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested, Beginning Balance (in dollars per share)",
        "periodEndLabel": "Nonvested, Ending Balance (in dollars per share)",
        "terseLabel": "Fair value per SAR (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r477"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive Income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r211",
      "r213",
      "r218",
      "r621",
      "r633"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Distributed (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total fair value of units vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local income taxes, net of federal tax benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r895"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributed (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax reserves",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r895"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r167",
      "r629",
      "r780",
      "r826",
      "r842",
      "r901"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total incremental cost to be recognized",
        "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost",
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited, canceled or expired (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r518"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r52",
      "r104",
      "r105",
      "r300",
      "r731",
      "r809"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r895"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease due to settlements with tax authorities",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Tax Benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r777",
      "r890"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r467",
      "r486",
      "r487",
      "r488",
      "r489",
      "r492",
      "r502",
      "r503",
      "r504",
      "r505"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxExemptIncome": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxExemptIncome",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Nontaxable items",
        "label": "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r895"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Authorized for future grant ( in shares )",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease due to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Additions charged to costs and expenses",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase due to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesDeductions",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deductions and other",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r237"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease due to lapse of statute of limitations",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase due to current year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work in process",
        "label": "Inventory, Work in Process, Gross",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total amortized intangible assets",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r606"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesBalance",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Beginning balance",
        "negatedPeriodEndLabel": "Ending balance",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "documentation": "Amount of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r238"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits including interest and penalties that would affect the effective tax rate if recognized",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r314",
      "r620",
      "r759",
      "r780",
      "r844",
      "r845"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized intangible assets - gross",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r607"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Other Intangible Assets",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesDomain",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "documentation": "Valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r237",
      "r238"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "documentation": "Information by valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r237",
      "r238"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails",
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails",
      "http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails",
      "http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails",
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r464",
      "r465",
      "r466",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492"
     ]
    },
    "embc_ThirdPartyAndRelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ThirdPartyAndRelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Party and Related Party Transactions [Abstract]",
        "documentation": "Third Party and Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Embecta Corp. Equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r506"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional amount",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r898"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails",
      "http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails",
      "http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails",
      "http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r461",
      "r464",
      "r465",
      "r466",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails",
      "http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails",
      "http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails",
      "http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r461",
      "r464",
      "r465",
      "r466",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOFR",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.embecta.com/role/SegmentandGeographicalDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r60"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r549"
     ]
    },
    "embc_IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "IncreaseDecreaseInOtherReceivablesAndOtherAccountsPayableNet",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Due from/due to Becton, Dickinson and Company",
        "label": "Increase (Decrease) In Other Receivables And Other Accounts Payable, Net",
        "documentation": "Increase (Decrease) In Other Receivables And Other Accounts Payable, Net"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and administrative expense",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract asset",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r363",
      "r382"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible asset amortization expense",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r61",
      "r64"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r356",
      "r573",
      "r823"
     ]
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-lived assets",
        "label": "Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income (Loss), net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r128"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Comprehensive Income (Loss), net of tax",
        "terseLabel": "Other comprehensive loss, net of taxes",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r16",
      "r161",
      "r210",
      "r213"
     ]
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "presentation": [
      "http://www.embecta.com/role/CollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement."
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r300",
      "r768",
      "r856",
      "r918",
      "r919"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency translation adjustments",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r16",
      "r161"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforward",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefit plan net loss and prior service credit, net of amortization",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r16",
      "r127",
      "r161"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.embecta.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity",
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome",
      "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income",
        "terseLabel": "Net Income",
        "verboseLabel": "Net income attributable to Diabetes Care Business/ Embecta Corp.",
        "netLabel": "Net Income attributable to Embecta",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r141",
      "r169",
      "r193",
      "r209",
      "r212",
      "r217",
      "r227",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251",
      "r260",
      "r273",
      "r286",
      "r291",
      "r294",
      "r307",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r559",
      "r564",
      "r632",
      "r691",
      "r710",
      "r711",
      "r756",
      "r791",
      "r852"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/EarningsperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Earnings per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r68"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r112",
      "r625",
      "r670"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanSponsorLocationAxis",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Sponsor Location [Axis]",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r437",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r859",
      "r860",
      "r861"
     ]
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetirementPlanSponsorLocationDomain",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Sponsor Location [Domain]",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r437",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r859",
      "r860",
      "r861"
     ]
    },
    "embc_CommonStockShareIssuanceRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "CommonStockShareIssuanceRatio",
     "presentation": [
      "http://www.embecta.com/role/BackgroundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, distribution ratio",
        "label": "Common Stock, Share Issuance Ratio",
        "documentation": "Common Stock, Share Issuance Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignPlanMember",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Plan",
        "label": "Foreign Plan [Member]",
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r859",
      "r860",
      "r861"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r500",
      "r501",
      "r656",
      "r834",
      "r835",
      "r836",
      "r900",
      "r922"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r780",
      "r921"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to net income to derive net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome",
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax provision",
        "totalLabel": "Income tax provision",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r188",
      "r250",
      "r251",
      "r277",
      "r514",
      "r536",
      "r635"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease, depreciation of assets",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r585",
      "r779"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accruals and reserves",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r892"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued balance",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r892"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Taxes on unremitted foreign earnings",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost, Product and Service [Extensible Enumeration]",
        "label": "Cost, Product and Service [Extensible Enumeration]",
        "documentation": "Indicates type of cost from product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "us-gaap_InterestPaidCapitalized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidCapitalized",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense capitalized",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity."
       }
      }
     },
     "auth_ref": [
      "r752",
      "r824"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation plans",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81",
      "r460"
     ]
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Debt Outstanding",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r69",
      "r70",
      "r106",
      "r107",
      "r109",
      "r113",
      "r152",
      "r153",
      "r761",
      "r763",
      "r828"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "embc_SeparationAndStandupCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "SeparationAndStandupCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/OtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Separation and stand-up costs",
        "label": "Separation and Standup Costs",
        "documentation": "Standup Costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Valuation allowance",
        "verboseLabel": "Valuation allowances",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock awards and equity units (share equivalent) (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r263",
      "r462"
     ]
    },
    "us-gaap_InterestCapitalizationPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestCapitalizationPolicyPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized Interest",
        "label": "Interest Capitalization, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for interest capitalization."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_LossContingencyDisclosures": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyDisclosures",
     "presentation": [
      "http://www.embecta.com/role/Contingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "label": "Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r326",
      "r328",
      "r329",
      "r330",
      "r331"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: amount representing interest",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r39",
      "r192",
      "r215",
      "r216",
      "r217",
      "r239",
      "r240",
      "r241",
      "r243",
      "r249",
      "r251",
      "r268",
      "r308",
      "r309",
      "r361",
      "r499",
      "r500",
      "r501",
      "r533",
      "r534",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r592",
      "r643",
      "r644",
      "r645",
      "r656",
      "r712"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails",
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Finance Lease Liabilities",
        "terseLabel": "Present value of lease liabilities",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r577",
      "r591"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r239",
      "r240",
      "r241",
      "r243",
      "r249",
      "r251",
      "r308",
      "r309",
      "r499",
      "r500",
      "r501",
      "r533",
      "r534",
      "r550",
      "r552",
      "r553",
      "r555",
      "r557",
      "r643",
      "r645",
      "r656",
      "r922"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r192",
      "r215",
      "r216",
      "r217",
      "r239",
      "r240",
      "r241",
      "r243",
      "r249",
      "r251",
      "r268",
      "r308",
      "r309",
      "r361",
      "r499",
      "r500",
      "r501",
      "r533",
      "r534",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r557",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r592",
      "r643",
      "r644",
      "r645",
      "r656",
      "r712"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "embc_NetParentInvestmentNetTransfersToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentNetTransfersToParent",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net transfers to Becton, Dickinson and Company",
        "totalLabel": "Net transfers to BD",
        "label": "Net Parent Investment, Net Transfers to Parent",
        "documentation": "Net Parent Investment, Net Transfers to Parent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassifications",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current finance lease liabilities",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts due from Becton, Dickinson and Company",
        "label": "Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Salaries, wages and related items",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non Current Finance Lease Liabilities",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r732"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r101",
      "r349",
      "r761",
      "r762"
     ]
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r596",
      "r598"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Right of use asset",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r892"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r17",
      "r41",
      "r551",
      "r554",
      "r592",
      "r643",
      "r644",
      "r819",
      "r820",
      "r821",
      "r834",
      "r835",
      "r836"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "embc_CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "CannulaSupplyAgreementTerminationPeriodSubsequentToDistributionDateMinimum",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cannula Supply Agreement, minimum period from distribution date to terminate agreement",
        "label": "Cannula Supply Agreement, Termination, Period subsequent to Distribution Date, Minimum",
        "documentation": "Cannula Supply Agreement, Termination, Period subsequent to Distribution Date, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expense",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r827",
      "r893"
     ]
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited, canceled or expired (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price",
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "embc_CannulaSupplyAgreementTerminationNoticePeriodMinimum": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "CannulaSupplyAgreementTerminationNoticePeriodMinimum",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cannula Supply Agreement, minimum notice period to terminate agreement",
        "label": "Cannula Supply Agreement, Termination, Notice Period, Minimum",
        "documentation": "Cannula Supply Agreement, Termination, Notice Period, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected to vest (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Outstanding, Number",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Outstanding, Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "embc_LesseeFinanceLeaseAreaOfPremisesLeased": {
     "xbrltype": "areaItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeFinanceLeaseAreaOfPremisesLeased",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of space leased (in square feet)",
        "label": "Lessee, Finance Lease, Area of Premises Leased",
        "documentation": "Lessee, Finance Lease, Area of Premises Leased"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Receivables",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r303",
      "r304",
      "r306"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r512",
      "r513",
      "r524",
      "r525",
      "r529",
      "r531",
      "r651"
     ]
    },
    "embc_DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DeferredCompensationArrangementWithIndividualBaseSalaryDeferralMaximumPercentage",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum deferral percentage of base salary under deferred compensation plan",
        "label": "Deferred Compensation Arrangement with Individual, Base Salary Deferral Maximum, Percentage",
        "documentation": "Deferred Compensation Arrangement with Individual, Base Salary Deferral Maximum, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "embc_TaxMattersAgreementCovenantRestrictionsPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "TaxMattersAgreementCovenantRestrictionsPeriod",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Matters Agreement, covenant restrictions period",
        "label": "Tax Matters Agreement, Covenant Restrictions, Period",
        "documentation": "Tax Matters Agreement, Covenant Restrictions, Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares related to stock-based compensation plans",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r120",
      "r121",
      "r154"
     ]
    },
    "us-gaap_GranteeStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusAxis",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Axis]",
        "label": "Grantee Status [Axis]",
        "documentation": "Information by status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r461",
      "r464",
      "r465",
      "r466",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492"
     ]
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r237",
      "r238"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Deferred total",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r159",
      "r187",
      "r537",
      "r538",
      "r827"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "embc_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Balance Sheet Information",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "documentation": "Assets And Liabilities, Lessee"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r237",
      "r238"
     ]
    },
    "embc_LesseeLeaseLiabilityToBePaidYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiabilityToBePaidYearOne",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "2024",
        "label": "Lessee, Lease, Liability, to be Paid, Year One",
        "documentation": "Lessee, Lease, Liability, to be Paid, Year One"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee",
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r464",
      "r465",
      "r466",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "embc_PaymentOfRevolvingCreditFacilityFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "PaymentOfRevolvingCreditFacilityFees",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of revolving credit facility fees",
        "label": "Payment of Revolving Credit Facility Fees",
        "documentation": "Payment of Revolving Credit Facility Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GranteeStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusDomain",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Domain]",
        "label": "Grantee Status [Domain]",
        "documentation": "Status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r461",
      "r464",
      "r465",
      "r466",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492"
     ]
    },
    "embc_BectonDickinsonAndCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "BectonDickinsonAndCompanyMember",
     "presentation": [
      "http://www.embecta.com/role/BackgroundDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Becton, Dickinson and Company",
        "label": "Becton, Dickinson and Company [Member]",
        "documentation": "Becton, Dickinson and Company"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "embc_BuildingLeaseFourYearExtensionOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "BuildingLeaseFourYearExtensionOptionMember",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building Lease, Four Year Extension Option",
        "label": "Building Lease, Four Year Extension Option [Member]",
        "documentation": "Building Lease, Four Year Extension Option"
       }
      }
     },
     "auth_ref": []
    },
    "embc_NetParentInvestmentPensionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentPensionExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentNetTransfersToParent",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Pension expense",
        "label": "Net Parent Investment, Pension Expense",
        "documentation": "Net Parent Investment, Pension Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "embc_PaymentForSpinoffTransactionFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "PaymentForSpinoffTransactionFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net consideration paid to Becton, Dickinson and Company in connection with the Separation",
        "label": "Payment for Spinoff Transaction, Financing Activities",
        "documentation": "Payment for Spinoff Transaction, Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r165",
      "r526"
     ]
    },
    "embc_FinanceLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "FinanceLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease cost",
        "label": "Finance Lease Cost",
        "documentation": "Finance Lease Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r779"
     ]
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonemployee",
        "label": "Share-Based Payment Arrangement, Nonemployee [Member]",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r464",
      "r465",
      "r466",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492"
     ]
    },
    "embc_DeferredTaxAssetsLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "documentation": "Deferred Tax Assets, Leasing Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price",
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "embc_CustomerOneCustomerTwoAndCustomerThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "CustomerOneCustomerTwoAndCustomerThreeMember",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Three Customers in Aggregate",
        "label": "Customer One, Customer Two and Customer Three [Member]",
        "documentation": "Customer One, Customer Two and Customer Three"
       }
      }
     },
     "auth_ref": []
    },
    "embc_NetParentInvestmentConsiderationPaidForSeparation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentConsiderationPaidForSeparation",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentNetTransfersToParent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net consideration paid to Becton, Dickinson, and Company in connection with Separation",
        "terseLabel": "Net consideration paid to BD in connection with the Separation",
        "label": "Net Parent Investment, Consideration Paid for Separation",
        "documentation": "Net Parent Investment, Consideration Paid for Separation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity",
      "http://www.embecta.com/role/EarningsperShareAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock in connection with the Separation and reclassification of Net Investment from Becton, Dickinson and Company (in shares)",
        "terseLabel": "Shares distributed",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r120",
      "r121",
      "r154",
      "r652",
      "r712",
      "r729"
     ]
    },
    "embc_NetParentInvestmentShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentShareBasedCompensationExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentNetTransfersToParent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Share-based compensation expense",
        "label": "Net Parent Investment, Share-Based Compensation Expense",
        "documentation": "Net Parent Investment, Share-Based Compensation Expense"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CEO",
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "embc_LesseeLeaseLiabilityToBePaidYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiabilityToBePaidYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "2025",
        "label": "Lessee, Lease, Liability, to be Paid, Year Two",
        "documentation": "Lessee, Lease, Liability, to be Paid, Year Two"
       }
      }
     },
     "auth_ref": []
    },
    "embc_HostingArrangementServiceContractAssetsInServiceUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "HostingArrangementServiceContractAssetsInServiceUsefulLife",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cloud computing arrangement assets in-service useful lives",
        "label": "Hosting Arrangement, Service Contract, Assets In-Service, Useful Life",
        "documentation": "Hosting Arrangement, Service Contract, Assets In-Service, Useful Life"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r779"
     ]
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "embc_NetTransfersToParentFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetTransfersToParentFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net transfers to Becton, Dickinson and Company",
        "label": "Net Transfers to Parent, Financing Activities",
        "documentation": "Net Transfers to Parent, Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r410",
      "r415",
      "r561",
      "r600",
      "r761",
      "r762",
      "r769",
      "r770",
      "r771"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares related to share-based compensation plans (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r120",
      "r121",
      "r154"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "embc_ContractuallySpecifiedServicingFeesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ContractuallySpecifiedServicingFeesPercentage",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Receivables Factoring Agreement Service fee as a percentage of annual revenue",
        "label": "Contractually Specified Servicing Fees, Percentage",
        "documentation": "Contractually Specified Servicing Fees, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Weighted Average Remaining Contractual Term",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetInterestCarryforward",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense carryforwards",
        "label": "Deferred Tax Asset, Interest Carryforward",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r200",
      "r227",
      "r273",
      "r287",
      "r292",
      "r307",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r545",
      "r547",
      "r564",
      "r624",
      "r683",
      "r780",
      "r792",
      "r852",
      "r853",
      "r908"
     ]
    },
    "embc_A2022EmployeeAndDirectorEquityBasedCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "A2022EmployeeAndDirectorEquityBasedCompensationPlanMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Employee and Director Equity Based Compensation Plan",
        "label": "2022 Employee and Director Equity Based Compensation Plan [Member]",
        "documentation": "2022 Employee and Director Equity Based Compensation Plan"
       }
      }
     },
     "auth_ref": []
    },
    "embc_CustomerOneAndCustomerTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "CustomerOneAndCustomerTwoMember",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Customers in Aggregate",
        "label": "Customer One and Customer Two [Member]",
        "documentation": "Customer One and Customer Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "embc_NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentCorporateAndSegmentAllocationsExcludingNonCashShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Corporate and segment allocations, excluding non-cash stock-based compensation",
        "label": "Net Parent Investment, Corporate And Segment Allocations, Excluding Non-Cash Share-Based Compensation",
        "documentation": "Net Parent Investment, Corporate And Segment Allocations, Excluding Non-Cash Share-Based Compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Gross",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r806",
      "r815",
      "r847"
     ]
    },
    "embc_ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ThirdPartyAndRelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosures"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Party Arrangements and Related Party Disclosures",
        "label": "Third Party and Related Party Transactions Disclosure [Text Block]",
        "documentation": "Third Party and Related Party Transactions Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r811",
      "r848"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaidYearOne",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "embc_NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentNetTransfersToParentIncludingSeparationAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Net transfers to Becton, Dickinson and Company including Separation adjustments",
        "label": "Net Parent Investment, Net Transfers to Parent, Including Separation Adjustments",
        "documentation": "Net Parent Investment, Net Transfers to Parent, Including Separation Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total fair value of SARs exercised",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Fair Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Net",
        "totalLabel": "Total Property, Plant and Equipment, Net",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r811",
      "r846"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaidYearFive",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "embc_LesseeLeaseLiabilityToBePaidAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiabilityToBePaidAbstract",
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Lessee, Lease, Liability, to be Paid [Abstract]",
        "documentation": "Lessee, Lease, Liability, to be Paid"
       }
      }
     },
     "auth_ref": []
    },
    "embc_LesseeLeaseLiabilityToBePaidYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiabilityToBePaidYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "2028",
        "label": "Lessee, Lease, Liability, to be Paid, Year Five",
        "documentation": "Lessee, Lease, Liability, to be Paid, Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs capitalized for cloud computing arrangements",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of capitalized implementation cost from hosting arrangement that is service contract."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r319"
     ]
    },
    "embc_LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LogisticsServicesAgreementAdministrativeFeePercentageOfNetRevenue",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Logistics Services Agreement, administrative fee as a percentage of net revenue",
        "label": "Logistics Services Agreement, Administrative Fee, Percentage of Net Revenue",
        "documentation": "Logistics Services Agreement, Administrative Fee, Percentage of Net Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaidYearFour",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r783",
      "r784",
      "r785",
      "r787",
      "r788",
      "r789",
      "r790",
      "r834",
      "r835",
      "r900",
      "r920",
      "r922"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaidYearThree",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r797",
      "r798",
      "r799"
     ]
    },
    "embc_TimeVestedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "TimeVestedRestrictedStockUnitsMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/StockBasedCompensationTotalFairValueofTimeVestedStockUnitsVestedDetails",
      "http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails",
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time Vested Restricted Stock Units",
        "verboseLabel": "Time-Vested Restricted Stock Units (TVUs)",
        "label": "Time Vested Restricted Stock Units [Member]",
        "documentation": "Time Vested Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaidYearTwo",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "embc_NetParentInvestmentSeparationRelatedAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentSeparationRelatedAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Separation related adjustments, net",
        "label": "Net Parent Investment, Separation Related Adjustments",
        "documentation": "Net Parent Investment, Separation Related Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "embc_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "presentation": [
      "http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right of use assets obtained in exchange for lease liabilities",
        "label": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "documentation": "Right-Of-Use Asset Obtained In Exchange For Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "embc_DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized research and development expenses",
        "label": "Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs",
        "documentation": "Deferred Tax Assets, Deferred Expense, Capitalized Research and Development Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts accrued under the deferred compensation plan",
        "label": "Deferred Compensation Liability, Current and Noncurrent",
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Operating Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Weighted Average Exercise Price (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r296",
      "r605",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r745",
      "r766",
      "r781",
      "r812",
      "r850",
      "r851",
      "r856",
      "r918"
     ]
    },
    "embc_NetParentInvestmentRelatedPartyDebtIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentRelatedPartyDebtIssued",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentNetTransfersToParent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party senior secured notes",
        "label": "Net Parent Investment, Related Party Debt Issued",
        "documentation": "Net Parent Investment, Related Party Debt Issued"
       }
      }
     },
     "auth_ref": []
    },
    "embc_CustomerRelationshipAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "CustomerRelationshipAndOtherMember",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Relationships and Other \u2013 net",
        "label": "Customer Relationship And Other [Member]",
        "documentation": "Customer relationship and other [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r296",
      "r605",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r745",
      "r766",
      "r781",
      "r812",
      "r850",
      "r851",
      "r856",
      "r918"
     ]
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest, Weighted Average Exercise Price (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "embc_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "embc_LesseeLeaseLiabilityToBePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiabilityToBePaid",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lessee, Lease, Liability, to be Paid",
        "documentation": "Lessee, Lease, Liability, to be Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating Income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r286",
      "r291",
      "r294",
      "r756"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails",
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SARs",
        "verboseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "srt_AsiaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AsiaMember",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asia",
        "label": "Asia [Member]"
       }
      }
     },
     "auth_ref": [
      "r924",
      "r925",
      "r926",
      "r927"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables, net (net of allowance for doubtful accounts of $1.0 million and $1.3 million as of September\u00a030, 2023 and September\u00a030, 2022, respectively)",
        "verboseLabel": "Trade receivables",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r302"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising costs",
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "embc_A675SeniorSecuredNotesDueFebruary2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "A675SeniorSecuredNotesDueFebruary2030Member",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "6.75% Senior Secured Notes due 2030",
        "verboseLabel": "6.75% Notes due February 2030",
        "label": "6.75% Senior Secured Notes due February 2030 [Member]",
        "documentation": "6.75% Senior Secured Notes due February 2030"
       }
      }
     },
     "auth_ref": []
    },
    "embc_CollaborativeArrangementPrincipalRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "CollaborativeArrangementPrincipalRightsPercentage",
     "presentation": [
      "http://www.embecta.com/role/CollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product sales percentage",
        "label": "Collaborative Arrangement, Principal Rights, Percentage",
        "documentation": "Collaborative Arrangement, Principal Rights, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Debt",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "embc_StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "StockIssuedDuringPeriodValueNewIssuesAndReclassificationOfNetParentInvestment",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with the Separation and reclassification of Net Investment from Becton, Dickinson and Company",
        "label": "Stock Issued During Period, Value, New Issues and Reclassification of Net Parent Investment",
        "documentation": "Stock Issued During Period, Value, New Issues and Reclassification of Net Parent Investment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Diluted weighted average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r263"
     ]
    },
    "embc_LesseeLeaseLiabilityToBePaidYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiabilityToBePaidYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "2027",
        "label": "Lessee, Lease, Liability, to be Paid, Year Four",
        "documentation": "Lessee, Lease, Liability, to be Paid, Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "embc_DebtInstrumentDiscountPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DebtInstrumentDiscountPercentage",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount percentage",
        "label": "Debt Instrument, Discount, Percentage",
        "documentation": "Debt Instrument, Discount, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "embc_LesseeLeaseLiabilityToBePaidYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiabilityToBePaidYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "2026",
        "label": "Lessee, Lease, Liability, to be Paid, Year Three",
        "documentation": "Lessee, Lease, Liability, to be Paid, Year Three"
       }
      }
     },
     "auth_ref": []
    },
    "embc_PropertyPlantAndEquipmentNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "PropertyPlantAndEquipmentNetMember",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Net",
        "label": "Property, Plant, And Equipment, Net [Member]",
        "documentation": "Property, Plant, And Equipment, Net"
       }
      }
     },
     "auth_ref": []
    },
    "embc_RevenueFromContractWithCustomerSalesDeductionsRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "RevenueFromContractWithCustomerSalesDeductionsRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rebates recorded",
        "label": "Revenue from Contract with Customer, Sales Deductions Recognized",
        "documentation": "Reduction in rebate liability."
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSummaryofSARsExercisedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total intrinsic value of SARs exercised",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Intrinsic Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic weighted average number of shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r263"
     ]
    },
    "us-gaap_NumberOfReportingUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportingUnits",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reporting units",
        "label": "Number of Reporting Units",
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment."
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number"
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected to vest (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Weighted Average Grant Date Fair value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected To Vest, Weighted Average Grant Date Fair value"
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price",
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Lived Assets by Geographic Area",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "embc_A500SeniorSecuredNotesDueFebruary2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "A500SeniorSecuredNotesDueFebruary2030Member",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "5.00% Senior Secured Notes due 2030",
        "verboseLabel": "5.00% Notes due February 2030",
        "label": "5.00% Senior Secured Notes due February 2030 [Member]",
        "documentation": "5.00% Senior Secured Notes due February 2030"
       }
      }
     },
     "auth_ref": []
    },
    "embc_DeferredIncomeTaxesAndOtherAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DeferredIncomeTaxesAndOtherAssetsMember",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Income Taxes and Other Assets",
        "label": "Deferred Income Taxes and Other Assets [Member]",
        "documentation": "Deferred Income Taxes and Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "embc_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable",
     "presentation": [
      "http://www.embecta.com/role/BackgroundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Table]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Table]",
        "documentation": "Organization, Consolidation and Presentation of Financial Statements [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising Costs",
        "label": "Advertising Cost [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "embc_DebtInstrumentVariableRateFloor": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DebtInstrumentVariableRateFloor",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable rate floor",
        "label": "Debt Instrument, Variable Rate, Floor",
        "documentation": "Debt Instrument, Variable Rate, Floor"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseMember",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (income) expense, net",
        "label": "Nonoperating Income (Expense) [Member]",
        "documentation": "Primary financial statement caption encompassing nonoperating income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentNetTransfersToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net transfers to BD as reflected in the Consolidated Statements of Cash Flows",
        "label": "Net Parent Investment, Transfers Reflected As Cash Flows From Financing Activities",
        "documentation": "Net Parent Investment, Transfers Reflected As Cash Flows From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r561",
      "r599",
      "r600",
      "r601",
      "r761",
      "r762",
      "r769",
      "r770",
      "r771"
     ]
    },
    "embc_LogisticsServicesAgreementMaximumTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LogisticsServicesAgreementMaximumTerm",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Logistics Services Agreement, maximum term",
        "label": "Logistics Services Agreement, Maximum Term",
        "documentation": "Logistics Services Agreement, Maximum Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill and Other Intangible Assets",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r606"
     ]
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, Beginning Balance (in dollars per share)",
        "periodEndLabel": "Outstanding, Ending Balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "embc_LesseeLeaseLiabilityToBePaidDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiabilityToBePaidDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Thereafter",
        "label": "Lessee, Lease, Liability, to be Paid, Due after Year Five",
        "documentation": "Lessee, Lease, Liability, to be Paid, Due after Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "embc_HostingArrangementServiceContractPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "HostingArrangementServiceContractPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cloud Computing Arrangements",
        "label": "Hosting Arrangement Service Contract [Policy Text Block]",
        "documentation": "Hosting Arrangement Service Contract"
       }
      }
     },
     "auth_ref": []
    },
    "embc_PerformanceBasedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "PerformanceBasedRestrictedStockUnitsMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/StockBasedCompensationWeightedAverageGrantDateFairValueofPerformanceBasedandTimeVestedRestrictedStockUnitsGrantedDetails",
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Based Restricted Stock Units",
        "verboseLabel": "Performance-Based Restricted Stock Units (PSUs)",
        "label": "Performance-Based Restricted Stock Units [Member]",
        "documentation": "Performance-Based Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Principal Payments Required on Long-Term Debt",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "embc_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease",
        "label": "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
        "documentation": "Finance Lease, Assets And Liabilities, Lessee"
       }
      }
     },
     "auth_ref": []
    },
    "embc_DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax loss and credit carryforwards",
        "label": "Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards",
        "documentation": "Deferred Tax Assets, Operating Loss And Tax Credit Carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "embc_DistributionAgreementDistributorAppointmentMaximumTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DistributionAgreementDistributorAppointmentMaximumTerm",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution Agreement, maximum term for distributor appointed",
        "label": "Distribution Agreement, Distributor Appointment, Maximum Term",
        "documentation": "Distribution Agreement, Distributor Appointment, Maximum Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r593",
      "r594",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r688",
      "r690",
      "r715",
      "r907"
     ]
    },
    "embc_ShareBasedPaymentArrangementLiabilityAwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedPaymentArrangementLiabilityAwardMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Awards",
        "label": "Share-Based Payment Arrangement, Liability Award [Member]",
        "documentation": "Share-Based Payment Arrangement, Liability Award"
       }
      }
     },
     "auth_ref": []
    },
    "embc_NetParentInvestmentCashPoolingAndGeneralFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentCashPoolingAndGeneralFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash pooling and general financing activities",
        "label": "Net Parent Investment, Cash Pooling And General Financing Activities",
        "documentation": "Net Parent Investment, Cash Pooling And General Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest, Weighted Average Remaining Contractual Term",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "auth_ref": []
    },
    "embc_SeniorSecuredRevolvingCreditFacilityMaturing2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "SeniorSecuredRevolvingCreditFacilityMaturing2027Member",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Senior Secured Revolving Credit Facility Maturing 2027 [Member]",
        "documentation": "Senior Secured Revolving Credit Facility Maturing 2027"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Activities",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "embc_NetParentInvestmentOtherTransfersToFromParentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentOtherTransfersToFromParentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentNetTransfersToParent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other transfers to (from) BD, net",
        "label": "Net Parent Investment, Other Transfers To (From) Parent, Net",
        "documentation": "Net Parent Investment, Other Transfers To (From) Parent, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, Beginning Balance (in shares)",
        "periodEndLabel": "Outstanding, Ending Balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22"
     ]
    },
    "embc_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems",
     "presentation": [
      "http://www.embecta.com/role/BackgroundDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Line Items]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Line Items]",
        "documentation": "Organization, Consolidation and Presentation of Financial Statements [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "embc_DebtInstrumentDiscountGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DebtInstrumentDiscountGross",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount",
        "label": "Debt Instrument, Discount, Gross",
        "documentation": "Debt Instrument, Discount, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used for Financing Activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationRestrictedStockUnitsActivityDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock Units (in thousands)",
        "terseLabel": "SARs (in thousands)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeaseRenewalTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeaseRenewalTerm1",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease renewal term",
        "label": "Lessee, Finance Lease, Renewal Term",
        "documentation": "Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used for Investing Activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Income Taxes",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing Activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables, allowance for doubtful accounts",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r305",
      "r310"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Provision (Benefit) for Income Taxes",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Provided by Operating Activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r140",
      "r141"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Tax Rate Reconciliation",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term (years)",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r779"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income Before Income Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r671"
     ]
    },
    "us-gaap_LesseeFinanceLeaseTermOfContract1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeaseTermOfContract1",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of finance lease",
        "label": "Lessee, Finance Lease, Term of Contract",
        "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards",
        "label": "Share-Based Payment Arrangement [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.embecta.com/role/SegmentandGeographicalDataDetails",
      "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r299",
      "r658",
      "r659",
      "r660",
      "r717",
      "r719",
      "r722",
      "r728",
      "r730",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r746",
      "r767",
      "r785",
      "r856",
      "r918"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of products sold",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r605"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Impairment expense",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r65"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r196",
      "r205",
      "r311",
      "r312",
      "r313",
      "r604",
      "r754"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of operating lease",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease renewal term",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.embecta.com/role/SegmentandGeographicalDataDetails",
      "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r299",
      "r658",
      "r659",
      "r660",
      "r717",
      "r719",
      "r722",
      "r728",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r746",
      "r767",
      "r785",
      "r856",
      "r918"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average remaining term of awards",
        "terseLabel": "Outstanding, Weighted Average Remaining Contractual Term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term (years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r779"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r606",
      "r607"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r893",
      "r894"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63"
     ]
    },
    "embc_TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "TransitionServicesAgreementPeriodOfContinuingInvolvementAfterSeparationMaximum",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction Services Agreement, maximum period",
        "label": "Transition Services Agreement, Period Of Continuing Involvement After Separation, Maximum",
        "documentation": "Transition Services Agreement, Period Of Continuing Involvement After Separation, Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross deferred tax assets before valuation allowance",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.embecta.com/role/CollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes, net of refunds",
        "label": "Income Taxes Paid, Net",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r230",
      "r231",
      "r344",
      "r360",
      "r595",
      "r749",
      "r751"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from Operating Leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r582",
      "r587"
     ]
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt outstanding",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated intangible asset amortization expense for 2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated intangible asset amortization expense for 2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated intangible asset amortization expense for 2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated intangible asset amortization expense for 2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated intangible asset amortization expense for 2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated intangible asset amortization expense for subsequent years thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments on finance lease",
        "terseLabel": "Financing cash flows from Finance Lease",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r580",
      "r587"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r181",
      "r185",
      "r630"
     ]
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r813",
      "r827"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r588",
      "r779"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r892"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Change in Cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r139"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r813",
      "r827",
      "r894"
     ]
    },
    "embc_DebtInstrumentPeriodicPaymentPrincipalPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DebtInstrumentPeriodicPaymentPrincipalPercentage",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Quarterly payment as a percentage of principal",
        "label": "Debt Instrument, Periodic Payment, Principal, Percentage",
        "documentation": "Debt Instrument, Periodic Payment, Principal, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Opening Cash and cash equivalents",
        "periodEndLabel": "Closing Cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents - condensed combined statements of cash flows",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r139",
      "r225"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r195",
      "r227",
      "r307",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r546",
      "r547",
      "r548",
      "r564",
      "r780",
      "r852",
      "r908",
      "r909"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r588",
      "r779"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current total",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r532",
      "r538",
      "r827"
     ]
    },
    "embc_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "documentation": "Operating Lease, Assets And Liabilities, Lessee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherGeneralExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherGeneralExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating expenses",
        "label": "Other General Expense",
        "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ParentMember",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parent",
        "label": "Parent [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Components of Deferred Tax Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation and benefits",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r892"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r52",
      "r104",
      "r105",
      "r300",
      "r731"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r52",
      "r104",
      "r105",
      "r300",
      "r649",
      "r731"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r232",
      "r352"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r663",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r700",
      "r701",
      "r702",
      "r703",
      "r706",
      "r707",
      "r708",
      "r709",
      "r723",
      "r724",
      "r725",
      "r726",
      "r783",
      "r785"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r232",
      "r352"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross Profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r227",
      "r273",
      "r286",
      "r291",
      "r294",
      "r307",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r564",
      "r756",
      "r852"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r232",
      "r352"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r232",
      "r855"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r232",
      "r352"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails",
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r321",
      "r697"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment useful life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtPrincipalPaymentsRequiredonLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r232",
      "r352"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails",
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r697"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt",
        "verboseLabel": "Long-term debt",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r109",
      "r341",
      "r574",
      "r761",
      "r762"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Benefit Plans",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r407",
      "r409",
      "r415",
      "r433",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r453",
      "r454",
      "r455",
      "r771"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r597"
     ]
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "embc_LesseeLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Present value of lease liabilities",
        "label": "Lessee, Lease, Liability",
        "documentation": "Lessee, Lease, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CH",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Swiss",
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "embc_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of SARs Valuation Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block]",
        "documentation": "Schedule of Share-Based Payment Award, Stock Appreciation Rights, Valuation Assumptions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r753"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total employer contributions",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases from BD",
        "label": "Related Party Transaction, Purchases from Related Party",
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r268",
      "r605",
      "r650",
      "r657",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r671",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r690",
      "r692",
      "r693",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r712",
      "r786"
     ]
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan assets",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r408",
      "r410",
      "r411",
      "r769",
      "r770",
      "r771"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.embecta.com/role/CollaborationAgreement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration Agreement",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r179",
      "r191"
     ]
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unfunded net pension obligation",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r406",
      "r771"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Benefit plan expense",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r443",
      "r771",
      "r772"
     ]
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Other",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets useful life",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/OtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance costs",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.embecta.com/role/BackgroundDetails",
      "http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.embecta.com/role/EarningsperShareAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Amortization Period (Years)",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r325",
      "r327",
      "r328",
      "r329",
      "r456",
      "r603",
      "r642",
      "r662",
      "r663",
      "r716",
      "r718",
      "r720",
      "r721",
      "r727",
      "r742",
      "r743",
      "r758",
      "r765",
      "r773",
      "r782",
      "r854",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "embc_GeneralCorporateExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "GeneralCorporateExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total General Corporate Expenses",
        "label": "General Corporate Expenses",
        "documentation": "General Corporate Expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r342"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r325",
      "r327",
      "r328",
      "r329",
      "r407",
      "r456",
      "r489",
      "r490",
      "r491",
      "r602",
      "r603",
      "r642",
      "r662",
      "r663",
      "r716",
      "r718",
      "r720",
      "r721",
      "r727",
      "r742",
      "r743",
      "r758",
      "r765",
      "r773",
      "r782",
      "r785",
      "r849",
      "r854",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "embc_ShareBasedPaymentArrangementPlanModificationExpenseRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedPaymentArrangementPlanModificationExpenseRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incremental cost recognized",
        "label": "Share-Based Payment Arrangement, Plan Modification, Expense Recognized",
        "documentation": "Share-Based Payment Arrangement, Plan Modification, Expense Recognized"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r325",
      "r327",
      "r328",
      "r329",
      "r407",
      "r456",
      "r489",
      "r490",
      "r491",
      "r602",
      "r603",
      "r642",
      "r662",
      "r663",
      "r716",
      "r718",
      "r720",
      "r721",
      "r727",
      "r742",
      "r743",
      "r758",
      "r765",
      "r773",
      "r782",
      "r785",
      "r849",
      "r854",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r121",
      "r671",
      "r689",
      "r922",
      "r923"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r164"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.01 par value Authorized - 250,000,000 Issued and outstanding - 57,333,353 as of September\u00a030, 2023 and 57,055,327 as of September\u00a030, 2022",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r626",
      "r780"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r66"
     ]
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TangibleAssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails",
      "http://www.embecta.com/role/PropertyPlantandEquipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of property, plant and equipment",
        "verboseLabel": "Impairment charges",
        "label": "Tangible Asset Impairment Charges",
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r150"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r71",
      "r72",
      "r73",
      "r74"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents - condensed combined balance sheets",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r197",
      "r747"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Cash Flow Information",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Leases",
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease costs",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r779"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period for recognition for unrecognized compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeasesTextBlock",
     "presentation": [
      "http://www.embecta.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Finance Leases [Text Block]",
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred:",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SegmentandGeographicalDataTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues by Geographical Region",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_IncomeTaxHolidayAggregateDollarAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxHolidayAggregateDollarAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax impact related to tax holidays",
        "label": "Income Tax Holiday, Aggregate Dollar Amount",
        "documentation": "The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast",
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r457",
      "r837"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r181",
      "r185",
      "r186"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable, accrued expenses and other current liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trade receivables, net",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ShippingAndHandlingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShippingAndHandlingMember",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shipping and Handling",
        "label": "Shipping and Handling [Member]",
        "documentation": "Packing and transport of product."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Axis]",
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r252",
      "r457",
      "r804",
      "r805",
      "r837"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Dividend declared",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r906"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Domain]",
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r252",
      "r457",
      "r804",
      "r837"
     ]
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_IncomeTaxHolidayIncomeTaxBenefitsPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxHolidayIncomeTaxBenefitsPerShare",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of tax holidays on diluted earnings per share (in dollars per share)",
        "label": "Income Tax Holiday, Income Tax Benefits Per Share",
        "documentation": "Per share amount effect of the income tax benefit resulting from the income tax holidays granted by taxing jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EMEAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EMEAMember",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe, Middle East, and Africa",
        "label": "EMEA [Member]",
        "documentation": "Regions of Europe, Middle East and Africa."
       }
      }
     },
     "auth_ref": [
      "r924",
      "r925",
      "r926",
      "r927"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableOtherCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts due to Becton, Dickinson and Company",
        "label": "Accounts Payable, Other, Current",
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r798",
      "r799"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r154",
      "r628",
      "r646",
      "r648",
      "r654",
      "r672",
      "r780"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Trade, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortized intangible assets - Less: accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r317"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/CollaborationAgreementDetails",
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expense",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r509",
      "r916"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "embc_PerformanceStockUnitsPSUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "PerformanceStockUnitsPSUsMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Stock Units (PSUs)",
        "label": "Performance Stock Units (PSUs) [Member]",
        "documentation": "Performance Stock Units (PSUs)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount drawn",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r166",
      "r917"
     ]
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r510",
      "r516",
      "r524",
      "r530",
      "r535",
      "r541",
      "r542",
      "r543",
      "r655"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments on long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r653"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesInterestandPenaltiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and penalties associated with unrecognized tax benefits on the Consolidated Balance Sheets",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r761",
      "r762"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Data",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r298",
      "r757"
     ]
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reported Value Measurement",
        "label": "Reported Value Measurement [Member]",
        "documentation": "Measured as reported on the statement of financial position (balance sheet)."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.embecta.com/role/CollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r55",
      "r178",
      "r180",
      "r182",
      "r183"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r563",
      "r761",
      "r762"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r52",
      "r104",
      "r105",
      "r300",
      "r731"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r599",
      "r600",
      "r601",
      "r761",
      "r762",
      "r769",
      "r770",
      "r771"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished products",
        "label": "Inventory, Finished Goods, Gross",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_InventoryRawMaterialsAndSupplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsAndSupplies",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Materials",
        "label": "Inventory, Raw Materials and Supplies, Gross",
        "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_InventoryNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNetAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories:",
        "label": "Inventory, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.embecta.com/role/Background"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Background",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r189"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r268",
      "r605",
      "r650",
      "r657",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r671",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r690",
      "r692",
      "r693",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r712",
      "r786"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.embecta.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment fee percentage",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used."
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.embecta.com/role/SegmentandGeographicalDataDetails",
      "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome",
      "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Earnings per common share - Diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r256",
      "r261",
      "r262",
      "r263",
      "r267",
      "r558",
      "r559",
      "r622",
      "r634",
      "r755"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r124",
      "r125",
      "r143",
      "r673",
      "r689",
      "r713",
      "r714",
      "r780",
      "r792",
      "r826",
      "r842",
      "r901",
      "r922"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Inventories",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r748",
      "r780"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Time-Vested Restricted Stock Units Outstanding",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]",
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "embc_LesseeLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "LesseeLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Less: amount representing interest",
        "label": "Lessee, Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Lessee, Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Performance Based Restricted Stock Units Outstanding",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]",
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.embecta.com/role/SegmentandGeographicalDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r924",
      "r925",
      "r926",
      "r927"
     ]
    },
    "us-gaap_DividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common dividends ($0.15 per share)",
        "label": "Dividends, Common Stock",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r154"
     ]
    },
    "embc_TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "TaxMattersAgreementCovenantRestrictionsChangeOfStockOwnershipThreshold",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Matters Agreement, covenant restrictions, change in stock ownership threshold",
        "label": "Tax Matters Agreement, Covenant Restrictions, Change of Stock Ownership Threshold",
        "documentation": "Tax Matters Agreement, Covenant Restrictions, Change of Stock Ownership Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt",
        "label": "Long-Term Debt [Text Block]",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r29"
     ]
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "embc_DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DistributionAgreementFeePaidPerTerritoryPercentageOfNetRevenue",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution Agreement, fee paid as a percentage of net revenue for each territory",
        "label": "Distribution Agreement, Fee Paid per Territory, Percentage of Net Revenue",
        "documentation": "Distribution Agreement, Fee Paid per Territory, Percentage of Net Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Notional Amounts of Derivative Instruments",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r827",
      "r893",
      "r894"
     ]
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "label": "Long-Term Debt, Fair Value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current debt obligations",
        "negatedTerseLabel": "Less: current debt obligations",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "embc_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationLongLivedAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Countries [Member]",
        "documentation": "Other Countries"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SegmentandGeographicalData"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment and Geographical Data",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r278",
      "r288",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r300"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: debt issuance costs and discounts",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r347",
      "r359",
      "r761",
      "r762"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.embecta.com/role/SegmentandGeographicalDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaid",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_ForeignExchangeContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignExchangeContractMember",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange contracts",
        "label": "Foreign Exchange Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r751",
      "r769",
      "r778"
     ]
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityToBePaidYearOne",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesProvisionBenefitforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r813",
      "r827",
      "r894"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Activities",
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Disclosures",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Finance Lease Liabilities",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from Finance Lease",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r587"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r463",
      "r494",
      "r495",
      "r498",
      "r774"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r226"
     ]
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Financial Information",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: amount representing interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangibles",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Finance Lease, Interest Expense",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r585",
      "r779"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome",
      "http://www.embecta.com/role/EarningsperShareComputationofEarningsperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Earnings per common share - Basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r254",
      "r256",
      "r261",
      "r262",
      "r263",
      "r267",
      "r558",
      "r559",
      "r622",
      "r634",
      "r755"
     ]
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "presentation": [
      "http://www.embecta.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities",
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesDeferredIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r597"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "embc_LesseeLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails",
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Lease Liabilities",
        "terseLabel": "Present value of lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r300"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.embecta.com/role/EarningsperShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r264",
      "r265",
      "r266"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r597"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r597"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome",
      "http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Before Income Taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r129",
      "r168",
      "r273",
      "r286",
      "r291",
      "r294",
      "r623",
      "r631",
      "r756"
     ]
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Other Intangible Assets",
        "totalLabel": "Total Goodwill and Other Intangible Assets",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of products sold",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.embecta.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r597"
     ]
    },
    "embc_CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "CannulaSupplyAgreementTerminationRelatedToYearlyMinimumPurchaseForecastWindDownPeriod",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cannula Supply Agreement, termination related to yearly forecasted purchase minimum, wind-down period",
        "label": "Cannula Supply Agreement, Termination Related to Yearly Minimum Purchase Forecast, Wind-down Period",
        "documentation": "Cannula Supply Agreement, Termination Related to Yearly Minimum Purchase Forecast, Wind-down Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r103"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Benefit Plans",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r14",
      "r15",
      "r20",
      "r75"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Income Taxes and Other Liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r808"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest, net of interest capitalized",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r223",
      "r224"
     ]
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForCreditLossMember",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for Doubtful Accounts",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r829",
      "r830",
      "r831",
      "r832",
      "r833"
     ]
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Allowance for Doubtful Accounts and Cash Discounts",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capital expenditures",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Operating Lease Assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r208",
      "r227",
      "r307",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r545",
      "r547",
      "r564",
      "r780",
      "r852",
      "r853",
      "r908"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r276"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Finance Lease Assets",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesInterestandPenaltiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and penalties expense (benefit) associated with unrecognized tax benefits on the Consolidated Statements of Income",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
        "documentation": "Amount of interest expense for an underpayment of income taxes."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r52",
      "r104",
      "r105",
      "r300"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.embecta.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of intangible assets",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome",
      "http://www.embecta.com/role/SegmentandGeographicalDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r275",
      "r285",
      "r289",
      "r290",
      "r296",
      "r298",
      "r300",
      "r380",
      "r381",
      "r605"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total principal debt issued",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r166",
      "r358"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Other Intangible Assets",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r60"
     ]
    },
    "us-gaap_LeaseContractualTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseContractualTermAxis",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Contractual Term [Axis]",
        "label": "Lease Contractual Term [Axis]",
        "documentation": "Information by contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.embecta.com/role/CollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://www.embecta.com/role/CollaborationAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r94",
      "r96",
      "r97",
      "r661",
      "r663",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r685",
      "r686",
      "r687",
      "r700",
      "r701",
      "r702",
      "r703",
      "r706",
      "r707",
      "r708",
      "r709",
      "r723",
      "r724",
      "r725",
      "r726",
      "r751",
      "r783",
      "r785"
     ]
    },
    "us-gaap_LeaseContractualTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseContractualTermDomain",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Contractual Term [Domain]",
        "label": "Lease Contractual Term [Domain]",
        "documentation": "Contractual term of lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIntangibleAssetsMember",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Intangible Assets",
        "label": "Other Intangible Assets [Member]",
        "documentation": "Intangible assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.embecta.com/role/BasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r325",
      "r327",
      "r328",
      "r329",
      "r456",
      "r603",
      "r642",
      "r662",
      "r663",
      "r716",
      "r718",
      "r720",
      "r721",
      "r727",
      "r742",
      "r743",
      "r758",
      "r765",
      "r773",
      "r782",
      "r854",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r593",
      "r594",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r688",
      "r690",
      "r715"
     ]
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PatentsMember",
     "presentation": [
      "http://www.embecta.com/role/GoodwillandOtherIntangibleAssetsSummaryDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patents \u2013 net",
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_ContractWithCustomerRefundLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerRefundLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.embecta.com/role/RevenuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer rebate liability",
        "label": "Contract with Customer, Refund Liability",
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer."
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.embecta.com/role/Revenues"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r383"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r232",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r574",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r825"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Income Taxes and Other Liabilities",
        "label": "Deferred Income Taxes and Other Liabilities, Noncurrent",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxesAndOtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxesAndOtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Income Taxes and Other Assets",
        "label": "Deferred Income Taxes and Other Assets, Noncurrent",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed after one year or normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Line Items]",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_RelatedPartiesAmountInCostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartiesAmountInCostOfSales",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of products sold from related party inventory purchases",
        "label": "Related Parties Amount in Cost of Sales",
        "documentation": "Amount included in cost of sales related to transactions with related parties incurred and recorded in the statement of operations for the period."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction Flag",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r797",
      "r798",
      "r799",
      "r801"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r300",
      "r768",
      "r856",
      "r918",
      "r919"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "embc_SeniorSecuredTermLoanBMaturingMarch2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "SeniorSecuredTermLoanBMaturingMarch2029Member",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan due March 2029",
        "label": "Senior Secured Term Loan B Maturing March 2029 [Member]",
        "documentation": "Senior Secured Term Loan B Maturing March 2029"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeTable",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurementsNotionalAmountsofDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r86",
      "r87",
      "r89",
      "r90",
      "r93",
      "r96",
      "r98",
      "r99",
      "r100",
      "r556"
     ]
    },
    "embc_OperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "OperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards, not subject to expiration",
        "label": "Operating Loss Carryforwards, Not Subject To Expiration",
        "documentation": "Operating Loss Carryforwards, Not Subject To Expiration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r780"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividend payments",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.embecta.com/role/FinancialInstrumentsandFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments and Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_OtherOperatingIncomeAndExpenseTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOperatingIncomeAndExpenseTextBlock",
     "presentation": [
      "http://www.embecta.com/role/OtherOperatingExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Operating Expenses",
        "label": "Other Operating Income and Expense [Text Block]",
        "documentation": "The entire disclosure for other operating income and other operating expense items."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the issuance of long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r652"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r127",
      "r203",
      "r627",
      "r647",
      "r648"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.embecta.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r798",
      "r799"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r574",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r825"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.embecta.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r798",
      "r799"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r116",
      "r117",
      "r163",
      "r166",
      "r232",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r574",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r825"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.embecta.com/role/BackgroundDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.embecta.com/role/LongTermDebtAdditionalInformationDetails",
      "http://www.embecta.com/role/LongTermDebtDebtOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r69",
      "r70",
      "r106",
      "r107",
      "r109",
      "r113",
      "r152",
      "r153",
      "r232",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r574",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r825"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.embecta.com/role/BackgroundDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.embecta.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r798",
      "r799"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of long-term debt issuance costs",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandMember",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land",
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.embecta.com/role/EarningsperShareAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net Income per common share:",
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Balance Sheet Location [Domain]",
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r95"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111",
      "r694",
      "r695",
      "r697"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer."
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "embc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceRollForward",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationSARsOutstandingandtheChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Weighted Average Exercise Price [Roll Forward]",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "embc_NetParentInvestmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentMember",
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Investment from Becton, Dickinson and Company",
        "label": "Net Parent Investment [Member]",
        "documentation": "Net Parent Investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of SAR's Outstanding and Changes",
        "label": "Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense, net",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "documentation": "The net amount of nonoperating interest income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresPurchasesfromParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r695",
      "r697"
     ]
    },
    "embc_SECSchedule1209AllowanceCashDiscountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "SECSchedule1209AllowanceCashDiscountsMember",
     "presentation": [
      "http://www.embecta.com/role/SupplementalFinancialInformationTradeReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for Cash Discounts",
        "label": "SEC Schedule, 12-09, Allowance, Cash Discounts [Member]",
        "documentation": "SEC Schedule, 12-09, Allowance, Cash Discounts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r539"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income and other net taxes payable",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition and Measurement of Revenues",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r744"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments related to tax withholding for stock-based compensation",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r220"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "embc_NetParentInvestmentTaxesDeemedSettledWithParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "NetParentInvestmentTaxesDeemedSettledWithParent",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails": {
       "parentTag": "embc_NetParentInvestmentTransfersReflectedAsCashFlowsFromFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresNetTransferstoParentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Taxes deemed settled with BD",
        "label": "Net Parent Investment, Taxes Deemed Settled With Parent",
        "documentation": "Net Parent Investment, Taxes Deemed Settled With Parent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesIncomeBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r539"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r230",
      "r231",
      "r344",
      "r360",
      "r595",
      "r750",
      "r751"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.embecta.com/role/StockBasedCompensationStockbasedCompensationExpenseDetails",
      "http://www.embecta.com/role/ThirdPartyArrangementsandRelatedPartyDisclosuresAllocationofGeneralCorporateExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and administrative expense",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.embecta.com/role/SegmentandGeographicalDataDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "embc_BuildingLeaseSixYearExtensionOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "BuildingLeaseSixYearExtensionOptionMember",
     "presentation": [
      "http://www.embecta.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building Lease, Six Year Extension Option",
        "label": "Building Lease, Six Year Extension Option [Member]",
        "documentation": "Building Lease, Six Year Extension Option"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r515"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowances",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r895"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://www.embecta.com/role/PropertyPlantandEquipmentComponentsofPropertyPlantandEquipmentNetDetails",
      "http://www.embecta.com/role/SummaryofAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Machinery and Equipment",
        "terseLabel": "Machinery, equipment and fixtures",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "embc_ShippingAndHandlingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "ShippingAndHandlingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.embecta.com/role/SummaryofAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shipping and Handling Costs",
        "label": "Shipping And Handling, Policy [Policy Text Block]",
        "documentation": "Shipping And Handling, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "embc_DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "DeferredCompensationArrangementWithIndividualBonusAndOtherEligibleCashCompensationDeferralMaximumPercentage",
     "presentation": [
      "http://www.embecta.com/role/BenefitPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum deferral percentage of bonus and other eligible cash compensation under deferred compensation plan",
        "label": "Deferred Compensation Arrangement with Individual, Bonus and other Eligible Cash Compensation Deferral Maximum, Percentage",
        "documentation": "Deferred Compensation Arrangement with Individual, Bonus and other Eligible Cash Compensation Deferral Maximum, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "embc_EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.embecta.com/20230930",
     "localname": "EffectiveIncomeTaxRateReconciliationUnremittedForeignEarningsPercent",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes on unremitted foreign earnings",
        "label": "Effective Income Tax Rate Reconciliation, Unremitted Foreign Earnings, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Unremitted Foreign Earnings, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal statutory tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r515",
      "r540"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/IncomeTaxesTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign income tax at rates other than 21%",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r888",
      "r895"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.embecta.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.embecta.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other assets and liabilities, net",
        "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net",
        "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i-k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "835",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481097/715-30-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "60",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "80",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(2)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "a",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "b",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "70",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350/tableOfContent"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "40",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482558/350-40-50-3"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//808/tableOfContent"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450-20/tableOfContent"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450-30/tableOfContent"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483049/450-30-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-27"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>113
<FILENAME>0001872789-23-000031-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001872789-23-000031-xbrl.zip
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M"!?N-M:T;@I85M)^>Z^QQO:=ACU^2A-4@>%*,N('3N\TZ''MD&,E-+O76"?
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MC&.K'04O%F2\5>)#P&KH(!<KAR R%L0=EX<G[ZW8XV+O;%T>W-[5]99(Z(K
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MKR^2H6FX^IK"9G@7K$DT9BW!.$-S]-_NH%QM4T-(L!/!'A%U3>?'M!WP@;I
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M7!5Z*W0QT KVF"FIVT&1Q+BY%"NIKI26L+((M &,PPYF=!PA@ * ON7FPR^
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M!A051=Y"/::!(18QLN$(]"OJ-NW( NE117R*Q'8%H(F_8MB[.]WG@;($70&
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M&A1!8_2\.['VCBZ3I9WN1OYSV;[9&9I(U H%TW0Z+5,N2GT9OC+*:)C9LF^
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M2SRE2B9C.P#+4\;F6?ZZABT#Y#%QB5HJ:)L3RGGLQ*RTL-DF?C(@^M-T;A=
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M$G/]W>[<#)%87MM20SK4<4I]"1F/,]1FD0ZYDUR;Y%=G(%U-/SNF9_/:P#-
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M.WJ-++")3HE@C=6"](W4#T"BS3AW@TU9!7O;E$RF0$$3[6;Q5)5$5(N=@@9
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M=%<"#<1K3%.ZM[V9K?>UQ>Y%03=0R88('EF5H(@$!=Q,XI\* YRQ(@:I4P6
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MX\BF#J*:@5W"J->B7[22R8&@BN<O),4-?6$K0&M^D>GK.A9BBM',L;#<"-?
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MO;J.T_CJ3HG(&[D0-+?V]+[7A/9+I!X)PURWU:!K84\(.-:M,GFVNQ^NIBI
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M@O$>V9.@!92@/%-T5;88GK\EYXQNP#R8FRYG*2%R,ID U9C-EK>P"ZBQXYS
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M:]G<?B$:]XF,/95?@;8BRA9E7F<W<1]L.:@HOGR<V8\YLX;.;-H!R;F(B.R
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M3K["2<-W*H/-@Z0F<+:(W:*Q8;4CG7Z*3Z(#9L;Z]#ZX:5*./Z4RE9/!CX^
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M@EO85Y(&H(_\J87Q#GYH&'\A+17;[D 6  (7TPIF/]D=:N7%$,VI-Q/U)\_
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M_?!,/ WI25<VEF4*J +!F>99$Q;*LZ1)&+1U5UW0:%\$\Y7R%+-PLR=*XV;
M"6*>FOSJ*T.H:OZOBOLB$3KQB9<Y_;87C3Q%TKO0$["T*ZKB__M#]>DG?RW^
M_*R\N/C\KY]]MGF6AS?Z\R=__N+9YY]\L?[LKQ?/_^^G?_G#\:UT]_A\F1W]
M*TJ\\M@SHTEP%%Z")6%X$(GP_PH+>^$];C>CSY_=8D8_YO1]>D[4D?NRNY4
M^IV;'#$3?^PM6 H.49D7_QSSCG=_;^YY, 3?YUU?[:E+.<,3_"_J<@O__NG-
M"Z9J?<D]S%P.(I@<P/74(1UV=PYQI2W;H.0NP4S7[ WQT4C-,488WZR^/O2
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M-'\FU$HHY&H.]0*>AQ')EIH+P-<P9/X<B-?'KLIG'V*!&0]#(V 3="4+M>Z
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MC:T'@=[]&=%J^A[ >@<#6_CWGZ F18XK]46F"GB)BUOP(Q>8$&YBK-22F1&
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MI %T*FD_!;,/1 !WI)YX'04FUD_-Y05FLX0T/5BX<7+&P^/1$'!C*HL;Z A
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M.*AR=)"XGI,^/L.?)CB %P%MXZV.F. !X,$  &QWFLX#1?!0M1Q\#8L"!9<
M453)QYV\O/CP_=O%*R.:1;&8X.\Q?'9BC()+#T')58CX=N#GJL830TZP;JK"
M_9!@J I0\G<?O_E=C+#B%O_\[>;[(A!V\FL4G\>0BFFQ;%$[.8:#@M04-CLF
M;$/48OQ1:(%S7/T@-F:(2$)@(;/G,3SI)+&:>$FUF&E\TM%XN75,8T6+#EJ!
MQ*&AKW;H\D!B*L&";>72.Z(HP+ AW$L QR/%F;MP;MEQ\;;G2$MJL"NI:I$:
MUAM><_DG\@3SY!%BM)**Z:R'E%86T6&MJEW(1'#2?01:!E4: QMS%H!$]:V
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M',^3["2F:'0:$8]4*,_*=CR5.R9V8[D^%;H:7P) N98*1 ,&DX))2/21[2&
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M-BZ"5HSAK,6WHD=CX;?<\\ -&3'X. %A(A=(PPI!<EIXV-S981YC57S\PV0
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MXN$^5>'CTT ^!B'\TS?L)(3#M&=&',++/%(M#"O%@X6N^!N1W5FT6MQ1RY"
M?R_A_@/!SE^[]IT?V2$\5O6X M6C]WCO8OD*1T\; Y]DJ,VA<;%_\;;;?M0
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M?0?_\R%#CNOXO16&,X#&?UM>(HI\HSAVJMDU.R6JUZEZ-524L((2>D]$"5=
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MO.UVVWO+9BZ9C^<8:Z&762+!%)8RJQDXSRHF0P3+?:;8*ZH&'XDKBV1'&:-
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MLS"X?^9 YM,_*Y-R&.TX55_HO,/:PO<2&?D-GQ.5%*3V?Y+U%<4.XY,[)_Q
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M\>M&1X]#SCRW_QK+LTZJ]_I+ "[QH_*/\[HHDWHCE0N4@6M=7L8F<8(I=)/
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MAOU&M?-6HY<3]L.HPHYK'[[LVEO-VGD[I\.%0I8^E9K+"DF:D6TRZ&NG&W
M]VT("GMZ)N7JC/[?QPKX>:^\MGP'\!)#T'/7H9:TI\0%W.(!NN#^\ \C_J%F
M=NVQ8=15S.>167TG?Q3I=IH0'"]5@I!\[R]14H$3/6%H526],$D&>FG.* PS
M 7(X]07YM]3W>+RCU%NRDP-6S$F)*<*2!PL&FX,EXXAN+$5+@>>B"%+[-9/9
MZF_RZ>06K0:9T$&EN/624H@,/:;JCU !"L\0>. S)GETPU-DT8"KT8>HD&#A
M#TFTV9C1O.:&5-D=N6U8+0FKEMZ3 U]%]%=<0.I5^%<J1L9-X3_@@?0MN8H'
M=,MERSJE-*8"R%6&\M:2"L[VUA"DAJ:D)P7+6 YEA@\XA4%1O)CPJN*=%*.D
M<B9R3>,WR2B[/RCSREGLWSV_8'ZZA0U3_37Y:5FEE$GN?G3N@D>@N;"N31L]
M)1WOT>P*0O, C]HKE*S?=<N\V1^ZCO4F,#7)%5A8FPXB:Q^TP%*>X9IS#80D
MZINDZ;?0AJ+.-($ A^Y/&Z,7H8U.E6ACQRV73!M=L!UAESN0QG^I@Y!^!IO+
M5 TCLYPHG3 W&\R-4!^5@M]ERRK3,)_KI9%/84*0A RR'(JB9$ISYXU:#["U
M:68TQCM3U2ANN2PLZ_UO@O]+$EG>R;54!5^"4(#/%?\#[*4KT&=\J45(MY='
MNF?T):/"A$>>U[$+)EN8*37$3*Z 9H\)54HEFX:FSCVO-]%='&JI:\VI?#5J
MY65?D5.[J&U,[I#*%*T*U1GC8)@!BZ6P@M__&2X7\43C[?.SR(];;[':_$()
M]2_N+^=W6?!KVI;94D:LXU.%P8:AHDU0JN.CL@@=HP>)X.IB6=E"P%!;GDPJ
MFI5\"XFRI=YV-L-)7(AUMC1"^V9\&Y/3\F6Z+,-(6286&Q5Z(?29^KI*:H)B
MNO/&9,IQUQK!'ZMU!SXF0XPLQ5@.&F%S%2LV9-T+PQ<#L\"R2%JZSM]]3Z?4
M(CH]K!D >UMBIR,?N;YL4->-='XRSH];X4F^RI#0A(:#P#<B+FAX4D4W\HHD
M5A$=-_OWTGLG;#&L__R7"!8X@>S?Y9TR#4S(.:1TW1PV5DO]@/4MABD]=JE+
M@W4,SS&F4I8)%PK",V:N-Z<:PH OT?R87)G49N4/<&X#BG-L>)R"GHJP@YOQ
MZRBRQ'AK!AST6*2&-61_5-IYX<L9:(IB+/*;LH&&H.7DI5(:BBIV9%*,&LY9
MI$<T]EE!1]5-O 3^ O;-XU]V468@":0@T'+@4O+"=X-I-RBI%;.BOR$DY5!\
M.:]I*<6$LO!=!?,G:0$"!Y[5;#3E&B<PJ#I7V7TJPX\^^H&&0:)_Q^4ZJ(QD
MQO"C''0=H1SDH3M8VT-U0G$P^4E3>&1X%)Q6=BF-3B3CK_!:RA^@C6RZT?P@
M#CN*7]D6)JQJ$$ X,JZ:M!*^_R@;=.;>G]BC&I.@@&.]I7\0>:NT/CY0NGU/
M2JO"%0?^1V[&@?MG4LF>!ZZ"NWD$#T(T8P'O]-XS8TBGP81G:+XG^/:$H?G;
M!M_*EC%&:Y,G@8-KX*\/V%&IWO!($V>8"]5MPA<(L(V-"B.1C.'EP.>'?:1V
M&EV.I1#FEG&DIK!091>7K8&VHVTFE\_].'#(%%;A5B.*9ZN]J/-((T!(SYW$
M"SM NIXR8-?_UK RRRF!+,BYEV27?YO]P-/YIL(G-W? 47CPN8'&0>V\EQMG
M#!UX%56I2W-?&>?,&NKIY8<;K2FWSI3[+;C%D-PDRNE2V1HMG.L?)QF6O(BA
M-GS,2%"BQU*I).I 7'UNX8*.="7&<_(M^DA6^B%V3:^T-J=7F.VE;YL8PW*2
MA1)SO^.86J?#;<C=AG&&.H52P;AT[9R4:BB\^S'(28KT:(Q<I;305$&&7Q@(
MNAA=-OY3=O" W8)^)0[<X< )?\I=,G"_MT$P94Q>0<?%X_)T$#BA(_G#)$VI
M$'G--AY=0!C,T9J3IG)^C5 ]&7BBII7(D-84W.%)C+$"O%XYJ5JA%'/= ?\;
M+I'.)TE&RG8D8S /N>EH61KG\,"EC<](FVW4#.OI_R+U<LQ&%<\^4>:L0/;I
MG1'&-BJ==]UBO_GB6VPW<8OMO.Q@9H]LQ?ZWZR_1D)"<_?ZULVQO7!-RT:V1
MWM[>K[NEP98;+<3]8AX\";$:"7'>U3[_?H&M-+)1<S6?E!,]03DRU\IP5?&B
M6$QYB'!:2W3^V=]SL_ BKJK>R%/BR<BJY&]*PYI/A7\QJ("2<O#V_P+[,!2W
M D?OC$,W^NDV-)ZQTQIP7"\@N9ETE0;F'*;T.]7S3J,O',?PH5?%D0^I8M85
M[OHT?-H=@X&>A,_0:C#Z3'E8%;<8RKK<)&V8G71&73^(9QA[A$_'7;$2L<@7
M,T\I24I<ZOG6ZCO86J-!._0DRP3\GCM]S988C5AM]L3@#K F-$9GW?.IIX:\
M417L5U/2J%P)M2DG<V_=4$X%F$A@$1JZI]^OEZX1+XSUR^X@AA,ACJ,GT):D
M]<F53#GS[=2&S08=:H2(U;!6/\AKI:/-(>('G$1$H:?D$(RAP7Q1TOO$TN-;
MQ!/AFN,CF*I'O=D4[*?9;Q+6W)P!AP2<JC'>%2VSOP4NDX2XT4H#&EO.;-H5
M@K+= FW>;>?@9O[O_]7J-S]J\,PX09KD3U*@H%YFTD.U&DTN9!5L<EV5Q6YT
M,M3%,?24@#L@74F0N>B:374BL^<25KMV/NCD](XZQ4E*&AX5IRB\HLK2TS8;
MXC4 .+=*5T1^DUB"9@LIN< Z3Y4_W3BCJZ^4,WN)=JL&GS32"V;K;LIKO[SS
M?+?N_"Y^>9. 5>U7( _V<XFMP.)UD_Q8,=@P#8)(R$O( W:<A>TWL?TFI]EO
M,CC1?I-V;K])9RTJ::4T3+:*+Z5>V/U1^'\ZP<S1B#4Z1T(=1")!5DP ,-2L
M9Y4]1]U&L+FN,UO&F(OG<?,7]/HU!E$&L%(/H>.8;,86N4HA<6Q6ER8:)*\L
MI0_1""O;P,2QG@9L\W/-2R"V]J@QV.:V^%/9GE]=YZ1"DT[+(D/E$Y='B'B)
MY;O0#"G^7!+LULZ'VQWGRGO'USA,T\O NY'J?EU2+.*Z5"K8>:T 5',*=U)#
M:<C^IURNX-Y_*FESYX$OTIBA*S 4>1CHSB,&Y< :1_R1I")Y8OXN=T*J0@62
ML/(\@R-2A6@W!..G4.JF&H_;B9;W< ,4R9,-(T^I)D43<@EC%XN\(TG\+(J8
M)1B/#(] $H7VA6>5#T9<R+>M%(&8XUO63MEIJRD[+4[\XL9U!Q#<J+SB-.YW
M$I-6]<B2+,H<>&/ V8/(YA#(5_\2UOAM]@.CN3M+4(1(')8ZCJKWTEOHU\Z[
MS9)'^'1DH)UN\-E3EG(&6.VX_9S95<;.!SB[:G7?^]!LT=SPJ*(39-:,E]/5
M<$C.OTL8V!_BE@)"%ZLC4D\@\;=6%R9U4E,'<>*ICM*/DY+!NE16(@=O=QTP
MK\S+:K#PN;A%5:?Q?@TH_LAYI_)AR)!U&D[1;G[\FZS 22[KL[2'Z NMC^_5
M;J1^:S@_L**&U5(DS-H;B2/#X/UI ,/,0R3TCKC'=P(G,.Y.DDJZ^7'!(@-8
M9!%$&F8@*F(7* @^61B= +SGV2?K]\\=+&-4[TEY3_8L]I@Y]6-R)Z;+N?@V
M6S<OY0:#):NC4MK#U3!$>UAH5,H1<-!-:A0 7?R&.UIQ<@LAF#FN0B*./NP\
M1/T9(]/E]>1<6ON8 LR#4:/3ZSXKP+SYLUYO4'K8>M#H#(]EK>!.=X=%GYH3
M.5:T 80K=O_F,83M1UME1Y=JSS $L4.HO8D[RCNQ49'M3ZAL['4.8&7P%+'T
M_UUC7:>.Q-[WIJ^.5<'ZX@-\UR%%XJB=5(08LFF8U2ED>#KH5!<XFT(;?FL'
MURIP< >5NJL%_I.)$+-9]B0=^K]Y?)HN"&[FV ;!XG78]C+/52Y"J=O.)$NE
MVWY7F&2;SA%(P__('F%YV_^832Q7:=\[I4?:^8$RZAN0?H9V,Y27D1<%&B'<
M5F=-$N1@%Z$8?H<+L?QD^>F _-0IAY\ZV%W3R0F)'Q5#O:0?=HR*_X?L_J,,
M7+K5369AR[7E-UB=Q\UU:S)6.W-=JW;>'31&*UQGKZ'0-:S)NNU\#>W:^6B8
M8TU8)^1P%_U]73-Q<4FTL_VTQQ&?#M/T2V(:Q.K+ >NU]W:@>QN4=&_=VGFO
MT:Z<K#L!D<8]SN\8\^"]$F2IP4)O3Z&_VXG(AUDBQUP]_.O9U-[#28*K93+O
M[844NY!1V1?21QB'55.KR(586^N95WX3X)B*]6G\2L5^WW*@ZD2C5&6YRPA]
MEM?;6W*0ZB1"OI:-3HZ-R@IW#$$%M_)\@./AHU), ?45=2$$5%2>,;A;SKX#
MYS,-EEB*ECJ[*KZPA-/7G:@KC>>O5/08B:03B0K@UQ6=<NWL(@P<X#-7ELXB
M2-X\&&.S)H'SW#+VJAI27G?NA#N=,%+[>A@]G(5E@.=-L;4&!W+_[OJN'LLU
M]^ G$L 'QW(ON$Z3BG?G3ZJU96N9[DHOC/&L! -(58+"/S=4@<KZ\;HL!Y4(
MSJ(!UX.\?2?F$LJO:/GPEM)A@@_'#AT%18S(0[)1A^?.)W?)+3T$_IH4%&LL
M03QL]3!9QVK>M8;>32V;P:+ITA-HS+K1[*00#Y)IW3,:K7SG$I 4US2;W5<+
M8$.J6);-6EGP:&.\,@Y IQTRNN'F[7GIX7#X_JTOYX?Q8#:D]7O8J[= B"="
M7DH13@9J.(K#Y82:BVFN$.:6@!,F!I+4O<M85 \N;&M)]<-NZHGYI?;<SNC/
M0E>_HIJ->CNV:'Q/=::D0,F+PK!E>E(J5TN>]/*EMA<*2=%),Y^L'M\  ;VI
MWV^=J##G*ZLY%RQD$ F:8-'T("H#Y^5>MLOH&JET:R!ADMYK\3 7_FU\UW V
MU)_G8!? 7SLKA\3%Z$FO(R'ITUS$,-/(E+3<I<OI5S1JMD=BS0H[N2OLKD57
M6$MJ1U-0/VPV6JWVFR]]+_S4U\H)G%"9.#E]99:)O[7*X"(EU6_U;(ZL:KIY
M5$'T:ZUNL^VRMCK35F?F!NP&S<*P &;CJ::T+T!HYG?R@GFC-5@&1U6X^68K
MH0LX4J?); 4WOA.W;8%>*H';NLTUL!M'Q6UEAF^WHX<>3^O[!0Y,,; A<&A
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MJM9=)2,TVFR%J@@T'C3.:*B32:E&;+)IQVRHN16L.)R6!(Q([5RLV*2"CJ(
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M7,=8A08.3WJ(JH*XRB/.)AGPHRZ+8$- ORY)T(1-A#R#']9,\U6C-$*L1-+
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M /IKL/>0L[>>._Y.L;=B;\7>E=C[%!'CDNP](O:>C.L.*)^%O655\3N-,$6
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MA!41U:( 2A#1)-6,=EXBJA4(HUW1]<+>==6P^RND5Y7YJLS7.E1@3IAPBGG
M7BN,5\50BJ$:Y _F,-1L7^MULQCJZA$UC>/:#506OB'2ZTJSA@? 3<K++AV+
M05427K'35;)3#E1>978:]3KSF:3&KHGL=,5HF6%3?E,# &5J8X\05ZUFW0.:
M,+QB&9/V._/^N#80RF8H/451IU8&^RAJ0!0U;05%7;T+6 22I>6^H,!PV1WK
MI$S;(T_F8F3= >TIL78_T0PL.(E]<G#8F0]&Q\O!&J^L'<ZFXE?%K\?8)E7Y
M=43\6O-XY+/P:R7<:0$-UQRDY4\[,>E4P5*$K_QL>.4@D0]T&B1+&[(P?&61
M:$<(_G$(UIB/3A03 34&QN)*BM9;:IL'$CLU;W."DPSR5%V9;0[($"VUT_&K
M[G2Z;TA3F9WV;S27(<PJ8@%;+UT-D<49,-PC5>?M9F3DU(\_Q(SE!N&L\0?7
M)JY8C);,^>$1?!(DUL,&_S';!=-.@&+7"C6^K[ HL3.!%O\9GOOCF5E/['?X
MD4WY:YJ]5BI!LG@$M?NQ<1DKO6K]S*O^")\MN^AQ[]Q'_>R47G/_W ?M!&[I
M16-@19*>JN.%M/A">&@27:5E<:T'=8=PR)7)<HB%"'G67%)0<V'I!0N/_3M@
MMH^"U&6$Q2S!>M\UH@I"/^O()140@7]S[(<?S'V\9PL_B_D['O$+,.V K>Y\
M\1H^I;5@RX,(;!FW?HM[UW#SAX" Y7.A7]N@I2<6GYJ2RUHV#43(ENND;)U/
MGS_ND@N>5#P_YQ/V-8))\0V4^7<?S8JOS,5N1^,A'J!S.XC):8RM'+UL.=Q?
MP(JP3>"5[VP9N& HX%UYVBI@8$,,>^7F5)_#E_AB:Q_9P@UP*'<_M#0_P!DO
M?2.<3%[.BQ@<,#O3-_'16+([@MHO+<? M!XCLO0!268\/+CL :VVK6O:2W/+
MZWO$G)JF$=HTE] \3FB>(#0[(K3X_L8W1'7:&[1X45H,P#UOV 9GN1LDUJ%5
M]W_]I1L!G$NX8K 8& /]M!XV[4K;\EDLG@8GAX>Z9U$G9]6FW:2>=Y/GO#DA
M@'&"!_*&QQ[-6\.V \.R7G#@1\0L:,'=!0\@?.$@?=/20/0$KNF_G/.*NTJ9
M(^%.3DJX$X*4F68A,"Y!F?]NN,N--NQS37YSE"J?#EY'DT_ Z1P4T.3EU75Z
M!_53TB"7DJBQ" [\J^'Z+Z%0\C5#6YG>,C0^:KD-&C&9WL>]^ W1F5SR-H;[
M.C_$79Q7/6- 4'; @LA]1WMWS\>7@944OHH>[=+P-B3Y33@K9JSXA\##_1<P
M"07YX(@7L&K'O<6_X%BH#<YH$_/UG"4(!I0,<%=W8$Y:FF"TKG:'GO)R<T-F
M OZD82]9&'V4+Q9^#8<?TJ+6I@U?P"%\>-Q/H(?X.CW:PA:H$K%8<.'TP/>.
M3:D1>BJ1JC!3UMI[?-Q'RWGVBL657T'GG)P@ONQ<QPT2@._"$]>,[BOO$IY-
M?T/7@"0.CD$T%ON<5D!)?^M UJ\V*3TJ)*7/:OP)5E^\1'H/>/IWQWV M0"7
MV!8C(S#B:I()S/4->)$[5'#U2#H;D-4D&[8!Z%,:2 H/W7D2O(=L+@2'SV@:
MHK,&DNON?A3HS\9D)J=$J2L'#_DWF*DT6X[DD^D'@BH7P0MSO9#W_\!0H>!Z
M+[6(;X'%M/YH=)>8S$BVC.F;\-&[)6F=OCX<WN!0.R 3E DDN^#U'0XB=Z=A
MEMLX3]^>DUW/J@JEI$3^?Z=IES=IY.61'NC\<E:Q!:(*#AHXSG17VI;4$UD?
MP)1"CG6U_)!$PZYYFFL3'^V:\U1PTS8\.[!AJB*E+3"\LTRXKJ(!IC?;Z7\/
MXLCTM;L'EY%MVH[(1E7WFH 2>7$"V@)+OGDCW'PJ(KM[,F'(\P;,?.?)Q"(G
M-$P.CWC,/S)1*W6+]7UO1WIW+#W&= WVL(\?.Y,!3V<P^?5\FB!]9(,9GH2A
M49+M-P<6\TX#R]FTT"_CVC5ZJ_-+:)C%6862%OP!T.3:+'ALXQP?M.!O0J_H
MG#KQ -"GOO^,\'*D\)W/CKL"DRDZDFDOFR>>]F[[:%@],3L/V?-<X?_D//5X
M"[C<6_3QLS/7SWJ'/K((N5)<^Y$'PR4H2$^=:W,SM&M<3-&97FGU/NR54N_O
M#,_TOF]=9JR^V/\P7!.+05'7]V/E/HKI XYV*,EQ: M\C+9U3++$GH2S%9KA
M^(*-)Y&(Z]#^W@@=\/W+QV^QW _YK:Z=2T*"R9U^M!S'E9DRTP'6\(VE:6Y8
ML+;&+_)KBR4CUID*OSL3X"QMJJ4DX:A B'._;38=YFVHJWV-L\$4$,PQK^.-
M+IU'>&?)HW__)[!9'$+3O@= U."^N_ 4L&;C3'/T.#1[87W+$&.P/*&CT"MZ
MW7R,K+G\RG\^VNN!XQKA<0UDIJP(9&*9DHG;VDFE"QK&C[CLT8"/ <4O#(N"
MH' &-&\ZV,(N0UO^C+H>/"Z\<F5>G=N\^L:>'.L)2478Q#LV5N[[W.8R#A5W
M!%N,BI4SQH8'RN!_@YU]6?/UA,OYW?AI/@:/[QS7=9YAN>^-+;P#RRQIH$W'
MA4I:6F"@#3-([%4-M(G$0)N@Q;,VGU@K[+/)/OM,:B.!3IF>-\,6D;*7""7G
ML^L"$TRA"KU!.T XQE2R./T5M.G6)\I%$P$Y%\,^W"1B&/5&/GUC1)[4TO H
M"V.!WO6 '6WG$>PHD?]*Q[]7CF5AF>H;\Q<>[T9#Q7'AW^(%PX)EX9?19F/\
M-_']1;%?^Q"XCL>CX1_^^/;IW9=O](@;RB-@@P%]>VL%'FULN[7,)6D[KC,T
M;&0(8_K\UW9B UWMCDP+TZ=(P9HQ_A2>$L!O!': "8@MU@'S-/C>V[B)C[2T
M17DH7RZ3?N^CQ7]D[("!,<TU,+"T&LGB<2_AGYR+>2HDRI)RN1MW&I53)<,2
MIYG6%6OS)UO=_H>Y3G2,O?@49YVY[61]$J'X-F!;+ABSM95K/-NA'9M++EWM
M<"VWN 1Q4B.T=[:.9^+/OG4)0O6)_?ILKOP-G'/O+^FZ:F%']>*O& O/L0(_
M_RO2D!^U[<4/I3[!)7+_UF-OP[_\"N['UC)>WIHV72Y]Z=>T13>6@ W@#_*W
MXT5U>WQA @9!_+)XNTMO[30]\O?T<7?$58+T[5ZWG_O>OL<.NL-9L:<> &_8
M,_'E]1J"9X?8D<[^GJ2[H&SN1($8%780]F<M@5-)=G@;?#/\( AXX ('&Q:>
M39#/D12.@^WY_=M5ST=.P-26>I[3FXQW6#NO!S;QY\:-C^&!W2Y<9OQY2ST?
M;PWKV7CQ.G]+.TO 5TFY4(JE^>(6[M_F.PL-^T%D!A7U<32S .^'1+^3KYF;
M]4>B#5]9O%"SC6_8Z&-;+V"Z6 )U,I$*I.>1Y8$?-E<FYI(> L.%KSGN3;*:
M*2QMX&R"'-.2 M.#A[R;0XD.F;O;9$AC<8<XL[_" 08^GBQE5QI623W-K:0.
M4Z88K6A6UG.67T3+UXS+0=I;$M0ZTJ@(A8)ENG2>&/S=]]"*%@ $6$%#P#LV
M\S6+\6%<:&J;3O3Y&U&&]\@,CZZ8XDWT$> /] "6R;JX^'F434<7P]S]##@N
M-KDY"P;TPA).C&_\9+# %=NZ<(Q< N%%)-N-;^B5!,>1QM&,%7((Q?UNM$?,
M8S\R6$7(CBL&1P&_;9E@-WMB3R@(X-Q\'EXT$L%$'FK&>,=R"58/A=2B:!OZ
MCU[H$N1R1<,(?M8O0O#G#VXTAMERZXS/7SJ#E2D:&DR<'Z1D*&2!%S.^J+##
MR@CB@AMD*Q "G'_\#;+D32:(8"QXN $8#9AR:[P@4L *?@3M/7A!U.IIR%7
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M".O=JU%JB_VF.BDU+7/_L*,!C%&=O\L>S>#QSE[11\4UO,=;D _9TK%SX_#
M]FN6NP@C2?6GJR2,I)I)4&,LLHY3NCH#+*FV/COV,M1<Y4PO'5&!;\;Z4#)I
M+RL"R@X%: $H#F:_9$IKM['I1J$:QG$:?=A<5,,]Y<?GJ4O01\VM2SAK_4A8
M=Q/W0NXV$V*YC\NPI#\'U.N=:)[[OF%8_X=P/5A+$"S#'@!B;2I(XG6O8F U
M?7#I/&X=FXDFS-,>1$E<B C'1$QJN,$"K;/R5M2]2[:0**5R!5@8G7+@83D
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M?73068-A=Z+X1_'/-?+/ =C50_S3[W7FH_Y(@L+61/X1QNA.C%<GYJA84EC
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M\$KLD'%%:F>'$8X7R>9TS\(-5Y3.K5XZ=14IEH(&4:J$H031C[%N2N7H6D9
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MZ[[ DIX-=^6%V_BC^[V+@SA3^\,7\]"?$FM;L*41>#@X4K/,1],7 T+%A,[
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MK,QW@H"B*/XD-B_'G;G>J"%!-:6/%'-<)G-,7Y,Y)O(FR=97#K=!#=XMEVX
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M0R1B:-;;!Z@$AV#A&I-M';M='9)0@NG%'2'-;_@0I"PJ2V\TF_GGI)*N]O%
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M;_YJD2RS(T"YQZDY)S1$"G+VA+1W<+9G\"9)BI02488KZRES"RE:5H^C<YO
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MP"5<K-:5'F(!GL+@*?U .VG!R?+!:.<>KLV+&]HF>B\C;@KVW7%?'&6\CW#
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MH X'X VY+Z@<1UCW:7$[*C,=6LN.)RHQV3T+2T MAUG_>W[_%2M#\2U,_&\
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M6U],F7,T=E*=0Z>PE6PFT^V'Q -#@.(>;OYS1Q9!<T_T>>@+!N@+U\%4AF0
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MCYV_?_KIIU__K]O]Y]7CO?.9NLD,A[%SS3"*L>>\D'CJQ%/L_$'9=_*,G&&
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MFP,_QFSA!WU!KS &5IW$V'(Q^Q],RY;?5R0.(!U[Q\/>9^(E*+BB89*;A)N
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MSNR >5?KSPN1TDVU]4LGN@V6#_+3[#1C(-F$E$R:![ME=):-<L."E\SQ'J$
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MK99!T:H$0E*8\GWOC$<>K3J%A@E!LK+5^6>&S#MO@7[&E>'2>=,Z GGGT>I
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MZP]K[ S>@[21Z[<Z(U^LA;X<Q6B8\45"]@Y)S:4(7BL/B02GF&5*I];FQ34
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M'60T]<I?%\O-M),.]-4N2'<*(++?"0=[%&H/%M9F:=1 UJU;!4;D88K,,H)
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M5#24I#VM)8JV'>8]%!^4RXR9XK;:H3=H[M9#AS/1=A+[I(7,&J8E+8"$/V\
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M/^!X-)E^P'0QQ?S;9(ZSGR[P%XS3BS#]*IADJ\TL*,\UV3J0+/F%2B*'6+P
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M)F>S!5:$(8!(/I.V 4KQY!);FQ0W6U'I!=7&>3)]FFNDQ]HXFRIK&&9YU%X
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M\FYXKC<=G %A'"]!<I7O7HK:R\G%MYGSS+AR?XKHPZVD\2KG!6/"Z4^C6;W
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M]U%=%G7? E=/AL0Z3/LQ(EKH;2,5=A!Z#YO$6GQ<^4*[((*-1'V%B79%6J*
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M-?)$4I%;*A-2>GC['DCGSY!CY;])#S64'C\"ZTPD@6,P#N=)&%XA+HU#UH>
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MX)PEQ""C!47824RH9L(7GSISQ#U8Q^A>QA<#C4F9H!&E 1A@HT)6"8:H"IZ
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M6"WW>WC)+[;%*I>NQ -V)I/5"ME8N\6ULV"Y#"90LXJU7-3T0C"5&!M%2I4
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M="S1+3N9(9U$.;4(O)=2*QVC'Q># RS35IEJ5VBGXE4H%&)BR9H0<R(@X!R
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M%5:S-6Z8;%2I]( G;34,K#9HU'IHCM5@N)1-.6PBK8(*(I[-6LV@#UE1::B
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MKTMW0P.CEZN$L1Y72&3A:J16M@T>C,U,#5#=)BM.OEO-!QF0'02&*F;D*#\
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M.A\MUG#^96&>E22SGO4?]Y5@L\/32T>&P9D8)?Q99!-=MU\H=7O?04(O+<+
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MKO#W[1_W]])0?L$UUZ*QU$^(7X1A N<TFB<BS=SD"=NM. @V_""8EJU.'QG
MI$NNS\$D>*) V?^>CU'L1*Y2UP(ZHP],C_-1]H8+(;L43>"V^/[\ZW./L<$V
MI[S#%-2^313_2UWC@ZJ0DD]'.?X'T""\_'?/AMN;7X$M_S]FZ^5F2+>@[2^@
M9T?U;S@_3.VH5@KWM03/FQ;@6VV/IA/C;!Y@3!8+KA<%YKN^<\W/K#>YONEE
M7IJP4&B+B)I\CXUZ7Z56^R-A'A4N8.P@]-)FM\KI3%8\]SE*DK$Q(@@3Z0W
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M,C,P.3,P7V<R+FIP9^R[=U03;=\U.DCO':0&*0+2E")2@S?21*6H(#4J'41
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M'*%4@<OC*'5P\GD5#?C!,4:B/Y0'>T<BQ"#:#9C2@.%5O_W#O5J(  ZD7H@
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ME]<Y(WY77B.E[OF3?@3=2H_,[J*R3UAEG^;"&4[?JHR>NU9@N' XR/PS@2P
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ME+ES"JN/9UY&YP[+2X2BP_^-,YV&)N<HN+R^BSD40,-W7@]C_!7H'Y*\;M(
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MQK&L*041+W=MB=?^N)"E>\N6)^)]*9.#./ULX;-M&N!B5@W<RR<XPW[SH(3
MR4O[$&_-$+F8MXA-P=>H/AH@5@\7G?R=X;.*\QBK<CMSZ)*1]AU+);0'#] -
M740E@G_6\^R?];RAAZ,(2J"N3I.X'=L(*E"*4=F8]F>V:DNXU/+^4D1BB1DR
MEJOC@57LB%+*DA1L)#\NPJ:$--.I:_]0T_+3+B?L2D/*K^$UF<PL>>O/G6LL
MZ'[$WRMG)F1PPBE5F*65A9#$ '"E9#_>\WE;M0$$/VP)5.==P"E!*-@P]M"
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M(0Q'Y-JS[=E)Z-PCE"<@M8 X5-HNF/XK3:U(X+IRDFFES]G@5)UXD#0.V$.
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MB7/8!@5NHV&P"EI6F"^^(@3W<WUU)49G^=9"#:*M5@E0'&O61<[CHK3AH3"
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M\&%PM_V9WF[S/H0C^EIEI?770/]=[K=?]9A1<WTF6Q VHS\O)C$^^5F'L9P
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MHJN_]6P3_NC*Z#FUD=^_8H.\6/CH*](!$N8&U=+0MIJ:T\RD4LHM>@SC(J!
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ML-R,K#\Z7&=0%)"\JJG0M_Z;96I":5-&.EG[S[5$B>;*W. #Q@>#KE%['_(
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M]]ETSF\KTVISR5":H"8EB9Y.NY6#:3IH@)VSPA =SAL_ZZ-L/OS8RD#^AXG
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M3"6ZF,*&#T&PA8J)Q$T@P8V+*8.Z_OY2&5R+-Q(YT^+]Y0XX(G5=CU/A_@I
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M\%X^J(Q40R54@Q1;1W*YE_(OP[ :F?NL)BW*-7TD2.P$<$-LGV[?NJ]PSL>
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M#UAM[U6X .76'A%%EF###DW]$$7RBAYZ/>\ 9'JN2%IX>8RF<-G?:INIA2E
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M8$<*)\CTY\4GPGC_6,=M6<RH_EI]MOJS7?[F^6\UO_6^E]V.YK@!G\VKJ-E
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MQ=NR\NI_'Z<TLC W? DV5QQY//E77DU8*^(F$LL6:+=TJ\GP2D'UMYYHG=1
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M;Z]([+X,O3M%9:,XX_<=^4F%%<P,%F<$2KH\XS8E/;]JN3+O19>65#JK1VH
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MO,/AV_B:2'A/,0<VK2J-J89GYD'"G@K*3BS('$Z$ 3^+(N<( K9R81+RM^L
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MX%'3WE0I0T+:\0V]=GKG<]>3?@F9%+F_D+!)E6C]9#_WMC^Q(>%OT?I\",P
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M(EK<[F6 Z\D*]/CJU,DQ2SWR.^)9%9$CVC?'DX>"F:*0?X[^'K.6RA3$@&3
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M7?W7=Z-1]0Q]18!T?VHIH6F=KW<UW(5@7-[7%&'Z6!?"7WA^/7P%KWF[MC[
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M OCB+9)<:)98A9PG;]VXZO,L23)R-><"U[U;+E"QT^5W&P[SJ8_ACE FH/O
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M1O@#&3+1V+KFAH:IVPVSBH%2K5Z< D^K)LUN..SKO@(%7="3_]6V9WD4W<F
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ML_#C,01E7 YZ'<TUK!XAG03*"PX4/;A9]UI<_)/GLU5NCP<Y F(>\QOL_36
M?'P_.NFPABP!96A7/ :=:FYWYVES[@K5<T7M\_E>DO2.-;FUV/P!A!R:[P?7
M*Y-Y[N&LN]DY_2C\4]NAUL+PK"O/=M[>GNXQ\N8>ND-LZ'V>61%3*^S!42BW
M2^8*[T'7*\7B(-P8\KU9#8NDJ,MPK\EM#5)=\"N#.Y1[FN8J)HO)IX:'Y ;]
MOGR&#<(61O?\ 1>&-.1YH+>[:,DR*,N?SUZ+[R>S>=#S+WX7^96^>;J]<)9O
MM8IYQ]#G*G;4T![UYPP(H(GP$]>P^] MONLJD#>P:_NQ'JKIGY04FGTI[O.]
MP2>/QP9/18?*1)NN'H,(-KN+WGBM'2TLE.DKAJW=TO]%;\7-D5!6Z1^;SO[^
M"ZLV)F/N]L./2V]=7N=4&3=@&$5CGQ<J !<(\3BK2OP$)]D4",7M"@&;OQN<
MCU3U[@[,^#:2\K?G_-F?ZI8;>P4^%4)\*$,T_&XB:Z1ULQ\J%+%3&WU5>PQ:
MKZ<Y8,;N M(%O]-V#&\1[N$=4A3)%^Y7^GQQF H5$9U\N_-;M>R@D=@>)Y[Z
MPB/H.A%LV.S]>WW/]^@Y68=TCBS30)")?ZOT6T@RS_E-4H?!&_-@]:=K?2 >
MDQ.O;+1EQZW,#V+V#H%L0ML@AK4>)0RPXS$/O(!\PJZ-)>JB,Y1CT5QCI/*:
MWCN[7.6.ZYI=C/<$:XB"A_M85'^US'I%#XP9V+UT_MW<]MSZR&ISMXR\@@*J
M/5/^Q?XU U$%-.%*T>(;DM,7&UA<>OOTR-2!]_7.TR]Q(U47W1[<RSQY?H(?
M1/,5S78,\D#%H!C)QK :N#5N+K[4WW[$GAFHWO_ >[U2=MS\JJ%8QC!=ZN^M
M>AL&*2(73OEAIY+OWIRK!N%E!OZ-\PV61N+F7/#**<=D7LNN'<D[P7/MGTE[
M@@#-*Y/:44):S^O7X;3T#_M0ZMV##9$%W#03@!;N&!1'$86;3/>L"4XJU,/8
MEDI-V?)]3SG:.>:@<COQ8^9ZYI*_:[+(-ZB.,?6HD&P9&JKW-O<M/+C"*ZK5
MZM6RA PDV.L&2)B@S<(VNQ?+34.4Z3H& 5+*O44/4 +JUF#?0EFB:-6A>HI>
M8=$K=1W$5-7K<>) ^<.X<9" &-?@Z)\:HLG(80POVN>;[IE7" WB]3 5GS>R
M1<:%% N-3'NYJR&A='R@P(/:!Q]_^._DR=(2]2%,U'S:  G".FFE*5?C+J0H
MOBTELCB*:/:W(MCWPM+*D<4(-N#%NAYD[]H[XOY @9(E7]]A6%;X:_^P=TL'
M]Q3."=Q4B0<\?&P=*_B]))@_1L::!L-X-MK?67-:T[V^:O;)9F33Y)08P5#D
M%2T61DMMS5N?%7@(+ /Q1D2M6.Y&SDT+^'?<\N;:M5R&!8DH_RW((W!]6J]R
M6O#X&@VQ\!G>W"W90J.*;7+ETB.L6@_.P[90U:$:/M%7!$A]V?Y)%*AXI@N6
MB57VE,RO85W3>W7S&!3&U<H!F-Z OL>0N4R[CT'O,?W+:2+?7.7G0K_E3%E8
M".E\74\VD.P*"[MR/YZ6=L-&U8IQ *3?7X+61F%?0'B/07Z81RC>@(:B./OY
M=5QUQR,/B[)O')L<]8OZP6TGM3P^1;./- ^P[<QNH!A1V$;!G93^CK2^79H;
MF#YAR:7<>$__^^X"W>ZPLVX[\]%?U:B>I?JZO6L,WA+25R@PW4 2V/=UBGT>
M_M%:[.Q3%]HWIR,09:(1]D_N*M2^*64P$;"_EF[ZJICAGU[M^>_$?WWOPL[%
MX4KC7'W;!^T]9>WQ[WQ->:IF:ZGECA[WAJ2K;0W #]?4":DUU#GTY>B-A@C[
MC7=9?6BVAL>N:Y_'L;2\;2_&%WR6BW^6#KIJ#I^&A"0?3.S8DG1&27K A/F<
MKDJE135"FRAI\0:P[DO/9/DH?"[EJ7O I*?AUPC-DW<@,)0_^R)?-Z9A/D:A
M'LIE?N\EYEN=P*^=VUW*10&.H&]Q=*KG:>4W7]\]]=9H /P>W7,6XJW,1OFP
MA'FL*';/K]<PRN0'1V7#4F[ZJJ'0Z9OQX5(V[OZJ!%;0?329Z]X>$+_WF$#6
MIR%V;!H1E2V:QAPXTTN=FPS'WAR#+&?8"W32"N!K7-_S*+[ZD@A]XOQV/O%]
M%"_EQB]E7GC8CI+";R%-.6':5OG'SJWG0&E]'.G&R!5D-[KQ;1;)B:SSHZ:0
M%8*73N%\65=>,R(M0K]"VVX5D?IJT!=;>IYA)N2?-@7_3G#(HGP$-X![TQ9S
M>[<J@5UHZH#ODX:7V4&ZRUMC88EB=TW@*PL&9J-,Y)4_IWB4(B* (V*IR:0^
M(W"965'7I2:WI.-I9^&A7A=7^%G^. 6W+-$/T<^'@O- 1^Q'E<<@?Q@=95B?
MK6ZNW2GH[???9T5%M,RG)YWP.Y.&=[5.\_#=#;H-7VGG-(#D4M2/6M&^1<O.
M_2DXU*,\UTI<"@3N64O(;UTI^;(1F7\,>C*@X\&?_DML?O/+H/)B#>[+SMF2
M;T[A?5"VP6KCEV-!BC>").,<!:+9WD@&5#=$@Y*Q.]>2'Z0V=4'8$,J$NMYT
M'_W3']6/06P^A*-1/6WZ!+75?-K/[JNIYM]]:), <\(7Z S$&\(.:*W++P*C
M+OD6O'G[2]R6/,.2Y%2S@T4'OUR*]-7%X0^!9 6 G;"/32W<*Z0G(+-P3S\)
M>>:,K#"6@W]-7<M% 5R"N[+%)][KWL")< T6BG1\1)B6+6[E*6X^:IG>Q=UX
M\>0D"ZW$"3;^$WJG&!K\)PU$SQZ#6*X1N"@)[#%4?W.-#[#]SQ\X-/ROON;P
M"H!T1S#T8MB6?$3Y)ZM"6#D_GHNQGBYVO)5VCS= /)I&H2]K)=/?+Q$D6_*_
MAORXOAAR',RL+^?'X2>J!*!PJRB;E-[JC<]%0E9F%WK-4\;0VYF&W^4GOQ:S
M<QR]0WL?6>^E [15 (,A$43HV!DUDKR:CO%^8K+\B//1E]$ %JSPZ0H&?DCV
M!T+DWO11_.(&826/3!%IDFJ"1\!VHLZEEJ>\.;F@=P-_;1?:],N&801-L(8L
MH08A#7P]'<Z.Q(FXDLG=^M'=6N/*I8N$Y4V)(,?7%\Z'2+ ^=% X=_)4C?='
ME \J3E^6V' ,BOE5(PH@]_LUU83N_WJZNTXR2!=6E?NB9(B-'6=G.-G!AE8X
M!OG   F%PY>UE5O'($:R"\M)O'>S"VT?TTAMI@5/Z@8MI^J=%]/3RFO1D&NR
M-:.HA7C3HUKD:3)B$L&Z;JGEV@G 2XQG/.:EG4>%?$Z(U,#"6]YU-\8F0!F"
M1]C>[&$&K9?E<5K;.'P*7R]%CZB\9U7YNG_O,2YQSCF&12<QP9/C#??%D1&V
M"W(K;IP@O<;$SPA:HEH/E$?=;I8,QELJ]RWYNVL)NDQ9O;8F-$Z%-3'$Q'2_
MS?OG5YK^=R _BO*%+;$;'CVEG-Y<TYG'1S977^[VK>C!27:TW'N,LQ=;/R_9
MR,;CB%UG^,'>CVD:W!$A0O!-#W5#R[YQ?K,XU1[(;#05^#8EM4+8;P"EJG:&
M9&O,H'">WNI$1C0-J< 8\8Q$BURU/P8U,L2'^BM"+9H^(H)+Y,PC?;W& M_>
MNO= ]TR"IU#<U*/:FY4KX<&?4 VY9!YF!P)[?P*%#\%'*$"G(!R\[P1\__[V
M5LZF9@OMYZ:FAR<=,F8^J0SUGA6R4C, O_CEL#'8K0S(6R>WZQ'UE>DI'UU9
MF@BM%JK=FB_HG^SQ"?K>86KH;^]/L#*4##QC=6?V\'&="2'!;K9$OMGLU)*#
MP'B4+,TOA_6!/\4NWP$I;+4HT7QL$9-%A6)?4J!DSU;D)?YMQ02#X9O>)SHL
M]LRHC%J!,#AZ ?&!G4+HSR&D<!U:5^;*FLW?5AD//B]TJ:]C;2N3R.(73GWT
MD>%;]7]]D?K_7M)&.J"Z;T&\,1R^%''"_F 1FZNKNB B[##HQ:>A[E^+G/;^
M_H^'+A@KD:Q4XA<B6FIF!0>)J$?U::* LSWA<X>[:'G)9LZ4D\O2%?T;MT/E
M>I=CNH5C'EXH9O\096$X!<&^@;[7ZVSQ:LPI$B%S\2U^66Y4"R&9_UA^*=[,
M=(,1)\5"TQ5 \4><!8KPQZ#%.OQJ?,(OS2PSHF9,"-'2-U3 9D%*NND9&]N4
MEKPR75@W*&T)MH"A,!)OD43(9L2T)#%BQUR;>^5BOI"%0'5_Z_+RP9NSOLOW
M.<TTY>)H#.C']0.4)S $N]V%9Z'+0C6I2/JZ&TJW$J!]<YIO,G3%0$U##%=+
M3UP)M0$#-]/96U%>X"7KGF-0@TS/,I@??M>09<6HTO?N>=]Z4KJ^3]%,N/W@
M6)DHF\'O5LH=:N95LY3?5_0>U2\/X_+IKPE)2GGG+ZBFO[!;_3,3LIAQ7_8H
M3;C2#56\&POAT=4@ONG2MDY&2+QZ6?%BTY91/ ,> L.G&E/XKF5[ZITJ9FM-
MI"K"/P+Y$<H%Y R$!>*U\"L,2,$_(>SNM3RYH;SP72D/IASTL_'42K16A23-
M3QN&U[90N6-0[R3:2_GP;-&!P2SD0# -B-#:[C\&&:L=@V0%*XY!$C8,L]<=
MJ*3]"[:81$GTIMAH6%-,:LK($O@/,H.%O%,(T^*UEZ4EFW.U:XLN P*7W@V]
MR'C7Q9%N2G="^S0KR'_R?X"/_W\/KWZ\I7A41!2GGOV(I=^I1S^^C=Z)PY\?
M[@I+TWGX/-6L'P1QF:^?8/ZZ']%8]\KIF[;+<R_G_.7%'/Y;AK,%"]&E*WD'
MM+UH@AU[+%+MZ(4Z),Y5Y-UL0Y*>TT[(5X0E]RW%O&\+<G(#"V')63%G!MAU
M+I-GL9 FF>TMDBUR!EH?-1BKL).G'%M;;UU^4Z@__G*<7DS(/(ASXES4.OV-
M>$)*^_PT^KTRF:L&M[M=M^<29H!P7O]U40C:D>:WS.M2U3CI\;B;+J6O+MUL
MA6;90 #<X$WF\NY%-3@,6,H,.C4E-P1RR@9*O$=/*_Y?S+UW6%/?MBX<!.D0
M>H>@- $I4J0G( (B4BR TB+2!*1WA01!JG05?H(T <%"[S5T! 2D=T@('2()
M0@PFA"_N[]SON?<\YW[WWG/VOGOG>>8?^6.M-==<H[SOF&.,^= 8-B[TI"_\
M+1\921IY]SFZJU-C[#OB/)F*P(2/P+9L@ZFQ&Q]B7'651P1^-+4\!),F&FP,
M]Z:0;@"JOJ<L_P66-0JI]]D7PV[A&S)F[^! BT=PSGF;TXQ9VXF-<WILKD$I
MUQ]:76?^YA<)<XKEKRPJ*P#VP[GA7;(47P]_+B(?9T. K 7BJ*P76<CI'UE$
MR*ICX$>#%S^LO&42<\O/1)AJA^ ^0>9?XOVJ<*E]+V>FCNT5S.NB+5\91E[I
MF.*W%+I6ZA%YZ"VFI2N$FVC/J H/0D* I%O8O")4/M?.U87-Z#*C#;NYY8KU
M='_Z7S1L] _U:,[17XP$PPD@BN47(?#C!@OKZW!W"-8VKP#N#I>87"Y(%3Q@
MXGN7UV776!^AGE(C4U/EXI@VY$]_7#D"3<G'&B"8/%<?3X&Y"!_0/;Q>F?8@
MN^4@5W.7!W$'3B+[$JH'JU@SB@E%K)GOCV$1-M_!%PB)JY9$ ^PKTTDY>8<U
M8;"$?7G]''-8'-U#/D&]W5X \'-9Y5BR&)GI"G8JW&#Z",@>J@_]'FABVUC?
M,)-6,JQN)>/@Z<O]7BCP[@5\92V,F^2/I>O'2!&-.COD)DBFWKR!+UW4E?7?
MP;_$H]#:*<)ZFY%:G_[9..-_8X!5_O0;#!>;)<N2AS(0<5[>JDP(5@^L9\"\
MK:SV*]OBNP87+(5O,C3F&QA6CE 6]0R ;QM764V$UK[H4*JWI],GN&;AU31+
MOG@I9O//7,O@2S>AO4-XXBWWJR5#%F^$CSTM:SM/5-A></B(7AQ>U+(W>R!:
M?S7XCAUO.M>5NW6.9JR&:\K1.]"\U;J0+D0TO"X.HT;45GM1-Z<"92#=FJS\
M4>D3#CGW8$3YHK)L#4:FYO-'EC<:%YZ/ &#1Y+$%8)?L"'>;+3;$"!OU8)4V
MRLNV)UC1X'*^8G"BM0$PS3<8(I9"QWWB> :@030U?(?[C+'/$_K6S#F,W3[;
MV+[%?@EB]XVU:":+"=CA9OG+5PF2TPVM6#7\&0"7U?U9^-YNBP#<?:?Q@)?=
M%&_DQ+SA']PDV[@XXNBP1S2%]:_20#Q\4C)60IG0(G$HR$MK#JW5G:<N4VJ;
MFZ&&_-^N#%4R#XEI?87T9#0O]5(/()"-&=LL.$%4ADU],T[)/0N^0$7_TZ Z
M$U+K<Y"\ZMX?L;=724UZU/HGLRPKN$.]_2VB[@OI_.4KWS"98>@8S/M'$0^F
M&<#')_7$<-B@C=%^80E!9N97?]:*%NY7?'%+ZU004_&5RU;CEXTYOK@LISQ8
M\G'5."0P10%WMKIRX-2D/^=JP0BTJVM'3\,=V 3.Y^RF[5G%;B[QS[M<S] I
MSQ"Y3IW"QQK'176B3V0GSS6":L3SE-LF2$ *&4BI+^_S$C"66+R6Z7O-V9V!
M29!GR=ELEW;T!'W,BU>EW#DCU A?.5N,+=E\J19%\KCHCIPL:>95=.B/EG?,
M>B2,=$E4BD[1>W)5QQI_9PI,MP=CF*Y7>'ZU15M$^-6=#*8=E9=T=<# Q.+8
M!^SW4?;!N$:60QST-8*K;A%R[@S09>LE%TY'8_5=*ODH*A,/O?S(N./;K'L,
M\9.#<0]5Y_DXO@+@TM,_<OT3N  EW\B*/P-@%L\ -Q]5Y/>O,#?C0N8ZQM9T
M;'O. &ZKK43YVZ#<5F^U=2&T#^A  +>: F4^:-/!-MI.2>(JXX-"48?*;A&^
MY<QO\U1/(AWFO_XZ%PE.?)]X"?!O@YH"CKPJH[//  .I\_G]#D!L?Z%$2F/
M.3O;_M1J'V:SFHBW8\7/@X^I)0+Z#<(I0)0FY_2+5,U4)1@0BG>_^M6%W"F0
M&<!9!HZ(IMVF9QXJ+>10".+^W0S-A];-DCAISP!K(1BI(M)M0M":)Y".*8>@
M<-RTSB'^?<E(U+6U;JZ87Y JL5JOC6<IA T EJ2L?QJY3XG\#<$.08ECIXM
ML>2+N=EC#\7=&Z4NSR0]DU<:?S6M)_1:_'"U*@3S\3-L$,)^U:%N(;5GV=7
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M1F1:!9#+@"T]$E<:SP=C.FL)"D1'V&J6'S0T.\)FL8=3/4.#9'!A4J6LWU]
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M#M7[J<WS)UO09/B)4\VHC&?=EBK1Z+F!A>3D>@G Z_=OS]&^H+$P&&>6""'
MJ[[B^,+D/HRU7;#3K\%@K_9SO"S3^IVD:Q*9GH!K8IMUM,WYNV&(Z+CEV<:)
M^DQ6(=J&\OY*XE=N*RJ_H=N33W!=UCR[/%D7NC<K_Y9FYIK(Q7<'#I)?ZXA(
M?,DWC_0OF5@T-"9 V\&HT>F+_3SC2L2=U<0F[]99GW8>&L[0-+/@4&Q6.K+7
M._'JZ,*4PRWO/U_Y[@T,E!B@:$!SX.<DOG/?ZY'$4]@;T-%(7'5)R>?[9F$E
MEX$_A?=9/M"%J0+F_^"-#E[>\;&K5VOM9K]E$'#YAN(UE^_?I+\0JPG07_L
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M->GN2\QXOEDWMTAX^Y*XIJK%H8_E<O*4)8V3RN'?CQ:)-_'1ZCVXPO11*_T
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M2OE,E,4C.Q;J0.$R9-O%; ?-NT9?!.U5K;'.J$&VG_OZ(C&?.Q@B3@&[_\/
M_*F\U-I5S7Z^L-B^HVB#D*)TP&=ISHR)5A9P>2S! C"D>DBC<K1P!UV@4^X.
M$GB+<L^\=35_/=MW,Y_0+]4!M5KN,)X35J\ \7!H(KAN$NN+EZ#!!%YA<BFH
M\ZNT:63';Y-XSXMB-9ZZ;D-H;W[AXK.X&4/T>RZC!V'LNS-.A$V\"39T6;*-
M@\Q7/R8'DP[QDT4,FV5L0=-F?<QG'V27)X0WX1CYL,@I><+)GTAG"*CB:T5\
MJ ?F<1['3.F^X,?19;%WS_T0^ U5V='PGB?P;DA5<C3B42Y[:/-B5R5,%_E"
M+K_BR:'CW0A/;/BJ$X/?K&)*6GB]Y:;[/U7A_(>#6U%<.+WUS',B]S-:!^$8
MP*WKZ_&4/_62DV.TGOGE;SJBD1VE]TR95A#8TK^5-2;@9S?38+>);)DUUC8#
MA.G6:TYBE$;C /47#4\X?FGK!=)_]=W;$9)W)G'3E)#5@_$L%$T#"WDYC>[S
MGI\?[65K.?_Z#VMP_LL9C9#\52K.[@RDJ DE$0Z-1^+NRY^F_J!%COAY$SI$
M(?FN;8+[P3SX$B53]%?P%TC #AUJD*^423P,8-H*ZMY-%&$F7ELLUK!>!G%9
MK:.9M?%S1I).OBGI5O?]1JJ%HK0-A?Y4AK?^K;D1.-XF ?_9QHL+"H,+9NMV
MJGW*%WZ1&+P38#@^P^AOU9]T0=LHW?/PWK5'FQ#I>H_*TR:@*,]6QZ>5(%#/
MB6QEKU:4U7:6;BM:O$!NI -?%R4#TO0XD*>>VEW*G4:CEDK<P0Q9[+JFKAF:
M-L? 79: >J?(FA6G*Q7Z+&%Z!M]^E0.A;O_]O2'\ C:<UD<I'&A[K#$'//Q=
MZRHQ(BQO!.M\#.A5P]\VO_87HX940!.$W[)K@Z^3/8C819H6Z@@2D<3_J.=(
M*=)/CU;\;1)P4>%\])6!IC]"' 5AIRI1N8G0NJ!>>>*ES!Y61 R5;D2N3.-\
MS6'&D9""9X)>$55K_U3, (H)''#G1+131OP2=)N"1U%9//"7R-[+QC9K79T>
MYY*,G^V<;QC6$WSGP:S*IM_XC<.HVNDW'$EFH&3#6$G*1#D(>["@OA'KT_J*
M2N>NN04#1HW^E5[K)E4AJ5\L "9,(Y=PA>8+!4D7UZLW9<[CP=V";QKFB1&N
MQ)><OW6?%%'L0F-)0[/++$BSG__HOH7#*9(-=8K*0DF%"1,H@8[%Q-2]JVJ6
M,9X%)S#8)L&9RLS3FH_$J@%%7VV1 <P0MU6P1&?ST,L Z[.R\H8U6=2=&^8]
MCG%74_KHBUF*XLC&Q'Z2+NP1S:5ED>]&MCN<'/'ZUX'B,?>,5AU+_O/UNF,'
MBHEI]6Z4]G>_A0\+.)-*]$$ON$$_1N/ITV5YIHWF.]F?['0]/0**]"6FO2;N
MO^JGC[5O5)/ZA%$];Y;NH/BGLFOA!?P4T<@MQ&,1R>)*/1.Q!]5:57HGB>T>
M2HN8T?ZAH,T4ILK/0[<*K?;>CB^@]D'8'@_+UO--U,^9.[>.[U^TCQ7O./$B
M%A*M)- ;(I[J^XII^-X_H!%@&R1_^+= :+UWA^W@67Y,?,^1Q1:6<1]W]0??
M6M2[.K\P'@*3T].&MOB/89#SB,6T8Z#>^%<71-B!3(__GCJ%=IB_U:PPOWH6
M9<9V8R)!<">67TB>_Q5GQ*/*27=R%FW0&N#]!R+<>-Y*U-!)W0M9QAJ&E90$
M&DI^T([8OT69ZY:JYN]ZH9%YL>T')1SION6-+EW,+J=L_TP^NQXN$[#EW'[1
M'GFAW:%?\N17>B:S U?ZC6?_]-+48H0=2H22/+JE*[%LO7-&EYCI>$9F7\^^
M>D%4R';VE8(EJ;)?=U,!-/''E FSNVU)\@FN)"CBQU$=-%0/;)R@GJYO]G 3
M:]9[GGWBX=,FH/_YT^P>2XVK?WX8(*8]P595^#-I+B5N0:_<SWJN2/MZ!GF(
MIE[*?\#27/7W)GW<828!0XEJ52?9$N\YV+SQ-WGY[(E,\^/:1E:%A!1/W_",
MA+0N/]-4/1UG[R'$-!.A']^X+887^;VDTH.%F"5W#-N]\9)Q,?^]7G-E*)?I
M8/')CE1!--.S1ZE"](3FN!^X@Y?^0V=< \_^B$=XE[BIX,I[RE?+_MZVB+Z?
M'L/ ::/T?\%FU_^TT>UEDGDLES-[Y*<G%ZGOEB'1.+??MEUPV8"W\D\&.QKC
M;G;?9;O,PA!V3ES$^1;1;Y*PB2OJ-4'3$USQNXGR2S_E->1=BFV)Y2L-OB<,
M'/\?YMXSK*FH6Q<-HC2!@/0:E*8@(EUI09 F(M@ 08@*2A.0'B$D"%*D%Q$+
M$!0!E=ZKA(Z(TFL02()(C224L#"%&[]SGG/V/7>?Y]G[N]_9]_Z8OY(UUYQK
MCCG&^XXYYAAWJGL%M9>>WXD1._[L=I B!>PX$G0 XE_5"7,I<_7[N)J=KBFB
M'9I^NO*[!+>Z[MGC3Z22D8&(VTR!O@E<V:8\!T)5HUO!@>#.EHI:3.)AW2\W
M&^Z\[Y2]);\=^:#WXN,^JB;+(IITA8=KEN!.$Q3H,S0DF65I9Y$.0#8^5[;D
M.&131,MS,["'"F+DA.]$Y\>GXBL, =E%'RC%Y.\=27CL-@$1*ASR:*VY\'WS
M<U*-IO*CP7NM[6(GU[X&L.R[*4J54-SQ,*;\L2'X23DNXB2=N%+:^0*S7IL:
M;)2CN8&+^3T7LUZV93D<2P[+;?.^S>D]O WQK,\R>2I6MG7")\V4M\)=V<E%
M[DZ&P#=C'85;E16-/-V1G-]!R$"F779$>:7&HB7T]7"PHW"!VW7DFTO)/YNS
M)M_>.VKJFRS=$W^>]73WSR=C=X8<J0(=S7'=JC,H!F<?_KN5.6G-&ZE)6HC#
M?7YC.IYA/2!A^>M2T@<3MH13HED'H**+P65^3YG$"Q*YP$:S]*R8AGLMNDQL
M+'RK;R0?&6EQ@)WG/=&>5$V.5;*0X1_2VE7^[U>B(PW9Z$R.A_O$  -O\9_O
M&Y[UPD(B$=:>04,/T_HT0[*UWURX5KIQ /IL-\_UTWU)2?<)^44J$NIC RAI
M53QK%?,[/_R>S)/RP=?-..:AYLX3QP<XP>TCC5A>WM4;TMX[YG^##*<H2""5
MP%D72YI8COU=+K>MD-JU%XME-R#S<\>#WQVAK<\@#S.^+?!"'\P=B]!IEY:(
M-J=>9?N].U?4W"1;_$HCHYO7PM8X*8<ETTBZ@&F^#U_'=@4W#,:>#]G9%M2&
MZFYM8JULZN)P%?%Y>AZN_I2'ZKTLD%4U^Y+_1T+(_WU)FW^WS$TNM"Z;=FS/
M"4!3C3P/0,?:!(&XRZ2(GMV?H:^;?VA6&92-:B\^]EEZ.U#/*J2'>KSMN_\,
M-F(Q7NHEUE IJI+D/I\+2SD U2[W5B2CJV#$I0_P+KO)7>O 3MV)D=::L?=-
M_G<C"C,;-CZ]FLXPYAWV3VL__R7S%X@>_ZZI(G:!7Q.2Z')X1/\N/G%I7%/%
M9<;7I]B%%WS$ 76TY%#I9Y-3[(5!M:";4H$F8ZW6!?.KNI^3VXH+Y[N';\_,
M=5>;:CX\^V6MBYMCPVM7D 78I]YCBJ"._BVJ(9#>IH1@R[Z6>;$RFUA6M+I]
M?KS63O+5\;O;5AS+3<%2H=R5E*'I. ;7Q_>TRXPADDT/-=&9O2>Y7L*&_X[I
M_0\-1M6I+8>+I^*G=Z8?%>^XM!VFUT-Q+]H@P)S69A)2C)[:B=3)#)IR#%?-
MOOL)>LWB*O65S5X[MF\39!D&^M-"B:3GMO)3+\-Y44>!J<M. P%B1-6WG7,.
M7\T.5_9'US6[!92RB?+W( WA?7\=(G^+F\%ZS^W2N<AU$,X%JR63CZ<?8GW+
M^/9;$U]N4YN,AL2X#>\EF5D'86H6B OD0(H4^1%PGXRZ.*'EQ^.Y<2)"P_8
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MO/N,$RV,,;)\]_W: Q#/=*..O6+^ Z+@XW79,*FW\;-&TAV+JN(K4%Z:%HH
M$?"BO)9^YBKV@O#GSU5)_XKQ7<5\UG_DK]F*H[QD3OXC?)FPG%A& U,-;JV)
M^Y1.G> (MO#1)UZ_D:E_6DW([Q2GU%GG6(V:K JYUYN4OP4M/]%LU,P,^_%Z
MG-M55CWO5KZ$">N_>J#,V*Z_<JAXCF[]EP[? \<M5/O&E[W#)KOWU/144[NG
M1E)K!_(^\OTTD4;%/#XGD<C' PH+;?]%+D5S($X<@/C;AIB >,!S1+N"<O_F
MU?-B,C'[)BR1LTCG=N*BT(__Y8@';MZ[.8W"]1%9Y::02B3G=][7?N9Z7U(8
M)%4Q%.$D>>CN\-F*V#85IHX[YOOBUAFD*.U"@L,S/<T%(>.KST,.0!9/KC A
MYL.X28S]R7QP._0(39G^H8V+YD;^]82T%1&VW,.0=#JWNXTO&:HM?2873FR0
M197;%B>]G?U"^'P!Y0N>C6X_BN9;P>[$8W:D2$8-Q#1."UD#008F[@>LQH_V
M7H-2<@ JUV5GI"=0E2*APO;,W4:]MI[>SX;&)ZM^!ZF%0WEO6ZQIK#C'&KYK
M;5G,)IZG7J8%-9"27,Z,!2LK6QF$82,$9X'PC?A@6U&C8\:O/,]^?SH7W=\G
MB:1.]6)(US#[1Q"'#D#5Q4R$MZ)AR]ZYA>R%U!<3Y=4O++ZAWUNXE%[3TC-_
MXM"D1EH@Q6-N)HR26*]GWX:08ZZA A!Z^?51S#-I_=8I+CSZ\K!*3^DMQNJK
M/0W5$5OJU&J=(,LRE /E#HM=8-DA>^)LV%:1TOO:!N-\F\W/PRSU?IFOTBY[
MCWSX3QRE/,R04ZO-4']W\O2W/A#+>.:5BOX%X%0H\199M@\M6@%U!\>]]GWK
MS>FAXI?1(T%\_2W3.",^6[*4Q4VL;[[K6(B_$<07H4MO;0,SS<B<3N<"M_>8
M%U+F9O:7EI0?]%@BP<[SF%C-=M;-!X/::>]+M +:F&@GRI,F2VKHFX,1WI.]
MQ'?I2SO-N?6IG_0#'&;F+(^GO[_)<13_;%HRK6E([M#YU&E6!N=2,6. 4@4,
M]&28?J)9M3:HH4\U.*U>;=Q_%W\ DGSZ:#3B)KS?KV[EGPIQ(V,87,'4<VN8
MFM1>HNQB1=<!2./26+"/Z9FE%R./-(G.-J\P8P]GK7#D1@OP82ZZ,CT#Y4%4
MIKP#%-\!@]U];._M-YH_/_7)] R+?/R,L?HE>-?>9;]\;)&],Y=],;0+Q@>7
M[:YG(--+G32/";$BK"?D+^\$/2HOGC!%ZC &H(+ZIDR[OD2OU$+',72?=^&]
MU]^/:<7]-%G*?.-LID8?EE3;K#87_0$"01HUK[NF*R2[)6>-1-Z_?_ZP]%/Q
MX'\]+NU&^ (>&#%#?J"E@^>C=4%RN/7K;IC3S]K3ZY'37WXT]=K+/OKRY7O(
MCBT['MT)25H0AN*RH9)^")%% ]WP34[G2_)MHW;&DWN/,NO\2G-(D*/$%M\^
MKJ]<R&&$"A-WI28QV,;TG7%T.RE7XW'9!9[NVT*R3"[S53>/*^^"4"]C#%7#
M'HWR2HVK@;OWV,W?_.;T?BPX7C"BV.9E$KO)G(U$&JD]1(9_7PAW !)'W&5*
MU#5:6.-(\!NS<9K*!T-JHLRWTUHECQZ=4?F1FG'S<&#2QWT'/E,0<G7D-K@#
MDF+(1W]K")D&NCK"7J_I.G^9E?.)R9NT_<>-Z(PS9N;&'#)I%PQV_S\G"/]?
M$XJ_3?:_'^=@-!C'41UG$3 \#+O>A>9'\G@U^\71E+"MNKG=ZI='K-Y7IHF-
MGFOO3M?]C8U,$4N+;%3<Z67"^8J^BJ2%6C33,A10?D\%PT2\=3'Q"' IK#^4
M+5-K0"MK/E,V77SV[;[L"Z%.6K[42F!6@--N=KNA_G";(ES#G R+K>/X1\9/
MIS=6'U)YBZND7O+=^/B3[\)/6_8+_\9!P=ZU0+HY]+3M:#,]BP9;O*6O\OX
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MG EX.O>GH@0Q6 X3,R=1<'],::_CYTD(ZU%/ G#XLY?*,D_2<-\<Y.LH.SO
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M<)5YO919[#/PF>$4<WE"LR,R=;/I;=A0JSK^8PF*XZ[Y5]Q0O$3*4I#>Y6/
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M@Q@$O]/,TTS_&'BK6G ,A%<> \\];^L)0'#QJ_"]DW\BE,] <(7_0UG3LNM
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MX,\9(Q(,;B;@3'H\G1*E=R<+:?G^RXKFTK ?3QG=^+1H5$G;Z%.55RZR&@Y
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M36^>A5"+&CF3OOHU&,/Q/#5GI!;V<Z(@$VA/H!@S<'X0NG+R?8.ZOWGQPYB
M]RKE@'0*]>3P!&*F[K:#.Q,0PD?7?"'MWOOEW \7_3VW^%4B0AMP8B[45U$
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MUN=+T\N$IP(>;3[3A/(YP0^[I]A)>VAU*GSN+G4Z(4$_9^!RILY9J4G+S :
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MO3OB\Z@>:%A@-Y$D01PGW)YH5O1:!?',(-(=O$6>PS)[;-8XGV5>:F^>M/=
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MG5%2(%+CN*39I.1[SJDG]G'[IM4"5=D6@V<A<O60OSXEIJ5J65_Y=UT<H*+
ME0(=D-E^VXD@>&P$#VU:PVY-R'>7#BS/68?HNEY]PM U5B\:&0"HT.T$_H."
M%3GX]Y5?Q%&\%@%%%&M5(?JX%"[K9/\T*,DBJ=>K395].KG%-P%4^EJ^6$:*
M :JKT!-@3"F*+4@QZNY1<M>BMX/R"L-3\[I&A\(LY?!&/?.>.IG"2Z(P[.O@
M-QL)/(<MOQ)K/[KX>X3!^1:SNV"\4_MO$6N&@FYNVIQ7Q9],J_Y<0M.<I_4X
MBWQM16"R ,<T,V>D9.I1M!5RES!DTM?E)<X,GDWV%,3<8FH#XVZ>8;I#3"2Y
M$#-61JM@BAU'<H_2/WY8\.#4FS:5,3;9B_RQ<#K%(TF6%@(Q:;9(&H^FJ"-#
MB+/A/'*9!=NV=EH_46-^8ENNA#GN!9>E5LI8!!-1L1-UZA='K*/8J#AN.1KN
M6U21.FTB9NJ;J92J2S%Y$141W.^1:N9.&497%471"!V$81%AUS95I];H,+B_
MQ1->B1F6&/CRS,1EWM?S\JX>2!O5;H[R]5F>+<>69L20I0-@S2$K?Z7([W$F
MS@458TPT#@+LG,5Z'P;=! WFSH2M)+<E/XU0:J"9DDAX6%?KA9J&_<!X61_>
MAMIHHDN0K':<HT/7[LG[_DWI%ZT)IJO0'3@.18C#JQ8]TSV+,&F^5F)K*Y]
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MM?=O?J)((QK66L-*3,BOY:J)?-FOOH G?R=$7WMDN$W6;W$AJ/Y]<@R[ $Y
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MY[ZA&B4-U10>SS/23I:(X?1VVUE3:]);XE )S95<4O[^KH&<0<FK8-6MCNV
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M0ORO=U'#;[[;W]75S4C'QRE^>"I,NBHXSAJ(/A.X;AL'@]$QVL,):+Z0@^2
M:H)N_IQ)I':,LK)S,9+OZM6X:RU5<VGWN-CJ.<\@2&[8/P=1K+XK9NL9L5ZN
M")*-^ES7<OICG->"WO)4.LK2=UG5J^N^&W?$GLS@P;6:+,/V#__,2EY,R>,]
MPE7LI0! I1AS2X>*Z EP7W]=1'RNDYA_9I<OP1WR.5CYFMZ+S;6  '?'"U"V
MJC#-N(5/\*8V=K(F<JJ=(4GFN7'^0=W+P*A7L.V3B6Z><]^P7>IS@RM'ZXE%
M5#>?.ASOB3R7ZK3%J2X#PX24$H:M@86F4@97:688@%DV[I/$W49YKJ3R4^SI
M+QW<)HD[ZB%PSN^Z.=6F;\S3M=X?+D2HNC^UE0N]T1OUC.U'C=,CQ@"Z#AV#
M]N-&'Q_"+Z@CQH2-?4.:Q-9:^(2UCG#Y[99DZ>_FG>FSGZIO^R]P6/1_E^5=
M'MUA"O?=$6+TMW&2OI0NP[EG-G/%>E;K=I?N)BK/S&R9W79RGCD2/A]&ZTI8
M*H_T^K\@6(ABW,<^HBR6,;[$SM];($=:A4F,.]D7=/F_"PH,>_>N$VF:V7%_
M#?83-5)O%/_U&0OV]G7;@BIO>VTAX(K;Z%;+P64CL<6!7=?0RLER=;F6>,_L
M.675;D]DG[[]4.A2M3I-,(^ ZQE.B^(E>33CTX]Z?)_=+CKZN+QPSMTL**!B
MS@75LGO*N6-QQGZW[+[!U(\A ;9=+YJ %J6-'+B5C$?S_"C@)[46- 9]\+ .
M5*6\RVQ]6=#M>#4T-2,WLB_PLW[J_E0'G+2/2V4"OY11?[]9A_YF O).1!N4
M$6N2*F"]5Y O'O.(#YEG2_K @+6FU@YYV3>G34J>M4C]*=N2*7A54_-8(29O
M((1QPEATB62#(&+3FWYW0V<=^G3);Y,,34*:#CWG.=T2-IESVH(/7;TCMQ5Q
M^/+]*&]$?@[VB=_?K([08U$ XRM&6(<)'$::6I!^>9R:X&F*?[*WX?7BK&O"
M3*SUXQS=:__DJG\YXMG'G3X%/1(U JW>>413+T:&FX&U),K@A5%_F:J:>EL!
M9X)^D5T";C,2P)ZD5[7XD$PIR2!W!1@PO*+>!:*L?>JO?E7+[7%4)-T]MO9:
M:3%PL/E;2OV-$T;OV+_A9EAX88B,(*SWP3F1ZNXDBSAL"#'</J[3\:M_Q>N&
M>B?_<IA'A,"'ZSM^[_Y<;93T_1$(*GH1(PE+,\+M#-$)0X7EAT;W5YQ;<A9=
MB?8G'YXU2OCP?E/\A!HU;>F?(/&]"I9_4Z:_>D4O@7OA>)%UEGRU_5G4LRZ)
M&KN(\T &/H27RXKSAK1DV8(B.]F5 74BXQA/ N.9 *C6Q@16!^@GZ7%P'TDT
MI004*= F*\2?('U[W91"$?<W37Y8:V;.WRF1PYU[ZG?>M]3&+=CCU]%P*9@,
MNN,V3!.)[A/[EGL;KWYD8Y+BE#E7GE;K$W%R]:Q$Q<RU %GQWC.=:;X5].=H
M_(<E088:*I@4'K.WQ(&\^_O25*B(WTG_0[,_E)-#PV;'UM:?6O7R4@;2LUV?
M3N(<O?_--@OIM!5SGKO+H@_RU2TQ9\NLTQ.%O@YQ#(C*F3>E:'[\-U? YK6E
MFOI.['&6B)U%^Y:?19!B/_%FU"/FI,0;,S(SYX2ZZS*AA%G1US?RG]T.T'/L
M2\2MJ1UC C,7641WM&%SSY1"H.?ZP^]B'C7E/!((LB"4GPUEQ(:!XFK9Z FA
MK<ST#(JHX[IW(60 !RIQ]DIRKRREMPDA-[NJ L9"T0=-U#,_<\]9J:MU9[3!
M$R4T,6ZW[IE%C=#XF$"F.AY*%?[%!.CR:;CGJ2X#U NXAC$=D9+:YLILXEIM
MPT&7(X()(4I1WWEX+<K1)KAC,&TS*IS1F=.FIZGD,8TT[S4R<H4:K=:1^X"^
MH&\&68R!2J(Q-!O* C7)4-((HLY_.]&K='9VXX'D9YA054O+RYNUB3DV]?S]
M6^?>'RFXV*@_(Y9Y3WD3.[<+?52@24^N&>8"E0E>C_8D$>T:L]:O9V; N"^N
MR0FO33@JE3X\>?Y"$P$<'Q+[K4,6WK*G"OQ8JNM+1#G+D4V1GK8CA6D/7[I8
MLZ/&W"ZNWWIXL7+WG%5/O82_!&H&ZL($NE+0/^K0:RRJNE##YLDX7$8>^U)%
M3N^T,5]9?\P$ K\K$6D*?N&*6ANH7"YXZXD][ @N>>D(38_<M;Q8B\<*78NL
M/S]Q8[>8RSA37J*XLI+3MP@8"!KGB=%4)H5W$<O1'2P*[+_I',J=V\P$'EM?
M<P[8EDWHHQ!UK[+E6V3%4':WN7-FN^^'?<-9XO!EIH1C(&1Y20JE2;9-T!XZ
M:]W@68;NU"L="LB:GC=O]LH:"/HF4U6X\TC#2-.;?16:"B=9!";##K<U-H.1
MZ+?@[PM.JARP!S-WN5K-5S,2/DF5R5^";>"=GFTP@1H]H@U5U+?N151Y*5AV
M[A%DNP8M9'IR*&5#(SO!)GONQ]>/,$);/3T:AW_KP4O"=E(#V5&WR8?>>);Y
M5%M3X'Q+%D:[BZ9R3SJM-J2,?WQI%Q(/._@G3L,907* S(TMJ_?NQ([08"3!
MSP6JN#S[N%T;YYG!P,!;,JHOXZXZAOL1!RH6/BSIF1A#(Z)Z<;5"&*H+2K26
M'"+D^V93:*P.4^;3WY/#G7WUIEV!E693U7K)A=52'9!(/8@>,#$\R@1NE.W0
M%1JPK6A\"A02BN&AL9,M$O84;]5]) M58-_*1:=K*GI.CU98+*A="UX:U/G3
M056EV; <5 =N3KRK39-L,Y[C<BB[S,,R/$A"55FFQD&Z4U$EZHY';"N -A,$
M_Q8Z273F)*)*CKTV79Z3U87CVOR\&.QU;> 4'%\!K:[+?3/O[N+[X$MUL%AF
MCN,+PT]R;R6 VX=CR3<0SQTL".G@*77B6YVAG#R=% /BJHU!;T=O]IMSQS6W
MP5['TV?:%V2!,]<5V2D_*1$-WF@O1%SPDD'G]V5WC?4($:#8Q=PYZRO;4)04
MN-GG B?&4I$P+,'F?M]YD@<66WR("3BV6%L_C)19>O1<[OJ[(1Z+E)]R_TB\
MH%]EP>]TVO4Z.@9W2_)NEV5HY7CH=%:7P15["9'1\S*7ST9_E(OF&TEZ,/4M
M?NOO*?+Z.-I/_> F0S&O%TYZ\MTE<O<[Y4L(IEZ\\0!G+L/5K$8:V?BGRNW7
M7#_G")SD2+=>AO>DQS$@9*>8*&FDGCL9$A^0^OA%0&KYK*UACA8O5Y_$DX2T
M\Q<!_>.-1(\^5@\/P>],@)N;@FXC2=+[GI>!:IN#3]RKACS/^,C WOHF9LV<
MXR6T/,'AXQ1\^GH_%\R0WC*!L*G/2Q_1W:G6%%MZ[=8O*)_>M.HVMH24ULRO
M>US/!U5SWQ:0^RXZCXX/O_B5LP+=X2^VPA#NB^Y"][VER5Y+QRY1K\PQ 9OL
M_9-4-GHZ0V1N&3Z-9F%93_F=_>^MM&$:.A+)PA!S%-^)*'64[$A+\/+@&?4]
MS"'#X7"? P&9KD?./7=C&Q29U?9#AQ8;E:VK@PI0FD!L%YH=Q8OC82A:1O@L
M4Z^M8BRG"A.W'4?DSA8<N6F,N+.[+6HJT<CA>2@:?F/SSRXX(0<GD;%\=2F7
MELG"JWT(P[]?#VB)3:U*OQE<)\E>>*=>]>,+&VB!$$QRE-A$A4*+JX_J=EM/
MX+?*V\XY(9;2IYXFC+S02)&<8)&[#AT&'X*%!VH7,03_NXQ3RR3B$DUN]EF]
M@SHF_+Z<NM"$@LK%Z3#IZP?/2&?W<^Y(HO[6B&*+6*&G,)3S4'\PTZL2T&5-
MZ4!:N,XOR6#T<<.CGN2SRSN)J!.E.>YP][$ [9D%8Y5$%;\GN4:]6^GW%-EW
M8QF'$R5+P7JRC 7\>]FK]LH0EO %L"1PW +Q,93&!%""8#QA!Y1?(MZ.*I ?
M.=GH>S+7:N(#7UUDW8"YX[5"SPZ.XOLG#"7\]3_U??_"XE<'[]!??D!)RE?[
M$FRL[<<?FZU\O3FJ=IR(85]5Z3_!^73X>5J#@@ ;Q2P*S9JR)TSO[A(OXQ"(
M[GAA]#GG,CBZ[8V]DUA7/6.<<#M^BG?L/*_!N]N&&MADW!U$ E04?3=][H%-
M8)>'S!1*A[>Q+-4)(6:TE>CO^_:$G6?0RP\<5ADEI/MS2&P5&E\-Y:Q%2*#X
M2'TIO\I\U#D?JW_3&^G.8T&K;#,?W()3DG0D^RKI*!"Q0^/W91S9(4T1]-H'
MH8D(OE\(T"JP]GO%(8RG47?EW*QKC[)IPWO-G*<%9WB=,X3O &<4UH?!4YQ;
MU<6,/H1PBR1!/>ZG^\:L6HU<Z\=8(D3N1>A:S=.<W6*_NJ7%<X,-.9SA^CV1
M4):ZC--Q,#$D% _#L'H3:A5^O >'#,*GL>KV0ZUK+54M2Y$F7!NC!D2_V^>.
MV4JCOO\M D9_KZT^.TRH?VQXED0,T!D2[]I4+7\S;Z?O;[Z[ML(CDY+:8Y%]
MO,)8I>>C1HPQK(5>VJ:V@$*R;(4E+@V[DF9DX5@[)D8ZWVPW;U%J*M!C<5O3
MO)NW_1%"]V]M-"9P"\..0K60,4DMZ#>08]_W^>=FG7W">3H72C*T6JH.RD9<
M/<]VR6E=+O9)WRBT%M+IBWV$(UW8 <^I#[RTMJX994P+K#D2;*Q$2^P>/I)+
M8=M)ZF;U?8()?%(!<UFV/ ]-/^;-3E@"3WEUP+E1'/2WVS6!!Z>/BINUCJF&
MZF_)A&G,]:^-=-[*%/BGWM-02/KZ=0BNA87).99!DR)&;S@W>OE=+51T'NF^
M9]EBH9W)_6['IO&Y"SSO<$*WHO'IJ^;$[LPHEN^-^83^-'^-"4Q7WV8"10'*
M>V..3"#+OY4)5%JR<'[*5\XU!1H?PJ6IEEZ"<B@I_J""-50VS.S"/&L)=YP3
M2;>3[*/QL*P(R17RYXPZ2PFFWT 8.>Z.3C2^>,8EG"OK=ZQ^,@&K<F4G!O<-
M)J!P$K]$%7C%@FF#[X'],@K+XL;XTZ2:Z 4M&F7(G2YEPHX F'<Q_DH;KH4U
M7FB-S$#E>;[<.SVW#[:1_?OTI2'#Y4[63?3'<'SA9@GX\'+>%DQRJCQ;OF'M
MS5A%II[WFUYVJ,S]XFC8C0; N&\C<,N?)0_\(#R(>@9TL")CDK=H)PFV/#Z.
M^^Y[!<42HI,<SIG>"9Q#B^\_7(VZ;LUS_0#:J,6TU)K*TNH.4Q;7B?.3S[4A
M'\+YKGT8N%+R\N[3WK$+\/C?IX5EQU>RQME_0$%5KUZBR\!.!X;+3^U6[>@V
MD;?YO87X=?>HO:)Z\YU:EU.NG#%6!>^51UG&%@K*IW<J8V>HG8NR8.PR#K1&
M61,B=24O^ZA5K">=O?#61"[H_-,F_Q.B>AJ# 0LQAX#=85 UO8/HZ._9OL1/
M5"UN&/6L]C_$<!Z3F>E.53F8?IWA5V3$9FSP$7N#GLRB2,70P\5T#$JY$+G9
M<PQIVKTH.G9CM.(Z+NU<O4:'2-J9UZ&7):J4,G%(W>64ZQF0&/3=X3@]#,D6
M,P>Q:0(?OILW"?27Q"5HZS5YRO;Q5_>2K)"+>47/#V^GL,EE^FYB0>50"HYL
M2G$'+58BA28W0*L?%_;<K12S7U[7TQVIK>ZW ([NRA,TG@/]"IRKB#EN0C>N
M'DN,?.M*,QS;5O<O25OJ>B&2J6O1:)9IX;/PX'5 CODGZKO"NM/&=%5Z&=S'
M7XLB")KAU;GNPB$*K#6BEI\*.9_IFK!<XQG($_3'83O-MBT_^DJ,X#Y1FXUD
MNU5-O1PU&"4 >KX%SQ+>ML_YMEX]UA-*0/I)CWMLY'A^T[K@Z(R4OJFYH-^.
MCW2B<C(^+U6_Q'9WD<67(3WE7MTO6A/S[B1-\<W]$=J-:7.C[)Z3#P6B)3*X
M%8V,^PK^5A[:TJ)>1IVM)-]>+"^B"9%UQF_],###)<I\S!Q=>3F0,<\@CAF6
M68AP\+6?85\-G,FU1',QEAA'1]N$-G,]I$>)ABXY=;,U0<]\A[2MZPCF[*#8
M_ 7+#0M]R6C8W_#G%71_&2F+@0M5IPL'>FQ2>6FJI+Y>#*@ B::)KZAJ43V[
M'CS3@_M64<]_C"CP*-4N_=D]L (1DQ+Q$C$\KMR)PS<L[2K1Y)@ =H&E3V9S
M4V,LA;R(^Z,Q' ?=ZZ4R >MM;_;=LQ07T&@9DK!4;YY%^MWM8D&)CUV?U+&^
MIKU4,R2T\2INK0BA(7E+1.-5OU]^</X+JCB#J_2=#Z[::XM,6L$'=I4%@A8M
MLF5NBPMNTQ9!*CNK/4H7936MMM:D'N8$9T:DL$5K(.19L+,MF>3$X%+E;2;D
M[8W4^"OTN-0(YX8?[C:&$D^O=<98?,;SIQE0L"Q6@2_/V;?H"XS!'8W20G(Q
MU(^!#C9M;:,!M>)7[FG()24P@=,<,H/^,@&]1YX&9;1_Y12G2EYC]'A(@H)O
M,<D&%>EER)^.QRU+2]X$(HFWVCP/+R?TYCD<%LAQ:,@QQ .&UGAT-P3R-XB2
M9&<DO[Z<GB W"8/.;Y)][-W52&K:<_5FWO/Z/+WPTZ'LZH<#K7[O3-?U4=3)
M?>TOX0RA*,SRD'#?"ZM/0N]GO[TU*O, MCQ?J"^^__1,B:NP7PG9>Z229$&
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MP>2\CY,/U[,[\^&'4JN"$>?LC:4L"$LSR1T,;7I^(:CPSKH4&_OJ8]68XX4
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M%E2;V&$CY;_EL?'7-B^CX*![:, MUE >2%[:4[]J,D/)28)79\V==5R%E'[
M@ H6?>HSB"[<H5]H7O UY"C2EW#\N?"5-K)."OI[\4"/A'O_FP/^BKI::J,0
MSIUCO)MX!$W(H1U]S-#,]S7XNW,* 5G\<3Y.\O+9D<A;DA^U3NVN>.<J5$BP
M?9*^-;5QUZ#__4!'=ISIJ7[92=P9]%UU4!X:#_<)%/7QT &-*I .G4UF"V5J
MKYM04;???.ZHRCK_$?5<J5OW,/7]/4OYMCDZAL9>CE(&U?%,@!.,OQKO.E%C
M!#."V9Q;<)8;E'+49 _NY. TZBB$F/P]=\<.8V>5&=P'\>E/HI1PI*5'-#WU
M;NY!T8O"8I@YL_+HIY=$SG=(O@%B](#W#V*Z7E!-5T(K*B-)B+[)1<D(63+'
M(G1<=NR%RHZP_*P)GUOPR[6@))H\/1HFC9( ?<EM+"N;ZJ+3RDBBJ!Y-[:$G
MMM95-?\\EB@7Z\N_&\=65S=JTD=6Y)QD"+*6GV!)?R41=1*\]+JG^,^V=KFO
M9H^4K<R9$UUU&C1O?2.M1_L*)-F5]5BT-Q.(IS!.D\Q?3\VZ96H?[]&,")[]
MW* J4$I38>,LY?A[#0 !1UT']4C<%#QH4K:!@^A #[B!9?T_0\I=+7>%OO5>
M-V53ZC:<2/UHJJQN_D7SH ,]&G<#)Q+5]^!WTK<)VHT2WWWS9A\NG9<IFJ_2
M" HG$=]6Q#U,-D>C82.OV^[1*] !6+:H_CK=R=F!82RR;O^$$2;^@XA*N1"A
MS:^*+Z%HX"-'C"4GU[T+?SB[,"0WZVLTXT0L2CYGV#2<;6VL]E50\/'U3+YE
ML^ 4<B.LAFT_#W'8'=UA'S5,=8'$H$D??GOUG%K&$(>)6Y&;CR"8U<B\I; A
MQESSU#2<"Z:,]%SQBOZ%%0'A#NE7O]:*_.[13-$\K>^]8*OTXSY7P6,G0M1;
M)G#*RY:J=(\)?'_PE7-[3W (90&F+@\_+N":0+D2%BY+BG?MWXKR'UIMSRC,
M> \ .7=N"BAR9!I+^OX,[V6-F9O;_:ZWX2E2E;^%5=HYV9:)T$>!*OT0SH$+
M;B=D,6T+WNQ[4DE_XBDF=!SJ"-4MLLSZ8UT#J2_%7^;GMZ^!:]=XGL;&RAV/
M-IP0%?US-2YJ^PSV%CA!?MN)J68"74/6O06:XT?C4F\=(.@LZ727_SZ1"$^<
M_B7!^]^(>_-P*,/W;WBDLAMDS3*5K2PI0MF&%$E2*6M,V26$A(P99-\CE,J2
M/22[+#,82Y(EN[',C+4PS*#I9A;O^+['^\?O][S/>SS/'\_Q_N$/A^N^G?=U
MG>?G_)S7=9[G59C*<HJU^1-:J?4ZTVY[&A(><.719++7S:Q6[(T?\@V<6:7&
ML49>9KK"9JK_7^A&*',4&TF%Z.OK^PD[_3#(O,=RF/[)3(#AG.&6&+K2^,9I
M@*L'_\#:[;*T7)ANUJ)Q[Q +8P@EXA72FR-=/UPQ>(W_1N"L_06(GVB6LG0H
MF^1M-O46TF1O)D00(07X])Q\:,7GT4S)/5[D)3D2E>&8P5KZC(/E*^:4@-H\
MFA>-+\;5Q=!4<E,:FS5ITN@I)"G"84U/8@<U1TEI#+:ZG?,"IZS3NC'XLT'M
M7U)HW^$Q&;T)2GC>FT\39:*,"E6<P0]FZSD S2"Q*"26\7-B8FI;)V.Z96#N
MWXRX[Z ?"&K@N<S\<\)AB[;HBR.MTB$'('8WFAQD9N<AII9JL:%G_*;ZPVI?
MU@OXT%,GE.<:)ZW]OV>&Z4OE4F61'185:(^MI)-(S$Q5#)H4:U9J]]#4,X3>
M0AE2M4[][CA-"=K_]-V_!7CIWSM] .*C>;B0<.UZTF2'@H'HF)*'3RR^$%O2
MSDY_9QLC]B["AJ 8[?6JZ=I%S0YD+/=&IJ:I6]5RRTQHL5U(U! Z_?+^2;KW
M?UJ4W#,_PNAM;DNJ[$RH$IJ?\>"KT3!)3-<I?/E*0JEPEX[_*\BRTTB#:C-*
M<QGV2'HWK$2/G2Q/DW/@&E8_ -724ZA6YHTHJAZ=8?7^)&I@2KRZ1:Q]4(N3
MX=;Z&'^%)DWP.;K6*!Y./O]>HT2@431)1;Y!(N3]"V@2TAC"]9>HW<E\"2Y2
M_:/#MJ3VS5':1;> P.!G!*=HF7JC0,>7(!;Y/_I2<=<1;O##A/^I(!\#LM!*
M+AX*>AA48A9M%E?QQ#:\VJ9]K8\];L9C]5C\!R<%+; ;_3427SQ_G%[2:@*.
MK)>4\V$%?@0H>[H$^#4*3Q9R9T1[?0[$GZA^X\S+)8%GW?BL^ YX389@T.PT
M<#G0TOTR\>7M\"+#57O[&UQ>8IQY9X_6JO'EZ_?)<-((9#::")=I(_EBPG7@
M;D!HGDPB^DGK1";7.XO+EOP5YTM]!T<&)L4DW5GGD%XIP-E)VD5<UT?Q3B2I
M"DDXS_@U8G&?ZG;H_MM&346R:C>VW>B6@<ZA&TZ)N2[ 1^H-9&<3_<W2X9$M
M^Q8E>>YDOQ6CBQJ8D5L7#&W9H35043[STX/SKW006L@.(Z:=J7 @QM "K2<6
MP>SU/U_\(;S=V%*J<II6+_HQ]U#MVM2/QA]KAN=.14MNLZWE)K=Z?8)?84YC
M\!\':3(DD@CW_S059&@<D@O&W92.)M^T.VOIF'R<ZSBU9)-Q"30TY4EA>JKH
MX7KR&QPIBDEA))E2K6/E<$188VC!T F) U!9@C=.'J?=XI1;YKF !.1R>U..
MP'VJ@4@&.Z!=")<QTS ]UF(F]T=>9,7 ]RMJZDS/0%(R&KZ[M8:N+R%6X\VG
MP<;52'[EB>H%'A.;C4O*VCX?SZ@<MW*]G'PA:-;/9'#\J09([]4GM$(^4^XE
M9!=^#\=6720,>DH6=GOPO=_?J^Z#V_(B??/O/@OU,F,$Q44O14%*XEO% L[%
MR6RK7%IO+PMT4;%/^U3-*IW:GFILV %B'7>OBD-ZJ@ *5A%H5YRX?9#:#1)Q
M*)EVUZD.5JB9X.'AOII[KGA:^E+8HPR.\%0NMU-!\M%,<M845>^>U07AB+1U
MDC Y_[[2YYUNI\YIN]\V"*:3*(>Q(P:0I/LPP-T'*VX&V!^ .(>HK,24H%PL
M>@;G,;UDJ/1M&_7SW=RRTQ:Y16=1B"+"9+,.4L X:<N0W!CEC?UG,'%JIW+I
M^=E%[@>_)FL5R\])?0[6]21K,SBJF1Z#FS1)?S$!W4U>"8,&EI_H8<@P,4JS
MXR4#34$V(%T\_HG@W'"U ]L%;M,M;-XO%B]?'C*T"^B&>Q]6MRUN447^@NER
M:6'0RU#"'N[OM0/0]OH!:%/AO_ZV5\+@\,\#Q+N0=?7C)5W*VAAL<<0EKA)K
M';.C)VSW.F^\2*T]TD*R8ZN20]NB"1:,?LBN' W"C(D<,@Y 77?8TA@]$-*]
M%,!S*$$$Q7D B@I@*DWN=-V[>O-&I'=H8V"6TL6]$+TA*;65U1=;A#]#$"^K
M=[3S0 #)'[-?/U%&6L5('1\-N$R@ZG9O1>U2+Q=;SZXZM7***HIV=%R6U2T/
MIU=!O<&LC.\OS=+6?8>^!!7<-=?HQ5#."]M(\]3U2Z=>\UWBXSA:?13TK L4
M*G0=X4QC E4$UEUK-5&Y0L>#M.;#_5M3-5*K*+J,,E%_%'_IM>B=YN3"LN\@
M@C79H?P_J3EF1+2["O867+&6Q/TRM# -)Z-W*L9!Y)R"76%BC=+5.3^)4[U#
M/9N[+/]XA,@Q1.;R'&/2]VAM(+T@R)PAM$63Q6&U;C[)?<K 4D6RFCT<MRFA
M.;<.0)\'-U+:$GW3_R(Q.&%D9S >PA/T?@/]F($=5:Z'U.SEN*6O7JMY.A?>
M(E[]@7LQ+X\WHE61TD=G,@9"&H(?LY@"&*$)BCOJEY]O?:6C-X)V!(QP*\'W
MGF^3DUI7JX3P*##S6S\Q;=6&:H7L9(;>46X4&%"ZV0JE?Z.WH>FW:HQ7@R&N
MDO!6(J[GY0>KS\R/O:JG %CAM]I#0D-Z(+S/#T#Q)TT]-2B8:V.KUHXV)Z_<
M'/CV*=7EZM<>W(+.,)L!510QAB--YG)LP9D4DKV7=@;I.EX\PL#0\RES\P_O
M]*WX;!?TP&>]9FBZP8OSY<M;@#RR.Y>#Y@R(E:[G\ !>)7#ED4^3WLJ0ZR.;
MPNZ%&8_#L_WZ!0W]V1[TX/ 2^T%6G3A J20*;K/PT:&_QX&=J>?2UT>?>I\?
M+&S&S13EW)A^<"H>7-O[;;81HBDJ0^( 03Z-62V_/?2LMLA.DS.0R'1)5M_[
M[ZG/N"J_$7X$B_NG$.9Z_R4AHFD\P#(S1I8F+&<ETD00DU@SC.A'64.)B=&S
MQP@9T*A)Z6*#HWPW3J7R,N)I]$;F&[\!(:;TO'HFKYU7)-T$/#'[Y_,_6\\%
M?:PO8&*IH<V/C ;A]LP,POW[8,S-X^;(2Y-H?)/E,/#IVB^$8%\@83S]B7EH
M!;OWTJWM;F'Y^Y<9D@-_\\!C6$4\+@Y&L@9'Z8D ;GF>\Z*C6_ '"V:.PND,
M_HG77KFW%6Z^#I 3/3W+.YR? 'X?9J"#V]ABZEDLZ5\W)%8+%@7WPO>0'HV?
M%Y@8M6H80XQ[UWSC3%"M<[]KRJ<9T>[L#.*ZP_:[7LC08;)NB^OWR^C:\GG#
M$@_;T-8LJ\ L7N'+CM>5-KMV04?,1]":" 6F'CS5T<P#XG?,29"P\SH6Q1BY
MK@EU9?VI"GR <^0U8MU.1/?MBQF2(+8_24+DJHT$IBP:)$VB[L(-N&SI'[4@
M2(]%F:>=8GE&4T/;*><*-2\+-.AC8L&I9]:K4N549\9A\GH?E)U [J5)PT@9
M>]D?M *G$#B*3G"<M,^.3IE6<%#/O/]D/.B?K>+.YW4&ESJ^'!+YTBVVB.2\
M$S1TI^F=2&=#=NEKKX6DAHK:.5$KUYT/9Y-2Q/Y$^!\"38>[CN8B5/1/,R2Y
ME4?^U495L?7Q>K<RKJ9'KJ<43<6O1=UQRSQ6/>D%0J3 UH2Q]F_^935>F,;:
MY:=Y)L1P2+@?-U63 K%^JU( U*CWX;KT/!V7A2TP '[@!0]ZK)RT67(TJ/9U
ML6J4]<,/?2FR->U>5\1-_5,^H/$5:";)5 "_>H$ZPE340*H=0U@R@YY+B9EI
MS=TX )VN3-Y2Z??1#/PXZN?D R?O]5-Y$+,04O<_!]7W##XT< M).&-Z;89>
M3H'4[AUWROVKNCFW&L(<2F*A'_E?3U,+@A*ODW +1HW"KQ93(N=EFKZ22Z).
MVGPB$<>6/%[N@AL'&CZJ'M\6?.IG-#KG)ZFONQ />%+"Z%]. U74H[1;9-BK
M $F[=H;V,*+7H]SC[FR?Q^??@;G>X3))[VXV'?5AZ=$\CW]F>'8W!<M*R9R\
M%&IQ S AI4VH"-!<)Y4%S.<_4E"0!A?QJBKQH]Q'./.7XXZ^RK "[;^(QR..
MT511P'72T$W2?-G"1ZN>[#HYDZV -D?7-,]W2W[;0GW:)_PER]+#P]."O^S_
MEPUQO?M,N,=_DCI"3P]@K^/8^ *W6[QRYL1'X<X'<5X%CS,\5D[MA<2<OEKK
M=#2,77Y)&P:<U_B:M;R)X+?N=TD^G>#P/%UGIW7F*V.+1-%KA3=2#>:L 7,&
MI\@"=2O>UFNP,<\.^+59+PYYJ]OSP0TL4"KC@AATZEPZ @*%#R"^!HGTP&K
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MD&)*;T9!$)-\]C:_SZQ?(YLE'EG8,1AKV(O0(:I>6_-5.*(O\R@)HZ"JMAN
M\/Q/><[- ]#)PP3L.J-79+;;Y,W4_=OI93_6';_^=,ON_I>?]![D<Q&J:[1E
MNY]"F:)70@G)#''W>24FD%HQ!+:(DC:7T$QRY4Y/Z)_CKME[3RM38Y2+/].C
M^/>PLPW76:W*QT'QM2C>$90@X&]337*>9%P>+\BV2^'M+CO>."IT7C9.9[WJ
MK'"@]81^ F3.-^VRW+_#M'BF%S7O0O*9%<*O#UL1)C>=LWGN.[QOT9B*^@'=
M''\=>_0\J_=E"0$6$)WG$_H\W(7Y!&IT VYQ24\8L-<H)P"%V*R7F944NX0H
MMJU@SQ.QVUHN[W$C* (]$_K$G!,Q >6%$A1(/\R=U.MPSF//RSN+0ZY$1'=(
M1]_C?=![U"W, ,0Z[5X5>P#R! ,*@<PXY !T&(@8D?[VINB8.5Y=X^)9P]K:
M7EGG?^\<5>B@FG]!+6+Z*/@X:8@FPH>JX@R*(4#3BZJ[:CVRA]YIA7S64:C<
M54+;@N@/JB*AKFA 085V29/(4TP[?T@!Z>&4WE9S(HRX5;>Q?3KSX1[,]=;F
M=O4_8"['-Y[*13#N5@'#GP"!^<!,9Z-72-XZ7_#$MI:@;[3"[_7IC/$W*0]T
M<NH/>SL?G3H O8D.\F2T>$+VC?WU(26X1I%#^LOM5!1D](_!-P3<@C:N?(MQ
MHY1,P5/..5T92C^_L9<SU0N?+$7\1(M#"05ZQP'8@@I%DR:-F_%@DFU7>CE1
MSSS+5^;RCH;<QEX(ZG>/[XPZ*88F(LZX#HO,_4LM0_YN>4G9FL(LR$"99!#_
M]B5;DC>_G!F;X?A?H6@CK&S0YN8[Z2'J+2$D_CX+%C$!(=V!,B.VFD3,C;%L
MY(F@[N$;*,C(7&!GH8OM@F&7?K)^AR/[Z6?^,+$#$(9<CR:>8JIJZ>X!:(-!
M0GJCW_]#KY:\3OX0.MA*M1K,K8:V3T.]D=CW%KD+Q_,#D"45%L KAPR7<\H$
M586*T_MY;J_]DV,K!,LZ(#6-2.9D=(@/<?83>@$+@LQ(8<J/<[SIW'Z[/035
MTE0H]7%CR#";"%4.,0\#0SVM5T9W?>I^2RG7QPPUD1B%5C\O1K"DB< R[Q\-
M,^=6^Q%F #697$9BH("L2A<Z"EJWC$ZDR2[R0*Z1BE]55JZDJX_5#(3Z>C:=
MX'[]Z5C'U5\7SZMR7.ZH^@5+0I]L5:3JT:Z,ZW@NBD_4_=K09SES9W3V!\Y/
M-/5ULY'N<7U\FO[1,-[->%H9&4P3$>LI4'"'L8]7",4F>QG:=]6H.-X]=1K<
ML+(_^0M6C:,)]G="ZC43SI!<*.'^>)R8&5>_IZ=L>W-#ZU311Z<W"JF$![F>
M9PFW11?"]'Y^0MG2OR&]P8 C%79\@!DEP&AR4-)K7:P78YP*GJ:%<PSMOPOT
MWFFK;D0%D=!Q$)(-DB/(KH,ATD0Z +V:Z7(X-WX)V K@45?7;V@V;?H>7K)=
MJQ06P!E_7%]&(HQE7^TZ7)-Z#MGQH%6$:A@TV-^!.C,L1Q*)"SAN_?SPW*^N
M[2UYF>.HN].+17>7CD%--Q"]3_]8$!O1ANI)TZ6G/6\Q7/#XH@[E@^6G]>N/
M'JG_6<JKTSM[M5?*3_/B*K?@Q:-@9%4[G83 PDAWXQZ3=6=,"'-V759<Y__$
M*WA8>DKO/=[6 )^9C<"(*@U,A.FUDG)IPE3,R6A4)N,,8%_V&ZM]0Q!G_>1/
MB$*9_,J%NHN\E_%7MB8E&(E!TCU8^2XD^Q\]>=)\OG!Y_I.&]0"/8 YMYZ08
M"2D#B8B2HWP&H A%PE!2+M/A.:M@ _5'&.* 12\$3!-;T.9J2K^-(NW;QME]
M?O_\]&LW<,MFM,];UKZJ?,8QFL@HVC%W>M7ZEW(]]0 DX&&KX+"NJ/$I-DE@
MS]4XZ2JOR-F!V>69*1!8G5Z.QA<CP5!7Z ETU*G1S5:OA:GC/DJ7]C)%G\:)
M<2AU25PY*OFY0G\]F86 =$L!%+?"]50 ;"]&2IG4-H3IKS2Z>^SC;G;$_/0[
MT;!RI9R'KKI=>,DB_['P@<,]IJ-+0( 3U1PQG74R)N4IGGR)#XL+RKI;/\9G
MRC/;<TW?V?)[P(ZW4$,.[Z\/B?&[N8"253N4@Z9(;L0<@ 2#3 V_DC80IQI:
M&MIJ1X@C\ZS*+=?Z53+#0#]K\:E7MGN"E\(0_5:=R+I FE C8;4#*HH#[#"V
M0I-=RE;F+Z*W%R;(7D\_O;M]\O1%X_,_#/KN*X!!Z1^>(R#T@@ CIK=UD.\^
MWN9*/BK%ESGNTRBP0E&=,#VG&QC\692Z@I)A#M"CL9-ZNX?B&%?((@EUBA !
M6\"O9UJ9&'!#>$&HZ5O:5=F+3:??*@F ;ER>RVDZQ4I4F88R.&/PYEB[[@D&
MW]BN72X+\'GG3 ]VC>A=Z2/JO.=QX;Z>Z_&K-=R[1S^P4C(0@DR<N*TG_ =6
MFT7T+5G3.U(?@[GPY&1 2:R7UVZ7M6--LTUAXMO7^NR:=A5O6<7\4PRH3J2A
M[G4R%P$=I7,O7$A]0&[4@@LR=\3]WFU=U!/0'T^F*V=:!)3 3R_YH@<^ '5^
MI<+2%RXS8W\F;^$X_G/KG=-.:VY-SOO:1N135]1^53LRJ9'?YG"_H]YF->-T
MA$ILYI!,VH4'UT5\!4QT09*_6?\MH&0/G\8704C?D<)*K4('(,YUAL!0W9\+
M:[G>C%FJ,$[5IN _VQN+/P:)N.[19$05T^?4XI'[$H>="U[=@ +--#?FG'8&
MO3(ERQ--"NP]3F;DE#U!"=4E#KAHW0J/&OBE^,U$K$,B)!Y$+P!"%H8 <QU6
M0M6)T*P-Z(RM2T,!!:;V<QO^.]/L_5=-IQ=JX1^>"PU;Y2*&*@[K<BP=A8RC
M+XV8_(;^DJY*0.DPO\>YE9]$[19Y"0G345'I$JK7>YB-P=&3!PJ/KOZ@S]1]
MUO+>,UCC$)5AW;T9#TA3G YOP A27'1+5-*1702#3?$\;G<S'M6T:D:L]7A8
M$YS<SB:=N-@N=LQ$Y^LBU"MHD6G"&"3[VKP\62Y?."/_CR71/S#PXI[3=;J)
M/(BE3X8ES9WU13RMD=Q($SG2B;/. 7/ %9O0H_QDH<WJ\H1@%UB04UPG$M=3
M=9N>A<17(@2!Y<4Y^0X'!5(A@V.B/GABU+PEGF0_/:0M87Q",O97K8#@L_8T
M52-WUM^P&7E*[@$HV@0P!B=#_U.F5O5SC#"*PE .0-6+/TW$D>^634;[>S1V
M<EKOPZICB&8'()Y@4LZ_'C0I$=DI3_&R]5+9@&(A7G/+W=PY3.JAH.,VT#.'
MQDSFZ$ 97+*'1\/,!7-2SV+$-U5!Z.%Z6DC,82&G!NH4S?@PM3PRA2K27<E$
MF*%Z>M;@#KH6?P"RJZ8L#LS]N_UB,7$)%-I?QIA@_ELEU&5W"(>R^MA$JV^Y
MV25EEV)'Y^IM0IHK]5H8T3#V^Q0'_'4&:S:67JBGRO3%>G !LGF7R@:2R/3%
MEYW>4[6)4->=QENO%W].47W1T.>[W0A6&C_]$Y)@QAA] 1%!$R",2>KY_)!0
M>A(%)QV(E7ZG$3QOY^3S\</&JH]!#M02 84_9\[6&^826P&U"U"*/$TZ=\;2
M[/\6OKQO.^ NV_Y<7(N>Y5;SQ1:)11G67\C'53.O&.)7)WLLD)TB3.\52).N
M<G^/K$?,45)T;ODSBI5;X+GP36(RHJ@*@P;D?8@I>-PT&^$ U&UOW'7'_@FV
MI]RW6"ZKP!IOXG?7N['VRMY=D9<NR>8_+Q2C(DE@FO".R9B.@8_G(CC:XC?V
MVNBQ4$/3<<08Y?=M3=%L05QR"3>OUI&@// 8IT).4H5-4(QQ]?CSF;=;S]=_
M2S<W?(M<EHT;4]7*P9<=#7VR#'($^GML(1@<UYJ>-/E\F>>GWR^?&WF6K_<=
M,19(OJ+;)P-BDTD%R83#/D"%H/B&E\?3*V9MX%  Z;L@+CJ=$6#O^&_#\_QE
M[J^?U;SD<]^]6?P<$;2 QM<=@"3^<J6(!%D0U*-&KQ?.V)S_5M9[(E4^Q_AY
ME 3R:W5M^ '(S&!#\7?*E#R%%?#"^T3DB))A"7#EXJ"6'H<S7U_=S_%Z,GY^
MH=;DOHG@A1[\9R$C^X&([D;_1!#+"H0#B6^0DIJH+P\!QR*.-)'FWE1\QJ)2
M@GP$SCSCTN&.[S#HD[5)UCK7"RW4$R-K9"RJ@/]@-V.0Q\L*UB[(#A0MUVXF
MNT^YV)CG'T>=H7^#XM\Q)(%Q E491C"/V86R ROSRP(NX=<S,I9KGS$<C5H,
M\S%L7&FLK+E94FW4XXQ!/75Z)H-W-DBE1TINE';MT]Z64L%HIH5D6G.*JFSP
MD<Q[^*8]JRRD+6C_9CSM+ST?C?\ZSP-8+9J98J0X26_F=7-O9Q"_!%B-60[V
M#SBP1\8N>=R7B'@6EOHB[8(Y#^FPCWQP,<QS> 88(GQ@!C[2"O6,E+*$LM-B
M2V]S+LUJD]K)P\-L:Y)"G4$S"Q,?"4/A+P] 741):;)P^F-"?XJ 3>&]MVG[
MHL1L LBOY%$ ZPK6M^6RKB(!PLTTQB>MFF5!FMU:#;6D33/Q!Z.,(:F,PH[*
MA*RQHM2^%B6OT1\W.H\,15/7+J:ILNQ;7(<G4#D1<Y.X!IUYQ>CU]EQ2?"\!
M(*29 O60NH[3;YKN=R1Q-DC[CR7RSKKU,?Z/HVC(\/_O34#_/W[8EGV(IE1]
MQNQ)MEX?$0^'8Z2AN(K6TVXOR1[F>< 5=>V0A,>,+S#=RN79GTVN+*A[-]J[
M@XUIEQII@FJ,< @?E#1K> #ZKO[_7,Q@>MAN]#<_F96)B5U0VJO_V=#S-HQ1
M&.E.J?>GP&%XH%]^]./WA+$G21LWIX^P#<?37P$AI9[9C6%P]="%$-%=M,"<
M1^;HD\P+'XK:9JX5NT^F=WY[=$7W/Q<+W&.NQA-#;ESMQY7*\Z,+/';=)P<V
M&Y:6L:2Y9LG5+_"ZA*IZN"GY!.40&<-Z%Y/\%"%<02TFM?';U@MU(SI<DL2*
M)Q)ATA\KG56_7(R9]Y] U4RJ*\,H'$#'PI" :0%L'0EJ]2W5J"V=]7@FMDI"
ME9V2>EXEL#TQ0CR:JN< 6M9/GZW;FI'&.Y3E,^/<#K)_1[E+H^_.W]+3&7X<
MH*X-&>YGSXK\?$?"H*<9%^'/Z/6TQZ3^+BWC+GOQ'N,.36$<^9)65MA"?:-U
MQBOOX*CLM^TN%DT7.EBS<:0AHBP5CB&T*>B*W"8O]R0VO%9^\PL.C7\>= 2L
MG&GH;!K1=+K&?U)>G8+K\HG-0I/NZ-K.$$HP-U2R\&.!KP<6P9(#W)FD)_S7
M3SF53&6"OMN_.>[;WD[\QYBIK7UE7ALQ@I6-P+)/G/V4^/CN_4=GI<)8]"$)
MN:01'.G.T/Y1N#[35_DR&=:I"5P$TB,%.*M"D\V^.1=DU;W?"O8_J9M3B;]6
M5_]&6$S@5D/UV[%_7NOA@YX4K7B0XHF>?\V#[_%MB"U,YMTUA].-HYNRHT^+
MO<I\_:JKXS6NB'(3#*Y(>GK'@VA.2&P(@Y.?_F6$2>74%A^+O,^MKL)T70B@
MMJ#Z6GQ0!Z >-$Q/:NWD2B4>P@,+RNG15>EJM'6IPQ8ERI_S>?'K7+;Z$NF+
M-:_YS=]G\\#9:'PA=-L9+8A>_X$[ -W$5\6C\3'0;76XW0&H2EGS &3TT J+
M)MV#[*G"XF%_EWT.0$7/K):8GIB%ZNZ.KAZL7M0><,-D,4[;O^2R=K(32U/C
MCRN2:=C\ML-F?A-$_UNUNDI@T3O#U*=T=_\_*:O=FEV9S<DWOO&PHSVXN%],
M<>Q;C2)/0O%UDZ@S)._\0K@VZ=(\9+SJM+M1_>?YBLHG8C=4)&[DB8C]J-5@
MD2C[<WBE!/-MSKJN.SWEY,9NV^<36KJ1 L:$\>:K2<$Z\7<W[TM55SQ=$R]0
M6X*D#A^%D.R0L<T?>[M\8ABL)[3<*=D6GDF<:<(VR]DW'KRO/OOU@F3OV_EZ
M2NZ&"E4EB(M0M3&*+T,23H[4*_MTG=1%E94_L<I\/:#<E<6O5*SZ$[PY?%F_
M(/&\;YK)WBJ#2Y*JOIZC-0S7)%M@,D\\<<-,C'CL_Q1><[A!Y-I[/2@(;DH<
MV=)]5?:[PEB$RA2[P[95FM2+SXG!5\5I";?YE@7Y#3Q5JN<1$'4S+7?OF;J;
ML918\/G8;4+#4NKMLZRK!Z##KF!T:8H+O4+)F\8B2B(V%#SV7- V#9$X8VW/
ML6RX%/[/"#@:]OQ8K"B(Y6\O37"K4XUI-[$H<?A#X1_J]@KBDK=7'<F2]31^
M#J:&-O3@2,=1E\B4MD4H<.X?,83U]TF9YH#*3L/'1R#S7S**N[KJ1IM  6G&
M>A4$$1TW2F-O[K'=7!$XZSA#N =EF>Z?IQ'S=,3O\5VV+"[R'+O1?B4(\? )
MI)X-RPP(4E_,2VDZKZ-G%/'%&#CC)A3;T?L/,2BLM+LJM*/2035SH]@ ,R3(
MPO$:1-_C<GJ6 _@'\6O:FJ>'@5ZQH.O^C?JES)>:<2KJW_4@8-WS11/"8QY/
M<6?;E$XM(4.@YSUW=QB<JR3.T4YT;56GLM6-& T&YT7 X]T)MHTA[T\:/BZ>
MC_1JJ,-L,<B.:_4).*P3@Y.E&*[URW7G7H\=F,M.U2_A4K)4,)A:I:T(N=%6
M3LG"9!_+BJ3I%OW.=CZ#,QOU<JRICWQ^HT _%AU1*@0<IO^D  &A9#=*Q03B
M]+K/^0(F\YO[@(V<3*>MF%(__<IW#,G0!.?>%Z+:Z!^[3GF+&/:BC>UT!D<K
M8U[,+K[06I2N= JB8J"D[""1+H34CDXNT4MC!?.S3UQGZIW:Z^\]F^. .E49
M#I]$/H)@[;I4@QHQDYK;QD(],5\\(LS27ZU(QSFY$F+=QR*"7/R'3@VSC>7^
MM^QCAQ32ZH)<":F$P=X/B=T-=IBQB#%NK8M8T(F)^A)@X]7:+9WZ0VX6[,A2
M%0?U]L%BS6?>+[A%*K?*$T)O#O::Q54\G]-[:A8<Z*O]94% )\SDQMA9)<3#
MU0_@<3,1RMUOASO12"R-=\PE&6>=A;F*->%*E] *A[J+27]6[E%+SKO#UGX
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MLT^DK/6% U#DD^_.$MMG0"F#*,O#+!T(\!5Q3/( 1) [3$,/4ME@DI!C]G7
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MCF\!/0D_70(TFWJ6B[M89MIK3?@+M,?__,QJ+"HZBP[ZL+2"RJ67HO'YD-K
MWJ&P[,GPIPQ)(+OW;O+/%/"L2<&4H?!'OU<7A=PW$XS>B5N?NF+Y^-5(ZRM*
M)^GV-ZHX8SZ)#/)PNC?\5_(Y4&ZV,\KGH)2VEZ71A0][D'.M]TY%4LI;JU&T
M&!I?">%41HG4X;AI"I,Y6BW7MKW^5DJIUU=?N;?B*+YZRAMT^E1.(6^>Q!:-
MGZTWJU*^BXD__8I])9^P3RB_TK>[3ZL(=H5\93I17/,>SN( ]*:VA)YQ&;G;
MYKF+8W!0R>\7V(@LI!YJ#TJ#!(NA2;OY7GYEDGZ]+G,6UY.WER[T^OV_D*^?
M#24R$&_%:-_'#D#+2G\.0"ZW(7056]!^ H,K>)%*A':BN5O%O0)D++4R!E:*
M0C@_*$4?BSL]M\:2;9%R!_S8P9,JCL#!:G$;DR1%<Q(SVE01P '9OV_N4_(]
MBJP')'?J$A\$]OE5_/K\]$Y%WK.@I?1=>9JP/%ZNDJR"'XII]?]DUQ?BBR_;
ME*)@!6=QCDW\>VGD/OZZB^F_*XCMQUOM*&?_TU]='H"11,Q(;EUMG,OJN6"9
M5*R#]9^RYRIXI<&P-*-I$6V]I^=8;K_$LRY#V6GV)#23R_CPL/7F<EU:W^(%
MKL($;8<\BNV-4ON%6@?C_(]_GQN_$R?W@"66TZK$X"^$)KS>FS4:1"5,1DRL
M/!A5WNT+B&E@XV^MN?E+\?5<AN,S7=9<"_O&C49J,,V87HSV,"# >."JI%S:
M:0&'MK&LVC\CRO-9)8K/MG\D.ZGR@5B]N;Z*]3)#+YJP/P4YH6-#\.&"W_M5
MF4,!@V6R7U0)WLT,JEQZ1![TI7%2,]ITN@]O$_B3,H7$@R-T3E#/ D?8X5>*
MY@86>#@G'XQ[GU=V>K<EVQSEXBLMM#?&H0$*X@1]\2>8TTZH$ ([MI),R&KZ
MXW!CS_*9)R?FI_X,SUV73"KT\SY^S$"8DBA=\PBMV UOH\HC.VQUA$B->+EP
M/ [B?G)W?S5Z(SK7P[< P_UUWJY'HYUWCZ^'H)&/?U7[PN]%8M44FI)#_P1]
M8HY="+Z$%EBSA/ BZYS' SY>(40OC'1B_"]9QF\;W<SJ[-+@ZUUY'%88Q@T%
ME%UC2MP/0,((2/_C$NRT26#1PR$_"JG"U8-[[_P2^%VRN7R.YRZ,HDPJCBMB
M_$1S_#55AIC7C6W"98OCMA[57\NVGR#7>C]3G3YU(KWO"(J#N?P$]\"+0"W!
MH9;R@BK18#6!=!=3;'..H^0:QGS_NSJ""F..\67,2/$ !03($=K)ZM'Z<J0@
M@,1PGO_R92'6%CK=VM30TWGUYXU'&(4++((L_^P1CY =ONBE!X#) 0C6G,5(
M:*P:W?]_*8F J#)&83RTK2D(Q8E,XW\T8USJ'NCG5)JVXI$'B<E@LI%02W/B
M1ZHIM-?GU0&HMC$F[QO5?B*=4"!7^%KRYR3*HPZ3LK7PLTDJ?35?B,(",&D$
MEQJ#O:5XIE?D74BAA^IZYJK86:^JXC3# Q#B&H9<-02;2B&@:<HIV!9";DR.
MBM9X?=#6E]3$<H.G/%WQH?%=5HQC^E)M3#A0!U[D<NB8D:PZ/L>GN:-Y*Y16
M9F@6RMU#V3B2_"PN*13)'"1&IO^+A.(_(GEV/^JMF;J23[KOATYF^J*FGV:[
MW0OEZA8V]GT]JKZS2A/&,&Z;=J IYYB2%&4]^+M*C".)/ #V#EDKZ6-.^-&L
M['\Q=0,J#G6U49HF <LV>WY=>7[6W4J)H+7O!6V@PQJZHP<@>BV*'?%#CW6\
M@.SVJM6P'%B]U_8BRW+T^;K)N)>&0N^1UD;V=K>0"UP1UFZ714E#V%>+/N%P
M%^H-8[(BOB>I+$AC1@,;WMC:$#W]::S S]9Z,=I8O^2I5X>8XU*R'R+^\/Y#
MQCR$E\%"@X[K<)"A1ED;U?-]H25/)BA<SXU(^?C7"!+F_+*T],HCW_!<0](6
M33"]!WT2[:'HPP8_!=@1/EIAM(I^6E+NK#<[)7Q?  5/JNFH>B6Q_>Q=]OI<
M4+;&\NMPSUE/SOX)D@4A8&/;VC A)=<<:NM^_\.%Y'G5^%X4SZ#O6AZERHXI
MBSE<F(2.8B*G+KB'_\^+6B"E^][<4"A226%[SW?6U#LU6OK,A=>K/F:#C#H<
MH*C2KFNW,+F!\ZC\K;&R=8_D,CWF7!>A:FNJ89:^P=K\6*;WGY,W4)6!?J0"
MG,N*@KI5O5HGK2\(9U28N14-7=HW8Z1P^R,VK3P<Q/@_LI\Q\JM0Y:5)MOCI
MZV 8G'VD&'W G&JAE",^2ABI@!L7&%0,>3Y)D##Q&S43C.(#B02F?0FUF?I7
M-0S%^C/NWF7JKZ-K'(VHN(VFS-+SZJ'8]$46($XN+O!3D&O(XZ+?_'.E\Q-?
MU81E8[A[3)R=ZE*+*$O$/OH=>@ET64@$0I%SSQT<"=-19+!['H!.527F_IUA
M6M2PC^**"M;1 ^J.!,ZY;$77]W];&CW?ZN)&N&Z9[A$Q?EY@.A.ZN;-RH=?2
M+U@.]9$YC2</0-\5F4'BBQ'DKO@/4@IP3J0S]P1C$-H@@Q2L^Z[I83M1Q!;[
M_/V.\./D?3GC-)$-ZQOAY#EGJ1@0I!+&AW8Y ,5 ^%!\.-J5W$ZLP_L\,U<O
MK^M);VY0N 5C5R*)>_;@GV#_R5,?R >@FMP-0WSN-*^]JP_[NM29,;>)Q_&*
MA/*Y:^0KB6F)91(W6,0_'/'3=U2#G84?'M(/!FE: RIE&((/3U#,+2 N]!%E
MN+(30S$5CS$K?GPAW3]2WH\65GTW]=N77@:'#9EU<:B'!]PUKP#$+50:6I%N
M^7(I\SUY,;RRLHYP>>?,+AN0>/:VG8?JA:5\+$L*>>4 1%&@OT7H]B\,^)BT
M3.K)SLSVE\Z[8Q^F/S&EO&N\F/D\QUS6N5^8\Z&0K)W[GAG\(S48,6.K2?3"
MMYV4Y"(\Z(UY3I>_;YG0G551J?:*.X%BGJ9;*AXSLZ*Y_SJ\0WWY,,<S'GZ%
M9$QI3;@+[.0-E,_\:?SGZ\D'LZ67$=JTVW-NO*>[3O-N1NXT'=%G^PT#SAD3
MZ_$I6,-V+7"XGLBTPQ,'R>&M46OT!,^K&0-^ZWEVIVN/Q*SHI[=M[COGB?7E
M@:L/0/C7%B8J&VZ%Y=4N*=;H:VR \5M>M@43FN?.T'\O'$$Q#EL4KF5.XFJ.
MV'4HM$[8TC?42G4*^"7"( !7&<T3#P'D>FF%:AC8WQGK ]"(=C:(/O]%<3&0
M]AH)04ZA2Y%_+F5@)X7(+8P;Z!3T!FP,NIM]$\2 HYT/0-.Y%O1RQEE3?*6\
M;=WPEX+1XC&S\26S,T))KV\2@OMVV)9ACP] F-3#8/*Z"H;)@H_IPFNIO(Q1
M+;>-?/(GY,DUK/)\BZ=<AMX'Y:?+UK.74L2/]_N&+^<.HJB'^?=!THRXDE@H
M20-,R@,_87Y***-+:W6#:0(<6Y2AN.<'('YDIS$%K+AQP0223D'6;<ZU?(&3
M$Y'/)U>JB(Z-4 @:7YA=$O77=";<,W2A'\)U+=#?B^V]4(,T6YBJ/9W#,22;
M+DK/8LYIB90HO81QWAK@,B595GZRG[,;>M:8%7A1Y\F9JTM\K3OQ@!V#\S$)
MW95;NTI,8F,R"8D_V7/$+VU%\Z)]\8I3.K4RYU\*XT33)2<,?KNS_JWJ@M5J
M8J "<)E<0AT*/.)%.SN1Y,E3V?;I7(/L,]FDZM=G3VF^^]?(G6:&N,R$0>5=
MR@C2!\P[55N1Y,E;QA)PA=L2^^ [K7P==WA]E@M<NA)^<1LNCC\ \?63H?=>
M;31DWT_ME:UOFTGZ/.]8[?'FXH]2_:$P]EM+\ "F?RC:@1*:=.17-G<0?67>
MN$FH<]:5?WE@X\.B.F1?7Y FH_LL<K=F#6UU ')#[YV"\4 W;$:ANYE:M#[F
MF%E Y&[, @2#%DMP\Y);-4V_X9EQ[X%<O-L;::FPFI]=O%3QX<D\&A=S:#U<
M@P3=P!%"V2Q_!4S3_ ET81XYW?,3T[9<?QXG7C^A-(-Z\*S43C%#-HPG/!6<
M@0 C?UC&T-]XF1^ ;GHK;L$ I2Q:MFXN/7$"MJ^P@+["Q'CMRA=4!N=I_/J0
MH'5?<5#R3G?:W!,-?R.G(&\959W8^]N%:E)@Z?RJ7RG_]>$P!62'*')I3!U-
M%?=A?LP(6N, ]#@WLEF^9VA&O--!E"S;[.!N%AP0$N@AK_CLZW69_A.\:S_C
M10/OC>\S ?4H4U_3[QR6RWNU,JW![B:M & CVST$Q,E48S(CO,2DW!Y ;'I^
MVQB&S&,SGC?=T]=FB9OUZ9CY.%?*2IFD+-$_POG)K!0K\I@R84#CQS\,5GFP
MLG!V&MO+G5DS<VWD<_Z="Q4G'CM$:I8>A3-GX.@U<N6&GA[PFG#"5]%C4LOY
MY.>9'"<3QS?7?NIRV+R!W"D8MC*F6AYR2BZR(@5)9HN$LWY:[UL G[#6>^\O
M5^DC>&?:[D>1_+*SU^:=FL1'\)FX18_?4'P"[DB #S=@T8T65'<_.3+9=417
MTR3YFL((YH1PYN.<TL$'1MI=C#$6LM%[T@'(#& &WL?.C,'/56 H'Z4M@)10
MH24QQ95.E2*/$Z<B6!5>OQ[2L?JC21,*(>"B\^D)6]Y>NZ9<)G!HJ!/][<1$
M'V3Z03&_JMRP1KZ-^++$\]VJ,-1_7>==)(.SXP D9\J,AO?IH^C=+PJ@O7(&
M>SXI5W^L@A9"/L*4(GK'OJ;YE>G7;Q\-Q>^?=7[3 YYS_?FH\>%YEHZGM$FF
MA/=(J'=XW(Q:%]NUVAA3NWY%Y:LWB'S74"'76"]SA8G%>\L$.)K?,PO-8,ZL
M\6$='!G,Z&$_ .V^4URJ A1[:3FWBPY CSS!=)92UDT8H-C896;<R7154N^*
MI^?ZCJ+D)I2?>O]$JKSS/IT9>,]8W^'LMG9B\KNJ9"B>&0TW!': IXW;7]8A
ME$B!L0%(B36K+R-K6.^/'EJ5Q=W6>*M,@BCWEBO+,U/N558(@FFXQGI'UM 0
MJ'-PQ2Z[3.MDJZXZJLW#C=,[;?U'W&*F+&M:SSGG1VR6UR77";F /))((&WA
M(1BZ17ONB5T/1+_D1A;V1:7/H\9K/IQ2'");W*J;]U3U7-E$Q4![DY0\8.8P
MFWN$GW83N%CPQ(&G8: ASVM+.;_!O?[L;&;F9<+KX7,SXL^,K+])?\@=&0(4
M+1M0<O385NWR7K$X=1X?LQ;KH0<"=K?;$?5+4I),8TX+FERT(LIZX;<B(5QP
MM<^ V_UO\?,_) -O^09+Z(.U5MRBS:KS]M[2*NOO!^B&8AA<)W-@&S&/PLYR
M+=B=CA*%K'EK\7:&Z6PQJ3<I!&,%XX1;D3FI1K5M9/'U@6+;^=G.&A,O[@N&
M\IMQ;(_=/M88<4RA(E!,9Q*!"F*[2I(GVGG(1978_4FH!%Y,WF^-G[AX4K<C
M9T4XM"#L9ON[7HOTL728YW\S<M3AY3/C!Z"^T2 [1E<_C'X>E0=N@3[QTAKJ
M@I!NVUL\&-L@_N6Y"3Z&'>"9^ZFPW;4E>&Q:-+%,AGM1K+TJ#8J/=Q#\I7/W
M,]SAY&!*R=J"Z/,"/E2]26MK_?R+33:Q]C^_%8G0I).20W%0_(>7XU$?6^P?
M-F)^N]RPT'[?7V=RF;6L\_G6"%H%C?^ ;K"*1#M+.O4VZBF/!E3>Q#VLJ[=S
M_K40;[3SV(-7PN0,B/W--D</6&*8;4M("&:.2K@_2JPZI9W7%.>:U/8@3'I7
MW?%_WBUJ3XW!*4:67\1A<ED!5UBXK1"E+#@P6.EET7Q&8=+MM?&KYV*5CDEX
M.3KWO[D\59 T2W?[WTM'^#\PU(&'>A<.(P]%6AF0-#MQ/ \]H7PT6Y?XWGM-
MC3X; U*"6-F6IJQC"'U\Y%*:D0'A(2MI<=$X!:4!8'KFS[4"49Z5-D'99JJB
MK882V0)__-I2,Z5/.%P7O!B!<GM=O^2 NL,6)30+9P/0U/M!:E;D-/B%KV3=
MS49?N Q9@H(22'F $H%<X/)7RARY67*:E*C/]N*X2=4O= JL1H2F@)LR7DB.
M(I3K6BV NZH$N+3;/&V3L:9MYK;-(L/:7Z]S4P5]%%YIZ\LL93K]@4JA7;?X
MY=J*:2Z NI(6I)NH\$NZ]6O64BU9_7/IG-N+;ZP(P:.I^ A!@0L589!<V/^8
M/\ ,>7B4F4#&?0#*,^X"TS3Y#D#;/(@Z&@=0IZ<!5QO5N<> C,,5@]5,?((+
MUH6WN"F-%Z^8..V%S>>/ASV[X/O]J)!4N#XD'O>__.ZQ7__;PP]/L[49<G D
MD$* "FOV>K'=&5FM^=9H)K=CR7RL9O/+*\6]CGSVL,^.2A<,TJ6Y/_C^[;_P
M0.8#2Y]<9GH5VVM]B )C'%8CWU$UPW6O-L5BLO)Y"@0#?NU6]D?SM?K,-4UH
MELQ1QE_0[!PK[[-V-V@N3A"-3X**M,I2$E+8UK4@R16C<I<M#1\' 0>@8C_7
MBP<@I.=/E"H Z<DEW<;-2$DB;];<KZL9*QK7@3[[;E9/C(P::S<O3<+*L[[^
MD,R93JEA?H(W G( ZM20\XEQD&7@MFN>1G6CI^$#Z,"AN1;O3<U@F][+1'V(
M(J,+W2#2536=M5B<3EKL:<06S@OD6IB=N#>L'N,6JF"4:B03\^*6@QV?C<BR
MRUS/BZ_T*_0VJ"<K598FK+7RT8OG7WR]9\H&46I^44[]39GKQ_:UZM+!^:52
MO(#Q4DH'D@OHI6S3ZT6ZY,VLA:FV*;83*_6&E%"M04V+I%[4&/^7VS:Q_Z1W
MY1E<+"2U+H@@BLU=2IY$_(#],,_7EKE &9RS6:(J??^\_9E[<ZI/3"_>OIE5
MGPG/VO14U&7&O!28C.RQ-^]B>X"*<TXQ9TRDOOL;7'"JCH\E,EK]6,9+.=HI
MD+?+'!,CGS&FLZTVLA941(,L>E_:3KMC(TR?34:,>BW7[[)/-:9&S=^EO.'T
MKR;IBW^8S$<PW37)HNH88@C)ZJ4G"6P93!0Q>K(7S+2HAM'G(G_U*_[L.],:
M5X_Y#DB?BE!KE*#54RW@]T8/0)Y#V)/_NB"\>I(.?S2ULH]IA:;5CZ\4*1Q7
M]B,;L5N=/;Y\*R5=)LTD#SR.G-)F<+*4,Z80,I//=0W;^8'0.KMCK4WC%7^/
M9[.]2#US?;GN4?[CE0O:,[$#"+__H2#,@>F5CV;0R[P0(L"\3^0_/>[W=W.[
M]R-:;0<SQ$*:"N]C!0@<'>&"VIL/!7]&1K,M[X !139:SF3" 6B]_S:3Y-TH
M9:VO PXK?HXTC^3;V0W%<KG(*)S9AIL(.*K^7^R]9U!3[]LMO)$F-73I(%V*
M2"\"09$F*E@0 2$J("4"*B(M$ 3I)8(""@H(TDOH("UT!*4C74*(2I<=P1 A
M"6_XO\\Y\YS_^?+,.3/O,^_,[\.:R8?<R;[+M:ZU]NQ]7:W>4@_M$ET$I9I5
M9QNI+!H$G3XLUU;K.4*I)DTUQ>";3V0T^,'Z@XJ]$AV#SH^=?<[IUS;;^/OA
M1ST)=#;O(9!B1S.V:)K2=IBJ!]054@7'=<=<D@!;4T%69F/F KW7BJE7@.\O
MK2RG(S_E0M*07NA9WJ7IK:@2^_Z2C:EF<Q0NYE/MY&[6I\RM/)&<SZG'D,'A
M/C[/8G3O:.2,;,?#0+.<A$6> ]/^R#_O(/TW/5^**IVL:D4@)_0T! \!3/U/
MF! "@K?^UQ.KG)@">T4'>Z]KZ]D23:YR<\2N\^MWY"?-MGB??1HV9[0\L$<N
M-4)IS( 3X=7I/NK:Z_O77OO\,G:S_3ZV9>77M\8 D=9R_-NGM L]!.X==02S
MV_Q,F+ D/<([;EWS9;$N*8PK\1#NKFU/D[:0YC%ID5-5B55.^%WS"W_V5F@D
M;86KCGK2@;Z4)-J'-;&O"%X0UD55H[1BO$T)+!,W&=NG\J?J/U;84'*NU"9-
MXA]MUS/ 7Z;?,_QT,/^OKG-R\TO8 Y&[1T:U%+ F22.[K#D]::[[5PD^3K,,
MCN+>T*_OS<<."0;Q3,F:WKJ1TUR0>?Y1TGRTWS-83DX#<[>W')9((B CZQ(L
M=K^=/@1ZGE;)MI66*IO]N.L^HZ_P38E+GY5R5#+#!#F0Y8DE"F,.@=$IC"$2
M#OU[48"FD5U\4#2Z=!AE7K/;&@%].YN9-T7PUIQK8>(3FT\PG&N/1@IZ1=FR
M[.(MP-5O)B^.WQ^^I>'Z]BVYGG9,M9HSMF!"WHTO62Y+7?ZXI.W+9(XC1X76
M'X31_@Q!L]]5&H? JB<,@NSDC&QX3WAK=GZ &"H//_.)6>>UC US+ME_$GH/
M-1N)GVP_-?4DZUO LFW%E^:HGZC"ST:%A3^=OKB]\Y'Y??-2]9V"SFLFWJ+"
M?TUHQ-.@B9R;[VS6=#C1U8+B7&N^4E@(Y7>NJ1NG9X]7,;(@YM[1V=H1H=C1
M1\"_0-U]^0-]EW*V@L3S"?CS6;<:)GRWI:9.MC<<7.]&!*",_G4#(\RET^ 7
M\((QE(6VIPJ4AE;> XM B#$HWW6@-&3>'2RV#S^QWUD=XB'MEK04K6EF,XC!
M(-)9-:K8OX\RSTJ %B4?,H@:X[8S-?WEL#QZLO079GJ"#%7K[\K_]L89#(GL
M%/]C!=^>I5-92G.&JX01A2;%K\8F&T/(C)-4+1!"YG6A7A/"H?>WRI%K8D-
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M)]16C/ZB+?/")6MJ&B>\3];712@Y>MR0>=CUC)OO"6M^N&'4OS>KC,'[,GC
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M1921P*J+.8B,T<2PK]UMS'(Z/29I]L#%CY'>[]%>LN6?RO1X!?H.Q*,#!C)
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M37S?3JHG\.)3O03FG%/ /1RQ@)+A79Y^9Z?5ZF1+JMW]&6Z#MED 4:FWW.J
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M!I@:]2N,%@4'AF1GDLH2Y>RYFJ\5K2%E2/?;"]\NKA++B D>C9+.++V=!H?
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MSR'^\WNU-J&\6JYWX"3_^+*<6C*]DDO)R&H!$';WJ(LP1QTD\A  ;T 3C3C
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M;AIMKCE],6D<$RVLX;\NDK =+"5[:CEL ",\M5AFY^^PD$GJ0P]@C($[;V&
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MU1$2397_"E76V8;FZ.WL7F6(W16.]&0!@ZS6X$&\=",'%;R#Z481JN"-%Q1
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MZ(>M/=C"/JB+UGNVU)+T7.>&JO6V/RQ7#1\O\[?\-2]#@CI-FV&^UCR#""?
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M*\_25OUBVI8X?C4AV%3 ?9!9V>E,/Q.AVHW#/GY(%K-IFPW-W*$GS+[.O^7
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M<GJ(\.6>8<6*PGJA'] '/%.M$)P'BX^7Q,8^6),G3%#)0,:#]%'EAUF<I=[
MU%G[&QU?O)6>7CSU0UO)JV?CM^>J[G#_ VS++@,=OI.W#W)_@?J)6:E 7)HB
MS, (C7"P*#&\1(^CU58.R![Y^9YQ&$PT%F)8,E]C _9!L2RI=B"95', D-[M
M"2.>QD[=T[$\]?ARC(5P =+DOHN$2'#V.>C.;BSV1",L'<_Y$)S<W/^P6L&Z
M+JKC>>MSD7J?4:5ONUT]>KI+QD,NA+OO6;-^]<B1?9 $YQGW?="AP-K[)I&B
M-X^@]( :6B0&4\>N#=H1]<X'W>]KIH>JE\3)^2?G7D-U\4\>9,73[[ F]T%-
M9:E-&\S"SE-$L@:1E1I*@P-FG0X0G6P!;=V@O >$'=L[%5N.L>YN''0SQ%T@
M@<I#^\!\90"E.G=;1^@/(L6HEATNF$*9:)A-2RNF82]0.?FN?@A7RH6[W6ZO
MO]O2[5F\]KX> 70P(&IQ#A/:]S>MQ?,,URAM<^Y5^'Q=1A3'SYI_-V+R?&DV
MK"^0>N6]"I5BU12#E^)GECXK?R^Z)?1- @_9A3P"_9V@E3!+.W7HBHRS'=2R
M)W>R_W3.-$[_[ CG5?XU>L!.2R$!!-70/BQBQ46 O/BYFX)J24IM/,0(*&48
M441S2H=Y6YLHU70S5>\GC.$.#0&CI?MN&A.*>H<A++ZM]I4W5']:T-3/F3II
MY/L0FO8,?W36]S3:U;?1Q48.(]['R7=K7/=!:;_V016P?="SAQR;\'H8.22(
M?@O0Z3O"1GN=>(P,\,"J=EM/]'7ZR:;6;OXS+I6:7C/=-VQC36X\4ONQNU!
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M"%F@M-0'XD<Y'?]&N:BXDFU2#9+C_7B"GD_Q.C,1+A5'?X025G&P>S5)F)-
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MH(OHMQ=J95OR.5"J=7CY9=47JBS2H\>0SN[V=V+:%PA@JL!UO'D_4@!+\;U
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M^>C"XJ:4U2#1L<'XW9>/,GB1"(_SA5VIW HBBS%G?VAKF9)YU'="RCW"+&3
M[QI%>. IJ'>4;2XDMQM;A6XNQ"&\O YL+_O'!9GUFS^P!\?!_%9]L?R$(V#
MFB);TSOHR[A]!"P$A 1W$>>WDLEZR?#ZH=N \OU4[0#QO0\GGJPYZ!Z<BIC#
M'8<\&)U#$JZ@TMH=!1$U!F4_QS:UTBV?!&T?%@4@SHKE1_Z(7C?NZM(IY!Y+
M4AB( &BS8':(9\*WR4[7,\AK4XJK?(N;P><Z&A?E+,3;F_]'@?,W#?M[K(,K
M+]VPXRGJ!WI;PR64P7Y>DQK%NR:EGN0]E\4W^I$KFJ?4S%CY!#]*I<DQ+FW4
MG*3K0"?8V<-2PVEP),S9]QW4J3 L];Q':5-KJC4IU+:B7F[#T;\P77W8.^2
M'$.!$S$#DB+$^"3]"R_-$V"7;GH&U3F-;!M.,/++%Z6=4],-NF8DF6@*0U7!
MNVPA[A+<?7P;=905JPQV@2S;NDEE'\4>QFBFA-@6NAYB/+OCM0EEIDQ>H"02
MPB&]$:+3WD\ZN&V0PXWH^G1]_VH+'</":%;]:%:=4Y%:VZF4$E)R%YPY4,_;
M;<#P5#UQYD7 8Z63K>B[O%_D1WAN2P:5@#MG&>C.;(IB<J"UQ>M9H$6R=?;R
M-SOM<J;_N')U-&^/6N&I<V&^"@73Q &JP $YA^)]8$[[3!.>,@2'%.!<G"'"
M1LWVR\Y= 3Y7LI>U^TZ]BPQEJ&U(?WR5$XAX9WYJ6*Q5XF/G.>D6S7[J5<HP
M'A6]'Q[W.Y5J>9_09O6'-NRMM,US.E=T[ARW#M/L]=(CX*/\(*VEG!:M\&/V
MOW;' !%)XU!5R@&-S>K $*9-RA] :$)/_-E/K>QG_Z2QP)[<HI3WA%/&PZYV
M+.$WCS&(B=?U-QZ<X"I.*2-8<?.'6#LVS#8HK.&8=U]],_L%:GVO+WB;52J:
MH9 +D;3GFP9M=.C&S:,5H)2;DDJ-XS[5L^$=T>:G^Z;>96JS%MO?_L#D(Z5L
M+%HC1Q2F"K*30TF_$PK'BTFP?8GAG@3\*^?:3.S27 '"EDUV^C/R*;#?G?29
MI)+4 &>A!!U 9S7U7&1-:V,7;^&6/DLCY 9(ZI*JU#V%]:R_#5Z'KQR<PEA(
M^2O=I<CF(^#N4@-3M+E(RH?-O-U^3B#<*S24"^5N,#V4S-G.VU!GL21XXU[6
MSV,?X B(4#N8]*IG8AO-2F)&)6HD5(N-?]MY_LPQV^Z%+F.ZA/6*W 35C\"=
M".?\0N+*KL1N%_"BZ[)?TOI-9+RY9OC\VZ-9\.;+3+PILUD1?<-$%5.*2H4U
M4>^:.U'@?%7O;*X#8DM58@S!?_;,KEUW0J\Y)+C&P(-QXZG"6@==;;\ZT-DP
ME H_2_4RV$@=\H?>W Q6=SXKLJ9CG1=6>-OOY^@8E"WBKX&+CW,CR4;!3.A2
M4&)A4!V;PRD>>=Q2^K:D5A?(*_*QN0##_'\>_?,/_S\&PRCUPA&0 >K%D3D^
M' 'C5Z %&**ERA^U(R#I"""+8HZ R2<=$7&P_P=7 7?^H[?3_0@X'I)+^)X4
M(4V)-ZF?U4SX%33>\&6JR')F1(Z0YN"1'<4V,BNB-'L\*J7)EX9#<>L;$(/)
MG8<O]-WQ2_*S/2_[&VL."ZB;[RN/ZR"VAECNVPC4*TU5#*=D1 9$N<8? 4QW
MCH LFYDC8,>[_0B8<+[TE2ZPWT+WH/![R /1:LC/=U:%3'][/[W.(Y'ZH41I
M?%S5#MD)FJ+Y<<'V0%?T\60/D\Q^W(\'CR35!%"MJF2]B"$4&XZ HBJ0B6<2
M8&?)\/KP^)W$/#?QWZOP%[BA$>J/O!]0ND_LLD.+47*&8"J45<(5@U]6F/CS
MQ4LXI^(<!=:<LR7/HT9Z,T^H2C!%_F1"NC;2(WA&&_T-YICLYUY]=1.UL^SE
MP6PYS=3RA0%DNX!VP06@=P*,P#KPKM,P#D,1NJ5\K2]9U]'M(596G9-E 7@*
MB2=O].0]C0.1:D[5'Q89\H;DDO<I1:LHY&R)S82^]A/E5(*+FLMYJP6;]U=)
ME0A->["<619G5^B@FY3;+ :?92@S1;U/ZB&_(+$TE@^6/L0VE7O!@\M'RERQ
MCCXJI1X)4CPWFA9YSMO+QL.LRFA=\.9X.L<GMGK$$#"][^*G-89#*X=FQBPF
M]2NX0;'J@_Q1GVF["5CC0H[1!6?R\\-,B(=U=.MP3K*:Z6J;B/XNRSZNYP?V
M<[TR:^RG=8;U%N9+M5@U;J9CAM6'+\1&R1.'4>VZY=2+H)NT^<D'$XVB"X=^
M.<O!"+W( 4B'Y W_;[3?.KNWX+M*] )[C*))'"4LUL.T6XF87K D3B#><N*1
M=]R4WGRDBBY2_,:QQU$Q]3Q O\4W],F(*2QR9_8 O(F&4)!%FTZRR)I=52^"
MBZ:87.K/MI<Z6CF*QY3%KA=HH77E64%?&W \:"T8WR35Y(#_YC#S2&W%MI]G
MJQEZUM4AN]R%<Y3/_9M,T7CK.E.6\G&%YEUH<@'WWWW.GM+G7[_]6CF%#V]<
M8^(MV+:MIS7\)/R)XF.K@%G$C0=R:D$)8P%I$?Y$%)6_IA\LBGF XZ&ZD"3+
M(@P-*6F[L&NE>I_'VBT^!$9%2DD/<:UOKF< XA=:#-\24$G:&.*UFCGM@8AC
MN9^;*5TESJ:"M/QSO.V_M?9*:R]5^#6/[#FICTGG@!A%@1^0N9*_HX]QQT3O
M:Q9\>)Q%(>_S&[:]N46)\'J1,F)YKA)][1![3(!91T<VT[+ZZC8YBF)22,/A
MV*B^Q&/?#R"724IK3G2FVPC\\ZCJYJVK&>H)+V[ NJ8_NFIW5Z5DH2(.X^&/
M1F/M,<P_K8_!K%LGJ.RK-:R=&F&#<#YG=KCNR<]F74N/1>0KZE0Y1*U%I&9-
M"VGS@R04N7$L0@+&12R/AUW#O])PI)JOM%5I&2EE0Y5GOHD" ) T5 Y+4]VK
MOLGXD6YJO>]ND^_31S9R@%2^PAU9K1]&G+29**J;K.83R [\9"\WW@3ZPU2Q
M+<WL_T&8X\::WR*EOA]5)TL54(-P>L3W<>)1PL[+ TIY&=B!LH?E)^/G<SRE
M/5 !/!?>J2Z^2VO_#>'!^%CA8L"-RR7$GE6AC%(/.+NF'L.9Q!5C3_70'0+K
M@8EZG4C7C[N/9#]_+B582G_QI<AE#^P4K5@CT,$](E0].,F5ML_Z<QS_1"1+
M3>75UU+I0;UGZ6KZW>M^&:V1$,>=7>S,"*MDJ'*!SK18:-/W]*C4X0:&K"D\
MPZCQ=0=&(LB:Q)5%U";\0B9;H?@7/(3.;;D^"$Z.BV**.KQY3M?P0_5^)$05
M_@!S?!/5.$L54%F%IE*#/<$)&M^/W<I7-YM42;?R%5I(O!/5I V6[U+8E19?
M5YIZ@'Y[6 FY,\H2,;G,.UEY2JB G23TZHD V?749,.:YTJJ]2B78);_^\V<
M/S<5&/JY/Q=PDK)S=T#TA050BL"]O&>R_K;TW4.^W41+\>@YFRN,3,K7VCQ^
M,WE%/!BZ5,O@K+F%^1L.Y,*$OG YQ0NOG?2(7DJLH>CFILGK)HF:S%&7*VZ]
ME__HV+G7[8]K7XI*&0.51,R"ZZ]FD7+QOG$_P0D0@77B0#Q5;<QE:[^ONX_#
MZ5E&O[3:99=.I&YZ5 NA%)1?W+[="VYJWKF#AX*0H/E\8==Q;_R!VL93:T3I
MA[@Q6)L_B76Q(%39<LM:UU"/'OS%K+Z9 O[#5[N&9V[=NA5B6<U#F5B]9)MA
M]909DW>L_#,K<M?5!KR[6A8N6$X;P]5^[P0?ZZL.L;I.E&CW,^)L1"%N1WO;
M!C&NVR;H[Z[A?7)/Y-6>> G\^=M3_*O:R8JD1XZ<#&3UU:!SF/B"5X?V9;3X
M_<:4X<#:=]579WEW[-?V8K*2A@X3],,AW4O<9!PIO!C1/JY<AFFV%V7Q&"D=
MC]EM48+24_HJ)>T(N'58"O'P&@ZX_,IX5O.%V_3KB>KT :4/F5NAHFSO.?=>
M///70SI!*71BB1)>B:9A([A"[1>]?D]XWG5WZ996G2KA1I*M&"DVH# ZZ153
MN G#5OBJT;Y1/L\9FC2I.5G3ZA/4?OJDXY<TC>=%;*-YZI<R]<YUW36+V*AQ
M)_GNJ!1"Z?G!31DG<-[7![W=!-'.//7)+5?)?I=":$[?XFEXM#'@Q9]MX(#*
MP^#SCX!&<!S&'<ZX#6$T5'VH"C,@N<<U.M?('KB?6QCE0+9'G?T3#'*7EF&Q
MOU#V82!\167!JA=Z NZ%!& ZAZA?SY_XLMVL;27EU LF63\D+]\5/JY0;39E
M;[-AY)YOM)0$K+?3U_K94J+L8;(:?)-S/=SKX"[\TQO8G;^'G-R@$[FCP@H*
M^[V?AS8,)5[WC4,)P:XS?<*_6I*:MPSGN$\M=FMI?H8_9IW[M>\DP'>#>+S&
M[+ .XO,];EF1PKB"8Z;JSLX.+)\CF6499#>ABA<&SR&65MW\]&N:'[(2^%29
MOC%Q1#+R,#3_W:7_"'CF0_?MO]:KX9MVTZ'Q5'[&SCK8U</(""F*I68;DC/5
M'8JIR[K18.=Y.W'7FRDNH/^2SRWR4L'TYA% O/K]C]DWY!'@ZO25ENWB\ D,
M*+=?I^L>IC@*1C86/::"(<@\=^DHNB/O*/#^P/)6T%XS_1MO=P#ATL22E>:=
MF ,^"K,^!TUW#&9>M5!/MXE;.4^=<8O0(<?$96)ITC'DLS-4.:AMP(_R[N])
M&.YV[[_'R%#"5JQCL)JS")AZI=,@\P[WW295UTO>U;%UI9?\:IMZ Z)RS63<
MLW8Q[W$IF'O6C+112>%IE5_@8YMH]>9Z1\T/5#,IVO0!E-IX_ M2-4L7>^KC
M0MJ?FE-9J_VYI $:6SXQM_^I,BKX/KX0,_=2LB3XT<SF6_,3P7(/$LZ!5?+5
MI;['B0+K1J#7M)EE@7'A_WB+C*U&EB<[']S/V6-X^$K9I5HY6",Y1=?@T[ 5
M/>(0TF%S+$R66$]P:<2&>'713DW=:YUE0;'@Y">.G\0>DUH/OKSGS>8_KK(*
MVJ67HRH]@OGNP8$^Y7=OW:<[!"\]FV;A%=DG*:=["^YT1U\=5^,#9$%E'G0:
M-J5+!((_59EB=6 &D\N$B&Q*LD[?1V?LWDG_T[02\OO2C3?>&5<\[/;:00\.
M"E\"XT3<;OX!=XA#)R]%OG]D@,;;&.G\R5T[[DSZ5=7HB9S8W(!,*RU+F;S9
M%_2[:],T0MRZX WN_3B6$'[;%C3%]$R^WTJJF'A9AMB9N&*."AF&J+UU.2N.
MC&-\5]4B7A-]=U</U$)J.A^'Y'SMDY08@^[0O$>RWCK+0YU;P!H1-A<F>/P9
M4L[YS%="YKZ2HTG"N[XKT$3AGLZ7D'@T=^>#R4!O)P79&!OT\H7=!\LV&9*.
MY&J!C\E9T1:@-'B7?(38)DK\#"6#M#V0PQ.2U2]6GG"_OKEEJM@Q9Y9W0 /)
M][Y3=O0B$W?V7;86IJ2_:K@.58^)I1K@<>RP:V.!82Y@QU?V8H:EC^[<S"'=
M0UA*9QJU,(]U#K:)GKK,%U1]YC NXIPG_#T*B3[U]T5("%H@L=&M8F-_?4O-
MR05AFO A2^1&ILZ=^V[])N]X.MG6X?AWN,::V BM$/ %HGG/PG?*I<!\!7ND
M[8SF-M.#NF@WCO&%A<H6[,[G'[4#X#81&02687_T?_JMX*QFJBTGMV7'E,^K
M^U5YW'X*3T^=?0!)UVBUID978K:3X!NG2M'U\;9U+0TMUFKL"=BS/$< WWLI
MY,<QT!<4E6^4<#6;M'RPHCWP/4%+B"9+<BVK&73WP#Z[<*_AE$:.0ZJS%)^L
MQ2PR^VXWGD^AA5Z0W]!&T>)-%,DC0!BF6;9 "1XPY,;4MR+M)^[>/),IVV)!
M7%?-S+3(5#B1+??8Z$S[*%F<TO6:UH76I\01A5=/?Z5*"^U6Y%\WG:TY%5C?
MSA&M%4XY:7LQZ8S]!NN3NR(,SG]W/L(.=N/ ^HQWB"KX]2WJ19)#LB:['>I
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M!BX-WKJ-<K9/ZI-TW+*QIV]?J&_L9W_2?=M-"?57%(7 0#,T5EJ?ZVE4;U.
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MJ$'S\&Y6_? &[4C#\_ N_0AIYQ 5*-*A8PPFR'2^JCQ+QM;QXY@W*V'J6(!
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M=9MG^>%CET57XR=L>D;7<H02A1EYW\CWIG]^RF<*"ST0HT)(D#X5RFEHWQ'
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M/YK?TL=;#JAF7W'HA,2#1;"R)$RTA@K_XH6"6PY.J2G^UGSW\M\J:[_Y-,+
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M #VUJ$$4^0*21/W+EX)2+-((4ZL01=.!Y[;[?2UR(;,UJ$6T6VR,L39;*\9
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M9+4-6+<P"$"ZNRWBDAU.>3]ION!$CKUY.SN'>XHMVKQ:4&UUTY.WKQW0ZBU
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M5;..L;IN!LUH=(H)>:%8[3UE0*<->-7J\T,]-2<.;1?@0T_[BRLCNP?C.TH
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M?VHE_@Q(+1LHQ8-N:)C77V^F1%?_,[04KYL:,RX='?"16;21?_&<(1<[BER
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M)H=HW)>6APH7H#4C-'> C<Q<?8S52NN.G<Q0<41#%P:;E&_,%'].+(9W#7?
M?VV=>;^0==N^^K-X: GKH_Q49CG+'G1E$<U:7]6\B&7D<>E%-(+4QQBBB'B0
M4"EA&(6^C .:L-2J'=DP,>;&..KEB^S]] /@-_?CCPOJQ'[^5@G%2;7-5(OK
MUMT_'"Z'QP$#A)C\N& X4*>.$ZYXVL#2E'NA)._;L.WVF',9IPQ[24I@F.B.
M>S@*81IY/F0LQB$*D2"^551'SUAS([!.O,YFLJPPV0.J&6,Y@FID6CJ(#5N
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MP3QE0H0IC*E GN])'K-@C%C!.9]IQ^-$"%H?9X\)Y=@GV9:1@:.<;P_%;^*
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MM0DL449$IR+JUY&U,,(#XC7X503;@KVH,[##SDBK#</ X#E5F@\&XF@5Y?N
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M@*PM76\'/HH'5,WEE3]6<%"[HI9_!E[)AW)9]4)O6PJ88%NQ6BSH>F.B,.K
M6]>XVPE /\\CRM(8QS#*: X1BB2DJ=#_$U&IGS.,DT@V3]7;I?A7?J9:]49Y
MHO1D_Y*/D\Q3%*49@5FNN$FGS"#+"P33K"!1E$=$HGR4F\(7>I1&ZT?S;"2K
MGI6O=U_^=9Z?@>\:7^BI&/$N\F+ $?L%SMY9&E@T'U7 =!(W-Z"^D-AJ;$ #
MS@QT&*P%"#0(@0HB8# "^R8\$[CB'&#-7_H*-*1*?XXKT@$6,=@5ZA"R!4W<
MJX8^K]Z<2LQ$P3*8TE1!Q$PZG\09C"G&,I))G.4X0%;7%1&FMKUVD_GJ?#JP
M;B*=MJLZKP^RBD-/HJH=Z\1X+)?E_CCH(HRQFVV:)+%9V\OMIK^-*OUP@'>K
MM9+E]FD=<N?Q1G/81+)K DPAJ<P"(,L$,YN1/'N4&*JNXS?:;EZ"RHCE0D$B
M33O,(LJ-"PI#GB1)6A0%(C)QZDUR,L74&._S6C[2\EPM+,>.)*=@VO%5/X@&
MYJ/:#FZCQ8)W-[NL>ZB6(Z<3C-MJY**")RU&+G_2(U>MSI;?Y<K?+463*=_X
M0:,H8XDQ=7(F$$2)N?1*HQ0621:IU)" (-:I9S<FF]H;?[62@$,:T2V,K[_^
MH9$;F BNEU^XZ6AV1\\AIRH@BB.E2/D]@FY)3I:H7,U9NC7&>"E(EMH<9!39
M?L>#7]O^+9^6LOWQ_L?*S-#^2^.Z"^[).(L3Q2!)$PQ1QK1YE1,%(\1QDLA<
MHL+JF.D\\]28MQ(-M()NJLJ7#P]K^6#=NL$=? L6'@K2@2EYU^-)RSW;H0JT
MZ#6;['Y1H>Y!T4XX._#U4'B/1-Y.N <B<Q_(KC*[TX#CT;R/G@><[S5 G[*!
M)O.AW/#%:O.TEEXE[LZ.,"&>Z?2 V<LY8*V[JW@$K7=W?J87J'EW5>7S=>^N
M?\7#I#DM35P=2?>-L$TJ3WU*/2Q9_%%NYQ&G<4XS#F,J"U/*1)LX22&@BADI
M",OC2$;S9;71BWM+2Z>/0%:O#ZE?GQ.QAGN5WCS)JIK=OPO]PW8%0AU%>ZV=
MA84T^%*\7/7U]\O&V=M1!FAMFM\>5V8W)=I<ZD;W6AD'FVJL%1K)QAI\I=S,
MKQ#H7C7'>DTPGGD6 H<#<RW(@)[Y_[O=T\3*[ITJ3:$!D_2SJ=PNK./SWNPL
M/)3S0J6<0,7-CD>*Q.3N('VHER98M4@9=NN]V$N<J9WT:X\EN^2Q]"XIW7/1
M[,SR\99B#&_R9;_Q(#9\&/!"9>_W$V;<G/T@P)UDZH<9U;V:Z=OEMMS^TJ>4
M]T*/N$NQ_/A4W18Q1#*<\Q22N(@A8G$,B40%5 QK\HS3B'%N6]KTZDQ3(\9:
MV.HP?2@NJ.6U+WAZ'>#K3!<4MH%)S!LQIYJH5FAX%4B]/O)HU5*M%.R63K7[
M@F_M);;]L%H^Z#?NNS;POGY;K;?F9\U0K%Q*<??=V'KS+,OR(J("1BIE$&4%
M@0QE$J)448HB$:/4*3[/;MJI44;556;UM-UL:94XX5HXR0IJ2\LH.( #DX<1
M> :,R+#*7#37*Y74U3]GH!4<U)*'+&?D@E2P8D56DXY<BL@%B--"0T[?]KW(
M?]8,MUK_,G<N><QE2E$"BR*C$"$90Z82 J44N919GO,HGV]-/1L[SND.[L0L
MNRD&],=697E:"3U:/79PL_5X^*$Q^,5@(U:@2Z-KZ@;S8'2&'MEE<:K4J8_B
MS&<\2QQHSFY\S&DA**$XAXI@ 9%".61Y3B F*6=%EL0BMXI:.QUZ:GN^D<RQ
M1L$>)KM7T4_Y@5]$(]0 94M.=0U51& _\+C5 DX4.BD+</H)M_=OL][.OYBK
MHJH)>)RI)$FIB027ILAI6D"2B1QR$B<%R:-<JLCFU3L8=6IOG>DE5FZV^J2S
M +]+:FY-FGLR^S;JA[!=?Q6]P1CZWM /!^O7\JS>U]Y(_87.VZC_M7\3#\<:
MY24\*W[[_IW_HX<_OJ[K417T:"MF_KI?O9*?:2G>/,D[D_+S7Y*NWY7/<AZK
M6#%<*$@+XXV(]1Y),48PYP779V561!S96*W.,T_.I/TFU[)*AW)PTCI!??V5
M'A3 H3??IN1/4^IG)_JL*=1IQ)\!$\-0YYL9%8#182BH'?S?0T$^DK\[//1N
M#FX?^*XZM)T&',^![:/G@</::P"_@T]3'^7K-RFW'U;U[6O30$%2@F54,!B3
M@D+$]1(P:OJXQU3I,Q!+$LY<#D*7IYJ:B=86C:E$!:VLGJTIKB!L=X8*@]O
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M+*&Y%AF'MM"M;6UMNY?EMK4UBM),\8PKY[3@_8&G1DNOJMMAHQRPVKGG A^
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MJ41.[>QFGIDL8)1&#:O#UBHX6 .3@$=<1J5Z<$P#AKYX8SN]V)=NC,,&OQS
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M.90($8@2+""E/(%9PF-,\IQDR(G5NX1,C<-;/<%.45!KZA[H=A'0;HH.!=/
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MUK,:Z3<+^6_V[+06C?3DO*G^^V_QV#B<9/X>#\(47'@O6Q<>[^'".WC"6E1
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M-0F.S=DG3:!*4IHHG"J=./5N"*S7U-: ^B[WP*[#M)2[*NEHJ<&:_>A1JC?
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M*2TD2D7F<R%X5LK4K@'KQ/[# I][%]]^&_#SN&JE%8MC#4DD<[,+B%+(\E1
M@M),*8ESA)W2R,+A.DJ;<%5:[MI62YA7T,[#0NMV@KD9L(%7YX.G[V[[^%UN
M;.Q])NE$(-#)X[R,4<\7G68>GR*Z/]SS:D1\57)C"\V\>7R:+W\JU01]7P@T
MF%=39W[ZJ'?D7J?%5Q4\[VT\X8P)FBG,*=0J,<2<4@PICB+(4D)Y:IZN3#H=
M(P;5<FH$=+:5UOY&JEE49=U*?+]:9MTB!/Q9V>5[!S/($^!X4_/<\_K<IYB;
MI]3_LF=(R$-="0VBX[@71T/"?'*]-*BP?@O+UK'W:3DOQ,][]6/]THC]:Q;E
M!DZA,JAH;+;J."&0$,I@:C:<..6)4'YAV9<$38W>=YYHWYWD12C=2#8$0 /S
MY X;F^!BM01_-O^UZH)*WX D> V20#QV4<RH5'3-V&,VN?IY/T*0JIB];JZB
MS [VR_IQ_6:U6JY>+5<KFS^^7+R=LX>9C,R1'6?$[!$Q@DBF%/(XMPW%(FD8
M@64\=0J?<A,W-7)H-6[.]84YX>]\097^8&< L!:X48@C^-U$$A[2@>G$#\T_
MK?8!R,4/IC,44RKQCX?EM_\P ]7L8G[8D8KC\*-0BY^I+<%X?JN'\^NHF\A'
MOF;%P@89O?DAOMI=]]OEZO#XO//Y1SI1/$DA%5$&D>("4J1RJ**$XA@G<>:6
M2'RC'E,CIM-(\Q(L&W-LT3'5&%1UZ^AY8W;KU#FXQ<:9D(%IK6[C]'&OC1-H
M#0'O%J UQ>9!'=T+__2.T+AU3CP<8N/,S4C>L!OF*) +['8X._U?-PP_GO/K
M=@P./%\!ANOM]BK69M1O5MC:2"K,P;S2H=SO0]+<(OTOQ5;W9O+4+!6("18C
MF.5"020HAIQ3:O[*XUB@G%.W,(X;]9C:8O:F7!>/K"Y@W%I1+VJ [9EADY<K
M][1=T\P;D'D[?GI-FK-K:.BI&-YY9"R E0E@9T/;F-!J+HX;/MT!:PFH3 GJ
M9+H%RW!NJ%Y:C.VHN@6J,ZZLFX:[H3 %OYX\R[V39U\\/*RJ]$]CS:I8E(6H
M\F0_;M:EL4X6BX>9Y#&+F$H@2U$"$>(:,L4-.Z=Q0LWA@AFN]BY'\4S&3(W8
M]U2[ UOUP5;_*\G^TWM8'-UG?Y-'8$0OV[ 5)BX^6G=@#YK 126>>8)#EI)X
M+E/&+R#QS)-VMFS$<^O4UY%H,X&6JY__6J[^>K?XM%H*598S*;1*(I7!'*44
M(L9BR!*D(8X13EC&$BQC/S?B.3%36^BL<O;:[:E6S]>/>!9)5R_BK?@,[D-L
M%+P#+4J-DG?@M]6R ZP>[L,N+((Y#\\*&=EUV&7HJ>.P\],3+2:WZ^LRHPEF
M":$I5%&:0D0C"FWM!J@0P41+F2C1I]K,B"8XO8_CUZMQ*!)7%88KIU89;N_A
M\-B23VBN_]UVX%L4=CW(_D8UW$XG[^]2J&U/\W^O:FRG4S)ZR;4S*O3P?;]6
M?+V3];HHA0T@;?HLL <U4WF<Y(PG$&74_!%)"2G*"4R5[2V<$,&(4_$+)VE3
MVSBW&MHBI(V*'H[0J]@ZN*!#(C9T_(Q1=8^)[T"K[;9G2V#X/+S%(6$<R2=\
M&YQ^WE]7>#I]O%<'&<^3ZVK/@;_6^4M]NLZ8(XTZRL&Y7[Y4MA'<#&O,DQ1C
M&,>(0!1S!JD6$90LC2G)*4$)=DE(O"K)BUY'2TJLXW^>ZB70)_BG$U0';@T%
MU<"\6JMY=Y(V=V<+^'-5=7(,A9I/LYA Z(W5(^86%#V[PS@@T]T4IFN $7O!
M.-AQV +&Y0O]+G1>+1=5:(QM9_]J4ZZ7CVKU6>G-0NZR9'F<Q3GF$41):H,Q
M*85,91&,L>#F?RE-I5<!)@>94]NPMFH">RF_WD557@X3ZXVVV\U&8 P'IMI6
M6_#=J M:?>] K?$0&<L>^ 0Z]+M('/6P[@'!\2';YZNW9CJ?1)PLY&_+I?Q>
MS.=5YMLNP8ID"3([N@RFFI@CLY((DIAGD&,<$QF1+.59OSQF9QVFQDNM"38F
MO-6XREZM;^N.X[D\751])LGQ8G98Z(>^8-U#_03B"O[M7-09P\/DS=T 8O#4
M8'<-GBGQUQNBRVF]_D/UX\CWR\6#;>YG#]"_L_5F565Q?%;MD>ZC_K0J%J)X
M8O-WBP]&Z/UW-?^F?C?D_;6<D1Q))G *!2'21KA%D!*AH(Z(R!C+,8J5#UO>
MI,W4>-,^R7Y<>-MDN+'B:! /?;(V=D!K"+"6V$ZAE2T_F[CACXN 4<-!, M$
MA[?I,BHQ!H'MF"+##-J/+#^KN?6??V(K<S9>L47)JAS&\N7/_7^IRF/G418+
ME.102!E#%*48$JUS&*6Q3*0V?(F9#S.ZBYX:#3;Z@4K!7B7(/6!WX\!AP!R8
M\ YPO!NF3+D_,(%8S4/PJ!3F#\@Q7_48X=;3[A?U8*G0<*+-JU@\O%OHY>JQ
MNJ-]^;/YQ[IF4X1BC!6+8<YB8?9O$8&$V?RQA(D\X0+'?F7_>N@P-;K:/W<U
M>H*M%6#/C+LJO*7YQ(UUN-QGS/?H.\@\C'CT#3<%-QQ]O4$,?O1UU^"9CK[>
M$%T^^OH/U<.I>_^U6#74NY"7.-JGWH#7@!-ZV2J]F\V9O54ZW*[M*]^OHH ?
MT!X^S,$ '\FIZ0Y\(-=F+\ Z?9U^(X[G_.QEZ8$WM-\(?7O5+,5?[\IRH^1K
M<YQ=/-21@56$87D^%''&"=,Y%0F,E6V,%]FV5GD<09D)@K66*$7:KU^-MPY3
MV[A9[:L2Q6;74(>6@U7S2JV7]6^:4JMB/U[YR0Q2WA"/WF/R'/=PPT[)T'NX
M>@9J_>_J,/#R[GPX^'YY5*;-L[+7USMDSYO>> ;K>^.OP<B];WI#=-K_IO]0
M-_7 \8S8_K!L0K-/0K??_% K492J;$.UM[VP9[ED,=5$0XU2<UA6B$.:8W.*
MUII*)I"DU"D3<7S5IT;:=12A-NKMJO!_>?&Y!*HQH5]#ES$> H<SP62G=@SR
MOY8<]+(S.<@@ &L(SN0)V9(Q#0RVQ%8-Q!VP4/C4?7B&AZ97UZ")/3S/T&5H
M6@]1WP9%(\ZC8T.C,31ZC@9((R)]H6'2F!KX5V=^LU@;*9_50V%/L(OU!_,>
MSN*<Y2)1MG]]8LZ4:1Y!CIB N:281"2+-'<*YK@D8&I[CUI'L%,26"W=JRR?
M!;%[5Q "FH'7;D]4O&HE=YG>JSKRV0%'JX?<9<Y^!>3.S_7NM=#VIC1,\[A<
MU >K%^OUJN";=14AMNQJWU;.D$Q32J6-LT>VG$HJ(%6*0Q5%DN:IUBSQBG2]
M7:6I$41UA@7,\G,=<:GJ3<1F4:Q+\$MU7U3]SAQ=C/Z_]K]%"C"=;I=*XT[2
MP%2UWZ"UMJ:Y9P+[]MC;O]?%?+.V/97?:*U$5=WZRDU4T-HQH3 /UZ3B5H7&
M;F<1", SC2]"C=R/Q^OG<=L.^I[]^,S651/-A2CF1;5]?+M<J>)A<?")UX7Y
MXLHH4+#Y+%,9C66.H?F==0:P#!*:Y=! G2(:LYC$7K5_0R@U-2YO] 5%W7=F
MS7X M@8KHW4)EKNJ(TG\__@Q=Y )=./NL:=EZ(UF:P[8]0("5E]P:%)5 :::
MN^//[1NV3:P/Q]LA\0[$W$%4&I6[0X)XS-Y!QQZM7/OWY2S!FB1<9) 3G4"$
M";<E@A&,M2(1IG$:<Z_"P+VTF!I#]RS5C@<OU6XFS(V@!Y^&@1GYEC+MWY?/
M6J1]A^/SE6@W.DR]0/L.I@#EV?<&ZUL7H%Q_U%_,X;G\73URM9HI%K$(Q3G,
M2&YVLG%B=K)((XAXIIA*49XI+V(\D3 UTK,*VM/HTVHI-V)=@G(Y=W1Y7D;1
MC:UNPF9@)FIAJ;0#?];Z!0SMO6A[L#S]X_%'SLJ_8-YI#OZE#_;O^%C:O=;J
M:6G/5M)F.51[+;&7OIT*+*(,IY EF89(: Y);C9"N> 2BYS3.'*J]>$E=6IO
M_E9QL*^Y#6C?ZN[?\/$Z]M?]$X,@.C!?.( )_@R:']\+J9LZ0%Z7,GHC2&?#
MS_6#=/]RS\QV6\JH+3*R87.;-%KE"'(<(:6U81ZJ,$2$*4A8)&T[:JY(HABG
M?DGK%P1-C7'JYG-[BH(J?;I/1N9%;-VV'B$0&YA1^H'EGUE^!8E02>.7Q(R;
M#W[%V)-4[VN?[WOL>'Q:+NI<\=>6=59*WK,?;=6A0NW246B*19(A#6.!#%6(
M3$+"20))'"4*15D<IUYA]NZBIT8>K;;5S?E>O]?_]#VL.&/O>HH9 M'!CS>M
MTO:0LX767FSO*>Z2;]7CY..+5[ CD;/@D<]*OH"<'J*\1QC.66A^^<K(+];E
M3*441PG/S5P@"5&N$*3,_D%%@A 15"+2]K8(YQC<*>#TPAUVIAB8Q.P+)FKE
MPGOY]I /Y\_S1'-JGCO[#[7^S^2?.\5O1$_<GO#)^=Q.@>GC73LSBO_%T8N-
M&6"YJL(GT\R6>Y41I$)PPUD,0R)I I,\IPQC1I/4*93A:-RI[:8:U3P#3O>!
MNGZ/T]/\@;G#R7*O6Y@S=O:Z9]D?9[2;E#/*[]^5G/OG/L4.;-)R85_8+VKU
MK1!F1_*P4E4 4QU3_E';8U:QV%3E%KXMY]^J?WQADS&_J">VJM[VW]F/XG'S
M.%,D$2E/S$XBP0(BB3)(TYA#173,1<9BQ_O; 72;VHN^ERX.6OO UL [\%BK
M;7N4=/4U&GQ*N^GDF2=J8$K:&79VBFKCP$<-=N:!/?M 92#866AK$58V/M]T
M^I31>+9I':O.QNC3ZUF68Y )Z*[;$5;DB(4]!L'JL/+',"+Z^U-KJ6\6\K79
M?L\23)(4F6VQMJE92*4,$IV877**4Z;S"%/I="-Y4<+45M!6R?9%-6H"JZ>_
M<_002'=':&]X1G)Z.B/3R[EYUOJ;')F'(X[NM#QKT#D'Y?D/]JT<^TTM-NJM
MT>A<WX,F< <3CF*59C!G,C4O-T>0L"2".;%E&B-%,^%5CM%)ZM1>^$9ISQLZ
M-X#=+N:"PS8P$33Z ON\;UV6AVU0P$NU$%\?V>JO :*IO/ *5C#61>;(M6(]
M8#@M$^OSY;XDM"N2O5]&>Y;F4:(S)"'%,8+(!D.8HSV&<<0DQ\KL+:*L1Q?L
M2_)Z. ;&:%G=9'>5P)P4YK:Z_-IZ_*51V)>*+L#LRCXWH#86X3QML=+@L!)_
M2%KI!B(8DUP0,S)Y=!M[RA=7/G]#7CDKU6M5__?=HFKR\\$8L5G9E)EM-Y(]
M]^8'M9XADJ T(C',$280)1&'3$L,LTBJB!M>X9'N02%]]9DHQ=0=D]BNA\]>
M),4=6"A/IND]6VY,-"CX(Z:(VTBN7UHC?K5MY.MYV!FRWU;I_?Z4?.B8DGZ)
MX#?@&3+]NX\:XR=]WP#6V53O6\;KG2!HBY)6H6S_4L7#5\,T+[ZI%7M0;9=B
MZU9MG.,S1E0F,UO(56I;AM\0JMF):4@%R9DB1@3*/3,#/<1/[2C8:@Q9K3*0
M;4_WE?,-4,^)<&/(X> =F!<;Q=N.NJWNH%%^VZ^\"NL8(':C'W#A<OM\A(^=
MU-<#F#/9?'U&N9WBMJT[=[PZB^.,1HACF&O,()*<09+G&NH\RA4FF%(M^W+:
M&7E3(S&C&7C5;#,.7KO]G49_+CN'N#]YW8CCN&RUU_][I^XPW-2!RP!D=$[:
ML[%/A^E==-/UM7[\\D)4A%5^5D(5WVQ-GA?S^?*[E?AVN:KCS]XOR_*H26S.
M99H+D4*4V]Z46"20JSR!-KN0R!1128D/[?138VILM-];9ZM_54OA]7+#UWHS
M!ZVAU6GH%2N_;G<#GC35<^+<V&OXZ1B8U+8P[RRX.YJ2V@I@S1BTR>]M6 8B
MPIY*C,J/MP%U3)LWCM:W[.LK9?T+\W<+J7[\?^KG+&4BCVG"(&9F:X:0+029
MT@A&)%4II9&(D5,U^XL2IL:!C7J@T@\8!7UKOAXC>#V6X&9<!B:C6C_@CDR/
MNJ\7K+^A\.OQB"-7?KU@T&GIUTL?[-DOZ')_M/?%0KU;J\=RQLT['3&9PY1@
M!1%GYJ7&&3,O=1*S5&9)JB.O!D$.0J?VGG?V#@1_6KU!I;AOWT:7"7#;Q82&
M=6":"("H?]\>#XA"->IQ$3EN9QX/$$Y:\?A\MQ\EO61E477>5F4;T/MB(;\4
M#XM"%X(MULU6Q_8!6LX+4:ARM]_7689C%#$HHIA#).(4LAP+&'$548FC*-9>
M44^W*#,U"JMLL6>U?6O\V.JFN7%CL;$0'YC=SH)=G8+W3 $[6T!K3.#:,B%A
M#<2(-ZDR*E.& .V808.,.8VN9O]4I?4%+&1;S?%^:7_U<;,NU^9)-Q8<^0L^
MJT=6+,SOCPIQS'2213I*-40DBB&*4@19E-OT\HQPR:(DEDZT/7E+I[8FU(;5
M#0G:DISK)?AF?GW&D[>UZJ28S?,VR0KW(':O49/7?T(+X/ MMYIGU\"V*R=[
MOZQ^?0?VL/N_\D%^WN9PS_) _]OTDAOWP7[V#G3!'Y:Q&]:%,^!OW=\N^#P.
MW0XOO,(]G=+SZJ53\KR-39WL61+'G&O,(=::U@4GN1((1K'9)1/SE&>IGAE%
M^=+9#>TDV(>#]\4/1\%UI]^JI=8Y(F[T]G0PNTV"HT,Y.+ C[M;.]E*_AJF_
MG]@+HE!^83>AX_J!O8 X\?OZ?3MX9Y+?5LNRG!'%<(8C#)6A(GN(MYT (P8C
MS+,HSTFFI&^H<:? J1VCF[8&9_J-E ""!ZMRL-8B->)N/!02QX$9J+-AB-D4
M_]8)8LB^( ?(#-\"I!8WE6X?!\9[-/8X_%[OA+&Z.%S#6B_50NEB/<-"<Z(S
M!JE6&B(N$L@8TC"-L&2YH%D>>_F?+\B9&JF\V[67>UHMOQ6EM[OF$J HBV(L
M;%D D6"(#(Z0V'CJA"HN4AJA-%&SM=UDC0?H5MK?$5 W-@X T\ DO%>#L]$1
M_-)H>;D+;9_<M2X<PJ6FG94R=N99EZEG$LLZ/]Z/5]M"POL;PVUH=9-.8$[!
M>T'_$4GR6.<)1!E7YH\H@A11 0D16M 4(11YQ3M[:S U+C8;O#J,68C5QFQ0
M-@M9M?E40+85M\7^$?3)?-N/6OPGR8UT!H5^8#K:5C,_.-[OI6RTN3#6?S5$
M^D9O\ )QF+_\4=FM-SS'O-=_H'Z,: ;ZH^UP)CC+8EL7F"#;)TX1!'E.%"1)
M)!.14$0D\N&ZO;&GQF)FTZY6BPI=-O>CIWW$W(BG)PX#4XIUO?SQ98#"16?,
M#40"^R./^GJ?,>GXQ3WWD1[!*1]7#VS1M(5\M5R4RWDAV]"8_4B9C[I.#RO8
M_(OY3=TV_?TN4#F.9)[E' HFS;8ES9 Y*.(,)MJ<$%-$<,*<"AH&U&EJ%+!O
MU1TXL*M:10_"U98:;&T#.^-ZA#N'G&6'&(WQYVY@VOHWF#:/B(3QIV^DV('Q
MIM'/JQ\6\$[_>R!1XWG*PV)SX-,./'3/%*"^CO43?WI5!.?^*VO\[:6_([V<
M9>85RFVQTHQ+5$>"<L(BF"*I*5$<"XW]G-R3LF]ZOO1M"%%;%V>U#2&J:A8:
M%F(6#4\'UJ10G_$\2;!.(^LR(!#%E$&NX@PRFD=$,YID?F>\25DWN2WFH*&7
MDYP"UPR]*>D\H=VM4T@E[PRI/(VC; KSK0U(H$&I?_1D0,_S)!^"4,F.D[)M
MW*S*29E^X;IFFDK>7BKLLY7X4?]1UM$(,\9S&0O"88IS"A'1%/*$*J@8CT2L
M9*2)4U<I!UE36WWKV,C#XF!UB$;_NF#'\#H''X4 ;?BXH_UZ8)6B<*GA'RUN
M=X!577M>"+%YW,Q9M6#4\5[=&;0W%0N[ -@ A<*.)3U;D; +)G<5"+OTE6GD
M1[[YH5:B*&W%G0^;VM<DLY@IGD'-\LAVNR.0L8A"RG02IY@*DCF5+QQ-XZFQ
MVYZ"X)=B 4IK8'DY-N69YMGABGIJLS>%+?Y-65-[UIO/5O9/[;%XWJ2\FQZ/
M?YOD.I_'Y-E3XRY.V=@I;J>*_*U3U2[B.G3*V67!_0Y!;QZ?YLN?RARRJHWI
M7A7@)FIF)G2J49(G,+9UNU"J<LCC*(*QUFE*",8953Y'H:L2I[9E^,+F;%4U
M8/AN3J-U)=)5K3PHK/_$[UQT'7&WTU%0' =>O%M=88O;05^+5Z&C[IRA"70:
MNBYOU#.1L_G')R/W+_;I^\U^_,[6]H7=]C!]M?RFS%EL_5D9?BNJQM3EJZ^6
M'#_J*CGSX_>%^?S7XNG>S%3Y=3F7LSS3<<(HA8*E&42,,D@QHQ!G$9),,TTR
MZM[O.XA.4R,L&WW?F+7?7%@TEAGRVIEF?ET99QO1E-8\L&SM ^O60)_>T6%F
MV>'\,_[<#4R2%Z:M-0I\/IBVVB[K7:TL UO3P/WS39M/J^_1IV^L%M^C3:-G
M:^^@@'>W] XC:L16WD&Q.6SA'7;HGJX.5JS^R>:;JN'*?%EN5OMU%5/*TP2G
M.8QDAB"B:0*IX CF,N&$1%DLL-.2ZB1M:HOE+D)NW_5K]_C6#%#9 7Y7S%I1
M_9NG%Z03>4<_2"@\A_:$[ #;TW2@>I1.H(3R=G3*&M??X6+VB<?#Z4L],V&J
M6XB/^N.36C%;=+*I\%O.)!)*Z51!A@B!2&M;RA\I2!#6@F$5";_V<1<E38U2
M:D7MFKYL505EHZMGTLQ%<-V8(PAD [/&#JVMEN#+-;3\LVNN(1$JU^:BG'$S
M;ZZ9>Y*'<_4+TW")7B^YU;A*<))B25D&4Z%MQR7,(!=1!O,49:G$D5:Y4P3'
M<QLR-7+K*/@Z'8>J\U/R/'[6(>;^;^]^=2]:.07?K/,3-O4ZJO\7>W*#/7'/
M[N;UG>;I%3C]=W *^\["\Y<G#>)"KB)YK=(K]=7H77Q3=14:VRWN@UI_U/?L
MQR<;[FC,6:]7!=^LJQYRRT^L<G<F">)8I1JF22P@$AF!-),1Q+E0N=:I3F+B
M4TSJ1GV\-EPC%)VJLQ .[ %-F:5?K$F_WH&%6MOSTYK]\#M>WCIS0J0Z(CPS
M\X42B)B0D//85I7->(ZTS 3W.N&/.7-CY#%5,R<.9FYN3-F?,-]NR[=.F=N]
MP8@3,?"^U>'M^5!/AC'I#C1&@7VK[/&FMBO<=40@@ -=6MRJS:A7&X&@.[X
M"35LCVN23VI5-4$SYE>K>^L74K+R!OVQ*-;;6D-1I*/(4*RD6021QA0RE$E(
MJ<IC3)B,$_=;#7>Y4V/6/<U!O?/?Z=XX4BOM/<Z('I,084R0D KR#&LS"8I
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M,,H3!5$>84CR7$$A%9'"<#:GD5];K>"8CQ/Q?!%U (%YX:3MNE[U\N;%POS
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M(5+S=5&QY3F.(">1@CKAF'"24X*]DB'.C#&UK6TC(JAE#$R%.(>E&Q_=B-#
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MS*TA807YHM;K>>WUM;*8Z\T?[C?KQV5=2V-&$DFD;<.625N,16()S8XM@[%
M6J:1^66,/#))!A'2::F.GW72*@.D6;OK)2AW:M2+=\U^ K93PX\6^YUF-^X<
M?];&(=A]O:I4XE:S.["=Q*UN-0U_.9[,6C]P[S"?WC0\".X]<76_LHU*Z(/
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M-?OZ9<8D)ED><Y@J22%&$8=,8 0SG21$QS0B;O;/[I%3(P3;(*CJH\76KN6
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M #%\!!PMR8$@X1/.Q[/\=IK?T E,4-91*D304EM0EH[.@&C!I" )Y#FPXIM
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M(W&,O^.;L P;MD8F)^8S&3Z94H6Z8N SMQ"M"+Y(1*O;W(7N6OTPB P^$=E
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M,G3?R_HP2/W4MS"-5- 42"_Y6+UIJ[.G/K[[9^POVO3LD7?,/JN$)2)(BAM
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MEAX,*@[*)@;>)%^]B!B+%RGPUJ]4GT5@.Z-[?RU:_IJ2>YN(1QXR;>#Z1-F
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MU0M,?SZ???^5/GJ]<>DOM_MUQX(]=H]_:47/VDB]9\"LJ7XSNPCCZ2A;D5)
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M<X"BI8G9VI3S03>$3RE^>]%^PIMFBC]:?@/(LNP]\E[]^$H?L3*$5BJ2 1=
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MG.(<M/:NOA(A04DF0 3.C5*H28J-C<\N.H;23^NECK.3=3% /-UTJ\O"E!!
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MYE4WMPCH)0G3R[%VN'8Z@-8C4KOQ<.FG[S]^9^NOKCG^P?8LW;%HBOJCBE&
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M;Q_U=^ MW0[LA5$^92T@<E^3H**&32K329F0',T0=&9_9_ :@^#)#-X^&ND
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MVQ"F(1AO(1.-S-519?9.A-=ZI.GQ3)QI8'=<0G)LH>^%G+'[2P[G?-=;F*U
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M=A2@C38\*U16MQZN\A0]1S>=(;&^NB?=5YM*8HH#U^M.N#2)Z>PA."Y V:3
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ML] Y0.@=@.?MG +5#0\Y;?=+S91WC*S)Q4+[I;7TIR YL)ALR;%$(5M7NCY
M1F^0.42_\[;"[@ O/[;?WZ:S_&:5ORPGTD:3I4Z0UJX@7S<T%0BE2*%U<@YU
M^P';]\@8]SG,,-'683+N"B:WTV@3K;,UCD3BA3(4-F0'(1L#AJM@!?<FY^&P
M<IN67GSA Y7\*&B.D/@+R'"W[AC;;.U3YZ]/WG/VR91E+ABT])9@9^G8Y(+"
M+[01BDU6V*A]:MZP<LAT]?5G__3])[RH+2 _?,YY]8_%_/)K+59>GP&6>544
MF5H0=>!9S+X^!&&07&4793"\=?W=+G1UG-C>!R7W<@"M5=+!,?KSG-BHN8RJ
MG9IZ^^E[S9BLHQ?-H^3*).#.2E#D0P)J$\%@,JBR0"=:7P ]04XGH&JF^WO#
M=MHHHD=,W<C!L2)3<&1Z)=2Q>K6.SO/D(1BF,%KR153K6J(GR!E[7DXCE3\'
MI0/EWP.4+I>K^9>\N,?25>(U!H&>0A_2NJDMVQ1MY\8"9]DF2;%S8KXUG)XF
MJ3-(':KZNY!JJ(<>8'7?\G[*L_CY"RXV=T\RAR2DXT!140$EG0;,(4,(O#AT
M5KOFB<WG:.JDN.J$Y]_A*ND28E?<;,TQ,5LX!=P0#7.TPQ<+(4;:Y@4/(?*B
MY/_?W9<].9D#>;[O_Y([NH^7C:!I>I8(NF$;>B;VR:$C!=XM;,:NHIOYZR?E
M<IW4X4.?I1H>*K"AOB^/GZ2\E*FFA]A=F@;;NXY"P+/P.D(= \#K3_R.BPO<
MM%K:YB)KKX"K?7J[+=NBBBNH 9E6U8I(X)QU4(22T6:F9/-!+#L1-AK0CL'"
M3ZT-6RNF(]K6J_/9[^'_+5=7Y*\W"S$*75PN&7+ !"J3<1J+SV!B=M[XXK7>
MR>JBQ]^"%'VZ@=/#;^X;@9_L#&P@YLX@^2-\Q??E#@]7:\DJ-,'&&F<6H+@6
MA'0G(:%-R*R7GN]TS#V#E4<)Z+/5M-#HLK5X>_<HOR+]_0*O_OKI[V6]]7'U
MB0" VQTR!1>,PT [I*?#WF4#OM@,P@:L?V)4]RHM'^E/OL];^X&ED8:7IQ#W
M0#BZS<W?RRTO+%M9.#H24:I]W!D'QTJ$PFWV(A&#RN\+G8=>U,<CFQXM1PMU
M /OXYJQ^X*2^3G+5]D";7-;K\&W3&^@F4\J]48')#"'5SBQ.,5H0DM:'DS&(
MHI)H'J@\EN:^/0HGCQ"<5*4#0/CJ/OCE9?'WYU]H%7KTVDI!GHF5D5:A2^"-
M*Q"B$CJFD'3ST4(/D#%**N84./AIH-5Q2AD 5Y_"XO.<%N-FU&#M^S-?;>3T
M):P^XWI&!XA&VM]!!%_OV)+?&X4MH(T,ECNA4;?.*3]-T2B!SPYH:ZBJ(:Y#
MOTII<]7Q3TPX_UY/A#_P?-LJ?.89*R9) <4Z7Z=)TS)"DAMQH[A'FUWS7,Y3
M](P2:^@ NV9J&@)T/X7[/N"J?A$^(Y\EZ8)/B4,(D9:0*@C1TF(BJ\25&@=4
MI7D"\0EZ1C'A.H"NF9H&+3'\L%I^P]7YCP\DVMJ\K?8(^+81X_+KM^4"-S?
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MP/EWG&GN2C%!U(F\CC9W2Z:%(4N[<):")>LZ\=85H+O2UK=;^T@ W%=1+P"
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MQ:'0Z9=0& $\>PM[=/A<UNR[PI#I!)@C@N(Y@N=& E-66$9_32PT04^_B/\
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M;6)C+3(P,C,P.3,P>#$P:V5X:&EB:70S,3(N:'1M[5IM;]LV$/Z^7\$E6)<
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M&B/)?#T,SP6"O>\'@IQDHL0F.[RL-K4%_$$<PWIM7)09V(-: 3NB3&7-8!/
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M[[F_+E/?NSGU]]OO[_N&PRH^#N]N?2TE<7=> :"[=H9KL:2" Y9-S;J\X\Y
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M_W<$GKHCT'V@(W 6?K1WYG\L^ ]02P,$%     @ \X-]5\7JWPH9!   /!
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MK0(X+0U.6./DA@H0*H^(:W\/CN\&M@I%$N]^.GD?*R0:^+:@?\ QL7B8JJ/
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M4=@@W(4+I5.1.[%X8=56WUT:D?0;;,(&H"NEB=QX0R>T7@IM ^C=V+O3,71
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MH$BT8O=]A]I-NR\BD:TW2DVS5'3"D*=:;K@ 2A:H]**V:IT9Q32P.;@0SQ$
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MCT#>\!^?_!-02P$"% ,4    " #S@WU7<:MA@R9] @ /B!D $0
M    @ $     96UB8RTR,#(S,#DS,"YH=&U02P$"% ,4    " #S@WU7GHSL
MT*07  #K'0$ $0              @ %5?0( 96UB8RTR,#(S,#DS,"YX<V10
M2P$"% ,4    " #S@WU74#Y Z&<M  ")U0$ %0              @ $HE0(
M96UB8RTR,#(S,#DS,%]C86PN>&UL4$L! A0#%     @ \X-]5R*>E-0180
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M+3(P,C,P.3,P7VQA8BYX;6Q02P$"% ,4    " #S@WU7[S4\$?6\  "6K@@
M%0              @ %0X @ 96UB8RTR,#(S,#DS,%]P<F4N>&UL4$L! A0#
M%     @ \X-]5ZY?0"#6!@  Q"D  !L              ( !>)T) &5M8F,M
M,C R,S Y,S!X,3!K97@Q,#(S+FAT;5!+ 0(4 Q0    ( /.#?5>C(SX_I0D
M (F8   ?              "  8>D"0!E;6)C+3(P,C,P.3,P>#$P:V5X:&EB
M:70R,3$N:'1M4$L! A0#%     @ \X-]5XE1P"?. @  #P@  !\
M     ( !::X) &5M8F,M,C R,S Y,S!X,3!K97AH:6)I=#(S,2YH=&U02P$"
M% ,4    " #S@WU7E=&A5IH'  #,)P  'P              @ %TL0D 96UB
M8RTR,#(S,#DS,'@Q,&ME>&AI8FET,S$Q+FAT;5!+ 0(4 Q0    ( /.#?5?)
M)!ZDA0<  #,H   ?              "  4NY"0!E;6)C+3(P,C,P.3,P>#$P
M:V5X:&EB:70S,3(N:'1M4$L! A0#%     @ \X-]5\7JWPH9!   /!   !\
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M,2YH=&U02P$"% ,4    " #S@WU72WD#'2()  "#(@  '@
M@ %BZ0D 96UB8RTY,S R,#(S>#$P:V5X:&EB:70Y-S(N:'1M4$L%!@     2
- !( " 4  ,#R"0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
